Gene,SubType,Spearman Rho,UniqueMutations,PV,Sig,RoleinCancer,BinnedRole,Pearson,PearsonPValue,EnsemblGeneId,Cellular Component,Biological Process,Molecular Function
CASP8,Nonsense,0.733497634544059,20,0.000233013176701884,Y,TSG,TSG,0.531224769889318,0.0159416542952424,ENSG00000064012,"GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005856|cytoskeleton, GO:0005741|mitochondrial outer membrane, GO:0005739|mitochondrion, GO:0031264|death-inducing signaling complex, GO:0097342|ripoptosome, GO:0031265|CD95 death-inducing signaling complex, GO:0005634|nucleus, GO:0032991|protein-containing complex, GO:0043005|neuron projection, GO:0044297|cell body, GO:0045121|membrane raft","GO:0042981|regulation of apoptotic process, GO:0006915|apoptotic process, GO:0006508|proteolysis, GO:0016032|viral process, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0071260|cellular response to mechanical stimulus, GO:0042113|B cell activation, GO:0035666|TRIF-dependent toll-like receptor signaling pathway, GO:0097190|apoptotic signaling pathway, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0007166|cell surface receptor signaling pathway, GO:0036462|TRAIL-activated apoptotic signaling pathway, GO:0097191|extrinsic apoptotic signaling pathway, GO:1902041|regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:1902042|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:0030101|natural killer cell activation, GO:0042110|T cell activation, GO:0097194|execution phase of apoptosis, GO:0034612|response to tumor necrosis factor, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0010803|regulation of tumor necrosis factor-mediated signaling pathway, GO:1900740|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, GO:0034138|toll-like receptor 3 signaling pathway, GO:0070423|nucleotide-binding oligomerization domain containing signaling pathway, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0071550|death-inducing signaling complex assembly, GO:0045651|positive regulation of macrophage differentiation, GO:0030225|macrophage differentiation, GO:0051603|proteolysis involved in cellular protein catabolic process, GO:0045862|positive regulation of proteolysis, GO:0097202|activation of cysteine-type endopeptidase activity, GO:0060544|regulation of necroptotic process, GO:0039650|suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process, GO:0060715|syncytiotrophoblast cell differentiation involved in labyrinthine layer development, GO:0097296|activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway, GO:0009409|response to cold, GO:0032025|response to cobalt ion, GO:0032355|response to estradiol, GO:0032496|response to lipopolysaccharide, GO:0045471|response to ethanol, GO:0046677|response to antibiotic, GO:0071407|cellular response to organic cyclic compound, GO:1901216|positive regulation of neuron death","GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0004197|cysteine-type endopeptidase activity, GO:0042802|identical protein binding, GO:0031625|ubiquitin protein ligase binding, GO:0097153|cysteine-type endopeptidase activity involved in apoptotic process, GO:0097199|cysteine-type endopeptidase activity involved in apoptotic signaling pathway, GO:0035877|death effector domain binding, GO:0097110|scaffold protein binding, GO:0005123|death receptor binding, GO:0005164|tumor necrosis factor receptor binding, GO:0044877|protein-containing complex binding"
FBXW7,Nonsense,0.690960959191143,26,9.30774716134133e-05,Y,TSG,TSG,0.651648550909205,0.000310545523215371,ENSG00000109670,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0005829|cytosol, GO:1990452|Parkin-FBXW7-Cul1 ubiquitin ligase complex, GO:0019005|SCF ubiquitin ligase complex, GO:0005739|mitochondrion, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0048471|perinuclear region of cytoplasm","GO:0010629|negative regulation of gene expression, GO:0050821|protein stabilization, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0010868|negative regulation of triglyceride biosynthetic process, GO:0055088|lipid homeostasis, GO:0045746|negative regulation of Notch signaling pathway, GO:0016567|protein ubiquitination, GO:0043161|proteasome-mediated ubiquitin-dependent protein catabolic process, GO:0043687|post-translational protein modification, GO:0016032|viral process, GO:1903146|regulation of autophagy of mitochondrion, GO:2000060|positive regulation of ubiquitin-dependent protein catabolic process, GO:1903955|positive regulation of protein targeting to mitochondrion, GO:0000209|protein polyubiquitination, GO:0001944|vasculature development, GO:1901800|positive regulation of proteasomal protein catabolic process, GO:0031398|positive regulation of protein ubiquitination, GO:0032880|regulation of protein localization, GO:2001205|negative regulation of osteoclast development, GO:0045741|positive regulation of epidermal growth factor-activated receptor activity, GO:1902806|regulation of cell cycle G1/S phase transition, GO:0031146|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process, GO:0007062|sister chromatid cohesion, GO:0032876|negative regulation of DNA endoreduplication, GO:0051443|positive regulation of ubiquitin-protein transferase activity, GO:1903378|positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway, GO:0001570|vasculogenesis, GO:0007219|Notch signaling pathway, GO:0010883|regulation of lipid storage, GO:0010992|ubiquitin recycling, GO:0030324|lung development, GO:0031648|protein destabilization, GO:0090049|regulation of cell migration involved in sprouting angiogenesis, GO:1903026|negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding, GO:2000346|negative regulation of hepatocyte proliferation, GO:2000639|negative regulation of SREBP signaling pathway","GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0043130|ubiquitin binding, GO:0030332|cyclin binding, GO:0031625|ubiquitin protein ligase binding, GO:0004842|ubiquitin-protein transferase activity, GO:0030674|protein binding, bridging, GO:0097027|ubiquitin-protein transferase activator activity, GO:0050816|phosphothreonine residue binding"
AMER1,Nonsense,0.687474419839082,21,0.000574071833742763,Y,TSG,TSG,0.602458385327368,0.00384958651511178,ENSG00000184675,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005886|plasma membrane, GO:0016604|nuclear body, GO:0005829|cytosol","GO:0016055|Wnt signaling pathway, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:1904886|beta-catenin destruction complex disassembly, GO:1904885|beta-catenin destruction complex assembly, GO:0031398|positive regulation of protein ubiquitination, GO:0060828|regulation of canonical Wnt signaling pathway, GO:1903364|positive regulation of cellular protein catabolic process, GO:0001822|kidney development, GO:0060348|bone development, GO:0060612|adipose tissue development, GO:0072161|mesenchymal cell differentiation involved in kidney development","GO:0005515|protein binding, GO:0008289|lipid binding, GO:0005546|phosphatidylinositol-4,5-bisphosphate binding, GO:0008013|beta-catenin binding, GO:1904713|beta-catenin destruction complex binding"
RUNX1T1,Nonsense,0.67828310417831,15,0.00544393121804987,Y,"oncogene, TSG, fusion","",0.744921218122194,0.00144030253888822,ENSG00000079102,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016363|nuclear matrix","GO:0006355|regulation of transcription, DNA-templated, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045599|negative regulation of fat cell differentiation, GO:0006091|generation of precursor metabolites and energy","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0003714|transcription corepressor activity, GO:0005515|protein binding"
PTCH1,Nonsense,0.627645914460848,13,0.0216408574773761,N,TSG,TSG,0.862757388808079,0.000146776042768156,ENSG00000185920,"GO:0048471|perinuclear region of cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0030666|endocytic vesicle membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005901|caveola, GO:0005794|Golgi apparatus, GO:0060170|ciliary membrane, GO:0005634|nucleus, GO:0005929|cilium, GO:0014069|postsynaptic density, GO:0030496|midbody, GO:0044294|dendritic growth cone, GO:0044295|axonal growth cone","GO:0071397|cellular response to cholesterol, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045668|negative regulation of osteoblast differentiation, GO:0007224|smoothened signaling pathway, GO:0060037|pharyngeal system development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0009887|animal organ morphogenesis, GO:0016485|protein processing, GO:0009953|dorsal/ventral pattern formation, GO:0040015|negative regulation of multicellular organism growth, GO:0010875|positive regulation of cholesterol efflux, GO:0072001|renal system development, GO:0007420|brain development, GO:0072659|protein localization to plasma membrane, GO:0008589|regulation of smoothened signaling pathway, GO:0045879|negative regulation of smoothened signaling pathway, GO:0061053|somite development, GO:0030326|embryonic limb morphogenesis, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0001701|in utero embryonic development, GO:0001709|cell fate determination, GO:0001841|neural tube formation, GO:0001843|neural tube closure, GO:0003007|heart morphogenesis, GO:0007165|signal transduction, GO:0007346|regulation of mitotic cell cycle, GO:0007389|pattern specification process, GO:0008285|negative regulation of cell proliferation, GO:0008544|epidermis development, GO:0009612|response to mechanical stimulus, GO:0009957|epidermal cell fate specification, GO:0010157|response to chlorate, GO:0014070|response to organic cyclic compound, GO:0021522|spinal cord motor neuron differentiation, GO:0021532|neural tube patterning, GO:0021904|dorsal/ventral neural tube patterning, GO:0021997|neural plate axis specification, GO:0030850|prostate gland development, GO:0030879|mammary gland development, GO:0032355|response to estradiol, GO:0032526|response to retinoic acid, GO:0032880|regulation of protein localization, GO:0035108|limb morphogenesis, GO:0035137|hindlimb morphogenesis, GO:0040008|regulation of growth, GO:0042127|regulation of cell proliferation, GO:0042493|response to drug, GO:0042593|glucose homeostasis, GO:0043616|keratinocyte proliferation, GO:0045606|positive regulation of epidermal cell differentiation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0048568|embryonic organ development, GO:0050680|negative regulation of epithelial cell proliferation, GO:0051782|negative regulation of cell division, GO:0060603|mammary gland duct morphogenesis, GO:0060644|mammary gland epithelial cell differentiation, GO:0060831|smoothened signaling pathway involved in dorsal/ventral neural tube patterning, GO:0061005|cell differentiation involved in kidney development, GO:0071679|commissural neuron axon guidance, GO:0072203|cell proliferation involved in metanephros development, GO:0097421|liver regeneration","GO:0005515|protein binding, GO:0015485|cholesterol binding, GO:0030332|cyclin binding, GO:0005113|patched binding, GO:0005119|smoothened binding, GO:0008158|hedgehog receptor activity, GO:0008201|heparin binding, GO:0044877|protein-containing complex binding, GO:0097108|hedgehog family protein binding"
BCOR,Nonsense,0.604009591154724,26,0.00108496641434553,Y,"TSG, fusion",TSG,0.782850705582932,2.28084166924952e-06,ENSG00000183337,"GO:0005634|nucleus, GO:0140261|BCOR complex","GO:0006325|chromatin organization, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007507|heart development, GO:0045892|negative regulation of transcription, DNA-templated, GO:0060021|roof of mouth development, GO:0051572|negative regulation of histone H3-K4 methylation, GO:0035518|histone H2A monoubiquitination, GO:0030502|negative regulation of bone mineralization, GO:0042476|odontogenesis, GO:0000415|negative regulation of histone H3-K36 methylation, GO:0065001|specification of axis polarity, GO:0070171|negative regulation of tooth mineralization, GO:0001835|blastocyst hatching","GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0003714|transcription corepressor activity, GO:0008134|transcription factor binding, GO:0044212|transcription regulatory region DNA binding, GO:0042826|histone deacetylase binding, GO:0031072|heat shock protein binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding"
RNF43,Nonsense,0.603371239142719,21,0.00378224863007464,Y,TSG,TSG,0.70463614953962,0.00036201259443998,ENSG00000108375,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0005635|nuclear envelope","GO:0016567|protein ubiquitination, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:0030178|negative regulation of Wnt signaling pathway, GO:0072089|stem cell proliferation, GO:0038018|Wnt receptor catabolic process","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0061630|ubiquitin protein ligase activity, GO:0005109|frizzled binding"
PTEN,Nonsense,0.597578584896215,49,5.80502725836628e-06,Y,TSG,TSG,0.827104862689757,2.40631811295076e-13,ENSG00000171862,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0005576|extracellular region, GO:0016324|apical plasma membrane, GO:0005739|mitochondrion, GO:0035749|myelin sheath adaxonal region, GO:0043005|neuron projection, GO:0043197|dendritic spine, GO:0043220|Schmidt-Lanterman incisure, GO:0045211|postsynaptic membrane, GO:0009898|cytoplasmic side of plasma membrane, GO:0016605|PML body","GO:0008284|positive regulation of cell proliferation, GO:1904706|negative regulation of vascular smooth muscle cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0051898|negative regulation of protein kinase B signaling, GO:0070373|negative regulation of ERK1 and ERK2 cascade, GO:0050821|protein stabilization, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle, GO:0030336|negative regulation of cell migration, GO:0010719|negative regulation of epithelial to mesenchymal transition, GO:0014067|negative regulation of phosphatidylinositol 3-kinase signaling, GO:0006629|lipid metabolic process, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0006915|apoptotic process, GO:0006470|protein dephosphorylation, GO:0046855|inositol phosphate dephosphorylation, GO:0046856|phosphatidylinositol dephosphorylation, GO:0007399|nervous system development, GO:0007507|heart development, GO:0016477|cell migration, GO:0016579|protein deubiquitination, GO:0008283|cell proliferation, GO:0001525|angiogenesis, GO:0001933|negative regulation of protein phosphorylation, GO:0002902|regulation of B cell apoptotic process, GO:0007270|neuron-neuron synaptic transmission, GO:0007416|synapse assembly, GO:0007417|central nervous system development, GO:0007568|aging, GO:0007584|response to nutrient, GO:0007611|learning or memory, GO:0007613|memory, GO:0007626|locomotory behavior, GO:0009749|response to glucose, GO:0010033|response to organic substance, GO:0010035|response to inorganic substance, GO:0010043|response to zinc ion, GO:0010628|positive regulation of gene expression, GO:0010666|positive regulation of cardiac muscle cell apoptotic process, GO:0010975|regulation of neuron projection development, GO:0014070|response to organic cyclic compound, GO:0014823|response to activity, GO:0021542|dentate gyrus development, GO:0021955|central nervous system neuron axonogenesis, GO:0030534|adult behavior, GO:0031175|neuron projection development, GO:0031642|negative regulation of myelination, GO:0032228|regulation of synaptic transmission, GABAergic, GO:0032286|central nervous system myelin maintenance, GO:0032355|response to estradiol, GO:0032535|regulation of cellular component size, GO:0032869|cellular response to insulin stimulus, GO:0033032|regulation of myeloid cell apoptotic process, GO:0033198|response to ATP, GO:0033555|multicellular organismal response to stress, GO:0035176|social behavior, GO:0036294|cellular response to decreased oxygen levels, GO:0042493|response to drug, GO:0042711|maternal behavior, GO:0043065|positive regulation of apoptotic process, GO:0043066|negative regulation of apoptotic process, GO:0043491|protein kinase B signaling, GO:0043542|endothelial cell migration, GO:0044320|cellular response to leptin stimulus, GO:0045471|response to ethanol, GO:0045475|locomotor rhythm, GO:0045666|positive regulation of neuron differentiation, GO:0045792|negative regulation of cell size, GO:0046621|negative regulation of organ growth, GO:0046685|response to arsenic-containing substance, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0048679|regulation of axon regeneration, GO:0048681|negative regulation of axon regeneration, GO:0048738|cardiac muscle tissue development, GO:0048853|forebrain morphogenesis, GO:0048854|brain morphogenesis, GO:0050680|negative regulation of epithelial cell proliferation, GO:0050765|negative regulation of phagocytosis, GO:0050771|negative regulation of axonogenesis, GO:0051726|regulation of cell cycle, GO:0060024|rhythmic synaptic transmission, GO:0060044|negative regulation of cardiac muscle cell proliferation, GO:0060074|synapse maturation, GO:0060134|prepulse inhibition, GO:0060179|male mating behavior, GO:0060291|long-term synaptic potentiation, GO:0060292|long-term synaptic depression, GO:0060341|regulation of cellular localization, GO:0060736|prostate gland growth, GO:0060997|dendritic spine morphogenesis, GO:0061002|negative regulation of dendritic spine morphogenesis, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0071361|cellular response to ethanol, GO:0071456|cellular response to hypoxia, GO:0090071|negative regulation of ribosome biogenesis, GO:0090344|negative regulation of cell aging, GO:0090394|negative regulation of excitatory postsynaptic potential, GO:0097105|presynaptic membrane assembly, GO:0097107|postsynaptic density assembly, GO:1901017|negative regulation of potassium ion transmembrane transporter activity, GO:1904668|positive regulation of ubiquitin protein ligase activity, GO:1990090|cellular response to nerve growth factor stimulus, GO:1990314|cellular response to insulin-like growth factor stimulus, GO:2000272|negative regulation of signaling receptor activity, GO:2000463|positive regulation of excitatory postsynaptic potential, GO:2000808|negative regulation of synaptic vesicle clustering, GO:2001235|positive regulation of apoptotic signaling pathway, GO:0031647|regulation of protein stability, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0006661|phosphatidylinositol biosynthetic process, GO:0060070|canonical Wnt signaling pathway, GO:0051895|negative regulation of focal adhesion assembly, GO:0043647|inositol phosphate metabolic process, GO:2000060|positive regulation of ubiquitin-dependent protein catabolic process, GO:0000079|regulation of cyclin-dependent protein serine/threonine kinase activity, GO:1903984|positive regulation of TRAIL-activated apoptotic signaling pathway, GO:0051548|negative regulation of keratinocyte migration, GO:0071257|cellular response to electrical stimulus, GO:1903690|negative regulation of wound healing, spreading of epidermal cells","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0008138|protein tyrosine/serine/threonine phosphatase activity, GO:0008289|lipid binding, GO:0042802|identical protein binding, GO:0005161|platelet-derived growth factor receptor binding, GO:0016314|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity, GO:0019901|protein kinase binding, GO:0030165|PDZ domain binding, GO:0035255|ionotropic glutamate receptor binding, GO:0051717|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity, GO:0051800|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity, GO:1990782|protein tyrosine kinase binding, GO:0019899|enzyme binding, GO:0004722|protein serine/threonine phosphatase activity, GO:0004438|phosphatidylinositol-3-phosphatase activity, GO:0010997|anaphase-promoting complex binding, GO:1990381|ubiquitin-specific protease binding"
TP53,Nonsense,0.59725081631346,66,1.19915970334979e-07,Y,"oncogene, TSG, fusion","",0.884196920927171,7.79598974463354e-23,ENSG00000141510,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005783|endoplasmic reticulum, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005759|mitochondrial matrix, GO:0005730|nucleolus, GO:0000790|nuclear chromatin, GO:0016363|nuclear matrix, GO:0032991|protein-containing complex, GO:0016605|PML body, GO:0005622|intracellular, GO:0005669|transcription factor TFIID complex, GO:0016604|nuclear body, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006915|apoptotic process, GO:0007049|cell cycle, GO:0051262|protein tetramerization, GO:0010628|positive regulation of gene expression, GO:0008285|negative regulation of cell proliferation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045899|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly, GO:0006974|cellular response to DNA damage stimulus, GO:0048511|rhythmic process, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0016579|protein deubiquitination, GO:0008283|cell proliferation, GO:0007050|cell cycle arrest, GO:0043065|positive regulation of apoptotic process, GO:0016032|viral process, GO:0006284|base-excision repair, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0008104|protein localization, GO:0030308|negative regulation of cell growth, GO:0042981|regulation of apoptotic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0019221|cytokine-mediated signaling pathway, GO:0035690|cellular response to drug, GO:0012501|programmed cell death, GO:0090200|positive regulation of release of cytochrome c from mitochondria, GO:2001244|positive regulation of intrinsic apoptotic signaling pathway, GO:0090399|replicative senescence, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0065003|protein-containing complex assembly, GO:0032461|positive regulation of protein oligomerization, GO:0009299|mRNA transcription, GO:0007569|cell aging, GO:0071456|cellular response to hypoxia, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:1900740|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, GO:0043153|entrainment of circadian clock by photoperiod, GO:0042149|cellular response to glucose starvation, GO:0071158|positive regulation of cell cycle arrest, GO:0072332|intrinsic apoptotic signaling pathway by p53 class mediator, GO:1990440|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0046677|response to antibiotic, GO:0097252|oligodendrocyte apoptotic process, GO:0048512|circadian behavior, GO:0000733|DNA strand renaturation, GO:0043066|negative regulation of apoptotic process, GO:1903800|positive regulation of production of miRNAs involved in gene silencing by miRNA, GO:2000379|positive regulation of reactive oxygen species metabolic process, GO:0048147|negative regulation of fibroblast proliferation, GO:0007265|Ras protein signal transduction, GO:0071480|cellular response to gamma radiation, GO:0006289|nucleotide-excision repair, GO:0006914|autophagy, GO:0006978|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator, GO:0006983|ER overload response, GO:0008340|determination of adult lifespan, GO:0010332|response to gamma radiation, GO:0031497|chromatin assembly, GO:0031571|mitotic G1 DNA damage checkpoint, GO:0034644|cellular response to UV, GO:0046827|positive regulation of protein export from nucleus, GO:0046902|regulation of mitochondrial membrane permeability, GO:0051097|negative regulation of helicase activity, GO:0051123|RNA polymerase II preinitiation complex assembly, GO:0051289|protein homotetramerization, GO:0051974|negative regulation of telomerase activity, GO:0070245|positive regulation of thymocyte apoptotic process, GO:0071479|cellular response to ionizing radiation, GO:0072331|signal transduction by p53 class mediator, GO:0072717|cellular response to actinomycin D, GO:0090403|oxidative stress-induced premature senescence, GO:0097193|intrinsic apoptotic signaling pathway, GO:1900119|positive regulation of execution phase of apoptosis, GO:1902749|regulation of cell cycle G2/M phase transition","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0044212|transcription regulatory region DNA binding, GO:0005524|ATP binding, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019901|protein kinase binding, GO:0003682|chromatin binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0031625|ubiquitin protein ligase binding, GO:0047485|protein N-terminus binding, GO:0019899|enzyme binding, GO:0019903|protein phosphatase binding, GO:0008134|transcription factor binding, GO:0002020|protease binding, GO:0005507|copper ion binding, GO:0046982|protein heterodimerization activity, GO:0001085|RNA polymerase II transcription factor binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0051087|chaperone binding, GO:0002039|p53 binding, GO:1990841|promoter-specific chromatin binding, GO:0051721|protein phosphatase 2A binding, GO:0003730|mRNA 3'-UTR binding, GO:0097718|disordered domain specific binding, GO:0035035|histone acetyltransferase binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001046|core promoter sequence-specific DNA binding, GO:0001094|TFIID-class transcription factor complex binding, GO:0030971|receptor tyrosine kinase binding, GO:0042826|histone deacetylase binding, GO:0043621|protein self-association"
CDKN2A,Nonsense,0.594306049822064,12,0.0415643532312685,N,TSG,TSG,0.802195265448477,0.00169285527970522,ENSG00000147889,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0035985|senescence-associated heterochromatin focus, GO:0005730|nucleolus, GO:0005739|mitochondrion, GO:0005654|nucleoplasm","GO:0008285|negative regulation of cell proliferation, GO:0001953|negative regulation of cell-matrix adhesion, GO:0032088|negative regulation of NF-kappaB transcription factor activity, GO:0016310|phosphorylation, GO:0007049|cell cycle, GO:0045892|negative regulation of transcription, DNA-templated, GO:0090399|replicative senescence, GO:0030308|negative regulation of cell growth, GO:0007050|cell cycle arrest, GO:0007265|Ras protein signal transduction, GO:0090398|cellular senescence, GO:0034393|positive regulation of smooth muscle cell apoptotic process, GO:0000082|G1/S transition of mitotic cell cycle, GO:0035986|senescence-associated heterochromatin focus assembly, GO:2000774|positive regulation of cellular senescence, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0042326|negative regulation of phosphorylation, GO:2000111|positive regulation of macrophage apoptotic process, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0006469|negative regulation of protein kinase activity, GO:0006915|apoptotic process, GO:0045893|positive regulation of transcription, DNA-templated, GO:0016925|protein sumoylation, GO:0006364|rRNA processing, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0043065|positive regulation of apoptotic process, GO:0070534|protein K63-linked ubiquitination, GO:0031647|regulation of protein stability, GO:0008637|apoptotic mitochondrial changes, GO:0051444|negative regulation of ubiquitin-protein transferase activity, GO:0000209|protein polyubiquitination, GO:1902510|regulation of apoptotic DNA fragmentation, GO:0010628|positive regulation of gene expression, GO:0050821|protein stabilization, GO:1990000|amyloid fibril formation, GO:0033088|negative regulation of immature T cell proliferation in thymus, GO:1904667|negative regulation of ubiquitin protein ligase activity, GO:2000059|negative regulation of ubiquitin-dependent protein catabolic process, GO:2000435|negative regulation of protein neddylation, GO:0031648|protein destabilization, GO:0030889|negative regulation of B cell proliferation, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0033235|positive regulation of protein sumoylation, GO:0048103|somatic stem cell division","GO:0003723|RNA binding, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0004861|cyclin-dependent protein serine/threonine kinase inhibitor activity, GO:0051059|NF-kappaB binding, GO:0003677|DNA binding, GO:0019789|SUMO transferase activity, GO:0008134|transcription factor binding, GO:0097718|disordered domain specific binding, GO:1990948|ubiquitin ligase inhibitor activity, GO:0055105|ubiquitin-protein transferase inhibitor activity"
MET,Nonsense,0.562867903239913,11,0.0714222273629546,N,Oncogene,Oncogene,0.675621512835376,0.0225052219872998,ENSG00000105976,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005576|extracellular region, GO:0009986|cell surface, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0009925|basal plasma membrane","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1901299|negative regulation of hydrogen peroxide-mediated programmed cell death, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0046854|phosphatidylinositol phosphorylation, GO:0030182|neuron differentiation, GO:0007399|nervous system development, GO:0010507|negative regulation of autophagy, GO:0016477|cell migration, GO:0007165|signal transduction, GO:0051897|positive regulation of protein kinase B signaling, GO:0000165|MAPK cascade, GO:0008283|cell proliferation, GO:0016055|Wnt signaling pathway, GO:0071526|semaphorin-plexin signaling pathway, GO:0048754|branching morphogenesis of an epithelial tube, GO:0050918|positive chemotaxis, GO:0035635|entry of bacterium into host cell, GO:0007166|cell surface receptor signaling pathway, GO:0006909|phagocytosis, GO:0001886|endothelial cell morphogenesis, GO:0001889|liver development, GO:0031016|pancreas development, GO:0031116|positive regulation of microtubule polymerization, GO:0035024|negative regulation of Rho protein signal transduction, GO:0048012|hepatocyte growth factor receptor signaling pathway, GO:0051497|negative regulation of stress fiber assembly, GO:0061436|establishment of skin barrier, GO:0070495|negative regulation of thrombin-activated receptor signaling pathway, GO:1905098|negative regulation of guanyl-nucleotide exchange factor activity, GO:2001028|positive regulation of endothelial cell chemotaxis","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0042802|identical protein binding, GO:0017147|Wnt-protein binding, GO:0019903|protein phosphatase binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005008|hepatocyte growth factor-activated receptor activity"
GATA2,Silent,0.54093465861962,19,0.0167779346631452,N,Oncogene,Oncogene,0.516231800137029,0.0236511845329403,ENSG00000179348,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex","GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0045766|positive regulation of angiogenesis, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:1903589|positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis, GO:0090050|positive regulation of cell migration involved in sprouting angiogenesis, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0006351|transcription, DNA-templated, GO:0030097|hemopoiesis, GO:0006909|phagocytosis, GO:0050766|positive regulation of phagocytosis, GO:0045599|negative regulation of fat cell differentiation, GO:0070345|negative regulation of fat cell proliferation, GO:0007596|blood coagulation, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0035854|eosinophil fate commitment, GO:0048565|digestive tract development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001655|urogenital system development, GO:0001709|cell fate determination, GO:0001764|neuron migration, GO:0001892|embryonic placenta development, GO:0007204|positive regulation of cytosolic calcium ion concentration, GO:0010725|regulation of primitive erythrocyte differentiation, GO:0021514|ventral spinal cord interneuron differentiation, GO:0021533|cell differentiation in hindbrain, GO:0021902|commitment of neuronal cell to specific neuron type in forebrain, GO:0021954|central nervous system neuron development, GO:0021983|pituitary gland development, GO:0030154|cell differentiation, GO:0030182|neuron differentiation, GO:0033993|response to lipid, GO:0035019|somatic stem cell population maintenance, GO:0035065|regulation of histone acetylation, GO:0042472|inner ear morphogenesis, GO:0043306|positive regulation of mast cell degranulation, GO:0045638|negative regulation of myeloid cell differentiation, GO:0045648|positive regulation of erythrocyte differentiation, GO:0045650|negative regulation of macrophage differentiation, GO:0045654|positive regulation of megakaryocyte differentiation, GO:0045666|positive regulation of neuron differentiation, GO:0045746|negative regulation of Notch signaling pathway, GO:0048469|cell maturation, GO:0048663|neuron fate commitment, GO:0048873|homeostasis of number of cells within a tissue, GO:0060100|positive regulation of phagocytosis, engulfment, GO:0060216|definitive hemopoiesis, GO:0060872|semicircular canal development, GO:0090102|cochlea development, GO:0097154|GABAergic neuron differentiation, GO:2000178|negative regulation of neural precursor cell proliferation, GO:2000977|regulation of forebrain neuron differentiation","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0070742|C2H2 zinc finger domain binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0001158|enhancer sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
SRC,Silent,0.533226955353434,19,0.0187247170394312,N,Oncogene,Oncogene,0.566127284902606,0.0115109088348875,ENSG00000197122,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005743|mitochondrial inner membrane, GO:0005886|plasma membrane, GO:0005739|mitochondrion, GO:0005856|cytoskeleton, GO:0048471|perinuclear region of cytoplasm, GO:0005764|lysosome, GO:0031234|extrinsic component of cytoplasmic side of plasma membrane, GO:0070062|extracellular exosome, GO:0005770|late endosome, GO:0005901|caveola, GO:0002102|podosome, GO:0005884|actin filament, GO:0014069|postsynaptic density, GO:0032587|ruffle membrane, GO:0043005|neuron projection","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007155|cell adhesion, GO:0007049|cell cycle, GO:0007229|integrin-mediated signaling pathway, GO:0002376|immune system process, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0050900|leukocyte migration, GO:0046854|phosphatidylinositol phosphorylation, GO:0030154|cell differentiation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0071902|positive regulation of protein serine/threonine kinase activity, GO:0016032|viral process, GO:0051902|negative regulation of mitochondrial depolarization, GO:0043066|negative regulation of apoptotic process, GO:0007165|signal transduction, GO:0030168|platelet activation, GO:0007411|axon guidance, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0051897|positive regulation of protein kinase B signaling, GO:0048013|ephrin receptor signaling pathway, GO:0046777|protein autophosphorylation, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:2001243|negative regulation of intrinsic apoptotic signaling pathway, GO:0035556|intracellular signal transduction, GO:0032463|negative regulation of protein homooligomerization, GO:0045453|bone resorption, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0007173|epidermal growth factor receptor signaling pathway, GO:2001237|negative regulation of extrinsic apoptotic signaling pathway, GO:0010634|positive regulation of epithelial cell migration, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0031295|T cell costimulation, GO:0051895|negative regulation of focal adhesion assembly, GO:0070555|response to interleukin-1, GO:0016236|macroautophagy, GO:0033625|positive regulation of integrin activation, GO:0035635|entry of bacterium into host cell, GO:2000641|regulation of early endosome to late endosome transport, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0051974|negative regulation of telomerase activity, GO:0045124|regulation of bone resorption, GO:2000811|negative regulation of anoikis, GO:0036035|osteoclast development, GO:0007172|signal complex assembly, GO:0032211|negative regulation of telomere maintenance via telomerase, GO:0043114|regulation of vascular permeability, GO:2000394|positive regulation of lamellipodium morphogenesis, GO:0001545|primary ovarian follicle growth, GO:0008283|cell proliferation, GO:0009612|response to mechanical stimulus, GO:0009615|response to virus, GO:0010447|response to acidic pH, GO:0010628|positive regulation of gene expression, GO:0010632|regulation of epithelial cell migration, GO:0010641|positive regulation of platelet-derived growth factor receptor signaling pathway, GO:0010907|positive regulation of glucose metabolic process, GO:0010954|positive regulation of protein processing, GO:0014911|positive regulation of smooth muscle cell migration, GO:0016477|cell migration, GO:0018105|peptidyl-serine phosphorylation, GO:0022407|regulation of cell-cell adhesion, GO:0030900|forebrain development, GO:0031648|protein destabilization, GO:0031667|response to nutrient levels, GO:0031954|positive regulation of protein autophosphorylation, GO:0032148|activation of protein kinase B activity, GO:0032869|cellular response to insulin stimulus, GO:0033146|regulation of intracellular estrogen receptor signaling pathway, GO:0034332|adherens junction organization, GO:0034446|substrate adhesion-dependent cell spreading, GO:0034614|cellular response to reactive oxygen species, GO:0036120|cellular response to platelet-derived growth factor stimulus, GO:0042493|response to drug, GO:0042542|response to hydrogen peroxide, GO:0043065|positive regulation of apoptotic process, GO:0043149|stress fiber assembly, GO:0043393|regulation of protein binding, GO:0043406|positive regulation of MAP kinase activity, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0045056|transcytosis, GO:0045737|positive regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0045785|positive regulation of cell adhesion, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0046628|positive regulation of insulin receptor signaling pathway, GO:0048011|neurotrophin TRK receptor signaling pathway, GO:0048477|oogenesis, GO:0050715|positive regulation of cytokine secretion, GO:0050847|progesterone receptor signaling pathway, GO:0051057|positive regulation of small GTPase mediated signal transduction, GO:0051222|positive regulation of protein transport, GO:0051385|response to mineralocorticoid, GO:0051602|response to electrical stimulus, GO:0060065|uterus development, GO:0060444|branching involved in mammary gland duct morphogenesis, GO:0060491|regulation of cell projection assembly, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0070542|response to fatty acid, GO:0071222|cellular response to lipopolysaccharide, GO:0071375|cellular response to peptide hormone stimulus, GO:0071393|cellular response to progesterone stimulus, GO:0071398|cellular response to fatty acid, GO:0071456|cellular response to hypoxia, GO:0071498|cellular response to fluid shear stress, GO:0071560|cellular response to transforming growth factor beta stimulus, GO:0071803|positive regulation of podosome assembly, GO:0086098|angiotensin-activated signaling pathway involved in heart process, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0098609|cell-cell adhesion, GO:1900182|positive regulation of protein localization to nucleus, GO:1902533|positive regulation of intracellular signal transduction, GO:1903997|positive regulation of non-membrane spanning protein tyrosine kinase activity, GO:2000386|positive regulation of ovarian follicle development, GO:2000573|positive regulation of DNA biosynthetic process, GO:2001286|regulation of caveolin-mediated endocytosis","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0020037|heme binding, GO:0045296|cadherin binding, GO:0042169|SH2 domain binding, GO:0005102|signaling receptor binding, GO:0044325|ion channel binding, GO:0019899|enzyme binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005070|SH3/SH2 adaptor activity, GO:0097110|scaffold protein binding, GO:0070851|growth factor receptor binding, GO:0051219|phosphoprotein binding, GO:0019900|kinase binding, GO:0008022|protein C-terminus binding, GO:0005178|integrin binding, GO:0046875|ephrin receptor binding, GO:0005080|protein kinase C binding, GO:0005158|insulin receptor binding, GO:0019901|protein kinase binding, GO:0019904|protein domain specific binding, GO:0030331|estrogen receptor binding, GO:0031625|ubiquitin protein ligase binding, GO:0044877|protein-containing complex binding, GO:0050839|cell adhesion molecule binding, GO:0071253|connexin binding"
PDE4DIP,Nonsense,0.525302210178447,15,0.0443393109159848,N,fusion,"",0.743726895003218,0.00148001621834805,ENSG00000178104,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005794|Golgi apparatus, GO:0005856|cytoskeleton, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0030016|myofibril","GO:0034622|cellular protein-containing complex assembly, GO:1903358|regulation of Golgi organization","GO:0005515|protein binding, GO:0019899|enzyme binding, GO:0032947|protein-containing complex scaffold activity"
CCNE1,Silent,0.523822721827184,10,0.120169763411872,N,Oncogene,Oncogene,0.531001702397898,0.114263248604823,ENSG00000105173,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005813|centrosome, GO:0000307|cyclin-dependent protein kinase holoenzyme complex, GO:0097134|cyclin E1-CDK2 complex","GO:1900087|positive regulation of G1/S transition of mitotic cell cycle, GO:0051301|cell division, GO:0007049|cell cycle, GO:0000082|G1/S transition of mitotic cell cycle, GO:0051726|regulation of cell cycle, GO:0045893|positive regulation of transcription, DNA-templated, GO:0008284|positive regulation of cell proliferation, GO:0000278|mitotic cell cycle, GO:0007129|synapsis, GO:0030521|androgen receptor signaling pathway, GO:0006468|protein phosphorylation, GO:0000083|regulation of transcription involved in G1/S transition of mitotic cell cycle, GO:0000079|regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0007088|regulation of mitotic nuclear division, GO:0045787|positive regulation of cell cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0000723|telomere maintenance, GO:0006270|DNA replication initiation, GO:0016055|Wnt signaling pathway, GO:0070192|chromosome organization involved in meiotic cell cycle, GO:1903827|regulation of cellular protein localization","GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0019901|protein kinase binding, GO:0050681|androgen receptor binding, GO:0004672|protein kinase activity, GO:0016538|cyclin-dependent protein serine/threonine kinase regulator activity, GO:0004693|cyclin-dependent protein serine/threonine kinase activity, GO:0016301|kinase activity"
P2RY8,Silent,0.523465637827272,26,0.00606356505336971,Y,"oncogene, fusion",Oncogene,0.377212442775571,0.0574755571115512,ENSG00000182162,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane","GO:0007186|G protein-coupled receptor signaling pathway, GO:0007165|signal transduction, GO:0035589|G protein-coupled purinergic nucleotide receptor signaling pathway, GO:0035025|positive regulation of Rho protein signal transduction, GO:0051482|positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway","GO:0004930|G protein-coupled receptor activity, GO:0045028|G protein-coupled purinergic nucleotide receptor activity"
CRLF2,Missense,0.521904684118017,20,0.0182586551702067,N,"oncogene, fusion",Oncogene,0.702259744244891,0.000556375610140439,ENSG00000205755,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0009897|external side of plasma membrane, GO:0043235|receptor complex","GO:0008284|positive regulation of cell proliferation, GO:0038111|interleukin-7-mediated signaling pathway, GO:0019221|cytokine-mediated signaling pathway, GO:1904894|positive regulation of STAT cascade, GO:2000664|positive regulation of interleukin-5 secretion, GO:0033005|positive regulation of mast cell activation","GO:0004896|cytokine receptor activity, GO:0019955|cytokine binding"
RSPO2,Missense,0.515171648215167,36,0.00130349719056463,Y,"TSG, fusion",TSG,0.492361519441126,0.00228565271457589,ENSG00000147655,"GO:0005576|extracellular region, GO:0005615|extracellular space, GO:0009986|cell surface","GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:0030177|positive regulation of Wnt signaling pathway, GO:0050896|response to stimulus, GO:0060173|limb development, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0001649|osteoblast differentiation, GO:0030282|bone mineralization, GO:0035115|embryonic forelimb morphogenesis, GO:0035116|embryonic hindlimb morphogenesis, GO:0042489|negative regulation of odontogenesis of dentin-containing tooth, GO:0060437|lung growth, GO:0060441|epithelial tube branching involved in lung morphogenesis, GO:0060535|trachea cartilage morphogenesis, GO:0071542|dopaminergic neuron differentiation","GO:0005515|protein binding, GO:0008201|heparin binding, GO:0005102|signaling receptor binding, GO:0005109|frizzled binding"
BIRC3,Silent,0.5,11,0.117306803014238,N,"oncogene, TSG, fusion","",0.781307651472219,0.00451686317052868,ENSG00000023445,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0045121|membrane raft","GO:0042981|regulation of apoptotic process, GO:0016567|protein ubiquitination, GO:0006915|apoptotic process, GO:0016579|protein deubiquitination, GO:0031398|positive regulation of protein ubiquitination, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0007249|I-kappaB kinase/NF-kappaB signaling, GO:0007166|cell surface receptor signaling pathway, GO:0043066|negative regulation of apoptotic process, GO:0033209|tumor necrosis factor-mediated signaling pathway, GO:0010803|regulation of tumor necrosis factor-mediated signaling pathway, GO:0090307|mitotic spindle assembly, GO:0060544|regulation of necroptotic process, GO:0050727|regulation of inflammatory response, GO:0045088|regulation of innate immune response, GO:2000116|regulation of cysteine-type endopeptidase activity, GO:0070424|regulation of nucleotide-binding oligomerization domain containing signaling pathway, GO:1990001|inhibition of cysteine-type endopeptidase activity involved in apoptotic process, GO:0007283|spermatogenesis, GO:0034121|regulation of toll-like receptor signaling pathway, GO:0038061|NIK/NF-kappaB signaling, GO:0039535|regulation of RIG-I signaling pathway, GO:0051291|protein heterooligomerization, GO:0060546|negative regulation of necroptotic process","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0061630|ubiquitin protein ligase activity, GO:0043027|cysteine-type endopeptidase inhibitor activity involved in apoptotic process"
FGFR2,Silent,0.492268856060063,32,0.00421035477956963,Y,"oncogene, fusion",Oncogene,0.521243885496219,0.00222005419638825,ENSG00000066468,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0031410|cytoplasmic vesicle, GO:0009986|cell surface, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0062023|collagen-containing extracellular matrix, GO:0005938|cell cortex, GO:0060076|excitatory synapse","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0006915|apoptotic process, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0030177|positive regulation of Wnt signaling pathway, GO:0060348|bone development, GO:0046854|phosphatidylinositol phosphorylation, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007409|axonogenesis, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0051781|positive regulation of cell division, GO:0043410|positive regulation of MAPK cascade, GO:0030282|bone mineralization, GO:0060349|bone morphogenesis, GO:0001525|angiogenesis, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0030855|epithelial cell differentiation, GO:0051897|positive regulation of protein kinase B signaling, GO:0031069|hair follicle morphogenesis, GO:0048562|embryonic organ morphogenesis, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0035265|organ growth, GO:0001701|in utero embryonic development, GO:0007267|cell-cell signaling, GO:0022612|gland morphogenesis, GO:0009887|animal organ morphogenesis, GO:0045787|positive regulation of cell cycle, GO:0045165|cell fate commitment, GO:0032808|lacrimal gland development, GO:0050679|positive regulation of epithelial cell proliferation, GO:0002053|positive regulation of mesenchymal cell proliferation, GO:0003148|outflow tract septum morphogenesis, GO:0042472|inner ear morphogenesis, GO:0048286|lung alveolus development, GO:0048557|embryonic digestive tract morphogenesis, GO:0048608|reproductive structure development, GO:0030901|midbrain development, GO:0001657|ureteric bud development, GO:0070372|regulation of ERK1 and ERK2 cascade, GO:0060484|lung-associated mesenchyme development, GO:0040014|regulation of multicellular organism growth, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0042476|odontogenesis, GO:0008589|regulation of smoothened signaling pathway, GO:0030324|lung development, GO:0048565|digestive tract development, GO:0010518|positive regulation of phospholipase activity, GO:0048705|skeletal system morphogenesis, GO:0048762|mesenchymal cell differentiation, GO:0010453|regulation of cell fate commitment, GO:0033688|regulation of osteoblast proliferation, GO:0045667|regulation of osteoblast differentiation, GO:0003149|membranous septum morphogenesis, GO:0009791|post-embryonic development, GO:0009880|embryonic pattern specification, GO:0016331|morphogenesis of embryonic epithelium, GO:0021769|orbitofrontal cortex development, GO:0021847|ventricular zone neuroblast division, GO:0021860|pyramidal neuron development, GO:0030916|otic vesicle formation, GO:0035264|multicellular organism growth, GO:0035602|fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow, GO:0035603|fibroblast growth factor receptor signaling pathway involved in hemopoiesis, GO:0035604|fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow, GO:0035607|fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development, GO:0040036|regulation of fibroblast growth factor receptor signaling pathway, GO:0048568|embryonic organ development, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0048730|epidermis morphogenesis, GO:0048755|branching morphogenesis of a nerve, GO:0051150|regulation of smooth muscle cell differentiation, GO:0055010|ventricular cardiac muscle tissue morphogenesis, GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0060174|limb bud formation, GO:0060442|branching involved in prostate gland morphogenesis, GO:0060445|branching involved in salivary gland morphogenesis, GO:0060449|bud elongation involved in lung branching, GO:0060463|lung lobe morphogenesis, GO:0060501|positive regulation of epithelial cell proliferation involved in lung morphogenesis, GO:0060512|prostate gland morphogenesis, GO:0060523|prostate epithelial cord elongation, GO:0060527|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis, GO:0060529|squamous basal epithelial stem cell differentiation involved in prostate gland acinus development, GO:0060595|fibroblast growth factor receptor signaling pathway involved in mammary gland specification, GO:0060601|lateral sprouting from an epithelium, GO:0060615|mammary gland bud formation, GO:0060664|epithelial cell proliferation involved in salivary gland morphogenesis, GO:0060667|branch elongation involved in salivary gland morphogenesis, GO:0060670|branching involved in labyrinthine layer morphogenesis, GO:0060687|regulation of branching involved in prostate gland morphogenesis, GO:0060688|regulation of morphogenesis of a branching structure, GO:0060915|mesenchymal cell differentiation involved in lung development, GO:0060916|mesenchymal cell proliferation involved in lung development, GO:0001837|epithelial to mesenchymal transition, GO:0003416|endochondral bone growth, GO:0032496|response to lipopolysaccharide, GO:0042060|wound healing, GO:0044344|cellular response to fibroblast growth factor stimulus, GO:0045471|response to ethanol, GO:0048333|mesodermal cell differentiation, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0050680|negative regulation of epithelial cell proliferation, GO:0071300|cellular response to retinoic acid, GO:0071560|cellular response to transforming growth factor beta stimulus","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005007|fibroblast growth factor-activated receptor activity, GO:0008201|heparin binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0017134|fibroblast growth factor binding"
RB1,Nonsense,0.491028768767327,52,0.000218979520989081,Y,TSG,TSG,0.638592856634248,3.51032688501634e-07,ENSG00000139687,"GO:0005634|nucleus, GO:0005667|transcription factor complex, GO:0005819|spindle, GO:0035189|Rb-E2F complex, GO:0005654|nucleoplasm, GO:0000785|chromatin, GO:0016605|PML body, GO:0016514|SWI/SNF complex, GO:0008024|cyclin/CDK positive transcription elongation factor complex, GO:0005575|cellular_component","GO:0050728|negative regulation of inflammatory response, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle, GO:0006325|chromatin organization, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006915|apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0007049|cell cycle, GO:0051726|regulation of cell cycle, GO:0008285|negative regulation of cell proliferation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000082|G1/S transition of mitotic cell cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001558|regulation of cell growth, GO:0001894|tissue homeostasis, GO:0003180|aortic valve morphogenesis, GO:0007050|cell cycle arrest, GO:0010629|negative regulation of gene expression, GO:0030182|neuron differentiation, GO:0031175|neuron projection development, GO:0034349|glial cell apoptotic process, GO:0035914|skeletal muscle cell differentiation, GO:0042551|neuron maturation, GO:0043353|enucleate erythrocyte differentiation, GO:0045651|positive regulation of macrophage differentiation, GO:0045786|negative regulation of cell cycle, GO:0045879|negative regulation of smoothened signaling pathway, GO:0045930|negative regulation of mitotic cell cycle, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048565|digestive tract development, GO:0048667|cell morphogenesis involved in neuron differentiation, GO:0050680|negative regulation of epithelial cell proliferation, GO:0051146|striated muscle cell differentiation, GO:0051301|cell division, GO:0051402|neuron apoptotic process, GO:0071466|cellular response to xenobiotic stimulus, GO:0071930|negative regulation of transcription involved in G1/S transition of mitotic cell cycle, GO:0097284|hepatocyte apoptotic process, GO:0120163|negative regulation of cold-induced thermogenesis, GO:1903055|positive regulation of extracellular matrix organization, GO:1904028|positive regulation of collagen fibril organization, GO:1904761|negative regulation of myofibroblast differentiation, GO:0030154|cell differentiation, GO:0016032|viral process, GO:0006355|regulation of transcription, DNA-templated, GO:0030521|androgen receptor signaling pathway, GO:0006338|chromatin remodeling, GO:0006469|negative regulation of protein kinase activity, GO:0007093|mitotic cell cycle checkpoint, GO:0007265|Ras protein signal transduction, GO:0007346|regulation of mitotic cell cycle, GO:0031134|sister chromatid biorientation, GO:0034088|maintenance of mitotic sister chromatid cohesion, GO:0043550|regulation of lipid kinase activity, GO:0045445|myoblast differentiation, GO:0045842|positive regulation of mitotic metaphase/anaphase transition, GO:0071459|protein localization to chromosome, centromeric region, GO:0071922|regulation of cohesin loading, GO:0090230|regulation of centromere complex assembly, GO:2000679|positive regulation of transcription regulatory region DNA binding, GO:0008150|biological_process","GO:0003677|DNA binding, GO:0008134|transcription factor binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0019899|enzyme binding, GO:0042802|identical protein binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0031625|ubiquitin protein ligase binding, GO:0003700|DNA-binding transcription factor activity, GO:0051219|phosphoprotein binding, GO:0019900|kinase binding, GO:0050681|androgen receptor binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0097718|disordered domain specific binding, GO:0061676|importin-alpha family protein binding, GO:0003674|molecular_function"
PCM1,Nonsense,0.490791108730343,12,0.105202324775109,N,fusion,"",0.967342550913599,2.7693350268323e-07,ENSG00000078674,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005813|centrosome, GO:0005829|cytosol, GO:0031965|nuclear membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0005815|microtubule organizing center, GO:0035869|ciliary transition zone, GO:0036064|ciliary basal body, GO:0034451|centriolar satellite, GO:0005814|centriole, GO:0032991|protein-containing complex, GO:0000242|pericentriolar material, GO:0045177|apical part of cell","GO:0060271|cilium assembly, GO:0071539|protein localization to centrosome, GO:0034454|microtubule anchoring at centrosome, GO:0035735|intraciliary transport involved in cilium assembly, GO:0030030|cell projection organization, GO:0000086|G2/M transition of mitotic cell cycle, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0097711|ciliary basal body-plasma membrane docking, GO:0007098|centrosome cycle, GO:0050768|negative regulation of neurogenesis, GO:0090316|positive regulation of intracellular protein transport, GO:1905515|non-motile cilium assembly, GO:0001764|neuron migration, GO:0022027|interkinetic nuclear migration, GO:0031122|cytoplasmic microtubule organization, GO:0033365|protein localization to organelle, GO:0034453|microtubule anchoring, GO:0035176|social behavior, GO:0097150|neuronal stem cell population maintenance","GO:0005515|protein binding, GO:0042802|identical protein binding"
CARS,Silent,0.490202516785345,23,0.0175670084222403,N,"TSG, fusion",TSG,0.554097928073722,0.00608008239834751,ENSG00000110619,"GO:0005737|cytoplasm, GO:0005829|cytosol","GO:0006412|translation, GO:0006418|tRNA aminoacylation for protein translation, GO:0006423|cysteinyl-tRNA aminoacylation","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0042803|protein homodimerization activity, GO:0016874|ligase activity, GO:0004812|aminoacyl-tRNA ligase activity, GO:0000049|tRNA binding, GO:0004817|cysteine-tRNA ligase activity, GO:0005515|protein binding"
PTPRT,Silent,0.484668675047136,77,7.94491836074888e-06,Y,TSG,TSG,0.495242710818389,4.67201646876164e-06,ENSG00000196090,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0009986|cell surface, GO:0005887|integral component of plasma membrane","GO:0030336|negative regulation of cell migration, GO:0007155|cell adhesion, GO:0006470|protein dephosphorylation, GO:0007165|signal transduction, GO:0016311|dephosphorylation, GO:0007156|homophilic cell adhesion via plasma membrane adhesion molecules, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0071354|cellular response to interleukin-6, GO:1904893|negative regulation of STAT cascade, GO:1990264|peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0005001|transmembrane receptor protein tyrosine phosphatase activity, GO:0008013|beta-catenin binding, GO:0019903|protein phosphatase binding, GO:0042803|protein homodimerization activity, GO:0045294|alpha-catenin binding, GO:0045295|gamma-catenin binding, GO:0045296|cadherin binding, GO:0070097|delta-catenin binding, GO:0097677|STAT family protein binding, GO:0016790|thiolester hydrolase activity, GO:0051393|alpha-actinin binding"
MYO5A,Nonsense,0.474912709445976,12,0.11871674283633,N,fusion,"",0.394171364767176,0.204838077125222,ENSG00000197535,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005783|endoplasmic reticulum, GO:0016459|myosin complex, GO:0005829|cytosol, GO:0042470|melanosome, GO:0005764|lysosome, GO:0005777|peroxisome, GO:0005769|early endosome, GO:0030426|growth cone, GO:0070062|extracellular exosome, GO:0005770|late endosome, GO:0055037|recycling endosome, GO:0001726|ruffle, GO:0043005|neuron projection, GO:0031982|vesicle, GO:0005884|actin filament, GO:0032433|filopodium tip, GO:0032593|insulin-responsive compartment, GO:0001750|photoreceptor outer segment, GO:0005794|Golgi apparatus, GO:0005882|intermediate filament, GO:0016461|unconventional myosin complex, GO:0030141|secretory granule, GO:0035371|microtubule plus-end, GO:0042641|actomyosin, GO:0043025|neuronal cell body","GO:0015031|protein transport, GO:0016192|vesicle-mediated transport, GO:0032869|cellular response to insulin stimulus, GO:0072659|protein localization to plasma membrane, GO:0030050|vesicle transport along actin filament, GO:0006892|post-Golgi vesicle-mediated transport, GO:0030048|actin filament-based movement, GO:0032402|melanosome transport, GO:0006582|melanin metabolic process, GO:0006887|exocytosis, GO:0007268|chemical synaptic transmission, GO:0007601|visual perception, GO:0030073|insulin secretion, GO:0030318|melanocyte differentiation, GO:0031585|regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity, GO:0031987|locomotion involved in locomotory behavior, GO:0032252|secretory granule localization, GO:0032400|melanosome localization, GO:0042438|melanin biosynthetic process, GO:0042476|odontogenesis, GO:0042552|myelination, GO:0042759|long-chain fatty acid biosynthetic process, GO:0043473|pigmentation, GO:0048066|developmental pigmentation, GO:0048820|hair follicle maturation, GO:0050808|synapse organization, GO:0051643|endoplasmic reticulum localization, GO:0099089|establishment of endoplasmic reticulum localization to postsynapse","GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0003774|motor activity, GO:0003779|actin binding, GO:0051015|actin filament binding, GO:0005516|calmodulin binding, GO:0005515|protein binding, GO:0017137|Rab GTPase binding, GO:0000146|microfilament motor activity, GO:0005509|calcium ion binding, GO:0042802|identical protein binding, GO:0097718|disordered domain specific binding"
HNF1A,Silent,0.469706457759953,30,0.00882246011851684,Y,TSG,TSG,0.554716816082644,0.00146632768927263,ENSG00000135100,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0032991|protein-containing complex, GO:0001750|photoreceptor outer segment, GO:0005667|transcription factor complex, GO:0045120|pronucleus","GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0001889|liver development, GO:0030073|insulin secretion, GO:0031016|pancreas development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0001779|natural killer cell differentiation, GO:0042593|glucose homeostasis, GO:0035623|renal glucose absorption, GO:0046323|glucose import, GO:0060261|positive regulation of transcription initiation from RNA polymerase II promoter, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001824|blastocyst development, GO:0001890|placenta development, GO:0006338|chromatin remodeling, GO:0006355|regulation of transcription, DNA-templated, GO:0006366|transcription by RNA polymerase II, GO:0006633|fatty acid biosynthetic process, GO:0006699|bile acid biosynthetic process, GO:0006783|heme biosynthetic process, GO:0006979|response to oxidative stress, GO:0008104|protein localization, GO:0008203|cholesterol metabolic process, GO:0009749|response to glucose, GO:0015721|bile acid and bile salt transport, GO:0015908|fatty acid transport, GO:0016573|histone acetylation, GO:0030111|regulation of Wnt signaling pathway, GO:0030326|embryonic limb morphogenesis, GO:0031018|endocrine pancreas development, GO:0043691|reverse cholesterol transport, GO:0045453|bone resorption, GO:0046883|regulation of hormone secretion, GO:0048341|paraxial mesoderm formation, GO:0048608|reproductive structure development, GO:0050796|regulation of insulin secretion, GO:0060395|SMAD protein signal transduction","GO:0003677|DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0046983|protein dimerization activity, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001221|transcription cofactor binding, GO:0003690|double-stranded DNA binding, GO:0008134|transcription factor binding, GO:0042803|protein homodimerization activity, GO:0043565|sequence-specific DNA binding, GO:0046982|protein heterodimerization activity"
SFRP4,Silent,0.468327706825387,16,0.0673079070236345,N,TSG,TSG,0.497004602962785,0.0501625345120799,ENSG00000106483,"GO:0005615|extracellular space, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005576|extracellular region, GO:0009986|cell surface","GO:0010628|positive regulation of gene expression, GO:0008285|negative regulation of cell proliferation, GO:0043065|positive regulation of apoptotic process, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:0030154|cell differentiation, GO:0060070|canonical Wnt signaling pathway, GO:0060349|bone morphogenesis, GO:0035567|non-canonical Wnt signaling pathway, GO:0002092|positive regulation of receptor internalization, GO:0030178|negative regulation of Wnt signaling pathway, GO:0009725|response to hormone, GO:0030510|regulation of BMP signaling pathway, GO:2000051|negative regulation of non-canonical Wnt signaling pathway, GO:0045606|positive regulation of epidermal cell differentiation, GO:0055062|phosphate ion homeostasis, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:1902174|positive regulation of keratinocyte apoptotic process, GO:2000119|negative regulation of sodium-dependent phosphate transport","GO:0017147|Wnt-protein binding, GO:0005515|protein binding"
BAX,Missense,0.467046296069373,10,0.173541402707492,N,TSG,TSG,0.607952290862753,0.0622292605672674,ENSG00000087088,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005741|mitochondrial outer membrane, GO:0070062|extracellular exosome, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0046930|pore complex, GO:0071944|cell periphery, GO:0005635|nuclear envelope, GO:0005757|mitochondrial permeability transition pore complex, GO:0097136|Bcl-2 family protein complex, GO:0097144|BAX complex, GO:0031966|mitochondrial membrane","GO:0042981|regulation of apoptotic process, GO:0006915|apoptotic process, GO:0043065|positive regulation of apoptotic process, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0051260|protein homooligomerization, GO:0016032|viral process, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0051259|protein complex oligomerization, GO:0043653|mitochondrial fragmentation involved in apoptotic process, GO:0090200|positive regulation of release of cytochrome c from mitochondria, GO:2001244|positive regulation of intrinsic apoptotic signaling pathway, GO:0032091|negative regulation of protein binding, GO:0070059|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, GO:0032461|positive regulation of protein oligomerization, GO:0097191|extrinsic apoptotic signaling pathway, GO:0001844|protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, GO:1903896|positive regulation of IRE1-mediated unfolded protein response, GO:0034620|cellular response to unfolded protein, GO:1900103|positive regulation of endoplasmic reticulum unfolded protein response, GO:0008053|mitochondrial fusion, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0001836|release of cytochrome c from mitochondria, GO:0097193|intrinsic apoptotic signaling pathway, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0009636|response to toxic substance, GO:0032469|endoplasmic reticulum calcium ion homeostasis, GO:0051881|regulation of mitochondrial membrane potential, GO:0097192|extrinsic apoptotic signaling pathway in absence of ligand, GO:0043525|positive regulation of neuron apoptotic process, GO:1901030|positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway, GO:0001783|B cell apoptotic process, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0008635|activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c, GO:0008637|apoptotic mitochondrial changes, GO:0010248|establishment or maintenance of transmembrane electrochemical gradient, GO:0032976|release of matrix enzymes from mitochondria, GO:0043496|regulation of protein homodimerization activity, GO:0043497|regulation of protein heterodimerization activity, GO:0097190|apoptotic signaling pathway, GO:1902512|positive regulation of apoptotic DNA fragmentation, GO:1990117|B cell receptor apoptotic signaling pathway, GO:0001541|ovarian follicle development, GO:0001764|neuron migration, GO:0001776|leukocyte homeostasis, GO:0001777|T cell homeostatic proliferation, GO:0001782|B cell homeostasis, GO:0001822|kidney development, GO:0001974|blood vessel remodeling, GO:0002262|myeloid cell homeostasis, GO:0002352|B cell negative selection, GO:0002358|B cell homeostatic proliferation, GO:0002904|positive regulation of B cell apoptotic process, GO:0006687|glycosphingolipid metabolic process, GO:0006808|regulation of nitrogen utilization, GO:0006974|cellular response to DNA damage stimulus, GO:0007281|germ cell development, GO:0007283|spermatogenesis, GO:0007399|nervous system development, GO:0007548|sex differentiation, GO:0008283|cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0008584|male gonad development, GO:0009566|fertilization, GO:0009611|response to wounding, GO:0009651|response to salt stress, GO:0009791|post-embryonic development, GO:0010212|response to ionizing radiation, GO:0010332|response to gamma radiation, GO:0010524|positive regulation of calcium ion transport into cytosol, GO:0021854|hypothalamus development, GO:0021987|cerebral cortex development, GO:0032471|negative regulation of endoplasmic reticulum calcium ion concentration, GO:0033137|negative regulation of peptidyl-serine phosphorylation, GO:0033599|regulation of mammary gland epithelial cell proliferation, GO:0034644|cellular response to UV, GO:0035108|limb morphogenesis, GO:0035234|ectopic germ cell programmed cell death, GO:0042475|odontogenesis of dentin-containing tooth, GO:0043281|regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0043523|regulation of neuron apoptotic process, GO:0043524|negative regulation of neuron apoptotic process, GO:0045136|development of secondary sexual characteristics, GO:0046666|retinal cell programmed cell death, GO:0048087|positive regulation of developmental pigmentation, GO:0048147|negative regulation of fibroblast proliferation, GO:0048515|spermatid differentiation, GO:0048597|post-embryonic camera-type eye morphogenesis, GO:0048678|response to axon injury, GO:0048872|homeostasis of number of cells, GO:0048873|homeostasis of number of cells within a tissue, GO:0051281|positive regulation of release of sequestered calcium ion into cytosol, GO:0051402|neuron apoptotic process, GO:0051726|regulation of cell cycle, GO:0060011|Sertoli cell proliferation, GO:0060041|retina development in camera-type eye, GO:0060058|positive regulation of apoptotic process involved in mammary gland involution, GO:0060068|vagina development, GO:0070242|thymocyte apoptotic process, GO:0070584|mitochondrion morphogenesis, GO:0071310|cellular response to organic substance, GO:0072332|intrinsic apoptotic signaling pathway by p53 class mediator, GO:0097296|activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway, GO:1902108|regulation of mitochondrial membrane permeability involved in apoptotic process, GO:1902110|positive regulation of mitochondrial membrane permeability involved in apoptotic process, GO:1902262|apoptotic process involved in blood vessel morphogenesis, GO:1902263|apoptotic process involved in embryonic digit morphogenesis, GO:1902445|regulation of mitochondrial membrane permeability involved in programmed necrotic cell death, GO:2001234|negative regulation of apoptotic signaling pathway","GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0051434|BH3 domain binding, GO:0015267|channel activity, GO:0042803|protein homodimerization activity, GO:0046982|protein heterodimerization activity, GO:0008289|lipid binding, GO:0030544|Hsp70 protein binding, GO:0051087|chaperone binding"
POLD1,Silent,0.466764794482628,48,0.000825029052305493,Y,TSG,TSG,0.393217653069089,0.00569540624003476,ENSG00000062822,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0016235|aggresome, GO:0043625|delta DNA polymerase complex, GO:0000784|nuclear chromosome, telomeric region, GO:0000109|nucleotide-excision repair complex","GO:0006260|DNA replication, GO:0071897|DNA biosynthetic process, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0006261|DNA-dependent DNA replication, GO:0019985|translesion synthesis, GO:0034644|cellular response to UV, GO:0006283|transcription-coupled nucleotide-excision repair, GO:0042769|DNA damage response, detection of DNA damage, GO:0006296|nucleotide-excision repair, DNA incision, 5'-to lesion, GO:0033683|nucleotide-excision repair, DNA incision, GO:0000731|DNA synthesis involved in DNA repair, GO:0032201|telomere maintenance via semi-conservative replication, GO:0006297|nucleotide-excision repair, DNA gap filling, GO:0000723|telomere maintenance, GO:0055089|fatty acid homeostasis, GO:0006287|base-excision repair, gap-filling, GO:0009411|response to UV, GO:0045004|DNA replication proofreading, GO:0090305|nucleic acid phosphodiester bond hydrolysis","GO:0003676|nucleic acid binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0000166|nucleotide binding, GO:0016779|nucleotidyltransferase activity, GO:0003887|DNA-directed DNA polymerase activity, GO:0046872|metal ion binding, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0004527|exonuclease activity, GO:0004518|nuclease activity, GO:0051536|iron-sulfur cluster binding, GO:0051539|4 iron, 4 sulfur cluster binding, GO:0003682|chromatin binding, GO:0003684|damaged DNA binding, GO:0008296|3'-5'-exodeoxyribonuclease activity, GO:0008408|3'-5' exonuclease activity, GO:0019899|enzyme binding"
IDH1,Silent,0.465620197179719,10,0.17503628233383,N,Oncogene,Oncogene,0.615220544230149,0.0583295275259523,ENSG00000138413,"GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005576|extracellular region, GO:0005777|peroxisome, GO:0070062|extracellular exosome, GO:0005782|peroxisomal matrix, GO:0034774|secretory granule lumen, GO:1904813|ficolin-1-rich granule lumen, GO:1904724|tertiary granule lumen, GO:0005739|mitochondrion","GO:0055114|oxidation-reduction process, GO:0006099|tricarboxylic acid cycle, GO:0006625|protein targeting to peroxisome, GO:0043312|neutrophil degranulation, GO:0006102|isocitrate metabolic process, GO:0006097|glyoxylate cycle, GO:0006103|2-oxoglutarate metabolic process, GO:0006739|NADP metabolic process, GO:0006740|NADPH regeneration, GO:0048545|response to steroid hormone, GO:0060696|regulation of phospholipid catabolic process, GO:0071071|regulation of phospholipid biosynthetic process, GO:0006749|glutathione metabolic process, GO:0006979|response to oxidative stress, GO:0008585|female gonad development, GO:0014070|response to organic cyclic compound","GO:0046872|metal ion binding, GO:0000287|magnesium ion binding, GO:0016491|oxidoreductase activity, GO:0042803|protein homodimerization activity, GO:0016616|oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor, GO:0051287|NAD binding, GO:0042802|identical protein binding, GO:0045296|cadherin binding, GO:0005102|signaling receptor binding, GO:0004450|isocitrate dehydrogenase (NADP+) activity, GO:0051990|(R)-2-hydroxyglutarate dehydrogenase activity, GO:0004448|isocitrate dehydrogenase activity, GO:0050661|NADP binding"
EIF4A2,Silent,0.465474668125631,13,0.108946901309612,N,fusion,"",0.584816915224744,0.0357885008037284,ENSG00000156976,"GO:0048471|perinuclear region of cytoplasm, GO:0005829|cytosol, GO:0016281|eukaryotic translation initiation factor 4F complex","GO:0006413|translational initiation, GO:0006412|translation, GO:0016032|viral process, GO:0006446|regulation of translational initiation, GO:1900260|negative regulation of RNA-directed 5'-3' RNA polymerase activity, GO:1990830|cellular response to leukemia inhibitory factor","GO:0003743|translation initiation factor activity, GO:0004004|ATP-dependent RNA helicase activity, GO:0003676|nucleic acid binding, GO:0005524|ATP binding, GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0004386|helicase activity, GO:0016887|ATPase activity"
RSPO2,Silent,0.462910049886276,13,0.111172952769057,N,"TSG, fusion",TSG,0.769901639375771,0.00208159035131468,ENSG00000147655,"GO:0005576|extracellular region, GO:0005615|extracellular space, GO:0009986|cell surface","GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:0030177|positive regulation of Wnt signaling pathway, GO:0050896|response to stimulus, GO:0060173|limb development, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0001649|osteoblast differentiation, GO:0030282|bone mineralization, GO:0035115|embryonic forelimb morphogenesis, GO:0035116|embryonic hindlimb morphogenesis, GO:0042489|negative regulation of odontogenesis of dentin-containing tooth, GO:0060437|lung growth, GO:0060441|epithelial tube branching involved in lung morphogenesis, GO:0060535|trachea cartilage morphogenesis, GO:0071542|dopaminergic neuron differentiation","GO:0005515|protein binding, GO:0008201|heparin binding, GO:0005102|signaling receptor binding, GO:0005109|frizzled binding"
RHOH,Missense,0.450638588894678,21,0.0403506688313861,N,"TSG, fusion",TSG,0.567873722706457,0.00724466801289241,ENSG00000168421,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005829|cytosol, GO:0005938|cell cortex, GO:0042995|cell projection, GO:0001772|immunological synapse","GO:0007264|small GTPase mediated signal transduction, GO:0051056|regulation of small GTPase mediated signal transduction, GO:0007266|Rho protein signal transduction, GO:0008360|regulation of cell shape, GO:0030036|actin cytoskeleton organization, GO:0007015|actin filament organization, GO:0032956|regulation of actin cytoskeleton organization, GO:0006355|regulation of transcription, DNA-templated, GO:0030217|T cell differentiation, GO:0034260|negative regulation of GTPase activity, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0007163|establishment or maintenance of cell polarity, GO:0033673|negative regulation of kinase activity, GO:0045576|mast cell activation","GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0017048|Rho GTPase binding, GO:0019210|kinase inhibitor activity, GO:0005095|GTPase inhibitor activity"
DDX3X,Silent,0.449691252107735,14,0.106681712524652,N,TSG,TSG,0.494645469068984,0.0721564746173188,ENSG00000215301,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0016020|membrane, GO:0005852|eukaryotic translation initiation factor 3 complex, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0022627|cytosolic small ribosomal subunit, GO:0005741|mitochondrial outer membrane, GO:0005576|extracellular region, GO:0070062|extracellular exosome, GO:0010494|cytoplasmic stress granule, GO:0034774|secretory granule lumen, GO:1904813|ficolin-1-rich granule lumen, GO:0016021|integral component of membrane","GO:0006413|translational initiation, GO:0032508|DNA duplex unwinding, GO:0006915|apoptotic process, GO:0016055|Wnt signaling pathway, GO:0045727|positive regulation of translation, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0042254|ribosome biogenesis, GO:0007059|chromosome segregation, GO:0045948|positive regulation of translational initiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0071902|positive regulation of protein serine/threonine kinase activity, GO:0006417|regulation of translation, GO:0009615|response to virus, GO:0043065|positive regulation of apoptotic process, GO:0016032|viral process, GO:0010628|positive regulation of gene expression, GO:0043312|neutrophil degranulation, GO:0017148|negative regulation of translation, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0043066|negative regulation of apoptotic process, GO:0030308|negative regulation of cell growth, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0030307|positive regulation of cell growth, GO:0035556|intracellular signal transduction, GO:0010501|RNA secondary structure unwinding, GO:0031333|negative regulation of protein complex assembly, GO:0032728|positive regulation of interferon-beta production, GO:0034063|stress granule assembly, GO:0042256|mature ribosome assembly, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0043280|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0045070|positive regulation of viral genome replication, GO:0071243|cellular response to arsenic-containing substance, GO:0071470|cellular response to osmotic stress, GO:0071651|positive regulation of chemokine (C-C motif) ligand 5 production, GO:0097193|intrinsic apoptotic signaling pathway, GO:1900087|positive regulation of G1/S transition of mitotic cell cycle, GO:1903608|protein localization to cytoplasmic stress granule, GO:2001243|negative regulation of intrinsic apoptotic signaling pathway","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004386|helicase activity, GO:0045296|cadherin binding, GO:0043539|protein serine/threonine kinase activator activity, GO:0016887|ATPase activity, GO:0004003|ATP-dependent DNA helicase activity, GO:0004004|ATP-dependent RNA helicase activity, GO:0008134|transcription factor binding, GO:0003924|GTPase activity, GO:0008143|poly(A) binding, GO:0008190|eukaryotic initiation factor 4E binding, GO:0017111|nucleoside-triphosphatase activity, GO:0031369|translation initiation factor binding, GO:0033592|RNA strand annealing activity, GO:0035613|RNA stem-loop binding, GO:0043024|ribosomal small subunit binding, GO:0043273|CTPase activity, GO:0048027|mRNA 5'-UTR binding"
EIF3E,Silent,0.447705850569725,14,0.10842825168962,N,"TSG, fusion",TSG,0.509374272384057,0.0628192609282517,ENSG00000104408,"GO:0005737|cytoplasm, GO:0005852|eukaryotic translation initiation factor 3 complex, GO:0005829|cytosol, GO:0016604|nuclear body, GO:0005634|nucleus, GO:0016020|membrane, GO:0016282|eukaryotic 43S preinitiation complex, GO:0033290|eukaryotic 48S preinitiation complex, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0071540|eukaryotic translation initiation factor 3 complex, eIF3e, GO:0000785|chromatin, GO:0016605|PML body","GO:0006413|translational initiation, GO:0001732|formation of cytoplasmic translation initiation complex, GO:0002183|cytoplasmic translational initiation, GO:0006412|translation, GO:0000184|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, GO:0045727|positive regulation of translation, GO:1902416|positive regulation of mRNA binding, GO:0006446|regulation of translational initiation, GO:0045947|negative regulation of translational initiation","GO:0003743|translation initiation factor activity, GO:0003723|RNA binding, GO:0005515|protein binding, GO:0045296|cadherin binding, GO:0047485|protein N-terminus binding"
PIK3R1,Nonsense,0.444768832812895,21,0.0433602228428784,N,TSG,TSG,0.41331229174253,0.0625569574330839,ENSG00000145675,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005801|cis-Golgi network, GO:0005829|cytosol, GO:0005911|cell-cell junction, GO:0005942|phosphatidylinositol 3-kinase complex, GO:0032991|protein-containing complex, GO:1990578|perinuclear endoplasmic reticulum membrane, GO:0005943|phosphatidylinositol 3-kinase complex, class IA","GO:0046326|positive regulation of glucose import, GO:1903078|positive regulation of protein localization to plasma membrane, GO:0015031|protein transport, GO:0007165|signal transduction, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0050900|leukocyte migration, GO:0043551|regulation of phosphatidylinositol 3-kinase activity, GO:0050852|T cell receptor signaling pathway, GO:0001678|cellular glucose homeostasis, GO:0001953|negative regulation of cell-matrix adhesion, GO:0006468|protein phosphorylation, GO:0006606|protein import into nucleus, GO:0007162|negative regulation of cell adhesion, GO:0008286|insulin receptor signaling pathway, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0030183|B cell differentiation, GO:0030335|positive regulation of cell migration, GO:0032760|positive regulation of tumor necrosis factor production, GO:0032869|cellular response to insulin stimulus, GO:0034644|cellular response to UV, GO:0034976|response to endoplasmic reticulum stress, GO:0042307|positive regulation of protein import into nucleus, GO:0043066|negative regulation of apoptotic process, GO:0045671|negative regulation of osteoclast differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046626|regulation of insulin receptor signaling pathway, GO:0051492|regulation of stress fiber assembly, GO:1903076|regulation of protein localization to plasma membrane, GO:0050821|protein stabilization, GO:0016032|viral process, GO:0007186|G protein-coupled receptor signaling pathway, GO:0046854|phosphatidylinositol phosphorylation, GO:0030168|platelet activation, GO:0007411|axon guidance, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0019221|cytokine-mediated signaling pathway, GO:0051897|positive regulation of protein kinase B signaling, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0048015|phosphatidylinositol-mediated signaling, GO:0060396|growth hormone receptor signaling pathway, GO:0038128|ERBB2 signaling pathway, GO:0031295|T cell costimulation, GO:0033120|positive regulation of RNA splicing, GO:1900103|positive regulation of endoplasmic reticulum unfolded protein response, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0048009|insulin-like growth factor receptor signaling pathway","GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0035014|phosphatidylinositol 3-kinase regulator activity, GO:0036312|phosphatidylinositol 3-kinase regulatory subunit binding, GO:0043560|insulin receptor substrate binding, GO:0046982|protein heterodimerization activity, GO:0046935|1-phosphatidylinositol-3-kinase regulator activity, GO:0019903|protein phosphatase binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0001784|phosphotyrosine residue binding, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0005159|insulin-like growth factor receptor binding, GO:0005158|insulin receptor binding, GO:0043559|insulin binding, GO:0005168|neurotrophin TRKA receptor binding, GO:0005068|transmembrane receptor protein tyrosine kinase adaptor activity, GO:0043125|ErbB-3 class receptor binding, GO:0043548|phosphatidylinositol 3-kinase binding"
NF1,Nonsense,0.44145133250297,84,2.62948349021955e-05,Y,"TSG, fusion",TSG,0.513300757075666,5.95011900525374e-07,ENSG00000196712,"GO:0005634|nucleus, GO:0016020|membrane, GO:0098793|presynapse, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005737|cytoplasm, GO:0030424|axon, GO:0030425|dendrite, GO:0016021|integral component of membrane","GO:0007165|signal transduction, GO:0043087|regulation of GTPase activity, GO:0043547|positive regulation of GTPase activity, GO:0050890|cognition, GO:0000165|MAPK cascade, GO:0007265|Ras protein signal transduction, GO:0048147|negative regulation of fibroblast proliferation, GO:0001937|negative regulation of endothelial cell proliferation, GO:0001649|osteoblast differentiation, GO:0001656|metanephros development, GO:0001666|response to hypoxia, GO:0001889|liver development, GO:0001952|regulation of cell-matrix adhesion, GO:0006469|negative regulation of protein kinase activity, GO:0007154|cell communication, GO:0007406|negative regulation of neuroblast proliferation, GO:0007420|brain development, GO:0007422|peripheral nervous system development, GO:0007507|heart development, GO:0008542|visual learning, GO:0014044|Schwann cell development, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0021510|spinal cord development, GO:0021897|forebrain astrocyte development, GO:0021987|cerebral cortex development, GO:0022011|myelination in peripheral nervous system, GO:0030036|actin cytoskeleton organization, GO:0030198|extracellular matrix organization, GO:0030199|collagen fibril organization, GO:0030325|adrenal gland development, GO:0030336|negative regulation of cell migration, GO:0042060|wound healing, GO:0043065|positive regulation of apoptotic process, GO:0043407|negative regulation of MAP kinase activity, GO:0043409|negative regulation of MAPK cascade, GO:0043473|pigmentation, GO:0043525|positive regulation of neuron apoptotic process, GO:0043535|regulation of blood vessel endothelial cell migration, GO:0045124|regulation of bone resorption, GO:0045685|regulation of glial cell differentiation, GO:0045762|positive regulation of adenylate cyclase activity, GO:0045765|regulation of angiogenesis, GO:0048485|sympathetic nervous system development, GO:0048593|camera-type eye morphogenesis, GO:0048715|negative regulation of oligodendrocyte differentiation, GO:0048745|smooth muscle tissue development, GO:0048844|artery morphogenesis, GO:0048853|forebrain morphogenesis, GO:0001938|positive regulation of endothelial cell proliferation, GO:0001953|negative regulation of cell-matrix adhesion, GO:0007519|skeletal muscle tissue development, GO:0008285|negative regulation of cell proliferation, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0010468|regulation of gene expression, GO:0016525|negative regulation of angiogenesis, GO:0021764|amygdala development, GO:0021915|neural tube development, GO:0032228|regulation of synaptic transmission, GABAergic, GO:0034605|cellular response to heat, GO:0035021|negative regulation of Rac protein signal transduction, GO:0042127|regulation of cell proliferation, GO:0042308|negative regulation of protein import into nucleus, GO:0043408|regulation of MAPK cascade, GO:0045671|negative regulation of osteoclast differentiation, GO:0046580|negative regulation of Ras protein signal transduction, GO:0046929|negative regulation of neurotransmitter secretion, GO:0048169|regulation of long-term neuronal synaptic plasticity, GO:0048712|negative regulation of astrocyte differentiation, GO:0048820|hair follicle maturation, GO:0061534|gamma-aminobutyric acid secretion, neurotransmission, GO:0061535|glutamate secretion, neurotransmission, GO:0098597|observational learning, GO:1900271|regulation of long-term synaptic potentiation, GO:1902043|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:2001241|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand","GO:0005515|protein binding, GO:0005096|GTPase activator activity, GO:0008289|lipid binding, GO:0008429|phosphatidylethanolamine binding, GO:0031210|phosphatidylcholine binding"
SRSF3,Missense,0.439209596414406,23,0.0360095649589587,N,"oncogene, fusion",Oncogene,0.467290985940535,0.0245628230743474,ENSG00000112081,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0005654|nucleoplasm","GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0051028|mRNA transport, GO:0006406|mRNA export from nucleus, GO:0000381|regulation of alternative mRNA splicing, via spliceosome, GO:0006405|RNA export from nucleus, GO:0031124|mRNA 3'-end processing, GO:0000398|mRNA splicing, via spliceosome, GO:0045292|mRNA cis splicing, via spliceosome, GO:0048024|regulation of mRNA splicing, via spliceosome","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0005515|protein binding, GO:1990825|sequence-specific mRNA binding"
HOXA11,Silent,0.439021778581364,12,0.153336659577789,N,"oncogene, TSG, fusion","",0.39756733286061,0.200611712337666,ENSG00000005073,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0032993|protein-DNA complex, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0001501|skeletal system development, GO:0032332|positive regulation of chondrocyte differentiation, GO:0009653|anatomical structure morphogenesis, GO:0009953|dorsal/ventral pattern formation, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0048589|developmental growth, GO:0001656|metanephros development, GO:0001759|organ induction, GO:0007283|spermatogenesis, GO:0007338|single fertilization, GO:0007501|mesodermal cell fate specification, GO:0008584|male gonad development, GO:0009952|anterior/posterior pattern specification, GO:0009954|proximal/distal pattern formation, GO:0010468|regulation of gene expression, GO:0010720|positive regulation of cell development, GO:0030326|embryonic limb morphogenesis, GO:0032330|regulation of chondrocyte differentiation, GO:0035115|embryonic forelimb morphogenesis, GO:0042733|embryonic digit morphogenesis, GO:0060065|uterus development, GO:0060272|embryonic skeletal joint morphogenesis, GO:0060348|bone development, GO:0060351|cartilage development involved in endochondral bone morphogenesis","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
POLQ,Missense,0.439021778581364,12,0.153336659577789,N,"oncogene, TSG","",0.634340391251259,0.0267265311896312,ENSG00000051341,"GO:0005634|nucleus, GO:0005694|chromosome, GO:0005737|cytoplasm, GO:0005654|nucleoplasm","GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0006302|double-strand break repair, GO:0006260|DNA replication, GO:0071897|DNA biosynthetic process, GO:0006261|DNA-dependent DNA replication, GO:0051260|protein homooligomerization, GO:2000042|negative regulation of double-strand break repair via homologous recombination, GO:0006284|base-excision repair, GO:0000724|double-strand break repair via homologous recombination, GO:0016446|somatic hypermutation of immunoglobulin genes, GO:0097681|double-strand break repair via alternative nonhomologous end joining","GO:0003676|nucleic acid binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0016779|nucleotidyltransferase activity, GO:0003887|DNA-directed DNA polymerase activity, GO:0005515|protein binding, GO:0003682|chromatin binding, GO:0003684|damaged DNA binding, GO:0043142|single-stranded DNA-dependent ATPase activity, GO:0051575|5'-deoxyribose-5-phosphate lyase activity"
NCOA2,Nonsense,0.435713318704049,14,0.119396172441398,N,"oncogene, fusion",Oncogene,0.58720659331223,0.0272555709349364,ENSG00000140396,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016604|nuclear body, GO:0032991|protein-containing complex, GO:0005737|cytoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0048511|rhythmic process, GO:0032922|circadian regulation of gene expression, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0019216|regulation of lipid metabolic process, GO:0015721|bile acid and bile salt transport, GO:0032870|cellular response to hormone stimulus, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007623|circadian rhythm, GO:0010468|regulation of gene expression, GO:0010906|regulation of glucose metabolic process, GO:0032570|response to progesterone, GO:0045475|locomotor rhythm, GO:0045892|negative regulation of transcription, DNA-templated, GO:1904017|cellular response to Thyroglobulin triiodothyronine, GO:1903508|positive regulation of nucleic acid-templated transcription","GO:0003713|transcription coactivator activity, GO:0046983|protein dimerization activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0030374|nuclear receptor transcription coactivator activity, GO:0035257|nuclear hormone receptor binding, GO:0017162|aryl hydrocarbon receptor binding, GO:0019904|protein domain specific binding, GO:0016922|nuclear receptor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001162|RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0005102|signaling receptor binding, GO:0008134|transcription factor binding, GO:0030375|thyroid hormone receptor coactivator activity"
FAM46C,Missense,0.433951880837326,29,0.0186738032734931,N,TSG,TSG,0.450739341649359,0.0141318244911855,ENSG00000183508,"GO:0005634|nucleus, GO:0005737|cytoplasm",GO:0048255|mRNA stabilization,"GO:0003723|RNA binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0016779|nucleotidyltransferase activity, GO:1990817|RNA adenylyltransferase activity, GO:0004652|polynucleotide adenylyltransferase activity"
STAG2,Nonsense,0.432286187415527,27,0.0243286399816338,N,TSG,TSG,0.417199659124061,0.0303814705546211,ENSG00000101972,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005694|chromosome, GO:0000775|chromosome, centromeric region, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0000785|chromatin, GO:0016363|nuclear matrix, GO:0097431|mitotic spindle pole, GO:0008278|cohesin complex","GO:0051301|cell division, GO:0007049|cell cycle, GO:0051321|meiotic cell cycle, GO:0007059|chromosome segregation, GO:1901673|regulation of mitotic spindle assembly, GO:0007062|sister chromatid cohesion, GO:0032876|negative regulation of DNA endoreduplication","GO:0005515|protein binding, GO:0003682|chromatin binding"
ARHGAP26,Missense,0.431923656605607,59,0.000635709362479603,Y,"TSG, fusion",TSG,0.575050550953955,1.90136959271742e-06,ENSG00000145819,"GO:0005737|cytoplasm, GO:0005856|cytoskeleton, GO:0030054|cell junction, GO:0005925|focal adhesion, GO:0005829|cytosol, GO:0005575|cellular_component","GO:0007165|signal transduction, GO:0043547|positive regulation of GTPase activity, GO:0030036|actin cytoskeleton organization, GO:0051056|regulation of small GTPase mediated signal transduction, GO:0007399|nervous system development","GO:0005096|GTPase activator activity, GO:0005515|protein binding, GO:0005543|phospholipid binding"
MSN,Missense,0.431735533627696,42,0.00430487437307238,Y,fusion,"",0.513166737682983,0.000510422812110553,ENSG00000147065,"GO:0005856|cytoskeleton, GO:0045177|apical part of cell, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0048471|perinuclear region of cytoplasm, GO:0005615|extracellular space, GO:0005925|focal adhesion, GO:0030175|filopodium, GO:0070062|extracellular exosome, GO:0071944|cell periphery, GO:0072562|blood microparticle, GO:0071437|invadopodium, GO:0005902|microvillus, GO:0016324|apical plasma membrane, GO:0031982|vesicle, GO:0031528|microvillus membrane, GO:0031143|pseudopodium, GO:0009986|cell surface, GO:0001931|uropod, GO:0016323|basolateral plasma membrane, GO:0043209|myelin sheath","GO:0007010|cytoskeleton organization, GO:0010628|positive regulation of gene expression, GO:0072678|T cell migration, GO:0045198|establishment of epithelial cell apical/basal polarity, GO:0008360|regulation of cell shape, GO:0035722|interleukin-12-mediated signaling pathway, GO:0061028|establishment of endothelial barrier, GO:0008361|regulation of cell size, GO:0022612|gland morphogenesis, GO:0042098|T cell proliferation, GO:0071394|cellular response to testosterone stimulus, GO:2000401|regulation of lymphocyte migration, GO:0007159|leukocyte cell-cell adhesion, GO:0022614|membrane to membrane docking, GO:0050900|leukocyte migration, GO:0001771|immunological synapse formation, GO:1902115|regulation of organelle assembly, GO:1902966|positive regulation of protein localization to early endosome, GO:1903364|positive regulation of cellular protein catabolic process, GO:2000643|positive regulation of early endosome to late endosome transport, GO:0070489|T cell aggregation, GO:0071803|positive regulation of podosome assembly","GO:0008092|cytoskeletal protein binding, GO:0003779|actin binding, GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0005102|signaling receptor binding, GO:0005200|structural constituent of cytoskeleton, GO:0003725|double-stranded RNA binding, GO:0019899|enzyme binding, GO:0050839|cell adhesion molecule binding"
SFRP4,Missense,0.429867157185731,52,0.00147042003389171,Y,TSG,TSG,0.431138783592041,0.00141828195279089,ENSG00000106483,"GO:0005615|extracellular space, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005576|extracellular region, GO:0009986|cell surface","GO:0010628|positive regulation of gene expression, GO:0008285|negative regulation of cell proliferation, GO:0043065|positive regulation of apoptotic process, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:0030154|cell differentiation, GO:0060070|canonical Wnt signaling pathway, GO:0060349|bone morphogenesis, GO:0035567|non-canonical Wnt signaling pathway, GO:0002092|positive regulation of receptor internalization, GO:0030178|negative regulation of Wnt signaling pathway, GO:0009725|response to hormone, GO:0030510|regulation of BMP signaling pathway, GO:2000051|negative regulation of non-canonical Wnt signaling pathway, GO:0045606|positive regulation of epidermal cell differentiation, GO:0055062|phosphate ion homeostasis, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:1902174|positive regulation of keratinocyte apoptotic process, GO:2000119|negative regulation of sodium-dependent phosphate transport","GO:0017147|Wnt-protein binding, GO:0005515|protein binding"
MYOD1,Silent,0.428342992314463,25,0.0326582007858916,N,Oncogene,Oncogene,0.284044139969148,0.168806513374938,ENSG00000129152,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0016604|nuclear body, GO:0005667|transcription factor complex, GO:0000790|nuclear chromatin, GO:0005737|cytoplasm, GO:0030016|myofibril","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0007517|muscle organ development, GO:0006468|protein phosphorylation, GO:0043967|histone H4 acetylation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043966|histone H3 acetylation, GO:0051149|positive regulation of muscle cell differentiation, GO:0071392|cellular response to estradiol stimulus, GO:0014904|myotube cell development, GO:0007519|skeletal muscle tissue development, GO:0035914|skeletal muscle cell differentiation, GO:0042693|muscle cell fate commitment, GO:0045663|positive regulation of myoblast differentiation, GO:0048743|positive regulation of skeletal muscle fiber development, GO:1901741|positive regulation of myoblast fusion, GO:0000381|regulation of alternative mRNA splicing, via spliceosome, GO:0007518|myoblast fate determination, GO:0007520|myoblast fusion, GO:0009267|cellular response to starvation, GO:0010468|regulation of gene expression, GO:0014902|myotube differentiation, GO:0014908|myotube differentiation involved in skeletal muscle regeneration, GO:0043415|positive regulation of skeletal muscle tissue regeneration, GO:0043484|regulation of RNA splicing, GO:0043503|skeletal muscle fiber adaptation, GO:0045445|myoblast differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0048741|skeletal muscle fiber development, GO:0051146|striated muscle cell differentiation, GO:0071356|cellular response to tumor necrosis factor, GO:0071385|cellular response to glucocorticoid stimulus, GO:0071453|cellular response to oxygen levels, GO:1905382|positive regulation of snRNA transcription by RNA polymerase II, GO:2000818|negative regulation of myoblast proliferation","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0031490|chromatin DNA binding, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0046982|protein heterodimerization activity, GO:0003713|transcription coactivator activity, GO:0070888|E-box binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0035257|nuclear hormone receptor binding, GO:1990841|promoter-specific chromatin binding, GO:0003700|DNA-binding transcription factor activity, GO:0008134|transcription factor binding, GO:0019899|enzyme binding, GO:0031625|ubiquitin protein ligase binding, GO:0043565|sequence-specific DNA binding"
CDH11,Silent,0.426265617028746,75,0.000137186988769938,Y,"TSG, fusion",TSG,0.431542221161801,0.000110830362923058,ENSG00000140937,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0009986|cell surface, GO:0070062|extracellular exosome, GO:0005913|cell-cell adherens junction, GO:0016342|catenin complex, GO:0005737|cytoplasm","GO:0007155|cell adhesion, GO:0007156|homophilic cell adhesion via plasma membrane adhesion molecules, GO:0098609|cell-cell adhesion, GO:0001503|ossification, GO:0007043|cell-cell junction assembly, GO:0001501|skeletal system development, GO:0034332|adherens junction organization, GO:0000902|cell morphogenesis, GO:0016339|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules, GO:0044331|cell-cell adhesion mediated by cadherin, GO:0021957|corticospinal tract morphogenesis","GO:0046872|metal ion binding, GO:0005509|calcium ion binding, GO:0045296|cadherin binding, GO:0042803|protein homodimerization activity, GO:0008092|cytoskeletal protein binding"
CCND2,Silent,0.425504791757357,13,0.147177473821492,N,"oncogene, fusion",Oncogene,0.397943900638684,0.178089334471065,ENSG00000118971,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005730|nucleolus, GO:0031965|nuclear membrane, GO:0000785|chromatin, GO:0000307|cyclin-dependent protein kinase holoenzyme complex","GO:0008284|positive regulation of cell proliferation, GO:1900087|positive regulation of G1/S transition of mitotic cell cycle, GO:0043066|negative regulation of apoptotic process, GO:0001934|positive regulation of protein phosphorylation, GO:0006468|protein phosphorylation, GO:0051301|cell division, GO:0007049|cell cycle, GO:0000278|mitotic cell cycle, GO:0000079|regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0007088|regulation of mitotic nuclear division, GO:0045787|positive regulation of cell cycle, GO:0045737|positive regulation of cyclin-dependent protein serine/threonine kinase activity","GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0004672|protein kinase activity, GO:0016538|cyclin-dependent protein serine/threonine kinase regulator activity"
ELF4,Silent,0.425431346552398,26,0.0302547595924573,N,"oncogene, TSG, fusion","",0.448904333689917,0.0214269988061079,ENSG00000102034,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016604|nuclear body, GO:0016605|PML body","GO:0006355|regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045087|innate immune response, GO:0001787|natural killer cell proliferation, GO:0001866|NK T cell proliferation, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
RAP1GDS1,Silent,0.420393251621427,16,0.104945442768549,N,"oncogene, fusion",Oncogene,0.755506298272317,0.000712758139610606,ENSG00000138698,"GO:0005783|endoplasmic reticulum, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0070062|extracellular exosome","GO:0043547|positive regulation of GTPase activity, GO:0032471|negative regulation of endoplasmic reticulum calcium ion concentration, GO:0051561|positive regulation of mitochondrial calcium ion concentration, GO:0014829|vascular smooth muscle contraction, GO:0031034|myosin filament assembly","GO:0005096|GTPase activator activity, GO:0005515|protein binding"
TNFAIP3,Silent,0.419196340204575,28,0.026387899214145,N,TSG,TSG,0.423138317640768,0.0248625274124641,ENSG00000118503,"GO:0043231|intracellular membrane-bounded organelle, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005764|lysosome, GO:0005829|cytosol, GO:0070062|extracellular exosome","GO:0016579|protein deubiquitination, GO:0016567|protein ubiquitination, GO:0050728|negative regulation of inflammatory response, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:0031397|negative regulation of protein ubiquitination, GO:0032088|negative regulation of NF-kappaB transcription factor activity, GO:0071222|cellular response to lipopolysaccharide, GO:0048662|negative regulation of smooth muscle cell proliferation, GO:0008152|metabolic process, GO:0006508|proteolysis, GO:0006915|apoptotic process, GO:0006954|inflammatory response, GO:0007010|cytoskeleton organization, GO:0045824|negative regulation of innate immune response, GO:0070536|protein K63-linked deubiquitination, GO:0071108|protein K48-linked deubiquitination, GO:0016477|cell migration, GO:0032715|negative regulation of interleukin-6 production, GO:0032720|negative regulation of tumor necrosis factor production, GO:0070936|protein K48-linked ubiquitination, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0010803|regulation of tumor necrosis factor-mediated signaling pathway, GO:0032480|negative regulation of type I interferon production, GO:0045732|positive regulation of protein catabolic process, GO:0070301|cellular response to hydrogen peroxide, GO:1902042|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:0070423|nucleotide-binding oligomerization domain containing signaling pathway, GO:0090291|negative regulation of osteoclast proliferation, GO:0032703|negative regulation of interleukin-2 production, GO:0045779|negative regulation of bone resorption, GO:0051259|protein complex oligomerization, GO:0002237|response to molecule of bacterial origin, GO:0034144|negative regulation of toll-like receptor 4 signaling pathway, GO:0001922|B-1 B cell homeostasis, GO:0002634|regulation of germinal center formation, GO:0030177|positive regulation of Wnt signaling pathway, GO:0034136|negative regulation of toll-like receptor 2 signaling pathway, GO:0034140|negative regulation of toll-like receptor 3 signaling pathway, GO:0035523|protein K29-linked deubiquitination, GO:0035871|protein K11-linked deubiquitination, GO:0050691|regulation of defense response to virus by host, GO:0050713|negative regulation of interleukin-1 beta secretion, GO:0050869|negative regulation of B cell activation, GO:0061043|regulation of vascular wound healing, GO:0071947|protein deubiquitination involved in ubiquitin-dependent protein catabolic process, GO:0072573|tolerance induction to lipopolysaccharide, GO:1990168|protein K33-linked deubiquitination, GO:2000349|negative regulation of CD40 signaling pathway, GO:0002677|negative regulation of chronic inflammatory response, GO:0032495|response to muramyl dipeptide, GO:0032691|negative regulation of interleukin-1 beta production, GO:0034148|negative regulation of toll-like receptor 5 signaling pathway, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0060548|negative regulation of cell death, GO:0070429|negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway, GO:0070433|negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway, GO:0072666|establishment of protein localization to vacuole, GO:1903364|positive regulation of cellular protein catabolic process, GO:2000347|positive regulation of hepatocyte proliferation","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003824|catalytic activity, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0004842|ubiquitin-protein transferase activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0042802|identical protein binding, GO:0004843|thiol-dependent ubiquitin-specific protease activity, GO:0061578|Lys63-specific deubiquitinase activity, GO:0002020|protease binding, GO:0043130|ubiquitin binding, GO:0043621|protein self-association, GO:0070530|K63-linked polyubiquitin modification-dependent protein binding, GO:0019900|kinase binding"
RBM10,Nonsense,0.418933491278917,21,0.0587238623330509,N,TSG,TSG,0.566387332298003,0.00743310762854258,ENSG00000182872,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0032991|protein-containing complex","GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0042981|regulation of apoptotic process, GO:0000381|regulation of alternative mRNA splicing, via spliceosome, GO:0008150|biological_process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0008285|negative regulation of cell proliferation, GO:0034391|regulation of smooth muscle cell apoptotic process, GO:0034393|positive regulation of smooth muscle cell apoptotic process, GO:0048025|negative regulation of mRNA splicing, via spliceosome, GO:0070935|3'-UTR-mediated mRNA stabilization","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0035198|miRNA binding"
PPP6C,Missense,0.418027950382927,29,0.0240339368513132,N,TSG,TSG,0.385355475381504,0.0389780192264938,ENSG00000119414,"GO:0005737|cytoplasm, GO:0005739|mitochondrion, GO:0000139|Golgi membrane, GO:0005829|cytosol","GO:0007049|cell cycle, GO:0006470|protein dephosphorylation, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0000082|G1/S transition of mitotic cell cycle, GO:0048208|COPII vesicle coating","GO:0046872|metal ion binding, GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004722|protein serine/threonine phosphatase activity"
NFKB2,Silent,0.41372283205379,14,0.141418215548177,N,"oncogene, TSG, fusion","",0.471680526355944,0.0886172304617365,ENSG00000077150,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0033257|Bcl3/NF-kappaB2 complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0048511|rhythmic process, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0038061|NIK/NF-kappaB signaling, GO:0032481|positive regulation of type I interferon production, GO:0002268|follicular dendritic cell differentiation, GO:0002467|germinal center formation, GO:0007568|aging, GO:0030198|extracellular matrix organization, GO:0032496|response to lipopolysaccharide, GO:0034097|response to cytokine, GO:0048536|spleen development","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003713|transcription coactivator activity"
WWTR1,Missense,0.411915307998104,22,0.056801322076267,N,"oncogene, fusion",Oncogene,0.339920236480681,0.121668420105197,ENSG00000018408,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0016604|nuclear body, GO:0005667|transcription factor complex","GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0006469|negative regulation of protein kinase activity, GO:0035329|hippo signaling, GO:0008284|positive regulation of cell proliferation, GO:0006355|regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0001933|negative regulation of protein phosphorylation, GO:0017145|stem cell division, GO:0060390|regulation of SMAD protein signal transduction, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001649|osteoblast differentiation, GO:0001894|tissue homeostasis, GO:0003015|heart process, GO:0016567|protein ubiquitination, GO:0031146|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process, GO:0032835|glomerulus development, GO:0035264|multicellular organism growth, GO:0045599|negative regulation of fat cell differentiation, GO:0048762|mesenchymal cell differentiation, GO:0060271|cilium assembly, GO:0060828|regulation of canonical Wnt signaling pathway, GO:0060993|kidney morphogenesis, GO:0072307|regulation of metanephric nephron tubule epithelial cell differentiation","GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0003714|transcription corepressor activity, GO:0042803|protein homodimerization activity"
BRCA1,Nonsense,0.410151556214798,18,0.0909275533188972,N,TSG,TSG,0.427845635346552,0.0765292880871134,ENSG00000012048,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005694|chromosome, GO:0031436|BRCA1-BARD1 complex, GO:0005886|plasma membrane, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0000151|ubiquitin ligase complex, GO:1990904|ribonucleoprotein complex, GO:0000800|lateral element, GO:0008274|gamma-tubulin ring complex, GO:0070531|BRCA1-A complex, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0000793|condensed chromosome, GO:0000794|condensed nuclear chromosome","GO:0016567|protein ubiquitination, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0010628|positive regulation of gene expression, GO:0045766|positive regulation of angiogenesis, GO:0071158|positive regulation of cell cycle arrest, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0071356|cellular response to tumor necrosis factor, GO:0006629|lipid metabolic process, GO:0006631|fatty acid metabolic process, GO:0006633|fatty acid biosynthetic process, GO:0006310|DNA recombination, GO:0007049|cell cycle, GO:0051865|protein autoubiquitination, GO:0085020|protein K6-linked ubiquitination, GO:0006915|apoptotic process, GO:0006302|double-strand break repair, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007059|chromosome segregation, GO:0016579|protein deubiquitination, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045739|positive regulation of DNA repair, GO:0031398|positive regulation of protein ubiquitination, GO:0042127|regulation of cell proliferation, GO:0042981|regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0006260|DNA replication, GO:0070317|negative regulation of G0 to G1 transition, GO:0030521|androgen receptor signaling pathway, GO:0043627|response to estrogen, GO:0072425|signal transduction involved in G2 DNA damage checkpoint, GO:0000724|double-strand break repair via homologous recombination, GO:1902042|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0000729|DNA double-strand break processing, GO:0006303|double-strand break repair via nonhomologous end joining, GO:0045717|negative regulation of fatty acid biosynthetic process, GO:0035066|positive regulation of histone acetylation, GO:0010212|response to ionizing radiation, GO:0046600|negative regulation of centriole replication, GO:0010575|positive regulation of vascular endothelial growth factor production, GO:0006978|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator, GO:0071681|cellular response to indole-3-methanol, GO:0051571|positive regulation of histone H3-K4 methylation, GO:0006301|postreplication repair, GO:0006359|regulation of transcription by RNA polymerase III, GO:0009048|dosage compensation by inactivation of X chromosome, GO:0033147|negative regulation of intracellular estrogen receptor signaling pathway, GO:0035067|negative regulation of histone acetylation, GO:0043009|chordate embryonic development, GO:0051573|negative regulation of histone H3-K9 methylation, GO:0070512|positive regulation of histone H4-K20 methylation, GO:2000378|negative regulation of reactive oxygen species metabolic process, GO:2000617|positive regulation of histone H3-K9 acetylation, GO:2000620|positive regulation of histone H4-K16 acetylation, GO:0006349|regulation of gene expression by genetic imprinting, GO:0007098|centrosome cycle, GO:0044030|regulation of DNA methylation, GO:0044818|mitotic G2/M transition checkpoint, GO:0051572|negative regulation of histone H3-K4 methylation, GO:0051574|positive regulation of histone H3-K9 methylation","GO:0008270|zinc ion binding, GO:0003677|DNA binding, GO:0004842|ubiquitin-protein transferase activity, GO:0044212|transcription regulatory region DNA binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0042802|identical protein binding, GO:0031625|ubiquitin protein ligase binding, GO:0019899|enzyme binding, GO:0015631|tubulin binding, GO:0050681|androgen receptor binding, GO:0070063|RNA polymerase binding, GO:0003723|RNA binding, GO:0003684|damaged DNA binding"
TCF7L2,Missense,0.408913620724407,60,0.00117910204791508,Y,"oncogene, fusion",Oncogene,0.436688456729151,0.0004860939150364,ENSG00000148737,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex, GO:0000790|nuclear chromatin, GO:0016605|PML body, GO:0032993|protein-DNA complex, GO:0070369|beta-catenin-TCF7L2 complex","GO:0009749|response to glucose, GO:0051897|positive regulation of protein kinase B signaling, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0042593|glucose homeostasis, GO:0060070|canonical Wnt signaling pathway, GO:0006357|regulation of transcription by RNA polymerase II, GO:0016055|Wnt signaling pathway, GO:0006355|regulation of transcription, DNA-templated, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0032024|positive regulation of insulin secretion, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:1904837|beta-catenin-TCF complex assembly, GO:0032092|positive regulation of protein binding, GO:0007223|Wnt signaling pathway, calcium modulating pathway, GO:0045444|fat cell differentiation, GO:2000675|negative regulation of type B pancreatic cell apoptotic process, GO:0007050|cell cycle arrest, GO:0046827|positive regulation of protein export from nucleus, GO:2001237|negative regulation of extrinsic apoptotic signaling pathway, GO:0008283|cell proliferation, GO:0010909|positive regulation of heparan sulfate proteoglycan biosynthetic process, GO:0044334|canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition, GO:0048660|regulation of smooth muscle cell proliferation, GO:0001568|blood vessel development, GO:0031016|pancreas development, GO:0048625|myoblast fate commitment, GO:0032350|regulation of hormone metabolic process, GO:0043570|maintenance of DNA repeat elements","GO:0008013|beta-catenin binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019901|protein kinase binding, GO:0070016|armadillo repeat domain binding, GO:0003682|chromatin binding, GO:0044212|transcription regulatory region DNA binding, GO:0001103|RNA polymerase II repressing transcription factor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0045295|gamma-catenin binding, GO:0035257|nuclear hormone receptor binding"
STRN,Silent,0.407489894210314,25,0.0431908428206301,N,fusion,"",0.460018016096297,0.0206805754860105,ENSG00000115808,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0042995|cell projection, GO:0045211|postsynaptic membrane, GO:0005923|bicellular tight junction, GO:0014069|postsynaptic density, GO:0043197|dendritic spine, GO:0030425|dendrite, GO:0043025|neuronal cell body, GO:0090443|FAR/SIN/STRIPAK complex","GO:0016055|Wnt signaling pathway, GO:0008285|negative regulation of cell proliferation, GO:0016358|dendrite development, GO:0070830|bicellular tight junction assembly, GO:0007626|locomotory behavior","GO:0005515|protein binding, GO:0005516|calmodulin binding, GO:0030331|estrogen receptor binding, GO:0044877|protein-containing complex binding, GO:0051721|protein phosphatase 2A binding, GO:0070016|armadillo repeat domain binding"
QKI,Missense,0.406199118868224,29,0.0287803370031548,N,"oncogene, TSG","",0.301373813717163,0.112116664133253,ENSG00000112531,"GO:0005634|nucleus, GO:0005737|cytoplasm","GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0051028|mRNA transport, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006417|regulation of translation","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0005515|protein binding, GO:0017124|SH3 domain binding"
KDR,Nonsense,0.405428189030937,16,0.119244552385909,N,Oncogene,Oncogene,0.438352715280831,0.0894342812526331,ENSG00000128052,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0030054|cell junction, GO:0031410|cytoplasmic vesicle, GO:0045121|membrane raft, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005768|endosome, GO:0005769|early endosome, GO:0097443|sorting endosome","GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:0010629|negative regulation of gene expression, GO:0045766|positive regulation of angiogenesis, GO:0008284|positive regulation of cell proliferation, GO:0010595|positive regulation of endothelial cell migration, GO:0090050|positive regulation of cell migration involved in sprouting angiogenesis, GO:0030335|positive regulation of cell migration, GO:0008360|regulation of cell shape, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0038084|vascular endothelial growth factor signaling pathway, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0001934|positive regulation of protein phosphorylation, GO:0016032|viral process, GO:0001525|angiogenesis, GO:0016477|cell migration, GO:0043066|negative regulation of apoptotic process, GO:0001938|positive regulation of endothelial cell proliferation, GO:0046777|protein autophosphorylation, GO:0030198|extracellular matrix organization, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:0035924|cellular response to vascular endothelial growth factor stimulus, GO:0002042|cell migration involved in sprouting angiogenesis, GO:0051894|positive regulation of focal adhesion assembly, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0002040|sprouting angiogenesis, GO:0016239|positive regulation of macroautophagy, GO:0001570|vasculogenesis, GO:0035584|calcium-mediated signaling using intracellular calcium source, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0038033|positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway, GO:0070371|ERK1 and ERK2 cascade, GO:0051901|positive regulation of mitochondrial depolarization, GO:0090141|positive regulation of mitochondrial fission, GO:0050927|positive regulation of positive chemotaxis, GO:0035162|embryonic hemopoiesis, GO:2001214|positive regulation of vasculogenesis, GO:0003158|endothelium development, GO:0043491|protein kinase B signaling, GO:0045446|endothelial cell differentiation, GO:0051770|positive regulation of nitric-oxide synthase biosynthetic process, GO:1904881|cellular response to hydrogen sulfide","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005021|vascular endothelial growth factor-activated receptor activity, GO:0019838|growth factor binding, GO:0042802|identical protein binding, GO:0051879|Hsp90 protein binding, GO:0005178|integrin binding, GO:0038085|vascular endothelial growth factor binding"
ITK,Silent,0.402619621249908,28,0.0336561536785578,N,fusion,"",0.426820618396631,0.0235032682141847,ENSG00000113263,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005911|cell-cell junction","GO:0035556|intracellular signal transduction, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0002376|immune system process, GO:0002250|adaptive immune response, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0050853|B cell receptor signaling pathway, GO:0050852|T cell receptor signaling pathway, GO:0001816|cytokine production, GO:0007165|signal transduction, GO:0042110|T cell activation, GO:0006968|cellular defense response, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0007202|activation of phospholipase C activity, GO:0001865|NK T cell differentiation, GO:0032609|interferon-gamma production, GO:0032633|interleukin-4 production","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity"
P2RY8,Missense,0.401867226343011,63,0.00109597560387128,Y,"oncogene, fusion",Oncogene,0.427729949363312,0.000471114696710151,ENSG00000182162,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane","GO:0007186|G protein-coupled receptor signaling pathway, GO:0007165|signal transduction, GO:0035589|G protein-coupled purinergic nucleotide receptor signaling pathway, GO:0035025|positive regulation of Rho protein signal transduction, GO:0051482|positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway","GO:0004930|G protein-coupled receptor activity, GO:0045028|G protein-coupled purinergic nucleotide receptor activity"
CCNB1IP1,Missense,0.401679952453012,30,0.0277918646191359,N,"TSG, fusion",TSG,0.65471597576612,8.65794793481633e-05,ENSG00000100814,"GO:0005634|nucleus, GO:0005694|chromosome, GO:0000795|synaptonemal complex, GO:0000794|condensed nuclear chromosome","GO:0016567|protein ubiquitination, GO:0051321|meiotic cell cycle, GO:0007131|reciprocal meiotic recombination, GO:0051026|chiasma assembly, GO:0001825|blastocyst formation, GO:0007286|spermatid development","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding"
RAD21,Missense,0.400456481130439,64,0.00104216306985047,Y,"oncogene, TSG","",0.530421445224761,6.5396938814842e-06,ENSG00000164754,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0000228|nuclear chromosome, GO:0000785|chromatin, GO:0000794|condensed nuclear chromosome, GO:0008278|cohesin complex, GO:0000775|chromosome, centromeric region, GO:0005829|cytosol, GO:0016363|nuclear matrix, GO:0030893|meiotic cohesin complex","GO:0051301|cell division, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0007049|cell cycle, GO:0006915|apoptotic process, GO:0007062|sister chromatid cohesion, GO:0010972|negative regulation of G2/M transition of mitotic cell cycle, GO:0045841|negative regulation of mitotic metaphase/anaphase transition, GO:0007059|chromosome segregation, GO:0006302|double-strand break repair, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006310|DNA recombination, GO:0007131|reciprocal meiotic recombination, GO:0045876|positive regulation of sister chromatid cohesion, GO:0051321|meiotic cell cycle, GO:0071168|protein localization to chromatin","GO:0005515|protein binding, GO:0003682|chromatin binding"
HOXA9,Missense,0.399843229466838,18,0.100170513777717,N,"oncogene, TSG, fusion","",0.384728814012831,0.11491686720727,ENSG00000078399,"GO:0005634|nucleus, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006351|transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0045638|negative regulation of myeloid cell differentiation, GO:0042118|endothelial cell activation, GO:0007283|spermatogenesis, GO:0007338|single fertilization, GO:0008584|male gonad development, GO:0009952|anterior/posterior pattern specification, GO:0009954|proximal/distal pattern formation, GO:0010468|regulation of gene expression, GO:0030879|mammary gland development, GO:0035115|embryonic forelimb morphogenesis, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048706|embryonic skeletal system development, GO:0060065|uterus development, GO:0060216|definitive hemopoiesis","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding"
CHD4,Missense,0.399733223880585,155,2.56596299318936e-07,Y,Oncogene,Oncogene,0.390010349072806,5.26535777004481e-07,ENSG00000111642,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0000790|nuclear chromatin, GO:0005856|cytoskeleton, GO:0005654|nucleoplasm, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0032991|protein-containing complex, GO:0016581|NuRD complex","GO:0006325|chromatin organization, GO:0016575|histone deacetylation, GO:0032508|DNA duplex unwinding, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043044|ATP-dependent chromatin remodeling","GO:0046872|metal ion binding, GO:0005524|ATP binding, GO:0000166|nucleotide binding, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004386|helicase activity, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0004407|histone deacetylase activity, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0004003|ATP-dependent DNA helicase activity, GO:0001103|RNA polymerase II repressing transcription factor binding, GO:0008270|zinc ion binding, GO:0042826|histone deacetylase binding, GO:0031492|nucleosomal DNA binding"
SOCS1,Silent,0.398685053255697,11,0.224535053876915,N,TSG,TSG,0.279560779097955,0.405088486356406,ENSG00000185338,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0031410|cytoplasmic vesicle, GO:0036464|cytoplasmic ribonucleoprotein granule, GO:0005829|cytosol, GO:0005942|phosphatidylinositol 3-kinase complex","GO:0016567|protein ubiquitination, GO:0035556|intracellular signal transduction, GO:0046426|negative regulation of JAK-STAT cascade, GO:0043551|regulation of phosphatidylinositol 3-kinase activity, GO:0040008|regulation of growth, GO:0006469|negative regulation of protein kinase activity, GO:0046854|phosphatidylinositol phosphorylation, GO:0019221|cytokine-mediated signaling pathway, GO:0009968|negative regulation of signal transduction, GO:0038111|interleukin-7-mediated signaling pathway, GO:0046627|negative regulation of insulin receptor signaling pathway, GO:0042532|negative regulation of tyrosine phosphorylation of STAT protein, GO:0060334|regulation of interferon-gamma-mediated signaling pathway, GO:0001932|regulation of protein phosphorylation, GO:0043372|positive regulation of CD4-positive, alpha-beta T cell differentiation, GO:0043377|negative regulation of CD8-positive, alpha-beta T cell differentiation, GO:0033673|negative regulation of kinase activity, GO:0045591|positive regulation of regulatory T cell differentiation, GO:0007259|JAK-STAT cascade, GO:0010533|regulation of activation of Janus kinase activity, GO:0042509|regulation of tyrosine phosphorylation of STAT protein, GO:0045444|fat cell differentiation, GO:0046425|regulation of JAK-STAT cascade, GO:0050707|regulation of cytokine secretion, GO:0071230|cellular response to amino acid stimulus","GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0046935|1-phosphatidylinositol-3-kinase regulator activity, GO:0005159|insulin-like growth factor receptor binding, GO:0004860|protein kinase inhibitor activity, GO:0019210|kinase inhibitor activity"
SIX1,Silent,0.397747564417433,10,0.255001765654848,N,Oncogene,Oncogene,0.480345088505581,0.159967698605273,ENSG00000126778,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005730|nucleolus, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0001822|kidney development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0008283|cell proliferation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048513|animal organ development, GO:0045892|negative regulation of transcription, DNA-templated, GO:0048856|anatomical structure development, GO:0043524|negative regulation of neuron apoptotic process, GO:0030855|epithelial cell differentiation, GO:0030878|thyroid gland development, GO:0048538|thymus development, GO:0048699|generation of neurons, GO:0034504|protein localization to nucleus, GO:0051451|myoblast migration, GO:0007389|pattern specification process, GO:0042472|inner ear morphogenesis, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0007519|skeletal muscle tissue development, GO:0001657|ureteric bud development, GO:0048839|inner ear development, GO:0090190|positive regulation of branching involved in ureteric bud morphogenesis, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0048704|embryonic skeletal system morphogenesis, GO:0072075|metanephric mesenchyme development, GO:0072107|positive regulation of ureteric bud formation, GO:0045664|regulation of neuron differentiation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001759|organ induction, GO:0003151|outflow tract morphogenesis, GO:0007605|sensory perception of sound, GO:0008582|regulation of synaptic growth at neuromuscular junction, GO:0010468|regulation of gene expression, GO:0014842|regulation of skeletal muscle satellite cell proliferation, GO:0014857|regulation of skeletal muscle cell proliferation, GO:0021610|facial nerve morphogenesis, GO:0022008|neurogenesis, GO:0030910|olfactory placode formation, GO:0032880|regulation of protein localization, GO:0035909|aorta morphogenesis, GO:0042474|middle ear morphogenesis, GO:0043066|negative regulation of apoptotic process, GO:0043586|tongue development, GO:0048665|neuron fate specification, GO:0048705|skeletal system morphogenesis, GO:0048741|skeletal muscle fiber development, GO:0050678|regulation of epithelial cell proliferation, GO:0060037|pharyngeal system development, GO:0061055|myotome development, GO:0061197|fungiform papilla morphogenesis, GO:0061551|trigeminal ganglion development, GO:0071599|otic vesicle development, GO:0072001|renal system development, GO:0072095|regulation of branch elongation involved in ureteric bud branching, GO:0072172|mesonephric tubule formation, GO:0072193|ureter smooth muscle cell differentiation, GO:0072513|positive regulation of secondary heart field cardioblast proliferation, GO:0090103|cochlea morphogenesis, GO:0090191|negative regulation of branching involved in ureteric bud morphogenesis, GO:1905243|cellular response to 3,3',5-triiodo-L-thyronine, GO:2000729|positive regulation of mesenchymal cell proliferation involved in ureter development, GO:2001014|regulation of skeletal muscle cell differentiation","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0001223|transcription coactivator binding, GO:0003682|chromatin binding"
DDIT3,Missense,0.397564901921271,18,0.102301278388081,N,"oncogene, fusion",Oncogene,0.696436514264931,0.00132319707714645,ENSG00000175197,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0036488|CHOP-C/EBP complex, GO:1990622|CHOP-ATF3 complex, GO:1990617|CHOP-ATF4 complex, GO:0032993|protein-DNA complex, GO:0035976|transcription factor AP-1 complex, GO:0005770|late endosome","GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0051898|negative regulation of protein kinase B signaling, GO:0006355|regulation of transcription, DNA-templated, GO:0007049|cell cycle, GO:0006915|apoptotic process, GO:0016055|Wnt signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006986|response to unfolded protein, GO:0007050|cell cycle arrest, GO:0120163|negative regulation of cold-induced thermogenesis, GO:0045892|negative regulation of transcription, DNA-templated, GO:0043161|proteasome-mediated ubiquitin-dependent protein catabolic process, GO:0034976|response to endoplasmic reticulum stress, GO:0070059|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, GO:0036500|ATF6-mediated unfolded protein response, GO:1990440|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress, GO:1902237|positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway, GO:0006974|cellular response to DNA damage stimulus, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0032757|positive regulation of interleukin-8 production, GO:0036499|PERK-mediated unfolded protein response, GO:1903026|negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding, GO:0043525|positive regulation of neuron apoptotic process, GO:0032792|negative regulation of CREB transcription factor activity, GO:0042789|mRNA transcription by RNA polymerase II, GO:0043620|regulation of DNA-templated transcription in response to stress, GO:0044324|regulation of transcription involved in anterior/posterior axis specification, GO:0045454|cell redox homeostasis, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0051259|protein complex oligomerization, GO:2000016|negative regulation of determination of dorsal identity, GO:0001955|blood vessel maturation, GO:0006983|ER overload response, GO:0030968|endoplasmic reticulum unfolded protein response, GO:0042594|response to starvation, GO:0043392|negative regulation of DNA binding, GO:0045599|negative regulation of fat cell differentiation, GO:0045662|negative regulation of myoblast differentiation, GO:0051209|release of sequestered calcium ion into cytosol, GO:0072655|establishment of protein localization to mitochondrion, GO:1901216|positive regulation of neuron death, GO:1990442|intrinsic apoptotic signaling pathway in response to nitrosative stress","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003714|transcription corepressor activity, GO:0046982|protein heterodimerization activity, GO:0042803|protein homodimerization activity, GO:0008140|cAMP response element binding protein binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0044212|transcription regulatory region DNA binding, GO:0043522|leucine zipper domain binding"
NFKBIE,Missense,0.396918779271442,36,0.0165364356854578,N,TSG,TSG,0.470211907145726,0.00380578857688086,ENSG00000146232,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0001650|fibrillar center, GO:0005737|cytoplasm, GO:0005794|Golgi apparatus, GO:0048471|perinuclear region of cytoplasm","GO:0042942|D-serine transport, GO:0042994|cytoplasmic sequestering of transcription factor",GO:0005515|protein binding
TBL1XR1,Silent,0.393730775333826,12,0.205390352320929,N,"oncogene, TSG, fusion","",0.442561360368435,0.149665924711311,ENSG00000177565,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000118|histone deacetylase complex, GO:0017053|transcriptional repressor complex, GO:0072686|mitotic spindle","GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0043161|proteasome-mediated ubiquitin-dependent protein catabolic process, GO:0019216|regulation of lipid metabolic process, GO:0016575|histone deacetylation, GO:0001835|blastocyst hatching, GO:0002021|response to dietary excess, GO:0010468|regulation of gene expression, GO:0016042|lipid catabolic process, GO:0035264|multicellular organism growth, GO:0045892|negative regulation of transcription, DNA-templated, GO:0050872|white fat cell differentiation, GO:0060612|adipose tissue development, GO:0060613|fat pad development, GO:0090207|regulation of triglyceride metabolic process","GO:0044212|transcription regulatory region DNA binding, GO:0005515|protein binding, GO:0003714|transcription corepressor activity, GO:0047485|protein N-terminus binding, GO:0042393|histone binding, GO:0008013|beta-catenin binding, GO:0003677|DNA binding"
PDGFRA,Silent,0.391724912309409,44,0.00854804961250855,Y,"oncogene, fusion",Oncogene,0.461331967070788,0.00162221471877981,ENSG00000134853,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0030054|cell junction, GO:0042995|cell projection, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005929|cilium, GO:0032991|protein-containing complex, GO:0031226|intrinsic component of plasma membrane, GO:0005902|microvillus, GO:0009897|external side of plasma membrane, GO:0009986|cell surface","GO:0008284|positive regulation of cell proliferation, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0030335|positive regulation of cell migration, GO:0048146|positive regulation of fibroblast proliferation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0007275|multicellular organism development, GO:0048015|phosphatidylinositol-mediated signaling, GO:0006935|chemotaxis, GO:0046854|phosphatidylinositol phosphorylation, GO:0002244|hematopoietic progenitor cell differentiation, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0016032|viral process, GO:0070527|platelet aggregation, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0007204|positive regulation of cytosolic calcium ion concentration, GO:0060326|cell chemotaxis, GO:0042060|wound healing, GO:2000249|regulation of actin cytoskeleton reorganization, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0048557|embryonic digestive tract morphogenesis, GO:0072277|metanephric glomerular capillary formation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0010863|positive regulation of phospholipase C activity, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0001775|cell activation, GO:0038091|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway, GO:0055003|cardiac myofibril assembly, GO:0061298|retina vasculature development in camera-type eye, GO:0001553|luteinization, GO:0001701|in utero embryonic development, GO:0008210|estrogen metabolic process, GO:0008585|female gonad development, GO:0009653|anatomical structure morphogenesis, GO:0009887|animal organ morphogenesis, GO:0010544|negative regulation of platelet activation, GO:0016477|cell migration, GO:0023019|signal transduction involved in regulation of gene expression, GO:0030198|extracellular matrix organization, GO:0030324|lung development, GO:0030325|adrenal gland development, GO:0030539|male genitalia development, GO:0033327|Leydig cell differentiation, GO:0034614|cellular response to reactive oxygen species, GO:0035790|platelet-derived growth factor receptor-alpha signaling pathway, GO:0042475|odontogenesis of dentin-containing tooth, GO:0048704|embryonic skeletal system morphogenesis, GO:0048705|skeletal system morphogenesis, GO:0050920|regulation of chemotaxis, GO:0060021|roof of mouth development, GO:0060325|face morphogenesis, GO:0071230|cellular response to amino acid stimulus, GO:2000739|regulation of mesenchymal stem cell differentiation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005018|platelet-derived growth factor alpha-receptor activity, GO:0048407|platelet-derived growth factor binding, GO:0042803|protein homodimerization activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005021|vascular endothelial growth factor-activated receptor activity, GO:0038085|vascular endothelial growth factor binding, GO:0005161|platelet-derived growth factor receptor binding, GO:0044877|protein-containing complex binding"
CDC73,Missense,0.389127614787099,49,0.00572001350466357,Y,TSG,TSG,0.397538040864356,0.00467628938249238,ENSG00000134371,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0016593|Cdc73/Paf1 complex, GO:0005654|nucleoplasm, GO:0000784|nuclear chromosome, telomeric region","GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0071222|cellular response to lipopolysaccharide, GO:0006357|regulation of transcription by RNA polymerase II, GO:0019827|stem cell population maintenance, GO:0043066|negative regulation of apoptotic process, GO:0001711|endodermal cell fate commitment, GO:0001558|regulation of cell growth, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0016570|histone modification, GO:0007049|cell cycle, GO:0016055|Wnt signaling pathway, GO:0030177|positive regulation of Wnt signaling pathway, GO:0010390|histone monoubiquitination, GO:0016567|protein ubiquitination, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0031648|protein destabilization, GO:0008285|negative regulation of cell proliferation, GO:0032968|positive regulation of transcription elongation from RNA polymerase II promoter, GO:1904837|beta-catenin-TCF complex assembly, GO:0006366|transcription by RNA polymerase II, GO:0045638|negative regulation of myeloid cell differentiation, GO:0050680|negative regulation of epithelial cell proliferation, GO:0034402|recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex, GO:0006378|mRNA polyadenylation, GO:0033523|histone H2B ubiquitination, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle, GO:0048147|negative regulation of fibroblast proliferation, GO:0031442|positive regulation of mRNA 3'-end processing, GO:1902808|positive regulation of cell cycle G1/S phase transition","GO:0005515|protein binding, GO:0000993|RNA polymerase II complex binding"
MITF,Silent,0.387916271380536,15,0.153082568631241,N,Oncogene,Oncogene,0.363323861016649,0.183153517279225,ENSG00000187098,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex","GO:0030336|negative regulation of cell migration, GO:0006355|regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007275|multicellular organism development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0010628|positive regulation of gene expression, GO:0065003|protein-containing complex assembly, GO:0006351|transcription, DNA-templated, GO:0010468|regulation of gene expression, GO:0016055|Wnt signaling pathway, GO:0030154|cell differentiation, GO:0030316|osteoclast differentiation, GO:0030318|melanocyte differentiation, GO:0042127|regulation of cell proliferation, GO:0043010|camera-type eye development, GO:0043066|negative regulation of apoptotic process, GO:0043473|pigmentation, GO:0044336|canonical Wnt signaling pathway involved in negative regulation of apoptotic process, GO:0045165|cell fate commitment, GO:0045670|regulation of osteoclast differentiation, GO:0046849|bone remodeling, GO:2000144|positive regulation of DNA-templated transcription, initiation, GO:2001141|regulation of RNA biosynthetic process, GO:0006959|humoral immune response","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0070888|E-box binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0003682|chromatin binding"
SMAD2,Missense,0.38742204448688,44,0.0093705340698733,Y,TSG,TSG,0.459015051339049,0.00172433421231426,ENSG00000175387,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005667|transcription factor complex, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0000790|nuclear chromatin, GO:0032991|protein-containing complex, GO:0032444|activin responsive factor complex, GO:0071141|SMAD protein complex, GO:0071144|heteromeric SMAD protein complex, GO:0016020|membrane, GO:0016021|integral component of membrane","GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0030513|positive regulation of BMP signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016579|protein deubiquitination, GO:0045892|negative regulation of transcription, DNA-templated, GO:0035556|intracellular signal transduction, GO:0062009|secondary palate development, GO:0017015|regulation of transforming growth factor beta receptor signaling pathway, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0045165|cell fate commitment, GO:0009952|anterior/posterior pattern specification, GO:0035019|somatic stem cell population maintenance, GO:0007352|zygotic specification of dorsal/ventral axis, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0032924|activin receptor signaling pathway, GO:0007369|gastrulation, GO:0001707|mesoderm formation, GO:0007183|SMAD protein complex assembly, GO:0051098|regulation of binding, GO:0070723|response to cholesterol, GO:0031053|primary miRNA processing, GO:0038092|nodal signaling pathway, GO:0001657|ureteric bud development, GO:0001701|in utero embryonic development, GO:0001706|endoderm formation, GO:0006468|protein phosphorylation, GO:0007182|common-partner SMAD protein phosphorylation, GO:0007389|pattern specification process, GO:0007492|endoderm development, GO:0007507|heart development, GO:0008285|negative regulation of cell proliferation, GO:0009749|response to glucose, GO:0009791|post-embryonic development, GO:0009880|embryonic pattern specification, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0023019|signal transduction involved in regulation of gene expression, GO:0030073|insulin secretion, GO:0030324|lung development, GO:0030325|adrenal gland development, GO:0031016|pancreas development, GO:0035265|organ growth, GO:0042060|wound healing, GO:0048340|paraxial mesoderm morphogenesis, GO:0048589|developmental growth, GO:0048617|embryonic foregut morphogenesis, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0060039|pericardium development, GO:0060395|SMAD protein signal transduction, GO:1900224|positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019902|phosphatase binding, GO:0003690|double-stranded DNA binding, GO:0008134|transcription factor binding, GO:0070412|R-SMAD binding, GO:0048156|tau protein binding, GO:0070410|co-SMAD binding, GO:0031625|ubiquitin protein ligase binding, GO:0034713|type I transforming growth factor beta receptor binding, GO:0070411|I-SMAD binding, GO:0030618|transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity, GO:0035326|enhancer binding, GO:0097718|disordered domain specific binding, GO:0033613|activating transcription factor binding, GO:0046332|SMAD binding, GO:0070878|primary miRNA binding, GO:0005160|transforming growth factor beta receptor binding, GO:0003682|chromatin binding, GO:0042803|protein homodimerization activity, GO:0046982|protein heterodimerization activity"
PPM1D,Silent,0.386822537961233,13,0.191647236546964,N,Oncogene,Oncogene,0.515162328146557,0.071598577078167,ENSG00000170836,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm","GO:0006468|protein phosphorylation, GO:0006470|protein dephosphorylation, GO:0007049|cell cycle, GO:0000086|G2/M transition of mitotic cell cycle, GO:0006306|DNA methylation, GO:0006342|chromatin silencing, GO:0009267|cellular response to starvation, GO:0009617|response to bacterium, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0008285|negative regulation of cell proliferation, GO:0009314|response to radiation, GO:0035970|peptidyl-threonine dephosphorylation, GO:0045814|negative regulation of gene expression, epigenetic","GO:0046872|metal ion binding, GO:0016787|hydrolase activity, GO:0003824|catalytic activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004722|protein serine/threonine phosphatase activity, GO:0043169|cation binding, GO:0004724|magnesium-dependent protein serine/threonine phosphatase activity, GO:0004674|protein serine/threonine kinase activity, GO:0051019|mitogen-activated protein kinase binding"
EBF1,Silent,0.385414004757395,36,0.0202672840498805,N,"TSG, fusion",TSG,0.357397285829799,0.0323589104166456,ENSG00000164330,GO:0005634|nucleus,"GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0045944|positive regulation of transcription by RNA polymerase II","GO:0046872|metal ion binding, GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0070742|C2H2 zinc finger domain binding"
PBRM1,Nonsense,0.384782083730531,69,0.00109651474245724,Y,TSG,TSG,0.518951411696808,4.91487607005793e-06,ENSG00000163939,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016586|RSC-type complex, GO:0000228|nuclear chromosome","GO:0006325|chromatin organization, GO:0006338|chromatin remodeling, GO:0043044|ATP-dependent chromatin remodeling, GO:0008285|negative regulation of cell proliferation, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0000278|mitotic cell cycle, GO:0006337|nucleosome disassembly","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003682|chromatin binding, GO:0015616|DNA translocase activity"
FOXP1,Missense,0.383344410937607,55,0.00386577832992298,Y,"oncogene, fusion",Oncogene,0.403070060904084,0.00227955938633865,ENSG00000114861,"GO:0005634|nucleus, GO:0005654|nucleoplasm","GO:0010629|negative regulation of gene expression, GO:0050861|positive regulation of B cell receptor signaling pathway, GO:0006974|cellular response to DNA damage stimulus, GO:0006355|regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0032496|response to lipopolysaccharide, GO:0042116|macrophage activation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0010595|positive regulation of endothelial cell migration, GO:0042118|endothelial cell activation, GO:0030316|osteoclast differentiation, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0035019|somatic stem cell population maintenance, GO:0050727|regulation of inflammatory response, GO:0060766|negative regulation of androgen receptor signaling pathway, GO:0032680|regulation of tumor necrosis factor production, GO:1901509|regulation of endothelial tube morphogenesis, GO:0036035|osteoclast development, GO:0042117|monocyte activation, GO:0061470|T follicular helper cell differentiation, GO:0002903|negative regulation of B cell apoptotic process, GO:0035926|chemokine (C-C motif) ligand 2 secretion, GO:0045655|regulation of monocyte differentiation, GO:0050706|regulation of interleukin-1 beta secretion, GO:0072619|interleukin-21 secretion, GO:1900424|regulation of defense response to bacterium, GO:1901256|regulation of macrophage colony-stimulating factor production, GO:2001182|regulation of interleukin-12 secretion","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0043621|protein self-association, GO:0050681|androgen receptor binding"
SMO,Silent,0.382639696613372,14,0.176921565994552,N,Oncogene,Oncogene,0.48933501349881,0.0757525244807084,ENSG00000128602,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0005929|cilium, GO:0097542|ciliary tip, GO:0070062|extracellular exosome, GO:0030425|dendrite, GO:0030666|endocytic vesicle membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005901|caveola, GO:0005794|Golgi apparatus, GO:0060170|ciliary membrane, GO:0005737|cytoplasm","GO:0071397|cellular response to cholesterol, GO:0010628|positive regulation of gene expression, GO:0030335|positive regulation of cell migration, GO:0007165|signal transduction, GO:0007166|cell surface receptor signaling pathway, GO:0007186|G protein-coupled receptor signaling pathway, GO:0007275|multicellular organism development, GO:0007224|smoothened signaling pathway, GO:0010629|negative regulation of gene expression, GO:0001947|heart looping, GO:0007417|central nervous system development, GO:0072001|renal system development, GO:0090190|positive regulation of branching involved in ureteric bud morphogenesis, GO:0043392|negative regulation of DNA binding, GO:0061053|somite development, GO:0045880|positive regulation of smoothened signaling pathway, GO:0048853|forebrain morphogenesis, GO:0003140|determination of left/right asymmetry in lateral mesoderm, GO:0007228|positive regulation of hh target transcription factor activity, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001503|ossification, GO:0001570|vasculogenesis, GO:0001649|osteoblast differentiation, GO:0001701|in utero embryonic development, GO:0001708|cell fate specification, GO:0001755|neural crest cell migration, GO:0002052|positive regulation of neuroblast proliferation, GO:0002053|positive regulation of mesenchymal cell proliferation, GO:0003007|heart morphogenesis, GO:0003323|type B pancreatic cell development, GO:0007368|determination of left/right symmetry, GO:0007371|ventral midline determination, GO:0007389|pattern specification process, GO:0007494|midgut development, GO:0008284|positive regulation of cell proliferation, GO:0009952|anterior/posterior pattern specification, GO:0009953|dorsal/ventral pattern formation, GO:0010468|regulation of gene expression, GO:0021542|dentate gyrus development, GO:0021696|cerebellar cortex morphogenesis, GO:0021794|thalamus development, GO:0021904|dorsal/ventral neural tube patterning, GO:0021910|smoothened signaling pathway involved in ventral spinal cord patterning, GO:0021938|smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation, GO:0021953|central nervous system neuron differentiation, GO:0021987|cerebral cortex development, GO:0030857|negative regulation of epithelial cell differentiation, GO:0031069|hair follicle morphogenesis, GO:0034504|protein localization to nucleus, GO:0035264|multicellular organism growth, GO:0040018|positive regulation of multicellular organism growth, GO:0042307|positive regulation of protein import into nucleus, GO:0042475|odontogenesis of dentin-containing tooth, GO:0043066|negative regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046622|positive regulation of organ growth, GO:0048143|astrocyte activation, GO:0048468|cell development, GO:0048565|digestive tract development, GO:0048568|embryonic organ development, GO:0048589|developmental growth, GO:0048741|skeletal muscle fiber development, GO:0048873|homeostasis of number of cells within a tissue, GO:0050679|positive regulation of epithelial cell proliferation, GO:0050821|protein stabilization, GO:0051451|myoblast migration, GO:0051799|negative regulation of hair follicle development, GO:0060248|detection of cell density by contact stimulus involved in contact inhibition, GO:0060413|atrial septum morphogenesis, GO:0060644|mammary gland epithelial cell differentiation, GO:0060684|epithelial-mesenchymal cell signaling, GO:0061113|pancreas morphogenesis, GO:0070986|left/right axis specification, GO:0071679|commissural neuron axon guidance, GO:0072285|mesenchymal to epithelial transition involved in metanephric renal vesicle formation, GO:2000036|regulation of stem cell population maintenance, GO:2000826|regulation of heart morphogenesis","GO:0004888|transmembrane signaling receptor activity, GO:0004930|G protein-coupled receptor activity, GO:0005515|protein binding, GO:0008144|drug binding, GO:0005113|patched binding"
CDH11,Missense,0.382186778778542,117,2.11701637365604e-05,Y,"TSG, fusion",TSG,0.46728817911557,1.08791684713878e-07,ENSG00000140937,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0009986|cell surface, GO:0070062|extracellular exosome, GO:0005913|cell-cell adherens junction, GO:0016342|catenin complex, GO:0005737|cytoplasm","GO:0007155|cell adhesion, GO:0007156|homophilic cell adhesion via plasma membrane adhesion molecules, GO:0098609|cell-cell adhesion, GO:0001503|ossification, GO:0007043|cell-cell junction assembly, GO:0001501|skeletal system development, GO:0034332|adherens junction organization, GO:0000902|cell morphogenesis, GO:0016339|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules, GO:0044331|cell-cell adhesion mediated by cadherin, GO:0021957|corticospinal tract morphogenesis","GO:0046872|metal ion binding, GO:0005509|calcium ion binding, GO:0045296|cadherin binding, GO:0042803|protein homodimerization activity, GO:0008092|cytoskeletal protein binding"
ARID2,Nonsense,0.380620603182769,76,0.000694337908927309,Y,TSG,TSG,0.541635531838279,4.35954261448868e-07,ENSG00000189079,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005886|plasma membrane","GO:0008285|negative regulation of cell proliferation, GO:0030336|negative regulation of cell migration, GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006337|nucleosome disassembly, GO:0003007|heart morphogenesis, GO:0042592|homeostatic process, GO:0048568|embryonic organ development, GO:0060038|cardiac muscle cell proliferation, GO:0060982|coronary artery morphogenesis, GO:0072358|cardiovascular system development","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
PTPRT,Missense,0.380474662941423,158,8.17000647376632e-07,Y,TSG,TSG,0.310407506045624,7.20898546552546e-05,ENSG00000196090,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0009986|cell surface, GO:0005887|integral component of plasma membrane","GO:0030336|negative regulation of cell migration, GO:0007155|cell adhesion, GO:0006470|protein dephosphorylation, GO:0007165|signal transduction, GO:0016311|dephosphorylation, GO:0007156|homophilic cell adhesion via plasma membrane adhesion molecules, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0071354|cellular response to interleukin-6, GO:1904893|negative regulation of STAT cascade, GO:1990264|peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0005001|transmembrane receptor protein tyrosine phosphatase activity, GO:0008013|beta-catenin binding, GO:0019903|protein phosphatase binding, GO:0042803|protein homodimerization activity, GO:0045294|alpha-catenin binding, GO:0045295|gamma-catenin binding, GO:0045296|cadherin binding, GO:0070097|delta-catenin binding, GO:0097677|STAT family protein binding, GO:0016790|thiolester hydrolase activity, GO:0051393|alpha-actinin binding"
HOXA13,Missense,0.378106645093627,20,0.100227402319598,N,"oncogene, fusion",Oncogene,0.79474566339357,2.836470937049e-05,ENSG00000106031,GO:0005634|nucleus,"GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0006357|regulation of transcription by RNA polymerase II, GO:0001501|skeletal system development","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
LIFR,Silent,0.377645043078608,40,0.0162872849975428,N,fusion,"",0.54466921473625,0.000279445676295336,ENSG00000113594,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0009897|external side of plasma membrane, GO:0043235|receptor complex, GO:0070062|extracellular exosome, GO:0005887|integral component of plasma membrane","GO:0008284|positive regulation of cell proliferation, GO:0007166|cell surface receptor signaling pathway, GO:0019221|cytokine-mediated signaling pathway, GO:0001959|regulation of cytokine-mediated signaling pathway, GO:0034097|response to cytokine, GO:0070120|ciliary neurotrophic factor-mediated signaling pathway, GO:0038165|oncostatin-M-mediated signaling pathway, GO:0048861|leukemia inhibitory factor signaling pathway","GO:0005515|protein binding, GO:0004896|cytokine receptor activity, GO:0019838|growth factor binding, GO:0005127|ciliary neurotrophic factor receptor binding, GO:0019955|cytokine binding, GO:0004897|ciliary neurotrophic factor receptor activity, GO:0004923|leukemia inhibitory factor receptor activity, GO:0004924|oncostatin-M receptor activity"
NUMA1,Nonsense,0.376112889103517,11,0.25427999887685,N,fusion,"",0.428186202524843,0.188895186353251,ENSG00000137497,"GO:0005654|nucleoplasm, GO:0000139|Golgi membrane, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005694|chromosome, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0005874|microtubule, GO:0000922|spindle pole, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0070062|extracellular exosome, GO:0005938|cell cortex, GO:0032991|protein-containing complex, GO:0005876|spindle microtubule, GO:0016328|lateral plasma membrane, GO:0016363|nuclear matrix, GO:0097431|mitotic spindle pole, GO:1990023|mitotic spindle midzone, GO:0099738|cell cortex region, GO:0005819|spindle, GO:0072686|mitotic spindle, GO:0097427|microtubule bundle, GO:0036449|microtubule minus-end, GO:0031616|spindle pole centrosome, GO:0019897|extrinsic component of plasma membrane, GO:0035371|microtubule plus-end, GO:0097575|lateral cell cortex, GO:0055028|cortical microtubule, GO:0061673|mitotic spindle astral microtubule, GO:1905720|cytoplasmic microtubule bundle, GO:0030425|dendrite, GO:0043025|neuronal cell body","GO:0051301|cell division, GO:0007049|cell cycle, GO:0007059|chromosome segregation, GO:0001578|microtubule bundle formation, GO:0000132|establishment of mitotic spindle orientation, GO:0006997|nucleus organization, GO:1904778|positive regulation of protein localization to cell cortex, GO:0045618|positive regulation of keratinocyte differentiation, GO:0031116|positive regulation of microtubule polymerization, GO:0030513|positive regulation of BMP signaling pathway, GO:0030953|astral microtubule organization, GO:0060236|regulation of mitotic spindle organization, GO:1905832|positive regulation of spindle assembly, GO:0032388|positive regulation of intracellular transport, GO:0090235|regulation of metaphase plate congression, GO:0051798|positive regulation of hair follicle development, GO:0051984|positive regulation of chromosome segregation, GO:0055048|anastral spindle assembly, GO:1902365|positive regulation of protein localization to spindle pole body, GO:1902846|positive regulation of mitotic spindle elongation, GO:1905820|positive regulation of chromosome separation, GO:0051321|meiotic cell cycle","GO:0005515|protein binding, GO:0008289|lipid binding, GO:0008017|microtubule binding, GO:0035091|phosphatidylinositol binding, GO:0070840|dynein complex binding, GO:0019904|protein domain specific binding, GO:0015631|tubulin binding, GO:0005198|structural molecule activity, GO:0044877|protein-containing complex binding, GO:0051010|microtubule plus-end binding, GO:0097718|disordered domain specific binding, GO:0008022|protein C-terminus binding, GO:0051011|microtubule minus-end binding"
MYB,Silent,0.374759904851986,18,0.125448161519773,N,"oncogene, fusion",Oncogene,0.400562653945844,0.0995043650063908,ENSG00000118513,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016363|nuclear matrix, GO:0016020|membrane, GO:0016021|integral component of membrane","GO:0006355|regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000278|mitotic cell cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0006338|chromatin remodeling, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0045624|positive regulation of T-helper cell differentiation, GO:0051571|positive regulation of histone H3-K4 methylation, GO:0051574|positive regulation of histone H3-K9 methylation, GO:0001666|response to hypoxia, GO:0032967|positive regulation of collagen biosynthetic process, GO:0043525|positive regulation of neuron apoptotic process, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0060252|positive regulation of glial cell proliferation, GO:0070301|cellular response to hydrogen peroxide, GO:0071300|cellular response to retinoic acid, GO:0071636|positive regulation of transforming growth factor beta production, GO:1901216|positive regulation of neuron death, GO:1904899|positive regulation of hepatic stellate cell proliferation, GO:2000491|positive regulation of hepatic stellate cell activation, GO:2000845|positive regulation of testosterone secretion","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
MET,Silent,0.373649668693643,41,0.0161099097938756,N,Oncogene,Oncogene,0.631662773607892,9.47248155804782e-06,ENSG00000105976,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005576|extracellular region, GO:0009986|cell surface, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0009925|basal plasma membrane","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1901299|negative regulation of hydrogen peroxide-mediated programmed cell death, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0046854|phosphatidylinositol phosphorylation, GO:0030182|neuron differentiation, GO:0007399|nervous system development, GO:0010507|negative regulation of autophagy, GO:0016477|cell migration, GO:0007165|signal transduction, GO:0051897|positive regulation of protein kinase B signaling, GO:0000165|MAPK cascade, GO:0008283|cell proliferation, GO:0016055|Wnt signaling pathway, GO:0071526|semaphorin-plexin signaling pathway, GO:0048754|branching morphogenesis of an epithelial tube, GO:0050918|positive chemotaxis, GO:0035635|entry of bacterium into host cell, GO:0007166|cell surface receptor signaling pathway, GO:0006909|phagocytosis, GO:0001886|endothelial cell morphogenesis, GO:0001889|liver development, GO:0031016|pancreas development, GO:0031116|positive regulation of microtubule polymerization, GO:0035024|negative regulation of Rho protein signal transduction, GO:0048012|hepatocyte growth factor receptor signaling pathway, GO:0051497|negative regulation of stress fiber assembly, GO:0061436|establishment of skin barrier, GO:0070495|negative regulation of thrombin-activated receptor signaling pathway, GO:1905098|negative regulation of guanyl-nucleotide exchange factor activity, GO:2001028|positive regulation of endothelial cell chemotaxis","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0042802|identical protein binding, GO:0017147|Wnt-protein binding, GO:0019903|protein phosphatase binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005008|hepatocyte growth factor-activated receptor activity"
CDH1,Nonsense,0.373070471571159,28,0.0505416765060293,N,TSG,TSG,0.253606177468725,0.192852925063045,ENSG00000039068,"GO:0048471|perinuclear region of cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005794|Golgi apparatus, GO:0030054|cell junction, GO:0005576|extracellular region, GO:0005737|cytoplasm, GO:0009986|cell surface, GO:0005768|endosome, GO:0030027|lamellipodium, GO:0070062|extracellular exosome, GO:0043296|apical junction complex, GO:0005913|cell-cell adherens junction, GO:0015629|actin cytoskeleton, GO:0009898|cytoplasmic side of plasma membrane, GO:0030864|cortical actin cytoskeleton, GO:0016328|lateral plasma membrane, GO:0016342|catenin complex, GO:0016600|flotillin complex, GO:0005802|trans-Golgi network","GO:0030336|negative regulation of cell migration, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007155|cell adhesion, GO:0007156|homophilic cell adhesion via plasma membrane adhesion molecules, GO:0098609|cell-cell adhesion, GO:0007416|synapse assembly, GO:0009636|response to toxic substance, GO:0010033|response to organic substance, GO:0021983|pituitary gland development, GO:0031175|neuron projection development, GO:0042493|response to drug, GO:0007043|cell-cell junction assembly, GO:0030198|extracellular matrix organization, GO:0022408|negative regulation of cell-cell adhesion, GO:0072659|protein localization to plasma membrane, GO:0034332|adherens junction organization, GO:0035635|entry of bacterium into host cell, GO:0000902|cell morphogenesis, GO:0010468|regulation of gene expression, GO:0042307|positive regulation of protein import into nucleus, GO:0016339|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules, GO:0044331|cell-cell adhesion mediated by cadherin, GO:0071285|cellular response to lithium ion, GO:0071681|cellular response to indole-3-methanol","GO:0046872|metal ion binding, GO:0005509|calcium ion binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0045296|cadherin binding, GO:0042803|protein homodimerization activity, GO:0008092|cytoskeletal protein binding, GO:0008013|beta-catenin binding, GO:0030506|ankyrin binding, GO:0050839|cell adhesion molecule binding, GO:0032794|GTPase activating protein binding, GO:0045295|gamma-catenin binding"
KEAP1,Missense,0.37190680045973,97,0.000176236297760224,Y,TSG,TSG,0.383822234944623,0.00010404945855052,ENSG00000079999,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005815|microtubule organizing center, GO:0005783|endoplasmic reticulum, GO:0005884|actin filament, GO:0031463|Cul3-RING ubiquitin ligase complex, GO:0032991|protein-containing complex, GO:0030496|midbody","GO:0016567|protein ubiquitination, GO:0001701|in utero embryonic development, GO:0006355|regulation of transcription, DNA-templated, GO:0045604|regulation of epidermal cell differentiation, GO:0071353|cellular response to interleukin-4, GO:0016579|protein deubiquitination, GO:0043687|post-translational protein modification, GO:0016032|viral process, GO:0010499|proteasomal ubiquitin-independent protein catabolic process, GO:0032436|positive regulation of proteasomal ubiquitin-dependent protein catabolic process, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0042994|cytoplasmic sequestering of transcription factor","GO:0008134|transcription factor binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0042803|protein homodimerization activity, GO:0097718|disordered domain specific binding"
GRIN2A,Missense,0.370622443714797,253,1.17247575623478e-09,Y,TSG,TSG,0.349088863918965,1.15931070567591e-08,ENSG00000183454,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0030054|cell junction, GO:0045202|synapse, GO:0045211|postsynaptic membrane, GO:0098839|postsynaptic density membrane, GO:0005887|integral component of plasma membrane, GO:0014069|postsynaptic density, GO:0009986|cell surface, GO:0017146|NMDA selective glutamate receptor complex, GO:0097060|synaptic membrane, GO:0005783|endoplasmic reticulum, GO:0008021|synaptic vesicle, GO:0042734|presynaptic membrane, GO:0043005|neuron projection, GO:0099061|integral component of postsynaptic density membrane","GO:0006811|ion transport, GO:0034220|ion transmembrane transport, GO:0070588|calcium ion transmembrane transport, GO:0098655|cation transmembrane transport, GO:0035235|ionotropic glutamate receptor signaling pathway, GO:0007268|chemical synaptic transmission, GO:0000165|MAPK cascade, GO:0060079|excitatory postsynaptic potential, GO:0007420|brain development, GO:0019722|calcium-mediated signaling, GO:0048167|regulation of synaptic plasticity, GO:0060291|long-term synaptic potentiation, GO:0097553|calcium ion transmembrane import into cytosol, GO:0098976|excitatory chemical synaptic transmission, GO:0007215|glutamate receptor signaling pathway, GO:0007611|learning or memory, GO:0045471|response to ethanol, GO:0001964|startle response, GO:0001975|response to amphetamine, GO:0006816|calcium ion transport, GO:0007612|learning, GO:0007613|memory, GO:0008542|visual learning, GO:0009611|response to wounding, GO:0019233|sensory perception of pain, GO:0022008|neurogenesis, GO:0030431|sleep, GO:0033058|directional locomotion, GO:0040011|locomotion, GO:0042177|negative regulation of protein catabolic process, GO:0042391|regulation of membrane potential, GO:0042417|dopamine metabolic process, GO:0042428|serotonin metabolic process, GO:0042493|response to drug, GO:0043065|positive regulation of apoptotic process, GO:0050804|modulation of chemical synaptic transmission, GO:0051930|regulation of sensory perception of pain, GO:0060078|regulation of postsynaptic membrane potential, GO:0097202|activation of cysteine-type endopeptidase activity, GO:1900273|positive regulation of long-term synaptic potentiation, GO:1903539|protein localization to postsynaptic membrane","GO:0046872|metal ion binding, GO:0005216|ion channel activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0038023|signaling receptor activity, GO:0004970|ionotropic glutamate receptor activity, GO:0001540|amyloid-beta binding, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0004972|NMDA glutamate receptor activity, GO:0022849|glutamate-gated calcium ion channel activity, GO:0005261|cation channel activity, GO:0005262|calcium channel activity"
SMARCB1,Silent,0.370603889511448,16,0.157631544772037,N,TSG,TSG,0.299228878122957,0.260222593819578,ENSG00000099956,"GO:0005634|nucleus, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0001650|fibrillar center, GO:0000790|nuclear chromatin, GO:0000228|nuclear chromosome, GO:0005730|nucleolus, GO:0032991|protein-containing complex, GO:0016514|SWI/SNF complex, GO:0071564|npBAF complex, GO:0071565|nBAF complex, GO:0001741|XY body","GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006325|chromatin organization, GO:0007049|cell cycle, GO:0006338|chromatin remodeling, GO:0007399|nervous system development, GO:0030154|cell differentiation, GO:0043044|ATP-dependent chromatin remodeling, GO:0006357|regulation of transcription by RNA polymerase II, GO:0008285|negative regulation of cell proliferation, GO:0016032|viral process, GO:0006337|nucleosome disassembly, GO:0001188|RNA polymerase I preinitiation complex assembly, GO:1901838|positive regulation of transcription of nucleolar large rRNA by RNA polymerase I, GO:0090240|positive regulation of histone H4 acetylation, GO:0043923|positive regulation by host of viral transcription, GO:1902661|positive regulation of glucose mediated signaling pathway, GO:0015074|DNA integration, GO:0039692|single stranded viral RNA replication via double stranded DNA intermediate, GO:1900110|negative regulation of histone H3-K9 dimethylation, GO:1900113|negative regulation of histone H3-K9 trimethylation, GO:2000617|positive regulation of histone H3-K9 acetylation, GO:0001824|blastocyst development, GO:0001835|blastocyst hatching","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0002039|p53 binding, GO:0031492|nucleosomal DNA binding, GO:0001164|RNA polymerase I CORE element sequence-specific DNA binding, GO:0030957|Tat protein binding"
AFF4,Missense,0.370448813618437,74,0.00115857395119648,Y,"oncogene, fusion",Oncogene,0.454349400336937,4.77678108354175e-05,ENSG00000072364,"GO:0005634|nucleus, GO:0001650|fibrillar center, GO:0005654|nucleoplasm, GO:0008023|transcription elongation factor complex, GO:0035327|transcriptionally active chromatin, GO:0032783|ELL-EAF complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006366|transcription by RNA polymerase II, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0007286|spermatid development","GO:0005515|protein binding, GO:0003700|DNA-binding transcription factor activity, GO:0003690|double-stranded DNA binding"
PTPRB,Missense,0.370216571280305,194,1.07715981924147e-07,Y,TSG,TSG,0.420126950353539,1.07109094172235e-09,ENSG00000127329,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0035579|specific granule membrane, GO:0070821|tertiary granule membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex","GO:0006470|protein dephosphorylation, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0001525|angiogenesis, GO:0043312|neutrophil degranulation, GO:0006796|phosphate-containing compound metabolic process","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0005001|transmembrane receptor protein tyrosine phosphatase activity"
AKT2,Silent,0.369754986443726,21,0.0989948083513382,N,Oncogene,Oncogene,0.389112074785699,0.0812607854437377,ENSG00000105221,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005768|endosome, GO:0005654|nucleoplasm, GO:0005769|early endosome, GO:0005938|cell cortex, GO:0032587|ruffle membrane, GO:0032991|protein-containing complex","GO:0046326|positive regulation of glucose import, GO:0030335|positive regulation of cell migration, GO:0032869|cellular response to insulin stimulus, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007165|signal transduction, GO:0006915|apoptotic process, GO:0005975|carbohydrate metabolic process, GO:0007275|multicellular organism development, GO:0008643|carbohydrate transport, GO:0043491|protein kinase B signaling, GO:0035556|intracellular signal transduction, GO:0018105|peptidyl-serine phosphorylation, GO:0045444|fat cell differentiation, GO:0001934|positive regulation of protein phosphorylation, GO:0006417|regulation of translation, GO:0090314|positive regulation of protein targeting to membrane, GO:0005977|glycogen metabolic process, GO:0006006|glucose metabolic process, GO:0008284|positive regulation of cell proliferation, GO:0005978|glycogen biosynthetic process, GO:0030334|regulation of cell migration, GO:0043066|negative regulation of apoptotic process, GO:0006464|cellular protein modification process, GO:0008286|insulin receptor signaling pathway, GO:2000147|positive regulation of cell motility, GO:0060644|mammary gland epithelial cell differentiation, GO:0045725|positive regulation of glycogen biosynthetic process, GO:0031340|positive regulation of vesicle fusion, GO:0010748|negative regulation of plasma membrane long-chain fatty acid transport, GO:0010907|positive regulation of glucose metabolic process, GO:0010918|positive regulation of mitochondrial membrane potential, GO:0032000|positive regulation of fatty acid beta-oxidation, GO:0032287|peripheral nervous system myelin maintenance, GO:0065002|intracellular protein transmembrane transport, GO:0071156|regulation of cell cycle arrest, GO:0071486|cellular response to high light intensity, GO:0072659|protein localization to plasma membrane, GO:0090630|activation of GTPase activity, GO:0097473|retinal rod cell apoptotic process","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding"
PIK3CB,Silent,0.369634682231515,21,0.0991132135435968,N,Oncogene,Oncogene,0.650970334771921,0.00139366425364704,ENSG00000051382,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005730|nucleolus, GO:0030496|midbody, GO:0005886|plasma membrane, GO:0016020|membrane, GO:0005829|cytosol, GO:0005942|phosphatidylinositol 3-kinase complex","GO:0016310|phosphorylation, GO:0007155|cell adhesion, GO:0007186|G protein-coupled receptor signaling pathway, GO:0006914|autophagy, GO:0046854|phosphatidylinositol phosphorylation, GO:0048015|phosphatidylinositol-mediated signaling, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0050900|leukocyte migration, GO:0050852|T cell receptor signaling pathway, GO:0006468|protein phosphorylation, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0006897|endocytosis, GO:0010508|positive regulation of autophagy, GO:0016477|cell migration, GO:0006935|chemotaxis, GO:0007165|signal transduction, GO:0070527|platelet aggregation, GO:0030168|platelet activation, GO:0007411|axon guidance, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0019221|cytokine-mediated signaling pathway, GO:0033031|positive regulation of neutrophil apoptotic process, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0051897|positive regulation of protein kinase B signaling, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0010628|positive regulation of gene expression, GO:0000187|activation of MAPK activity, GO:0001952|regulation of cell-matrix adhesion, GO:2000369|regulation of clathrin-dependent endocytosis, GO:0001935|endothelial cell proliferation, GO:0006874|cellular calcium ion homeostasis, GO:0007156|homophilic cell adhesion via plasma membrane adhesion molecules, GO:0009611|response to wounding, GO:0040016|embryonic cleavage, GO:0060055|angiogenesis involved in wound healing","GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0035004|phosphatidylinositol 3-kinase activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0035005|1-phosphatidylinositol-4-phosphate 3-kinase activity, GO:0043560|insulin receptor substrate binding"
CBLB,Silent,0.367899647401701,36,0.0272745079098298,N,TSG,TSG,0.455843628592978,0.00520619529835914,ENSG00000114423,"GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0045121|membrane raft","GO:0016567|protein ubiquitination, GO:0023051|regulation of signaling, GO:0007166|cell surface receptor signaling pathway, GO:0007165|signal transduction, GO:0006607|NLS-bearing protein import into nucleus, GO:0007175|negative regulation of epidermal growth factor-activated receptor activity, GO:2000583|regulation of platelet-derived growth factor receptor-alpha signaling pathway","GO:0005509|calcium ion binding, GO:0004842|ubiquitin-protein transferase activity, GO:0001784|phosphotyrosine residue binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0061630|ubiquitin protein ligase activity, GO:0017124|SH3 domain binding, GO:0008270|zinc ion binding, GO:0030971|receptor tyrosine kinase binding"
TP63,Missense,0.367213558523444,94,0.000271908928204566,Y,"oncogene, TSG","",0.38035174713657,0.000155908556825081,ENSG00000073282,"GO:0005739|mitochondrion, GO:0005634|nucleus, GO:0005794|Golgi apparatus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005791|rough endoplasmic reticulum, GO:0030425|dendrite, GO:0032991|protein-containing complex, GO:0043005|neuron projection, GO:0000790|nuclear chromatin, GO:0005737|cytoplasm","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045669|positive regulation of osteoblast differentiation, GO:0006355|regulation of transcription, DNA-templated, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0051262|protein tetramerization, GO:0007219|Notch signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0032502|developmental process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001302|replicative cell aging, GO:0001501|skeletal system development, GO:0001736|establishment of planar polarity, GO:0001738|morphogenesis of a polarized epithelium, GO:0001942|hair follicle development, GO:0002064|epithelial cell development, GO:0006338|chromatin remodeling, GO:0007283|spermatogenesis, GO:0007389|pattern specification process, GO:0007499|ectoderm and mesoderm interaction, GO:0007568|aging, GO:0007569|cell aging, GO:0008283|cell proliferation, GO:0008544|epidermis development, GO:0009887|animal organ morphogenesis, GO:0009913|epidermal cell differentiation, GO:0009954|proximal/distal pattern formation, GO:0010259|multicellular organism aging, GO:0010481|epidermal cell division, GO:0010482|regulation of epidermal cell division, GO:0010838|positive regulation of keratinocyte proliferation, GO:0030154|cell differentiation, GO:0030216|keratinocyte differentiation, GO:0030326|embryonic limb morphogenesis, GO:0030850|prostate gland development, GO:0030855|epithelial cell differentiation, GO:0030859|polarized epithelial cell differentiation, GO:0031069|hair follicle morphogenesis, GO:0033147|negative regulation of intracellular estrogen receptor signaling pathway, GO:0035115|embryonic forelimb morphogenesis, GO:0035116|embryonic hindlimb morphogenesis, GO:0036342|post-anal tail morphogenesis, GO:0042475|odontogenesis of dentin-containing tooth, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0043281|regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0043589|skin morphogenesis, GO:0045617|negative regulation of keratinocyte differentiation, GO:0045747|positive regulation of Notch signaling pathway, GO:0048485|sympathetic nervous system development, GO:0048646|anatomical structure formation involved in morphogenesis, GO:0048807|female genitalia morphogenesis, GO:0051402|neuron apoptotic process, GO:0060197|cloacal septation, GO:0060513|prostatic bud formation, GO:0060529|squamous basal epithelial stem cell differentiation involved in prostate gland acinus development, GO:0061436|establishment of skin barrier, GO:0098773|skin epidermis development, GO:1904674|positive regulation of somatic stem cell population maintenance, GO:1904888|cranial skeletal system development, GO:2000381|negative regulation of mesoderm development, GO:2001235|positive regulation of apoptotic signaling pathway, GO:0042981|regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0051289|protein homotetramerization, GO:1900740|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, GO:2000271|positive regulation of fibroblast apoptotic process, GO:0007049|cell cycle","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0044212|transcription regulatory region DNA binding, GO:0042802|identical protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0003684|damaged DNA binding, GO:0003690|double-stranded DNA binding, GO:0019904|protein domain specific binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0002039|p53 binding, GO:0097371|MDM2/MDM4 family protein binding, GO:0050699|WW domain binding"
KDR,Missense,0.364972119319751,202,9.27385243365093e-08,Y,Oncogene,Oncogene,0.373814005220019,4.25592799627618e-08,ENSG00000128052,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0030054|cell junction, GO:0031410|cytoplasmic vesicle, GO:0045121|membrane raft, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005768|endosome, GO:0005769|early endosome, GO:0097443|sorting endosome","GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:0010629|negative regulation of gene expression, GO:0045766|positive regulation of angiogenesis, GO:0008284|positive regulation of cell proliferation, GO:0010595|positive regulation of endothelial cell migration, GO:0090050|positive regulation of cell migration involved in sprouting angiogenesis, GO:0030335|positive regulation of cell migration, GO:0008360|regulation of cell shape, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0038084|vascular endothelial growth factor signaling pathway, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0001934|positive regulation of protein phosphorylation, GO:0016032|viral process, GO:0001525|angiogenesis, GO:0016477|cell migration, GO:0043066|negative regulation of apoptotic process, GO:0001938|positive regulation of endothelial cell proliferation, GO:0046777|protein autophosphorylation, GO:0030198|extracellular matrix organization, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:0035924|cellular response to vascular endothelial growth factor stimulus, GO:0002042|cell migration involved in sprouting angiogenesis, GO:0051894|positive regulation of focal adhesion assembly, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0002040|sprouting angiogenesis, GO:0016239|positive regulation of macroautophagy, GO:0001570|vasculogenesis, GO:0035584|calcium-mediated signaling using intracellular calcium source, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0038033|positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway, GO:0070371|ERK1 and ERK2 cascade, GO:0051901|positive regulation of mitochondrial depolarization, GO:0090141|positive regulation of mitochondrial fission, GO:0050927|positive regulation of positive chemotaxis, GO:0035162|embryonic hemopoiesis, GO:2001214|positive regulation of vasculogenesis, GO:0003158|endothelium development, GO:0043491|protein kinase B signaling, GO:0045446|endothelial cell differentiation, GO:0051770|positive regulation of nitric-oxide synthase biosynthetic process, GO:1904881|cellular response to hydrogen sulfide","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005021|vascular endothelial growth factor-activated receptor activity, GO:0019838|growth factor binding, GO:0042802|identical protein binding, GO:0051879|Hsp90 protein binding, GO:0005178|integrin binding, GO:0038085|vascular endothelial growth factor binding"
NKX2-1,Missense,0.364768614197897,37,0.0264354014008383,N,"oncogene, TSG","",0.4521535955745,0.00496102769506868,ENSG00000136352,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0048511|rhythmic process, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0010628|positive regulation of gene expression, GO:0045892|negative regulation of transcription, DNA-templated, GO:0042753|positive regulation of circadian rhythm, GO:0030878|thyroid gland development, GO:0007420|brain development, GO:0010719|negative regulation of epithelial to mesenchymal transition, GO:0030336|negative regulation of cell migration, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0009725|response to hormone, GO:0030324|lung development, GO:0030900|forebrain development, GO:0021759|globus pallidus development, GO:0060441|epithelial tube branching involved in lung morphogenesis, GO:0001764|neuron migration, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006644|phospholipid metabolic process, GO:0007389|pattern specification process, GO:0007411|axon guidance, GO:0007492|endoderm development, GO:0007626|locomotory behavior, GO:0009887|animal organ morphogenesis, GO:0021537|telencephalon development, GO:0021766|hippocampus development, GO:0021795|cerebral cortex cell migration, GO:0021798|forebrain dorsal/ventral pattern formation, GO:0021877|forebrain neuron fate commitment, GO:0021879|forebrain neuron differentiation, GO:0021892|cerebral cortex GABAergic interneuron differentiation, GO:0021895|cerebral cortex neuron differentiation, GO:0021983|pituitary gland development, GO:0022029|telencephalon cell migration, GO:0031128|developmental induction, GO:0033327|Leydig cell differentiation, GO:0048646|anatomical structure formation involved in morphogenesis, GO:0048663|neuron fate commitment, GO:0048709|oligodendrocyte differentiation, GO:0060430|lung saccule development, GO:0060486|Clara cell differentiation, GO:0060510|type II pneumocyte differentiation","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0044212|transcription regulatory region DNA binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0001161|intronic transcription regulatory region sequence-specific DNA binding, GO:0044213|intronic transcription regulatory region DNA binding"
PIK3R1,Silent,0.364340818071904,16,0.165323498622937,N,TSG,TSG,0.406060858731984,0.118614016120668,ENSG00000145675,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005801|cis-Golgi network, GO:0005829|cytosol, GO:0005911|cell-cell junction, GO:0005942|phosphatidylinositol 3-kinase complex, GO:0032991|protein-containing complex, GO:1990578|perinuclear endoplasmic reticulum membrane, GO:0005943|phosphatidylinositol 3-kinase complex, class IA","GO:0046326|positive regulation of glucose import, GO:1903078|positive regulation of protein localization to plasma membrane, GO:0015031|protein transport, GO:0007165|signal transduction, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0050900|leukocyte migration, GO:0043551|regulation of phosphatidylinositol 3-kinase activity, GO:0050852|T cell receptor signaling pathway, GO:0001678|cellular glucose homeostasis, GO:0001953|negative regulation of cell-matrix adhesion, GO:0006468|protein phosphorylation, GO:0006606|protein import into nucleus, GO:0007162|negative regulation of cell adhesion, GO:0008286|insulin receptor signaling pathway, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0030183|B cell differentiation, GO:0030335|positive regulation of cell migration, GO:0032760|positive regulation of tumor necrosis factor production, GO:0032869|cellular response to insulin stimulus, GO:0034644|cellular response to UV, GO:0034976|response to endoplasmic reticulum stress, GO:0042307|positive regulation of protein import into nucleus, GO:0043066|negative regulation of apoptotic process, GO:0045671|negative regulation of osteoclast differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046626|regulation of insulin receptor signaling pathway, GO:0051492|regulation of stress fiber assembly, GO:1903076|regulation of protein localization to plasma membrane, GO:0050821|protein stabilization, GO:0016032|viral process, GO:0007186|G protein-coupled receptor signaling pathway, GO:0046854|phosphatidylinositol phosphorylation, GO:0030168|platelet activation, GO:0007411|axon guidance, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0019221|cytokine-mediated signaling pathway, GO:0051897|positive regulation of protein kinase B signaling, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0048015|phosphatidylinositol-mediated signaling, GO:0060396|growth hormone receptor signaling pathway, GO:0038128|ERBB2 signaling pathway, GO:0031295|T cell costimulation, GO:0033120|positive regulation of RNA splicing, GO:1900103|positive regulation of endoplasmic reticulum unfolded protein response, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0048009|insulin-like growth factor receptor signaling pathway","GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0035014|phosphatidylinositol 3-kinase regulator activity, GO:0036312|phosphatidylinositol 3-kinase regulatory subunit binding, GO:0043560|insulin receptor substrate binding, GO:0046982|protein heterodimerization activity, GO:0046935|1-phosphatidylinositol-3-kinase regulator activity, GO:0019903|protein phosphatase binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0001784|phosphotyrosine residue binding, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0005159|insulin-like growth factor receptor binding, GO:0005158|insulin receptor binding, GO:0043559|insulin binding, GO:0005168|neurotrophin TRKA receptor binding, GO:0005068|transmembrane receptor protein tyrosine kinase adaptor activity, GO:0043125|ErbB-3 class receptor binding, GO:0043548|phosphatidylinositol 3-kinase binding"
ARID1A,Nonsense,0.363469292285038,145,7.00519840528466e-06,Y,"TSG, fusion",TSG,0.701347242109694,8.92569046296561e-23,ENSG00000117713,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016514|SWI/SNF complex, GO:0070603|SWI/SNF superfamily-type complex, GO:0000790|nuclear chromatin, GO:0071564|npBAF complex, GO:0071565|nBAF complex","GO:0006338|chromatin remodeling, GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007399|nervous system development, GO:0030521|androgen receptor signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001704|formation of primary germ layer, GO:0001843|neural tube closure, GO:0003205|cardiac chamber development, GO:0003408|optic cup formation involved in camera-type eye development, GO:0006337|nucleosome disassembly, GO:0006344|maintenance of chromatin silencing, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007369|gastrulation, GO:0007566|embryo implantation, GO:0019827|stem cell population maintenance, GO:0030520|intracellular estrogen receptor signaling pathway, GO:0030900|forebrain development, GO:0042766|nucleosome mobilization, GO:0042921|glucocorticoid receptor signaling pathway, GO:0043044|ATP-dependent chromatin remodeling, GO:0048096|chromatin-mediated maintenance of transcription, GO:0055007|cardiac muscle cell differentiation, GO:0060674|placenta blood vessel development, GO:1901998|toxin transport","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003713|transcription coactivator activity, GO:0016922|nuclear receptor binding, GO:0031491|nucleosome binding"
AMER1,Missense,0.361815365017382,74,0.00153747130262743,Y,TSG,TSG,0.609446581465925,8.28417782129677e-09,ENSG00000184675,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005886|plasma membrane, GO:0016604|nuclear body, GO:0005829|cytosol","GO:0016055|Wnt signaling pathway, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:1904886|beta-catenin destruction complex disassembly, GO:1904885|beta-catenin destruction complex assembly, GO:0031398|positive regulation of protein ubiquitination, GO:0060828|regulation of canonical Wnt signaling pathway, GO:1903364|positive regulation of cellular protein catabolic process, GO:0001822|kidney development, GO:0060348|bone development, GO:0060612|adipose tissue development, GO:0072161|mesenchymal cell differentiation involved in kidney development","GO:0005515|protein binding, GO:0008289|lipid binding, GO:0005546|phosphatidylinositol-4,5-bisphosphate binding, GO:0008013|beta-catenin binding, GO:1904713|beta-catenin destruction complex binding"
BRD3,Missense,0.361807205253495,61,0.00416877373734695,Y,"oncogene, fusion",Oncogene,0.379322977048639,0.00257094072377998,ENSG00000169925,GO:0005634|nucleus,"GO:0006325|chromatin organization, GO:0006357|regulation of transcription by RNA polymerase II","GO:0005515|protein binding, GO:0003682|chromatin binding, GO:0070577|lysine-acetylated histone binding"
SMAD3,Missense,0.359809916806674,58,0.00553457169122578,Y,TSG,TSG,0.453916792469829,0.000345168104235275,ENSG00000166949,"GO:0005667|transcription factor complex, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0032991|protein-containing complex, GO:0005637|nuclear inner membrane, GO:0000790|nuclear chromatin, GO:0043235|receptor complex, GO:0071141|SMAD protein complex, GO:0071144|heteromeric SMAD protein complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0010628|positive regulation of gene expression, GO:0045599|negative regulation of fat cell differentiation, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045930|negative regulation of mitotic cell cycle, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001501|skeletal system development, GO:0001649|osteoblast differentiation, GO:0001657|ureteric bud development, GO:0001701|in utero embryonic development, GO:0001707|mesoderm formation, GO:0001756|somitogenesis, GO:0001889|liver development, GO:0001947|heart looping, GO:0002076|osteoblast development, GO:0002520|immune system development, GO:0007183|SMAD protein complex assembly, GO:0007369|gastrulation, GO:0007492|endoderm development, GO:0008285|negative regulation of cell proliferation, GO:0009880|embryonic pattern specification, GO:0010694|positive regulation of alkaline phosphatase activity, GO:0016202|regulation of striated muscle tissue development, GO:0017015|regulation of transforming growth factor beta receptor signaling pathway, GO:0023019|signal transduction involved in regulation of gene expression, GO:0030325|adrenal gland development, GO:0030335|positive regulation of cell migration, GO:0030501|positive regulation of bone mineralization, GO:0030878|thyroid gland development, GO:0032332|positive regulation of chondrocyte differentiation, GO:0032731|positive regulation of interleukin-1 beta production, GO:0032916|positive regulation of transforming growth factor beta3 production, GO:0033689|negative regulation of osteoblast proliferation, GO:0042110|T cell activation, GO:0042177|negative regulation of protein catabolic process, GO:0043066|negative regulation of apoptotic process, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0045668|negative regulation of osteoblast differentiation, GO:0048340|paraxial mesoderm morphogenesis, GO:0048589|developmental growth, GO:0048617|embryonic foregut morphogenesis, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0050678|regulation of epithelial cell proliferation, GO:0050728|negative regulation of inflammatory response, GO:0050776|regulation of immune response, GO:0050821|protein stabilization, GO:0050927|positive regulation of positive chemotaxis, GO:0051098|regulation of binding, GO:0051496|positive regulation of stress fiber assembly, GO:0051894|positive regulation of focal adhesion assembly, GO:0060039|pericardium development, GO:0060290|transdifferentiation, GO:0060395|SMAD protein signal transduction, GO:0061045|negative regulation of wound healing, GO:0061767|negative regulation of lung blood pressure, GO:0070306|lens fiber cell differentiation, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0097296|activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway, GO:1903243|negative regulation of cardiac muscle hypertrophy in response to stress, GO:0016579|protein deubiquitination, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0097191|extrinsic apoptotic signaling pathway, GO:0030308|negative regulation of cell growth, GO:0006955|immune response, GO:0032924|activin receptor signaling pathway, GO:0071345|cellular response to cytokine stimulus, GO:0007050|cell cycle arrest, GO:0019049|evasion or tolerance of host defenses by virus, GO:0042307|positive regulation of protein import into nucleus, GO:0045216|cell-cell junction organization, GO:1901203|positive regulation of extracellular matrix assembly, GO:0042060|wound healing, GO:0071560|cellular response to transforming growth factor beta stimulus, GO:0001666|response to hypoxia, GO:0006366|transcription by RNA polymerase II, GO:0051481|negative regulation of cytosolic calcium ion concentration, GO:0032909|regulation of transforming growth factor beta2 production, GO:0006357|regulation of transcription by RNA polymerase II, GO:0031053|primary miRNA processing, GO:0038092|nodal signaling pathway","GO:0003700|DNA-binding transcription factor activity, GO:0044212|transcription regulatory region DNA binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0003690|double-stranded DNA binding, GO:0005518|collagen binding, GO:0008013|beta-catenin binding, GO:0008134|transcription factor binding, GO:0019899|enzyme binding, GO:0031490|chromatin DNA binding, GO:0042803|protein homodimerization activity, GO:0043565|sequence-specific DNA binding, GO:0046332|SMAD binding, GO:0046982|protein heterodimerization activity, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0019901|protein kinase binding, GO:0019902|phosphatase binding, GO:0043130|ubiquitin binding, GO:0043425|bHLH transcription factor binding, GO:0070412|R-SMAD binding, GO:0070410|co-SMAD binding, GO:0003712|transcription coregulator activity, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0031625|ubiquitin protein ligase binding, GO:0030618|transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity, GO:0035326|enhancer binding, GO:0070878|primary miRNA binding, GO:0005160|transforming growth factor beta receptor binding, GO:0035259|glucocorticoid receptor binding, GO:0016251|RNA polymerase II general transcription initiation factor activity, GO:0017151|DEAD/H-box RNA helicase binding, GO:0031962|mineralocorticoid receptor binding"
ATM,Nonsense,0.359062899516437,49,0.01128744901095,N,TSG,TSG,0.468776897631762,0.000680455149024542,ENSG00000149311,"GO:0005634|nucleus, GO:0031410|cytoplasmic vesicle, GO:0005730|nucleolus, GO:0005654|nucleoplasm, GO:0000784|nuclear chromosome, telomeric region, GO:0000781|chromosome, telomeric region, GO:1990391|DNA repair complex, GO:0005737|cytoplasm","GO:0000077|DNA damage checkpoint, GO:0006281|DNA repair, GO:0000723|telomere maintenance, GO:0010212|response to ionizing radiation, GO:0016572|histone phosphorylation, GO:0090399|replicative senescence, GO:0010628|positive regulation of gene expression, GO:0030335|positive regulation of cell migration, GO:0016310|phosphorylation, GO:0006974|cellular response to DNA damage stimulus, GO:0007049|cell cycle, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:1904262|negative regulation of TORC1 signaling, GO:0043065|positive regulation of apoptotic process, GO:0007165|signal transduction, GO:0042981|regulation of apoptotic process, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0006260|DNA replication, GO:0006468|protein phosphorylation, GO:0046777|protein autophosphorylation, GO:0032212|positive regulation of telomere maintenance via telomerase, GO:0006975|DNA damage induced protein phosphorylation, GO:0071044|histone mRNA catabolic process, GO:0018105|peptidyl-serine phosphorylation, GO:0007131|reciprocal meiotic recombination, GO:0007094|mitotic spindle assembly checkpoint, GO:0000729|DNA double-strand break processing, GO:0006303|double-strand break repair via nonhomologous end joining, GO:1904354|negative regulation of telomere capping, GO:1900034|regulation of cellular response to heat, GO:0030889|negative regulation of B cell proliferation, GO:0032210|regulation of telomere maintenance via telomerase, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0007050|cell cycle arrest, GO:0071480|cellular response to gamma radiation, GO:0010506|regulation of autophagy, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0002331|pre-B cell allelic exclusion, GO:0071300|cellular response to retinoic acid, GO:1904358|positive regulation of telomere maintenance via telomere lengthening, GO:0043517|positive regulation of DNA damage response, signal transduction by p53 class mediator, GO:0045785|positive regulation of cell adhesion, GO:0036289|peptidyl-serine autophosphorylation, GO:0071481|cellular response to X-ray, GO:0071500|cellular response to nitrosative stress, GO:0072434|signal transduction involved in mitotic G2 DNA damage checkpoint, GO:0097694|establishment of RNA localization to telomere, GO:0097695|establishment of protein-containing complex localization to telomere, GO:1904884|positive regulation of telomerase catalytic core complex assembly, GO:0001666|response to hypoxia, GO:0006915|apoptotic process, GO:0033129|positive regulation of histone phosphorylation, GO:0043525|positive regulation of neuron apoptotic process, GO:0051726|regulation of cell cycle, GO:1901216|positive regulation of neuron death, GO:1903626|positive regulation of DNA catabolic process, GO:1903978|regulation of microglial cell activation, GO:1905843|regulation of cellular response to gamma radiation, GO:2001022|positive regulation of response to DNA damage stimulus","GO:0004674|protein serine/threonine kinase activity, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0047485|protein N-terminus binding, GO:0044877|protein-containing complex binding, GO:0046983|protein dimerization activity, GO:0004677|DNA-dependent protein kinase activity"
MAPK1,Missense,0.358349509622915,35,0.0345323089487991,N,Oncogene,Oncogene,0.426142766111604,0.0106939398066316,ENSG00000100030,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005794|Golgi apparatus, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0005901|caveola, GO:0005925|focal adhesion, GO:0005815|microtubule organizing center, GO:0005819|spindle, GO:0005576|extracellular region, GO:0005654|nucleoplasm, GO:0005769|early endosome, GO:0005770|late endosome, GO:1904813|ficolin-1-rich granule lumen, GO:0035578|azurophil granule lumen, GO:0072686|mitotic spindle, GO:0030424|axon, GO:0031143|pseudopodium, GO:0032839|dendrite cytoplasm, GO:0032991|protein-containing complex, GO:0043204|perikaryon","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007049|cell cycle, GO:0006915|apoptotic process, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0035556|intracellular signal transduction, GO:0010800|positive regulation of peptidyl-threonine phosphorylation, GO:0016032|viral process, GO:0043312|neutrophil degranulation, GO:0031647|regulation of protein stability, GO:0006935|chemotaxis, GO:0007165|signal transduction, GO:0070371|ERK1 and ERK2 cascade, GO:0030168|platelet activation, GO:0007411|axon guidance, GO:0007268|chemical synaptic transmission, GO:0000165|MAPK cascade, GO:0032212|positive regulation of telomere maintenance via telomerase, GO:0051973|positive regulation of telomerase activity, GO:1904355|positive regulation of telomere capping, GO:0018107|peptidyl-threonine phosphorylation, GO:0014066|regulation of phosphatidylinositol 3-kinase signaling, GO:0034614|cellular response to reactive oxygen species, GO:0071276|cellular response to cadmium ion, GO:0010468|regulation of gene expression, GO:0018105|peptidyl-serine phosphorylation, GO:0071310|cellular response to organic substance, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0051493|regulation of cytoskeleton organization, GO:0000187|activation of MAPK activity, GO:2000641|regulation of early endosome to late endosome transport, GO:1900034|regulation of cellular response to heat, GO:0007611|learning or memory, GO:0051090|regulation of DNA-binding transcription factor activity, GO:0010628|positive regulation of gene expression, GO:1903351|cellular response to dopamine, GO:0070849|response to epidermal growth factor, GO:0034198|cellular response to amino acid starvation, GO:0032872|regulation of stress-activated MAPK cascade, GO:0051403|stress-activated MAPK cascade, GO:0072584|caveolin-mediated endocytosis, GO:0090170|regulation of Golgi inheritance, GO:0006974|cellular response to DNA damage stimulus, GO:0007507|heart development, GO:0007568|aging, GO:0008284|positive regulation of cell proliferation, GO:0009636|response to toxic substance, GO:0009887|animal organ morphogenesis, GO:0014032|neural crest cell development, GO:0015966|diadenosine tetraphosphate biosynthetic process, GO:0019233|sensory perception of pain, GO:0019858|cytosine metabolic process, GO:0030278|regulation of ossification, GO:0030335|positive regulation of cell migration, GO:0030641|regulation of cellular pH, GO:0030878|thyroid gland development, GO:0031663|lipopolysaccharide-mediated signaling pathway, GO:0032496|response to lipopolysaccharide, GO:0033160|positive regulation of protein import into nucleus, translocation, GO:0033598|mammary gland epithelial cell proliferation, GO:0035094|response to nicotine, GO:0038127|ERBB signaling pathway, GO:0042473|outer ear morphogenesis, GO:0043330|response to exogenous dsRNA, GO:0043627|response to estrogen, GO:0045596|negative regulation of cell differentiation, GO:0045727|positive regulation of translation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0046697|decidualization, GO:0048538|thymus development, GO:0050852|T cell receptor signaling pathway, GO:0050853|B cell receptor signaling pathway, GO:0060020|Bergmann glial cell differentiation, GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0060291|long-term synaptic potentiation, GO:0060324|face development, GO:0060425|lung morphogenesis, GO:0060440|trachea formation, GO:0060716|labyrinthine layer blood vessel development, GO:0061308|cardiac neural crest cell development involved in heart development, GO:0071356|cellular response to tumor necrosis factor, GO:0097011|cellular response to granulocyte macrophage colony-stimulating factor stimulus","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0004707|MAP kinase activity, GO:0016301|kinase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0019902|phosphatase binding, GO:0008353|RNA polymerase II CTD heptapeptide repeat kinase activity, GO:0001784|phosphotyrosine residue binding, GO:0003690|double-stranded DNA binding, GO:0004708|MAP kinase kinase activity, GO:0008134|transcription factor binding, GO:0019901|protein kinase binding, GO:0031435|mitogen-activated protein kinase kinase kinase binding"
EWSR1,Missense,0.35417630245547,63,0.00440177456616183,Y,"oncogene, fusion",Oncogene,0.416818725540027,0.000678249677780724,ENSG00000182944,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005730|nucleolus, GO:0005886|plasma membrane","GO:0006355|regulation of transcription, DNA-templated","GO:0003723|RNA binding, GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0005516|calmodulin binding"
TRIM33,Silent,0.353903270333117,23,0.0975741352088697,N,"TSG, fusion",TSG,0.630307945672343,0.00126480680794563,ENSG00000197323,"GO:0005634|nucleus, GO:0005654|nucleoplasm","GO:0016567|protein ubiquitination, GO:0045892|negative regulation of transcription, DNA-templated, GO:0030514|negative regulation of BMP signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0017015|regulation of transforming growth factor beta receptor signaling pathway","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0070412|R-SMAD binding, GO:0070410|co-SMAD binding, GO:0004842|ubiquitin-protein transferase activity"
LEF1,Missense,0.353596939696179,35,0.0371795016822137,N,"oncogene, TSG","",0.524412366770707,0.00122160496117694,ENSG00000138795,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005667|transcription factor complex, GO:0005654|nucleoplasm, GO:0032993|protein-DNA complex, GO:1990907|beta-catenin-TCF complex","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0071345|cellular response to cytokine stimulus, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043401|steroid hormone mediated signaling pathway, GO:0016055|Wnt signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001569|branching involved in blood vessel morphogenesis, GO:0001756|somitogenesis, GO:0001837|epithelial to mesenchymal transition, GO:0001944|vasculature development, GO:0002040|sprouting angiogenesis, GO:0021542|dentate gyrus development, GO:0021766|hippocampus development, GO:0021861|forebrain radial glial cell differentiation, GO:0021873|forebrain neuroblast division, GO:0021943|formation of radial glial scaffolds, GO:0022407|regulation of cell-cell adhesion, GO:0030111|regulation of Wnt signaling pathway, GO:0030326|embryonic limb morphogenesis, GO:0030509|BMP signaling pathway, GO:0030879|mammary gland development, GO:0033153|T cell receptor V(D)J recombination, GO:0042100|B cell proliferation, GO:0042475|odontogenesis of dentin-containing tooth, GO:0043586|tongue development, GO:0045063|T-helper 1 cell differentiation, GO:0045843|negative regulation of striated muscle tissue development, GO:0045892|negative regulation of transcription, DNA-templated, GO:0046632|alpha-beta T cell differentiation, GO:0048341|paraxial mesoderm formation, GO:0048468|cell development, GO:0050909|sensory perception of taste, GO:0060033|anatomical structure regression, GO:0060070|canonical Wnt signaling pathway, GO:0060325|face morphogenesis, GO:0060561|apoptotic process involved in morphogenesis, GO:0060710|chorio-allantoic fusion, GO:0061153|trachea gland development, GO:0062009|secondary palate development, GO:1902262|apoptotic process involved in blood vessel morphogenesis, GO:0006355|regulation of transcription, DNA-templated, GO:0030335|positive regulation of cell migration, GO:0010628|positive regulation of gene expression, GO:0008284|positive regulation of cell proliferation, GO:0030854|positive regulation of granulocyte differentiation, GO:0043066|negative regulation of apoptotic process, GO:0043967|histone H4 acetylation, GO:1904837|beta-catenin-TCF complex assembly, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0030307|positive regulation of cell growth, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0060326|cell chemotaxis, GO:0043966|histone H3 acetylation, GO:0007223|Wnt signaling pathway, calcium modulating pathway, GO:0006366|transcription by RNA polymerase II, GO:0001649|osteoblast differentiation, GO:0043392|negative regulation of DNA binding, GO:0043923|positive regulation by host of viral transcription, GO:0071353|cellular response to interleukin-4, GO:0032696|negative regulation of interleukin-13 production, GO:0032714|negative regulation of interleukin-5 production, GO:0030223|neutrophil differentiation, GO:0071899|negative regulation of estrogen receptor binding, GO:0032713|negative regulation of interleukin-4 production, GO:0071895|odontoblast differentiation, GO:0048069|eye pigmentation, GO:0071864|positive regulation of cell proliferation in bone marrow, GO:0071866|negative regulation of apoptotic process in bone marrow","GO:0008013|beta-catenin binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0003700|DNA-binding transcription factor activity, GO:0008134|transcription factor binding, GO:0008301|DNA binding, bending, GO:0044212|transcription regulatory region DNA binding, GO:0030331|estrogen receptor binding, GO:0070016|armadillo repeat domain binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0045295|gamma-catenin binding, GO:0042393|histone binding, GO:0043027|cysteine-type endopeptidase inhibitor activity involved in apoptotic process, GO:0042826|histone deacetylase binding, GO:0030284|estrogen receptor activity, GO:0070742|C2H2 zinc finger domain binding, GO:0035326|enhancer binding"
NFATC2,Missense,0.353378825754058,100,0.000310416059722644,Y,"oncogene, fusion",Oncogene,0.376060374856257,0.000115322235241545,ENSG00000101096,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0044798|nuclear transcription factor complex, GO:0005667|transcription factor complex, GO:0000790|nuclear chromatin, GO:1990904|ribonucleoprotein complex","GO:1905064|negative regulation of vascular smooth muscle cell differentiation, GO:0006355|regulation of transcription, DNA-templated, GO:0006974|cellular response to DNA damage stimulus, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016477|cell migration, GO:0050853|B cell receptor signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0042493|response to drug, GO:0001816|cytokine production, GO:0033173|calcineurin-NFAT signaling cascade, GO:0045589|regulation of regulatory T cell differentiation, GO:0030890|positive regulation of B cell proliferation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0010628|positive regulation of gene expression, GO:0014904|myotube cell development, GO:1901741|positive regulation of myoblast fusion","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0019902|phosphatase binding, GO:0003682|chromatin binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0043565|sequence-specific DNA binding, GO:0044212|transcription regulatory region DNA binding"
EPAS1,Silent,0.352434771339074,18,0.15145335042649,N,"oncogene, TSG","",0.373275877734683,0.127071993957823,ENSG00000116016,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005667|transcription factor complex, GO:0016607|nuclear speck, GO:0005654|nucleoplasm, GO:0005829|cytosol","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0043687|post-translational protein modification, GO:0001525|angiogenesis, GO:0007165|signal transduction, GO:0006366|transcription by RNA polymerase II, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0071456|cellular response to hypoxia, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0001666|response to hypoxia, GO:0001892|embryonic placenta development, GO:0001974|blood vessel remodeling, GO:0002027|regulation of heart rate, GO:0006979|response to oxidative stress, GO:0007005|mitochondrion organization, GO:0007601|visual perception, GO:0030097|hemopoiesis, GO:0030218|erythrocyte differentiation, GO:0030324|lung development, GO:0042415|norepinephrine metabolic process, GO:0043129|surfactant homeostasis, GO:0043619|regulation of transcription from RNA polymerase II promoter in response to oxidative stress, GO:0048469|cell maturation, GO:0048625|myoblast fate commitment, GO:0055072|iron ion homeostasis","GO:0046983|protein dimerization activity, GO:0003700|DNA-binding transcription factor activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0046982|protein heterodimerization activity, GO:0043565|sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0035035|histone acetyltransferase binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
ESR1,Missense,0.35191125251219,64,0.00434953700077376,Y,"oncogene, TSG, fusion","",0.417426820517257,0.000599818043558331,ENSG00000091831,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0000790|nuclear chromatin, GO:0032991|protein-containing complex, GO:0035327|transcriptionally active chromatin, GO:0097550|transcriptional preinitiation complex","GO:0006355|regulation of transcription, DNA-templated, GO:0043401|steroid hormone mediated signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0030522|intracellular receptor signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0046854|phosphatidylinositol phosphorylation, GO:0016579|protein deubiquitination, GO:0007165|signal transduction, GO:0010629|negative regulation of gene expression, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0051897|positive regulation of protein kinase B signaling, GO:0007204|positive regulation of cytosolic calcium ion concentration, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0030518|intracellular steroid hormone receptor signaling pathway, GO:0030520|intracellular estrogen receptor signaling pathway, GO:0032355|response to estradiol, GO:0043627|response to estrogen, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0006338|chromatin remodeling, GO:0030111|regulation of Wnt signaling pathway, GO:0033146|regulation of intracellular estrogen receptor signaling pathway, GO:0006366|transcription by RNA polymerase II, GO:0006351|transcription, DNA-templated, GO:0071392|cellular response to estradiol stimulus, GO:1903799|negative regulation of production of miRNAs involved in gene silencing by miRNA, GO:0006357|regulation of transcription by RNA polymerase II, GO:0010863|positive regulation of phospholipase C activity, GO:0007200|phospholipase C-activating G protein-coupled receptor signaling pathway, GO:0045899|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly, GO:0071168|protein localization to chromatin, GO:0001547|antral ovarian follicle growth, GO:0002064|epithelial cell development, GO:0008209|androgen metabolic process, GO:0008584|male gonad development, GO:0034121|regulation of toll-like receptor signaling pathway, GO:0042981|regulation of apoptotic process, GO:0048146|positive regulation of fibroblast proliferation, GO:0048863|stem cell differentiation, GO:0050727|regulation of inflammatory response, GO:0060065|uterus development, GO:0060068|vagina development, GO:0060523|prostate epithelial cord elongation, GO:0060527|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis, GO:0060687|regulation of branching involved in prostate gland morphogenesis, GO:0060745|mammary gland branching involved in pregnancy, GO:0060749|mammary gland alveolus development, GO:0060750|epithelial cell proliferation involved in mammary gland duct elongation, GO:0071391|cellular response to estrogen stimulus","GO:0003677|DNA binding, GO:0005496|steroid binding, GO:0030284|estrogen receptor activity, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0003707|steroid hormone receptor activity, GO:0008289|lipid binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0019901|protein kinase binding, GO:0003682|chromatin binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0008134|transcription factor binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0008013|beta-catenin binding, GO:0034056|estrogen response element binding, GO:0001223|transcription coactivator binding, GO:0030235|nitric-oxide synthase regulator activity, GO:0001093|TFIIB-class transcription factor binding, GO:0004879|nuclear receptor activity, GO:0017025|TBP-class protein binding, GO:0030331|estrogen receptor binding, GO:0051117|ATPase binding"
MAP2K4,Nonsense,0.351319163746143,16,0.182108207431898,N,"oncogene, TSG","",0.104675625541174,0.699644056064476,ENSG00000065559,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0030424|axon, GO:0032839|dendrite cytoplasm, GO:0043204|perikaryon","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0006915|apoptotic process, GO:0071260|cellular response to mechanical stimulus, GO:0007165|signal transduction, GO:0023014|signal transduction by protein phosphorylation, GO:0031098|stress-activated protein kinase signaling cascade, GO:0032147|activation of protein kinase activity, GO:0000187|activation of MAPK activity, GO:0007257|activation of JUN kinase activity, GO:0007254|JNK cascade, GO:0000165|MAPK cascade, GO:0001934|positive regulation of protein phosphorylation, GO:0009611|response to wounding, GO:0034393|positive regulation of smooth muscle cell apoptotic process, GO:0043065|positive regulation of apoptotic process, GO:0043525|positive regulation of neuron apoptotic process, GO:0045740|positive regulation of DNA replication, GO:0051770|positive regulation of nitric-oxide synthase biosynthetic process, GO:0061049|cell growth involved in cardiac muscle cell development, GO:0072709|cellular response to sorbitol, GO:2000672|negative regulation of motor neuron apoptotic process","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004708|MAP kinase kinase activity, GO:0008545|JUN kinase kinase activity, GO:0031435|mitogen-activated protein kinase kinase kinase binding"
GAS7,Missense,0.351236773304393,46,0.016690579865484,N,fusion,"",0.397135146635803,0.00628056070882324,ENSG00000007237,"GO:0005737|cytoplasm, GO:0005886|plasma membrane, GO:0005884|actin filament, GO:0005856|cytoskeleton","GO:0007275|multicellular organism development, GO:0006355|regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0007399|nervous system development, GO:0030182|neuron differentiation, GO:0048812|neuron projection morphogenesis, GO:0007050|cell cycle arrest, GO:0030041|actin filament polymerization","GO:0005515|protein binding, GO:0051015|actin filament binding, GO:0003700|DNA-binding transcription factor activity, GO:0008092|cytoskeletal protein binding"
LMO2,Missense,0.351152948119939,21,0.118562534638298,N,"oncogene, fusion",Oncogene,0.384801039447395,0.0849881995403293,ENSG00000135363,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0007275|multicellular organism development, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0097067|cellular response to thyroid hormone stimulus, GO:0042789|mRNA transcription by RNA polymerase II","GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0043425|bHLH transcription factor binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0070888|E-box binding, GO:0048037|cofactor binding"
FOXP1,Silent,0.350561342195601,22,0.109701043361329,N,"oncogene, fusion",Oncogene,0.357511891074162,0.102362400067724,ENSG00000114861,"GO:0005634|nucleus, GO:0005654|nucleoplasm","GO:0010629|negative regulation of gene expression, GO:0050861|positive regulation of B cell receptor signaling pathway, GO:0006974|cellular response to DNA damage stimulus, GO:0006355|regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0032496|response to lipopolysaccharide, GO:0042116|macrophage activation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0010595|positive regulation of endothelial cell migration, GO:0042118|endothelial cell activation, GO:0030316|osteoclast differentiation, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0035019|somatic stem cell population maintenance, GO:0050727|regulation of inflammatory response, GO:0060766|negative regulation of androgen receptor signaling pathway, GO:0032680|regulation of tumor necrosis factor production, GO:1901509|regulation of endothelial tube morphogenesis, GO:0036035|osteoclast development, GO:0042117|monocyte activation, GO:0061470|T follicular helper cell differentiation, GO:0002903|negative regulation of B cell apoptotic process, GO:0035926|chemokine (C-C motif) ligand 2 secretion, GO:0045655|regulation of monocyte differentiation, GO:0050706|regulation of interleukin-1 beta secretion, GO:0072619|interleukin-21 secretion, GO:1900424|regulation of defense response to bacterium, GO:1901256|regulation of macrophage colony-stimulating factor production, GO:2001182|regulation of interleukin-12 secretion","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0043621|protein self-association, GO:0050681|androgen receptor binding"
FCRL4,Missense,0.349144207663987,72,0.00264756377031953,Y,"oncogene, fusion",Oncogene,0.415505689670828,0.000283924853801965,ENSG00000163518,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0009986|cell surface","GO:0002376|immune system process, GO:0002250|adaptive immune response",GO:0005515|protein binding
RARA,Missense,0.348985254025418,44,0.0202442030886885,N,"oncogene, fusion",Oncogene,0.363608127165866,0.0152596878155687,ENSG00000131759,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0015629|actin cytoskeleton, GO:0005654|nucleoplasm, GO:0090575|RNA polymerase II transcription factor complex, GO:0009986|cell surface, GO:0000790|nuclear chromatin, GO:0030425|dendrite, GO:0043005|neuron projection, GO:0048471|perinuclear region of cytoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0043401|steroid hormone mediated signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030154|cell differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0060349|bone morphogenesis, GO:0009755|hormone-mediated signaling pathway, GO:0048384|retinoic acid receptor signaling pathway, GO:0008284|positive regulation of cell proliferation, GO:0032689|negative regulation of interferon-gamma production, GO:0032720|negative regulation of tumor necrosis factor production, GO:0045892|negative regulation of transcription, DNA-templated, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0006468|protein phosphorylation, GO:0071300|cellular response to retinoic acid, GO:0043277|apoptotic cell clearance, GO:0032526|response to retinoic acid, GO:0045787|positive regulation of cell cycle, GO:0071391|cellular response to estrogen stimulus, GO:0007275|multicellular organism development, GO:0007165|signal transduction, GO:0001889|liver development, GO:0001657|ureteric bud development, GO:0001843|neural tube closure, GO:0002068|glandular epithelial cell development, GO:0003148|outflow tract septum morphogenesis, GO:0003417|growth plate cartilage development, GO:0007281|germ cell development, GO:0007283|spermatogenesis, GO:0007565|female pregnancy, GO:0008285|negative regulation of cell proliferation, GO:0008584|male gonad development, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0017148|negative regulation of translation, GO:0021766|hippocampus development, GO:0030850|prostate gland development, GO:0030852|regulation of granulocyte differentiation, GO:0030853|negative regulation of granulocyte differentiation, GO:0031076|embryonic camera-type eye development, GO:0031641|regulation of myelination, GO:0032355|response to estradiol, GO:0032736|positive regulation of interleukin-13 production, GO:0032753|positive regulation of interleukin-4 production, GO:0032754|positive regulation of interleukin-5 production, GO:0033189|response to vitamin A, GO:0033993|response to lipid, GO:0034097|response to cytokine, GO:0035264|multicellular organism growth, GO:0042981|regulation of apoptotic process, GO:0043066|negative regulation of apoptotic process, GO:0045471|response to ethanol, GO:0045596|negative regulation of cell differentiation, GO:0045630|positive regulation of T-helper 2 cell differentiation, GO:0045666|positive regulation of neuron differentiation, GO:0048167|regulation of synaptic plasticity, GO:0048732|gland development, GO:0051099|positive regulation of binding, GO:0055012|ventricular cardiac muscle cell differentiation, GO:0060010|Sertoli cell fate commitment, GO:0060173|limb development, GO:0060324|face development, GO:0060348|bone development, GO:0060429|epithelium development, GO:0060534|trachea cartilage development, GO:0060591|chondroblast differentiation, GO:0061037|negative regulation of cartilage development, GO:0071222|cellular response to lipopolysaccharide","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0031490|chromatin DNA binding, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0003707|steroid hormone receptor activity, GO:0003713|transcription coactivator activity, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003714|transcription corepressor activity, GO:0008134|transcription factor binding, GO:0038023|signaling receptor activity, GO:0005102|signaling receptor binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0019899|enzyme binding, GO:0019904|protein domain specific binding, GO:0046982|protein heterodimerization activity, GO:0004879|nuclear receptor activity, GO:0001972|retinoic acid binding, GO:0051018|protein kinase A binding, GO:0030374|nuclear receptor transcription coactivator activity, GO:0043422|protein kinase B binding, GO:0000900|translation repressor activity, mRNA regulatory element binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0008144|drug binding, GO:0042826|histone deacetylase binding, GO:0044212|transcription regulatory region DNA binding, GO:0044323|retinoic acid-responsive element binding, GO:0048027|mRNA 5'-UTR binding, GO:0051393|alpha-actinin binding"
DNAJB1,Missense,0.347165691662136,24,0.096487923013509,N,fusion,"",0.840318792810828,2.77787641960297e-07,ENSG00000132002,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0005730|nucleolus, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0043025|neuronal cell body, GO:0043197|dendritic spine, GO:0061827|sperm head","GO:0006457|protein folding, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006986|response to unfolded protein, GO:0090084|negative regulation of inclusion body assembly, GO:1900034|regulation of cellular response to heat, GO:0051085|chaperone cofactor-dependent protein refolding, GO:0097201|negative regulation of transcription from RNA polymerase II promoter in response to stress, GO:0032781|positive regulation of ATPase activity, GO:0030900|forebrain development","GO:0005515|protein binding, GO:0051082|unfolded protein binding, GO:0003714|transcription corepressor activity, GO:0045296|cadherin binding, GO:0051117|ATPase binding, GO:0051087|chaperone binding, GO:0030544|Hsp70 protein binding, GO:0001671|ATPase activator activity"
LIFR,Missense,0.347136827101466,127,6.37657256964687e-05,Y,fusion,"",0.484363372315546,7.93720446778692e-09,ENSG00000113594,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0009897|external side of plasma membrane, GO:0043235|receptor complex, GO:0070062|extracellular exosome, GO:0005887|integral component of plasma membrane","GO:0008284|positive regulation of cell proliferation, GO:0007166|cell surface receptor signaling pathway, GO:0019221|cytokine-mediated signaling pathway, GO:0001959|regulation of cytokine-mediated signaling pathway, GO:0034097|response to cytokine, GO:0070120|ciliary neurotrophic factor-mediated signaling pathway, GO:0038165|oncostatin-M-mediated signaling pathway, GO:0048861|leukemia inhibitory factor signaling pathway","GO:0005515|protein binding, GO:0004896|cytokine receptor activity, GO:0019838|growth factor binding, GO:0005127|ciliary neurotrophic factor receptor binding, GO:0019955|cytokine binding, GO:0004897|ciliary neurotrophic factor receptor activity, GO:0004923|leukemia inhibitory factor receptor activity, GO:0004924|oncostatin-M receptor activity"
ETV1,Missense,0.346918049768827,57,0.00819796217136109,Y,"oncogene, fusion",Oncogene,0.431209364276542,0.000811763721267433,ENSG00000006468,GO:0005634|nucleus,"GO:0006355|regulation of transcription, DNA-templated, GO:0006366|transcription by RNA polymerase II, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048935|peripheral nervous system neuron development, GO:0007411|axon guidance, GO:0007517|muscle organ development, GO:0007638|mechanosensory behavior, GO:0045893|positive regulation of transcription, DNA-templated","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
PTPRT,Nonsense,0.346355792815094,13,0.24633120844564,N,TSG,TSG,0.276727465225788,0.360046244055491,ENSG00000196090,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0009986|cell surface, GO:0005887|integral component of plasma membrane","GO:0030336|negative regulation of cell migration, GO:0007155|cell adhesion, GO:0006470|protein dephosphorylation, GO:0007165|signal transduction, GO:0016311|dephosphorylation, GO:0007156|homophilic cell adhesion via plasma membrane adhesion molecules, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0071354|cellular response to interleukin-6, GO:1904893|negative regulation of STAT cascade, GO:1990264|peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0005001|transmembrane receptor protein tyrosine phosphatase activity, GO:0008013|beta-catenin binding, GO:0019903|protein phosphatase binding, GO:0042803|protein homodimerization activity, GO:0045294|alpha-catenin binding, GO:0045295|gamma-catenin binding, GO:0045296|cadherin binding, GO:0070097|delta-catenin binding, GO:0097677|STAT family protein binding, GO:0016790|thiolester hydrolase activity, GO:0051393|alpha-actinin binding"
MYO5A,Missense,0.345830384459874,134,4.262147532103e-05,Y,fusion,"",0.456450239886905,2.97296168192812e-08,ENSG00000197535,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005783|endoplasmic reticulum, GO:0016459|myosin complex, GO:0005829|cytosol, GO:0042470|melanosome, GO:0005764|lysosome, GO:0005777|peroxisome, GO:0005769|early endosome, GO:0030426|growth cone, GO:0070062|extracellular exosome, GO:0005770|late endosome, GO:0055037|recycling endosome, GO:0001726|ruffle, GO:0043005|neuron projection, GO:0031982|vesicle, GO:0005884|actin filament, GO:0032433|filopodium tip, GO:0032593|insulin-responsive compartment, GO:0001750|photoreceptor outer segment, GO:0005794|Golgi apparatus, GO:0005882|intermediate filament, GO:0016461|unconventional myosin complex, GO:0030141|secretory granule, GO:0035371|microtubule plus-end, GO:0042641|actomyosin, GO:0043025|neuronal cell body","GO:0015031|protein transport, GO:0016192|vesicle-mediated transport, GO:0032869|cellular response to insulin stimulus, GO:0072659|protein localization to plasma membrane, GO:0030050|vesicle transport along actin filament, GO:0006892|post-Golgi vesicle-mediated transport, GO:0030048|actin filament-based movement, GO:0032402|melanosome transport, GO:0006582|melanin metabolic process, GO:0006887|exocytosis, GO:0007268|chemical synaptic transmission, GO:0007601|visual perception, GO:0030073|insulin secretion, GO:0030318|melanocyte differentiation, GO:0031585|regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity, GO:0031987|locomotion involved in locomotory behavior, GO:0032252|secretory granule localization, GO:0032400|melanosome localization, GO:0042438|melanin biosynthetic process, GO:0042476|odontogenesis, GO:0042552|myelination, GO:0042759|long-chain fatty acid biosynthetic process, GO:0043473|pigmentation, GO:0048066|developmental pigmentation, GO:0048820|hair follicle maturation, GO:0050808|synapse organization, GO:0051643|endoplasmic reticulum localization, GO:0099089|establishment of endoplasmic reticulum localization to postsynapse","GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0003774|motor activity, GO:0003779|actin binding, GO:0051015|actin filament binding, GO:0005516|calmodulin binding, GO:0005515|protein binding, GO:0017137|Rab GTPase binding, GO:0000146|microfilament motor activity, GO:0005509|calcium ion binding, GO:0042802|identical protein binding, GO:0097718|disordered domain specific binding"
PAX8,Silent,0.34517473926561,19,0.147794605036321,N,fusion,"",0.424068803906929,0.0703755250118273,ENSG00000125618,"GO:0005634|nucleus, GO:0005654|nucleoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0001822|kidney development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006351|transcription, DNA-templated, GO:0038194|thyroid-stimulating hormone signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0042981|regulation of apoptotic process, GO:0030878|thyroid gland development, GO:0009653|anatomical structure morphogenesis, GO:0001823|mesonephros development, GO:0042472|inner ear morphogenesis, GO:0007417|central nervous system development, GO:0090190|positive regulation of branching involved in ureteric bud morphogenesis, GO:0001658|branching involved in ureteric bud morphogenesis, GO:2000611|positive regulation of thyroid hormone generation, GO:0003337|mesenchymal to epithelial transition involved in metanephros morphogenesis, GO:0071371|cellular response to gonadotropin stimulus, GO:0072207|metanephric epithelium development, GO:0072284|metanephric S-shaped body morphogenesis, GO:0001655|urogenital system development, GO:0048793|pronephros development, GO:0072289|metanephric nephron tubule formation, GO:0039003|pronephric field specification, GO:0072108|positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis, GO:0072221|metanephric distal convoluted tubule development, GO:0072305|negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis, GO:0072307|regulation of metanephric nephron tubule epithelial cell differentiation, GO:1900212|negative regulation of mesenchymal cell apoptotic process involved in metanephros development, GO:1900215|negative regulation of apoptotic process involved in metanephric collecting duct development, GO:1900218|negative regulation of apoptotic process involved in metanephric nephron tubule development, GO:2000594|positive regulation of metanephric DCT cell differentiation, GO:0071599|otic vesicle development, GO:0072278|metanephric comma-shaped body morphogenesis, GO:2000612|regulation of thyroid-stimulating hormone secretion, GO:0001656|metanephros development, GO:0003281|ventricular septum development, GO:0006790|sulfur compound metabolic process, GO:0010667|negative regulation of cardiac muscle cell apoptotic process, GO:0072050|S-shaped body morphogenesis, GO:0072073|kidney epithelium development, GO:0072164|mesonephric tubule development","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0004996|thyroid-stimulating hormone receptor activity, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0043565|sequence-specific DNA binding"
LRP1B,Silent,0.34358010690224,262,1.13314510906607e-08,Y,TSG,TSG,0.343302939240018,1.16627778209428e-08,ENSG00000168702,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0043235|receptor complex","GO:0006897|endocytosis, GO:0006898|receptor-mediated endocytosis, GO:0015031|protein transport",GO:0005509|calcium ion binding
ARID2,Silent,0.34349357946984,42,0.0259363637405541,N,TSG,TSG,0.374979113041107,0.0144122117930878,ENSG00000189079,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005886|plasma membrane","GO:0008285|negative regulation of cell proliferation, GO:0030336|negative regulation of cell migration, GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006337|nucleosome disassembly, GO:0003007|heart morphogenesis, GO:0042592|homeostatic process, GO:0048568|embryonic organ development, GO:0060038|cardiac muscle cell proliferation, GO:0060982|coronary artery morphogenesis, GO:0072358|cardiovascular system development","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
NFATC2,Silent,0.34311408121392,42,0.0261120356009152,N,"oncogene, fusion",Oncogene,0.281372596501534,0.0710531818550439,ENSG00000101096,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0044798|nuclear transcription factor complex, GO:0005667|transcription factor complex, GO:0000790|nuclear chromatin, GO:1990904|ribonucleoprotein complex","GO:1905064|negative regulation of vascular smooth muscle cell differentiation, GO:0006355|regulation of transcription, DNA-templated, GO:0006974|cellular response to DNA damage stimulus, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016477|cell migration, GO:0050853|B cell receptor signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0042493|response to drug, GO:0001816|cytokine production, GO:0033173|calcineurin-NFAT signaling cascade, GO:0045589|regulation of regulatory T cell differentiation, GO:0030890|positive regulation of B cell proliferation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0010628|positive regulation of gene expression, GO:0014904|myotube cell development, GO:1901741|positive regulation of myoblast fusion","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0019902|phosphatase binding, GO:0003682|chromatin binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0043565|sequence-specific DNA binding, GO:0044212|transcription regulatory region DNA binding"
LRP1B,Nonsense,0.341912096035973,66,0.00495637853782778,Y,TSG,TSG,0.322483577906773,0.00827183854092043,ENSG00000168702,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0043235|receptor complex","GO:0006897|endocytosis, GO:0006898|receptor-mediated endocytosis, GO:0015031|protein transport",GO:0005509|calcium ion binding
MECOM,Missense,0.341824617236269,138,4.07290752354379e-05,Y,"oncogene, fusion",Oncogene,0.320149124845672,0.00012921752662876,ENSG00000085276,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0000118|histone deacetylase complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0034968|histone lysine methylation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0046329|negative regulation of JNK cascade, GO:0051726|regulation of cell cycle, GO:0071425|hematopoietic stem cell proliferation, GO:0043069|negative regulation of programmed cell death","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0018024|histone-lysine N-methyltransferase activity"
ETV6,Silent,0.341139258726661,15,0.213369738352696,N,"TSG, fusion",TSG,0.4073182367904,0.131830094299979,ENSG00000139083,"GO:0005634|nucleus, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0016020|membrane, GO:0016021|integral component of membrane","GO:0006355|regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0007296|vitellogenesis, GO:0022008|neurogenesis, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0097152|mesenchymal cell apoptotic process, GO:0006357|regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0071425|hematopoietic stem cell proliferation","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0019904|protein domain specific binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding"
TCF3,Silent,0.341139258726661,15,0.213369738352696,N,"oncogene, TSG, fusion","",0.374683262564355,0.168821439058997,ENSG00000071564,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex, GO:0000790|nuclear chromatin, GO:0090575|RNA polymerase II transcription factor complex","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0006351|transcription, DNA-templated, GO:0007399|nervous system development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0051149|positive regulation of muscle cell differentiation, GO:0045666|positive regulation of neuron differentiation, GO:0030183|B cell differentiation, GO:0002326|B cell lineage commitment, GO:0033152|immunoglobulin V(D)J recombination","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0046982|protein heterodimerization activity, GO:0043425|bHLH transcription factor binding, GO:0070491|repressing transcription factor binding, GO:0070888|E-box binding, GO:0008134|transcription factor binding, GO:0035326|enhancer binding, GO:0070644|vitamin D response element binding, GO:0031435|mitogen-activated protein kinase kinase kinase binding"
APC,Nonsense,0.33852450288012,140,4.29475633575171e-05,Y,TSG,TSG,0.525232297553706,2.69431862830037e-11,ENSG00000134982,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0030054|cell junction, GO:0005874|microtubule, GO:0005813|centrosome, GO:0000776|kinetochore, GO:0005923|bicellular tight junction, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0030027|lamellipodium, GO:0032587|ruffle membrane, GO:0005912|adherens junction, GO:0005881|cytoplasmic microtubule, GO:0030877|beta-catenin destruction complex, GO:0016328|lateral plasma membrane, GO:1990909|Wnt signalosome, GO:0005913|cell-cell adherens junction, GO:0048471|perinuclear region of cytoplasm, GO:0016342|catenin complex","GO:0006974|cellular response to DNA damage stimulus, GO:0007050|cell cycle arrest, GO:0016477|cell migration, GO:0008285|negative regulation of cell proliferation, GO:0043065|positive regulation of apoptotic process, GO:0000281|mitotic cytokinesis, GO:0007026|negative regulation of microtubule depolymerization, GO:0030178|negative regulation of Wnt signaling pathway, GO:0016055|Wnt signaling pathway, GO:0007155|cell adhesion, GO:0045732|positive regulation of protein catabolic process, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0016579|protein deubiquitination, GO:0001708|cell fate specification, GO:0007389|pattern specification process, GO:0045595|regulation of cell differentiation, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0120162|positive regulation of cold-induced thermogenesis, GO:1904886|beta-catenin destruction complex disassembly, GO:0065003|protein-containing complex assembly, GO:1904885|beta-catenin destruction complex assembly, GO:0070830|bicellular tight junction assembly, GO:0051260|protein homooligomerization, GO:0032886|regulation of microtubule-based process, GO:0030335|positive regulation of cell migration, GO:0007094|mitotic spindle assembly checkpoint, GO:0008286|insulin receptor signaling pathway, GO:0010942|positive regulation of cell death, GO:0031274|positive regulation of pseudopodium assembly, GO:0051988|regulation of attachment of spindle microtubules to kinetochore, GO:1904781|positive regulation of protein localization to centrosome","GO:0008013|beta-catenin binding, GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0019901|protein kinase binding, GO:0045295|gamma-catenin binding, GO:0042802|identical protein binding, GO:0051010|microtubule plus-end binding, GO:0019887|protein kinase regulator activity, GO:0031625|ubiquitin protein ligase binding, GO:0070840|dynein complex binding"
PLCG1,Missense,0.337700896935769,93,0.00093148754709184,Y,"oncogene, fusion",Oncogene,0.329096112834813,0.00127750633396996,ENSG00000124181,"GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0030027|lamellipodium, GO:0008180|COP9 signalosome, GO:0001726|ruffle, GO:0005737|cytoplasm, GO:0005911|cell-cell junction","GO:1905564|positive regulation of vascular endothelial cell proliferation, GO:2000353|positive regulation of endothelial cell apoptotic process, GO:0035556|intracellular signal transduction, GO:0007165|signal transduction, GO:0006629|lipid metabolic process, GO:0009395|phospholipid catabolic process, GO:0016042|lipid catabolic process, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0050900|leukocyte migration, GO:0050852|T cell receptor signaling pathway, GO:0016032|viral process, GO:0007411|axon guidance, GO:0006816|calcium ion transport, GO:0043647|inositol phosphate metabolic process, GO:0010634|positive regulation of epithelial cell migration, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0016477|cell migration, GO:0019722|calcium-mediated signaling, GO:0051281|positive regulation of release of sequestered calcium ion into cytosol, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:0045766|positive regulation of angiogenesis, GO:0001701|in utero embryonic development, GO:0007202|activation of phospholipase C activity, GO:0010863|positive regulation of phospholipase C activity","GO:0046872|metal ion binding, GO:0016787|hydrolase activity, GO:0005509|calcium ion binding, GO:0005515|protein binding, GO:0008081|phosphoric diester hydrolase activity, GO:0004435|phosphatidylinositol phospholipase C activity, GO:0019901|protein kinase binding, GO:0004629|phospholipase C activity, GO:0005168|neurotrophin TRKA receptor binding, GO:0030971|receptor tyrosine kinase binding, GO:0035254|glutamate receptor binding"
CNOT3,Missense,0.337054521042219,51,0.0155797180856662,N,TSG,TSG,0.389507221733281,0.00472519166123701,ENSG00000088038,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0030015|CCR4-NOT core complex, GO:0000932|P-body, GO:0005829|cytosol, GO:0030014|CCR4-NOT complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0031047|gene silencing by RNA, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0000289|nuclear-transcribed mRNA poly(A) tail shortening, GO:0006417|regulation of translation, GO:0017148|negative regulation of translation, GO:2000036|regulation of stem cell population maintenance, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0001829|trophectodermal cell differentiation",GO:0005515|protein binding
UBR5,Nonsense,0.336231884986598,18,0.172500235656754,N,TSG,TSG,0.372126651767346,0.12833958018941,ENSG00000104517,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0048471|perinuclear region of cytoplasm","GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0016567|protein ubiquitination, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0016032|viral process, GO:0000209|protein polyubiquitination, GO:0008283|cell proliferation, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0010628|positive regulation of gene expression, GO:0033160|positive regulation of protein import into nucleus, translocation, GO:0050847|progesterone receptor signaling pathway, GO:0070936|protein K48-linked ubiquitination, GO:1901315|negative regulation of histone H2A K63-linked ubiquitination, GO:2000780|negative regulation of double-strand break repair","GO:0003723|RNA binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0004842|ubiquitin-protein transferase activity, GO:0005515|protein binding, GO:0043130|ubiquitin binding, GO:0034450|ubiquitin-ubiquitin ligase activity, GO:0061630|ubiquitin protein ligase activity"
NT5C2,Missense,0.336105970640784,42,0.029538105827204,N,Oncogene,Oncogene,0.381557964028911,0.0126568076529653,ENSG00000076685,"GO:0005737|cytoplasm, GO:0005829|cytosol","GO:0016311|dephosphorylation, GO:0008152|metabolic process, GO:0016310|phosphorylation, GO:0009117|nucleotide metabolic process, GO:0006195|purine nucleotide catabolic process, GO:0017144|drug metabolic process, GO:0046040|IMP metabolic process, GO:0046085|adenosine metabolic process","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0003824|catalytic activity, GO:0008253|5'-nucleotidase activity, GO:0050146|nucleoside phosphotransferase activity"
NIN,Missense,0.33467872803889,141,4.98514394562578e-05,Y,fusion,"",0.424553400234515,1.54775250548661e-07,ENSG00000100503,"GO:0005813|centrosome, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005730|nucleolus, GO:0005856|cytoskeleton, GO:0005874|microtubule, GO:0005815|microtubule organizing center, GO:0005814|centriole, GO:0120103|centriolar subdistal appendage, GO:0072686|mitotic spindle, GO:0097539|ciliary transition fiber, GO:0000922|spindle pole, GO:0036449|microtubule minus-end, GO:0000242|pericentriolar material, GO:0097431|mitotic spindle pole, GO:0005886|plasma membrane, GO:0030424|axon, GO:0030425|dendrite, GO:0044295|axonal growth cone, GO:0045177|apical part of cell","GO:0034454|microtubule anchoring at centrosome, GO:0008104|protein localization, GO:0010457|centriole-centriole cohesion, GO:0051642|centrosome localization, GO:0090222|centrosome-templated microtubule nucleation, GO:0021540|corpus callosum morphogenesis, GO:0021957|corticospinal tract morphogenesis, GO:0031116|positive regulation of microtubule polymerization, GO:0048668|collateral sprouting, GO:0050772|positive regulation of axonogenesis","GO:0005509|calcium ion binding, GO:0000166|nucleotide binding, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0019900|kinase binding"
ROS1,Silent,0.333589554660235,77,0.00302896695372917,Y,"oncogene, fusion",Oncogene,0.233842904631628,0.0406705006957485,ENSG00000047936,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0009986|cell surface, GO:0048471|perinuclear region of cytoplasm","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0030154|cell differentiation, GO:0007283|spermatogenesis, GO:0008283|cell proliferation, GO:0001558|regulation of cell growth, GO:0032006|regulation of TOR signaling, GO:0070372|regulation of ERK1 and ERK2 cascade, GO:0002066|columnar/cuboidal epithelial cell development, GO:0010629|negative regulation of gene expression, GO:0010966|regulation of phosphate transport, GO:0023014|signal transduction by protein phosphorylation, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0019903|protein phosphatase binding"
JAK1,Silent,0.333501478592279,25,0.103277385439549,N,"oncogene, TSG","",0.39197729295705,0.0526345548722513,ENSG00000162434,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005856|cytoskeleton, GO:0005925|focal adhesion, GO:0005829|cytosol, GO:0012505|endomembrane system, GO:0005768|endosome","GO:1903672|positive regulation of sprouting angiogenesis, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0019221|cytokine-mediated signaling pathway, GO:0035722|interleukin-12-mediated signaling pathway, GO:0000165|MAPK cascade, GO:0060333|interferon-gamma-mediated signaling pathway, GO:0038111|interleukin-7-mediated signaling pathway, GO:0060334|regulation of interferon-gamma-mediated signaling pathway, GO:0070102|interleukin-6-mediated signaling pathway, GO:0060337|type I interferon signaling pathway, GO:0046677|response to antibiotic, GO:0070106|interleukin-27-mediated signaling pathway, GO:0070757|interleukin-35-mediated signaling pathway, GO:0038110|interleukin-2-mediated signaling pathway, GO:0035723|interleukin-15-mediated signaling pathway, GO:0038113|interleukin-9-mediated signaling pathway, GO:0038114|interleukin-21-mediated signaling pathway","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0031625|ubiquitin protein ligase binding, GO:0019903|protein phosphatase binding, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005131|growth hormone receptor binding, GO:0031730|CCR5 chemokine receptor binding"
FUS,Silent,0.333431358135727,21,0.13965837231921,N,"TSG, fusion",TSG,0.364423668340203,0.104342142704358,ENSG00000089280,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005737|cytoplasm, GO:0005844|polysome, GO:0030425|dendrite, GO:0043025|neuronal cell body, GO:0043197|dendritic spine, GO:0043204|perikaryon, GO:0044327|dendritic spine head, GO:0048471|perinuclear region of cytoplasm","GO:0008380|RNA splicing, GO:0006355|regulation of transcription, DNA-templated, GO:1903508|positive regulation of nucleic acid-templated transcription, GO:0051260|protein homooligomerization, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043484|regulation of RNA splicing, GO:0000398|mRNA splicing, via spliceosome, GO:0071277|cellular response to calcium ion, GO:1905168|positive regulation of double-strand break repair via homologous recombination","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0003682|chromatin binding, GO:0003713|transcription coactivator activity, GO:0030331|estrogen receptor binding, GO:0031489|myosin V binding, GO:0035255|ionotropic glutamate receptor binding, GO:0046965|retinoid X receptor binding, GO:0046966|thyroid hormone receptor binding"
CBLC,Silent,0.332872014664161,18,0.177099519912861,N,"oncogene, TSG","",0.716561237333931,0.000820624623861544,ENSG00000142273,"GO:0005886|plasma membrane, GO:0045121|membrane raft","GO:0043407|negative regulation of MAP kinase activity, GO:0023051|regulation of signaling, GO:0007166|cell surface receptor signaling pathway, GO:0007165|signal transduction, GO:0007175|negative regulation of epidermal growth factor-activated receptor activity, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0016567|protein ubiquitination, GO:0042059|negative regulation of epidermal growth factor receptor signaling pathway","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005509|calcium ion binding, GO:0004842|ubiquitin-protein transferase activity, GO:0001784|phosphotyrosine residue binding, GO:0061630|ubiquitin protein ligase activity, GO:0017124|SH3 domain binding, GO:0008270|zinc ion binding, GO:0030971|receptor tyrosine kinase binding, GO:0005154|epidermal growth factor receptor binding"
KDM6A,Nonsense,0.330389223537992,38,0.0427741480327173,N,"oncogene, TSG","",0.0969567978241765,0.562532955989913,ENSG00000147050,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0044666|MLL3/4 complex, GO:0035097|histone methyltransferase complex","GO:0055114|oxidation-reduction process, GO:0006325|chromatin organization, GO:0010468|regulation of gene expression, GO:0071557|histone H3-K27 demethylation, GO:0051568|histone H3-K4 methylation, GO:0006338|chromatin remodeling, GO:0001701|in utero embryonic development, GO:0001843|neural tube closure, GO:0003007|heart morphogenesis, GO:0003016|respiratory system process, GO:0007507|heart development, GO:0010628|positive regulation of gene expression, GO:0021915|neural tube development, GO:0032525|somite rostral/caudal axis specification, GO:0035264|multicellular organism growth, GO:0048333|mesodermal cell differentiation, GO:0048568|embryonic organ development, GO:0048570|notochord morphogenesis, GO:0060070|canonical Wnt signaling pathway, GO:0072358|cardiovascular system development","GO:0046872|metal ion binding, GO:0016491|oxidoreductase activity, GO:0051213|dioxygenase activity, GO:0071558|histone demethylase activity (H3-K27 specific), GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0043565|sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0031490|chromatin DNA binding, GO:0032452|histone demethylase activity, GO:0042802|identical protein binding"
GRIN2A,Silent,0.32940753855917,135,9.57024989615354e-05,Y,TSG,TSG,0.350995089552235,2.99484184731214e-05,ENSG00000183454,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0030054|cell junction, GO:0045202|synapse, GO:0045211|postsynaptic membrane, GO:0098839|postsynaptic density membrane, GO:0005887|integral component of plasma membrane, GO:0014069|postsynaptic density, GO:0009986|cell surface, GO:0017146|NMDA selective glutamate receptor complex, GO:0097060|synaptic membrane, GO:0005783|endoplasmic reticulum, GO:0008021|synaptic vesicle, GO:0042734|presynaptic membrane, GO:0043005|neuron projection, GO:0099061|integral component of postsynaptic density membrane","GO:0006811|ion transport, GO:0034220|ion transmembrane transport, GO:0070588|calcium ion transmembrane transport, GO:0098655|cation transmembrane transport, GO:0035235|ionotropic glutamate receptor signaling pathway, GO:0007268|chemical synaptic transmission, GO:0000165|MAPK cascade, GO:0060079|excitatory postsynaptic potential, GO:0007420|brain development, GO:0019722|calcium-mediated signaling, GO:0048167|regulation of synaptic plasticity, GO:0060291|long-term synaptic potentiation, GO:0097553|calcium ion transmembrane import into cytosol, GO:0098976|excitatory chemical synaptic transmission, GO:0007215|glutamate receptor signaling pathway, GO:0007611|learning or memory, GO:0045471|response to ethanol, GO:0001964|startle response, GO:0001975|response to amphetamine, GO:0006816|calcium ion transport, GO:0007612|learning, GO:0007613|memory, GO:0008542|visual learning, GO:0009611|response to wounding, GO:0019233|sensory perception of pain, GO:0022008|neurogenesis, GO:0030431|sleep, GO:0033058|directional locomotion, GO:0040011|locomotion, GO:0042177|negative regulation of protein catabolic process, GO:0042391|regulation of membrane potential, GO:0042417|dopamine metabolic process, GO:0042428|serotonin metabolic process, GO:0042493|response to drug, GO:0043065|positive regulation of apoptotic process, GO:0050804|modulation of chemical synaptic transmission, GO:0051930|regulation of sensory perception of pain, GO:0060078|regulation of postsynaptic membrane potential, GO:0097202|activation of cysteine-type endopeptidase activity, GO:1900273|positive regulation of long-term synaptic potentiation, GO:1903539|protein localization to postsynaptic membrane","GO:0046872|metal ion binding, GO:0005216|ion channel activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0038023|signaling receptor activity, GO:0004970|ionotropic glutamate receptor activity, GO:0001540|amyloid-beta binding, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0004972|NMDA glutamate receptor activity, GO:0022849|glutamate-gated calcium ion channel activity, GO:0005261|cation channel activity, GO:0005262|calcium channel activity"
RAD51B,Missense,0.328028501401103,27,0.094836839512102,N,"TSG, fusion",TSG,0.665112621654883,0.000153662225147965,ENSG00000182185,"GO:0033063|Rad51B-Rad51C-Rad51D-XRCC2 complex, GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005657|replication fork, GO:0016020|membrane, GO:0016021|integral component of membrane","GO:0006281|DNA repair, GO:0000724|double-strand break repair via homologous recombination, GO:0006310|DNA recombination, GO:0006974|cellular response to DNA damage stimulus, GO:0010971|positive regulation of G2/M transition of mitotic cell cycle, GO:0007596|blood coagulation, GO:0007131|reciprocal meiotic recombination","GO:0005524|ATP binding, GO:0003677|DNA binding, GO:0008094|DNA-dependent ATPase activity, GO:0000166|nucleotide binding, GO:0005515|protein binding, GO:0003690|double-stranded DNA binding, GO:0000400|four-way junction DNA binding, GO:0003697|single-stranded DNA binding"
ERBB4,Silent,0.327838618754006,66,0.00720561550924269,Y,"oncogene, TSG","",0.410261207791004,0.000623368412727501,ENSG00000178568,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005739|mitochondrion, GO:0005886|plasma membrane, GO:0045211|postsynaptic membrane, GO:0005576|extracellular region, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005759|mitochondrial matrix, GO:0009925|basal plasma membrane, GO:0016323|basolateral plasma membrane","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0007165|signal transduction, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0046854|phosphatidylinositol phosphorylation, GO:0007399|nervous system development, GO:0008284|positive regulation of cell proliferation, GO:0001934|positive regulation of protein phosphorylation, GO:0007507|heart development, GO:0008285|negative regulation of cell proliferation, GO:0016477|cell migration, GO:0030334|regulation of cell migration, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0043653|mitochondrial fragmentation involved in apoptotic process, GO:0000165|MAPK cascade, GO:0008283|cell proliferation, GO:0038128|ERBB2 signaling pathway, GO:2000145|regulation of cell motility, GO:0060644|mammary gland epithelial cell differentiation, GO:0007595|lactation, GO:0001755|neural crest cell migration, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0046427|positive regulation of JAK-STAT cascade, GO:0009880|embryonic pattern specification, GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0060749|mammary gland alveolus development, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0021551|central nervous system morphogenesis, GO:0021889|olfactory bulb interneuron differentiation, GO:0045165|cell fate commitment, GO:0061026|cardiac muscle tissue regeneration, GO:0071364|cellular response to epidermal growth factor stimulus, GO:2000010|positive regulation of protein localization to cell surface, GO:2001223|negative regulation of neuron migration","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0044212|transcription regulatory region DNA binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005154|epidermal growth factor receptor binding"
SIX1,Missense,0.327038713594605,22,0.137381290426865,N,Oncogene,Oncogene,0.444462972800128,0.0382239345038425,ENSG00000126778,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005730|nucleolus, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0001822|kidney development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0008283|cell proliferation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048513|animal organ development, GO:0045892|negative regulation of transcription, DNA-templated, GO:0048856|anatomical structure development, GO:0043524|negative regulation of neuron apoptotic process, GO:0030855|epithelial cell differentiation, GO:0030878|thyroid gland development, GO:0048538|thymus development, GO:0048699|generation of neurons, GO:0034504|protein localization to nucleus, GO:0051451|myoblast migration, GO:0007389|pattern specification process, GO:0042472|inner ear morphogenesis, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0007519|skeletal muscle tissue development, GO:0001657|ureteric bud development, GO:0048839|inner ear development, GO:0090190|positive regulation of branching involved in ureteric bud morphogenesis, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0048704|embryonic skeletal system morphogenesis, GO:0072075|metanephric mesenchyme development, GO:0072107|positive regulation of ureteric bud formation, GO:0045664|regulation of neuron differentiation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001759|organ induction, GO:0003151|outflow tract morphogenesis, GO:0007605|sensory perception of sound, GO:0008582|regulation of synaptic growth at neuromuscular junction, GO:0010468|regulation of gene expression, GO:0014842|regulation of skeletal muscle satellite cell proliferation, GO:0014857|regulation of skeletal muscle cell proliferation, GO:0021610|facial nerve morphogenesis, GO:0022008|neurogenesis, GO:0030910|olfactory placode formation, GO:0032880|regulation of protein localization, GO:0035909|aorta morphogenesis, GO:0042474|middle ear morphogenesis, GO:0043066|negative regulation of apoptotic process, GO:0043586|tongue development, GO:0048665|neuron fate specification, GO:0048705|skeletal system morphogenesis, GO:0048741|skeletal muscle fiber development, GO:0050678|regulation of epithelial cell proliferation, GO:0060037|pharyngeal system development, GO:0061055|myotome development, GO:0061197|fungiform papilla morphogenesis, GO:0061551|trigeminal ganglion development, GO:0071599|otic vesicle development, GO:0072001|renal system development, GO:0072095|regulation of branch elongation involved in ureteric bud branching, GO:0072172|mesonephric tubule formation, GO:0072193|ureter smooth muscle cell differentiation, GO:0072513|positive regulation of secondary heart field cardioblast proliferation, GO:0090103|cochlea morphogenesis, GO:0090191|negative regulation of branching involved in ureteric bud morphogenesis, GO:1905243|cellular response to 3,3',5-triiodo-L-thyronine, GO:2000729|positive regulation of mesenchymal cell proliferation involved in ureter development, GO:2001014|regulation of skeletal muscle cell differentiation","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0001223|transcription coactivator binding, GO:0003682|chromatin binding"
MLLT1,Silent,0.324717891519041,23,0.130595464445389,N,fusion,"",0.300296903494461,0.163849809106559,ENSG00000130382,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0001650|fibrillar center, GO:0008023|transcription elongation factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006366|transcription by RNA polymerase II, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0006469|negative regulation of protein kinase activity","GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003677|DNA binding"
SFPQ,Missense,0.3231807509855,42,0.0368311864252995,N,"TSG, fusion",TSG,0.501012056294395,0.00072609851054164,ENSG00000116560,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0005654|nucleoplasm, GO:0032839|dendrite cytoplasm, GO:0016363|nuclear matrix, GO:0090575|RNA polymerase II transcription factor complex, GO:0000785|chromatin, GO:0042382|paraspeckles","GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0006281|DNA repair, GO:0006310|DNA recombination, GO:0006974|cellular response to DNA damage stimulus, GO:0048511|rhythmic process, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0002218|activation of innate immune response, GO:0042752|regulation of circadian rhythm, GO:0042754|negative regulation of circadian rhythm, GO:0070932|histone H3 deacetylation, GO:0000380|alternative mRNA splicing, via spliceosome, GO:0000724|double-strand break repair via homologous recombination, GO:0045876|positive regulation of sister chromatid cohesion, GO:0051276|chromosome organization, GO:0051726|regulation of cell cycle, GO:1902177|positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0003677|DNA binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0070888|E-box binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0042826|histone deacetylase binding, GO:0044212|transcription regulatory region DNA binding"
DICER1,Silent,0.321738449138959,42,0.0377293425111259,N,TSG,TSG,0.320510833844061,0.0385078536716276,ENSG00000100697,"GO:0070062|extracellular exosome, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0070578|RISC-loading complex, GO:0035068|micro-ribonucleoprotein complex, GO:0016442|RISC complex, GO:0033167|ARC complex, GO:0005793|endoplasmic reticulum-Golgi intermediate compartment, GO:0030424|axon, GO:0030425|dendrite, GO:0030426|growth cone","GO:0032720|negative regulation of tumor necrosis factor production, GO:0038061|NIK/NF-kappaB signaling, GO:0006396|RNA processing, GO:0031047|gene silencing by RNA, GO:0006309|apoptotic DNA fragmentation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030422|production of siRNA involved in RNA interference, GO:0021675|nerve development, GO:0010586|miRNA metabolic process, GO:0031054|pre-miRNA processing, GO:0035196|production of miRNAs involved in gene silencing by miRNA, GO:0048812|neuron projection morphogenesis, GO:0030423|targeting of mRNA for destruction involved in RNA interference, GO:0035280|miRNA loading onto RISC involved in gene silencing by miRNA, GO:0035087|siRNA loading onto RISC involved in RNA interference, GO:0010626|negative regulation of Schwann cell proliferation, GO:0014040|positive regulation of Schwann cell differentiation, GO:0031643|positive regulation of myelination, GO:0032290|peripheral nervous system myelin formation, GO:0033168|conversion of ds siRNA to ss siRNA involved in RNA interference, GO:0036404|conversion of ds siRNA to ss siRNA, GO:0090502|RNA phosphodiester bond hydrolysis, endonucleolytic, GO:0090501|RNA phosphodiester bond hydrolysis","GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004519|endonuclease activity, GO:0004518|nuclease activity, GO:0004525|ribonuclease III activity, GO:0004386|helicase activity, GO:0019904|protein domain specific binding, GO:0016891|endoribonuclease activity, producing 5'-phosphomonoesters, GO:0003725|double-stranded RNA binding, GO:0070883|pre-miRNA binding, GO:0004530|deoxyribonuclease I activity, GO:0035197|siRNA binding, GO:0004521|endoribonuclease activity"
CBFA2T3,Missense,0.321508769601575,71,0.00625718209329633,Y,"TSG, fusion",TSG,0.323830205757987,0.00587167103600554,ENSG00000129993,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005794|Golgi apparatus, GO:0000139|Golgi membrane, GO:0005730|nucleolus","GO:0006355|regulation of transcription, DNA-templated, GO:0045892|negative regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0008285|negative regulation of cell proliferation, GO:0001666|response to hypoxia, GO:0008283|cell proliferation, GO:0030851|granulocyte differentiation, GO:0032436|positive regulation of proteasomal ubiquitin-dependent protein catabolic process, GO:0045820|negative regulation of glycolytic process, GO:1903715|regulation of aerobic respiration","GO:0046872|metal ion binding, GO:0003700|DNA-binding transcription factor activity, GO:0003714|transcription corepressor activity, GO:0005515|protein binding"
TP63,Silent,0.321496679413295,52,0.0201221170204088,N,"oncogene, TSG","",0.338226701125154,0.0141886333642079,ENSG00000073282,"GO:0005739|mitochondrion, GO:0005634|nucleus, GO:0005794|Golgi apparatus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005791|rough endoplasmic reticulum, GO:0030425|dendrite, GO:0032991|protein-containing complex, GO:0043005|neuron projection, GO:0000790|nuclear chromatin, GO:0005737|cytoplasm","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045669|positive regulation of osteoblast differentiation, GO:0006355|regulation of transcription, DNA-templated, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0051262|protein tetramerization, GO:0007219|Notch signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0032502|developmental process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001302|replicative cell aging, GO:0001501|skeletal system development, GO:0001736|establishment of planar polarity, GO:0001738|morphogenesis of a polarized epithelium, GO:0001942|hair follicle development, GO:0002064|epithelial cell development, GO:0006338|chromatin remodeling, GO:0007283|spermatogenesis, GO:0007389|pattern specification process, GO:0007499|ectoderm and mesoderm interaction, GO:0007568|aging, GO:0007569|cell aging, GO:0008283|cell proliferation, GO:0008544|epidermis development, GO:0009887|animal organ morphogenesis, GO:0009913|epidermal cell differentiation, GO:0009954|proximal/distal pattern formation, GO:0010259|multicellular organism aging, GO:0010481|epidermal cell division, GO:0010482|regulation of epidermal cell division, GO:0010838|positive regulation of keratinocyte proliferation, GO:0030154|cell differentiation, GO:0030216|keratinocyte differentiation, GO:0030326|embryonic limb morphogenesis, GO:0030850|prostate gland development, GO:0030855|epithelial cell differentiation, GO:0030859|polarized epithelial cell differentiation, GO:0031069|hair follicle morphogenesis, GO:0033147|negative regulation of intracellular estrogen receptor signaling pathway, GO:0035115|embryonic forelimb morphogenesis, GO:0035116|embryonic hindlimb morphogenesis, GO:0036342|post-anal tail morphogenesis, GO:0042475|odontogenesis of dentin-containing tooth, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0043281|regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0043589|skin morphogenesis, GO:0045617|negative regulation of keratinocyte differentiation, GO:0045747|positive regulation of Notch signaling pathway, GO:0048485|sympathetic nervous system development, GO:0048646|anatomical structure formation involved in morphogenesis, GO:0048807|female genitalia morphogenesis, GO:0051402|neuron apoptotic process, GO:0060197|cloacal septation, GO:0060513|prostatic bud formation, GO:0060529|squamous basal epithelial stem cell differentiation involved in prostate gland acinus development, GO:0061436|establishment of skin barrier, GO:0098773|skin epidermis development, GO:1904674|positive regulation of somatic stem cell population maintenance, GO:1904888|cranial skeletal system development, GO:2000381|negative regulation of mesoderm development, GO:2001235|positive regulation of apoptotic signaling pathway, GO:0042981|regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0051289|protein homotetramerization, GO:1900740|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, GO:2000271|positive regulation of fibroblast apoptotic process, GO:0007049|cell cycle","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0044212|transcription regulatory region DNA binding, GO:0042802|identical protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0003684|damaged DNA binding, GO:0003690|double-stranded DNA binding, GO:0019904|protein domain specific binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0002039|p53 binding, GO:0097371|MDM2/MDM4 family protein binding, GO:0050699|WW domain binding"
KLK2,Missense,0.319456846876863,26,0.111651719716257,N,fusion,"",0.484019972616492,0.0122294442317365,ENSG00000167751,"GO:0005576|extracellular region, GO:0070062|extracellular exosome, GO:0030141|secretory granule","GO:0006508|proteolysis, GO:0022617|extracellular matrix disassembly, GO:0031638|zymogen activation, GO:0003073|regulation of systemic arterial blood pressure","GO:0016787|hydrolase activity, GO:0008233|peptidase activity, GO:0004252|serine-type endopeptidase activity, GO:0008236|serine-type peptidase activity"
BTK,Silent,0.318885845908772,20,0.1705720525677,N,"oncogene, TSG","",0.413248253226737,0.0701336333815573,ENSG00000010671,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0042629|mast cell granule, GO:0045121|membrane raft, GO:0031410|cytoplasmic vesicle, GO:0048471|perinuclear region of cytoplasm","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0006915|apoptotic process, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0002250|adaptive immune response, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0050853|B cell receptor signaling pathway, GO:0042113|B cell activation, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0002755|MyD88-dependent toll-like receptor signaling pathway, GO:0050852|T cell receptor signaling pathway, GO:0007498|mesoderm development, GO:0019722|calcium-mediated signaling, GO:0097190|apoptotic signaling pathway, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0045579|positive regulation of B cell differentiation, GO:0002721|regulation of B cell cytokine production, GO:0002902|regulation of B cell apoptotic process, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0001805|positive regulation of type III hypersensitivity, GO:0001812|positive regulation of type I hypersensitivity, GO:0001818|negative regulation of cytokine production, GO:0002344|B cell affinity maturation, GO:0002553|histamine secretion by mast cell, GO:0007249|I-kappaB kinase/NF-kappaB signaling, GO:0010033|response to organic substance, GO:0030889|negative regulation of B cell proliferation, GO:0034614|cellular response to reactive oxygen species, GO:0046777|protein autophosphorylation, GO:0048469|cell maturation, GO:0071226|cellular response to molecule of fungal origin, GO:0098761|cellular response to interleukin-7","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0008289|lipid binding, GO:0042802|identical protein binding, GO:0005547|phosphatidylinositol-3,4,5-trisphosphate binding"
ESR1,Silent,0.315189786615547,16,0.234400077269189,N,"oncogene, TSG, fusion","",0.323581458755054,0.221495511510472,ENSG00000091831,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0000790|nuclear chromatin, GO:0032991|protein-containing complex, GO:0035327|transcriptionally active chromatin, GO:0097550|transcriptional preinitiation complex","GO:0006355|regulation of transcription, DNA-templated, GO:0043401|steroid hormone mediated signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0030522|intracellular receptor signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0046854|phosphatidylinositol phosphorylation, GO:0016579|protein deubiquitination, GO:0007165|signal transduction, GO:0010629|negative regulation of gene expression, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0051897|positive regulation of protein kinase B signaling, GO:0007204|positive regulation of cytosolic calcium ion concentration, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0030518|intracellular steroid hormone receptor signaling pathway, GO:0030520|intracellular estrogen receptor signaling pathway, GO:0032355|response to estradiol, GO:0043627|response to estrogen, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0006338|chromatin remodeling, GO:0030111|regulation of Wnt signaling pathway, GO:0033146|regulation of intracellular estrogen receptor signaling pathway, GO:0006366|transcription by RNA polymerase II, GO:0006351|transcription, DNA-templated, GO:0071392|cellular response to estradiol stimulus, GO:1903799|negative regulation of production of miRNAs involved in gene silencing by miRNA, GO:0006357|regulation of transcription by RNA polymerase II, GO:0010863|positive regulation of phospholipase C activity, GO:0007200|phospholipase C-activating G protein-coupled receptor signaling pathway, GO:0045899|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly, GO:0071168|protein localization to chromatin, GO:0001547|antral ovarian follicle growth, GO:0002064|epithelial cell development, GO:0008209|androgen metabolic process, GO:0008584|male gonad development, GO:0034121|regulation of toll-like receptor signaling pathway, GO:0042981|regulation of apoptotic process, GO:0048146|positive regulation of fibroblast proliferation, GO:0048863|stem cell differentiation, GO:0050727|regulation of inflammatory response, GO:0060065|uterus development, GO:0060068|vagina development, GO:0060523|prostate epithelial cord elongation, GO:0060527|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis, GO:0060687|regulation of branching involved in prostate gland morphogenesis, GO:0060745|mammary gland branching involved in pregnancy, GO:0060749|mammary gland alveolus development, GO:0060750|epithelial cell proliferation involved in mammary gland duct elongation, GO:0071391|cellular response to estrogen stimulus","GO:0003677|DNA binding, GO:0005496|steroid binding, GO:0030284|estrogen receptor activity, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0003707|steroid hormone receptor activity, GO:0008289|lipid binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0019901|protein kinase binding, GO:0003682|chromatin binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0008134|transcription factor binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0008013|beta-catenin binding, GO:0034056|estrogen response element binding, GO:0001223|transcription coactivator binding, GO:0030235|nitric-oxide synthase regulator activity, GO:0001093|TFIIB-class transcription factor binding, GO:0004879|nuclear receptor activity, GO:0017025|TBP-class protein binding, GO:0030331|estrogen receptor binding, GO:0051117|ATPase binding"
HNF1A,Missense,0.314477235080365,64,0.0113803491389722,N,TSG,TSG,0.350360137244889,0.00453687924914141,ENSG00000135100,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0032991|protein-containing complex, GO:0001750|photoreceptor outer segment, GO:0005667|transcription factor complex, GO:0045120|pronucleus","GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0001889|liver development, GO:0030073|insulin secretion, GO:0031016|pancreas development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0001779|natural killer cell differentiation, GO:0042593|glucose homeostasis, GO:0035623|renal glucose absorption, GO:0046323|glucose import, GO:0060261|positive regulation of transcription initiation from RNA polymerase II promoter, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001824|blastocyst development, GO:0001890|placenta development, GO:0006338|chromatin remodeling, GO:0006355|regulation of transcription, DNA-templated, GO:0006366|transcription by RNA polymerase II, GO:0006633|fatty acid biosynthetic process, GO:0006699|bile acid biosynthetic process, GO:0006783|heme biosynthetic process, GO:0006979|response to oxidative stress, GO:0008104|protein localization, GO:0008203|cholesterol metabolic process, GO:0009749|response to glucose, GO:0015721|bile acid and bile salt transport, GO:0015908|fatty acid transport, GO:0016573|histone acetylation, GO:0030111|regulation of Wnt signaling pathway, GO:0030326|embryonic limb morphogenesis, GO:0031018|endocrine pancreas development, GO:0043691|reverse cholesterol transport, GO:0045453|bone resorption, GO:0046883|regulation of hormone secretion, GO:0048341|paraxial mesoderm formation, GO:0048608|reproductive structure development, GO:0050796|regulation of insulin secretion, GO:0060395|SMAD protein signal transduction","GO:0003677|DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0046983|protein dimerization activity, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001221|transcription cofactor binding, GO:0003690|double-stranded DNA binding, GO:0008134|transcription factor binding, GO:0042803|protein homodimerization activity, GO:0043565|sequence-specific DNA binding, GO:0046982|protein heterodimerization activity"
HLA-A,Nonsense,0.314449526431345,11,0.346305914479095,N,fusion,"",0.08346757606474,0.807241277252162,ENSG00000206503,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0009986|cell surface, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0042612|MHC class I protein complex, GO:0005789|endoplasmic reticulum membrane, GO:0070062|extracellular exosome, GO:0030670|phagocytic vesicle membrane, GO:0000139|Golgi membrane, GO:0012507|ER to Golgi transport vesicle membrane, GO:0071556|integral component of lumenal side of endoplasmic reticulum membrane, GO:0031901|early endosome membrane, GO:0055038|recycling endosome membrane","GO:0006955|immune response, GO:0002376|immune system process, GO:0050776|regulation of immune response, GO:0019882|antigen processing and presentation, GO:0002474|antigen processing and presentation of peptide antigen via MHC class I, GO:0016567|protein ubiquitination, GO:0002479|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, GO:0060333|interferon-gamma-mediated signaling pathway, GO:0060337|type I interferon signaling pathway, GO:0002480|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent, GO:0042270|protection from natural killer cell mediated cytotoxicity","GO:0042605|peptide antigen binding, GO:0030881|beta-2-microglobulin binding, GO:0046977|TAP binding"
EP300,Nonsense,0.313256260061424,28,0.104551801057485,N,"TSG, fusion",TSG,0.541857815127587,0.00289862003089721,ENSG00000100393,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0000123|histone acetyltransferase complex, GO:0032993|protein-DNA complex, GO:0005667|transcription factor complex, GO:0032991|protein-containing complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007049|cell cycle, GO:0007623|circadian rhythm, GO:0048511|rhythmic process, GO:0006915|apoptotic process, GO:0016573|histone acetylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045444|fat cell differentiation, GO:0031648|protein destabilization, GO:0050821|protein stabilization, GO:0045721|negative regulation of gluconeogenesis, GO:0001666|response to hypoxia, GO:0016032|viral process, GO:0007399|nervous system development, GO:0045815|positive regulation of gene expression, epigenetic, GO:0043967|histone H4 acetylation, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:1904837|beta-catenin-TCF complex assembly, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0043627|response to estrogen, GO:0045652|regulation of megakaryocyte differentiation, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0034644|cellular response to UV, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0006283|transcription-coupled nucleotide-excision repair, GO:0006473|protein acetylation, GO:1900034|regulation of cellular response to heat, GO:0051726|regulation of cell cycle, GO:0018393|internal peptidyl-lysine acetylation, GO:0007219|Notch signaling pathway, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0010976|positive regulation of neuron projection development, GO:0010506|regulation of autophagy, GO:0032481|positive regulation of type I interferon production, GO:0006990|positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response, GO:0060765|regulation of androgen receptor signaling pathway, GO:0006475|internal protein amino acid acetylation, GO:0010742|macrophage derived foam cell differentiation, GO:0007221|positive regulation of transcription of Notch receptor target, GO:0045747|positive regulation of Notch signaling pathway, GO:0043923|positive regulation by host of viral transcription, GO:0045893|positive regulation of transcription, DNA-templated, GO:0001756|somitogenesis, GO:0007507|heart development, GO:0007519|skeletal muscle tissue development, GO:0009887|animal organ morphogenesis, GO:0010628|positive regulation of gene expression, GO:0018076|N-terminal peptidyl-lysine acetylation, GO:0018394|peptidyl-lysine acetylation, GO:0030183|B cell differentiation, GO:0030220|platelet formation, GO:0030324|lung development, GO:0032092|positive regulation of protein binding, GO:0032460|negative regulation of protein oligomerization, GO:0035855|megakaryocyte development, GO:0043969|histone H2B acetylation, GO:0061921|peptidyl-lysine propionylation, GO:0090043|regulation of tubulin deacetylation, GO:0140066|peptidyl-lysine crotonylation, GO:0140067|peptidyl-lysine butyrylation","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003713|transcription coactivator activity, GO:0003712|transcription coregulator activity, GO:0003677|DNA binding, GO:0016746|transferase activity, transferring acyl groups, GO:0005515|protein binding, GO:0004402|histone acetyltransferase activity, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0048156|tau protein binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0008013|beta-catenin binding, GO:0003684|damaged DNA binding, GO:0035257|nuclear hormone receptor binding, GO:0050681|androgen receptor binding, GO:0008022|protein C-terminus binding, GO:0033613|activating transcription factor binding, GO:0016407|acetyltransferase activity, GO:0001085|RNA polymerase II transcription factor binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0002039|p53 binding, GO:0004468|lysine N-acetyltransferase activity, acting on acetyl phosphate as donor, GO:0031490|chromatin DNA binding, GO:0034212|peptide N-acetyltransferase activity, GO:0061733|peptide-lysine-N-acetyltransferase activity, GO:0061920|protein propionyltransferase activity, GO:0097157|pre-mRNA intronic binding, GO:0097677|STAT family protein binding, GO:0140065|peptide butyryltransferase activity, GO:0140068|histone crotonyltransferase activity, GO:0140069|histone butyryltransferase activity"
AXIN2,Silent,0.312968466325928,26,0.119529438647312,N,TSG,TSG,0.34191164736696,0.0873337837878039,ENSG00000168646,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005813|centrosome, GO:0030877|beta-catenin destruction complex","GO:0008285|negative regulation of cell proliferation, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0001934|positive regulation of protein phosphorylation, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0010942|positive regulation of cell death, GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:1904837|beta-catenin-TCF complex assembly, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0034613|cellular protein localization, GO:0042476|odontogenesis, GO:0070602|regulation of centromeric sister chromatid cohesion, GO:0048255|mRNA stabilization, GO:0043570|maintenance of DNA repeat elements, GO:0001756|somitogenesis, GO:0001957|intramembranous ossification, GO:0003139|secondary heart field specification, GO:0003413|chondrocyte differentiation involved in endochondral bone morphogenesis, GO:0008283|cell proliferation, GO:0030111|regulation of Wnt signaling pathway, GO:0030282|bone mineralization, GO:0032423|regulation of mismatch repair, GO:0045668|negative regulation of osteoblast differentiation, GO:0061181|regulation of chondrocyte development","GO:0005515|protein binding, GO:0031625|ubiquitin protein ligase binding, GO:0019899|enzyme binding, GO:0008013|beta-catenin binding, GO:0070411|I-SMAD binding"
KLF4,Silent,0.312054926501022,13,0.29928170858881,N,"oncogene, TSG","",0.240760469257418,0.42814618298828,ENSG00000136826,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin, GO:0000785|chromatin, GO:0005667|transcription factor complex, GO:0005719|nuclear euchromatin, GO:0005737|cytoplasm, GO:0044798|nuclear transcription factor complex","GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0090051|negative regulation of cell migration involved in sprouting angiogenesis, GO:0050728|negative regulation of inflammatory response, GO:0016525|negative regulation of angiogenesis, GO:0034115|negative regulation of heterotypic cell-cell adhesion, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle, GO:0071499|cellular response to laminar fluid shear stress, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1903672|positive regulation of sprouting angiogenesis, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0032088|negative regulation of NF-kappaB transcription factor activity, GO:0045893|positive regulation of transcription, DNA-templated, GO:0043551|regulation of phosphatidylinositol 3-kinase activity, GO:0006357|regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0008285|negative regulation of cell proliferation, GO:0051973|positive regulation of telomerase activity, GO:0032270|positive regulation of cellular protein metabolic process, GO:0006351|transcription, DNA-templated, GO:0006366|transcription by RNA polymerase II, GO:0007500|mesodermal cell fate determination, GO:0009913|epidermal cell differentiation, GO:0010033|response to organic substance, GO:0014067|negative regulation of phosphatidylinositol 3-kinase signaling, GO:0014740|negative regulation of muscle hyperplasia, GO:0019827|stem cell population maintenance, GO:0030154|cell differentiation, GO:0030336|negative regulation of cell migration, GO:0031077|post-embryonic camera-type eye development, GO:0032526|response to retinoic acid, GO:0035019|somatic stem cell population maintenance, GO:0035166|post-embryonic hemopoiesis, GO:0042127|regulation of cell proliferation, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045415|negative regulation of interleukin-8 biosynthetic process, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0045444|fat cell differentiation, GO:0045595|regulation of cell differentiation, GO:0046985|positive regulation of hemoglobin biosynthetic process, GO:0048662|negative regulation of smooth muscle cell proliferation, GO:0048679|regulation of axon regeneration, GO:0048730|epidermis morphogenesis, GO:0051247|positive regulation of protein metabolic process, GO:0051898|negative regulation of protein kinase B signaling, GO:0060070|canonical Wnt signaling pathway, GO:0060761|negative regulation of response to cytokine stimulus, GO:0061614|pri-miRNA transcription by RNA polymerase II, GO:0070301|cellular response to hydrogen peroxide, GO:0070373|negative regulation of ERK1 and ERK2 cascade, GO:0071300|cellular response to retinoic acid, GO:0071363|cellular response to growth factor stimulus, GO:0071407|cellular response to organic cyclic compound, GO:0071409|cellular response to cycloheximide, GO:1901653|cellular response to peptide, GO:1904798|positive regulation of core promoter binding, GO:1904998|negative regulation of leukocyte adhesion to arterial endothelial cell, GO:1990830|cellular response to leukemia inhibitory factor, GO:2000342|negative regulation of chemokine (C-X-C motif) ligand 2 production","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0001010|RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity, GO:0001221|transcription cofactor binding, GO:0003690|double-stranded DNA binding, GO:0008013|beta-catenin binding, GO:0008134|transcription factor binding, GO:0035014|phosphatidylinositol 3-kinase regulator activity, GO:0042826|histone deacetylase binding, GO:0043565|sequence-specific DNA binding, GO:1990841|promoter-specific chromatin binding"
RNF43,Missense,0.310935189926687,83,0.00422204267392707,Y,TSG,TSG,0.445025497928032,2.49385892245033e-05,ENSG00000108375,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0005635|nuclear envelope","GO:0016567|protein ubiquitination, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:0030178|negative regulation of Wnt signaling pathway, GO:0072089|stem cell proliferation, GO:0038018|Wnt receptor catabolic process","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0061630|ubiquitin protein ligase activity, GO:0005109|frizzled binding"
NCOA2,Silent,0.310416649554281,38,0.0578583455066725,N,"oncogene, fusion",Oncogene,0.272667621753029,0.0976734548817404,ENSG00000140396,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016604|nuclear body, GO:0032991|protein-containing complex, GO:0005737|cytoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0048511|rhythmic process, GO:0032922|circadian regulation of gene expression, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0019216|regulation of lipid metabolic process, GO:0015721|bile acid and bile salt transport, GO:0032870|cellular response to hormone stimulus, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007623|circadian rhythm, GO:0010468|regulation of gene expression, GO:0010906|regulation of glucose metabolic process, GO:0032570|response to progesterone, GO:0045475|locomotor rhythm, GO:0045892|negative regulation of transcription, DNA-templated, GO:1904017|cellular response to Thyroglobulin triiodothyronine, GO:1903508|positive regulation of nucleic acid-templated transcription","GO:0003713|transcription coactivator activity, GO:0046983|protein dimerization activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0030374|nuclear receptor transcription coactivator activity, GO:0035257|nuclear hormone receptor binding, GO:0017162|aryl hydrocarbon receptor binding, GO:0019904|protein domain specific binding, GO:0016922|nuclear receptor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001162|RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0005102|signaling receptor binding, GO:0008134|transcription factor binding, GO:0030375|thyroid hormone receptor coactivator activity"
ETV1,Silent,0.310292124040342,14,0.280276832161119,N,"oncogene, fusion",Oncogene,0.363424223840316,0.201513763438901,ENSG00000006468,GO:0005634|nucleus,"GO:0006355|regulation of transcription, DNA-templated, GO:0006366|transcription by RNA polymerase II, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048935|peripheral nervous system neuron development, GO:0007411|axon guidance, GO:0007517|muscle organ development, GO:0007638|mechanosensory behavior, GO:0045893|positive regulation of transcription, DNA-templated","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
TNFAIP3,Missense,0.309465069028662,56,0.020293102107374,N,TSG,TSG,0.398660518826677,0.00234025635077972,ENSG00000118503,"GO:0043231|intracellular membrane-bounded organelle, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005764|lysosome, GO:0005829|cytosol, GO:0070062|extracellular exosome","GO:0016579|protein deubiquitination, GO:0016567|protein ubiquitination, GO:0050728|negative regulation of inflammatory response, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:0031397|negative regulation of protein ubiquitination, GO:0032088|negative regulation of NF-kappaB transcription factor activity, GO:0071222|cellular response to lipopolysaccharide, GO:0048662|negative regulation of smooth muscle cell proliferation, GO:0008152|metabolic process, GO:0006508|proteolysis, GO:0006915|apoptotic process, GO:0006954|inflammatory response, GO:0007010|cytoskeleton organization, GO:0045824|negative regulation of innate immune response, GO:0070536|protein K63-linked deubiquitination, GO:0071108|protein K48-linked deubiquitination, GO:0016477|cell migration, GO:0032715|negative regulation of interleukin-6 production, GO:0032720|negative regulation of tumor necrosis factor production, GO:0070936|protein K48-linked ubiquitination, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0010803|regulation of tumor necrosis factor-mediated signaling pathway, GO:0032480|negative regulation of type I interferon production, GO:0045732|positive regulation of protein catabolic process, GO:0070301|cellular response to hydrogen peroxide, GO:1902042|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:0070423|nucleotide-binding oligomerization domain containing signaling pathway, GO:0090291|negative regulation of osteoclast proliferation, GO:0032703|negative regulation of interleukin-2 production, GO:0045779|negative regulation of bone resorption, GO:0051259|protein complex oligomerization, GO:0002237|response to molecule of bacterial origin, GO:0034144|negative regulation of toll-like receptor 4 signaling pathway, GO:0001922|B-1 B cell homeostasis, GO:0002634|regulation of germinal center formation, GO:0030177|positive regulation of Wnt signaling pathway, GO:0034136|negative regulation of toll-like receptor 2 signaling pathway, GO:0034140|negative regulation of toll-like receptor 3 signaling pathway, GO:0035523|protein K29-linked deubiquitination, GO:0035871|protein K11-linked deubiquitination, GO:0050691|regulation of defense response to virus by host, GO:0050713|negative regulation of interleukin-1 beta secretion, GO:0050869|negative regulation of B cell activation, GO:0061043|regulation of vascular wound healing, GO:0071947|protein deubiquitination involved in ubiquitin-dependent protein catabolic process, GO:0072573|tolerance induction to lipopolysaccharide, GO:1990168|protein K33-linked deubiquitination, GO:2000349|negative regulation of CD40 signaling pathway, GO:0002677|negative regulation of chronic inflammatory response, GO:0032495|response to muramyl dipeptide, GO:0032691|negative regulation of interleukin-1 beta production, GO:0034148|negative regulation of toll-like receptor 5 signaling pathway, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0060548|negative regulation of cell death, GO:0070429|negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway, GO:0070433|negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway, GO:0072666|establishment of protein localization to vacuole, GO:1903364|positive regulation of cellular protein catabolic process, GO:2000347|positive regulation of hepatocyte proliferation","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003824|catalytic activity, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0004842|ubiquitin-protein transferase activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0042802|identical protein binding, GO:0004843|thiol-dependent ubiquitin-specific protease activity, GO:0061578|Lys63-specific deubiquitinase activity, GO:0002020|protease binding, GO:0043130|ubiquitin binding, GO:0043621|protein self-association, GO:0070530|K63-linked polyubiquitin modification-dependent protein binding, GO:0019900|kinase binding"
TCL1A,Missense,0.309200482327575,16,0.243893316908368,N,"oncogene, fusion",Oncogene,0.358384080377397,0.172868122741024,ENSG00000100721,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005783|endoplasmic reticulum, GO:0043231|intracellular membrane-bounded organelle, GO:0032991|protein-containing complex","GO:0008284|positive regulation of cell proliferation, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:0071902|positive regulation of protein serine/threonine kinase activity, GO:0071356|cellular response to tumor necrosis factor, GO:0043066|negative regulation of apoptotic process, GO:0007275|multicellular organism development, GO:0032461|positive regulation of protein oligomerization, GO:0070207|protein homotrimerization, GO:0010918|positive regulation of mitochondrial membrane potential","GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0019901|protein kinase binding, GO:0043539|protein serine/threonine kinase activator activity"
CBLC,Missense,0.308775048951021,40,0.0525494414550866,N,"oncogene, TSG","",0.331649077058702,0.0365641751471153,ENSG00000142273,"GO:0005886|plasma membrane, GO:0045121|membrane raft","GO:0043407|negative regulation of MAP kinase activity, GO:0023051|regulation of signaling, GO:0007166|cell surface receptor signaling pathway, GO:0007165|signal transduction, GO:0007175|negative regulation of epidermal growth factor-activated receptor activity, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0016567|protein ubiquitination, GO:0042059|negative regulation of epidermal growth factor receptor signaling pathway","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005509|calcium ion binding, GO:0004842|ubiquitin-protein transferase activity, GO:0001784|phosphotyrosine residue binding, GO:0061630|ubiquitin protein ligase activity, GO:0017124|SH3 domain binding, GO:0008270|zinc ion binding, GO:0030971|receptor tyrosine kinase binding, GO:0005154|epidermal growth factor receptor binding"
NOTCH2,Nonsense,0.3083027881301,25,0.133771203488892,N,"oncogene, TSG","",0.277598027597955,0.179105875789121,ENSG00000134250,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0009986|cell surface, GO:0005576|extracellular region, GO:0005887|integral component of plasma membrane, GO:0005789|endoplasmic reticulum membrane, GO:0000139|Golgi membrane, GO:0043235|receptor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006915|apoptotic process, GO:0007219|Notch signaling pathway, GO:0007399|nervous system development, GO:0050793|regulation of developmental process, GO:0007050|cell cycle arrest, GO:0043066|negative regulation of apoptotic process, GO:0010629|negative regulation of gene expression, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0001709|cell fate determination, GO:0002315|marginal zone B cell differentiation, GO:0030097|hemopoiesis, GO:0009887|animal organ morphogenesis, GO:0046579|positive regulation of Ras protein signal transduction, GO:0019827|stem cell population maintenance, GO:0003184|pulmonary valve morphogenesis, GO:0046849|bone remodeling, GO:0061314|Notch signaling involved in heart development, GO:0060413|atrial septum morphogenesis, GO:0045967|negative regulation of growth rate, GO:2001204|regulation of osteoclast development","GO:0005509|calcium ion binding, GO:0038023|signaling receptor activity, GO:0005515|protein binding"
PLAG1,Missense,0.308146397924312,53,0.0247823208797408,N,"oncogene, fusion",Oncogene,0.325890048195094,0.0172491361179733,ENSG00000181690,"GO:0005634|nucleus, GO:0016607|nuclear speck","GO:0006351|transcription, DNA-templated, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0022612|gland morphogenesis, GO:0035264|multicellular organism growth, GO:0035265|organ growth, GO:0060252|positive regulation of glial cell proliferation, GO:0060736|prostate gland growth, GO:0006355|regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
MYCN,Silent,0.30769825774902,17,0.2295727526453,N,Oncogene,Oncogene,0.306410556515112,0.231628743486009,ENSG00000134323,"GO:0005634|nucleus, GO:0005730|nucleolus, GO:0000785|chromatin","GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0006355|regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006357|regulation of transcription by RNA polymerase II, GO:1903800|positive regulation of production of miRNAs involved in gene silencing by miRNA","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019900|kinase binding"
CUX1,Missense,0.307697502530267,110,0.00107545002170355,Y,"oncogene, TSG","",0.361943006487077,0.000102199599156492,ENSG00000257923,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0005654|nucleoplasm, GO:0000139|Golgi membrane, GO:0030173|integral component of Golgi membrane, GO:0005829|cytosol","GO:0006355|regulation of transcription, DNA-templated, GO:0006891|intra-Golgi vesicle-mediated transport, GO:0006357|regulation of transcription by RNA polymerase II, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0007275|multicellular organism development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0048193|Golgi vesicle transport, GO:0050775|positive regulation of dendrite morphogenesis, GO:0000301|retrograde transport, vesicle recycling within Golgi","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0004713|protein tyrosine kinase activity, GO:0030674|protein binding, bridging"
CRLF2,Silent,0.307443661405259,10,0.387511844562658,N,"oncogene, fusion",Oncogene,0.387728956104208,0.268260078162817,ENSG00000205755,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0009897|external side of plasma membrane, GO:0043235|receptor complex","GO:0008284|positive regulation of cell proliferation, GO:0038111|interleukin-7-mediated signaling pathway, GO:0019221|cytokine-mediated signaling pathway, GO:1904894|positive regulation of STAT cascade, GO:2000664|positive regulation of interleukin-5 secretion, GO:0033005|positive regulation of mast cell activation","GO:0004896|cytokine receptor activity, GO:0019955|cytokine binding"
MAP2K4,Missense,0.305380798973381,59,0.0186741072747172,N,"oncogene, TSG","",0.69394283262878,1.10193975770574e-09,ENSG00000065559,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0030424|axon, GO:0032839|dendrite cytoplasm, GO:0043204|perikaryon","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0006915|apoptotic process, GO:0071260|cellular response to mechanical stimulus, GO:0007165|signal transduction, GO:0023014|signal transduction by protein phosphorylation, GO:0031098|stress-activated protein kinase signaling cascade, GO:0032147|activation of protein kinase activity, GO:0000187|activation of MAPK activity, GO:0007257|activation of JUN kinase activity, GO:0007254|JNK cascade, GO:0000165|MAPK cascade, GO:0001934|positive regulation of protein phosphorylation, GO:0009611|response to wounding, GO:0034393|positive regulation of smooth muscle cell apoptotic process, GO:0043065|positive regulation of apoptotic process, GO:0043525|positive regulation of neuron apoptotic process, GO:0045740|positive regulation of DNA replication, GO:0051770|positive regulation of nitric-oxide synthase biosynthetic process, GO:0061049|cell growth involved in cardiac muscle cell development, GO:0072709|cellular response to sorbitol, GO:2000672|negative regulation of motor neuron apoptotic process","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004708|MAP kinase kinase activity, GO:0008545|JUN kinase kinase activity, GO:0031435|mitogen-activated protein kinase kinase kinase binding"
BCL11B,Silent,0.305331698072964,43,0.0464782170343152,N,"oncogene, TSG, fusion","",0.265410409827302,0.0854090096731811,ENSG00000127152,"GO:0005634|nucleus, GO:0043005|neuron projection","GO:0006355|regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0003334|keratinocyte development, GO:0003382|epithelial cell morphogenesis, GO:0007409|axonogenesis, GO:0008285|negative regulation of cell proliferation, GO:0009791|post-embryonic development, GO:0010468|regulation of gene expression, GO:0010837|regulation of keratinocyte proliferation, GO:0019216|regulation of lipid metabolic process, GO:0021773|striatal medium spiny neuron differentiation, GO:0021902|commitment of neuronal cell to specific neuron type in forebrain, GO:0021953|central nervous system neuron differentiation, GO:0031077|post-embryonic camera-type eye development, GO:0033077|T cell differentiation in thymus, GO:0033153|T cell receptor V(D)J recombination, GO:0042475|odontogenesis of dentin-containing tooth, GO:0043066|negative regulation of apoptotic process, GO:0043368|positive T cell selection, GO:0043588|skin development, GO:0045664|regulation of neuron differentiation, GO:0046632|alpha-beta T cell differentiation, GO:0048538|thymus development, GO:0071678|olfactory bulb axon guidance, GO:0035701|hematopoietic stem cell migration, GO:0097535|lymphoid lineage cell migration into thymus","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding"
PRKACA,Silent,0.305166160983345,14,0.288714785934602,N,Oncogene,Oncogene,0.412497362816564,0.142719760226633,ENSG00000072062,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0016020|membrane, GO:0005829|cytosol, GO:0031514|motile cilium, GO:0045171|intercellular bridge, GO:0005739|mitochondrion, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0048471|perinuclear region of cytoplasm, GO:0031410|cytoplasmic vesicle, GO:0001669|acrosomal vesicle, GO:0005952|cAMP-dependent protein kinase complex, GO:0031594|neuromuscular junction, GO:0036126|sperm flagellum, GO:0043197|dendritic spine, GO:0097546|ciliary base, GO:0005813|centrosome, GO:0005929|cilium, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0005930|axoneme, GO:0034704|calcium channel complex, GO:0044853|plasma membrane raft","GO:0010881|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion, GO:0002027|regulation of heart rate, GO:0006397|mRNA processing, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0001707|mesoderm formation, GO:0001843|neural tube closure, GO:0010737|protein kinase A signaling, GO:0018105|peptidyl-serine phosphorylation, GO:0018107|peptidyl-threonine phosphorylation, GO:0046777|protein autophosphorylation, GO:0046827|positive regulation of protein export from nucleus, GO:0048240|sperm capacitation, GO:0050804|modulation of chemical synaptic transmission, GO:0070613|regulation of protein processing, GO:0071158|positive regulation of cell cycle arrest, GO:0071333|cellular response to glucose stimulus, GO:0071374|cellular response to parathyroid hormone stimulus, GO:1901621|negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning, GO:0000086|G2/M transition of mitotic cell cycle, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0097711|ciliary basal body-plasma membrane docking, GO:2000810|regulation of bicellular tight junction assembly, GO:0019221|cytokine-mediated signaling pathway, GO:0061136|regulation of proteasomal protein catabolic process, GO:0007596|blood coagulation, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:1903779|regulation of cardiac conduction, GO:0055117|regulation of cardiac muscle contraction, GO:0016241|regulation of macroautophagy, GO:0003091|renal water homeostasis, GO:0071377|cellular response to glucagon stimulus, GO:0034605|cellular response to heat, GO:0034380|high-density lipoprotein particle assembly, GO:0051480|regulation of cytosolic calcium ion concentration, GO:0086064|cell communication by electrical coupling involved in cardiac conduction, GO:0034199|activation of protein kinase A activity, GO:0060314|regulation of ryanodine-sensitive calcium-release channel activity, GO:0035584|calcium-mediated signaling using intracellular calcium source, GO:0043393|regulation of protein binding, GO:0045667|regulation of osteoblast differentiation, GO:0071872|cellular response to epinephrine stimulus","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0000287|magnesium ion binding, GO:0004691|cAMP-dependent protein kinase activity, GO:0019904|protein domain specific binding, GO:0030145|manganese ion binding, GO:0034237|protein kinase A regulatory subunit binding, GO:0019901|protein kinase binding, GO:0031625|ubiquitin protein ligase binding, GO:0004712|protein serine/threonine/tyrosine kinase activity"
DDR2,Missense,0.305056969449033,69,0.0108104365949914,N,Oncogene,Oncogene,0.369356986835895,0.00178836047559587,ENSG00000162733,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005887|integral component of plasma membrane, GO:0005886|plasma membrane, GO:0015629|actin cytoskeleton, GO:0016324|apical plasma membrane, GO:0005925|focal adhesion, GO:0043235|receptor complex","GO:0006468|protein phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0038063|collagen-activated tyrosine kinase receptor signaling pathway, GO:0016310|phosphorylation, GO:0003416|endochondral bone growth, GO:0008284|positive regulation of cell proliferation, GO:0010763|positive regulation of fibroblast migration, GO:0030199|collagen fibril organization, GO:0031214|biomineral tissue development, GO:0035988|chondrocyte proliferation, GO:0046777|protein autophosphorylation, GO:0048146|positive regulation of fibroblast proliferation, GO:0090091|positive regulation of extracellular matrix disassembly, GO:0030154|cell differentiation, GO:0030500|regulation of bone mineralization, GO:0007160|cell-matrix adhesion, GO:0001503|ossification, GO:0007165|signal transduction, GO:0007155|cell adhesion, GO:0030198|extracellular matrix organization, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0045860|positive regulation of protein kinase activity, GO:0045669|positive regulation of osteoblast differentiation, GO:0010715|regulation of extracellular matrix disassembly, GO:0001952|regulation of cell-matrix adhesion, GO:1903053|regulation of extracellular matrix organization","GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0004713|protein tyrosine kinase activity, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0038062|protein tyrosine kinase collagen receptor activity, GO:0000166|nucleotide binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0005518|collagen binding"
NIN,Silent,0.303103039976751,55,0.0244841460216251,N,fusion,"",0.333040000363003,0.0129720237073291,ENSG00000100503,"GO:0005813|centrosome, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005730|nucleolus, GO:0005856|cytoskeleton, GO:0005874|microtubule, GO:0005815|microtubule organizing center, GO:0005814|centriole, GO:0120103|centriolar subdistal appendage, GO:0072686|mitotic spindle, GO:0097539|ciliary transition fiber, GO:0000922|spindle pole, GO:0036449|microtubule minus-end, GO:0000242|pericentriolar material, GO:0097431|mitotic spindle pole, GO:0005886|plasma membrane, GO:0030424|axon, GO:0030425|dendrite, GO:0044295|axonal growth cone, GO:0045177|apical part of cell","GO:0034454|microtubule anchoring at centrosome, GO:0008104|protein localization, GO:0010457|centriole-centriole cohesion, GO:0051642|centrosome localization, GO:0090222|centrosome-templated microtubule nucleation, GO:0021540|corpus callosum morphogenesis, GO:0021957|corticospinal tract morphogenesis, GO:0031116|positive regulation of microtubule polymerization, GO:0048668|collateral sprouting, GO:0050772|positive regulation of axonogenesis","GO:0005509|calcium ion binding, GO:0000166|nucleotide binding, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0019900|kinase binding"
FHIT,Missense,0.302428199083264,19,0.208217213202288,N,"TSG, fusion",TSG,0.334424532364688,0.161681020514718,ENSG00000189283,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0001650|fibrillar center, GO:0005886|plasma membrane, GO:0005829|cytosol, GO:0005739|mitochondrion","GO:0006915|apoptotic process, GO:0006163|purine nucleotide metabolic process, GO:0032435|negative regulation of proteasomal ubiquitin-dependent protein catabolic process, GO:0072332|intrinsic apoptotic signaling pathway by p53 class mediator, GO:0009117|nucleotide metabolic process","GO:0000166|nucleotide binding, GO:0016787|hydrolase activity, GO:0003824|catalytic activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0031625|ubiquitin protein ligase binding, GO:0047710|bis(5'-adenosyl)-triphosphatase activity"
HOOK3,Silent,0.300684151401615,11,0.368938990523154,N,fusion,"",0.386605148740724,0.240187207212681,ENSG00000168172,"GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005794|Golgi apparatus, GO:0005856|cytoskeleton, GO:0005874|microtubule, GO:0030897|HOPS complex, GO:0005813|centrosome, GO:0005801|cis-Golgi network, GO:0000242|pericentriolar material, GO:0034451|centriolar satellite, GO:0070695|FHF complex","GO:0015031|protein transport, GO:0007032|endosome organization, GO:0007040|lysosome organization, GO:0008333|endosome to lysosome transport, GO:0045022|early endosome to late endosome transport, GO:0030705|cytoskeleton-dependent intracellular transport, GO:0031122|cytoplasmic microtubule organization, GO:0051645|Golgi localization, GO:0050768|negative regulation of neurogenesis, GO:0022027|interkinetic nuclear migration, GO:0071539|protein localization to centrosome, GO:0034454|microtubule anchoring at centrosome, GO:0097150|neuronal stem cell population maintenance","GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0045505|dynein intermediate chain binding, GO:0051959|dynein light intermediate chain binding, GO:0042802|identical protein binding, GO:0034452|dynactin binding, GO:0045503|dynein light chain binding"
PAX7,Silent,0.299264743952875,18,0.227658129769251,N,fusion,"",0.3295186894551,0.181771310100135,ENSG00000009709,GO:0005634|nucleus,"GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0007517|muscle organ development, GO:0043066|negative regulation of apoptotic process, GO:0009653|anatomical structure morphogenesis, GO:0006338|chromatin remodeling, GO:0006366|transcription by RNA polymerase II, GO:0007519|skeletal muscle tissue development, GO:0010453|regulation of cell fate commitment, GO:0010468|regulation of gene expression, GO:0014813|skeletal muscle satellite cell commitment, GO:0021527|spinal cord association neuron differentiation, GO:0021904|dorsal/ventral neural tube patterning, GO:0031062|positive regulation of histone methylation, GO:0043393|regulation of protein binding, GO:0043403|skeletal muscle tissue regeneration, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048663|neuron fate commitment, GO:0048706|embryonic skeletal system development, GO:0051216|cartilage development, GO:0060415|muscle tissue morphogenesis, GO:2000288|positive regulation of myoblast proliferation","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003700|DNA-binding transcription factor activity, GO:0016251|RNA polymerase II general transcription initiation factor activity"
HSP90AA1,Silent,0.298842730967092,20,0.200580089897312,N,fusion,"",0.35410779189815,0.125576779696322,ENSG00000080824,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0042470|melanosome, GO:0005576|extracellular region, GO:0009986|cell surface, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0032991|protein-containing complex, GO:0043025|neuronal cell body, GO:0034774|secretory granule lumen, GO:1904813|ficolin-1-rich granule lumen, GO:0048471|perinuclear region of cytoplasm, GO:0044295|axonal growth cone, GO:0071682|endocytic vesicle lumen, GO:0043209|myelin sheath, GO:0043202|lysosomal lumen, GO:0044294|dendritic growth cone","GO:0051897|positive regulation of protein kinase B signaling, GO:0001934|positive regulation of protein phosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0006457|protein folding, GO:0007165|signal transduction, GO:0009409|response to cold, GO:0009408|response to heat, GO:0006898|receptor-mediated endocytosis, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0034605|cellular response to heat, GO:0006986|response to unfolded protein, GO:0050821|protein stabilization, GO:0000086|G2/M transition of mitotic cell cycle, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0097711|ciliary basal body-plasma membrane docking, GO:0043312|neutrophil degranulation, GO:0046677|response to antibiotic, GO:0019221|cytokine-mediated signaling pathway, GO:0050999|regulation of nitric-oxide synthase activity, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0038128|ERBB2 signaling pathway, GO:0051973|positive regulation of telomerase activity, GO:0007004|telomere maintenance via telomerase, GO:0042026|protein refolding, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:1900034|regulation of cellular response to heat, GO:1902949|positive regulation of tau-protein kinase activity, GO:0006839|mitochondrial transport, GO:0021955|central nervous system neuron axonogenesis, GO:0030010|establishment of cell polarity, GO:0031396|regulation of protein ubiquitination, GO:0032273|positive regulation of protein polymerization, GO:0043254|regulation of protein complex assembly, GO:0043335|protein unfolding, GO:0045040|protein import into mitochondrial outer membrane, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0048675|axon extension, GO:0051131|chaperone-mediated protein complex assembly, GO:0051186|cofactor metabolic process, GO:0061684|chaperone-mediated autophagy, GO:1903364|positive regulation of cellular protein catabolic process, GO:1903827|regulation of cellular protein localization, GO:1905323|telomerase holoenzyme complex assembly","GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0051082|unfolded protein binding, GO:0042802|identical protein binding, GO:0016887|ATPase activity, GO:0030911|TPR domain binding, GO:0048156|tau protein binding, GO:0004713|protein tyrosine kinase activity, GO:0042826|histone deacetylase binding, GO:0097110|scaffold protein binding, GO:0051020|GTPase binding, GO:0097718|disordered domain specific binding, GO:0030235|nitric-oxide synthase regulator activity, GO:1990782|protein tyrosine kinase binding, GO:0023026|MHC class II protein complex binding, GO:0031625|ubiquitin protein ligase binding, GO:0042623|ATPase activity, coupled, GO:0070182|DNA polymerase binding"
CBL,Missense,0.298503670681015,54,0.0283454756788826,N,"oncogene, TSG, fusion","",0.34541837446818,0.010522310060025,ENSG00000110395,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0042629|mast cell granule, GO:0005929|cilium, GO:0045121|membrane raft, GO:0016600|flotillin complex, GO:0005925|focal adhesion, GO:0030424|axon, GO:0030426|growth cone, GO:0048471|perinuclear region of cytoplasm","GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0016567|protein ubiquitination, GO:0023051|regulation of signaling, GO:0007166|cell surface receptor signaling pathway, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0007165|signal transduction, GO:0043066|negative regulation of apoptotic process, GO:0048260|positive regulation of receptor-mediated endocytosis, GO:0061024|membrane organization, GO:0019221|cytokine-mediated signaling pathway, GO:0070102|interleukin-6-mediated signaling pathway, GO:0042059|negative regulation of epidermal growth factor receptor signaling pathway, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0035635|entry of bacterium into host cell, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0000209|protein polyubiquitination, GO:0006513|protein monoubiquitination, GO:0006974|cellular response to DNA damage stimulus, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0007175|negative regulation of epidermal growth factor-activated receptor activity, GO:0008584|male gonad development, GO:0010332|response to gamma radiation, GO:0014823|response to activity, GO:0032487|regulation of Rap protein signal transduction, GO:0033574|response to testosterone, GO:0036120|cellular response to platelet-derived growth factor stimulus, GO:0042594|response to starvation, GO:0043303|mast cell degranulation, GO:0045471|response to ethanol, GO:0045742|positive regulation of epidermal growth factor receptor signaling pathway, GO:0046677|response to antibiotic, GO:0070997|neuron death, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0090650|cellular response to oxygen-glucose deprivation, GO:1901215|negative regulation of neuron death, GO:1990090|cellular response to nerve growth factor stimulus, GO:2000583|regulation of platelet-derived growth factor receptor-alpha signaling pathway","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005509|calcium ion binding, GO:0004842|ubiquitin-protein transferase activity, GO:0005515|protein binding, GO:0001784|phosphotyrosine residue binding, GO:0061630|ubiquitin protein ligase activity, GO:0045296|cadherin binding, GO:0017124|SH3 domain binding, GO:0030971|receptor tyrosine kinase binding, GO:0046875|ephrin receptor binding, GO:0005154|epidermal growth factor receptor binding, GO:0019901|protein kinase binding, GO:0036312|phosphatidylinositol 3-kinase regulatory subunit binding, GO:1990782|protein tyrosine kinase binding"
FOXO1,Silent,0.298137216842712,24,0.157063590602054,N,"oncogene, TSG, fusion","",0.330875072465714,0.114272893742365,ENSG00000150907,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005654|nucleoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0006974|cellular response to DNA damage stimulus, GO:0006915|apoptotic process, GO:0006914|autophagy, GO:0030154|cell differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045444|fat cell differentiation, GO:0010508|positive regulation of autophagy, GO:0009267|cellular response to starvation, GO:0043065|positive regulation of apoptotic process, GO:0008286|insulin receptor signaling pathway, GO:0042593|glucose homeostasis, GO:0034599|cellular response to oxidative stress, GO:0043066|negative regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045599|negative regulation of fat cell differentiation, GO:0019221|cytokine-mediated signaling pathway, GO:0001678|cellular glucose homeostasis, GO:0032869|cellular response to insulin stimulus, GO:0097009|energy homeostasis, GO:0006473|protein acetylation, GO:0031018|endocrine pancreas development, GO:0045732|positive regulation of protein catabolic process, GO:0001659|temperature homeostasis, GO:0071455|cellular response to hyperoxia, GO:1903243|negative regulation of cardiac muscle hypertrophy in response to stress, GO:0032873|negative regulation of stress-activated MAPK cascade, GO:0071732|cellular response to nitric oxide, GO:0001568|blood vessel development, GO:0006357|regulation of transcription by RNA polymerase II, GO:0032868|response to insulin, GO:0035947|regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter, GO:0042127|regulation of cell proliferation, GO:0045722|positive regulation of gluconeogenesis, GO:0070166|enamel mineralization, GO:0070301|cellular response to hydrogen peroxide, GO:0070417|cellular response to cold, GO:0071549|cellular response to dexamethasone stimulus, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0097150|neuronal stem cell population maintenance, GO:1902617|response to fluoride, GO:2000177|regulation of neural precursor cell proliferation, GO:2000377|regulation of reactive oxygen species metabolic process","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0003682|chromatin binding, GO:0031625|ubiquitin protein ligase binding, GO:0008013|beta-catenin binding, GO:0051721|protein phosphatase 2A binding, GO:0001223|transcription coactivator binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific"
SETBP1,Missense,0.292421302566244,173,9.46155635347707e-05,Y,"oncogene, fusion",Oncogene,0.284250508714687,0.00015057997595202,ENSG00000152217,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0016604|nuclear body",GO:0006357|regulation of transcription by RNA polymerase II,"GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
COL1A1,Silent,0.292078604620103,52,0.0356353487262592,N,fusion,"",0.353165183046465,0.010224480904274,ENSG00000108821,"GO:0005615|extracellular space, GO:0005576|extracellular region, GO:0005581|collagen trimer, GO:0005737|cytoplasm, GO:0062023|collagen-containing extracellular matrix, GO:0031012|extracellular matrix, GO:0005788|endoplasmic reticulum lumen, GO:0005584|collagen type I trimer, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0030141|secretory granule","GO:0048706|embryonic skeletal system development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0050776|regulation of immune response, GO:0050900|leukocyte migration, GO:0001501|skeletal system development, GO:0001568|blood vessel development, GO:0030335|positive regulation of cell migration, GO:0007601|visual perception, GO:0030198|extracellular matrix organization, GO:0007605|sensory perception of sound, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0030168|platelet activation, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0007596|blood coagulation, GO:0034504|protein localization to nucleus, GO:0030199|collagen fibril organization, GO:0001503|ossification, GO:0001649|osteoblast differentiation, GO:0001957|intramembranous ossification, GO:0001958|endochondral ossification, GO:0007584|response to nutrient, GO:0009612|response to mechanical stimulus, GO:0010812|negative regulation of cell-substrate adhesion, GO:0015031|protein transport, GO:0031667|response to nutrient levels, GO:0031960|response to corticosteroid, GO:0032355|response to estradiol, GO:0032964|collagen biosynthetic process, GO:0034505|tooth mineralization, GO:0038063|collagen-activated tyrosine kinase receptor signaling pathway, GO:0042060|wound healing, GO:0042493|response to drug, GO:0042542|response to hydrogen peroxide, GO:0043434|response to peptide hormone, GO:0043588|skin development, GO:0043589|skin morphogenesis, GO:0044344|cellular response to fibroblast growth factor stimulus, GO:0044691|tooth eruption, GO:0048545|response to steroid hormone, GO:0048705|skeletal system morphogenesis, GO:0051591|response to cAMP, GO:0055093|response to hyperoxia, GO:0060325|face morphogenesis, GO:0060346|bone trabecula formation, GO:0060351|cartilage development involved in endochondral bone morphogenesis, GO:0070208|protein heterotrimerization, GO:0071230|cellular response to amino acid stimulus, GO:0071260|cellular response to mechanical stimulus, GO:0071300|cellular response to retinoic acid, GO:0071306|cellular response to vitamin E, GO:0071356|cellular response to tumor necrosis factor, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0071560|cellular response to transforming growth factor beta stimulus, GO:1902617|response to fluoride, GO:1902618|cellular response to fluoride","GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0005201|extracellular matrix structural constituent, GO:0042802|identical protein binding, GO:0030020|extracellular matrix structural constituent conferring tensile strength, GO:0002020|protease binding, GO:0048407|platelet-derived growth factor binding"
PREX2,Nonsense,0.29012942659283,10,0.41612025350706,N,Oncogene,Oncogene,0.0924879410401776,0.799404391460447,ENSG00000046889,"GO:0005886|plasma membrane, GO:0005829|cytosol","GO:0035556|intracellular signal transduction, GO:0035023|regulation of Rho protein signal transduction, GO:0043547|positive regulation of GTPase activity, GO:0007186|G protein-coupled receptor signaling pathway, GO:0008344|adult locomotory behavior, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0048813|dendrite morphogenesis","GO:0005085|guanyl-nucleotide exchange factor activity, GO:0005089|Rho guanyl-nucleotide exchange factor activity, GO:0005096|GTPase activator activity, GO:0030676|Rac guanyl-nucleotide exchange factor activity"
GNAQ,Silent,0.29012942659283,10,0.41612025350706,N,Oncogene,Oncogene,0.30792416168886,0.386731900766041,ENSG00000156052,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005765|lysosomal membrane, GO:0005834|heterotrimeric G-protein complex, GO:0001750|photoreceptor outer segment, GO:0005886|plasma membrane, GO:0070062|extracellular exosome, GO:0031965|nuclear membrane, GO:0005737|cytoplasm","GO:0050821|protein stabilization, GO:0006469|negative regulation of protein kinase activity, GO:0007186|G protein-coupled receptor signaling pathway, GO:0007165|signal transduction, GO:0043547|positive regulation of GTPase activity, GO:0007213|G protein-coupled acetylcholine receptor signaling pathway, GO:0007603|phototransduction, visible light, GO:0009649|entrainment of circadian clock, GO:0007188|adenylate cyclase-modulating G protein-coupled receptor signaling pathway, GO:0007596|blood coagulation, GO:0030168|platelet activation, GO:0007189|adenylate cyclase-activating G protein-coupled receptor signaling pathway, GO:0060828|regulation of canonical Wnt signaling pathway, GO:0007202|activation of phospholipase C activity, GO:0001508|action potential, GO:0007215|glutamate receptor signaling pathway","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0001664|G protein-coupled receptor binding, GO:0005515|protein binding, GO:0019001|guanyl nucleotide binding, GO:0031683|G-protein beta/gamma-subunit complex binding, GO:0005096|GTPase activator activity, GO:0031826|type 2A serotonin receptor binding"
PLCG1,Silent,0.288595790238615,40,0.0709174051445506,N,"oncogene, fusion",Oncogene,0.350271540593843,0.0267060666298952,ENSG00000124181,"GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0030027|lamellipodium, GO:0008180|COP9 signalosome, GO:0001726|ruffle, GO:0005737|cytoplasm, GO:0005911|cell-cell junction","GO:1905564|positive regulation of vascular endothelial cell proliferation, GO:2000353|positive regulation of endothelial cell apoptotic process, GO:0035556|intracellular signal transduction, GO:0007165|signal transduction, GO:0006629|lipid metabolic process, GO:0009395|phospholipid catabolic process, GO:0016042|lipid catabolic process, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0050900|leukocyte migration, GO:0050852|T cell receptor signaling pathway, GO:0016032|viral process, GO:0007411|axon guidance, GO:0006816|calcium ion transport, GO:0043647|inositol phosphate metabolic process, GO:0010634|positive regulation of epithelial cell migration, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0016477|cell migration, GO:0019722|calcium-mediated signaling, GO:0051281|positive regulation of release of sequestered calcium ion into cytosol, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:0045766|positive regulation of angiogenesis, GO:0001701|in utero embryonic development, GO:0007202|activation of phospholipase C activity, GO:0010863|positive regulation of phospholipase C activity","GO:0046872|metal ion binding, GO:0016787|hydrolase activity, GO:0005509|calcium ion binding, GO:0005515|protein binding, GO:0008081|phosphoric diester hydrolase activity, GO:0004435|phosphatidylinositol phospholipase C activity, GO:0019901|protein kinase binding, GO:0004629|phospholipase C activity, GO:0005168|neurotrophin TRKA receptor binding, GO:0030971|receptor tyrosine kinase binding, GO:0035254|glutamate receptor binding"
JAK3,Missense,0.286369755380608,95,0.00490185914333637,Y,Oncogene,Oncogene,0.345316324557402,0.000609763851576924,ENSG00000105639,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005856|cytoskeleton, GO:0005886|plasma membrane, GO:0005829|cytosol, GO:0012505|endomembrane system, GO:0005768|endosome","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0002250|adaptive immune response, GO:0042102|positive regulation of T cell proliferation, GO:0019221|cytokine-mediated signaling pathway, GO:0000165|MAPK cascade, GO:0038111|interleukin-7-mediated signaling pathway, GO:0032695|negative regulation of interleukin-12 production, GO:0043029|T cell homeostasis, GO:0007167|enzyme linked receptor protein signaling pathway, GO:0007260|tyrosine phosphorylation of STAT protein, GO:0030218|erythrocyte differentiation, GO:0060397|JAK-STAT cascade involved in growth hormone signaling pathway, GO:0046425|regulation of JAK-STAT cascade, GO:0030183|B cell differentiation, GO:0038110|interleukin-2-mediated signaling pathway, GO:0070244|negative regulation of thymocyte apoptotic process, GO:0035723|interleukin-15-mediated signaling pathway, GO:0038113|interleukin-9-mediated signaling pathway, GO:0070232|regulation of T cell apoptotic process, GO:0038114|interleukin-21-mediated signaling pathway, GO:0045626|negative regulation of T-helper 1 cell differentiation, GO:0032693|negative regulation of interleukin-10 production, GO:0002731|negative regulation of dendritic cell cytokine production, GO:0035771|interleukin-4-mediated signaling pathway, GO:0045221|negative regulation of FasL biosynthetic process, GO:0050868|negative regulation of T cell activation, GO:0070669|response to interleukin-2, GO:0070670|response to interleukin-4, GO:0070672|response to interleukin-15, GO:0071104|response to interleukin-9","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0019903|protein phosphatase binding, GO:0005088|Ras guanyl-nucleotide exchange factor activity"
NCOR1,Missense,0.286005631725297,171,0.000149378785343291,Y,TSG,TSG,0.334955400773659,7.53358041118774e-06,ENSG00000141027,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin, GO:0000118|histone deacetylase complex, GO:0017053|transcriptional repressor complex, GO:0072686|mitotic spindle, GO:0016580|Sin3 complex","GO:0006325|chromatin organization, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0046329|negative regulation of JNK cascade, GO:0006366|transcription by RNA polymerase II, GO:0007623|circadian rhythm, GO:0019216|regulation of lipid metabolic process, GO:0051225|spindle assembly, GO:0060766|negative regulation of androgen receptor signaling pathway, GO:0072362|regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter, GO:0072368|regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter, GO:1903799|negative regulation of production of miRNAs involved in gene silencing by miRNA, GO:2000191|regulation of fatty acid transport","GO:0044212|transcription regulatory region DNA binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003714|transcription corepressor activity, GO:0003682|chromatin binding, GO:0042826|histone deacetylase binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0035257|nuclear hormone receptor binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0046966|thyroid hormone receptor binding"
BRCA2,Nonsense,0.285850380648215,32,0.112744912882592,N,TSG,TSG,0.138602376918904,0.449336397711535,ENSG00000139618,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005856|cytoskeleton, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0032991|protein-containing complex, GO:0000784|nuclear chromosome, telomeric region, GO:0030141|secretory granule, GO:0000800|lateral element, GO:0033593|BRCA2-MAGE-D1 complex","GO:0006281|DNA repair, GO:0006310|DNA recombination, GO:0006974|cellular response to DNA damage stimulus, GO:0007049|cell cycle, GO:0006302|double-strand break repair, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000724|double-strand break repair via homologous recombination, GO:0007283|spermatogenesis, GO:0043967|histone H4 acetylation, GO:0000281|mitotic cytokinesis, GO:0070200|establishment of protein localization to telomere, GO:0043966|histone H3 acetylation, GO:0051298|centrosome duplication, GO:0006289|nucleotide-excision repair, GO:0033600|negative regulation of mammary gland epithelial cell proliferation, GO:0000722|telomere maintenance via recombination, GO:0001556|oocyte maturation, GO:0001833|inner cell mass cell proliferation, GO:0006978|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator, GO:0007141|male meiosis I, GO:0007420|brain development, GO:0007569|cell aging, GO:0008283|cell proliferation, GO:0008585|female gonad development, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0010165|response to X-ray, GO:0010225|response to UV-C, GO:0010332|response to gamma radiation, GO:0030097|hemopoiesis, GO:0032465|regulation of cytokinesis, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0043009|chordate embryonic development, GO:0045931|positive regulation of mitotic cell cycle, GO:0048478|replication fork protection, GO:0051276|chromosome organization, GO:1990426|mitotic recombination-dependent replication fork processing","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0002020|protease binding, GO:0010485|H4 histone acetyltransferase activity, GO:0003697|single-stranded DNA binding, GO:0043015|gamma-tubulin binding, GO:0008022|protein C-terminus binding, GO:0010484|H3 histone acetyltransferase activity"
JAK3,Silent,0.285686523552658,36,0.0912133989412952,N,Oncogene,Oncogene,0.301730402942192,0.073706007289772,ENSG00000105639,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005856|cytoskeleton, GO:0005886|plasma membrane, GO:0005829|cytosol, GO:0012505|endomembrane system, GO:0005768|endosome","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0002250|adaptive immune response, GO:0042102|positive regulation of T cell proliferation, GO:0019221|cytokine-mediated signaling pathway, GO:0000165|MAPK cascade, GO:0038111|interleukin-7-mediated signaling pathway, GO:0032695|negative regulation of interleukin-12 production, GO:0043029|T cell homeostasis, GO:0007167|enzyme linked receptor protein signaling pathway, GO:0007260|tyrosine phosphorylation of STAT protein, GO:0030218|erythrocyte differentiation, GO:0060397|JAK-STAT cascade involved in growth hormone signaling pathway, GO:0046425|regulation of JAK-STAT cascade, GO:0030183|B cell differentiation, GO:0038110|interleukin-2-mediated signaling pathway, GO:0070244|negative regulation of thymocyte apoptotic process, GO:0035723|interleukin-15-mediated signaling pathway, GO:0038113|interleukin-9-mediated signaling pathway, GO:0070232|regulation of T cell apoptotic process, GO:0038114|interleukin-21-mediated signaling pathway, GO:0045626|negative regulation of T-helper 1 cell differentiation, GO:0032693|negative regulation of interleukin-10 production, GO:0002731|negative regulation of dendritic cell cytokine production, GO:0035771|interleukin-4-mediated signaling pathway, GO:0045221|negative regulation of FasL biosynthetic process, GO:0050868|negative regulation of T cell activation, GO:0070669|response to interleukin-2, GO:0070670|response to interleukin-4, GO:0070672|response to interleukin-15, GO:0071104|response to interleukin-9","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0019903|protein phosphatase binding, GO:0005088|Ras guanyl-nucleotide exchange factor activity"
PTPN13,Nonsense,0.284277296029416,16,0.285933892900241,N,TSG,TSG,0.338705416645113,0.199401181366462,ENSG00000163629,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0005654|nucleoplasm, GO:0030027|lamellipodium, GO:0070062|extracellular exosome, GO:0043005|neuron projection, GO:0044297|cell body","GO:0006470|protein dephosphorylation, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0006661|phosphatidylinositol biosynthetic process, GO:0014066|regulation of phosphatidylinositol 3-kinase signaling, GO:0071345|cellular response to cytokine stimulus, GO:0070830|bicellular tight junction assembly","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0036312|phosphatidylinositol 3-kinase regulatory subunit binding"
TFE3,Silent,0.282984239985339,16,0.288226527978426,N,"oncogene, fusion",Oncogene,0.312274575224665,0.238991300942537,ENSG00000068323,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0006959|humoral immune response, GO:0045670|regulation of osteoclast differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0002376|immune system process, GO:0002250|adaptive immune response, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0120163|negative regulation of cold-induced thermogenesis, GO:0045785|positive regulation of cell adhesion","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
SMARCB1,Missense,0.282925997278173,47,0.0539810510329314,N,TSG,TSG,0.344406978110218,0.0177598858529475,ENSG00000099956,"GO:0005634|nucleus, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0001650|fibrillar center, GO:0000790|nuclear chromatin, GO:0000228|nuclear chromosome, GO:0005730|nucleolus, GO:0032991|protein-containing complex, GO:0016514|SWI/SNF complex, GO:0071564|npBAF complex, GO:0071565|nBAF complex, GO:0001741|XY body","GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006325|chromatin organization, GO:0007049|cell cycle, GO:0006338|chromatin remodeling, GO:0007399|nervous system development, GO:0030154|cell differentiation, GO:0043044|ATP-dependent chromatin remodeling, GO:0006357|regulation of transcription by RNA polymerase II, GO:0008285|negative regulation of cell proliferation, GO:0016032|viral process, GO:0006337|nucleosome disassembly, GO:0001188|RNA polymerase I preinitiation complex assembly, GO:1901838|positive regulation of transcription of nucleolar large rRNA by RNA polymerase I, GO:0090240|positive regulation of histone H4 acetylation, GO:0043923|positive regulation by host of viral transcription, GO:1902661|positive regulation of glucose mediated signaling pathway, GO:0015074|DNA integration, GO:0039692|single stranded viral RNA replication via double stranded DNA intermediate, GO:1900110|negative regulation of histone H3-K9 dimethylation, GO:1900113|negative regulation of histone H3-K9 trimethylation, GO:2000617|positive regulation of histone H3-K9 acetylation, GO:0001824|blastocyst development, GO:0001835|blastocyst hatching","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0002039|p53 binding, GO:0031492|nucleosomal DNA binding, GO:0001164|RNA polymerase I CORE element sequence-specific DNA binding, GO:0030957|Tat protein binding"
TPR,Nonsense,0.281653699561868,15,0.309159912780589,N,fusion,"",0.422000131886924,0.117150004855993,ENSG00000047410,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0031965|nuclear membrane, GO:0005694|chromosome, GO:0005856|cytoskeleton, GO:0005643|nuclear pore, GO:0005819|spindle, GO:0000775|chromosome, centromeric region, GO:0000776|kinetochore, GO:0005868|cytoplasmic dynein complex, GO:0005654|nucleoplasm, GO:0019898|extrinsic component of membrane, GO:0005635|nuclear envelope, GO:0072686|mitotic spindle, GO:0042405|nuclear inclusion body, GO:0034399|nuclear periphery, GO:0044615|nuclear pore nuclear basket","GO:0051028|mRNA transport, GO:0015031|protein transport, GO:0051301|cell division, GO:0007049|cell cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006406|mRNA export from nucleus, GO:0016032|viral process, GO:0042307|positive regulation of protein import into nucleus, GO:0006606|protein import into nucleus, GO:0007094|mitotic spindle assembly checkpoint, GO:0090267|positive regulation of mitotic cell cycle spindle assembly checkpoint, GO:0090316|positive regulation of intracellular protein transport, GO:0034605|cellular response to heat, GO:0032880|regulation of protein localization, GO:1901673|regulation of mitotic spindle assembly, GO:0045947|negative regulation of translational initiation, GO:0046827|positive regulation of protein export from nucleus, GO:0006404|RNA import into nucleus, GO:0006405|RNA export from nucleus, GO:0006999|nuclear pore organization, GO:0010965|regulation of mitotic sister chromatid separation, GO:0031453|positive regulation of heterochromatin assembly, GO:0031990|mRNA export from nucleus in response to heat stress, GO:0035457|cellular response to interferon-alpha, GO:0046832|negative regulation of RNA export from nucleus, GO:0070849|response to epidermal growth factor","GO:0003723|RNA binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0003729|mRNA binding, GO:0003682|chromatin binding, GO:0070840|dynein complex binding, GO:0017056|structural constituent of nuclear pore, GO:0015631|tubulin binding, GO:0051019|mitogen-activated protein kinase binding, GO:0031072|heat shock protein binding"
ZFHX3,Nonsense,0.281136077180569,39,0.0829656545597805,N,TSG,TSG,0.356476557611966,0.0259130330723927,ENSG00000140836,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex, GO:0016604|nuclear body","GO:0006355|regulation of transcription, DNA-templated, GO:0032922|circadian regulation of gene expression, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007517|muscle organ development, GO:0006366|transcription by RNA polymerase II, GO:0007420|brain development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045664|regulation of neuron differentiation, GO:0045785|positive regulation of cell adhesion, GO:0071559|response to transforming growth factor beta, GO:1904059|regulation of locomotor rhythm, GO:0007050|cell cycle arrest","GO:0003676|nucleic acid binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0044212|transcription regulatory region DNA binding"
BRCA1,Silent,0.280842837520388,34,0.107638603620464,N,TSG,TSG,0.293627280289552,0.0918982659269692,ENSG00000012048,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005694|chromosome, GO:0031436|BRCA1-BARD1 complex, GO:0005886|plasma membrane, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0000151|ubiquitin ligase complex, GO:1990904|ribonucleoprotein complex, GO:0000800|lateral element, GO:0008274|gamma-tubulin ring complex, GO:0070531|BRCA1-A complex, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0000793|condensed chromosome, GO:0000794|condensed nuclear chromosome","GO:0016567|protein ubiquitination, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0010628|positive regulation of gene expression, GO:0045766|positive regulation of angiogenesis, GO:0071158|positive regulation of cell cycle arrest, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0071356|cellular response to tumor necrosis factor, GO:0006629|lipid metabolic process, GO:0006631|fatty acid metabolic process, GO:0006633|fatty acid biosynthetic process, GO:0006310|DNA recombination, GO:0007049|cell cycle, GO:0051865|protein autoubiquitination, GO:0085020|protein K6-linked ubiquitination, GO:0006915|apoptotic process, GO:0006302|double-strand break repair, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007059|chromosome segregation, GO:0016579|protein deubiquitination, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045739|positive regulation of DNA repair, GO:0031398|positive regulation of protein ubiquitination, GO:0042127|regulation of cell proliferation, GO:0042981|regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0006260|DNA replication, GO:0070317|negative regulation of G0 to G1 transition, GO:0030521|androgen receptor signaling pathway, GO:0043627|response to estrogen, GO:0072425|signal transduction involved in G2 DNA damage checkpoint, GO:0000724|double-strand break repair via homologous recombination, GO:1902042|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0000729|DNA double-strand break processing, GO:0006303|double-strand break repair via nonhomologous end joining, GO:0045717|negative regulation of fatty acid biosynthetic process, GO:0035066|positive regulation of histone acetylation, GO:0010212|response to ionizing radiation, GO:0046600|negative regulation of centriole replication, GO:0010575|positive regulation of vascular endothelial growth factor production, GO:0006978|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator, GO:0071681|cellular response to indole-3-methanol, GO:0051571|positive regulation of histone H3-K4 methylation, GO:0006301|postreplication repair, GO:0006359|regulation of transcription by RNA polymerase III, GO:0009048|dosage compensation by inactivation of X chromosome, GO:0033147|negative regulation of intracellular estrogen receptor signaling pathway, GO:0035067|negative regulation of histone acetylation, GO:0043009|chordate embryonic development, GO:0051573|negative regulation of histone H3-K9 methylation, GO:0070512|positive regulation of histone H4-K20 methylation, GO:2000378|negative regulation of reactive oxygen species metabolic process, GO:2000617|positive regulation of histone H3-K9 acetylation, GO:2000620|positive regulation of histone H4-K16 acetylation, GO:0006349|regulation of gene expression by genetic imprinting, GO:0007098|centrosome cycle, GO:0044030|regulation of DNA methylation, GO:0044818|mitotic G2/M transition checkpoint, GO:0051572|negative regulation of histone H3-K4 methylation, GO:0051574|positive regulation of histone H3-K9 methylation","GO:0008270|zinc ion binding, GO:0003677|DNA binding, GO:0004842|ubiquitin-protein transferase activity, GO:0044212|transcription regulatory region DNA binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0042802|identical protein binding, GO:0031625|ubiquitin protein ligase binding, GO:0019899|enzyme binding, GO:0015631|tubulin binding, GO:0050681|androgen receptor binding, GO:0070063|RNA polymerase binding, GO:0003723|RNA binding, GO:0003684|damaged DNA binding"
STRN,Missense,0.280842152794834,61,0.0283506220658308,N,fusion,"",0.322654238446486,0.0112094086404017,ENSG00000115808,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0042995|cell projection, GO:0045211|postsynaptic membrane, GO:0005923|bicellular tight junction, GO:0014069|postsynaptic density, GO:0043197|dendritic spine, GO:0030425|dendrite, GO:0043025|neuronal cell body, GO:0090443|FAR/SIN/STRIPAK complex","GO:0016055|Wnt signaling pathway, GO:0008285|negative regulation of cell proliferation, GO:0016358|dendrite development, GO:0070830|bicellular tight junction assembly, GO:0007626|locomotory behavior","GO:0005515|protein binding, GO:0005516|calmodulin binding, GO:0030331|estrogen receptor binding, GO:0044877|protein-containing complex binding, GO:0051721|protein phosphatase 2A binding, GO:0070016|armadillo repeat domain binding"
BCL6,Silent,0.280207487956209,19,0.245260064905175,N,"oncogene, fusion",Oncogene,0.155715400626782,0.524405083762587,ENSG00000113916,"GO:0005634|nucleus, GO:0005794|Golgi apparatus, GO:0005654|nucleoplasm, GO:0005657|replication fork","GO:0006974|cellular response to DNA damage stimulus, GO:0006954|inflammatory response, GO:0002376|immune system process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0043065|positive regulation of apoptotic process, GO:0030308|negative regulation of cell growth, GO:0042981|regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0019221|cytokine-mediated signaling pathway, GO:0045591|positive regulation of regulatory T cell differentiation, GO:0050727|regulation of inflammatory response, GO:0000060|protein import into nucleus, translocation, GO:0042127|regulation of cell proliferation, GO:0050776|regulation of immune response, GO:0000902|cell morphogenesis, GO:0001953|negative regulation of cell-matrix adhesion, GO:0002467|germinal center formation, GO:0002634|regulation of germinal center formation, GO:0002829|negative regulation of type 2 immune response, GO:0002903|negative regulation of B cell apoptotic process, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007266|Rho protein signal transduction, GO:0007283|spermatogenesis, GO:0008104|protein localization, GO:0008285|negative regulation of cell proliferation, GO:0030036|actin cytoskeleton organization, GO:0030183|B cell differentiation, GO:0030890|positive regulation of B cell proliferation, GO:0031065|positive regulation of histone deacetylation, GO:0032764|negative regulation of mast cell cytokine production, GO:0035024|negative regulation of Rho protein signal transduction, GO:0042092|type 2 immune response, GO:0043066|negative regulation of apoptotic process, GO:0043087|regulation of GTPase activity, GO:0043380|regulation of memory T cell differentiation, GO:0045596|negative regulation of cell differentiation, GO:0045629|negative regulation of T-helper 2 cell differentiation, GO:0045666|positive regulation of neuron differentiation, GO:0045746|negative regulation of Notch signaling pathway, GO:0048294|negative regulation of isotype switching to IgE isotypes, GO:0048821|erythrocyte development, GO:0051272|positive regulation of cellular component movement, GO:1903464|negative regulation of mitotic cell cycle DNA replication, GO:2000773|negative regulation of cellular senescence","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0042802|identical protein binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0001161|intronic transcription regulatory region sequence-specific DNA binding, GO:0031490|chromatin DNA binding"
LRP1B,Missense,0.279543146412694,855,8.18130549995455e-17,Y,TSG,TSG,0.308693916764998,2.471573810483e-20,ENSG00000168702,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0043235|receptor complex","GO:0006897|endocytosis, GO:0006898|receptor-mediated endocytosis, GO:0015031|protein transport",GO:0005509|calcium ion binding
ROS1,Missense,0.278718702387226,254,6.48821833351052e-06,Y,"oncogene, fusion",Oncogene,0.244752259682622,8.09454121773996e-05,ENSG00000047936,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0009986|cell surface, GO:0048471|perinuclear region of cytoplasm","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0030154|cell differentiation, GO:0007283|spermatogenesis, GO:0008283|cell proliferation, GO:0001558|regulation of cell growth, GO:0032006|regulation of TOR signaling, GO:0070372|regulation of ERK1 and ERK2 cascade, GO:0002066|columnar/cuboidal epithelial cell development, GO:0010629|negative regulation of gene expression, GO:0010966|regulation of phosphate transport, GO:0023014|signal transduction by protein phosphorylation, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0019903|protein phosphatase binding"
PBRM1,Missense,0.27846584884867,118,0.00226305792676417,Y,TSG,TSG,0.380030058858407,2.18968978246159e-05,ENSG00000163939,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016586|RSC-type complex, GO:0000228|nuclear chromosome","GO:0006325|chromatin organization, GO:0006338|chromatin remodeling, GO:0043044|ATP-dependent chromatin remodeling, GO:0008285|negative regulation of cell proliferation, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0000278|mitotic cell cycle, GO:0006337|nucleosome disassembly","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003682|chromatin binding, GO:0015616|DNA translocase activity"
TRRAP,Silent,0.277771988108316,143,0.000782625242194225,Y,Oncogene,Oncogene,0.274615626478976,0.00090290749210529,ENSG00000196367,"GO:0005634|nucleus, GO:0005794|Golgi apparatus, GO:0005654|nucleoplasm, GO:0000123|histone acetyltransferase complex, GO:0033276|transcription factor TFTC complex, GO:0000125|PCAF complex, GO:0030914|STAGA complex, GO:0000124|SAGA complex, GO:0035267|NuA4 histone acetyltransferase complex, GO:0000812|Swr1 complex","GO:0006325|chromatin organization, GO:0016573|histone acetylation, GO:0016578|histone deubiquitination, GO:0006355|regulation of transcription, DNA-templated, GO:0016579|protein deubiquitination, GO:0043967|histone H4 acetylation, GO:1904837|beta-catenin-TCF complex assembly, GO:0006281|DNA repair, GO:0043968|histone H2A acetylation, GO:0016310|phosphorylation","GO:0005515|protein binding, GO:0003712|transcription coregulator activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0016740|transferase activity, GO:0016301|kinase activity"
PTPRK,Silent,0.27770332592536,51,0.0484921027830123,N,"TSG, fusion",TSG,0.281821357572139,0.0451209584375688,ENSG00000152894,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005886|plasma membrane, GO:0030054|cell junction, GO:0009986|cell surface, GO:0005887|integral component of plasma membrane, GO:0005912|adherens junction, GO:0005911|cell-cell junction, GO:0031256|leading edge membrane, GO:0001750|photoreceptor outer segment, GO:0030424|axon, GO:0030425|dendrite, GO:0043025|neuronal cell body","GO:0007155|cell adhesion, GO:0006470|protein dephosphorylation, GO:0007165|signal transduction, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0008285|negative regulation of cell proliferation, GO:0016477|cell migration, GO:0048041|focal adhesion assembly, GO:0045786|negative regulation of cell cycle, GO:0045892|negative regulation of transcription, DNA-templated, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0034394|protein localization to cell surface, GO:0030336|negative regulation of cell migration, GO:0034644|cellular response to UV, GO:0034614|cellular response to reactive oxygen species, GO:0010839|negative regulation of keratinocyte proliferation, GO:0031175|neuron projection development","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0019901|protein kinase binding, GO:0008013|beta-catenin binding, GO:0045295|gamma-catenin binding, GO:0005001|transmembrane receptor protein tyrosine phosphatase activity"
TCF12,Missense,0.277274378951608,49,0.0537530390913535,N,fusion,"",0.381610345760187,0.00681937069234106,ENSG00000140262,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex, GO:0000790|nuclear chromatin, GO:0090575|RNA polymerase II transcription factor complex","GO:0007275|multicellular organism development, GO:0010628|positive regulation of gene expression, GO:0045666|positive regulation of neuron differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0030154|cell differentiation, GO:0007399|nervous system development, GO:0006955|immune response, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007517|muscle organ development, GO:1902036|regulation of hematopoietic stem cell differentiation","GO:0044212|transcription regulatory region DNA binding, GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0035497|cAMP response element binding, GO:0046982|protein heterodimerization activity, GO:0070888|E-box binding, GO:0071837|HMG box domain binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0043425|bHLH transcription factor binding, GO:0042803|protein homodimerization activity, GO:0046332|SMAD binding, GO:0008134|transcription factor binding, GO:0035326|enhancer binding"
CIC,Missense,0.276634910468969,108,0.00375305435386487,Y,"oncogene, TSG, fusion","",0.272256537452848,0.00436499821739041,ENSG00000079432,"GO:0005634|nucleus, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex","GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007613|memory, GO:0045892|negative regulation of transcription, DNA-templated, GO:0007420|brain development, GO:0007612|learning, GO:0035176|social behavior, GO:0048286|lung alveolus development","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding"
BTK,Missense,0.275326642711111,71,0.0201322523481174,N,"oncogene, TSG","",0.312768846484509,0.00791576443490545,ENSG00000010671,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0042629|mast cell granule, GO:0045121|membrane raft, GO:0031410|cytoplasmic vesicle, GO:0048471|perinuclear region of cytoplasm","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0006915|apoptotic process, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0002250|adaptive immune response, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0050853|B cell receptor signaling pathway, GO:0042113|B cell activation, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0002755|MyD88-dependent toll-like receptor signaling pathway, GO:0050852|T cell receptor signaling pathway, GO:0007498|mesoderm development, GO:0019722|calcium-mediated signaling, GO:0097190|apoptotic signaling pathway, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0045579|positive regulation of B cell differentiation, GO:0002721|regulation of B cell cytokine production, GO:0002902|regulation of B cell apoptotic process, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0001805|positive regulation of type III hypersensitivity, GO:0001812|positive regulation of type I hypersensitivity, GO:0001818|negative regulation of cytokine production, GO:0002344|B cell affinity maturation, GO:0002553|histamine secretion by mast cell, GO:0007249|I-kappaB kinase/NF-kappaB signaling, GO:0010033|response to organic substance, GO:0030889|negative regulation of B cell proliferation, GO:0034614|cellular response to reactive oxygen species, GO:0046777|protein autophosphorylation, GO:0048469|cell maturation, GO:0071226|cellular response to molecule of fungal origin, GO:0098761|cellular response to interleukin-7","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0008289|lipid binding, GO:0042802|identical protein binding, GO:0005547|phosphatidylinositol-3,4,5-trisphosphate binding"
SMARCA4,Missense,0.275204838202201,200,8.01273374126999e-05,Y,TSG,TSG,0.280809313876946,5.63268550386019e-05,ENSG00000127616,"GO:0005634|nucleus, GO:0016020|membrane, GO:0000790|nuclear chromatin, GO:0016514|SWI/SNF complex, GO:0005615|extracellular space, GO:0005730|nucleolus, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0071564|npBAF complex, GO:0071565|nBAF complex","GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0043044|ATP-dependent chromatin remodeling, GO:0007399|nervous system development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:1904837|beta-catenin-TCF complex assembly, GO:0045892|negative regulation of transcription, DNA-templated, GO:0006337|nucleosome disassembly, GO:0006338|chromatin remodeling, GO:0006357|regulation of transcription by RNA polymerase II, GO:0038111|interleukin-7-mediated signaling pathway, GO:0030177|positive regulation of Wnt signaling pathway, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0030308|negative regulation of cell growth, GO:0060766|negative regulation of androgen receptor signaling pathway, GO:0003407|neural retina development, GO:0001188|RNA polymerase I preinitiation complex assembly, GO:1901838|positive regulation of transcription of nucleolar large rRNA by RNA polymerase I, GO:0043923|positive regulation by host of viral transcription, GO:1902661|positive regulation of glucose mediated signaling pathway","GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0016887|ATPase activity, GO:0042393|histone binding, GO:0004386|helicase activity, GO:0016817|hydrolase activity, acting on acid anhydrides, GO:0003714|transcription corepressor activity, GO:0047485|protein N-terminus binding, GO:0008134|transcription factor binding, GO:0003713|transcription coactivator activity, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0050681|androgen receptor binding, GO:0002039|p53 binding, GO:0031492|nucleosomal DNA binding, GO:0070182|DNA polymerase binding, GO:0001164|RNA polymerase I CORE element sequence-specific DNA binding, GO:0070577|lysine-acetylated histone binding, GO:0008094|DNA-dependent ATPase activity, GO:0030957|Tat protein binding"
SYK,Silent,0.274917593970303,24,0.193552930397858,N,"oncogene, fusion",Oncogene,0.242428103396368,0.253712855696431,ENSG00000165025,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0019815|B cell receptor complex, GO:0032009|early phagosome, GO:0032991|protein-containing complex, GO:0005634|nucleus, GO:0042101|T cell receptor complex","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0000187|activation of MAPK activity, GO:0001820|serotonin secretion, GO:0001945|lymph vessel development, GO:0002092|positive regulation of receptor internalization, GO:0002281|macrophage activation involved in immune response, GO:0002283|neutrophil activation involved in immune response, GO:0002366|leukocyte activation involved in immune response, GO:0002554|serotonin secretion by platelet, GO:0007166|cell surface receptor signaling pathway, GO:0007167|enzyme linked receptor protein signaling pathway, GO:0007229|integrin-mediated signaling pathway, GO:0007257|activation of JUN kinase activity, GO:0010543|regulation of platelet activation, GO:0018105|peptidyl-serine phosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0019370|leukotriene biosynthetic process, GO:0031623|receptor internalization, GO:0032481|positive regulation of type I interferon production, GO:0032753|positive regulation of interleukin-4 production, GO:0032928|regulation of superoxide anion generation, GO:0033630|positive regulation of cell adhesion mediated by integrin, GO:0038063|collagen-activated tyrosine kinase receptor signaling pathway, GO:0038156|interleukin-3-mediated signaling pathway, GO:0042742|defense response to bacterium, GO:0043306|positive regulation of mast cell degranulation, GO:0043313|regulation of neutrophil degranulation, GO:0043366|beta selection, GO:0045087|innate immune response, GO:0045401|positive regulation of interleukin-3 biosynthetic process, GO:0045425|positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process, GO:0045579|positive regulation of B cell differentiation, GO:0045588|positive regulation of gamma-delta T cell differentiation, GO:0045780|positive regulation of bone resorption, GO:0046638|positive regulation of alpha-beta T cell differentiation, GO:0046641|positive regulation of alpha-beta T cell proliferation, GO:0046777|protein autophosphorylation, GO:0048514|blood vessel morphogenesis, GO:0050715|positive regulation of cytokine secretion, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0050764|regulation of phagocytosis, GO:0050850|positive regulation of calcium-mediated signaling, GO:0050853|B cell receptor signaling pathway, GO:0070372|regulation of ERK1 and ERK2 cascade, GO:0071226|cellular response to molecule of fungal origin, GO:0071404|cellular response to low-density lipoprotein particle stimulus, GO:0090237|regulation of arachidonic acid secretion, GO:0090330|regulation of platelet aggregation, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0002376|immune system process, GO:0002250|adaptive immune response, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0030593|neutrophil chemotaxis, GO:0016032|viral process, GO:0001525|angiogenesis, GO:0030168|platelet activation, GO:0008283|cell proliferation, GO:0009887|animal organ morphogenesis, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0006606|protein import into nucleus, GO:0038110|interleukin-2-mediated signaling pathway, GO:0007159|leukocyte cell-cell adhesion, GO:0010803|regulation of tumor necrosis factor-mediated signaling pathway, GO:0051090|regulation of DNA-binding transcription factor activity","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0019901|protein kinase binding, GO:0019902|phosphatase binding, GO:0035325|Toll-like receptor binding, GO:0042169|SH2 domain binding, GO:0005178|integrin binding, GO:0001784|phosphotyrosine residue binding, GO:0004674|protein serine/threonine kinase activity"
EBF1,Missense,0.274893578300038,86,0.0104219297250021,N,"TSG, fusion",TSG,0.40484063009035,0.000110498415276787,ENSG00000164330,GO:0005634|nucleus,"GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0045944|positive regulation of transcription by RNA polymerase II","GO:0046872|metal ion binding, GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0070742|C2H2 zinc finger domain binding"
SET,Missense,0.273567935001194,17,0.288021705000594,N,"oncogene, fusion",Oncogene,0.293378199623306,0.253094449005432,ENSG00000119335,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005783|endoplasmic reticulum, GO:0005829|cytosol, GO:0005811|lipid droplet, GO:0048471|perinuclear region of cytoplasm, GO:0032991|protein-containing complex","GO:0006334|nucleosome assembly, GO:0032515|negative regulation of phosphoprotein phosphatase activity, GO:0043666|regulation of phosphoprotein phosphatase activity, GO:0016032|viral process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0043488|regulation of mRNA stability, GO:0006260|DNA replication, GO:0006337|nucleosome disassembly, GO:0043524|negative regulation of neuron apoptotic process, GO:0035067|negative regulation of histone acetylation","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0019888|protein phosphatase regulator activity, GO:0042393|histone binding, GO:0004864|protein phosphatase inhibitor activity"
IRS4,Missense,0.273381980615834,132,0.00151553642897914,Y,"oncogene, TSG","",0.384053429595816,5.46599988507941e-06,ENSG00000133124,"GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005829|cytosol","GO:0009967|positive regulation of signal transduction, GO:0007165|signal transduction, GO:0008286|insulin receptor signaling pathway","GO:0005515|protein binding, GO:0005158|insulin receptor binding, GO:0005070|SH3/SH2 adaptor activity, GO:0043548|phosphatidylinositol 3-kinase binding"
STIL,Missense,0.27337144333565,74,0.0184393411253596,N,"oncogene, fusion",Oncogene,0.561822366583608,1.90716211896277e-07,ENSG00000123473,"GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005856|cytoskeleton, GO:0005813|centrosome, GO:0005814|centriole","GO:0043066|negative regulation of apoptotic process, GO:0007275|multicellular organism development, GO:0008283|cell proliferation, GO:0001947|heart looping, GO:0007368|determination of left/right symmetry, GO:0000578|embryonic axis specification, GO:0021915|neural tube development, GO:0001843|neural tube closure, GO:0007052|mitotic spindle organization, GO:0030903|notochord development, GO:0033504|floor plate development, GO:0046599|regulation of centriole replication, GO:0007224|smoothened signaling pathway, GO:0001701|in utero embryonic development, GO:0051298|centrosome duplication, GO:0071539|protein localization to centrosome, GO:0030900|forebrain development, GO:0035264|multicellular organism growth","GO:0005515|protein binding, GO:0042802|identical protein binding"
NCOR1,Nonsense,0.273302866009824,31,0.136844985047065,N,TSG,TSG,0.241375075289192,0.190827948142732,ENSG00000141027,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin, GO:0000118|histone deacetylase complex, GO:0017053|transcriptional repressor complex, GO:0072686|mitotic spindle, GO:0016580|Sin3 complex","GO:0006325|chromatin organization, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0046329|negative regulation of JNK cascade, GO:0006366|transcription by RNA polymerase II, GO:0007623|circadian rhythm, GO:0019216|regulation of lipid metabolic process, GO:0051225|spindle assembly, GO:0060766|negative regulation of androgen receptor signaling pathway, GO:0072362|regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter, GO:0072368|regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter, GO:1903799|negative regulation of production of miRNAs involved in gene silencing by miRNA, GO:2000191|regulation of fatty acid transport","GO:0044212|transcription regulatory region DNA binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003714|transcription corepressor activity, GO:0003682|chromatin binding, GO:0042826|histone deacetylase binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0035257|nuclear hormone receptor binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0046966|thyroid hormone receptor binding"
ACVR2A,Missense,0.273182883147988,74,0.0185234341805258,N,TSG,TSG,0.351691355622375,0.00212161679658544,ENSG00000121989,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005737|cytoplasm, GO:0034673|inhibin-betaglycan-ActRII complex, GO:0009986|cell surface, GO:0048179|activin receptor complex","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0030509|BMP signaling pathway, GO:0045669|positive regulation of osteoblast differentiation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007178|transmembrane receptor protein serine/threonine kinase signaling pathway, GO:0007389|pattern specification process, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0030501|positive regulation of bone mineralization, GO:0071773|cellular response to BMP stimulus, GO:0010862|positive regulation of pathway-restricted SMAD protein phosphorylation, GO:0032924|activin receptor signaling pathway, GO:0045648|positive regulation of erythrocyte differentiation, GO:0001934|positive regulation of protein phosphorylation, GO:0001702|gastrulation with mouth forming second, GO:0007283|spermatogenesis, GO:0007368|determination of left/right symmetry, GO:0007498|mesoderm development, GO:0008584|male gonad development, GO:0009952|anterior/posterior pattern specification, GO:0009966|regulation of signal transduction, GO:0030510|regulation of BMP signaling pathway, GO:0032927|positive regulation of activin receptor signaling pathway, GO:0042713|sperm ejaculation, GO:0043084|penile erection, GO:0048706|embryonic skeletal system development, GO:0050999|regulation of nitric-oxide synthase activity, GO:0060011|Sertoli cell proliferation","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004675|transmembrane receptor protein serine/threonine kinase activity, GO:0005515|protein binding, GO:0005024|transforming growth factor beta-activated receptor activity, GO:0019838|growth factor binding, GO:0046332|SMAD binding, GO:0015026|coreceptor activity, GO:0017002|activin-activated receptor activity, GO:0048185|activin binding, GO:0005026|transforming growth factor beta receptor activity, type II, GO:0030165|PDZ domain binding, GO:0034711|inhibin binding, GO:0034713|type I transforming growth factor beta receptor binding, GO:0043621|protein self-association, GO:0098821|BMP receptor activity"
CBL,Silent,0.273061804926292,27,0.168176381733682,N,"oncogene, TSG, fusion","",0.261096547729244,0.188356746146236,ENSG00000110395,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0042629|mast cell granule, GO:0005929|cilium, GO:0045121|membrane raft, GO:0016600|flotillin complex, GO:0005925|focal adhesion, GO:0030424|axon, GO:0030426|growth cone, GO:0048471|perinuclear region of cytoplasm","GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0016567|protein ubiquitination, GO:0023051|regulation of signaling, GO:0007166|cell surface receptor signaling pathway, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0007165|signal transduction, GO:0043066|negative regulation of apoptotic process, GO:0048260|positive regulation of receptor-mediated endocytosis, GO:0061024|membrane organization, GO:0019221|cytokine-mediated signaling pathway, GO:0070102|interleukin-6-mediated signaling pathway, GO:0042059|negative regulation of epidermal growth factor receptor signaling pathway, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0035635|entry of bacterium into host cell, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0000209|protein polyubiquitination, GO:0006513|protein monoubiquitination, GO:0006974|cellular response to DNA damage stimulus, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0007175|negative regulation of epidermal growth factor-activated receptor activity, GO:0008584|male gonad development, GO:0010332|response to gamma radiation, GO:0014823|response to activity, GO:0032487|regulation of Rap protein signal transduction, GO:0033574|response to testosterone, GO:0036120|cellular response to platelet-derived growth factor stimulus, GO:0042594|response to starvation, GO:0043303|mast cell degranulation, GO:0045471|response to ethanol, GO:0045742|positive regulation of epidermal growth factor receptor signaling pathway, GO:0046677|response to antibiotic, GO:0070997|neuron death, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0090650|cellular response to oxygen-glucose deprivation, GO:1901215|negative regulation of neuron death, GO:1990090|cellular response to nerve growth factor stimulus, GO:2000583|regulation of platelet-derived growth factor receptor-alpha signaling pathway","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005509|calcium ion binding, GO:0004842|ubiquitin-protein transferase activity, GO:0005515|protein binding, GO:0001784|phosphotyrosine residue binding, GO:0061630|ubiquitin protein ligase activity, GO:0045296|cadherin binding, GO:0017124|SH3 domain binding, GO:0030971|receptor tyrosine kinase binding, GO:0046875|ephrin receptor binding, GO:0005154|epidermal growth factor receptor binding, GO:0019901|protein kinase binding, GO:0036312|phosphatidylinositol 3-kinase regulatory subunit binding, GO:1990782|protein tyrosine kinase binding"
RUNX1T1,Missense,0.272394068330613,153,0.000658391970849185,Y,"oncogene, TSG, fusion","",0.339909151902156,1.71830347406853e-05,ENSG00000079102,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016363|nuclear matrix","GO:0006355|regulation of transcription, DNA-templated, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045599|negative regulation of fat cell differentiation, GO:0006091|generation of precursor metabolites and energy","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0003714|transcription corepressor activity, GO:0005515|protein binding"
CLTCL1,Missense,0.272104244188226,116,0.00312789813068474,Y,"TSG, fusion",TSG,0.315992553405862,0.000549343017046708,ENSG00000070371,"GO:0016020|membrane, GO:0031410|cytoplasmic vesicle, GO:0030659|cytoplasmic vesicle membrane, GO:0005905|clathrin-coated pit, GO:0030130|clathrin coat of trans-Golgi network vesicle, GO:0005819|spindle, GO:0071439|clathrin complex, GO:0030136|clathrin-coated vesicle, GO:0005829|cytosol, GO:0070062|extracellular exosome, GO:0005802|trans-Golgi network, GO:0005770|late endosome, GO:0045334|clathrin-coated endocytic vesicle, GO:0030135|coated vesicle, GO:0097443|sorting endosome, GO:0005623|cell, GO:0030132|clathrin coat of coated pit","GO:0006886|intracellular protein transport, GO:0016192|vesicle-mediated transport, GO:0048268|clathrin coat assembly, GO:0042147|retrograde transport, endosome to Golgi, GO:0061024|membrane organization, GO:0009653|anatomical structure morphogenesis, GO:0000278|mitotic cell cycle, GO:0006898|receptor-mediated endocytosis, GO:0046326|positive regulation of glucose import","GO:0005198|structural molecule activity, GO:0032051|clathrin light chain binding, GO:0005515|protein binding"
CHD4,Nonsense,0.270775776572863,13,0.37089004930318,N,Oncogene,Oncogene,0.26017423835832,0.39062835432494,ENSG00000111642,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0000790|nuclear chromatin, GO:0005856|cytoskeleton, GO:0005654|nucleoplasm, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0032991|protein-containing complex, GO:0016581|NuRD complex","GO:0006325|chromatin organization, GO:0016575|histone deacetylation, GO:0032508|DNA duplex unwinding, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043044|ATP-dependent chromatin remodeling","GO:0046872|metal ion binding, GO:0005524|ATP binding, GO:0000166|nucleotide binding, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004386|helicase activity, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0004407|histone deacetylase activity, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0004003|ATP-dependent DNA helicase activity, GO:0001103|RNA polymerase II repressing transcription factor binding, GO:0008270|zinc ion binding, GO:0042826|histone deacetylase binding, GO:0031492|nucleosomal DNA binding"
ATRX,Nonsense,0.269549201770648,51,0.0557717694671854,N,TSG,TSG,0.327344912220686,0.019039203153383,ENSG00000085224,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0016604|nuclear body, GO:0000781|chromosome, telomeric region, GO:0000228|nuclear chromosome, GO:0000780|condensed nuclear chromosome, centromeric region, GO:0000784|nuclear chromosome, telomeric region, GO:0000792|heterochromatin, GO:0005721|pericentric heterochromatin, GO:0016605|PML body, GO:0031618|nuclear pericentric heterochromatin, GO:0031933|telomeric heterochromatin, GO:0005720|nuclear heterochromatin, GO:1990707|nuclear subtelomeric heterochromatin","GO:0006325|chromatin organization, GO:0006334|nucleosome assembly, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000212|meiotic spindle organization, GO:0007283|spermatogenesis, GO:0010571|positive regulation of nuclear cell cycle DNA replication, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0030900|forebrain development, GO:0031297|replication fork processing, GO:0032206|positive regulation of telomere maintenance, GO:0035128|post-embryonic forelimb morphogenesis, GO:0035264|multicellular organism growth, GO:0060009|Sertoli cell development, GO:0070192|chromosome organization involved in meiotic cell cycle, GO:0070198|protein localization to chromosome, telomeric region, GO:0072520|seminiferous tubule development, GO:0072711|cellular response to hydroxyurea, GO:1901581|negative regulation of telomeric RNA transcription from RNA pol II promoter, GO:0006336|DNA replication-independent nucleosome assembly, GO:0006355|regulation of transcription, DNA-templated, GO:0006338|chromatin remodeling, GO:1904908|negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric, GO:0006306|DNA methylation, GO:1900112|regulation of histone H3-K9 trimethylation, GO:1901582|positive regulation of telomeric RNA transcription from RNA pol II promoter","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004386|helicase activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0042393|histone binding, GO:0035064|methylated histone binding, GO:0070087|chromo shadow domain binding, GO:0015616|DNA translocase activity"
NSD2,Missense,0.269159211914183,94,0.00870877721076724,Y,"oncogene, fusion",Oncogene,0.333012550442777,0.00103948339045433,ENSG00000109685,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0000785|chromatin","GO:0032259|methylation, GO:0006325|chromatin organization, GO:0006355|regulation of transcription, DNA-templated, GO:0006303|double-strand break repair via nonhomologous end joining, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0003149|membranous septum morphogenesis, GO:0003289|atrial septum primum morphogenesis, GO:0003290|atrial septum secundum morphogenesis, GO:0010452|histone H3-K36 methylation, GO:0034770|histone H4-K20 methylation, GO:0048298|positive regulation of isotype switching to IgA isotypes, GO:0060348|bone development, GO:0070201|regulation of establishment of protein localization, GO:2001032|regulation of double-strand break repair via nonhomologous end joining","GO:0046872|metal ion binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0042799|histone methyltransferase activity (H4-K20 specific), GO:0046975|histone methyltransferase activity (H3-K36 specific), GO:0003682|chromatin binding, GO:0043565|sequence-specific DNA binding"
ARID2,Missense,0.267628267087543,142,0.00128228449502289,Y,TSG,TSG,0.281934877173033,0.00067590155862354,ENSG00000189079,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005886|plasma membrane","GO:0008285|negative regulation of cell proliferation, GO:0030336|negative regulation of cell migration, GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006337|nucleosome disassembly, GO:0003007|heart morphogenesis, GO:0042592|homeostatic process, GO:0048568|embryonic organ development, GO:0060038|cardiac muscle cell proliferation, GO:0060982|coronary artery morphogenesis, GO:0072358|cardiovascular system development","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
XPO1,Missense,0.264467177830736,72,0.0247721410050303,N,Oncogene,Oncogene,0.411141883889856,0.000333689907345812,ENSG00000082898,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0031965|nuclear membrane, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0000776|kinetochore, GO:0032991|protein-containing complex, GO:0005635|nuclear envelope, GO:0043657|host cell, GO:0005642|annulate lamellae, GO:0015030|Cajal body, GO:1990904|ribonucleoprotein complex, GO:0005623|cell","GO:0051028|mRNA transport, GO:0006886|intracellular protein transport, GO:0015031|protein transport, GO:0000056|ribosomal small subunit export from nucleus, GO:0016032|viral process, GO:0000055|ribosomal large subunit export from nucleus, GO:0043488|regulation of mRNA stability, GO:0000054|ribosomal subunit export from nucleus, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006611|protein export from nucleus, GO:0006913|nucleocytoplasmic transport, GO:0010824|regulation of centrosome duplication, GO:0034504|protein localization to nucleus, GO:0042176|regulation of protein catabolic process, GO:0042254|ribosome biogenesis, GO:0042493|response to drug, GO:0046825|regulation of protein export from nucleus, GO:0075733|intracellular transport of virus","GO:0003723|RNA binding, GO:0005515|protein binding, GO:0008536|Ran GTPase binding, GO:0005049|nuclear export signal receptor activity, GO:0005215|transporter activity, GO:0008565|protein transporter activity, GO:0019904|protein domain specific binding"
RET,Silent,0.264451490286223,75,0.0218634360941464,N,"oncogene, fusion",Oncogene,0.266562431350039,0.0207929764213303,ENSG00000165731,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005768|endosome, GO:0010008|endosome membrane, GO:0030424|axon, GO:0098797|plasma membrane protein complex, GO:0005769|early endosome, GO:0030425|dendrite, GO:0043025|neuronal cell body, GO:0045121|membrane raft","GO:0007156|homophilic cell adhesion via plasma membrane adhesion molecules, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007155|cell adhesion, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0035860|glial cell-derived neurotrophic factor receptor signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0043410|positive regulation of MAPK cascade, GO:0007399|nervous system development, GO:0030335|positive regulation of cell migration, GO:0030155|regulation of cell adhesion, GO:0007165|signal transduction, GO:0007411|axon guidance, GO:0000165|MAPK cascade, GO:0051897|positive regulation of protein kinase B signaling, GO:0000187|activation of MAPK activity, GO:0022008|neurogenesis, GO:2001241|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand, GO:0033619|membrane protein proteolysis, GO:0048265|response to pain, GO:0010976|positive regulation of neuron projection development, GO:0071300|cellular response to retinoic acid, GO:0007158|neuron cell-cell adhesion, GO:0007497|posterior midgut development, GO:0033630|positive regulation of cell adhesion mediated by integrin, GO:0061146|Peyer's patch morphogenesis, GO:0072300|positive regulation of metanephric glomerulus development, GO:0097021|lymphocyte migration into lymphoid organs, GO:0001657|ureteric bud development, GO:0001755|neural crest cell migration, GO:0001838|embryonic epithelial tube formation, GO:0010628|positive regulation of gene expression, GO:0014042|positive regulation of neuron maturation, GO:0030182|neuron differentiation, GO:0033141|positive regulation of peptidyl-serine phosphorylation of STAT protein, GO:0035799|ureter maturation, GO:0042493|response to drug, GO:0042551|neuron maturation, GO:0045793|positive regulation of cell size, GO:0048484|enteric nervous system development, GO:0050770|regulation of axonogenesis, GO:0060041|retina development in camera-type eye, GO:0060384|innervation","GO:0005509|calcium ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0038023|signaling receptor activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity"
NSD2,Silent,0.26312840094077,36,0.121016851980408,N,"oncogene, fusion",Oncogene,0.311910488053138,0.0640373774211595,ENSG00000109685,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0000785|chromatin","GO:0032259|methylation, GO:0006325|chromatin organization, GO:0006355|regulation of transcription, DNA-templated, GO:0006303|double-strand break repair via nonhomologous end joining, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0003149|membranous septum morphogenesis, GO:0003289|atrial septum primum morphogenesis, GO:0003290|atrial septum secundum morphogenesis, GO:0010452|histone H3-K36 methylation, GO:0034770|histone H4-K20 methylation, GO:0048298|positive regulation of isotype switching to IgA isotypes, GO:0060348|bone development, GO:0070201|regulation of establishment of protein localization, GO:2001032|regulation of double-strand break repair via nonhomologous end joining","GO:0046872|metal ion binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0042799|histone methyltransferase activity (H4-K20 specific), GO:0046975|histone methyltransferase activity (H3-K36 specific), GO:0003682|chromatin binding, GO:0043565|sequence-specific DNA binding"
MTOR,Silent,0.262788937208531,70,0.0279599843905967,N,Oncogene,Oncogene,0.238812569570914,0.0464828365717899,ENSG00000198793,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0031090|organelle membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005794|Golgi apparatus, GO:0005765|lysosomal membrane, GO:0005739|mitochondrion, GO:0000139|Golgi membrane, GO:0005741|mitochondrial outer membrane, GO:0005764|lysosome, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0012505|endomembrane system, GO:0016605|PML body, GO:0031931|TORC1 complex, GO:0031932|TORC2 complex, GO:0030425|dendrite, GO:0032991|protein-containing complex, GO:0043025|neuronal cell body","GO:0016310|phosphorylation, GO:0006468|protein phosphorylation, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:1903691|positive regulation of wound healing, spreading of epidermal cells, GO:0045727|positive regulation of translation, GO:0010507|negative regulation of autophagy, GO:0001934|positive regulation of protein phosphorylation, GO:0010628|positive regulation of gene expression, GO:0032956|regulation of actin cytoskeleton organization, GO:0009267|cellular response to starvation, GO:0001558|regulation of cell growth, GO:0030163|protein catabolic process, GO:0018105|peptidyl-serine phosphorylation, GO:0071456|cellular response to hypoxia, GO:0032148|activation of protein kinase B activity, GO:0007050|cell cycle arrest, GO:0016241|regulation of macroautophagy, GO:0046889|positive regulation of lipid biosynthetic process, GO:1900034|regulation of cellular response to heat, GO:0031669|cellular response to nutrient levels, GO:0045670|regulation of osteoclast differentiation, GO:0051549|positive regulation of keratinocyte migration, GO:1901838|positive regulation of transcription of nucleolar large rRNA by RNA polymerase I, GO:0031929|TOR signaling, GO:0034198|cellular response to amino acid starvation, GO:0043276|anoikis, GO:0007584|response to nutrient, GO:0001932|regulation of protein phosphorylation, GO:0001933|negative regulation of protein phosphorylation, GO:0001938|positive regulation of endothelial cell proliferation, GO:0002296|T-helper 1 cell lineage commitment, GO:0003007|heart morphogenesis, GO:0003179|heart valve morphogenesis, GO:0005979|regulation of glycogen biosynthetic process, GO:0006109|regulation of carbohydrate metabolic process, GO:0006112|energy reserve metabolic process, GO:0006207|'de novo' pyrimidine nucleobase biosynthetic process, GO:0007281|germ cell development, GO:0007420|brain development, GO:0007569|cell aging, GO:0007616|long-term memory, GO:0008361|regulation of cell size, GO:0008542|visual learning, GO:0009791|post-embryonic development, GO:0010592|positive regulation of lamellipodium assembly, GO:0010831|positive regulation of myotube differentiation, GO:0010942|positive regulation of cell death, GO:0010976|positive regulation of neuron projection development, GO:0014042|positive regulation of neuron maturation, GO:0014736|negative regulation of muscle atrophy, GO:0014823|response to activity, GO:0016242|negative regulation of macroautophagy, GO:0018107|peptidyl-threonine phosphorylation, GO:0021510|spinal cord development, GO:0030030|cell projection organization, GO:0030838|positive regulation of actin filament polymerization, GO:0031397|negative regulation of protein ubiquitination, GO:0031529|ruffle organization, GO:0031641|regulation of myelination, GO:0031998|regulation of fatty acid beta-oxidation, GO:0032095|regulation of response to food, GO:0032516|positive regulation of phosphoprotein phosphatase activity, GO:0032868|response to insulin, GO:0035176|social behavior, GO:0035264|multicellular organism growth, GO:0038202|TORC1 signaling, GO:0042060|wound healing, GO:0042220|response to cocaine, GO:0043087|regulation of GTPase activity, GO:0043200|response to amino acid, GO:0043278|response to morphine, GO:0043610|regulation of carbohydrate utilization, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0045792|negative regulation of cell size, GO:0045859|regulation of protein kinase activity, GO:0045945|positive regulation of transcription by RNA polymerase III, GO:0046777|protein autophosphorylation, GO:0048255|mRNA stabilization, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0048714|positive regulation of oligodendrocyte differentiation, GO:0048738|cardiac muscle tissue development, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0050769|positive regulation of neurogenesis, GO:0050882|voluntary musculoskeletal movement, GO:0051496|positive regulation of stress fiber assembly, GO:0051896|regulation of protein kinase B signaling, GO:0051897|positive regulation of protein kinase B signaling, GO:0055006|cardiac cell development, GO:0055013|cardiac muscle cell development, GO:0060048|cardiac muscle contraction, GO:0060135|maternal process involved in female pregnancy, GO:0060252|positive regulation of glial cell proliferation, GO:0060999|positive regulation of dendritic spine development, GO:0061051|positive regulation of cell growth involved in cardiac muscle cell development, GO:0070885|negative regulation of calcineurin-NFAT signaling cascade, GO:0071230|cellular response to amino acid stimulus, GO:0071233|cellular response to leucine, GO:0090335|regulation of brown fat cell differentiation, GO:0090559|regulation of membrane permeability, GO:1901216|positive regulation of neuron death, GO:1904000|positive regulation of eating behavior, GO:1904056|positive regulation of cholangiocyte proliferation, GO:1904058|positive regulation of sensory perception of pain, GO:1904193|negative regulation of cholangiocyte apoptotic process, GO:1904197|positive regulation of granulosa cell proliferation, GO:1904206|positive regulation of skeletal muscle hypertrophy, GO:1904213|negative regulation of iodide transmembrane transport, GO:1904690|positive regulation of cytoplasmic translational initiation, GO:1990253|cellular response to leucine starvation","GO:0000166|nucleotide binding, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0044877|protein-containing complex binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0051219|phosphoprotein binding, GO:0001030|RNA polymerase III type 1 promoter DNA binding, GO:0001031|RNA polymerase III type 2 promoter DNA binding, GO:0001032|RNA polymerase III type 3 promoter DNA binding, GO:0001156|TFIIIC-class transcription factor complex binding, GO:0004672|protein kinase activity, GO:0019901|protein kinase binding, GO:0019904|protein domain specific binding, GO:0043022|ribosome binding"
TPR,Silent,0.26149189279107,43,0.0903028133997756,N,fusion,"",0.545472975442628,0.000155073868858942,ENSG00000047410,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0031965|nuclear membrane, GO:0005694|chromosome, GO:0005856|cytoskeleton, GO:0005643|nuclear pore, GO:0005819|spindle, GO:0000775|chromosome, centromeric region, GO:0000776|kinetochore, GO:0005868|cytoplasmic dynein complex, GO:0005654|nucleoplasm, GO:0019898|extrinsic component of membrane, GO:0005635|nuclear envelope, GO:0072686|mitotic spindle, GO:0042405|nuclear inclusion body, GO:0034399|nuclear periphery, GO:0044615|nuclear pore nuclear basket","GO:0051028|mRNA transport, GO:0015031|protein transport, GO:0051301|cell division, GO:0007049|cell cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006406|mRNA export from nucleus, GO:0016032|viral process, GO:0042307|positive regulation of protein import into nucleus, GO:0006606|protein import into nucleus, GO:0007094|mitotic spindle assembly checkpoint, GO:0090267|positive regulation of mitotic cell cycle spindle assembly checkpoint, GO:0090316|positive regulation of intracellular protein transport, GO:0034605|cellular response to heat, GO:0032880|regulation of protein localization, GO:1901673|regulation of mitotic spindle assembly, GO:0045947|negative regulation of translational initiation, GO:0046827|positive regulation of protein export from nucleus, GO:0006404|RNA import into nucleus, GO:0006405|RNA export from nucleus, GO:0006999|nuclear pore organization, GO:0010965|regulation of mitotic sister chromatid separation, GO:0031453|positive regulation of heterochromatin assembly, GO:0031990|mRNA export from nucleus in response to heat stress, GO:0035457|cellular response to interferon-alpha, GO:0046832|negative regulation of RNA export from nucleus, GO:0070849|response to epidermal growth factor","GO:0003723|RNA binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0003729|mRNA binding, GO:0003682|chromatin binding, GO:0070840|dynein complex binding, GO:0017056|structural constituent of nuclear pore, GO:0015631|tubulin binding, GO:0051019|mitogen-activated protein kinase binding, GO:0031072|heat shock protein binding"
BRD3,Silent,0.261354763817098,38,0.1129735473554,N,"oncogene, fusion",Oncogene,0.253443892758934,0.124701926703765,ENSG00000169925,GO:0005634|nucleus,"GO:0006325|chromatin organization, GO:0006357|regulation of transcription by RNA polymerase II","GO:0005515|protein binding, GO:0003682|chromatin binding, GO:0070577|lysine-acetylated histone binding"
HIF1A,Missense,0.261321056266328,56,0.0517278150135599,N,Oncogene,Oncogene,0.433710519415595,0.000839936161979901,ENSG00000100644,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005654|nucleoplasm, GO:1904115|axon cytoplasm, GO:0005829|cytosol, GO:0016604|nuclear body, GO:0032991|protein-containing complex, GO:0005667|transcription factor complex, GO:0090575|RNA polymerase II transcription factor complex, GO:0031514|motile cilium","GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0045766|positive regulation of angiogenesis, GO:0030949|positive regulation of vascular endothelial growth factor receptor signaling pathway, GO:0010634|positive regulation of epithelial cell migration, GO:0045648|positive regulation of erythrocyte differentiation, GO:0032963|collagen metabolic process, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006366|transcription by RNA polymerase II, GO:0016579|protein deubiquitination, GO:0043687|post-translational protein modification, GO:0001666|response to hypoxia, GO:0001938|positive regulation of endothelial cell proliferation, GO:0032722|positive regulation of chemokine production, GO:0019221|cytokine-mediated signaling pathway, GO:0051000|positive regulation of nitric-oxide synthase activity, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0010573|vascular endothelial growth factor production, GO:0071456|cellular response to hypoxia, GO:0001837|epithelial to mesenchymal transition, GO:1903377|negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway, GO:0019896|axonal transport of mitochondrion, GO:0007165|signal transduction, GO:0010468|regulation of gene expression, GO:0010575|positive regulation of vascular endothelial growth factor production, GO:0002248|connective tissue replacement involved in inflammatory response wound healing, GO:0045821|positive regulation of glycolytic process, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0010870|positive regulation of receptor biosynthetic process, GO:0070101|positive regulation of chemokine-mediated signaling pathway, GO:0043619|regulation of transcription from RNA polymerase II promoter in response to oxidative stress, GO:0010039|response to iron ion, GO:0042789|mRNA transcription by RNA polymerase II, GO:0071347|cellular response to interleukin-1, GO:0061419|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0046886|positive regulation of hormone biosynthetic process, GO:0032909|regulation of transforming growth factor beta2 production, GO:0032364|oxygen homeostasis, GO:0051541|elastin metabolic process, GO:0001525|angiogenesis, GO:0001568|blood vessel development, GO:0001755|neural crest cell migration, GO:0001892|embryonic placenta development, GO:0001922|B-1 B cell homeostasis, GO:0001944|vasculature development, GO:0001947|heart looping, GO:0002052|positive regulation of neuroblast proliferation, GO:0003151|outflow tract morphogenesis, GO:0003208|cardiac ventricle morphogenesis, GO:0006089|lactate metabolic process, GO:0006110|regulation of glycolytic process, GO:0006879|cellular iron ion homeostasis, GO:0007595|lactation, GO:0008542|visual learning, GO:0010508|positive regulation of autophagy, GO:0014850|response to muscle activity, GO:0016239|positive regulation of macroautophagy, GO:0021502|neural fold elevation formation, GO:0021987|cerebral cortex development, GO:0030154|cell differentiation, GO:0030279|negative regulation of ossification, GO:0030502|negative regulation of bone mineralization, GO:0032007|negative regulation of TOR signaling, GO:0035162|embryonic hemopoiesis, GO:0035774|positive regulation of insulin secretion involved in cellular response to glucose stimulus, GO:0042127|regulation of cell proliferation, GO:0042541|hemoglobin biosynthetic process, GO:0042593|glucose homeostasis, GO:0043066|negative regulation of apoptotic process, GO:0043524|negative regulation of neuron apoptotic process, GO:0045926|negative regulation of growth, GO:0046716|muscle cell cellular homeostasis, GO:0048514|blood vessel morphogenesis, GO:0048546|digestive tract morphogenesis, GO:0048593|camera-type eye morphogenesis, GO:0050790|regulation of catalytic activity, GO:0051216|cartilage development, GO:0060574|intestinal epithelial cell maturation, GO:0061030|epithelial cell differentiation involved in mammary gland alveolus development, GO:0061072|iris morphogenesis, GO:0061298|retina vasculature development in camera-type eye, GO:0070243|regulation of thymocyte apoptotic process, GO:0070244|negative regulation of thymocyte apoptotic process, GO:0071542|dopaminergic neuron differentiation, GO:0097411|hypoxia-inducible factor-1alpha signaling pathway, GO:1903599|positive regulation of autophagy of mitochondrion, GO:1903715|regulation of aerobic respiration, GO:2000378|negative regulation of reactive oxygen species metabolic process, GO:2001054|negative regulation of mesenchymal cell apoptotic process","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019901|protein kinase binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0031625|ubiquitin protein ligase binding, GO:0046982|protein heterodimerization activity, GO:0019899|enzyme binding, GO:0019904|protein domain specific binding, GO:0051879|Hsp90 protein binding, GO:0002039|p53 binding, GO:0043565|sequence-specific DNA binding, GO:0035257|nuclear hormone receptor binding, GO:0008134|transcription factor binding, GO:0035035|histone acetyltransferase binding, GO:0042826|histone deacetylase binding, GO:0070888|E-box binding"
ACVR1,Silent,0.261294700187214,16,0.328311446593183,N,Oncogene,Oncogene,0.218268091534775,0.416726823616567,ENSG00000115170,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0045177|apical part of cell, GO:0048179|activin receptor complex","GO:0030335|positive regulation of cell migration, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0060412|ventricular septum morphogenesis, GO:0030509|BMP signaling pathway, GO:0045669|positive regulation of osteoblast differentiation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007178|transmembrane receptor protein serine/threonine kinase signaling pathway, GO:0007507|heart development, GO:0001569|branching involved in blood vessel morphogenesis, GO:0001701|in utero embryonic development, GO:0001702|gastrulation with mouth forming second, GO:0001707|mesoderm formation, GO:0001755|neural crest cell migration, GO:0002526|acute inflammatory response, GO:0003181|atrioventricular valve morphogenesis, GO:0003203|endocardial cushion morphogenesis, GO:0003274|endocardial cushion fusion, GO:0003289|atrial septum primum morphogenesis, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0007281|germ cell development, GO:0007368|determination of left/right symmetry, GO:0007369|gastrulation, GO:0007498|mesoderm development, GO:0010862|positive regulation of pathway-restricted SMAD protein phosphorylation, GO:0051145|smooth muscle cell differentiation, GO:0060037|pharyngeal system development, GO:0061312|BMP signaling pathway involved in heart development, GO:1905007|positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation, GO:0007389|pattern specification process, GO:0030501|positive regulation of bone mineralization, GO:0071773|cellular response to BMP stimulus, GO:0060389|pathway-restricted SMAD protein phosphorylation, GO:0018107|peptidyl-threonine phosphorylation, GO:0003183|mitral valve morphogenesis, GO:0032924|activin receptor signaling pathway, GO:2001237|negative regulation of extrinsic apoptotic signaling pathway, GO:0000082|G1/S transition of mitotic cell cycle, GO:0060923|cardiac muscle cell fate commitment, GO:0009968|negative regulation of signal transduction, GO:0003143|embryonic heart tube morphogenesis, GO:0030278|regulation of ossification, GO:0032926|negative regulation of activin receptor signaling pathway, GO:0061445|endocardial cushion cell fate commitment, GO:2000017|positive regulation of determination of dorsal identity","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004675|transmembrane receptor protein serine/threonine kinase activity, GO:0005515|protein binding, GO:0005025|transforming growth factor beta receptor activity, type I, GO:0016361|activin receptor activity, type I, GO:0019838|growth factor binding, GO:0048185|activin binding, GO:0050431|transforming growth factor beta binding, GO:0042803|protein homodimerization activity, GO:0005024|transforming growth factor beta-activated receptor activity, GO:0046332|SMAD binding, GO:0017046|peptide hormone binding, GO:0098821|BMP receptor activity"
EZH2,Silent,0.260623345657842,20,0.26707990621447,N,"oncogene, TSG","",0.314098999726767,0.177441071368088,ENSG00000106462,"GO:0005634|nucleus, GO:0000790|nuclear chromatin, GO:0005654|nucleoplasm, GO:0035098|ESC/E(Z) complex, GO:0005737|cytoplasm, GO:0045120|pronucleus","GO:0034968|histone lysine methylation, GO:0008284|positive regulation of cell proliferation, GO:0032259|methylation, GO:0006325|chromatin organization, GO:0048511|rhythmic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0043547|positive regulation of GTPase activity, GO:0071902|positive regulation of protein serine/threonine kinase activity, GO:0048387|negative regulation of retinoic acid receptor signaling pathway, GO:0045892|negative regulation of transcription, DNA-templated, GO:0070317|negative regulation of G0 to G1 transition, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0006355|regulation of transcription, DNA-templated, GO:0042752|regulation of circadian rhythm, GO:0045814|negative regulation of gene expression, epigenetic, GO:0043406|positive regulation of MAP kinase activity, GO:1902808|positive regulation of cell cycle G1/S phase transition, GO:0016571|histone methylation, GO:0070734|histone H3-K27 methylation, GO:0001932|regulation of protein phosphorylation, GO:0006306|DNA methylation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0010468|regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0014013|regulation of gliogenesis, GO:0014834|skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration, GO:0014898|cardiac muscle hypertrophy in response to stress, GO:0021695|cerebellar cortex development, GO:0021766|hippocampus development, GO:0032355|response to estradiol, GO:0034244|negative regulation of transcription elongation from RNA polymerase II promoter, GO:0035984|cellular response to trichostatin A, GO:0036333|hepatocyte homeostasis, GO:0042127|regulation of cell proliferation, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045605|negative regulation of epidermal cell differentiation, GO:0050767|regulation of neurogenesis, GO:0051154|negative regulation of striated muscle cell differentiation, GO:0070301|cellular response to hydrogen peroxide, GO:0070314|G1 to G0 transition, GO:0071168|protein localization to chromatin, GO:0097421|liver regeneration, GO:0098532|histone H3-K27 trimethylation, GO:1900006|positive regulation of dendrite development, GO:1904772|response to tetrachloromethane, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle","GO:0018024|histone-lysine N-methyltransferase activity, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0031490|chromatin DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0003677|DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0042054|histone methyltransferase activity, GO:1990841|promoter-specific chromatin binding, GO:0046976|histone methyltransferase activity (H3-K27 specific), GO:0016279|protein-lysine N-methyltransferase activity, GO:0000979|RNA polymerase II core promoter sequence-specific DNA binding, GO:0003723|RNA binding, GO:0043021|ribonucleoprotein complex binding, GO:0043565|sequence-specific DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0070878|primary miRNA binding"
WIF1,Missense,0.259829135656417,39,0.110173975530358,N,"TSG, fusion",TSG,0.454717569075028,0.00363466769900079,ENSG00000156076,"GO:0005576|extracellular region, GO:0009986|cell surface","GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:0048856|anatomical structure development, GO:0007165|signal transduction, GO:0030178|negative regulation of Wnt signaling pathway, GO:0045600|positive regulation of fat cell differentiation","GO:0005515|protein binding, GO:0017147|Wnt-protein binding, GO:0005102|signaling receptor binding"
PPARG,Silent,0.259290514656764,20,0.269622190989376,N,"TSG, fusion",TSG,0.255597275266997,0.276745767411902,ENSG00000132170,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0090575|RNA polymerase II transcription factor complex, GO:0005829|cytosol, GO:0032991|protein-containing complex, GO:0048471|perinuclear region of cytoplasm","GO:0043537|negative regulation of blood vessel endothelial cell migration, GO:1905563|negative regulation of vascular endothelial cell proliferation, GO:1904706|negative regulation of vascular smooth muscle cell proliferation, GO:0071404|cellular response to low-density lipoprotein particle stimulus, GO:0016525|negative regulation of angiogenesis, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1905461|positive regulation of vascular associated smooth muscle cell apoptotic process, GO:0055088|lipid homeostasis, GO:0042953|lipoprotein transport, GO:0045893|positive regulation of transcription, DNA-templated, GO:0032869|cellular response to insulin stimulus, GO:0042593|glucose homeostasis, GO:0048662|negative regulation of smooth muscle cell proliferation, GO:0006355|regulation of transcription, DNA-templated, GO:0030522|intracellular receptor signaling pathway, GO:0043401|steroid hormone mediated signaling pathway, GO:0048511|rhythmic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030154|cell differentiation, GO:0007186|G protein-coupled receptor signaling pathway, GO:0006357|regulation of transcription by RNA polymerase II, GO:0009755|hormone-mediated signaling pathway, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045087|innate immune response, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0006629|lipid metabolic process, GO:0048469|cell maturation, GO:0042752|regulation of circadian rhythm, GO:0050872|white fat cell differentiation, GO:0060850|regulation of transcription involved in cell fate commitment, GO:0006631|fatty acid metabolic process, GO:0007584|response to nutrient, GO:0032526|response to retinoic acid, GO:0061614|pri-miRNA transcription by RNA polymerase II, GO:0007275|multicellular organism development, GO:0007165|signal transduction, GO:0008217|regulation of blood pressure, GO:0010745|negative regulation of macrophage derived foam cell differentiation, GO:0010887|negative regulation of cholesterol storage, GO:0060965|negative regulation of gene silencing by miRNA, GO:0019216|regulation of lipid metabolic process, GO:0033993|response to lipid, GO:0030855|epithelial cell differentiation, GO:0045165|cell fate commitment, GO:0010871|negative regulation of receptor biosynthetic process, GO:0001890|placenta development, GO:0010742|macrophage derived foam cell differentiation, GO:0010891|negative regulation of sequestering of triglyceride, GO:0015909|long-chain fatty acid transport, GO:0030224|monocyte differentiation, GO:0035357|peroxisome proliferator activated receptor signaling pathway, GO:0043388|positive regulation of DNA binding, GO:0045600|positive regulation of fat cell differentiation, GO:0045713|low-density lipoprotein particle receptor biosynthetic process, GO:0060336|negative regulation of interferon-gamma-mediated signaling pathway, GO:0060694|regulation of cholesterol transporter activity, GO:0002674|negative regulation of acute inflammatory response, GO:0007507|heart development, GO:0008285|negative regulation of cell proliferation, GO:0009409|response to cold, GO:0009612|response to mechanical stimulus, GO:0010033|response to organic substance, GO:0014070|response to organic cyclic compound, GO:0019395|fatty acid oxidation, GO:0030308|negative regulation of cell growth, GO:0031000|response to caffeine, GO:0031100|animal organ regeneration, GO:0032966|negative regulation of collagen biosynthetic process, GO:0033189|response to vitamin A, GO:0035902|response to immobilization stress, GO:0042493|response to drug, GO:0042594|response to starvation, GO:0043065|positive regulation of apoptotic process, GO:0043627|response to estrogen, GO:0045598|regulation of fat cell differentiation, GO:0046321|positive regulation of fatty acid oxidation, GO:0048714|positive regulation of oligodendrocyte differentiation, GO:0051974|negative regulation of telomerase activity, GO:0060100|positive regulation of phagocytosis, engulfment, GO:0071300|cellular response to retinoic acid, GO:0071306|cellular response to vitamin E, GO:0071379|cellular response to prostaglandin stimulus, GO:0071380|cellular response to prostaglandin E stimulus, GO:0071455|cellular response to hyperoxia, GO:1901558|response to metformin, GO:2000230|negative regulation of pancreatic stellate cell proliferation","GO:0044212|transcription regulatory region DNA binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0003707|steroid hormone receptor activity, GO:0004879|nuclear receptor activity, GO:0030374|nuclear receptor transcription coactivator activity, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0003682|chromatin binding, GO:0038023|signaling receptor activity, GO:0008289|lipid binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0019899|enzyme binding, GO:0070888|E-box binding, GO:0046982|protein heterodimerization activity, GO:0005504|fatty acid binding, GO:0001103|RNA polymerase II repressing transcription factor binding, GO:0008144|drug binding, GO:0008022|protein C-terminus binding, GO:0051393|alpha-actinin binding, GO:0003690|double-stranded DNA binding, GO:0046965|retinoid X receptor binding, GO:0042277|peptide binding, GO:0050692|DBD domain binding, GO:0050693|LBD domain binding, GO:0033613|activating transcription factor binding, GO:0043621|protein self-association, GO:0004955|prostaglandin receptor activity, GO:0050544|arachidonic acid binding, GO:0019903|protein phosphatase binding, GO:0030331|estrogen receptor binding"
PAX5,Missense,0.258283865523609,38,0.117423255941301,N,"oncogene, TSG, fusion","",0.331095299150964,0.0423057522753191,ENSG00000196092,"GO:0005634|nucleus, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0001650|fibrillar center","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0007283|spermatogenesis, GO:0007399|nervous system development, GO:0006366|transcription by RNA polymerase II, GO:0009887|animal organ morphogenesis, GO:0006959|humoral immune response, GO:0050855|regulation of B cell receptor signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007568|aging, GO:0021670|lateral ventricle development, GO:0021987|cerebral cortex development, GO:0030534|adult behavior, GO:0035914|skeletal muscle cell differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0051573|negative regulation of histone H3-K9 methylation","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003700|DNA-binding transcription factor activity"
MET,Missense,0.258246676371835,124,0.0037809796551513,Y,Oncogene,Oncogene,0.265026181266728,0.00293274069205267,ENSG00000105976,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005576|extracellular region, GO:0009986|cell surface, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0009925|basal plasma membrane","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1901299|negative regulation of hydrogen peroxide-mediated programmed cell death, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0046854|phosphatidylinositol phosphorylation, GO:0030182|neuron differentiation, GO:0007399|nervous system development, GO:0010507|negative regulation of autophagy, GO:0016477|cell migration, GO:0007165|signal transduction, GO:0051897|positive regulation of protein kinase B signaling, GO:0000165|MAPK cascade, GO:0008283|cell proliferation, GO:0016055|Wnt signaling pathway, GO:0071526|semaphorin-plexin signaling pathway, GO:0048754|branching morphogenesis of an epithelial tube, GO:0050918|positive chemotaxis, GO:0035635|entry of bacterium into host cell, GO:0007166|cell surface receptor signaling pathway, GO:0006909|phagocytosis, GO:0001886|endothelial cell morphogenesis, GO:0001889|liver development, GO:0031016|pancreas development, GO:0031116|positive regulation of microtubule polymerization, GO:0035024|negative regulation of Rho protein signal transduction, GO:0048012|hepatocyte growth factor receptor signaling pathway, GO:0051497|negative regulation of stress fiber assembly, GO:0061436|establishment of skin barrier, GO:0070495|negative regulation of thrombin-activated receptor signaling pathway, GO:1905098|negative regulation of guanyl-nucleotide exchange factor activity, GO:2001028|positive regulation of endothelial cell chemotaxis","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0042802|identical protein binding, GO:0017147|Wnt-protein binding, GO:0019903|protein phosphatase binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005008|hepatocyte growth factor-activated receptor activity"
KCNJ5,Silent,0.25748855740241,30,0.16953835595711,N,Oncogene,Oncogene,0.271638256373592,0.146482189804123,ENSG00000120457,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0008076|voltage-gated potassium channel complex, GO:0009897|external side of plasma membrane, GO:0030315|T-tubule","GO:0006811|ion transport, GO:0006813|potassium ion transport, GO:0034765|regulation of ion transmembrane transport, GO:0098915|membrane repolarization during ventricular cardiac muscle cell action potential, GO:1990573|potassium ion import across plasma membrane, GO:0086091|regulation of heart rate by cardiac conduction, GO:0098914|membrane repolarization during atrial cardiac muscle cell action potential, GO:0099625|ventricular cardiac muscle cell membrane repolarization","GO:0005244|voltage-gated ion channel activity, GO:0005242|inward rectifier potassium channel activity, GO:0005515|protein binding, GO:1902282|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization, GO:0086089|voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization, GO:0015467|G-protein activated inward rectifier potassium channel activity"
TP53,Missense,0.257044514850564,390,2.65167727918645e-07,Y,"oncogene, TSG, fusion","",0.397379787436348,3.32484235069045e-16,ENSG00000141510,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005783|endoplasmic reticulum, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005759|mitochondrial matrix, GO:0005730|nucleolus, GO:0000790|nuclear chromatin, GO:0016363|nuclear matrix, GO:0032991|protein-containing complex, GO:0016605|PML body, GO:0005622|intracellular, GO:0005669|transcription factor TFIID complex, GO:0016604|nuclear body, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006915|apoptotic process, GO:0007049|cell cycle, GO:0051262|protein tetramerization, GO:0010628|positive regulation of gene expression, GO:0008285|negative regulation of cell proliferation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045899|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly, GO:0006974|cellular response to DNA damage stimulus, GO:0048511|rhythmic process, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0016579|protein deubiquitination, GO:0008283|cell proliferation, GO:0007050|cell cycle arrest, GO:0043065|positive regulation of apoptotic process, GO:0016032|viral process, GO:0006284|base-excision repair, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0008104|protein localization, GO:0030308|negative regulation of cell growth, GO:0042981|regulation of apoptotic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0019221|cytokine-mediated signaling pathway, GO:0035690|cellular response to drug, GO:0012501|programmed cell death, GO:0090200|positive regulation of release of cytochrome c from mitochondria, GO:2001244|positive regulation of intrinsic apoptotic signaling pathway, GO:0090399|replicative senescence, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0065003|protein-containing complex assembly, GO:0032461|positive regulation of protein oligomerization, GO:0009299|mRNA transcription, GO:0007569|cell aging, GO:0071456|cellular response to hypoxia, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:1900740|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, GO:0043153|entrainment of circadian clock by photoperiod, GO:0042149|cellular response to glucose starvation, GO:0071158|positive regulation of cell cycle arrest, GO:0072332|intrinsic apoptotic signaling pathway by p53 class mediator, GO:1990440|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0046677|response to antibiotic, GO:0097252|oligodendrocyte apoptotic process, GO:0048512|circadian behavior, GO:0000733|DNA strand renaturation, GO:0043066|negative regulation of apoptotic process, GO:1903800|positive regulation of production of miRNAs involved in gene silencing by miRNA, GO:2000379|positive regulation of reactive oxygen species metabolic process, GO:0048147|negative regulation of fibroblast proliferation, GO:0007265|Ras protein signal transduction, GO:0071480|cellular response to gamma radiation, GO:0006289|nucleotide-excision repair, GO:0006914|autophagy, GO:0006978|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator, GO:0006983|ER overload response, GO:0008340|determination of adult lifespan, GO:0010332|response to gamma radiation, GO:0031497|chromatin assembly, GO:0031571|mitotic G1 DNA damage checkpoint, GO:0034644|cellular response to UV, GO:0046827|positive regulation of protein export from nucleus, GO:0046902|regulation of mitochondrial membrane permeability, GO:0051097|negative regulation of helicase activity, GO:0051123|RNA polymerase II preinitiation complex assembly, GO:0051289|protein homotetramerization, GO:0051974|negative regulation of telomerase activity, GO:0070245|positive regulation of thymocyte apoptotic process, GO:0071479|cellular response to ionizing radiation, GO:0072331|signal transduction by p53 class mediator, GO:0072717|cellular response to actinomycin D, GO:0090403|oxidative stress-induced premature senescence, GO:0097193|intrinsic apoptotic signaling pathway, GO:1900119|positive regulation of execution phase of apoptosis, GO:1902749|regulation of cell cycle G2/M phase transition","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0044212|transcription regulatory region DNA binding, GO:0005524|ATP binding, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019901|protein kinase binding, GO:0003682|chromatin binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0031625|ubiquitin protein ligase binding, GO:0047485|protein N-terminus binding, GO:0019899|enzyme binding, GO:0019903|protein phosphatase binding, GO:0008134|transcription factor binding, GO:0002020|protease binding, GO:0005507|copper ion binding, GO:0046982|protein heterodimerization activity, GO:0001085|RNA polymerase II transcription factor binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0051087|chaperone binding, GO:0002039|p53 binding, GO:1990841|promoter-specific chromatin binding, GO:0051721|protein phosphatase 2A binding, GO:0003730|mRNA 3'-UTR binding, GO:0097718|disordered domain specific binding, GO:0035035|histone acetyltransferase binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001046|core promoter sequence-specific DNA binding, GO:0001094|TFIID-class transcription factor complex binding, GO:0030971|receptor tyrosine kinase binding, GO:0042826|histone deacetylase binding, GO:0043621|protein self-association"
U2AF1,Missense,0.257005543782004,18,0.303231954601813,N,Oncogene,Oncogene,-0.127359962109609,0.614535642219123,ENSG00000160201,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005654|nucleoplasm, GO:0005681|spliceosomal complex, GO:0071013|catalytic step 2 spliceosome, GO:0089701|U2AF, GO:0015030|Cajal body","GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0000398|mRNA splicing, via spliceosome, GO:0006406|mRNA export from nucleus, GO:0006405|RNA export from nucleus, GO:0031124|mRNA 3'-end processing","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0030628|pre-mRNA 3'-splice site binding, GO:0050733|RS domain binding"
PAX3,Missense,0.25652980873076,61,0.0459726161261142,N,"oncogene, fusion",Oncogene,0.272055137279561,0.0339179342102294,ENSG00000135903,"GO:0005634|nucleus, GO:0005654|nucleoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0007399|nervous system development, GO:0007517|muscle organ development, GO:0006366|transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0009887|animal organ morphogenesis, GO:0006915|apoptotic process, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007605|sensory perception of sound","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003700|DNA-binding transcription factor activity, GO:0071837|HMG box domain binding"
NUP98,Silent,0.255926254594708,25,0.216901047564576,N,"oncogene, fusion",Oncogene,0.270750124020829,0.190516148403213,ENSG00000110713,"GO:0005634|nucleus, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0005643|nuclear pore, GO:0000776|kinetochore, GO:0005829|cytosol, GO:0005635|nuclear envelope, GO:0031965|nuclear membrane, GO:1990904|ribonucleoprotein complex, GO:0031080|nuclear pore outer ring, GO:0016604|nuclear body, GO:0042405|nuclear inclusion body, GO:0034399|nuclear periphery, GO:0044615|nuclear pore nuclear basket, GO:0044614|nuclear pore cytoplasmic filaments","GO:0051028|mRNA transport, GO:0015031|protein transport, GO:1903508|positive regulation of nucleic acid-templated transcription, GO:0006913|nucleocytoplasmic transport, GO:0006508|proteolysis, GO:0006260|DNA replication, GO:0016032|viral process, GO:0006406|mRNA export from nucleus, GO:0006606|protein import into nucleus, GO:0006999|nuclear pore organization, GO:0048026|positive regulation of mRNA splicing, via spliceosome, GO:0051292|nuclear pore complex assembly, GO:0000973|posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery, GO:0006405|RNA export from nucleus, GO:0034398|telomere tethering at nuclear periphery, GO:0016973|poly(A)+ mRNA export from nucleus","GO:0016787|hydrolase activity, GO:0017056|structural constituent of nuclear pore, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008236|serine-type peptidase activity, GO:0003713|transcription coactivator activity, GO:0003729|mRNA binding, GO:0003723|RNA binding, GO:0008139|nuclear localization sequence binding, GO:0005215|transporter activity, GO:1990841|promoter-specific chromatin binding, GO:0042277|peptide binding"
PIK3CB,Missense,0.255902968624687,72,0.030031642657632,N,Oncogene,Oncogene,0.284747292593847,0.0153383357927751,ENSG00000051382,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005730|nucleolus, GO:0030496|midbody, GO:0005886|plasma membrane, GO:0016020|membrane, GO:0005829|cytosol, GO:0005942|phosphatidylinositol 3-kinase complex","GO:0016310|phosphorylation, GO:0007155|cell adhesion, GO:0007186|G protein-coupled receptor signaling pathway, GO:0006914|autophagy, GO:0046854|phosphatidylinositol phosphorylation, GO:0048015|phosphatidylinositol-mediated signaling, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0050900|leukocyte migration, GO:0050852|T cell receptor signaling pathway, GO:0006468|protein phosphorylation, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0006897|endocytosis, GO:0010508|positive regulation of autophagy, GO:0016477|cell migration, GO:0006935|chemotaxis, GO:0007165|signal transduction, GO:0070527|platelet aggregation, GO:0030168|platelet activation, GO:0007411|axon guidance, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0019221|cytokine-mediated signaling pathway, GO:0033031|positive regulation of neutrophil apoptotic process, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0051897|positive regulation of protein kinase B signaling, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0010628|positive regulation of gene expression, GO:0000187|activation of MAPK activity, GO:0001952|regulation of cell-matrix adhesion, GO:2000369|regulation of clathrin-dependent endocytosis, GO:0001935|endothelial cell proliferation, GO:0006874|cellular calcium ion homeostasis, GO:0007156|homophilic cell adhesion via plasma membrane adhesion molecules, GO:0009611|response to wounding, GO:0040016|embryonic cleavage, GO:0060055|angiogenesis involved in wound healing","GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0035004|phosphatidylinositol 3-kinase activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0035005|1-phosphatidylinositol-4-phosphate 3-kinase activity, GO:0043560|insulin receptor substrate binding"
CIC,Silent,0.255463953920307,38,0.121624129492601,N,"oncogene, TSG, fusion","",0.297312151509435,0.0698672987065381,ENSG00000079432,"GO:0005634|nucleus, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex","GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007613|memory, GO:0045892|negative regulation of transcription, DNA-templated, GO:0007420|brain development, GO:0007612|learning, GO:0035176|social behavior, GO:0048286|lung alveolus development","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding"
MN1,Missense,0.255251098657753,95,0.0125445003105643,N,"oncogene, fusion",Oncogene,0.279698232065456,0.00604947834719059,ENSG00000169184,GO:0005575|cellular_component,"GO:0006355|regulation of transcription, DNA-templated, GO:0001957|intramembranous ossification, GO:0007275|multicellular organism development, GO:0008150|biological_process",GO:0003674|molecular_function
COL2A1,Silent,0.254099183256172,39,0.11853210414361,N,fusion,"",0.329659555332705,0.0404204732164952,ENSG00000139219,"GO:0005576|extracellular region, GO:0005581|collagen trimer, GO:0005615|extracellular space, GO:0062023|collagen-containing extracellular matrix, GO:0031012|extracellular matrix, GO:0005788|endoplasmic reticulum lumen, GO:0005585|collagen type II trimer, GO:0005604|basement membrane, GO:0005737|cytoplasm","GO:0050776|regulation of immune response, GO:0001501|skeletal system development, GO:0007601|visual perception, GO:0030198|extracellular matrix organization, GO:0030199|collagen fibril organization, GO:0007605|sensory perception of sound, GO:0001502|cartilage condensation, GO:0001503|ossification, GO:0001894|tissue homeostasis, GO:0001958|endochondral ossification, GO:0002062|chondrocyte differentiation, GO:0003007|heart morphogenesis, GO:0006029|proteoglycan metabolic process, GO:0007417|central nervous system development, GO:0010468|regulation of gene expression, GO:0030903|notochord development, GO:0035108|limb morphogenesis, GO:0042472|inner ear morphogenesis, GO:0048705|skeletal system morphogenesis, GO:0048839|inner ear development, GO:0051216|cartilage development, GO:0060021|roof of mouth development, GO:0060174|limb bud formation, GO:0060272|embryonic skeletal joint morphogenesis, GO:0060348|bone development, GO:0060351|cartilage development involved in endochondral bone morphogenesis, GO:0071599|otic vesicle development, GO:0071773|cellular response to BMP stimulus, GO:0097065|anterior head development, GO:2001240|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand","GO:0046872|metal ion binding, GO:0005201|extracellular matrix structural constituent, GO:0030020|extracellular matrix structural constituent conferring tensile strength, GO:0042802|identical protein binding, GO:0042289|MHC class II protein binding, GO:0048407|platelet-derived growth factor binding, GO:0043394|proteoglycan binding"
PREX2,Missense,0.253656512125904,307,6.79200924175701e-06,Y,Oncogene,Oncogene,0.299497723232373,8.81922064322342e-08,ENSG00000046889,"GO:0005886|plasma membrane, GO:0005829|cytosol","GO:0035556|intracellular signal transduction, GO:0035023|regulation of Rho protein signal transduction, GO:0043547|positive regulation of GTPase activity, GO:0007186|G protein-coupled receptor signaling pathway, GO:0008344|adult locomotory behavior, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0048813|dendrite morphogenesis","GO:0005085|guanyl-nucleotide exchange factor activity, GO:0005089|Rho guanyl-nucleotide exchange factor activity, GO:0005096|GTPase activator activity, GO:0030676|Rac guanyl-nucleotide exchange factor activity"
WT1,Missense,0.253373598482172,65,0.0417012545175331,N,"oncogene, TSG, fusion","",0.401709790754102,0.000910724480255384,ENSG00000184937,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005730|nucleolus","GO:0010628|positive regulation of gene expression, GO:0008380|RNA splicing, GO:0006355|regulation of transcription, DNA-templated, GO:0001822|kidney development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043066|negative regulation of apoptotic process, GO:0007507|heart development, GO:0008285|negative regulation of cell proliferation, GO:0008584|male gonad development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030308|negative regulation of cell growth, GO:0045892|negative regulation of transcription, DNA-templated, GO:0030855|epithelial cell differentiation, GO:0071320|cellular response to cAMP, GO:0030539|male genitalia development, GO:0072112|glomerular visceral epithelial cell differentiation, GO:0007530|sex determination, GO:0032835|glomerulus development, GO:0060539|diaphragm development, GO:0032836|glomerular basement membrane development, GO:0001570|vasculogenesis, GO:0001657|ureteric bud development, GO:0030325|adrenal gland development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0043010|camera-type eye development, GO:1905643|positive regulation of DNA methylation, GO:0003156|regulation of animal organ formation, GO:0007281|germ cell development, GO:0007356|thorax and anterior abdomen determination, GO:0008406|gonad development, GO:0009888|tissue development, GO:0035802|adrenal cortex formation, GO:0060231|mesenchymal to epithelial transition, GO:0060421|positive regulation of heart growth, GO:0060923|cardiac muscle cell fate commitment, GO:0061032|visceral serous pericardium development, GO:0071371|cellular response to gonadotropin stimulus, GO:0072075|metanephric mesenchyme development, GO:0072166|posterior mesonephric tubule development, GO:0072207|metanephric epithelium development, GO:0072284|metanephric S-shaped body morphogenesis, GO:0072302|negative regulation of metanephric glomerular mesangial cell proliferation, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:2000020|positive regulation of male gonad development, GO:2000195|negative regulation of female gonad development, GO:2001076|positive regulation of metanephric ureteric bud development","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0010385|double-stranded methylated DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0044729|hemi-methylated DNA-binding, GO:0070742|C2H2 zinc finger domain binding"
SALL4,Missense,0.252332581120188,123,0.00486798452478865,Y,Oncogene,Oncogene,0.220402403073299,0.014300499795705,ENSG00000101115,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0000792|heterochromatin, GO:0032991|protein-containing complex","GO:0006355|regulation of transcription, DNA-templated, GO:0035019|somatic stem cell population maintenance, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001701|in utero embryonic development, GO:0001833|inner cell mass cell proliferation, GO:0001843|neural tube closure, GO:0003281|ventricular septum development, GO:0007507|heart development, GO:0009888|tissue development, GO:0019827|stem cell population maintenance, GO:0021915|neural tube development, GO:0030326|embryonic limb morphogenesis, GO:0045944|positive regulation of transcription by RNA polymerase II","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding"
SS18,Missense,0.252318521472992,36,0.137643474010444,N,fusion,"",0.347890112534679,0.0376065206870612,ENSG00000141380,"GO:0005634|nucleus, GO:0005881|cytoplasmic microtubule, GO:0016514|SWI/SNF complex, GO:0071564|npBAF complex","GO:1903508|positive regulation of nucleic acid-templated transcription, GO:0000226|microtubule cytoskeleton organization, GO:0000902|cell morphogenesis, GO:0007010|cytoskeleton organization, GO:0035556|intracellular signal transduction, GO:0042493|response to drug, GO:0048013|ephrin receptor signaling pathway, GO:0097150|neuronal stem cell population maintenance, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated","GO:0003713|transcription coactivator activity, GO:0005515|protein binding, GO:0030374|nuclear receptor transcription coactivator activity"
ARID1A,Missense,0.252102798796537,170,0.000911523392757655,Y,"TSG, fusion",TSG,0.235665891455061,0.00197656490573572,ENSG00000117713,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016514|SWI/SNF complex, GO:0070603|SWI/SNF superfamily-type complex, GO:0000790|nuclear chromatin, GO:0071564|npBAF complex, GO:0071565|nBAF complex","GO:0006338|chromatin remodeling, GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007399|nervous system development, GO:0030521|androgen receptor signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001704|formation of primary germ layer, GO:0001843|neural tube closure, GO:0003205|cardiac chamber development, GO:0003408|optic cup formation involved in camera-type eye development, GO:0006337|nucleosome disassembly, GO:0006344|maintenance of chromatin silencing, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007369|gastrulation, GO:0007566|embryo implantation, GO:0019827|stem cell population maintenance, GO:0030520|intracellular estrogen receptor signaling pathway, GO:0030900|forebrain development, GO:0042766|nucleosome mobilization, GO:0042921|glucocorticoid receptor signaling pathway, GO:0043044|ATP-dependent chromatin remodeling, GO:0048096|chromatin-mediated maintenance of transcription, GO:0055007|cardiac muscle cell differentiation, GO:0060674|placenta blood vessel development, GO:1901998|toxin transport","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003713|transcription coactivator activity, GO:0016922|nuclear receptor binding, GO:0031491|nucleosome binding"
ZNF521,Silent,0.251518854597197,78,0.026328505383662,N,"oncogene, fusion",Oncogene,0.245275671742412,0.0304320105430908,ENSG00000198795,GO:0005634|nucleus,"GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0048663|neuron fate commitment","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019904|protein domain specific binding"
CACNA1D,Missense,0.250873239968105,191,0.000464338031417605,Y,Oncogene,Oncogene,0.265581629898552,0.000204635567884714,ENSG00000157388,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005891|voltage-gated calcium channel complex, GO:0005886|plasma membrane, GO:0030018|Z disc, GO:1990454|L-type voltage-gated calcium channel complex","GO:0055085|transmembrane transport, GO:0006811|ion transport, GO:0034765|regulation of ion transmembrane transport, GO:0006816|calcium ion transport, GO:0070588|calcium ion transmembrane transport, GO:0099533|positive regulation of presynaptic cytosolic calcium concentration, GO:0099703|induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration, GO:1901016|regulation of potassium ion transmembrane transporter activity, GO:0050796|regulation of insulin secretion, GO:0070509|calcium ion import, GO:0086002|cardiac muscle cell action potential involved in contraction, GO:0086046|membrane depolarization during SA node cell action potential, GO:0086091|regulation of heart rate by cardiac conduction, GO:0007605|sensory perception of sound, GO:0086012|membrane depolarization during cardiac muscle cell action potential, GO:0051928|positive regulation of calcium ion transport, GO:0060372|regulation of atrial cardiac muscle cell membrane repolarization, GO:1901379|regulation of potassium ion transmembrane transport, GO:0045762|positive regulation of adenylate cyclase activity, GO:0007188|adenylate cyclase-modulating G protein-coupled receptor signaling pathway","GO:0005216|ion channel activity, GO:0005244|voltage-gated ion channel activity, GO:0005245|voltage-gated calcium channel activity, GO:0005262|calcium channel activity, GO:0046872|metal ion binding, GO:0008331|high voltage-gated calcium channel activity, GO:0086059|voltage-gated calcium channel activity involved SA node cell action potential, GO:0030506|ankyrin binding, GO:0051393|alpha-actinin binding, GO:0086007|voltage-gated calcium channel activity involved in cardiac muscle cell action potential"
NTRK1,Missense,0.247433573352669,96,0.0150776928710133,N,"oncogene, TSG, fusion","",0.223078174293576,0.0289117127484309,ENSG00000198400,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005887|integral component of plasma membrane, GO:0005886|plasma membrane, GO:0031902|late endosome membrane, GO:0043235|receptor complex, GO:0005768|endosome, GO:0005769|early endosome, GO:0031901|early endosome membrane, GO:0010008|endosome membrane, GO:0032991|protein-containing complex, GO:0005770|late endosome, GO:0030424|axon, GO:0000139|Golgi membrane, GO:0005737|cytoplasm, GO:0009986|cell surface, GO:0030425|dendrite, GO:0031410|cytoplasmic vesicle, GO:0043025|neuronal cell body, GO:0055037|recycling endosome","GO:0043066|negative regulation of apoptotic process, GO:0001934|positive regulation of protein phosphorylation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0007275|multicellular organism development, GO:0048013|ephrin receptor signaling pathway, GO:0030154|cell differentiation, GO:0007399|nervous system development, GO:0043410|positive regulation of MAPK cascade, GO:0043547|positive regulation of GTPase activity, GO:0008285|negative regulation of cell proliferation, GO:0043524|negative regulation of neuron apoptotic process, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0043408|regulation of MAPK cascade, GO:0046777|protein autophosphorylation, GO:0048015|phosphatidylinositol-mediated signaling, GO:0046579|positive regulation of Ras protein signal transduction, GO:0010976|positive regulation of neuron projection development, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0000186|activation of MAPKK activity, GO:0038180|nerve growth factor signaling pathway, GO:0048011|neurotrophin TRK receptor signaling pathway, GO:0043068|positive regulation of programmed cell death, GO:0010623|programmed cell death involved in cell development, GO:0048485|sympathetic nervous system development, GO:0060385|axonogenesis involved in innervation, GO:1990090|cellular response to nerve growth factor stimulus, GO:0038179|neurotrophin signaling pathway, GO:0007411|axon guidance, GO:0007568|aging, GO:0007611|learning or memory, GO:0007623|circadian rhythm, GO:0009314|response to radiation, GO:0019233|sensory perception of pain, GO:0021553|olfactory nerve development, GO:0030183|B cell differentiation, GO:0031667|response to nutrient levels, GO:0035094|response to nicotine, GO:0042490|mechanoreceptor differentiation, GO:0042493|response to drug, GO:0048678|response to axon injury, GO:0050965|detection of temperature stimulus involved in sensory perception of pain, GO:0050966|detection of mechanical stimulus involved in sensory perception of pain, GO:0051599|response to hydrostatic pressure, GO:0051602|response to electrical stimulus, GO:0051965|positive regulation of synapse assembly, GO:0051968|positive regulation of synaptic transmission, glutamatergic, GO:0060009|Sertoli cell development, GO:0060384|innervation, GO:0061368|behavioral response to formalin induced pain, GO:0071316|cellular response to nicotine, GO:0071363|cellular response to growth factor stimulus, GO:1901215|negative regulation of neuron death","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005030|neurotrophin receptor activity, GO:0010465|nerve growth factor receptor activity, GO:0043121|neurotrophin binding, GO:0048406|nerve growth factor binding, GO:0005004|GPI-linked ephrin receptor activity, GO:0005166|neurotrophin p75 receptor binding, GO:0019900|kinase binding"
MDM4,Missense,0.246915323217065,30,0.188368285528691,N,Oncogene,Oncogene,0.450021710238517,0.0125862768483637,ENSG00000198625,"GO:0005634|nucleus, GO:0005654|nucleoplasm","GO:0043066|negative regulation of apoptotic process, GO:0016567|protein ubiquitination, GO:0071157|negative regulation of cell cycle arrest, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0050821|protein stabilization, GO:0016579|protein deubiquitination, GO:0008283|cell proliferation, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0008285|negative regulation of cell proliferation, GO:0042177|negative regulation of protein catabolic process, GO:0065003|protein-containing complex assembly, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0045023|G0 to G1 transition, GO:0071456|cellular response to hypoxia","GO:0046872|metal ion binding, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0061630|ubiquitin protein ligase activity, GO:0019899|enzyme binding"
SETBP1,Silent,0.246839187560935,72,0.03659025622154,N,"oncogene, fusion",Oncogene,0.237837088826334,0.0442449937708237,ENSG00000152217,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0016604|nuclear body",GO:0006357|regulation of transcription by RNA polymerase II,"GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
FLT3,Silent,0.246766903405156,34,0.159447482675623,N,Oncogene,Oncogene,0.165077096087708,0.350832661926479,ENSG00000122025,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005886|plasma membrane, GO:0005788|endoplasmic reticulum lumen, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0032991|protein-containing complex","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0030154|cell differentiation, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0038084|vascular endothelial growth factor signaling pathway, GO:0002244|hematopoietic progenitor cell differentiation, GO:0008284|positive regulation of cell proliferation, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0016032|viral process, GO:0030097|hemopoiesis, GO:0019221|cytokine-mediated signaling pathway, GO:0042981|regulation of apoptotic process, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0071345|cellular response to cytokine stimulus, GO:0043406|positive regulation of MAP kinase activity, GO:0097028|dendritic cell differentiation, GO:0030183|B cell differentiation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0035726|common myeloid progenitor cell proliferation, GO:0001776|leukocyte homeostasis, GO:0002318|myeloid progenitor cell differentiation, GO:0002328|pro-B cell differentiation, GO:0002521|leukocyte differentiation, GO:0010243|response to organonitrogen compound, GO:0030098|lymphocyte differentiation, GO:0031100|animal organ regeneration, GO:0046651|lymphocyte proliferation, GO:0071385|cellular response to glucocorticoid stimulus","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0005021|vascular endothelial growth factor-activated receptor activity, GO:0004896|cytokine receptor activity, GO:0035259|glucocorticoid receptor binding, GO:0043621|protein self-association, GO:0044877|protein-containing complex binding"
CARD11,Missense,0.244532858898628,185,0.000794977849027276,Y,Oncogene,Oncogene,0.285343339429322,8.25241174209326e-05,ENSG00000198286,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0045121|membrane raft, GO:0001772|immunological synapse, GO:0005829|cytosol, GO:0070062|extracellular exosome, GO:0032449|CBM complex","GO:0042981|regulation of apoptotic process, GO:0002377|immunoglobulin production, GO:0007165|signal transduction, GO:0030183|B cell differentiation, GO:0030890|positive regulation of B cell proliferation, GO:0042100|B cell proliferation, GO:0042102|positive regulation of T cell proliferation, GO:0042110|T cell activation, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0045061|thymic T cell selection, GO:0045086|positive regulation of interleukin-2 biosynthetic process, GO:0045577|regulation of B cell differentiation, GO:0045580|regulation of T cell differentiation, GO:0046649|lymphocyte activation, GO:0048872|homeostasis of number of cells, GO:0050776|regulation of immune response, GO:0050870|positive regulation of T cell activation, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0070970|interleukin-2 secretion, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0050852|T cell receptor signaling pathway, GO:0001819|positive regulation of cytokine production, GO:0046037|GMP metabolic process, GO:0046710|GDP metabolic process, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0007249|I-kappaB kinase/NF-kappaB signaling, GO:0031295|T cell costimulation, GO:0038202|TORC1 signaling","GO:0005515|protein binding, GO:0050700|CARD domain binding, GO:0004385|guanylate kinase activity"
PTPN13,Silent,0.24431676361763,61,0.0577533924596167,N,TSG,TSG,0.281767050185812,0.0278120489428589,ENSG00000163629,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0005654|nucleoplasm, GO:0030027|lamellipodium, GO:0070062|extracellular exosome, GO:0043005|neuron projection, GO:0044297|cell body","GO:0006470|protein dephosphorylation, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0006661|phosphatidylinositol biosynthetic process, GO:0014066|regulation of phosphatidylinositol 3-kinase signaling, GO:0071345|cellular response to cytokine stimulus, GO:0070830|bicellular tight junction assembly","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0036312|phosphatidylinositol 3-kinase regulatory subunit binding"
MAX,Missense,0.244294946581099,17,0.344680535008068,N,TSG,TSG,0.18326671441441,0.481388730446985,ENSG00000125952,"GO:0071339|MLL1 complex, GO:0090575|RNA polymerase II transcription factor complex, GO:0005634|nucleus, GO:0042995|cell projection, GO:0030425|dendrite, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin, GO:0032993|protein-DNA complex, GO:0005737|cytoplasm, GO:0016605|PML body","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006366|transcription by RNA polymerase II, GO:0000082|G1/S transition of mitotic cell cycle, GO:0070317|negative regulation of G0 to G1 transition, GO:0006355|regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0009267|cellular response to starvation, GO:0010243|response to organonitrogen compound, GO:0010629|negative regulation of gene expression, GO:0032868|response to insulin, GO:0048678|response to axon injury, GO:0051402|neuron apoptotic process, GO:0060041|retina development in camera-type eye, GO:0065003|protein-containing complex assembly, GO:0071375|cellular response to peptide hormone stimulus","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003713|transcription coactivator activity, GO:0016251|RNA polymerase II general transcription initiation factor activity, GO:0003700|DNA-binding transcription factor activity, GO:0003712|transcription coregulator activity, GO:0042803|protein homodimerization activity, GO:0070888|E-box binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0043565|sequence-specific DNA binding, GO:0044877|protein-containing complex binding, GO:0046982|protein heterodimerization activity"
ACSL3,Missense,0.24362754234994,42,0.12000103182532,N,fusion,"",0.216913658298907,0.16763907270566,ENSG00000123983,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0031090|organelle membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005794|Golgi apparatus, GO:0005739|mitochondrion, GO:0048471|perinuclear region of cytoplasm, GO:0005741|mitochondrial outer membrane, GO:0005777|peroxisome, GO:0005778|peroxisomal membrane, GO:0005811|lipid droplet","GO:0006629|lipid metabolic process, GO:0006631|fatty acid metabolic process, GO:0001676|long-chain fatty acid metabolic process, GO:0006633|fatty acid biosynthetic process, GO:0007420|brain development, GO:0007584|response to nutrient, GO:0014070|response to organic cyclic compound, GO:0035338|long-chain fatty-acyl-CoA biosynthetic process, GO:0044539|long-chain fatty acid import, GO:0034379|very-low-density lipoprotein particle assembly, GO:0042998|positive regulation of Golgi to plasma membrane protein transport, GO:0051047|positive regulation of secretion, GO:2001247|positive regulation of phosphatidylcholine biosynthetic process","GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0003824|catalytic activity, GO:0016874|ligase activity, GO:0004467|long-chain fatty acid-CoA ligase activity, GO:0019901|protein kinase binding, GO:0019904|protein domain specific binding, GO:0102391|decanoate-CoA ligase activity"
FGFR4,Missense,0.24298559239834,68,0.0458692681896069,N,Oncogene,Oncogene,0.250923281541814,0.0390223508395613,ENSG00000160867,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005768|endosome, GO:0005911|cell-cell junction, GO:0030133|transport vesicle","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0046854|phosphatidylinositol phosphorylation, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0007399|nervous system development, GO:0010628|positive regulation of gene expression, GO:0016477|cell migration, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0019216|regulation of lipid metabolic process, GO:0042632|cholesterol homeostasis, GO:0045862|positive regulation of proteolysis, GO:0042593|glucose homeostasis, GO:0043085|positive regulation of catalytic activity, GO:0018108|peptidyl-tyrosine phosphorylation, GO:2000573|positive regulation of DNA biosynthetic process, GO:0010715|regulation of extracellular matrix disassembly, GO:0055062|phosphate ion homeostasis, GO:0070857|regulation of bile acid biosynthetic process","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005007|fibroblast growth factor-activated receptor activity, GO:0008201|heparin binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0017134|fibroblast growth factor binding"
CARS,Missense,0.242983258389786,44,0.111994879281945,N,"TSG, fusion",TSG,0.238991244213578,0.11819665698208,ENSG00000110619,"GO:0005737|cytoplasm, GO:0005829|cytosol","GO:0006412|translation, GO:0006418|tRNA aminoacylation for protein translation, GO:0006423|cysteinyl-tRNA aminoacylation","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0042803|protein homodimerization activity, GO:0016874|ligase activity, GO:0004812|aminoacyl-tRNA ligase activity, GO:0000049|tRNA binding, GO:0004817|cysteine-tRNA ligase activity, GO:0005515|protein binding"
TNFRSF14,Missense,0.242538107984568,17,0.348270267343466,N,TSG,TSG,0.0212930347424887,0.935350700233819,ENSG00000157873,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0009897|external side of plasma membrane","GO:0046718|viral entry into host cell, GO:0016032|viral process, GO:0006955|immune response, GO:0050829|defense response to Gram-negative bacterium, GO:0007166|cell surface receptor signaling pathway, GO:0033209|tumor necrosis factor-mediated signaling pathway, GO:0031295|T cell costimulation, GO:0050830|defense response to Gram-positive bacterium, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0002741|positive regulation of cytokine secretion involved in immune response, GO:0046642|negative regulation of alpha-beta T cell proliferation, GO:2000406|positive regulation of T cell migration","GO:0005515|protein binding, GO:0031625|ubiquitin protein ligase binding, GO:0001618|virus receptor activity, GO:0005031|tumor necrosis factor-activated receptor activity"
AXIN1,Missense,0.242250296225449,69,0.0449096089677866,N,TSG,TSG,0.289751418366947,0.01573793519605,ENSG00000103126,"GO:0048471|perinuclear region of cytoplasm, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0030877|beta-catenin destruction complex, GO:0005829|cytosol, GO:0031410|cytoplasmic vesicle, GO:0016328|lateral plasma membrane, GO:0071944|cell periphery","GO:0001934|positive regulation of protein phosphorylation, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:1904886|beta-catenin destruction complex disassembly, GO:0031398|positive regulation of protein ubiquitination, GO:0010800|positive regulation of peptidyl-threonine phosphorylation, GO:0030111|regulation of Wnt signaling pathway, GO:0032147|activation of protein kinase activity, GO:0033146|regulation of intracellular estrogen receptor signaling pathway, GO:0034622|cellular protein-containing complex assembly, GO:0045732|positive regulation of protein catabolic process, GO:0046330|positive regulation of JNK cascade, GO:0051443|positive regulation of ubiquitin-protein transferase activity, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:1904885|beta-catenin destruction complex assembly, GO:2000060|positive regulation of ubiquitin-dependent protein catabolic process","GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0030159|receptor signaling complex scaffold activity, GO:0032947|protein-containing complex scaffold activity, GO:0070016|armadillo repeat domain binding, GO:0031625|ubiquitin protein ligase binding, GO:0019899|enzyme binding, GO:0019901|protein kinase binding, GO:0008013|beta-catenin binding, GO:0070411|I-SMAD binding, GO:0035591|signaling adaptor activity, GO:0046332|SMAD binding"
TGFBR2,Missense,0.242227968115287,75,0.0362766169507261,N,TSG,TSG,0.379953155316744,0.000773067016658969,ENSG00000163513,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0045121|membrane raft, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005829|cytosol, GO:0009897|external side of plasma membrane, GO:0005901|caveola, GO:0005737|cytoplasm, GO:0009986|cell surface","GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0060412|ventricular septum morphogenesis, GO:0003151|outflow tract morphogenesis, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0006915|apoptotic process, GO:0030154|cell differentiation, GO:0007178|transmembrane receptor protein serine/threonine kinase signaling pathway, GO:0040008|regulation of growth, GO:0007507|heart development, GO:0007389|pattern specification process, GO:0001947|heart looping, GO:0062009|secondary palate development, GO:0001569|branching involved in blood vessel morphogenesis, GO:0003148|outflow tract septum morphogenesis, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0060389|pathway-restricted SMAD protein phosphorylation, GO:0032147|activation of protein kinase activity, GO:0018105|peptidyl-serine phosphorylation, GO:0018107|peptidyl-threonine phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0003181|atrioventricular valve morphogenesis, GO:0002053|positive regulation of mesenchymal cell proliferation, GO:0042127|regulation of cell proliferation, GO:2000379|positive regulation of reactive oxygen species metabolic process, GO:0001570|vasculogenesis, GO:0070723|response to cholesterol, GO:0007420|brain development, GO:0003149|membranous septum morphogenesis, GO:0042493|response to drug, GO:0003214|cardiac left ventricle morphogenesis, GO:0002666|positive regulation of T cell tolerance induction, GO:1905007|positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0003186|tricuspid valve morphogenesis, GO:0001568|blood vessel development, GO:0002651|positive regulation of tolerance induction to self antigen, GO:0002663|positive regulation of B cell tolerance induction, GO:0003274|endocardial cushion fusion, GO:0035162|embryonic hemopoiesis, GO:0043011|myeloid dendritic cell differentiation, GO:0051138|positive regulation of NK T cell differentiation, GO:1905317|inferior endocardial cushion morphogenesis, GO:1990428|miRNA transport, GO:2000563|positive regulation of CD4-positive, alpha-beta T cell proliferation, GO:0001666|response to hypoxia, GO:0001701|in utero embryonic development, GO:0002088|lens development in camera-type eye, GO:0003417|growth plate cartilage development, GO:0003430|growth plate cartilage chondrocyte growth, GO:0006898|receptor-mediated endocytosis, GO:0007182|common-partner SMAD protein phosphorylation, GO:0007219|Notch signaling pathway, GO:0007224|smoothened signaling pathway, GO:0007369|gastrulation, GO:0007566|embryo implantation, GO:0007568|aging, GO:0007584|response to nutrient, GO:0008285|negative regulation of cell proliferation, GO:0009612|response to mechanical stimulus, GO:0009749|response to glucose, GO:0009887|animal organ morphogenesis, GO:0010033|response to organic substance, GO:0010468|regulation of gene expression, GO:0010634|positive regulation of epithelial cell migration, GO:0014070|response to organic cyclic compound, GO:0030324|lung development, GO:0031100|animal organ regeneration, GO:0042060|wound healing, GO:0043415|positive regulation of skeletal muscle tissue regeneration, GO:0043627|response to estrogen, GO:0045766|positive regulation of angiogenesis, GO:0048545|response to steroid hormone, GO:0048565|digestive tract development, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0051216|cartilage development, GO:0060044|negative regulation of cardiac muscle cell proliferation, GO:0060425|lung morphogenesis, GO:0060433|bronchus development, GO:0060434|bronchus morphogenesis, GO:0060439|trachea morphogenesis, GO:0060440|trachea formation, GO:0060443|mammary gland morphogenesis, GO:0060463|lung lobe morphogenesis, GO:1990086|lens fiber cell apoptotic process","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0038023|signaling receptor activity, GO:0004675|transmembrane receptor protein serine/threonine kinase activity, GO:0005026|transforming growth factor beta receptor activity, type II, GO:0005024|transforming growth factor beta-activated receptor activity, GO:0019838|growth factor binding, GO:0046332|SMAD binding, GO:0034713|type I transforming growth factor beta receptor binding, GO:0050431|transforming growth factor beta binding, GO:0005539|glycosaminoglycan binding, GO:0031435|mitogen-activated protein kinase kinase kinase binding"
PTPN11,Silent,0.242017619336981,23,0.265884364338631,N,Oncogene,Oncogene,0.292529051066844,0.175565779266648,ENSG00000179295,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0032991|protein-containing complex, GO:0005739|mitochondrion","GO:0046326|positive regulation of glucose import, GO:0006470|protein dephosphorylation, GO:0016311|dephosphorylation, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0050900|leukocyte migration, GO:0046854|phosphatidylinositol phosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0030168|platelet activation, GO:0007411|axon guidance, GO:0019221|cytokine-mediated signaling pathway, GO:0051897|positive regulation of protein kinase B signaling, GO:0070102|interleukin-6-mediated signaling pathway, GO:0007507|heart development, GO:0033628|regulation of cell adhesion mediated by integrin, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0031295|T cell costimulation, GO:0048013|ephrin receptor signaling pathway, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0043254|regulation of protein complex assembly, GO:0071345|cellular response to cytokine stimulus, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0046628|positive regulation of insulin receptor signaling pathway, GO:0007420|brain development, GO:0032760|positive regulation of tumor necrosis factor production, GO:0060325|face morphogenesis, GO:0060338|regulation of type I interferon-mediated signaling pathway, GO:0032755|positive regulation of interleukin-6 production, GO:0038127|ERBB signaling pathway, GO:0048806|genitalia development, GO:0048839|inner ear development, GO:0032728|positive regulation of interferon-beta production, GO:0036302|atrioventricular canal development, GO:0000077|DNA damage checkpoint, GO:0000187|activation of MAPK activity, GO:0006629|lipid metabolic process, GO:0006641|triglyceride metabolic process, GO:0007229|integrin-mediated signaling pathway, GO:0007409|axonogenesis, GO:0009755|hormone-mediated signaling pathway, GO:0009967|positive regulation of signal transduction, GO:0021697|cerebellar cortex formation, GO:0030220|platelet formation, GO:0032528|microvillus organization, GO:0033277|abortive mitotic cell cycle, GO:0033629|negative regulation of cell adhesion mediated by integrin, GO:0035264|multicellular organism growth, GO:0035265|organ growth, GO:0035855|megakaryocyte development, GO:0040014|regulation of multicellular organism growth, GO:0042445|hormone metabolic process, GO:0042593|glucose homeostasis, GO:0045931|positive regulation of mitotic cell cycle, GO:0046676|negative regulation of insulin secretion, GO:0046825|regulation of protein export from nucleus, GO:0046887|positive regulation of hormone secretion, GO:0046888|negative regulation of hormone secretion, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0048011|neurotrophin TRK receptor signaling pathway, GO:0048609|multicellular organismal reproductive process, GO:0048873|homeostasis of number of cells within a tissue, GO:0051463|negative regulation of cortisol secretion, GO:0060020|Bergmann glial cell differentiation, GO:0060125|negative regulation of growth hormone secretion, GO:0061582|intestinal epithelial cell migration, GO:0071260|cellular response to mechanical stimulus","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0005158|insulin receptor binding, GO:0019901|protein kinase binding, GO:0001784|phosphotyrosine residue binding, GO:0005070|SH3/SH2 adaptor activity, GO:0004726|non-membrane spanning protein tyrosine phosphatase activity, GO:0019904|protein domain specific binding, GO:0030971|receptor tyrosine kinase binding, GO:0031748|D1 dopamine receptor binding, GO:0043274|phospholipase binding, GO:0043560|insulin receptor substrate binding, GO:0050839|cell adhesion molecule binding, GO:0051428|peptide hormone receptor binding, GO:1990782|protein tyrosine kinase binding"
ARHGEF12,Missense,0.241897603114385,122,0.00726756419587948,Y,"TSG, fusion",TSG,0.274396989769059,0.00222415427479931,ENSG00000196914,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0070062|extracellular exosome","GO:0007186|G protein-coupled receptor signaling pathway, GO:0035556|intracellular signal transduction, GO:0035023|regulation of Rho protein signal transduction, GO:0043547|positive regulation of GTPase activity, GO:0007266|Rho protein signal transduction, GO:0051056|regulation of small GTPase mediated signal transduction, GO:0043065|positive regulation of apoptotic process","GO:0001664|G protein-coupled receptor binding, GO:0005085|guanyl-nucleotide exchange factor activity, GO:0005089|Rho guanyl-nucleotide exchange factor activity, GO:0005096|GTPase activator activity, GO:0005515|protein binding"
RAC1,Missense,0.24118260849105,25,0.245471324365027,N,Oncogene,Oncogene,0.309841422998504,0.131741733920019,ENSG00000136238,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0042470|melanosome, GO:0005925|focal adhesion, GO:0005789|endoplasmic reticulum membrane, GO:0030027|lamellipodium, GO:0070062|extracellular exosome, GO:0032587|ruffle membrane, GO:0055038|recycling endosome membrane, GO:0030667|secretory granule membrane, GO:0005884|actin filament, GO:0098978|glutamatergic synapse, GO:0036464|cytoplasmic ribonucleoprotein granule, GO:0101003|ficolin-1-rich granule membrane, GO:0043197|dendritic spine, GO:0098794|postsynapse, GO:0005802|trans-Golgi network, GO:0000139|Golgi membrane, GO:0031410|cytoplasmic vesicle","GO:0006468|protein phosphorylation, GO:0007264|small GTPase mediated signal transduction, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0046854|phosphatidylinositol phosphorylation, GO:0051056|regulation of small GTPase mediated signal transduction, GO:0001934|positive regulation of protein phosphorylation, GO:0007266|Rho protein signal transduction, GO:0043312|neutrophil degranulation, GO:0030041|actin filament polymerization, GO:0030334|regulation of cell migration, GO:0048812|neuron projection morphogenesis, GO:0006954|inflammatory response, GO:0007155|cell adhesion, GO:0032707|negative regulation of interleukin-23 production, GO:0030032|lamellipodium assembly, GO:0009611|response to wounding, GO:0051897|positive regulation of protein kinase B signaling, GO:0048013|ephrin receptor signaling pathway, GO:0009653|anatomical structure morphogenesis, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0007596|blood coagulation, GO:0060071|Wnt signaling pathway, planar cell polarity pathway, GO:0035556|intracellular signal transduction, GO:0051496|positive regulation of stress fiber assembly, GO:0008361|regulation of cell size, GO:0010592|positive regulation of lamellipodium assembly, GO:0071526|semaphorin-plexin signaling pathway, GO:0031295|T cell costimulation, GO:0001764|neuron migration, GO:0050690|regulation of defense response to virus by virus, GO:0045428|regulation of nitric oxide biosynthetic process, GO:0048870|cell motility, GO:0034446|substrate adhesion-dependent cell spreading, GO:0010811|positive regulation of cell-substrate adhesion, GO:0035025|positive regulation of Rho protein signal transduction, GO:1900026|positive regulation of substrate adhesion-dependent cell spreading, GO:0007160|cell-matrix adhesion, GO:0051894|positive regulation of focal adhesion assembly, GO:0031529|ruffle organization, GO:0031116|positive regulation of microtubule polymerization, GO:0010310|regulation of hydrogen peroxide metabolic process, GO:0016601|Rac protein signal transduction, GO:0030031|cell projection assembly, GO:0060263|regulation of respiratory burst, GO:0090023|positive regulation of neutrophil chemotaxis, GO:0048012|hepatocyte growth factor receptor signaling pathway, GO:0010591|regulation of lamellipodium assembly, GO:0051492|regulation of stress fiber assembly, GO:0030036|actin cytoskeleton organization, GO:0097178|ruffle assembly, GO:0051668|localization within membrane, GO:0048261|negative regulation of receptor-mediated endocytosis, GO:0002551|mast cell chemotaxis, GO:0006935|chemotaxis, GO:0007015|actin filament organization, GO:0008283|cell proliferation, GO:0045453|bone resorption, GO:0045740|positive regulation of DNA replication, GO:0071260|cellular response to mechanical stimulus","GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0004674|protein serine/threonine kinase activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0031996|thioesterase binding, GO:0044877|protein-containing complex binding, GO:0019899|enzyme binding, GO:0019901|protein kinase binding, GO:0051022|Rho GDP-dissociation inhibitor binding, GO:0017137|Rab GTPase binding, GO:0042826|histone deacetylase binding, GO:0051117|ATPase binding"
BIRC3,Missense,0.240339089046947,51,0.0893542355918077,N,"oncogene, TSG, fusion","",0.533887609186221,5.46832930892975e-05,ENSG00000023445,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0045121|membrane raft","GO:0042981|regulation of apoptotic process, GO:0016567|protein ubiquitination, GO:0006915|apoptotic process, GO:0016579|protein deubiquitination, GO:0031398|positive regulation of protein ubiquitination, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0007249|I-kappaB kinase/NF-kappaB signaling, GO:0007166|cell surface receptor signaling pathway, GO:0043066|negative regulation of apoptotic process, GO:0033209|tumor necrosis factor-mediated signaling pathway, GO:0010803|regulation of tumor necrosis factor-mediated signaling pathway, GO:0090307|mitotic spindle assembly, GO:0060544|regulation of necroptotic process, GO:0050727|regulation of inflammatory response, GO:0045088|regulation of innate immune response, GO:2000116|regulation of cysteine-type endopeptidase activity, GO:0070424|regulation of nucleotide-binding oligomerization domain containing signaling pathway, GO:1990001|inhibition of cysteine-type endopeptidase activity involved in apoptotic process, GO:0007283|spermatogenesis, GO:0034121|regulation of toll-like receptor signaling pathway, GO:0038061|NIK/NF-kappaB signaling, GO:0039535|regulation of RIG-I signaling pathway, GO:0051291|protein heterooligomerization, GO:0060546|negative regulation of necroptotic process","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0061630|ubiquitin protein ligase activity, GO:0043027|cysteine-type endopeptidase inhibitor activity involved in apoptotic process"
ZNF384,Missense,0.23970397343702,34,0.172119389893174,N,fusion,"",0.326876115189965,0.0591723253538811,ENSG00000126746,GO:0005634|nucleus,GO:0006357|regulation of transcription by RNA polymerase II,"GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
TBX3,Missense,0.238752555731328,87,0.0259447097445313,N,"oncogene, TSG","",0.270900615036216,0.0111522339779844,ENSG00000135111,GO:0005634|nucleus,"GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001501|skeletal system development, GO:0006357|regulation of transcription by RNA polymerase II, GO:0008284|positive regulation of cell proliferation, GO:0043066|negative regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045662|negative regulation of myoblast differentiation, GO:0007569|cell aging, GO:0008595|anterior/posterior axis specification, embryo, GO:0009887|animal organ morphogenesis, GO:0030539|male genitalia development, GO:0030540|female genitalia development, GO:0030879|mammary gland development, GO:0032275|luteinizing hormone secretion, GO:0035115|embryonic forelimb morphogenesis, GO:0035136|forelimb morphogenesis, GO:0042733|embryonic digit morphogenesis, GO:0045787|positive regulation of cell cycle, GO:0046884|follicle-stimulating hormone secretion, GO:0048332|mesoderm morphogenesis, GO:0090398|cellular senescence, GO:0001568|blood vessel development, GO:0001701|in utero embryonic development, GO:0001947|heart looping, GO:0003007|heart morphogenesis, GO:0003151|outflow tract morphogenesis, GO:0003167|atrioventricular bundle cell differentiation, GO:0010159|specification of animal organ position, GO:0019827|stem cell population maintenance, GO:0021761|limbic system development, GO:0030857|negative regulation of epithelial cell differentiation, GO:0035050|embryonic heart tube development, GO:0035108|limb morphogenesis, GO:0035116|embryonic hindlimb morphogenesis, GO:0042127|regulation of cell proliferation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0055007|cardiac muscle cell differentiation, GO:0060021|roof of mouth development, GO:0060412|ventricular septum morphogenesis, GO:0060444|branching involved in mammary gland duct morphogenesis, GO:0060596|mammary placode formation, GO:0060923|cardiac muscle cell fate commitment, GO:0060931|sinoatrial node cell development, GO:2000648|positive regulation of stem cell proliferation","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0001085|RNA polymerase II transcription factor binding, GO:0001102|RNA polymerase II activating transcription factor binding"
ARID1B,Silent,0.238286989608019,47,0.10675462320824,N,TSG,TSG,0.208305702875594,0.159996103412176,ENSG00000049618,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0016514|SWI/SNF complex, GO:0071565|nBAF complex, GO:0070603|SWI/SNF superfamily-type complex, GO:0005737|cytoplasm","GO:0006325|chromatin organization, GO:0006338|chromatin remodeling, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007399|nervous system development, GO:0048096|chromatin-mediated maintenance of transcription, GO:0060996|dendritic spine development, GO:0002931|response to ischemia, GO:0007270|neuron-neuron synaptic transmission, GO:0097026|dendritic cell dendrite assembly, GO:1904385|cellular response to angiotensin","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
SRC,Missense,0.237982003291476,32,0.18965298515692,N,Oncogene,Oncogene,0.243171893326127,0.179890647986835,ENSG00000197122,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005743|mitochondrial inner membrane, GO:0005886|plasma membrane, GO:0005739|mitochondrion, GO:0005856|cytoskeleton, GO:0048471|perinuclear region of cytoplasm, GO:0005764|lysosome, GO:0031234|extrinsic component of cytoplasmic side of plasma membrane, GO:0070062|extracellular exosome, GO:0005770|late endosome, GO:0005901|caveola, GO:0002102|podosome, GO:0005884|actin filament, GO:0014069|postsynaptic density, GO:0032587|ruffle membrane, GO:0043005|neuron projection","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007155|cell adhesion, GO:0007049|cell cycle, GO:0007229|integrin-mediated signaling pathway, GO:0002376|immune system process, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0050900|leukocyte migration, GO:0046854|phosphatidylinositol phosphorylation, GO:0030154|cell differentiation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0071902|positive regulation of protein serine/threonine kinase activity, GO:0016032|viral process, GO:0051902|negative regulation of mitochondrial depolarization, GO:0043066|negative regulation of apoptotic process, GO:0007165|signal transduction, GO:0030168|platelet activation, GO:0007411|axon guidance, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0051897|positive regulation of protein kinase B signaling, GO:0048013|ephrin receptor signaling pathway, GO:0046777|protein autophosphorylation, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:2001243|negative regulation of intrinsic apoptotic signaling pathway, GO:0035556|intracellular signal transduction, GO:0032463|negative regulation of protein homooligomerization, GO:0045453|bone resorption, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0007173|epidermal growth factor receptor signaling pathway, GO:2001237|negative regulation of extrinsic apoptotic signaling pathway, GO:0010634|positive regulation of epithelial cell migration, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0031295|T cell costimulation, GO:0051895|negative regulation of focal adhesion assembly, GO:0070555|response to interleukin-1, GO:0016236|macroautophagy, GO:0033625|positive regulation of integrin activation, GO:0035635|entry of bacterium into host cell, GO:2000641|regulation of early endosome to late endosome transport, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0051974|negative regulation of telomerase activity, GO:0045124|regulation of bone resorption, GO:2000811|negative regulation of anoikis, GO:0036035|osteoclast development, GO:0007172|signal complex assembly, GO:0032211|negative regulation of telomere maintenance via telomerase, GO:0043114|regulation of vascular permeability, GO:2000394|positive regulation of lamellipodium morphogenesis, GO:0001545|primary ovarian follicle growth, GO:0008283|cell proliferation, GO:0009612|response to mechanical stimulus, GO:0009615|response to virus, GO:0010447|response to acidic pH, GO:0010628|positive regulation of gene expression, GO:0010632|regulation of epithelial cell migration, GO:0010641|positive regulation of platelet-derived growth factor receptor signaling pathway, GO:0010907|positive regulation of glucose metabolic process, GO:0010954|positive regulation of protein processing, GO:0014911|positive regulation of smooth muscle cell migration, GO:0016477|cell migration, GO:0018105|peptidyl-serine phosphorylation, GO:0022407|regulation of cell-cell adhesion, GO:0030900|forebrain development, GO:0031648|protein destabilization, GO:0031667|response to nutrient levels, GO:0031954|positive regulation of protein autophosphorylation, GO:0032148|activation of protein kinase B activity, GO:0032869|cellular response to insulin stimulus, GO:0033146|regulation of intracellular estrogen receptor signaling pathway, GO:0034332|adherens junction organization, GO:0034446|substrate adhesion-dependent cell spreading, GO:0034614|cellular response to reactive oxygen species, GO:0036120|cellular response to platelet-derived growth factor stimulus, GO:0042493|response to drug, GO:0042542|response to hydrogen peroxide, GO:0043065|positive regulation of apoptotic process, GO:0043149|stress fiber assembly, GO:0043393|regulation of protein binding, GO:0043406|positive regulation of MAP kinase activity, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0045056|transcytosis, GO:0045737|positive regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0045785|positive regulation of cell adhesion, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0046628|positive regulation of insulin receptor signaling pathway, GO:0048011|neurotrophin TRK receptor signaling pathway, GO:0048477|oogenesis, GO:0050715|positive regulation of cytokine secretion, GO:0050847|progesterone receptor signaling pathway, GO:0051057|positive regulation of small GTPase mediated signal transduction, GO:0051222|positive regulation of protein transport, GO:0051385|response to mineralocorticoid, GO:0051602|response to electrical stimulus, GO:0060065|uterus development, GO:0060444|branching involved in mammary gland duct morphogenesis, GO:0060491|regulation of cell projection assembly, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0070542|response to fatty acid, GO:0071222|cellular response to lipopolysaccharide, GO:0071375|cellular response to peptide hormone stimulus, GO:0071393|cellular response to progesterone stimulus, GO:0071398|cellular response to fatty acid, GO:0071456|cellular response to hypoxia, GO:0071498|cellular response to fluid shear stress, GO:0071560|cellular response to transforming growth factor beta stimulus, GO:0071803|positive regulation of podosome assembly, GO:0086098|angiotensin-activated signaling pathway involved in heart process, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0098609|cell-cell adhesion, GO:1900182|positive regulation of protein localization to nucleus, GO:1902533|positive regulation of intracellular signal transduction, GO:1903997|positive regulation of non-membrane spanning protein tyrosine kinase activity, GO:2000386|positive regulation of ovarian follicle development, GO:2000573|positive regulation of DNA biosynthetic process, GO:2001286|regulation of caveolin-mediated endocytosis","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0020037|heme binding, GO:0045296|cadherin binding, GO:0042169|SH2 domain binding, GO:0005102|signaling receptor binding, GO:0044325|ion channel binding, GO:0019899|enzyme binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005070|SH3/SH2 adaptor activity, GO:0097110|scaffold protein binding, GO:0070851|growth factor receptor binding, GO:0051219|phosphoprotein binding, GO:0019900|kinase binding, GO:0008022|protein C-terminus binding, GO:0005178|integrin binding, GO:0046875|ephrin receptor binding, GO:0005080|protein kinase C binding, GO:0005158|insulin receptor binding, GO:0019901|protein kinase binding, GO:0019904|protein domain specific binding, GO:0030331|estrogen receptor binding, GO:0031625|ubiquitin protein ligase binding, GO:0044877|protein-containing complex binding, GO:0050839|cell adhesion molecule binding, GO:0071253|connexin binding"
PTPRK,Missense,0.237490162618515,135,0.00554529122865054,Y,"TSG, fusion",TSG,0.297398625047783,0.000460168794972913,ENSG00000152894,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005886|plasma membrane, GO:0030054|cell junction, GO:0009986|cell surface, GO:0005887|integral component of plasma membrane, GO:0005912|adherens junction, GO:0005911|cell-cell junction, GO:0031256|leading edge membrane, GO:0001750|photoreceptor outer segment, GO:0030424|axon, GO:0030425|dendrite, GO:0043025|neuronal cell body","GO:0007155|cell adhesion, GO:0006470|protein dephosphorylation, GO:0007165|signal transduction, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0008285|negative regulation of cell proliferation, GO:0016477|cell migration, GO:0048041|focal adhesion assembly, GO:0045786|negative regulation of cell cycle, GO:0045892|negative regulation of transcription, DNA-templated, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0034394|protein localization to cell surface, GO:0030336|negative regulation of cell migration, GO:0034644|cellular response to UV, GO:0034614|cellular response to reactive oxygen species, GO:0010839|negative regulation of keratinocyte proliferation, GO:0031175|neuron projection development","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0019901|protein kinase binding, GO:0008013|beta-catenin binding, GO:0045295|gamma-catenin binding, GO:0005001|transmembrane receptor protein tyrosine phosphatase activity"
MYCN,Missense,0.237314934986184,38,0.151393638360619,N,Oncogene,Oncogene,0.0303312537209275,0.85654815519243,ENSG00000134323,"GO:0005634|nucleus, GO:0005730|nucleolus, GO:0000785|chromatin","GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0006355|regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006357|regulation of transcription by RNA polymerase II, GO:1903800|positive regulation of production of miRNAs involved in gene silencing by miRNA","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019900|kinase binding"
KCNJ5,Missense,0.237301416396417,45,0.116511854083612,N,Oncogene,Oncogene,0.250328580761864,0.0972115422158847,ENSG00000120457,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0008076|voltage-gated potassium channel complex, GO:0009897|external side of plasma membrane, GO:0030315|T-tubule","GO:0006811|ion transport, GO:0006813|potassium ion transport, GO:0034765|regulation of ion transmembrane transport, GO:0098915|membrane repolarization during ventricular cardiac muscle cell action potential, GO:1990573|potassium ion import across plasma membrane, GO:0086091|regulation of heart rate by cardiac conduction, GO:0098914|membrane repolarization during atrial cardiac muscle cell action potential, GO:0099625|ventricular cardiac muscle cell membrane repolarization","GO:0005244|voltage-gated ion channel activity, GO:0005242|inward rectifier potassium channel activity, GO:0005515|protein binding, GO:1902282|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization, GO:0086089|voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization, GO:0015467|G-protein activated inward rectifier potassium channel activity"
NCOR2,Nonsense,0.233386532908428,13,0.442849840174397,N,TSG,TSG,0.239154033432998,0.431328503814101,ENSG00000196498,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000785|chromatin, GO:0016020|membrane, GO:0000790|nuclear chromatin, GO:0016363|nuclear matrix, GO:0000118|histone deacetylase complex, GO:0017053|transcriptional repressor complex, GO:0016604|nuclear body","GO:0007595|lactation, GO:0010243|response to organonitrogen compound, GO:0032355|response to estradiol, GO:0044849|estrous cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0019216|regulation of lipid metabolic process, GO:0060766|negative regulation of androgen receptor signaling pathway, GO:1903799|negative regulation of production of miRNAs involved in gene silencing by miRNA, GO:0072365|regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter","GO:0003677|DNA binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0003682|chromatin binding, GO:0016922|nuclear receptor binding, GO:0035259|glucocorticoid receptor binding, GO:0042974|retinoic acid receptor binding, GO:0044877|protein-containing complex binding, GO:0046965|retinoid X receptor binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003714|transcription corepressor activity, GO:0042826|histone deacetylase binding, GO:0047485|protein N-terminus binding, GO:0005112|Notch binding, GO:0035257|nuclear hormone receptor binding"
DCTN1,Missense,0.232683123970171,80,0.0377990545126501,N,fusion,"",0.166624031690527,0.139615789501349,ENSG00000204843,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005813|centrosome, GO:0005829|cytosol, GO:0045111|intermediate filament cytoskeleton, GO:0005856|cytoskeleton, GO:0005874|microtubule, GO:0000922|spindle pole, GO:0005815|microtubule organizing center, GO:0005819|spindle, GO:0000776|kinetochore, GO:0005869|dynactin complex, GO:0030286|dynein complex, GO:0005814|centriole, GO:0005938|cell cortex, GO:0120103|centriolar subdistal appendage, GO:0043005|neuron projection, GO:0043025|neuronal cell body, GO:0005635|nuclear envelope, GO:0099738|cell cortex region, GO:0030904|retromer complex, GO:0035371|microtubule plus-end, GO:0005875|microtubule associated complex, GO:0030424|axon","GO:0051301|cell division, GO:0007049|cell cycle, GO:0007399|nervous system development, GO:0042147|retrograde transport, endosome to Golgi, GO:0000086|G2/M transition of mitotic cell cycle, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0097711|ciliary basal body-plasma membrane docking, GO:0010970|transport along microtubule, GO:0019886|antigen processing and presentation of exogenous peptide antigen via MHC class II, GO:0006888|ER to Golgi vesicle-mediated transport, GO:0036498|IRE1-mediated unfolded protein response, GO:0000132|establishment of mitotic spindle orientation, GO:0000278|mitotic cell cycle, GO:1990535|neuron projection maintenance, GO:0070050|neuron cellular homeostasis, GO:0031116|positive regulation of microtubule polymerization, GO:0090063|positive regulation of microtubule nucleation, GO:0060236|regulation of mitotic spindle organization, GO:0051081|nuclear envelope disassembly, GO:0061744|motor behavior, GO:0007528|neuromuscular junction development, GO:0010457|centriole-centriole cohesion, GO:0021517|ventral spinal cord development, GO:0034454|microtubule anchoring at centrosome, GO:0050905|neuromuscular process, GO:0099558|maintenance of synapse structure, GO:1904398|positive regulation of neuromuscular junction development, GO:1905515|non-motile cilium assembly","GO:0003774|motor activity, GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0070840|dynein complex binding, GO:0015631|tubulin binding, GO:0048156|tau protein binding, GO:0019901|protein kinase binding"
BRCA1,Missense,0.231878210969456,124,0.00955987835518551,Y,TSG,TSG,0.237994915853869,0.00777429610480847,ENSG00000012048,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005694|chromosome, GO:0031436|BRCA1-BARD1 complex, GO:0005886|plasma membrane, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0000151|ubiquitin ligase complex, GO:1990904|ribonucleoprotein complex, GO:0000800|lateral element, GO:0008274|gamma-tubulin ring complex, GO:0070531|BRCA1-A complex, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0000793|condensed chromosome, GO:0000794|condensed nuclear chromosome","GO:0016567|protein ubiquitination, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0010628|positive regulation of gene expression, GO:0045766|positive regulation of angiogenesis, GO:0071158|positive regulation of cell cycle arrest, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0071356|cellular response to tumor necrosis factor, GO:0006629|lipid metabolic process, GO:0006631|fatty acid metabolic process, GO:0006633|fatty acid biosynthetic process, GO:0006310|DNA recombination, GO:0007049|cell cycle, GO:0051865|protein autoubiquitination, GO:0085020|protein K6-linked ubiquitination, GO:0006915|apoptotic process, GO:0006302|double-strand break repair, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007059|chromosome segregation, GO:0016579|protein deubiquitination, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045739|positive regulation of DNA repair, GO:0031398|positive regulation of protein ubiquitination, GO:0042127|regulation of cell proliferation, GO:0042981|regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0006260|DNA replication, GO:0070317|negative regulation of G0 to G1 transition, GO:0030521|androgen receptor signaling pathway, GO:0043627|response to estrogen, GO:0072425|signal transduction involved in G2 DNA damage checkpoint, GO:0000724|double-strand break repair via homologous recombination, GO:1902042|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0000729|DNA double-strand break processing, GO:0006303|double-strand break repair via nonhomologous end joining, GO:0045717|negative regulation of fatty acid biosynthetic process, GO:0035066|positive regulation of histone acetylation, GO:0010212|response to ionizing radiation, GO:0046600|negative regulation of centriole replication, GO:0010575|positive regulation of vascular endothelial growth factor production, GO:0006978|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator, GO:0071681|cellular response to indole-3-methanol, GO:0051571|positive regulation of histone H3-K4 methylation, GO:0006301|postreplication repair, GO:0006359|regulation of transcription by RNA polymerase III, GO:0009048|dosage compensation by inactivation of X chromosome, GO:0033147|negative regulation of intracellular estrogen receptor signaling pathway, GO:0035067|negative regulation of histone acetylation, GO:0043009|chordate embryonic development, GO:0051573|negative regulation of histone H3-K9 methylation, GO:0070512|positive regulation of histone H4-K20 methylation, GO:2000378|negative regulation of reactive oxygen species metabolic process, GO:2000617|positive regulation of histone H3-K9 acetylation, GO:2000620|positive regulation of histone H4-K16 acetylation, GO:0006349|regulation of gene expression by genetic imprinting, GO:0007098|centrosome cycle, GO:0044030|regulation of DNA methylation, GO:0044818|mitotic G2/M transition checkpoint, GO:0051572|negative regulation of histone H3-K4 methylation, GO:0051574|positive regulation of histone H3-K9 methylation","GO:0008270|zinc ion binding, GO:0003677|DNA binding, GO:0004842|ubiquitin-protein transferase activity, GO:0044212|transcription regulatory region DNA binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0042802|identical protein binding, GO:0031625|ubiquitin protein ligase binding, GO:0019899|enzyme binding, GO:0015631|tubulin binding, GO:0050681|androgen receptor binding, GO:0070063|RNA polymerase binding, GO:0003723|RNA binding, GO:0003684|damaged DNA binding"
FLT4,Silent,0.229469642902384,84,0.0357537410395464,N,Oncogene,Oncogene,0.217273386977391,0.0471121536692014,ENSG00000037280,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005887|integral component of plasma membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0043235|receptor complex","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0008284|positive regulation of cell proliferation, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0002040|sprouting angiogenesis, GO:0001934|positive regulation of protein phosphorylation, GO:0001525|angiogenesis, GO:0043066|negative regulation of apoptotic process, GO:0046777|protein autophosphorylation, GO:0010595|positive regulation of endothelial cell migration, GO:0035924|cellular response to vascular endothelial growth factor stimulus, GO:0046330|positive regulation of JNK cascade, GO:0048514|blood vessel morphogenesis, GO:0001938|positive regulation of endothelial cell proliferation, GO:0090037|positive regulation of protein kinase C signaling, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0001944|vasculature development, GO:0060312|regulation of blood vessel remodeling, GO:0010575|positive regulation of vascular endothelial growth factor production, GO:0001946|lymphangiogenesis, GO:0001945|lymph vessel development, GO:0003016|respiratory system process, GO:0007585|respiratory gaseous exchange, GO:0038084|vascular endothelial growth factor signaling pathway, GO:0048286|lung alveolus development","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005021|vascular endothelial growth factor-activated receptor activity, GO:0019903|protein phosphatase binding, GO:0019838|growth factor binding, GO:0038085|vascular endothelial growth factor binding, GO:0036328|VEGF-C-activated receptor activity"
PDE4DIP,Missense,0.22752333136345,209,0.000922678783433736,Y,fusion,"",0.307287829766763,6.01822920976759e-06,ENSG00000178104,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005794|Golgi apparatus, GO:0005856|cytoskeleton, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0030016|myofibril","GO:0034622|cellular protein-containing complex assembly, GO:1903358|regulation of Golgi organization","GO:0005515|protein binding, GO:0019899|enzyme binding, GO:0032947|protein-containing complex scaffold activity"
MAP3K13,Missense,0.227303268074839,82,0.0400061707952544,N,"oncogene, TSG","",0.312998532285714,0.00419485656548222,ENSG00000073803,"GO:0005737|cytoplasm, GO:0016020|membrane","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0000186|activation of MAPKK activity, GO:0007254|JNK cascade, GO:0046777|protein autophosphorylation, GO:0150012|positive regulation of neuron projection arborization, GO:0007257|activation of JUN kinase activity, GO:0000165|MAPK cascade, GO:0007256|activation of JNKK activity, GO:0014042|positive regulation of neuron maturation, GO:0018105|peptidyl-serine phosphorylation, GO:0045773|positive regulation of axon extension, GO:1905492|positive regulation of branching morphogenesis of a nerve","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0042803|protein homodimerization activity, GO:0004709|MAP kinase kinase kinase activity, GO:0042802|identical protein binding, GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0004706|JUN kinase kinase kinase activity, GO:0106137|IkappaB kinase complex binding"
GNAS,Missense,0.227285685616132,26,0.264152992826452,N,Oncogene,Oncogene,0.496028610585319,0.00996172226260118,ENSG00000087460,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005576|extracellular region, GO:0048471|perinuclear region of cytoplasm, GO:0031410|cytoplasmic vesicle, GO:0030133|transport vesicle, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005834|heterotrimeric G-protein complex, GO:0070062|extracellular exosome, GO:0016324|apical plasma membrane, GO:0030425|dendrite, GO:0042995|cell projection, GO:0001726|ruffle, GO:0032588|trans-Golgi network membrane, GO:0031224|intrinsic component of membrane","GO:0071107|response to parathyroid hormone, GO:0007565|female pregnancy, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0009306|protein secretion, GO:0040015|negative regulation of multicellular organism growth, GO:0007186|G protein-coupled receptor signaling pathway, GO:0007165|signal transduction, GO:0043085|positive regulation of catalytic activity, GO:0060348|bone development, GO:0007188|adenylate cyclase-modulating G protein-coupled receptor signaling pathway, GO:0070527|platelet aggregation, GO:0007189|adenylate cyclase-activating G protein-coupled receptor signaling pathway, GO:0048589|developmental growth, GO:0007191|adenylate cyclase-activating dopamine receptor signaling pathway, GO:0001501|skeletal system development, GO:0001894|tissue homeostasis, GO:0001958|endochondral ossification, GO:0006112|energy reserve metabolic process, GO:0006306|DNA methylation, GO:0009791|post-embryonic development, GO:0035116|embryonic hindlimb morphogenesis, GO:0035264|multicellular organism growth, GO:0040032|post-embryonic body morphogenesis, GO:0042493|response to drug, GO:0043588|skin development, GO:0045669|positive regulation of osteoblast differentiation, GO:0045672|positive regulation of osteoclast differentiation, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0051216|cartilage development, GO:0071514|genetic imprinting, GO:2000828|regulation of parathyroid hormone secretion, GO:0050890|cognition, GO:0060789|hair follicle placode formation, GO:0009966|regulation of signal transduction, GO:0007608|sensory perception of smell, GO:0043547|positive regulation of GTPase activity, GO:0050796|regulation of insulin secretion, GO:0043950|positive regulation of cAMP-mediated signaling, GO:0003091|renal water homeostasis, GO:0071377|cellular response to glucagon stimulus, GO:0071380|cellular response to prostaglandin E stimulus, GO:0071870|cellular response to catecholamine stimulus, GO:0071880|adenylate cyclase-activating adrenergic receptor signaling pathway, GO:0046907|intracellular transport, GO:0007190|activation of adenylate cyclase activity","GO:0003674|molecular_function, GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0019001|guanyl nucleotide binding, GO:0031683|G-protein beta/gamma-subunit complex binding, GO:0035255|ionotropic glutamate receptor binding, GO:0001664|G protein-coupled receptor binding, GO:0031852|mu-type opioid receptor binding, GO:0051430|corticotropin-releasing hormone receptor 1 binding, GO:0010856|adenylate cyclase activator activity, GO:0031698|beta-2 adrenergic receptor binding, GO:0005159|insulin-like growth factor receptor binding, GO:0031748|D1 dopamine receptor binding"
NFKB2,Missense,0.226016039705249,51,0.110762458692898,N,"oncogene, TSG, fusion","",0.2920540364366,0.0375664896305482,ENSG00000077150,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0033257|Bcl3/NF-kappaB2 complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0048511|rhythmic process, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0038061|NIK/NF-kappaB signaling, GO:0032481|positive regulation of type I interferon production, GO:0002268|follicular dendritic cell differentiation, GO:0002467|germinal center formation, GO:0007568|aging, GO:0030198|extracellular matrix organization, GO:0032496|response to lipopolysaccharide, GO:0034097|response to cytokine, GO:0048536|spleen development","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003713|transcription coactivator activity"
BRCA2,Missense,0.225908669543218,233,0.00051117778592243,Y,TSG,TSG,0.340558475805956,9.78662012174557e-08,ENSG00000139618,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005856|cytoskeleton, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0032991|protein-containing complex, GO:0000784|nuclear chromosome, telomeric region, GO:0030141|secretory granule, GO:0000800|lateral element, GO:0033593|BRCA2-MAGE-D1 complex","GO:0006281|DNA repair, GO:0006310|DNA recombination, GO:0006974|cellular response to DNA damage stimulus, GO:0007049|cell cycle, GO:0006302|double-strand break repair, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000724|double-strand break repair via homologous recombination, GO:0007283|spermatogenesis, GO:0043967|histone H4 acetylation, GO:0000281|mitotic cytokinesis, GO:0070200|establishment of protein localization to telomere, GO:0043966|histone H3 acetylation, GO:0051298|centrosome duplication, GO:0006289|nucleotide-excision repair, GO:0033600|negative regulation of mammary gland epithelial cell proliferation, GO:0000722|telomere maintenance via recombination, GO:0001556|oocyte maturation, GO:0001833|inner cell mass cell proliferation, GO:0006978|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator, GO:0007141|male meiosis I, GO:0007420|brain development, GO:0007569|cell aging, GO:0008283|cell proliferation, GO:0008585|female gonad development, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0010165|response to X-ray, GO:0010225|response to UV-C, GO:0010332|response to gamma radiation, GO:0030097|hemopoiesis, GO:0032465|regulation of cytokinesis, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0043009|chordate embryonic development, GO:0045931|positive regulation of mitotic cell cycle, GO:0048478|replication fork protection, GO:0051276|chromosome organization, GO:1990426|mitotic recombination-dependent replication fork processing","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0002020|protease binding, GO:0010485|H4 histone acetyltransferase activity, GO:0003697|single-stranded DNA binding, GO:0043015|gamma-tubulin binding, GO:0008022|protein C-terminus binding, GO:0010484|H3 histone acetyltransferase activity"
ACVR1,Missense,0.225369114227547,30,0.231140512378862,N,Oncogene,Oncogene,0.25671941300764,0.170861296639389,ENSG00000115170,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0045177|apical part of cell, GO:0048179|activin receptor complex","GO:0030335|positive regulation of cell migration, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0060412|ventricular septum morphogenesis, GO:0030509|BMP signaling pathway, GO:0045669|positive regulation of osteoblast differentiation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007178|transmembrane receptor protein serine/threonine kinase signaling pathway, GO:0007507|heart development, GO:0001569|branching involved in blood vessel morphogenesis, GO:0001701|in utero embryonic development, GO:0001702|gastrulation with mouth forming second, GO:0001707|mesoderm formation, GO:0001755|neural crest cell migration, GO:0002526|acute inflammatory response, GO:0003181|atrioventricular valve morphogenesis, GO:0003203|endocardial cushion morphogenesis, GO:0003274|endocardial cushion fusion, GO:0003289|atrial septum primum morphogenesis, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0007281|germ cell development, GO:0007368|determination of left/right symmetry, GO:0007369|gastrulation, GO:0007498|mesoderm development, GO:0010862|positive regulation of pathway-restricted SMAD protein phosphorylation, GO:0051145|smooth muscle cell differentiation, GO:0060037|pharyngeal system development, GO:0061312|BMP signaling pathway involved in heart development, GO:1905007|positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation, GO:0007389|pattern specification process, GO:0030501|positive regulation of bone mineralization, GO:0071773|cellular response to BMP stimulus, GO:0060389|pathway-restricted SMAD protein phosphorylation, GO:0018107|peptidyl-threonine phosphorylation, GO:0003183|mitral valve morphogenesis, GO:0032924|activin receptor signaling pathway, GO:2001237|negative regulation of extrinsic apoptotic signaling pathway, GO:0000082|G1/S transition of mitotic cell cycle, GO:0060923|cardiac muscle cell fate commitment, GO:0009968|negative regulation of signal transduction, GO:0003143|embryonic heart tube morphogenesis, GO:0030278|regulation of ossification, GO:0032926|negative regulation of activin receptor signaling pathway, GO:0061445|endocardial cushion cell fate commitment, GO:2000017|positive regulation of determination of dorsal identity","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004675|transmembrane receptor protein serine/threonine kinase activity, GO:0005515|protein binding, GO:0005025|transforming growth factor beta receptor activity, type I, GO:0016361|activin receptor activity, type I, GO:0019838|growth factor binding, GO:0048185|activin binding, GO:0050431|transforming growth factor beta binding, GO:0042803|protein homodimerization activity, GO:0005024|transforming growth factor beta-activated receptor activity, GO:0046332|SMAD binding, GO:0017046|peptide hormone binding, GO:0098821|BMP receptor activity"
BAP1,Nonsense,0.225367394890986,28,0.248881028519824,N,TSG,TSG,0.166918179446454,0.395904659231915,ENSG00000163930,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0035517|PR-DUB complex","GO:0006325|chromatin organization, GO:0006508|proteolysis, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0010035|response to inorganic substance, GO:0050727|regulation of inflammatory response, GO:0061519|macrophage homeostasis, GO:1900015|regulation of cytokine production involved in inflammatory response, GO:0016579|protein deubiquitination, GO:0071108|protein K48-linked deubiquitination, GO:0001558|regulation of cell growth, GO:0051726|regulation of cell cycle, GO:0006464|cellular protein modification process, GO:0008285|negative regulation of cell proliferation, GO:1903955|positive regulation of protein targeting to mitochondrion, GO:0035520|monoubiquitinated protein deubiquitination, GO:0035522|monoubiquitinated histone H2A deubiquitination","GO:0004843|thiol-dependent ubiquitin-specific protease activity, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0003682|chromatin binding"
CLIP1,Missense,0.225005862059076,88,0.0350595782718349,N,fusion,"",0.25317310862186,0.0173160006085344,ENSG00000130779,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0031410|cytoplasmic vesicle, GO:0005874|microtubule, GO:0030659|cytoplasmic vesicle membrane, GO:0005813|centrosome, GO:0000776|kinetochore, GO:0005829|cytosol, GO:0015630|microtubule cytoskeleton, GO:0001726|ruffle, GO:0005768|endosome, GO:0005882|intermediate filament, GO:0035371|microtubule plus-end, GO:0044354|macropinosome, GO:0005635|nuclear envelope, GO:0005881|cytoplasmic microtubule","GO:0001578|microtubule bundle formation, GO:0000278|mitotic cell cycle, GO:0031116|positive regulation of microtubule polymerization, GO:0044861|protein transport into plasma membrane raft","GO:0046872|metal ion binding, GO:0008270|zinc ion binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0015631|tubulin binding, GO:0051010|microtubule plus-end binding"
ALK,Missense,0.224427624992554,183,0.00225620115144677,Y,"oncogene, fusion",Oncogene,0.263859266151657,0.000307217062564979,ENSG00000171094,"GO:0016021|integral component of membrane, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0070062|extracellular exosome, GO:0032991|protein-containing complex","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007165|signal transduction, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0000187|activation of MAPK activity, GO:0048666|neuron development, GO:0008283|cell proliferation, GO:0042981|regulation of apoptotic process, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0046777|protein autophosphorylation, GO:0042127|regulation of cell proliferation, GO:0045664|regulation of neuron differentiation, GO:0038061|NIK/NF-kappaB signaling, GO:0007399|nervous system development, GO:0007420|brain development, GO:0021766|hippocampus development, GO:0030534|adult behavior, GO:0036269|swimming behavior, GO:0060159|regulation of dopamine receptor signaling pathway, GO:0090648|response to environmental enrichment","GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0000166|nucleotide binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0004704|NF-kappaB-inducing kinase activity"
STK11,Missense,0.223889533839092,39,0.170635310755455,N,TSG,TSG,0.293092524140691,0.0701703505642565,ENSG00000118046,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005739|mitochondrion, GO:0070062|extracellular exosome","GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0001558|regulation of cell growth, GO:0006974|cellular response to DNA damage stimulus, GO:0007049|cell cycle, GO:0006915|apoptotic process, GO:0006914|autophagy, GO:0030010|establishment of cell polarity, GO:0030154|cell differentiation, GO:0007283|spermatogenesis, GO:0032147|activation of protein kinase activity, GO:0001894|tissue homeostasis, GO:0001944|vasculature development, GO:0007409|axonogenesis, GO:0008285|negative regulation of cell proliferation, GO:0010212|response to ionizing radiation, GO:0030111|regulation of Wnt signaling pathway, GO:0030308|negative regulation of cell growth, GO:0042593|glucose homeostasis, GO:0045059|positive thymic T cell selection, GO:0046777|protein autophosphorylation, GO:0048814|regulation of dendrite morphogenesis, GO:0050772|positive regulation of axonogenesis, GO:0050852|T cell receptor signaling pathway, GO:0051645|Golgi localization, GO:0051896|regulation of protein kinase B signaling, GO:0060070|canonical Wnt signaling pathway, GO:0060770|negative regulation of epithelial cell proliferation involved in prostate gland development, GO:0071493|cellular response to UV-B, GO:0097484|dendrite extension, GO:0120163|negative regulation of cold-induced thermogenesis, GO:1900182|positive regulation of protein localization to nucleus, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0007050|cell cycle arrest, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0006470|protein dephosphorylation, GO:0072332|intrinsic apoptotic signaling pathway by p53 class mediator, GO:0043276|anoikis, GO:0010508|positive regulation of autophagy, GO:1904262|negative regulation of TORC1 signaling","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0000287|magnesium ion binding, GO:0030275|LRR domain binding, GO:0030295|protein kinase activator activity, GO:0002039|p53 binding"
CCNE1,Missense,0.223886698830177,32,0.21801795707828,N,Oncogene,Oncogene,0.319653090474518,0.0745194128008003,ENSG00000105173,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005813|centrosome, GO:0000307|cyclin-dependent protein kinase holoenzyme complex, GO:0097134|cyclin E1-CDK2 complex","GO:1900087|positive regulation of G1/S transition of mitotic cell cycle, GO:0051301|cell division, GO:0007049|cell cycle, GO:0000082|G1/S transition of mitotic cell cycle, GO:0051726|regulation of cell cycle, GO:0045893|positive regulation of transcription, DNA-templated, GO:0008284|positive regulation of cell proliferation, GO:0000278|mitotic cell cycle, GO:0007129|synapsis, GO:0030521|androgen receptor signaling pathway, GO:0006468|protein phosphorylation, GO:0000083|regulation of transcription involved in G1/S transition of mitotic cell cycle, GO:0000079|regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0007088|regulation of mitotic nuclear division, GO:0045787|positive regulation of cell cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0000723|telomere maintenance, GO:0006270|DNA replication initiation, GO:0016055|Wnt signaling pathway, GO:0070192|chromosome organization involved in meiotic cell cycle, GO:1903827|regulation of cellular protein localization","GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0019901|protein kinase binding, GO:0050681|androgen receptor binding, GO:0004672|protein kinase activity, GO:0016538|cyclin-dependent protein serine/threonine kinase regulator activity, GO:0004693|cyclin-dependent protein serine/threonine kinase activity, GO:0016301|kinase activity"
TRRAP,Missense,0.223739191356531,283,0.000147379897143575,Y,Oncogene,Oncogene,0.117396449911387,0.0484954990398644,ENSG00000196367,"GO:0005634|nucleus, GO:0005794|Golgi apparatus, GO:0005654|nucleoplasm, GO:0000123|histone acetyltransferase complex, GO:0033276|transcription factor TFTC complex, GO:0000125|PCAF complex, GO:0030914|STAGA complex, GO:0000124|SAGA complex, GO:0035267|NuA4 histone acetyltransferase complex, GO:0000812|Swr1 complex","GO:0006325|chromatin organization, GO:0016573|histone acetylation, GO:0016578|histone deubiquitination, GO:0006355|regulation of transcription, DNA-templated, GO:0016579|protein deubiquitination, GO:0043967|histone H4 acetylation, GO:1904837|beta-catenin-TCF complex assembly, GO:0006281|DNA repair, GO:0043968|histone H2A acetylation, GO:0016310|phosphorylation","GO:0005515|protein binding, GO:0003712|transcription coregulator activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0016740|transferase activity, GO:0016301|kinase activity"
SDHA,Silent,0.220853126622258,26,0.278272709116009,N,TSG,TSG,0.278570567619949,0.168192098353515,ENSG00000073578,"GO:0016020|membrane, GO:0005730|nucleolus, GO:0005739|mitochondrion, GO:0005743|mitochondrial inner membrane, GO:0043209|myelin sheath, GO:0005749|mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone), GO:0045282|plasma membrane succinate dehydrogenase complex","GO:0055114|oxidation-reduction process, GO:0006099|tricarboxylic acid cycle, GO:0006105|succinate metabolic process, GO:0022900|electron transport chain, GO:0022904|respiratory electron transport chain, GO:0007399|nervous system development, GO:0006121|mitochondrial electron transport, succinate to ubiquinone","GO:0016491|oxidoreductase activity, GO:0050660|flavin adenine dinucleotide binding, GO:0008177|succinate dehydrogenase (ubiquinone) activity, GO:0016627|oxidoreductase activity, acting on the CH-CH group of donors, GO:0005515|protein binding, GO:0000104|succinate dehydrogenase activity, GO:0009055|electron transfer activity"
ZNF521,Missense,0.220664189818519,191,0.00215840261977604,Y,"oncogene, fusion",Oncogene,0.265875932515935,0.000201209236964533,ENSG00000198795,GO:0005634|nucleus,"GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0048663|neuron fate commitment","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019904|protein domain specific binding"
NRG1,Missense,0.22040503545352,82,0.0466180609713376,N,"TSG, fusion",TSG,0.224674098284801,0.0424277318813674,ENSG00000157168,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005634|nucleus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0005615|extracellular space, GO:0005737|cytoplasm, GO:0005887|integral component of plasma membrane, GO:0030424|axon, GO:0031594|neuromuscular junction, GO:0045202|synapse","GO:0007399|nervous system development, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0010469|regulation of signaling receptor activity, GO:0046854|phosphatidylinositol phosphorylation, GO:0061098|positive regulation of protein tyrosine kinase activity, GO:0035556|intracellular signal transduction, GO:0008284|positive regulation of cell proliferation, GO:0051897|positive regulation of protein kinase B signaling, GO:0000165|MAPK cascade, GO:0038128|ERBB2 signaling pathway, GO:2000145|regulation of cell motility, GO:0032148|activation of protein kinase B activity, GO:0055007|cardiac muscle cell differentiation, GO:0000187|activation of MAPK activity, GO:0014032|neural crest cell development, GO:0045892|negative regulation of transcription, DNA-templated, GO:0051048|negative regulation of secretion, GO:0042060|wound healing, GO:0030879|mammary gland development, GO:0003222|ventricular trabecula myocardium morphogenesis, GO:0038127|ERBB signaling pathway, GO:0060956|endocardial cell differentiation, GO:0007154|cell communication, GO:0007171|activation of transmembrane receptor protein tyrosine kinase activity, GO:0038129|ERBB3 signaling pathway, GO:0043496|regulation of protein homodimerization activity, GO:0043497|regulation of protein heterodimerization activity, GO:0051155|positive regulation of striated muscle cell differentiation, GO:0060379|cardiac muscle cell myoblast differentiation, GO:0000902|cell morphogenesis, GO:0003161|cardiac conduction system development, GO:0007416|synapse assembly, GO:0007420|brain development, GO:0007422|peripheral nervous system development, GO:0007507|heart development, GO:0007517|muscle organ development, GO:0007626|locomotory behavior, GO:0010001|glial cell differentiation, GO:0010628|positive regulation of gene expression, GO:0016477|cell migration, GO:0021781|glial cell fate commitment, GO:0021842|chemorepulsion involved in interneuron migration from the subpallium to the cortex, GO:0022011|myelination in peripheral nervous system, GO:0042177|negative regulation of protein catabolic process, GO:0045213|neurotransmitter receptor metabolic process, GO:0045595|regulation of cell differentiation, GO:0045860|positive regulation of protein kinase activity, GO:0046579|positive regulation of Ras protein signal transduction, GO:0048663|neuron fate commitment, GO:0048709|oligodendrocyte differentiation, GO:0048738|cardiac muscle tissue development, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0070886|positive regulation of calcineurin-NFAT signaling cascade, GO:2000727|positive regulation of cardiac muscle cell differentiation, GO:2001223|negative regulation of neuron migration","GO:0005102|signaling receptor binding, GO:0008083|growth factor activity, GO:0005178|integrin binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0030971|receptor tyrosine kinase binding, GO:0005125|cytokine activity, GO:0004713|protein tyrosine kinase activity, GO:0030297|transmembrane receptor protein tyrosine kinase activator activity, GO:0043125|ErbB-3 class receptor binding, GO:0003712|transcription coregulator activity, GO:0030296|protein tyrosine kinase activator activity, GO:0005176|ErbB-2 class receptor binding, GO:0045499|chemorepellent activity"
CAMTA1,Missense,0.220241616270311,141,0.00868401882638231,Y,"TSG, fusion",TSG,0.271268430991407,0.00113915590368468,ENSG00000171735,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005730|nucleolus, GO:0005829|cytosol","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0035307|positive regulation of protein dephosphorylation, GO:0070886|positive regulation of calcineurin-NFAT signaling cascade, GO:0050885|neuromuscular process controlling balance, GO:0006357|regulation of transcription by RNA polymerase II","GO:0003677|DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0043565|sequence-specific DNA binding"
ABL1,Missense,0.219884429068181,86,0.0419259130023311,N,"oncogene, fusion",Oncogene,0.221944897998667,0.0399945773027197,ENSG00000097007,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005739|mitochondrion, GO:0005856|cytoskeleton, GO:0016604|nuclear body, GO:0048471|perinuclear region of cytoplasm, GO:0005829|cytosol, GO:0031965|nuclear membrane, GO:0043025|neuronal cell body, GO:0032991|protein-containing complex, GO:0005730|nucleolus, GO:0015629|actin cytoskeleton, GO:0030425|dendrite, GO:0031252|cell leading edge, GO:0098794|postsynapse","GO:0010595|positive regulation of endothelial cell migration, GO:0071901|negative regulation of protein serine/threonine kinase activity, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007155|cell adhesion, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0006915|apoptotic process, GO:0006914|autophagy, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0030154|cell differentiation, GO:0006897|endocytosis, GO:0001934|positive regulation of protein phosphorylation, GO:0032956|regulation of actin cytoskeleton organization, GO:0030155|regulation of cell adhesion, GO:0043065|positive regulation of apoptotic process, GO:0030036|actin cytoskeleton organization, GO:2000251|positive regulation of actin cytoskeleton reorganization, GO:0010506|regulation of autophagy, GO:0006464|cellular protein modification process, GO:0006975|DNA damage induced protein phosphorylation, GO:0007229|integrin-mediated signaling pathway, GO:0032489|regulation of Cdc42 protein signal transduction, GO:0038189|neuropilin signaling pathway, GO:0043542|endothelial cell migration, GO:0051496|positive regulation of stress fiber assembly, GO:0051894|positive regulation of focal adhesion assembly, GO:1900026|positive regulation of substrate adhesion-dependent cell spreading, GO:0006355|regulation of transcription, DNA-templated, GO:2000249|regulation of actin cytoskeleton reorganization, GO:0006298|mismatch repair, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:2000145|regulation of cell motility, GO:0034599|cellular response to oxidative stress, GO:0045184|establishment of protein localization, GO:1903351|cellular response to dopamine, GO:0051149|positive regulation of muscle cell differentiation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0046777|protein autophosphorylation, GO:0000278|mitotic cell cycle, GO:0001843|neural tube closure, GO:0001922|B-1 B cell homeostasis, GO:0002322|B cell proliferation involved in immune response, GO:0002333|transitional one stage B cell differentiation, GO:0006909|phagocytosis, GO:0006979|response to oxidative stress, GO:0007050|cell cycle arrest, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0007204|positive regulation of cytosolic calcium ion concentration, GO:0009791|post-embryonic development, GO:0021587|cerebellum morphogenesis, GO:0022408|negative regulation of cell-cell adhesion, GO:0030035|microspike assembly, GO:0030100|regulation of endocytosis, GO:0030182|neuron differentiation, GO:0030514|negative regulation of BMP signaling pathway, GO:0030516|regulation of axon extension, GO:0031113|regulation of microtubule polymerization, GO:0033690|positive regulation of osteoblast proliferation, GO:0034446|substrate adhesion-dependent cell spreading, GO:0035791|platelet-derived growth factor receptor-beta signaling pathway, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0042100|B cell proliferation, GO:0042127|regulation of cell proliferation, GO:0042770|signal transduction in response to DNA damage, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0045580|regulation of T cell differentiation, GO:0045930|negative regulation of mitotic cell cycle, GO:0045931|positive regulation of mitotic cell cycle, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046632|alpha-beta T cell differentiation, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0048536|spleen development, GO:0048538|thymus development, GO:0048668|collateral sprouting, GO:0050798|activated T cell proliferation, GO:0050852|T cell receptor signaling pathway, GO:0050853|B cell receptor signaling pathway, GO:0050885|neuromuscular process controlling balance, GO:0051281|positive regulation of release of sequestered calcium ion into cytosol, GO:0051353|positive regulation of oxidoreductase activity, GO:0051444|negative regulation of ubiquitin-protein transferase activity, GO:0051726|regulation of cell cycle, GO:0051882|mitochondrial depolarization, GO:0060020|Bergmann glial cell differentiation, GO:0060563|neuroepithelial cell differentiation, GO:0070301|cellular response to hydrogen peroxide, GO:0070373|negative regulation of ERK1 and ERK2 cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0071103|DNA conformation change, GO:0071222|cellular response to lipopolysaccharide, GO:0072358|cardiovascular system development, GO:0090050|positive regulation of cell migration involved in sprouting angiogenesis, GO:0090135|actin filament branching, GO:1900042|positive regulation of interleukin-2 secretion, GO:1900272|negative regulation of long-term synaptic potentiation, GO:1900275|negative regulation of phospholipase C activity, GO:1901216|positive regulation of neuron death, GO:1902715|positive regulation of interferon-gamma secretion, GO:1903053|regulation of extracellular matrix organization, GO:1904528|positive regulation of microtubule binding, GO:1904531|positive regulation of actin filament binding, GO:1905244|regulation of modification of synaptic structure, GO:1905555|positive regulation blood vessel branching, GO:1990051|activation of protein kinase C activity, GO:2000096|positive regulation of Wnt signaling pathway, planar cell polarity pathway, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:2000772|regulation of cellular senescence, GO:2000773|negative regulation of cellular senescence, GO:2001020|regulation of response to DNA damage stimulus","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0003677|DNA binding, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0000287|magnesium ion binding, GO:0030145|manganese ion binding, GO:0004515|nicotinate-nucleotide adenylyltransferase activity, GO:0003785|actin monomer binding, GO:0008022|protein C-terminus binding, GO:0017124|SH3 domain binding, GO:0019905|syntaxin binding, GO:0070064|proline-rich region binding, GO:0001784|phosphotyrosine residue binding, GO:0000400|four-way junction DNA binding, GO:0000405|bubble DNA binding, GO:0003713|transcription coactivator activity, GO:0005080|protein kinase C binding, GO:0019904|protein domain specific binding, GO:0038191|neuropilin binding, GO:0042169|SH2 domain binding, GO:0046875|ephrin receptor binding, GO:0051015|actin filament binding, GO:0051019|mitogen-activated protein kinase binding, GO:1990837|sequence-specific double-stranded DNA binding"
KAT6B,Missense,0.218783291660196,140,0.00940387424001201,Y,"TSG, fusion",TSG,0.269606324837949,0.00127615087379861,ENSG00000156650,"GO:0005634|nucleus, GO:0000786|nucleosome, GO:0000790|nuclear chromatin, GO:0005654|nucleoplasm, GO:0000123|histone acetyltransferase complex, GO:0070776|MOZ/MORF histone acetyltransferase complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0006334|nucleosome assembly, GO:0016573|histone acetylation, GO:0043967|histone H4 acetylation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0043966|histone H3 acetylation, GO:1990830|cellular response to leukemia inhibitory factor","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0016746|transferase activity, transferring acyl groups, GO:0004402|histone acetyltransferase activity, GO:0042393|histone binding, GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0010485|H4 histone acetyltransferase activity, GO:0016407|acetyltransferase activity"
ASXL1,Nonsense,0.218571428571429,22,0.32845407783572,N,TSG,TSG,0.166996953189347,0.457600692659246,ENSG00000171456,"GO:0005634|nucleus, GO:0000790|nuclear chromatin, GO:0005654|nucleoplasm, GO:0035517|PR-DUB complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0006351|transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016579|protein deubiquitination, GO:0045599|negative regulation of fat cell differentiation, GO:0032526|response to retinoic acid, GO:0048386|positive regulation of retinoic acid receptor signaling pathway, GO:0009887|animal organ morphogenesis, GO:0035359|negative regulation of peroxisome proliferator activated receptor signaling pathway, GO:0035522|monoubiquitinated histone H2A deubiquitination, GO:0000902|cell morphogenesis, GO:0003007|heart morphogenesis, GO:0030097|hemopoiesis, GO:0048534|hematopoietic or lymphoid organ development, GO:0048538|thymus development, GO:0048539|bone marrow development, GO:0048872|homeostasis of number of cells, GO:0060348|bone development, GO:0060430|lung saccule development","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0042974|retinoic acid receptor binding, GO:0003682|chromatin binding, GO:0042975|peroxisome proliferator activated receptor binding"
CRTC1,Silent,0.218452071548492,24,0.305120339909868,N,"oncogene, fusion",Oncogene,0.237166430330241,0.264481073940378,ENSG00000105662,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0016604|nuclear body, GO:0030425|dendrite, GO:0043025|neuronal cell body, GO:0045202|synapse","GO:0051289|protein homotetramerization, GO:0048511|rhythmic process, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016032|viral process, GO:0032793|positive regulation of CREB transcription factor activity, GO:0043153|entrainment of circadian clock by photoperiod, GO:0007613|memory, GO:0097009|energy homeostasis, GO:1900006|positive regulation of dendrite development, GO:1900273|positive regulation of long-term synaptic potentiation, GO:1902631|negative regulation of membrane hyperpolarization","GO:0005515|protein binding, GO:0008140|cAMP response element binding protein binding"
ATR,Missense,0.217965717825082,177,0.00356346035035677,Y,TSG,TSG,0.260232333815985,0.00046858116287872,ENSG00000175054,"GO:0005634|nucleus, GO:0005794|Golgi apparatus, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0000784|nuclear chromosome, telomeric region, GO:0016605|PML body","GO:0016310|phosphorylation, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0036297|interstrand cross-link repair, GO:0007275|multicellular organism development, GO:0006260|DNA replication, GO:0032212|positive regulation of telomere maintenance via telomerase, GO:0090399|replicative senescence, GO:0000077|DNA damage checkpoint, GO:0018105|peptidyl-serine phosphorylation, GO:0034644|cellular response to UV, GO:0000723|telomere maintenance, GO:1900034|regulation of cellular response to heat, GO:0008156|negative regulation of DNA replication, GO:0070198|protein localization to chromosome, telomeric region, GO:0046777|protein autophosphorylation, GO:0043517|positive regulation of DNA damage response, signal transduction by p53 class mediator, GO:0071480|cellular response to gamma radiation, GO:0097694|establishment of RNA localization to telomere, GO:0097695|establishment of protein-containing complex localization to telomere, GO:1904884|positive regulation of telomerase catalytic core complex assembly, GO:0042493|response to drug","GO:0016301|kinase activity, GO:0000166|nucleotide binding, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004672|protein kinase activity, GO:0032405|MutLalpha complex binding, GO:0032407|MutSalpha complex binding"
ZFHX3,Missense,0.21776679161265,280,0.000240851200516701,Y,TSG,TSG,0.248799324811449,2.54255989224957e-05,ENSG00000140836,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex, GO:0016604|nuclear body","GO:0006355|regulation of transcription, DNA-templated, GO:0032922|circadian regulation of gene expression, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007517|muscle organ development, GO:0006366|transcription by RNA polymerase II, GO:0007420|brain development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045664|regulation of neuron differentiation, GO:0045785|positive regulation of cell adhesion, GO:0071559|response to transforming growth factor beta, GO:1904059|regulation of locomotor rhythm, GO:0007050|cell cycle arrest","GO:0003676|nucleic acid binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0044212|transcription regulatory region DNA binding"
PML,Silent,0.217566207681327,34,0.216444617425277,N,"TSG, fusion",TSG,0.24601828621389,0.160757819649504,ENSG00000140464,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0005768|endosome, GO:0031901|early endosome membrane, GO:0000784|nuclear chromosome, telomeric region, GO:0016605|PML body, GO:0042406|extrinsic component of endoplasmic reticulum membrane, GO:0016363|nuclear matrix, GO:0000792|heterochromatin","GO:0008285|negative regulation of cell proliferation, GO:1903508|positive regulation of nucleic acid-templated transcription, GO:0048511|rhythmic process, GO:0006915|apoptotic process, GO:0032922|circadian regulation of gene expression, GO:0016925|protein sumoylation, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0051607|defense response to virus, GO:0006355|regulation of transcription, DNA-templated, GO:0001666|response to hypoxia, GO:0016032|viral process, GO:0030308|negative regulation of cell growth, GO:0045892|negative regulation of transcription, DNA-templated, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0043161|proteasome-mediated ubiquitin-dependent protein catabolic process, GO:0016525|negative regulation of angiogenesis, GO:0060333|interferon-gamma-mediated signaling pathway, GO:0065003|protein-containing complex assembly, GO:0001932|regulation of protein phosphorylation, GO:0042752|regulation of circadian rhythm, GO:0090398|cellular senescence, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0043153|entrainment of circadian clock by photoperiod, GO:2001238|positive regulation of extrinsic apoptotic signaling pathway, GO:2000059|negative regulation of ubiquitin-dependent protein catabolic process, GO:1902187|negative regulation of viral release from host cell, GO:0032206|positive regulation of telomere maintenance, GO:0034097|response to cytokine, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0032469|endoplasmic reticulum calcium ion homeostasis, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0007050|cell cycle arrest, GO:0010522|regulation of calcium ion transport into cytosol, GO:0030578|PML body organization, GO:0051457|maintenance of protein location in nucleus, GO:2000779|regulation of double-strand break repair, GO:0006606|protein import into nucleus, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0007182|common-partner SMAD protein phosphorylation, GO:0007569|cell aging, GO:0008631|intrinsic apoptotic signaling pathway in response to oxidative stress, GO:0009411|response to UV, GO:0010332|response to gamma radiation, GO:0010761|fibroblast migration, GO:0030099|myeloid cell differentiation, GO:0030155|regulation of cell adhesion, GO:0045165|cell fate commitment, GO:0048146|positive regulation of fibroblast proliferation, GO:0048384|retinoic acid receptor signaling pathway, GO:0050711|negative regulation of interleukin-1 secretion, GO:0050713|negative regulation of interleukin-1 beta secretion, GO:0060444|branching involved in mammary gland duct morphogenesis, GO:0070059|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, GO:0071353|cellular response to interleukin-4, GO:0072332|intrinsic apoptotic signaling pathway by p53 class mediator, GO:0097191|extrinsic apoptotic signaling pathway, GO:1990830|cellular response to leukemia inhibitory factor, GO:2001235|positive regulation of apoptotic signaling pathway","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0031625|ubiquitin protein ligase binding, GO:0042803|protein homodimerization activity, GO:0046332|SMAD binding, GO:0019789|SUMO transferase activity, GO:0032183|SUMO binding"
AR,Silent,0.217049210411273,44,0.157001278316826,N,Oncogene,Oncogene,0.205684612316946,0.180423278693569,ENSG00000169083,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0032991|protein-containing complex, GO:0000790|nuclear chromatin, GO:0005886|plasma membrane, GO:0016607|nuclear speck","GO:0008284|positive regulation of cell proliferation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0006351|transcription, DNA-templated, GO:0030521|androgen receptor signaling pathway, GO:0010628|positive regulation of gene expression, GO:0008285|negative regulation of cell proliferation, GO:0016579|protein deubiquitination, GO:0008283|cell proliferation, GO:0007548|sex differentiation, GO:0007165|signal transduction, GO:0007267|cell-cell signaling, GO:0045597|positive regulation of cell differentiation, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0042327|positive regulation of phosphorylation, GO:0030850|prostate gland development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:2001237|negative regulation of extrinsic apoptotic signaling pathway, GO:0051259|protein complex oligomerization, GO:0001701|in utero embryonic development, GO:0003073|regulation of systemic arterial blood pressure, GO:0003382|epithelial cell morphogenesis, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007283|spermatogenesis, GO:0007338|single fertilization, GO:0008584|male gonad development, GO:0009566|fertilization, GO:0009987|cellular process, GO:0010468|regulation of gene expression, GO:0019102|male somatic sex determination, GO:0030522|intracellular receptor signaling pathway, GO:0033148|positive regulation of intracellular estrogen receptor signaling pathway, GO:0033327|Leydig cell differentiation, GO:0035264|multicellular organism growth, GO:0043410|positive regulation of MAPK cascade, GO:0043568|positive regulation of insulin-like growth factor receptor signaling pathway, GO:0045720|negative regulation of integrin biosynthetic process, GO:0045726|positive regulation of integrin biosynthetic process, GO:0045945|positive regulation of transcription by RNA polymerase III, GO:0048608|reproductive structure development, GO:0048638|regulation of developmental growth, GO:0048645|animal organ formation, GO:0048808|male genitalia morphogenesis, GO:0050680|negative regulation of epithelial cell proliferation, GO:0050790|regulation of catalytic activity, GO:0060520|activation of prostate induction by androgen receptor signaling pathway, GO:0060571|morphogenesis of an epithelial fold, GO:0060599|lateral sprouting involved in mammary gland duct morphogenesis, GO:0060685|regulation of prostatic bud formation, GO:0060736|prostate gland growth, GO:0060740|prostate gland epithelium morphogenesis, GO:0060742|epithelial cell differentiation involved in prostate gland development, GO:0060748|tertiary branching involved in mammary gland duct morphogenesis, GO:0060749|mammary gland alveolus development, GO:0060769|positive regulation of epithelial cell proliferation involved in prostate gland development, GO:0061458|reproductive system development, GO:0071383|cellular response to steroid hormone stimulus, GO:0071394|cellular response to testosterone stimulus, GO:0072520|seminiferous tubule development, GO:1903076|regulation of protein localization to plasma membrane, GO:0043401|steroid hormone mediated signaling pathway","GO:0044212|transcription regulatory region DNA binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0008289|lipid binding, GO:0005496|steroid binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0005102|signaling receptor binding, GO:0019899|enzyme binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0004879|nuclear receptor activity, GO:0008013|beta-catenin binding, GO:0046983|protein dimerization activity, GO:0008134|transcription factor binding, GO:0051117|ATPase binding, GO:0001091|RNA polymerase II basal transcription factor binding, GO:0003707|steroid hormone receptor activity, GO:0005497|androgen binding, GO:0070974|POU domain binding"
MLH1,Missense,0.216398335888004,51,0.127204958794234,N,TSG,TSG,0.302507051925068,0.0309583396302069,ENSG00000076242,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0032300|mismatch repair complex, GO:0000793|condensed chromosome, GO:0000794|condensed nuclear chromosome, GO:0000795|synaptonemal complex, GO:0001673|male germ cell nucleus, GO:0005712|chiasma, GO:0005715|late recombination nodule, GO:0032389|MutLalpha complex","GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0007049|cell cycle, GO:0006298|mismatch repair, GO:0000289|nuclear-transcribed mRNA poly(A) tail shortening, GO:0000712|resolution of meiotic recombination intermediates, GO:0002204|somatic recombination of immunoglobulin genes involved in immune response, GO:0006303|double-strand break repair via nonhomologous end joining, GO:0007060|male meiosis chromosome segregation, GO:0007129|synapsis, GO:0007131|reciprocal meiotic recombination, GO:0007140|male meiotic nuclear division, GO:0007283|spermatogenesis, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0009617|response to bacterium, GO:0016321|female meiosis chromosome segregation, GO:0016446|somatic hypermutation of immunoglobulin genes, GO:0016447|somatic recombination of immunoglobulin gene segments, GO:0043060|meiotic metaphase I plate congression, GO:0045132|meiotic chromosome segregation, GO:0045141|meiotic telomere clustering, GO:0045143|homologous chromosome segregation, GO:0045190|isotype switching, GO:0045950|negative regulation of mitotic recombination, GO:0048298|positive regulation of isotype switching to IgA isotypes, GO:0048304|positive regulation of isotype switching to IgG isotypes, GO:0048477|oogenesis, GO:0051257|meiotic spindle midzone assembly, GO:0051321|meiotic cell cycle","GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0005515|protein binding, GO:0016887|ATPase activity, GO:0030983|mismatched DNA binding, GO:0003682|chromatin binding, GO:0019899|enzyme binding, GO:0003697|single-stranded DNA binding, GO:0032407|MutSalpha complex binding, GO:0032137|guanine/thymine mispair binding"
KMT2C,Nonsense,0.215740536827043,108,0.0249336293600645,N,TSG,TSG,0.178766983095753,0.0641516441119039,ENSG00000055609,"GO:0005634|nucleus, GO:0044666|MLL3/4 complex, GO:0005654|nucleoplasm, GO:0035097|histone methyltransferase complex","GO:0051568|histone H3-K4 methylation, GO:0006355|regulation of transcription, DNA-templated, GO:0032259|methylation, GO:0006325|chromatin organization, GO:0034968|histone lysine methylation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045652|regulation of megakaryocyte differentiation","GO:0046872|metal ion binding, GO:0042800|histone methyltransferase activity (H3-K4 specific), GO:0003723|RNA binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0016746|transferase activity, transferring acyl groups, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0042393|histone binding, GO:0003713|transcription coactivator activity"
PML,Missense,0.215428251118423,61,0.0954386018183701,N,"TSG, fusion",TSG,0.239014563102067,0.0635773741730971,ENSG00000140464,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0005768|endosome, GO:0031901|early endosome membrane, GO:0000784|nuclear chromosome, telomeric region, GO:0016605|PML body, GO:0042406|extrinsic component of endoplasmic reticulum membrane, GO:0016363|nuclear matrix, GO:0000792|heterochromatin","GO:0008285|negative regulation of cell proliferation, GO:1903508|positive regulation of nucleic acid-templated transcription, GO:0048511|rhythmic process, GO:0006915|apoptotic process, GO:0032922|circadian regulation of gene expression, GO:0016925|protein sumoylation, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0051607|defense response to virus, GO:0006355|regulation of transcription, DNA-templated, GO:0001666|response to hypoxia, GO:0016032|viral process, GO:0030308|negative regulation of cell growth, GO:0045892|negative regulation of transcription, DNA-templated, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0043161|proteasome-mediated ubiquitin-dependent protein catabolic process, GO:0016525|negative regulation of angiogenesis, GO:0060333|interferon-gamma-mediated signaling pathway, GO:0065003|protein-containing complex assembly, GO:0001932|regulation of protein phosphorylation, GO:0042752|regulation of circadian rhythm, GO:0090398|cellular senescence, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0043153|entrainment of circadian clock by photoperiod, GO:2001238|positive regulation of extrinsic apoptotic signaling pathway, GO:2000059|negative regulation of ubiquitin-dependent protein catabolic process, GO:1902187|negative regulation of viral release from host cell, GO:0032206|positive regulation of telomere maintenance, GO:0034097|response to cytokine, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0032469|endoplasmic reticulum calcium ion homeostasis, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0007050|cell cycle arrest, GO:0010522|regulation of calcium ion transport into cytosol, GO:0030578|PML body organization, GO:0051457|maintenance of protein location in nucleus, GO:2000779|regulation of double-strand break repair, GO:0006606|protein import into nucleus, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0007182|common-partner SMAD protein phosphorylation, GO:0007569|cell aging, GO:0008631|intrinsic apoptotic signaling pathway in response to oxidative stress, GO:0009411|response to UV, GO:0010332|response to gamma radiation, GO:0010761|fibroblast migration, GO:0030099|myeloid cell differentiation, GO:0030155|regulation of cell adhesion, GO:0045165|cell fate commitment, GO:0048146|positive regulation of fibroblast proliferation, GO:0048384|retinoic acid receptor signaling pathway, GO:0050711|negative regulation of interleukin-1 secretion, GO:0050713|negative regulation of interleukin-1 beta secretion, GO:0060444|branching involved in mammary gland duct morphogenesis, GO:0070059|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, GO:0071353|cellular response to interleukin-4, GO:0072332|intrinsic apoptotic signaling pathway by p53 class mediator, GO:0097191|extrinsic apoptotic signaling pathway, GO:1990830|cellular response to leukemia inhibitory factor, GO:2001235|positive regulation of apoptotic signaling pathway","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0031625|ubiquitin protein ligase binding, GO:0042803|protein homodimerization activity, GO:0046332|SMAD binding, GO:0019789|SUMO transferase activity, GO:0032183|SUMO binding"
PREX2,Silent,0.215330782563236,92,0.0392658541846016,N,Oncogene,Oncogene,0.15076654640628,0.151417101423535,ENSG00000046889,"GO:0005886|plasma membrane, GO:0005829|cytosol","GO:0035556|intracellular signal transduction, GO:0035023|regulation of Rho protein signal transduction, GO:0043547|positive regulation of GTPase activity, GO:0007186|G protein-coupled receptor signaling pathway, GO:0008344|adult locomotory behavior, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0048813|dendrite morphogenesis","GO:0005085|guanyl-nucleotide exchange factor activity, GO:0005089|Rho guanyl-nucleotide exchange factor activity, GO:0005096|GTPase activator activity, GO:0030676|Rac guanyl-nucleotide exchange factor activity"
BCL11A,Missense,0.215276614042399,120,0.0182104757593568,N,"oncogene, fusion",Oncogene,0.239777216113524,0.00834627381622262,ENSG00000119866,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0014069|postsynaptic density","GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0016925|protein sumoylation, GO:0010628|positive regulation of gene expression, GO:1903860|negative regulation of dendrite extension, GO:1904800|negative regulation of neuron remodeling, GO:1905232|cellular response to L-glutamate, GO:2000171|negative regulation of dendrite development, GO:2000173|negative regulation of branching morphogenesis of a nerve","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0019901|protein kinase binding"
BRAF,Silent,0.214653003798613,28,0.272685262266835,N,"oncogene, fusion",Oncogene,0.11109712516138,0.573560535015768,ENSG00000157764,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005739|mitochondrion, GO:0043005|neuron projection, GO:0044297|cell body","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0007165|signal transduction, GO:0010628|positive regulation of gene expression, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0000186|activation of MAPKK activity, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:0043066|negative regulation of apoptotic process, GO:0000165|MAPK cascade, GO:0009887|animal organ morphogenesis, GO:0002318|myeloid progenitor cell differentiation, GO:0008542|visual learning, GO:0010764|negative regulation of fibroblast migration, GO:0010828|positive regulation of glucose transmembrane transport, GO:0030154|cell differentiation, GO:0030878|thyroid gland development, GO:0035019|somatic stem cell population maintenance, GO:0035690|cellular response to drug, GO:0042127|regulation of cell proliferation, GO:0043367|CD4-positive, alpha-beta T cell differentiation, GO:0043368|positive T cell selection, GO:0043369|CD4-positive or CD8-positive, alpha-beta T cell lineage commitment, GO:0043434|response to peptide hormone, GO:0043524|negative regulation of neuron apoptotic process, GO:0045580|regulation of T cell differentiation, GO:0046632|alpha-beta T cell differentiation, GO:0048538|thymus development, GO:0048679|regulation of axon regeneration, GO:0048680|positive regulation of axon regeneration, GO:0050772|positive regulation of axonogenesis, GO:0050852|T cell receptor signaling pathway, GO:0051291|protein heterooligomerization, GO:0051496|positive regulation of stress fiber assembly, GO:0051591|response to cAMP, GO:0060291|long-term synaptic potentiation, GO:0060323|head morphogenesis, GO:0060324|face development, GO:0070413|trehalose metabolism in response to stress, GO:0071277|cellular response to calcium ion, GO:0090150|establishment of protein localization to membrane, GO:1900026|positive regulation of substrate adhesion-dependent cell spreading, GO:1990090|cellular response to nerve growth factor stimulus, GO:2000301|negative regulation of synaptic vesicle exocytosis, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:0018108|peptidyl-tyrosine phosphorylation","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0005509|calcium ion binding, GO:0004709|MAP kinase kinase kinase activity, GO:0031434|mitogen-activated protein kinase kinase binding, GO:0046982|protein heterodimerization activity, GO:0004713|protein tyrosine kinase activity"
PRDM16,Missense,0.213657379573374,149,0.00888780897550926,Y,"oncogene, fusion",Oncogene,0.234534945007225,0.00398910527122144,ENSG00000142611,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0016235|aggresome, GO:0017053|transcriptional repressor complex","GO:0030154|cell differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0034968|histone lysine methylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0050873|brown fat cell differentiation, GO:0043457|regulation of cellular respiration, GO:0019827|stem cell population maintenance, GO:0022008|neurogenesis, GO:0035019|somatic stem cell population maintenance, GO:0043586|tongue development, GO:0050872|white fat cell differentiation, GO:0060021|roof of mouth development, GO:0090336|positive regulation of brown fat cell differentiation","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003713|transcription coactivator activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0018024|histone-lysine N-methyltransferase activity, GO:0033613|activating transcription factor binding, GO:0046332|SMAD binding"
FAS,Missense,0.212752474240562,25,0.307229924436872,N,TSG,TSG,0.12150380520584,0.562881517690559,ENSG00000026103,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0016604|nuclear body, GO:0045121|membrane raft, GO:0009986|cell surface, GO:0070062|extracellular exosome, GO:0031264|death-inducing signaling complex, GO:0031265|CD95 death-inducing signaling complex","GO:0007165|signal transduction, GO:0006915|apoptotic process, GO:0006955|immune response, GO:0043065|positive regulation of apoptotic process, GO:0071260|cellular response to mechanical stimulus, GO:0042981|regulation of apoptotic process, GO:0097190|apoptotic signaling pathway, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0097191|extrinsic apoptotic signaling pathway, GO:1902041|regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:1902042|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:0043066|negative regulation of apoptotic process, GO:0065003|protein-containing complex assembly, GO:0071455|cellular response to hyperoxia, GO:0097527|necroptotic signaling pathway, GO:0001934|positive regulation of protein phosphorylation, GO:0032872|regulation of stress-activated MAPK cascade, GO:0034198|cellular response to amino acid starvation, GO:0036337|Fas signaling pathway, GO:2001235|positive regulation of apoptotic signaling pathway, GO:2001269|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway","GO:0004888|transmembrane signaling receptor activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0005516|calmodulin binding, GO:0038023|signaling receptor activity, GO:0019900|kinase binding"
SMAD4,Missense,0.212514386488118,118,0.0208671664656782,N,TSG,TSG,0.390024013929469,1.26638614834121e-05,ENSG00000141646,"GO:0005634|nucleus, GO:0005667|transcription factor complex, GO:0005737|cytoplasm, GO:0005813|centrosome, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin, GO:0032444|activin responsive factor complex, GO:0071141|SMAD protein complex, GO:0090575|RNA polymerase II transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0070373|negative regulation of ERK1 and ERK2 cascade, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0010614|negative regulation of cardiac muscle hypertrophy, GO:0060412|ventricular septum morphogenesis, GO:0030513|positive regulation of BMP signaling pathway, GO:0030509|BMP signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:0016579|protein deubiquitination, GO:0071773|cellular response to BMP stimulus, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0062009|secondary palate development, GO:0003148|outflow tract septum morphogenesis, GO:0017015|regulation of transforming growth factor beta receptor signaling pathway, GO:0060395|SMAD protein signal transduction, GO:1901522|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus, GO:0030308|negative regulation of cell growth, GO:0070207|protein homotrimerization, GO:0035019|somatic stem cell population maintenance, GO:0010862|positive regulation of pathway-restricted SMAD protein phosphorylation, GO:0007183|SMAD protein complex assembly, GO:0060391|positive regulation of SMAD protein signal transduction, GO:0070102|interleukin-6-mediated signaling pathway, GO:0001666|response to hypoxia, GO:0006879|cellular iron ion homeostasis, GO:0051571|positive regulation of histone H3-K4 methylation, GO:2000617|positive regulation of histone H3-K9 acetylation, GO:0032909|regulation of transforming growth factor beta2 production, GO:0003220|left ventricular cardiac muscle tissue morphogenesis, GO:0035556|intracellular signal transduction, GO:0071559|response to transforming growth factor beta, GO:1905305|negative regulation of cardiac myofibril assembly, GO:0001541|ovarian follicle development, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0001701|in utero embryonic development, GO:0001702|gastrulation with mouth forming second, GO:0001822|kidney development, GO:0003190|atrioventricular valve formation, GO:0003198|epithelial to mesenchymal transition involved in endocardial cushion formation, GO:0003251|positive regulation of cell proliferation involved in heart valve morphogenesis, GO:0003279|cardiac septum development, GO:0003360|brainstem development, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007283|spermatogenesis, GO:0007338|single fertilization, GO:0007369|gastrulation, GO:0007411|axon guidance, GO:0007492|endoderm development, GO:0007498|mesoderm development, GO:0008283|cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0008584|male gonad development, GO:0008585|female gonad development, GO:0009952|anterior/posterior pattern specification, GO:0014033|neural crest cell differentiation, GO:0032525|somite rostral/caudal axis specification, GO:0033686|positive regulation of luteinizing hormone secretion, GO:0036302|atrioventricular canal development, GO:0042118|endothelial cell activation, GO:0042127|regulation of cell proliferation, GO:0042733|embryonic digit morphogenesis, GO:0046881|positive regulation of follicle-stimulating hormone secretion, GO:0048589|developmental growth, GO:0048663|neuron fate commitment, GO:0048729|tissue morphogenesis, GO:0048733|sebaceous gland development, GO:0048859|formation of anatomical boundary, GO:0051098|regulation of binding, GO:0051797|regulation of hair follicle development, GO:0060065|uterus development, GO:0060548|negative regulation of cell death, GO:0060956|endocardial cell differentiation, GO:0061040|female gonad morphogenesis, GO:0061614|pri-miRNA transcription by RNA polymerase II, GO:0072133|metanephric mesenchyme morphogenesis, GO:0072134|nephrogenic mesenchyme morphogenesis, GO:0072520|seminiferous tubule development","GO:0003700|DNA-binding transcription factor activity, GO:0044212|transcription regulatory region DNA binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0042803|protein homodimerization activity, GO:0070412|R-SMAD binding, GO:0003712|transcription coregulator activity, GO:0070411|I-SMAD binding, GO:0043565|sequence-specific DNA binding, GO:0043199|sulfate binding, GO:0030616|transforming growth factor beta receptor, common-partner cytoplasmic mediator activity, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0003682|chromatin binding, GO:0005518|collagen binding, GO:0046982|protein heterodimerization activity"
FOXO1,Missense,0.211643563659871,50,0.140087264564339,N,"oncogene, TSG, fusion","",0.279514629163588,0.0493154128531237,ENSG00000150907,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005654|nucleoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0006974|cellular response to DNA damage stimulus, GO:0006915|apoptotic process, GO:0006914|autophagy, GO:0030154|cell differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045444|fat cell differentiation, GO:0010508|positive regulation of autophagy, GO:0009267|cellular response to starvation, GO:0043065|positive regulation of apoptotic process, GO:0008286|insulin receptor signaling pathway, GO:0042593|glucose homeostasis, GO:0034599|cellular response to oxidative stress, GO:0043066|negative regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045599|negative regulation of fat cell differentiation, GO:0019221|cytokine-mediated signaling pathway, GO:0001678|cellular glucose homeostasis, GO:0032869|cellular response to insulin stimulus, GO:0097009|energy homeostasis, GO:0006473|protein acetylation, GO:0031018|endocrine pancreas development, GO:0045732|positive regulation of protein catabolic process, GO:0001659|temperature homeostasis, GO:0071455|cellular response to hyperoxia, GO:1903243|negative regulation of cardiac muscle hypertrophy in response to stress, GO:0032873|negative regulation of stress-activated MAPK cascade, GO:0071732|cellular response to nitric oxide, GO:0001568|blood vessel development, GO:0006357|regulation of transcription by RNA polymerase II, GO:0032868|response to insulin, GO:0035947|regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter, GO:0042127|regulation of cell proliferation, GO:0045722|positive regulation of gluconeogenesis, GO:0070166|enamel mineralization, GO:0070301|cellular response to hydrogen peroxide, GO:0070417|cellular response to cold, GO:0071549|cellular response to dexamethasone stimulus, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0097150|neuronal stem cell population maintenance, GO:1902617|response to fluoride, GO:2000177|regulation of neural precursor cell proliferation, GO:2000377|regulation of reactive oxygen species metabolic process","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0003682|chromatin binding, GO:0031625|ubiquitin protein ligase binding, GO:0008013|beta-catenin binding, GO:0051721|protein phosphatase 2A binding, GO:0001223|transcription coactivator binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific"
PHOX2B,Missense,0.210097409543159,39,0.199228082254702,N,TSG,TSG,0.267064112598326,0.100267578724136,ENSG00000109132,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0071157|negative regulation of cell cycle arrest, GO:0071773|cellular response to BMP stimulus, GO:0010971|positive regulation of G2/M transition of mitotic cell cycle, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0001764|neuron migration, GO:1901166|neural crest cell migration involved in autonomic nervous system development, GO:0003357|noradrenergic neuron differentiation, GO:0071542|dopaminergic neuron differentiation, GO:0010468|regulation of gene expression, GO:0048484|enteric nervous system development, GO:0061549|sympathetic ganglion development, GO:0003358|noradrenergic neuron development, GO:0048839|inner ear development, GO:0021533|cell differentiation in hindbrain, GO:0003360|brainstem development, GO:0048485|sympathetic nervous system development, GO:0002087|regulation of respiratory gaseous exchange by neurological system process, GO:0008285|negative regulation of cell proliferation, GO:0010001|glial cell differentiation, GO:0021723|medullary reticular formation development, GO:0021934|hindbrain tangential cell migration, GO:0030182|neuron differentiation, GO:0035914|skeletal muscle cell differentiation, GO:0045665|negative regulation of neuron differentiation, GO:0045666|positive regulation of neuron differentiation, GO:0048468|cell development, GO:0048483|autonomic nervous system development, GO:0048486|parasympathetic nervous system development, GO:0048894|efferent axon development in a lateral line nerve, GO:0060541|respiratory system development, GO:0061452|retrotrapezoid nucleus neuron differentiation","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding"
LZTR1,Missense,0.209972502266288,90,0.0469964736682659,N,TSG,TSG,0.251013009391413,0.0170155191584749,ENSG00000099949,GO:0005794|Golgi apparatus,"GO:0006355|regulation of transcription, DNA-templated, GO:0009653|anatomical structure morphogenesis",GO:0003700|DNA-binding transcription factor activity
BCL2,Missense,0.208958584277967,72,0.0781464697604094,N,"oncogene, fusion",Oncogene,0.0375752920415525,0.754001471575658,ENSG00000171791,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0031965|nuclear membrane, GO:0005739|mitochondrion, GO:0005829|cytosol, GO:0031966|mitochondrial membrane, GO:0043209|myelin sheath, GO:0005741|mitochondrial outer membrane, GO:0032991|protein-containing complex, GO:0046930|pore complex","GO:0043066|negative regulation of apoptotic process, GO:0042981|regulation of apoptotic process, GO:0006974|cellular response to DNA damage stimulus, GO:0000902|cell morphogenesis, GO:0001503|ossification, GO:0001541|ovarian follicle development, GO:0001656|metanephros development, GO:0001657|ureteric bud development, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0001662|behavioral fear response, GO:0001776|leukocyte homeostasis, GO:0001782|B cell homeostasis, GO:0001822|kidney development, GO:0001836|release of cytochrome c from mitochondria, GO:0001952|regulation of cell-matrix adhesion, GO:0002260|lymphocyte homeostasis, GO:0002320|lymphoid progenitor cell differentiation, GO:0002326|B cell lineage commitment, GO:0002360|T cell lineage commitment, GO:0002520|immune system development, GO:0002931|response to ischemia, GO:0003014|renal system process, GO:0006470|protein dephosphorylation, GO:0006582|melanin metabolic process, GO:0006808|regulation of nitrogen utilization, GO:0006874|cellular calcium ion homeostasis, GO:0006915|apoptotic process, GO:0006979|response to oxidative stress, GO:0007015|actin filament organization, GO:0007409|axonogenesis, GO:0007569|cell aging, GO:0008283|cell proliferation, GO:0008284|positive regulation of cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0008584|male gonad development, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0008631|intrinsic apoptotic signaling pathway in response to oxidative stress, GO:0008637|apoptotic mitochondrial changes, GO:0009636|response to toxic substance, GO:0009791|post-embryonic development, GO:0009887|animal organ morphogenesis, GO:0010224|response to UV-B, GO:0010332|response to gamma radiation, GO:0010468|regulation of gene expression, GO:0010506|regulation of autophagy, GO:0010507|negative regulation of autophagy, GO:0010523|negative regulation of calcium ion transport into cytosol, GO:0010559|regulation of glycoprotein biosynthetic process, GO:0014031|mesenchymal cell development, GO:0014042|positive regulation of neuron maturation, GO:0014911|positive regulation of smooth muscle cell migration, GO:0018105|peptidyl-serine phosphorylation, GO:0018107|peptidyl-threonine phosphorylation, GO:0021747|cochlear nucleus development, GO:0022612|gland morphogenesis, GO:0030097|hemopoiesis, GO:0030183|B cell differentiation, GO:0030217|T cell differentiation, GO:0030279|negative regulation of ossification, GO:0030308|negative regulation of cell growth, GO:0030318|melanocyte differentiation, GO:0030336|negative regulation of cell migration, GO:0031069|hair follicle morphogenesis, GO:0031103|axon regeneration, GO:0031647|regulation of protein stability, GO:0032469|endoplasmic reticulum calcium ion homeostasis, GO:0032835|glomerulus development, GO:0032880|regulation of protein localization, GO:0033033|negative regulation of myeloid cell apoptotic process, GO:0033077|T cell differentiation in thymus, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:0033689|negative regulation of osteoblast proliferation, GO:0034097|response to cytokine, GO:0035265|organ growth, GO:0040008|regulation of growth, GO:0040018|positive regulation of multicellular organism growth, GO:0042149|cellular response to glucose starvation, GO:0042493|response to drug, GO:0042542|response to hydrogen peroxide, GO:0043029|T cell homeostasis, GO:0043067|regulation of programmed cell death, GO:0043085|positive regulation of catalytic activity, GO:0043375|CD8-positive, alpha-beta T cell lineage commitment, GO:0043473|pigmentation, GO:0043524|negative regulation of neuron apoptotic process, GO:0043583|ear development, GO:0045069|regulation of viral genome replication, GO:0045636|positive regulation of melanocyte differentiation, GO:0045930|negative regulation of mitotic cell cycle, GO:0046671|negative regulation of retinal cell programmed cell death, GO:0046902|regulation of mitochondrial membrane permeability, GO:0048041|focal adhesion assembly, GO:0048066|developmental pigmentation, GO:0048070|regulation of developmental pigmentation, GO:0048087|positive regulation of developmental pigmentation, GO:0048536|spleen development, GO:0048538|thymus development, GO:0048545|response to steroid hormone, GO:0048546|digestive tract morphogenesis, GO:0048589|developmental growth, GO:0048599|oocyte development, GO:0048743|positive regulation of skeletal muscle fiber development, GO:0048753|pigment granule organization, GO:0048873|homeostasis of number of cells within a tissue, GO:0050790|regulation of catalytic activity, GO:0051384|response to glucocorticoid, GO:0051402|neuron apoptotic process, GO:0051726|regulation of cell cycle, GO:0051881|regulation of mitochondrial membrane potential, GO:0071310|cellular response to organic substance, GO:0071456|cellular response to hypoxia, GO:0072593|reactive oxygen species metabolic process, GO:0097192|extrinsic apoptotic signaling pathway in absence of ligand, GO:0098609|cell-cell adhesion, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle, GO:2000378|negative regulation of reactive oxygen species metabolic process, GO:2001234|negative regulation of apoptotic signaling pathway, GO:0055085|transmembrane transport, GO:0051607|defense response to virus, GO:0051902|negative regulation of mitochondrial depolarization, GO:0007565|female pregnancy, GO:0019221|cytokine-mediated signaling pathway, GO:0050853|B cell receptor signaling pathway, GO:2001243|negative regulation of intrinsic apoptotic signaling pathway, GO:1900740|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, GO:0009314|response to radiation, GO:2001244|positive regulation of intrinsic apoptotic signaling pathway, GO:1902166|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0006959|humoral immune response, GO:0000209|protein polyubiquitination, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0022898|regulation of transmembrane transporter activity, GO:0030890|positive regulation of B cell proliferation, GO:2000811|negative regulation of anoikis, GO:0010039|response to iron ion, GO:0030307|positive regulation of cell growth, GO:0032848|negative regulation of cellular pH reduction, GO:0035094|response to nicotine, GO:0042100|B cell proliferation, GO:0043496|regulation of protein homodimerization activity, GO:0043497|regulation of protein heterodimerization activity, GO:0051924|regulation of calcium ion transport, GO:0070059|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, GO:2001240|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand","GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0019903|protein phosphatase binding, GO:0046982|protein heterodimerization activity, GO:0051721|protein phosphatase 2A binding, GO:0042802|identical protein binding, GO:0051434|BH3 domain binding, GO:0031625|ubiquitin protein ligase binding, GO:0002020|protease binding, GO:0043565|sequence-specific DNA binding, GO:0015267|channel activity, GO:0016248|channel inhibitor activity"
HIP1,Missense,0.207104812420049,69,0.0877329386172874,N,"oncogene, fusion",Oncogene,0.324564620298664,0.00651114136443956,ENSG00000127946,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0031410|cytoplasmic vesicle, GO:0030136|clathrin-coated vesicle, GO:0005829|cytosol, GO:0012505|endomembrane system, GO:0030479|actin cortical patch, GO:0030665|clathrin-coated vesicle membrane, GO:0030122|AP-2 adaptor complex, GO:0005794|Golgi apparatus, GO:0005856|cytoskeleton, GO:0031234|extrinsic component of cytoplasmic side of plasma membrane, GO:0098793|presynapse, GO:0098794|postsynapse, GO:0098888|extrinsic component of presynaptic membrane, GO:0098890|extrinsic component of postsynaptic membrane","GO:0006897|endocytosis, GO:0006915|apoptotic process, GO:0048268|clathrin coat assembly, GO:0030154|cell differentiation, GO:0072583|clathrin-dependent endocytosis, GO:0007015|actin filament organization, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0030100|regulation of endocytosis, GO:0042981|regulation of apoptotic process, GO:0045742|positive regulation of epidermal growth factor receptor signaling pathway, GO:0048260|positive regulation of receptor-mediated endocytosis, GO:0050821|protein stabilization, GO:0051897|positive regulation of protein kinase B signaling, GO:0061024|membrane organization, GO:0097190|apoptotic signaling pathway, GO:0099637|neurotransmitter receptor transport, GO:2000588|positive regulation of platelet-derived growth factor receptor-beta signaling pathway","GO:0003779|actin binding, GO:0030276|clathrin binding, GO:0005515|protein binding, GO:0005543|phospholipid binding, GO:0035091|phosphatidylinositol binding, GO:0032051|clathrin light chain binding, GO:0051015|actin filament binding, GO:0080025|phosphatidylinositol-3,5-bisphosphate binding, GO:0005154|epidermal growth factor receptor binding, GO:0005200|structural constituent of cytoskeleton, GO:0032266|phosphatidylinositol-3-phosphate binding, GO:0035254|glutamate receptor binding, GO:0035612|AP-2 adaptor complex binding, GO:0035615|clathrin adaptor activity, GO:0042803|protein homodimerization activity, GO:0043325|phosphatidylinositol-3,4-bisphosphate binding, GO:0046982|protein heterodimerization activity"
CDK6,Silent,0.206633469493719,14,0.478463988997344,N,"oncogene, fusion",Oncogene,0.194772409196684,0.504604743131224,ENSG00000105810,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0001726|ruffle, GO:0000307|cyclin-dependent protein kinase holoenzyme complex, GO:0097132|cyclin D2-CDK6 complex","GO:0050680|negative regulation of epithelial cell proliferation, GO:0048146|positive regulation of fibroblast proliferation, GO:0045668|negative regulation of osteoblast differentiation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0051301|cell division, GO:0007049|cell cycle, GO:0030154|cell differentiation, GO:0042127|regulation of cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0009615|response to virus, GO:0007050|cell cycle arrest, GO:0045786|negative regulation of cell cycle, GO:0045638|negative regulation of myeloid cell differentiation, GO:0003323|type B pancreatic cell development, GO:0014002|astrocyte development, GO:0045596|negative regulation of cell differentiation, GO:0001954|positive regulation of cell-matrix adhesion, GO:0048699|generation of neurons, GO:2000145|regulation of cell motility, GO:0045656|negative regulation of monocyte differentiation, GO:0010468|regulation of gene expression, GO:0000082|G1/S transition of mitotic cell cycle, GO:0045646|regulation of erythrocyte differentiation, GO:0021670|lateral ventricle development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0002244|hematopoietic progenitor cell differentiation, GO:0007219|Notch signaling pathway, GO:0010628|positive regulation of gene expression, GO:0021542|dentate gyrus development, GO:0030097|hemopoiesis, GO:0033077|T cell differentiation in thymus, GO:0042063|gliogenesis, GO:0043697|cell dedifferentiation, GO:0060218|hematopoietic stem cell differentiation, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:2000773|negative regulation of cellular senescence","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0004693|cyclin-dependent protein serine/threonine kinase activity, GO:0030332|cyclin binding, GO:0098770|FBXO family protein binding"
VHL,Nonsense,0.206338322557165,27,0.301792486748783,N,TSG,TSG,0.155806866632035,0.43772269626384,ENSG00000134086,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005783|endoplasmic reticulum, GO:0005739|mitochondrion, GO:0005829|cytosol, GO:0030891|VCB complex","GO:0016567|protein ubiquitination, GO:0045893|positive regulation of transcription, DNA-templated, GO:0050821|protein stabilization, GO:0043687|post-translational protein modification, GO:0043066|negative regulation of apoptotic process, GO:0045597|positive regulation of cell differentiation, GO:0008285|negative regulation of cell proliferation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006508|proteolysis, GO:0006355|regulation of transcription, DNA-templated, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0000902|cell morphogenesis, GO:0010629|negative regulation of gene expression, GO:0046426|negative regulation of JAK-STAT cascade, GO:0061428|negative regulation of transcription from RNA polymerase II promoter in response to hypoxia","GO:0005515|protein binding, GO:0061630|ubiquitin protein ligase activity, GO:0008134|transcription factor binding, GO:0019899|enzyme binding, GO:0004842|ubiquitin-protein transferase activity"
CARD11,Silent,0.205590935408924,94,0.0468229677313258,N,Oncogene,Oncogene,0.223600732365655,0.0302812350851295,ENSG00000198286,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0045121|membrane raft, GO:0001772|immunological synapse, GO:0005829|cytosol, GO:0070062|extracellular exosome, GO:0032449|CBM complex","GO:0042981|regulation of apoptotic process, GO:0002377|immunoglobulin production, GO:0007165|signal transduction, GO:0030183|B cell differentiation, GO:0030890|positive regulation of B cell proliferation, GO:0042100|B cell proliferation, GO:0042102|positive regulation of T cell proliferation, GO:0042110|T cell activation, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0045061|thymic T cell selection, GO:0045086|positive regulation of interleukin-2 biosynthetic process, GO:0045577|regulation of B cell differentiation, GO:0045580|regulation of T cell differentiation, GO:0046649|lymphocyte activation, GO:0048872|homeostasis of number of cells, GO:0050776|regulation of immune response, GO:0050870|positive regulation of T cell activation, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0070970|interleukin-2 secretion, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0050852|T cell receptor signaling pathway, GO:0001819|positive regulation of cytokine production, GO:0046037|GMP metabolic process, GO:0046710|GDP metabolic process, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0007249|I-kappaB kinase/NF-kappaB signaling, GO:0031295|T cell costimulation, GO:0038202|TORC1 signaling","GO:0005515|protein binding, GO:0050700|CARD domain binding, GO:0004385|guanylate kinase activity"
CREBBP,Missense,0.205372161827713,244,0.00125533929772956,Y,"oncogene, TSG, fusion","",0.215086972915391,0.000719116348737094,ENSG00000005339,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0000123|histone acetyltransferase complex, GO:0016604|nuclear body, GO:0000790|nuclear chromatin","GO:0006355|regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0048511|rhythmic process, GO:0016573|histone acetylation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0031648|protein destabilization, GO:0001666|response to hypoxia, GO:0016032|viral process, GO:0042981|regulation of apoptotic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1904837|beta-catenin-TCF complex assembly, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0065003|protein-containing complex assembly, GO:0042592|homeostatic process, GO:0042733|embryonic digit morphogenesis, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0034644|cellular response to UV, GO:0019216|regulation of lipid metabolic process, GO:0006473|protein acetylation, GO:1900034|regulation of cellular response to heat, GO:0007219|Notch signaling pathway, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0045637|regulation of myeloid cell differentiation, GO:0032481|positive regulation of type I interferon production, GO:0007221|positive regulation of transcription of Notch receptor target, GO:0045747|positive regulation of Notch signaling pathway, GO:0018076|N-terminal peptidyl-lysine acetylation, GO:0008589|regulation of smoothened signaling pathway","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003713|transcription coactivator activity, GO:0003712|transcription coregulator activity, GO:0016746|transferase activity, transferring acyl groups, GO:0005515|protein binding, GO:0004402|histone acetyltransferase activity, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0003714|transcription corepressor activity, GO:0002039|p53 binding, GO:0003684|damaged DNA binding, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0016407|acetyltransferase activity, GO:0034212|peptide N-acetyltransferase activity, GO:0043426|MRF binding"
BCL6,Missense,0.205254246997913,72,0.0836970559166518,N,"oncogene, fusion",Oncogene,0.282035130304417,0.0163857081998442,ENSG00000113916,"GO:0005634|nucleus, GO:0005794|Golgi apparatus, GO:0005654|nucleoplasm, GO:0005657|replication fork","GO:0006974|cellular response to DNA damage stimulus, GO:0006954|inflammatory response, GO:0002376|immune system process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0043065|positive regulation of apoptotic process, GO:0030308|negative regulation of cell growth, GO:0042981|regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0019221|cytokine-mediated signaling pathway, GO:0045591|positive regulation of regulatory T cell differentiation, GO:0050727|regulation of inflammatory response, GO:0000060|protein import into nucleus, translocation, GO:0042127|regulation of cell proliferation, GO:0050776|regulation of immune response, GO:0000902|cell morphogenesis, GO:0001953|negative regulation of cell-matrix adhesion, GO:0002467|germinal center formation, GO:0002634|regulation of germinal center formation, GO:0002829|negative regulation of type 2 immune response, GO:0002903|negative regulation of B cell apoptotic process, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007266|Rho protein signal transduction, GO:0007283|spermatogenesis, GO:0008104|protein localization, GO:0008285|negative regulation of cell proliferation, GO:0030036|actin cytoskeleton organization, GO:0030183|B cell differentiation, GO:0030890|positive regulation of B cell proliferation, GO:0031065|positive regulation of histone deacetylation, GO:0032764|negative regulation of mast cell cytokine production, GO:0035024|negative regulation of Rho protein signal transduction, GO:0042092|type 2 immune response, GO:0043066|negative regulation of apoptotic process, GO:0043087|regulation of GTPase activity, GO:0043380|regulation of memory T cell differentiation, GO:0045596|negative regulation of cell differentiation, GO:0045629|negative regulation of T-helper 2 cell differentiation, GO:0045666|positive regulation of neuron differentiation, GO:0045746|negative regulation of Notch signaling pathway, GO:0048294|negative regulation of isotype switching to IgE isotypes, GO:0048821|erythrocyte development, GO:0051272|positive regulation of cellular component movement, GO:1903464|negative regulation of mitotic cell cycle DNA replication, GO:2000773|negative regulation of cellular senescence","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0042802|identical protein binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0001161|intronic transcription regulatory region sequence-specific DNA binding, GO:0031490|chromatin DNA binding"
FBXW7,Missense,0.204800393535599,98,0.0430831378470069,N,TSG,TSG,0.395392726463157,5.59079675919561e-05,ENSG00000109670,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0005829|cytosol, GO:1990452|Parkin-FBXW7-Cul1 ubiquitin ligase complex, GO:0019005|SCF ubiquitin ligase complex, GO:0005739|mitochondrion, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0048471|perinuclear region of cytoplasm","GO:0010629|negative regulation of gene expression, GO:0050821|protein stabilization, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0010868|negative regulation of triglyceride biosynthetic process, GO:0055088|lipid homeostasis, GO:0045746|negative regulation of Notch signaling pathway, GO:0016567|protein ubiquitination, GO:0043161|proteasome-mediated ubiquitin-dependent protein catabolic process, GO:0043687|post-translational protein modification, GO:0016032|viral process, GO:1903146|regulation of autophagy of mitochondrion, GO:2000060|positive regulation of ubiquitin-dependent protein catabolic process, GO:1903955|positive regulation of protein targeting to mitochondrion, GO:0000209|protein polyubiquitination, GO:0001944|vasculature development, GO:1901800|positive regulation of proteasomal protein catabolic process, GO:0031398|positive regulation of protein ubiquitination, GO:0032880|regulation of protein localization, GO:2001205|negative regulation of osteoclast development, GO:0045741|positive regulation of epidermal growth factor-activated receptor activity, GO:1902806|regulation of cell cycle G1/S phase transition, GO:0031146|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process, GO:0007062|sister chromatid cohesion, GO:0032876|negative regulation of DNA endoreduplication, GO:0051443|positive regulation of ubiquitin-protein transferase activity, GO:1903378|positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway, GO:0001570|vasculogenesis, GO:0007219|Notch signaling pathway, GO:0010883|regulation of lipid storage, GO:0010992|ubiquitin recycling, GO:0030324|lung development, GO:0031648|protein destabilization, GO:0090049|regulation of cell migration involved in sprouting angiogenesis, GO:1903026|negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding, GO:2000346|negative regulation of hepatocyte proliferation, GO:2000639|negative regulation of SREBP signaling pathway","GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0043130|ubiquitin binding, GO:0030332|cyclin binding, GO:0031625|ubiquitin protein ligase binding, GO:0004842|ubiquitin-protein transferase activity, GO:0030674|protein binding, bridging, GO:0097027|ubiquitin-protein transferase activator activity, GO:0050816|phosphothreonine residue binding"
LZTR1,Silent,0.20397069029166,19,0.402262750184761,N,TSG,TSG,0.174086604285471,0.475980986793529,ENSG00000099949,GO:0005794|Golgi apparatus,"GO:0006355|regulation of transcription, DNA-templated, GO:0009653|anatomical structure morphogenesis",GO:0003700|DNA-binding transcription factor activity
PTPRK,Nonsense,0.203763607749611,21,0.375654297767839,N,"TSG, fusion",TSG,0.194447339042018,0.398327588299502,ENSG00000152894,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005886|plasma membrane, GO:0030054|cell junction, GO:0009986|cell surface, GO:0005887|integral component of plasma membrane, GO:0005912|adherens junction, GO:0005911|cell-cell junction, GO:0031256|leading edge membrane, GO:0001750|photoreceptor outer segment, GO:0030424|axon, GO:0030425|dendrite, GO:0043025|neuronal cell body","GO:0007155|cell adhesion, GO:0006470|protein dephosphorylation, GO:0007165|signal transduction, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0008285|negative regulation of cell proliferation, GO:0016477|cell migration, GO:0048041|focal adhesion assembly, GO:0045786|negative regulation of cell cycle, GO:0045892|negative regulation of transcription, DNA-templated, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0034394|protein localization to cell surface, GO:0030336|negative regulation of cell migration, GO:0034644|cellular response to UV, GO:0034614|cellular response to reactive oxygen species, GO:0010839|negative regulation of keratinocyte proliferation, GO:0031175|neuron projection development","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0019901|protein kinase binding, GO:0008013|beta-catenin binding, GO:0045295|gamma-catenin binding, GO:0005001|transmembrane receptor protein tyrosine phosphatase activity"
CRTC3,Missense,0.203692698199842,36,0.23343141482467,N,fusion,"",0.218951952420762,0.199498201575326,ENSG00000140577,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm","GO:0051289|protein homotetramerization, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016032|viral process, GO:0032793|positive regulation of CREB transcription factor activity, GO:0042116|macrophage activation, GO:0043951|negative regulation of cAMP-mediated signaling, GO:0050995|negative regulation of lipid catabolic process, GO:0097009|energy homeostasis",GO:0008140|cAMP response element binding protein binding
CYLD,Missense,0.203400379585484,65,0.104144419035953,N,TSG,TSG,0.307017508258034,0.0128599415364135,ENSG00000083799,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0048471|perinuclear region of cytoplasm, GO:0005874|microtubule, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0005819|spindle, GO:0030496|midbody, GO:0036064|ciliary basal body, GO:0031234|extrinsic component of cytoplasmic side of plasma membrane, GO:0005881|cytoplasmic microtubule, GO:0097542|ciliary tip","GO:0016579|protein deubiquitination, GO:0006508|proteolysis, GO:0007049|cell cycle, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0016055|Wnt signaling pathway, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0070507|regulation of microtubule cytoskeleton organization, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:1902017|regulation of cilium assembly, GO:0032088|negative regulation of NF-kappaB transcription factor activity, GO:0070536|protein K63-linked deubiquitination, GO:0007346|regulation of mitotic cell cycle, GO:0071108|protein K48-linked deubiquitination, GO:0046329|negative regulation of JNK cascade, GO:0010803|regulation of tumor necrosis factor-mediated signaling pathway, GO:0032480|negative regulation of type I interferon production, GO:0060544|regulation of necroptotic process, GO:0070423|nucleotide-binding oligomerization domain containing signaling pathway, GO:2001238|positive regulation of extrinsic apoptotic signaling pathway, GO:1901223|negative regulation of NIK/NF-kappaB signaling, GO:0050727|regulation of inflammatory response, GO:1903753|negative regulation of p38MAPK cascade, GO:2001242|regulation of intrinsic apoptotic signaling pathway, GO:1990108|protein linear deubiquitination, GO:0070266|necroptotic process, GO:0043369|CD4-positive or CD8-positive, alpha-beta T cell lineage commitment, GO:0043393|regulation of protein binding, GO:0045577|regulation of B cell differentiation, GO:0045582|positive regulation of T cell differentiation, GO:0048872|homeostasis of number of cells, GO:0050862|positive regulation of T cell receptor signaling pathway, GO:1901026|ripoptosome assembly involved in necroptotic process, GO:1903829|positive regulation of cellular protein localization","GO:0046872|metal ion binding, GO:0016787|hydrolase activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0004843|thiol-dependent ubiquitin-specific protease activity, GO:0019901|protein kinase binding, GO:0061578|Lys63-specific deubiquitinase activity, GO:0070064|proline-rich region binding, GO:1990380|Lys48-specific deubiquitinase activity"
TRAF7,Missense,0.203377342566484,57,0.129177077989319,N,TSG,TSG,0.200987714484861,0.133834485770731,ENSG00000131653,"GO:0043231|intracellular membrane-bounded organelle, GO:0005886|plasma membrane, GO:0031410|cytoplasmic vesicle, GO:0005730|nucleolus, GO:0000151|ubiquitin ligase complex","GO:0016567|protein ubiquitination, GO:0006915|apoptotic process, GO:0000027|ribosomal large subunit assembly, GO:0007219|Notch signaling pathway, GO:0000185|activation of MAPKKK activity, GO:2001235|positive regulation of apoptotic signaling pathway, GO:0043410|positive regulation of MAPK cascade","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity"
MYH9,Missense,0.202651363874688,163,0.00947716206649061,Y,"TSG, fusion",TSG,0.213339828154475,0.00625071545098159,ENSG00000100345,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016459|myosin complex, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0001725|stress fiber, GO:0001772|immunological synapse, GO:0001931|uropod, GO:0005819|spindle, GO:0005903|brush border, GO:0005913|cell-cell adherens junction, GO:0005925|focal adhesion, GO:0005938|cell cortex, GO:0016460|myosin II complex, GO:0030863|cortical cytoskeleton, GO:0031594|neuromuscular junction, GO:0031252|cell leading edge, GO:0070062|extracellular exosome, GO:0008180|COP9 signalosome, GO:0032154|cleavage furrow, GO:0032991|protein-containing complex, GO:0001726|ruffle, GO:0015629|actin cytoskeleton, GO:0005826|actomyosin contractile ring, GO:0042641|actomyosin, GO:0097513|myosin II filament","GO:0015031|protein transport, GO:0007155|cell adhesion, GO:0000212|meiotic spindle organization, GO:0000904|cell morphogenesis involved in differentiation, GO:0001701|in utero embryonic development, GO:0001768|establishment of T cell polarity, GO:0006911|phagocytosis, engulfment, GO:0007520|myoblast fusion, GO:0008360|regulation of cell shape, GO:0032796|uropod organization, GO:0051295|establishment of meiotic spindle localization, GO:0098609|cell-cell adhesion, GO:1903919|negative regulation of actin filament severing, GO:1903923|positive regulation of protein processing in phagocytic vesicle, GO:0007229|integrin-mediated signaling pathway, GO:0032506|cytokinetic process, GO:0001525|angiogenesis, GO:0070527|platelet aggregation, GO:0006509|membrane protein ectodomain proteolysis, GO:0031532|actin cytoskeleton reorganization, GO:0030048|actin filament-based movement, GO:0030220|platelet formation, GO:0030224|monocyte differentiation, GO:0031032|actomyosin structure organization, GO:0043534|blood vessel endothelial cell migration, GO:0050900|leukocyte migration","GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0003774|motor activity, GO:0003779|actin binding, GO:0051015|actin filament binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0019904|protein domain specific binding, GO:0005516|calmodulin binding, GO:0045296|cadherin binding, GO:0016887|ATPase activity, GO:0005178|integrin binding, GO:0000146|microfilament motor activity, GO:0043495|protein membrane anchor, GO:0030898|actin-dependent ATPase activity, GO:0043531|ADP binding"
IRS4,Silent,0.202201121616535,51,0.154749978844958,N,"oncogene, TSG","",0.168239396106727,0.237953265966982,ENSG00000133124,"GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005829|cytosol","GO:0009967|positive regulation of signal transduction, GO:0007165|signal transduction, GO:0008286|insulin receptor signaling pathway","GO:0005515|protein binding, GO:0005158|insulin receptor binding, GO:0005070|SH3/SH2 adaptor activity, GO:0043548|phosphatidylinositol 3-kinase binding"
RB1,Missense,0.202085616902424,76,0.0800053497527978,N,TSG,TSG,0.195461076117017,0.0906243878172733,ENSG00000139687,"GO:0005634|nucleus, GO:0005667|transcription factor complex, GO:0005819|spindle, GO:0035189|Rb-E2F complex, GO:0005654|nucleoplasm, GO:0000785|chromatin, GO:0016605|PML body, GO:0016514|SWI/SNF complex, GO:0008024|cyclin/CDK positive transcription elongation factor complex, GO:0005575|cellular_component","GO:0050728|negative regulation of inflammatory response, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle, GO:0006325|chromatin organization, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006915|apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0007049|cell cycle, GO:0051726|regulation of cell cycle, GO:0008285|negative regulation of cell proliferation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000082|G1/S transition of mitotic cell cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001558|regulation of cell growth, GO:0001894|tissue homeostasis, GO:0003180|aortic valve morphogenesis, GO:0007050|cell cycle arrest, GO:0010629|negative regulation of gene expression, GO:0030182|neuron differentiation, GO:0031175|neuron projection development, GO:0034349|glial cell apoptotic process, GO:0035914|skeletal muscle cell differentiation, GO:0042551|neuron maturation, GO:0043353|enucleate erythrocyte differentiation, GO:0045651|positive regulation of macrophage differentiation, GO:0045786|negative regulation of cell cycle, GO:0045879|negative regulation of smoothened signaling pathway, GO:0045930|negative regulation of mitotic cell cycle, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048565|digestive tract development, GO:0048667|cell morphogenesis involved in neuron differentiation, GO:0050680|negative regulation of epithelial cell proliferation, GO:0051146|striated muscle cell differentiation, GO:0051301|cell division, GO:0051402|neuron apoptotic process, GO:0071466|cellular response to xenobiotic stimulus, GO:0071930|negative regulation of transcription involved in G1/S transition of mitotic cell cycle, GO:0097284|hepatocyte apoptotic process, GO:0120163|negative regulation of cold-induced thermogenesis, GO:1903055|positive regulation of extracellular matrix organization, GO:1904028|positive regulation of collagen fibril organization, GO:1904761|negative regulation of myofibroblast differentiation, GO:0030154|cell differentiation, GO:0016032|viral process, GO:0006355|regulation of transcription, DNA-templated, GO:0030521|androgen receptor signaling pathway, GO:0006338|chromatin remodeling, GO:0006469|negative regulation of protein kinase activity, GO:0007093|mitotic cell cycle checkpoint, GO:0007265|Ras protein signal transduction, GO:0007346|regulation of mitotic cell cycle, GO:0031134|sister chromatid biorientation, GO:0034088|maintenance of mitotic sister chromatid cohesion, GO:0043550|regulation of lipid kinase activity, GO:0045445|myoblast differentiation, GO:0045842|positive regulation of mitotic metaphase/anaphase transition, GO:0071459|protein localization to chromosome, centromeric region, GO:0071922|regulation of cohesin loading, GO:0090230|regulation of centromere complex assembly, GO:2000679|positive regulation of transcription regulatory region DNA binding, GO:0008150|biological_process","GO:0003677|DNA binding, GO:0008134|transcription factor binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0019899|enzyme binding, GO:0042802|identical protein binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0031625|ubiquitin protein ligase binding, GO:0003700|DNA-binding transcription factor activity, GO:0051219|phosphoprotein binding, GO:0019900|kinase binding, GO:0050681|androgen receptor binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0097718|disordered domain specific binding, GO:0061676|importin-alpha family protein binding, GO:0003674|molecular_function"
BARD1,Missense,0.201966352471239,39,0.217576833988601,N,TSG,TSG,0.0466689209649708,0.777852539843672,ENSG00000138376,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0031436|BRCA1-BARD1 complex, GO:0036464|cytoplasmic ribonucleoprotein granule, GO:0005654|nucleoplasm, GO:0000151|ubiquitin ligase complex, GO:0070531|BRCA1-A complex","GO:0016567|protein ubiquitination, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0085020|protein K6-linked ubiquitination, GO:0043065|positive regulation of apoptotic process, GO:0016579|protein deubiquitination, GO:0007050|cell cycle arrest, GO:0043066|negative regulation of apoptotic process, GO:0006260|DNA replication, GO:0001894|tissue homeostasis, GO:0042325|regulation of phosphorylation, GO:0000729|DNA double-strand break processing, GO:0006303|double-strand break repair via nonhomologous end joining, GO:0045732|positive regulation of protein catabolic process, GO:0046826|negative regulation of protein export from nucleus, GO:0031441|negative regulation of mRNA 3'-end processing","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0046982|protein heterodimerization activity, GO:0019900|kinase binding, GO:0003723|RNA binding"
STIL,Silent,0.20170916226372,27,0.313005544853787,N,"oncogene, fusion",Oncogene,0.258546773922885,0.19286485125853,ENSG00000123473,"GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005856|cytoskeleton, GO:0005813|centrosome, GO:0005814|centriole","GO:0043066|negative regulation of apoptotic process, GO:0007275|multicellular organism development, GO:0008283|cell proliferation, GO:0001947|heart looping, GO:0007368|determination of left/right symmetry, GO:0000578|embryonic axis specification, GO:0021915|neural tube development, GO:0001843|neural tube closure, GO:0007052|mitotic spindle organization, GO:0030903|notochord development, GO:0033504|floor plate development, GO:0046599|regulation of centriole replication, GO:0007224|smoothened signaling pathway, GO:0001701|in utero embryonic development, GO:0051298|centrosome duplication, GO:0071539|protein localization to centrosome, GO:0030900|forebrain development, GO:0035264|multicellular organism growth","GO:0005515|protein binding, GO:0042802|identical protein binding"
SOX2,Missense,0.201647449194427,27,0.313156746379165,N,Oncogene,Oncogene,0.206937815732967,0.300358949823643,ENSG00000181449,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0044798|nuclear transcription factor complex, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0007275|multicellular organism development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030154|cell differentiation, GO:0030182|neuron differentiation, GO:0021984|adenohypophysis development, GO:0022409|positive regulation of cell-cell adhesion, GO:0042246|tissue regeneration, GO:0045597|positive regulation of cell differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0001654|eye development, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0007050|cell cycle arrest, GO:0043410|positive regulation of MAPK cascade, GO:0019221|cytokine-mediated signaling pathway, GO:0045665|negative regulation of neuron differentiation, GO:0097150|neuronal stem cell population maintenance, GO:0007417|central nervous system development, GO:0045165|cell fate commitment, GO:0050680|negative regulation of epithelial cell proliferation, GO:0035019|somatic stem cell population maintenance, GO:0001649|osteoblast differentiation, GO:0009611|response to wounding, GO:0021983|pituitary gland development, GO:0048839|inner ear development, GO:0010468|regulation of gene expression, GO:0070848|response to growth factor, GO:0030900|forebrain development, GO:0001714|endodermal cell fate specification, GO:0021781|glial cell fate commitment, GO:0043281|regulation of cysteine-type endopeptidase activity involved in apoptotic process","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0043565|sequence-specific DNA binding, GO:0035198|miRNA binding"
FES,Silent,0.200748177428117,20,0.396073363391746,N,"oncogene, TSG","",0.271797257537317,0.246360608027888,ENSG00000182511,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005794|Golgi apparatus, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0030054|cell junction, GO:0031410|cytoplasmic vesicle, GO:0005925|focal adhesion, GO:0031234|extrinsic component of cytoplasmic side of plasma membrane, GO:0015630|microtubule cytoskeleton, GO:0016021|integral component of membrane","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0007155|cell adhesion, GO:0030155|regulation of cell adhesion, GO:0008360|regulation of cell shape, GO:0042127|regulation of cell proliferation, GO:0007275|multicellular organism development, GO:0046777|protein autophosphorylation, GO:0006935|chemotaxis, GO:0008283|cell proliferation, GO:2000145|regulation of cell motility, GO:0010976|positive regulation of neuron projection development, GO:0045595|regulation of cell differentiation, GO:0031116|positive regulation of microtubule polymerization, GO:0043304|regulation of mast cell degranulation, GO:0045639|positive regulation of myeloid cell differentiation, GO:0060627|regulation of vesicle-mediated transport, GO:2000251|positive regulation of actin cytoskeleton reorganization, GO:0001578|microtubule bundle formation, GO:0007098|centrosome cycle","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0008289|lipid binding, GO:0035091|phosphatidylinositol binding, GO:0034987|immunoglobulin receptor binding, GO:0008017|microtubule binding"
FOXO3,Missense,0.20063301214343,38,0.227125119167667,N,"oncogene, TSG, fusion","",0.128463516407351,0.442106014065107,ENSG00000118689,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005741|mitochondrial outer membrane, GO:0005759|mitochondrial matrix, GO:0032991|protein-containing complex","GO:0043065|positive regulation of apoptotic process, GO:0030336|negative regulation of cell migration, GO:0006355|regulation of transcription, DNA-templated, GO:0006915|apoptotic process, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006417|regulation of translation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0008286|insulin receptor signaling pathway, GO:0042593|glucose homeostasis, GO:0034599|cellular response to oxidative stress, GO:0019221|cytokine-mediated signaling pathway, GO:0006390|mitochondrial transcription, GO:0033209|tumor necrosis factor-mediated signaling pathway, GO:0043525|positive regulation of neuron apoptotic process, GO:0045648|positive regulation of erythrocyte differentiation, GO:0001542|ovulation from ovarian follicle, GO:0001544|initiation of primordial ovarian follicle growth, GO:0001547|antral ovarian follicle growth, GO:0001556|oocyte maturation, GO:0007568|aging, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0031667|response to nutrient levels, GO:0042493|response to drug, GO:0045665|negative regulation of neuron differentiation, GO:0048854|brain morphogenesis, GO:0071333|cellular response to glucose stimulus, GO:0071386|cellular response to corticosterone stimulus, GO:0071456|cellular response to hypoxia, GO:0071548|response to dexamethasone, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0097150|neuronal stem cell population maintenance, GO:0097192|extrinsic apoptotic signaling pathway in absence of ligand, GO:1901300|positive regulation of hydrogen peroxide-mediated programmed cell death, GO:1903428|positive regulation of reactive oxygen species biosynthetic process, GO:1904646|cellular response to amyloid-beta, GO:1990090|cellular response to nerve growth factor stimulus, GO:1990785|response to water-immersion restraint stress, GO:2000177|regulation of neural precursor cell proliferation, GO:2000353|positive regulation of endothelial cell apoptotic process, GO:2000377|regulation of reactive oxygen species metabolic process","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0031490|chromatin DNA binding, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0019901|protein kinase binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0008013|beta-catenin binding, GO:0034246|mitochondrial sequence-specific DNA-binding transcription factor activity, GO:0001221|transcription cofactor binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
RHOA,Missense,0.200505089301702,37,0.234087991960485,N,"oncogene, TSG","",0.368199146124702,0.0249469289204305,ENSG00000067560,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0005634|nucleus, GO:0030027|lamellipodium, GO:0030424|axon, GO:0032587|ruffle membrane, GO:0005925|focal adhesion, GO:0030496|midbody, GO:0043231|intracellular membrane-bounded organelle, GO:0005789|endoplasmic reticulum membrane, GO:0031234|extrinsic component of cytoplasmic side of plasma membrane, GO:0070062|extracellular exosome, GO:0071944|cell periphery, GO:0005938|cell cortex, GO:0032154|cleavage furrow, GO:0043296|apical junction complex, GO:0032153|cell division site, GO:0030667|secretory granule membrane, GO:0030054|cell junction, GO:0098978|glutamatergic synapse, GO:0101003|ficolin-1-rich granule membrane, GO:0043197|dendritic spine, GO:0098794|postsynapse, GO:0031982|vesicle, GO:0005768|endosome","GO:0071345|cellular response to cytokine stimulus, GO:0051301|cell division, GO:0007264|small GTPase mediated signal transduction, GO:0044319|wound healing, spreading of cells, GO:1902766|skeletal muscle satellite cell migration, GO:0007049|cell cycle, GO:0000902|cell morphogenesis, GO:0001666|response to hypoxia, GO:0001998|angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure, GO:0002363|alpha-beta T cell lineage commitment, GO:0003100|regulation of systemic arterial blood pressure by endothelin, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007010|cytoskeleton organization, GO:0007155|cell adhesion, GO:0007160|cell-matrix adhesion, GO:0007266|Rho protein signal transduction, GO:0007519|skeletal muscle tissue development, GO:0008064|regulation of actin polymerization or depolymerization, GO:0009612|response to mechanical stimulus, GO:0009749|response to glucose, GO:0010812|negative regulation of cell-substrate adhesion, GO:0010975|regulation of neuron projection development, GO:0010977|negative regulation of neuron projection development, GO:0021795|cerebral cortex cell migration, GO:0021861|forebrain radial glial cell differentiation, GO:0030036|actin cytoskeleton organization, GO:0030154|cell differentiation, GO:0030307|positive regulation of cell growth, GO:0030335|positive regulation of cell migration, GO:0030521|androgen receptor signaling pathway, GO:0030838|positive regulation of actin filament polymerization, GO:0031098|stress-activated protein kinase signaling cascade, GO:0032956|regulation of actin cytoskeleton organization, GO:0033144|negative regulation of intracellular steroid hormone receptor signaling pathway, GO:0033688|regulation of osteoblast proliferation, GO:0042476|odontogenesis, GO:0042493|response to drug, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0043149|stress fiber assembly, GO:0043200|response to amino acid, GO:0043280|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0043297|apical junction assembly, GO:0043366|beta selection, GO:0043524|negative regulation of neuron apoptotic process, GO:0043525|positive regulation of neuron apoptotic process, GO:0043931|ossification involved in bone maturation, GO:0045471|response to ethanol, GO:0045665|negative regulation of neuron differentiation, GO:0045727|positive regulation of translation, GO:0045785|positive regulation of cell adhesion, GO:0045907|positive regulation of vasoconstriction, GO:0045987|positive regulation of smooth muscle contraction, GO:0046039|GTP metabolic process, GO:0046638|positive regulation of alpha-beta T cell differentiation, GO:0048812|neuron projection morphogenesis, GO:0050773|regulation of dendrite development, GO:0051384|response to glucocorticoid, GO:0051924|regulation of calcium ion transport, GO:0060548|negative regulation of cell death, GO:0061383|trabecula morphogenesis, GO:0070507|regulation of microtubule cytoskeleton organization, GO:0071803|positive regulation of podosome assembly, GO:0090324|negative regulation of oxidative phosphorylation, GO:1903427|negative regulation of reactive oxygen species biosynthetic process, GO:1904695|positive regulation of vascular smooth muscle contraction, GO:1905244|regulation of modification of synaptic structure, GO:2000177|regulation of neural precursor cell proliferation, GO:0030334|regulation of cell migration, GO:0051056|regulation of small GTPase mediated signal transduction, GO:0071222|cellular response to lipopolysaccharide, GO:0071902|positive regulation of protein serine/threonine kinase activity, GO:0016477|cell migration, GO:0016579|protein deubiquitination, GO:0016032|viral process, GO:0008360|regulation of cell shape, GO:0007186|G protein-coupled receptor signaling pathway, GO:0051017|actin filament bundle assembly, GO:0034329|cell junction assembly, GO:0045198|establishment of epithelial cell apical/basal polarity, GO:0043312|neutrophil degranulation, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0021762|substantia nigra development, GO:1901224|positive regulation of NIK/NF-kappaB signaling, GO:0007015|actin filament organization, GO:0030950|establishment or maintenance of actin cytoskeleton polarity, GO:0048013|ephrin receptor signaling pathway, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0048015|phosphatidylinositol-mediated signaling, GO:2000145|regulation of cell motility, GO:0032467|positive regulation of cytokinesis, GO:0060071|Wnt signaling pathway, planar cell polarity pathway, GO:0090307|mitotic spindle assembly, GO:0031532|actin cytoskeleton reorganization, GO:0050919|negative chemotaxis, GO:0043542|endothelial cell migration, GO:1904996|positive regulation of leukocyte adhesion to vascular endothelial cell, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0050772|positive regulation of axonogenesis, GO:0038027|apolipoprotein A-I-mediated signaling pathway, GO:0060193|positive regulation of lipase activity, GO:0050771|negative regulation of axonogenesis, GO:2000406|positive regulation of T cell migration, GO:0051496|positive regulation of stress fiber assembly, GO:0035385|Roundabout signaling pathway, GO:0036089|cleavage furrow formation, GO:0045666|positive regulation of neuron differentiation, GO:0045792|negative regulation of cell size, GO:0051893|regulation of focal adhesion assembly, GO:0090051|negative regulation of cell migration involved in sprouting angiogenesis, GO:0097498|endothelial tube lumen extension, GO:1903673|mitotic cleavage furrow formation, GO:1905274|regulation of modification of postsynaptic actin cytoskeleton, GO:1990869|cellular response to chemokine","GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0019003|GDP binding, GO:0019904|protein domain specific binding, GO:0051022|Rho GDP-dissociation inhibitor binding, GO:0019901|protein kinase binding, GO:0017022|myosin binding"
JAK2,Silent,0.200171159637658,26,0.326864467944508,N,"oncogene, fusion",Oncogene,0.0853960454803757,0.678302974628678,ENSG00000096968,"GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0005925|focal adhesion, GO:0005856|cytoskeleton, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0012505|endomembrane system, GO:0031904|endosome lumen, GO:0005901|caveola, GO:0016363|nuclear matrix, GO:0045121|membrane raft","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0008285|negative regulation of cell proliferation, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0006325|chromatin organization, GO:0007165|signal transduction, GO:0030218|erythrocyte differentiation, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0002250|adaptive immune response, GO:0030154|cell differentiation, GO:0019221|cytokine-mediated signaling pathway, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0035722|interleukin-12-mediated signaling pathway, GO:0032496|response to lipopolysaccharide, GO:0032760|positive regulation of tumor necrosis factor production, GO:0051770|positive regulation of nitric-oxide synthase biosynthetic process, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0060333|interferon-gamma-mediated signaling pathway, GO:0007596|blood coagulation, GO:0007259|JAK-STAT cascade, GO:0060396|growth hormone receptor signaling pathway, GO:0060334|regulation of interferon-gamma-mediated signaling pathway, GO:0070102|interleukin-6-mediated signaling pathway, GO:0034612|response to tumor necrosis factor, GO:0033209|tumor necrosis factor-mediated signaling pathway, GO:0007498|mesoderm development, GO:0097191|extrinsic apoptotic signaling pathway, GO:0043392|negative regulation of DNA binding, GO:0000186|activation of MAPKK activity, GO:0006915|apoptotic process, GO:0006979|response to oxidative stress, GO:0007167|enzyme linked receptor protein signaling pathway, GO:0007186|G protein-coupled receptor signaling pathway, GO:0007204|positive regulation of cytosolic calcium ion concentration, GO:0007260|tyrosine phosphorylation of STAT protein, GO:0008284|positive regulation of cell proliferation, GO:0008631|intrinsic apoptotic signaling pathway in response to oxidative stress, GO:0009755|hormone-mediated signaling pathway, GO:0010667|negative regulation of cardiac muscle cell apoptotic process, GO:0010811|positive regulation of cell-substrate adhesion, GO:0022408|negative regulation of cell-cell adhesion, GO:0030041|actin filament polymerization, GO:0030335|positive regulation of cell migration, GO:0031103|axon regeneration, GO:0031959|mineralocorticoid receptor signaling pathway, GO:0032024|positive regulation of insulin secretion, GO:0032516|positive regulation of phosphoprotein phosphatase activity, GO:0032731|positive regulation of interleukin-1 beta production, GO:0033160|positive regulation of protein import into nucleus, translocation, GO:0033194|response to hydroperoxide, GO:0035409|histone H3-Y41 phosphorylation, GO:0038155|interleukin-23-mediated signaling pathway, GO:0042976|activation of Janus kinase activity, GO:0043065|positive regulation of apoptotic process, GO:0043388|positive regulation of DNA binding, GO:0043524|negative regulation of neuron apoptotic process, GO:0045428|regulation of nitric oxide biosynthetic process, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0045597|positive regulation of cell differentiation, GO:0045822|negative regulation of heart contraction, GO:0046425|regulation of JAK-STAT cascade, GO:0046579|positive regulation of Ras protein signal transduction, GO:0046677|response to antibiotic, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0050727|regulation of inflammatory response, GO:0050729|positive regulation of inflammatory response, GO:0050867|positive regulation of cell activation, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0060397|JAK-STAT cascade involved in growth hormone signaling pathway, GO:0060399|positive regulation of growth hormone receptor signaling pathway, GO:0060548|negative regulation of cell death, GO:0061180|mammary gland epithelium development, GO:0070106|interleukin-27-mediated signaling pathway, GO:0070671|response to interleukin-12, GO:0070757|interleukin-35-mediated signaling pathway, GO:0097296|activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway, GO:1902728|positive regulation of growth factor dependent skeletal muscle satellite cell proliferation, GO:1904037|positive regulation of epithelial cell apoptotic process, GO:1904707|positive regulation of vascular smooth muscle cell proliferation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0042393|histone binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0020037|heme binding, GO:0042169|SH2 domain binding, GO:0005102|signaling receptor binding, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0019901|protein kinase binding, GO:0005131|growth hormone receptor binding, GO:0005143|interleukin-12 receptor binding, GO:0008022|protein C-terminus binding, GO:0031702|type 1 angiotensin receptor binding, GO:0033130|acetylcholine receptor binding, GO:0035401|histone kinase activity (H3-Y41 specific), GO:0043548|phosphatidylinositol 3-kinase binding, GO:0043560|insulin receptor substrate binding, GO:0051428|peptide hormone receptor binding"
TBL1XR1,Missense,0.200058948610724,66,0.107275456807446,N,"oncogene, TSG, fusion","",0.195939391404613,0.114857465377958,ENSG00000177565,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000118|histone deacetylase complex, GO:0017053|transcriptional repressor complex, GO:0072686|mitotic spindle","GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0043161|proteasome-mediated ubiquitin-dependent protein catabolic process, GO:0019216|regulation of lipid metabolic process, GO:0016575|histone deacetylation, GO:0001835|blastocyst hatching, GO:0002021|response to dietary excess, GO:0010468|regulation of gene expression, GO:0016042|lipid catabolic process, GO:0035264|multicellular organism growth, GO:0045892|negative regulation of transcription, DNA-templated, GO:0050872|white fat cell differentiation, GO:0060612|adipose tissue development, GO:0060613|fat pad development, GO:0090207|regulation of triglyceride metabolic process","GO:0044212|transcription regulatory region DNA binding, GO:0005515|protein binding, GO:0003714|transcription corepressor activity, GO:0047485|protein N-terminus binding, GO:0042393|histone binding, GO:0008013|beta-catenin binding, GO:0003677|DNA binding"
NDRG1,Silent,0.199908063431371,20,0.398094427589908,N,"TSG, fusion",TSG,0.231007713045442,0.327127025379833,ENSG00000104419,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0015630|microtubule cytoskeleton, GO:0005856|cytoskeleton, GO:0048471|perinuclear region of cytoplasm, GO:0005874|microtubule, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0070062|extracellular exosome, GO:0055038|recycling endosome membrane, GO:0005913|cell-cell adherens junction, GO:0043209|myelin sheath","GO:0007165|signal transduction, GO:0042127|regulation of cell proliferation, GO:0032287|peripheral nervous system myelin maintenance, GO:0045576|mast cell activation, GO:0042981|regulation of apoptotic process, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0071456|cellular response to hypoxia, GO:0010038|response to metal ion, GO:0008285|negative regulation of cell proliferation","GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0045296|cadherin binding, GO:0017137|Rab GTPase binding, GO:0043015|gamma-tubulin binding"
NUP98,Missense,0.198626406593473,150,0.0148242073817188,N,"oncogene, fusion",Oncogene,0.287266147315502,0.000364866226585414,ENSG00000110713,"GO:0005634|nucleus, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0005643|nuclear pore, GO:0000776|kinetochore, GO:0005829|cytosol, GO:0005635|nuclear envelope, GO:0031965|nuclear membrane, GO:1990904|ribonucleoprotein complex, GO:0031080|nuclear pore outer ring, GO:0016604|nuclear body, GO:0042405|nuclear inclusion body, GO:0034399|nuclear periphery, GO:0044615|nuclear pore nuclear basket, GO:0044614|nuclear pore cytoplasmic filaments","GO:0051028|mRNA transport, GO:0015031|protein transport, GO:1903508|positive regulation of nucleic acid-templated transcription, GO:0006913|nucleocytoplasmic transport, GO:0006508|proteolysis, GO:0006260|DNA replication, GO:0016032|viral process, GO:0006406|mRNA export from nucleus, GO:0006606|protein import into nucleus, GO:0006999|nuclear pore organization, GO:0048026|positive regulation of mRNA splicing, via spliceosome, GO:0051292|nuclear pore complex assembly, GO:0000973|posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery, GO:0006405|RNA export from nucleus, GO:0034398|telomere tethering at nuclear periphery, GO:0016973|poly(A)+ mRNA export from nucleus","GO:0016787|hydrolase activity, GO:0017056|structural constituent of nuclear pore, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008236|serine-type peptidase activity, GO:0003713|transcription coactivator activity, GO:0003729|mRNA binding, GO:0003723|RNA binding, GO:0008139|nuclear localization sequence binding, GO:0005215|transporter activity, GO:1990841|promoter-specific chromatin binding, GO:0042277|peptide binding"
BRD4,Silent,0.198365965781391,23,0.364226768566654,N,"oncogene, fusion",Oncogene,0.265644082499747,0.220538315837843,ENSG00000141867,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0000794|condensed nuclear chromosome","GO:0006325|chromatin organization, GO:0006468|protein phosphorylation, GO:0006974|cellular response to DNA damage stimulus, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016032|viral process, GO:0032968|positive regulation of transcription elongation from RNA polymerase II promoter, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0000083|regulation of transcription involved in G1/S transition of mitotic cell cycle, GO:0010971|positive regulation of G2/M transition of mitotic cell cycle, GO:0050727|regulation of inflammatory response, GO:1901407|regulation of phosphorylation of RNA polymerase II C-terminal domain, GO:2001255|positive regulation of histone H3-K36 trimethylation","GO:0005515|protein binding, GO:0003682|chromatin binding, GO:0019899|enzyme binding, GO:0002039|p53 binding, GO:0070577|lysine-acetylated histone binding, GO:0008353|RNA polymerase II CTD heptapeptide repeat kinase activity, GO:0099122|RNA polymerase II C-terminal domain binding, GO:0106140|P-TEFb complex binding"
SSX1,Missense,0.198339283601097,25,0.341902299266069,N,"oncogene, fusion",Oncogene,0.0268725811316082,0.89853939265905,ENSG00000126752,GO:0005634|nucleus,"GO:0006355|regulation of transcription, DNA-templated, GO:1903507|negative regulation of nucleic acid-templated transcription","GO:0003676|nucleic acid binding, GO:0005515|protein binding, GO:0003714|transcription corepressor activity"
ATP2B3,Missense,0.197228615079642,103,0.0458378396408562,N,TSG,TSG,0.239738539592699,0.0147251916422145,ENSG00000067842,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0098793|presynapse, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:1903561|extracellular vesicle, GO:0098978|glutamatergic synapse, GO:0098982|GABA-ergic synapse","GO:0006811|ion transport, GO:0006816|calcium ion transport, GO:0070588|calcium ion transmembrane transport, GO:0099132|ATP hydrolysis coupled cation transmembrane transport, GO:0099509|regulation of presynaptic cytosolic calcium ion concentration, GO:0034220|ion transmembrane transport, GO:1903779|regulation of cardiac conduction, GO:0006874|cellular calcium ion homeostasis, GO:0051480|regulation of cytosolic calcium ion concentration, GO:1990034|calcium ion export across plasma membrane","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0005388|calcium-transporting ATPase activity, GO:0005516|calmodulin binding, GO:0030165|PDZ domain binding, GO:0005515|protein binding, GO:0015085|calcium ion transmembrane transporter activity, GO:1905056|calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration"
FOXO4,Silent,0.196909856514301,16,0.464808735945841,N,"oncogene, TSG, fusion","",0.264580234934379,0.322042740794323,ENSG00000184481,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0005829|cytosol, GO:0005654|nucleoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0007049|cell cycle, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007517|muscle organ development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0008285|negative regulation of cell proliferation, GO:0016579|protein deubiquitination, GO:0007050|cell cycle arrest, GO:0048863|stem cell differentiation, GO:0008286|insulin receptor signaling pathway, GO:0042593|glucose homeostasis, GO:0006366|transcription by RNA polymerase II, GO:0016525|negative regulation of angiogenesis, GO:0051151|negative regulation of smooth muscle cell differentiation, GO:0071158|positive regulation of cell cycle arrest, GO:0070317|negative regulation of G0 to G1 transition, GO:0007095|mitotic G2 DNA damage checkpoint, GO:0007568|aging, GO:0014911|positive regulation of smooth muscle cell migration, GO:0031667|response to nutrient levels, GO:0045893|positive regulation of transcription, DNA-templated, GO:1990785|response to water-immersion restraint stress","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0008013|beta-catenin binding, GO:1990841|promoter-specific chromatin binding"
FGFR3,Silent,0.195884737266041,35,0.259425236919875,N,"oncogene, fusion",Oncogene,0.207425278041346,0.231838983367259,ENSG00000068078,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0031410|cytoplasmic vesicle, GO:0005925|focal adhesion, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0030133|transport vesicle, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0009986|cell surface","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0006915|apoptotic process, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0046854|phosphatidylinositol phosphorylation, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0043410|positive regulation of MAPK cascade, GO:0060349|bone morphogenesis, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0001501|skeletal system development, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0002062|chondrocyte differentiation, GO:0001958|endochondral ossification, GO:0030282|bone mineralization, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0070977|bone maturation, GO:0010518|positive regulation of phospholipase activity, GO:0003416|endochondral bone growth, GO:0035988|chondrocyte proliferation, GO:0048640|negative regulation of developmental growth, GO:1902178|fibroblast growth factor receptor apoptotic signaling pathway, GO:0007267|cell-cell signaling","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0042802|identical protein binding, GO:0005007|fibroblast growth factor-activated receptor activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0017134|fibroblast growth factor binding"
NF1,Missense,0.19531821981815,218,0.00378921638558018,Y,"TSG, fusion",TSG,0.133227674802869,0.0494674540873926,ENSG00000196712,"GO:0005634|nucleus, GO:0016020|membrane, GO:0098793|presynapse, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005737|cytoplasm, GO:0030424|axon, GO:0030425|dendrite, GO:0016021|integral component of membrane","GO:0007165|signal transduction, GO:0043087|regulation of GTPase activity, GO:0043547|positive regulation of GTPase activity, GO:0050890|cognition, GO:0000165|MAPK cascade, GO:0007265|Ras protein signal transduction, GO:0048147|negative regulation of fibroblast proliferation, GO:0001937|negative regulation of endothelial cell proliferation, GO:0001649|osteoblast differentiation, GO:0001656|metanephros development, GO:0001666|response to hypoxia, GO:0001889|liver development, GO:0001952|regulation of cell-matrix adhesion, GO:0006469|negative regulation of protein kinase activity, GO:0007154|cell communication, GO:0007406|negative regulation of neuroblast proliferation, GO:0007420|brain development, GO:0007422|peripheral nervous system development, GO:0007507|heart development, GO:0008542|visual learning, GO:0014044|Schwann cell development, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0021510|spinal cord development, GO:0021897|forebrain astrocyte development, GO:0021987|cerebral cortex development, GO:0022011|myelination in peripheral nervous system, GO:0030036|actin cytoskeleton organization, GO:0030198|extracellular matrix organization, GO:0030199|collagen fibril organization, GO:0030325|adrenal gland development, GO:0030336|negative regulation of cell migration, GO:0042060|wound healing, GO:0043065|positive regulation of apoptotic process, GO:0043407|negative regulation of MAP kinase activity, GO:0043409|negative regulation of MAPK cascade, GO:0043473|pigmentation, GO:0043525|positive regulation of neuron apoptotic process, GO:0043535|regulation of blood vessel endothelial cell migration, GO:0045124|regulation of bone resorption, GO:0045685|regulation of glial cell differentiation, GO:0045762|positive regulation of adenylate cyclase activity, GO:0045765|regulation of angiogenesis, GO:0048485|sympathetic nervous system development, GO:0048593|camera-type eye morphogenesis, GO:0048715|negative regulation of oligodendrocyte differentiation, GO:0048745|smooth muscle tissue development, GO:0048844|artery morphogenesis, GO:0048853|forebrain morphogenesis, GO:0001938|positive regulation of endothelial cell proliferation, GO:0001953|negative regulation of cell-matrix adhesion, GO:0007519|skeletal muscle tissue development, GO:0008285|negative regulation of cell proliferation, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0010468|regulation of gene expression, GO:0016525|negative regulation of angiogenesis, GO:0021764|amygdala development, GO:0021915|neural tube development, GO:0032228|regulation of synaptic transmission, GABAergic, GO:0034605|cellular response to heat, GO:0035021|negative regulation of Rac protein signal transduction, GO:0042127|regulation of cell proliferation, GO:0042308|negative regulation of protein import into nucleus, GO:0043408|regulation of MAPK cascade, GO:0045671|negative regulation of osteoclast differentiation, GO:0046580|negative regulation of Ras protein signal transduction, GO:0046929|negative regulation of neurotransmitter secretion, GO:0048169|regulation of long-term neuronal synaptic plasticity, GO:0048712|negative regulation of astrocyte differentiation, GO:0048820|hair follicle maturation, GO:0061534|gamma-aminobutyric acid secretion, neurotransmission, GO:0061535|glutamate secretion, neurotransmission, GO:0098597|observational learning, GO:1900271|regulation of long-term synaptic potentiation, GO:1902043|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:2001241|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand","GO:0005515|protein binding, GO:0005096|GTPase activator activity, GO:0008289|lipid binding, GO:0008429|phosphatidylethanolamine binding, GO:0031210|phosphatidylcholine binding"
ZFHX3,Silent,0.194864299479102,124,0.030099707141089,N,TSG,TSG,0.215703636193702,0.0161263447325735,ENSG00000140836,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex, GO:0016604|nuclear body","GO:0006355|regulation of transcription, DNA-templated, GO:0032922|circadian regulation of gene expression, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007517|muscle organ development, GO:0006366|transcription by RNA polymerase II, GO:0007420|brain development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045664|regulation of neuron differentiation, GO:0045785|positive regulation of cell adhesion, GO:0071559|response to transforming growth factor beta, GO:1904059|regulation of locomotor rhythm, GO:0007050|cell cycle arrest","GO:0003676|nucleic acid binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0044212|transcription regulatory region DNA binding"
USP6,Missense,0.194222770427469,70,0.107156165225098,N,"oncogene, fusion",Oncogene,0.162528081500376,0.17885766856988,ENSG00000129204,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005768|endosome, GO:0055037|recycling endosome, GO:0005764|lysosome","GO:0016579|protein deubiquitination, GO:0006508|proteolysis, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0006886|intracellular protein transport, GO:0090630|activation of GTPase activity, GO:0006464|cellular protein modification process, GO:0060627|regulation of vesicle-mediated transport","GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0005096|GTPase activator activity, GO:0017137|Rab GTPase binding, GO:0005516|calmodulin binding, GO:0004843|thiol-dependent ubiquitin-specific protease activity, GO:0003676|nucleic acid binding, GO:0004197|cysteine-type endopeptidase activity"
STAG2,Missense,0.194087406465745,86,0.0733537250052214,N,TSG,TSG,0.194090813009477,0.0733485801234284,ENSG00000101972,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005694|chromosome, GO:0000775|chromosome, centromeric region, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0000785|chromatin, GO:0016363|nuclear matrix, GO:0097431|mitotic spindle pole, GO:0008278|cohesin complex","GO:0051301|cell division, GO:0007049|cell cycle, GO:0051321|meiotic cell cycle, GO:0007059|chromosome segregation, GO:1901673|regulation of mitotic spindle assembly, GO:0007062|sister chromatid cohesion, GO:0032876|negative regulation of DNA endoreduplication","GO:0005515|protein binding, GO:0003682|chromatin binding"
EGFR,Silent,0.193910338930274,74,0.0978363260156422,N,Oncogene,Oncogene,0.199362704882357,0.0885818216408391,ENSG00000146648,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0000139|Golgi membrane, GO:0005615|extracellular space, GO:0045121|membrane raft, GO:0009986|cell surface, GO:0005925|focal adhesion, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005768|endosome, GO:0031901|early endosome membrane, GO:0010008|endosome membrane, GO:0032991|protein-containing complex, GO:0031965|nuclear membrane, GO:0030665|clathrin-coated vesicle membrane, GO:0009925|basal plasma membrane, GO:0016323|basolateral plasma membrane, GO:0070435|Shc-EGFR complex, GO:0097489|multivesicular body, internal vesicle lumen, GO:0016324|apical plasma membrane, GO:0030139|endocytic vesicle, GO:0045202|synapse, GO:0048471|perinuclear region of cytoplasm","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0006898|receptor-mediated endocytosis, GO:0008284|positive regulation of cell proliferation, GO:0051897|positive regulation of protein kinase B signaling, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0007165|signal transduction, GO:0007275|multicellular organism development, GO:0046718|viral entry into host cell, GO:0046854|phosphatidylinositol phosphorylation, GO:0030154|cell differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0043066|negative regulation of apoptotic process, GO:0001934|positive regulation of protein phosphorylation, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:0008283|cell proliferation, GO:0030335|positive regulation of cell migration, GO:0045739|positive regulation of DNA repair, GO:0001503|ossification, GO:0061024|membrane organization, GO:0045746|negative regulation of Notch signaling pathway, GO:0046777|protein autophosphorylation, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0000165|MAPK cascade, GO:0030307|positive regulation of cell growth, GO:0038128|ERBB2 signaling pathway, GO:2000145|regulation of cell motility, GO:0042177|negative regulation of protein catabolic process, GO:0042327|positive regulation of phosphorylation, GO:0045740|positive regulation of DNA replication, GO:0042059|negative regulation of epidermal growth factor receptor signaling pathway, GO:0034614|cellular response to reactive oxygen species, GO:0045893|positive regulation of transcription, DNA-templated, GO:0071276|cellular response to cadmium ion, GO:0098609|cell-cell adhesion, GO:0050679|positive regulation of epithelial cell proliferation, GO:0051205|protein insertion into membrane, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0071392|cellular response to estradiol stimulus, GO:1901224|positive regulation of NIK/NF-kappaB signaling, GO:0043406|positive regulation of MAP kinase activity, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007166|cell surface receptor signaling pathway, GO:0007202|activation of phospholipase C activity, GO:0007611|learning or memory, GO:0010750|positive regulation of nitric oxide mediated signal transduction, GO:0014066|regulation of phosphatidylinositol 3-kinase signaling, GO:0043006|activation of phospholipase A2 activity by calcium-mediated signaling, GO:0046328|regulation of JNK cascade, GO:0050730|regulation of peptidyl-tyrosine phosphorylation, GO:0050999|regulation of nitric-oxide synthase activity, GO:0070141|response to UV-A, GO:0070372|regulation of ERK1 and ERK2 cascade, GO:1900020|positive regulation of protein kinase C activity, GO:1901185|negative regulation of ERBB signaling pathway, GO:1903078|positive regulation of protein localization to plasma membrane, GO:1903800|positive regulation of production of miRNAs involved in gene silencing by miRNA, GO:1905208|negative regulation of cardiocyte differentiation, GO:0000186|activation of MAPKK activity, GO:0000902|cell morphogenesis, GO:0001889|liver development, GO:0001892|embryonic placenta development, GO:0001942|hair follicle development, GO:0006412|translation, GO:0006970|response to osmotic stress, GO:0006979|response to oxidative stress, GO:0007435|salivary gland morphogenesis, GO:0007494|midgut development, GO:0007623|circadian rhythm, GO:0008544|epidermis development, GO:0010960|magnesium ion homeostasis, GO:0014070|response to organic cyclic compound, GO:0016101|diterpenoid metabolic process, GO:0021795|cerebral cortex cell migration, GO:0030324|lung development, GO:0032355|response to estradiol, GO:0032930|positive regulation of superoxide anion generation, GO:0033590|response to cobalamin, GO:0033594|response to hydroxyisoflavone, GO:0033993|response to lipid, GO:0035556|intracellular signal transduction, GO:0035690|cellular response to drug, GO:0042060|wound healing, GO:0042127|regulation of cell proliferation, GO:0042698|ovulation cycle, GO:0042743|hydrogen peroxide metabolic process, GO:0043586|tongue development, GO:0045780|positive regulation of bone resorption, GO:0045907|positive regulation of vasoconstriction, GO:0045930|negative regulation of mitotic cell cycle, GO:0048143|astrocyte activation, GO:0048146|positive regulation of fibroblast proliferation, GO:0048546|digestive tract morphogenesis, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0048812|neuron projection morphogenesis, GO:0050729|positive regulation of inflammatory response, GO:0051592|response to calcium ion, GO:0051968|positive regulation of synaptic transmission, glutamatergic, GO:0060571|morphogenesis of an epithelial fold, GO:0061029|eyelid development in camera-type eye, GO:0071230|cellular response to amino acid stimulus, GO:0071260|cellular response to mechanical stimulus, GO:0071363|cellular response to growth factor stimulus, GO:0071549|cellular response to dexamethasone stimulus, GO:0097421|liver regeneration, GO:0097755|positive regulation of blood vessel diameter, GO:1902722|positive regulation of prolactin secretion","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004709|MAP kinase kinase kinase activity, GO:0042802|identical protein binding, GO:0045296|cadherin binding, GO:0051015|actin filament binding, GO:0003682|chromatin binding, GO:0031625|ubiquitin protein ligase binding, GO:0003690|double-stranded DNA binding, GO:0019899|enzyme binding, GO:0019903|protein phosphatase binding, GO:0046982|protein heterodimerization activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0001618|virus receptor activity, GO:0030235|nitric-oxide synthase regulator activity, GO:0004888|transmembrane signaling receptor activity, GO:0005006|epidermal growth factor-activated receptor activity, GO:0048408|epidermal growth factor binding, GO:0005102|signaling receptor binding, GO:0005178|integrin binding, GO:0005516|calmodulin binding, GO:0019901|protein kinase binding"
KIT,Silent,0.193547201847178,40,0.231447237012589,N,Oncogene,Oncogene,0.198565780659594,0.219337020117603,ENSG00000157404,"GO:0005615|extracellular space, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0042629|mast cell granule, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0001669|acrosomal vesicle, GO:0005911|cell-cell junction, GO:0009897|external side of plasma membrane, GO:0009898|cytoplasmic side of plasma membrane, GO:0009986|cell surface","GO:1905065|positive regulation of vascular smooth muscle cell differentiation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0030218|erythrocyte differentiation, GO:0006954|inflammatory response, GO:0007283|spermatogenesis, GO:0038093|Fc receptor signaling pathway, GO:0038109|Kit signaling pathway, GO:0046854|phosphatidylinositol phosphorylation, GO:0002244|hematopoietic progenitor cell differentiation, GO:0008284|positive regulation of cell proliferation, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0008584|male gonad development, GO:0048863|stem cell differentiation, GO:0008360|regulation of cell shape, GO:0042127|regulation of cell proliferation, GO:0007165|signal transduction, GO:0030032|lamellipodium assembly, GO:0002551|mast cell chemotaxis, GO:0030217|T cell differentiation, GO:0043303|mast cell degranulation, GO:0051897|positive regulation of protein kinase B signaling, GO:0060374|mast cell differentiation, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0030097|hemopoiesis, GO:0060326|cell chemotaxis, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0019221|cytokine-mediated signaling pathway, GO:0030335|positive regulation of cell migration, GO:0000187|activation of MAPK activity, GO:0031532|actin cytoskeleton reorganization, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0019827|stem cell population maintenance, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0030318|melanocyte differentiation, GO:0035855|megakaryocyte development, GO:0001541|ovarian follicle development, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0010863|positive regulation of phospholipase C activity, GO:0043406|positive regulation of MAP kinase activity, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0046427|positive regulation of JAK-STAT cascade, GO:0030183|B cell differentiation, GO:0038162|erythropoietin-mediated signaling pathway, GO:0050910|detection of mechanical stimulus involved in sensory perception of sound, GO:0032762|mast cell cytokine production, GO:0002327|immature B cell differentiation, GO:0002371|dendritic cell cytokine production, GO:0035162|embryonic hemopoiesis, GO:0043473|pigmentation, GO:0048565|digestive tract development, GO:0070662|mast cell proliferation, GO:0097324|melanocyte migration, GO:0097326|melanocyte adhesion, GO:0002318|myeloid progenitor cell differentiation, GO:0002320|lymphoid progenitor cell differentiation, GO:0002573|myeloid leukocyte differentiation, GO:0006687|glycosphingolipid metabolic process, GO:0007286|spermatid development, GO:0008354|germ cell migration, GO:0008542|visual learning, GO:0009314|response to radiation, GO:0010628|positive regulation of gene expression, GO:0031274|positive regulation of pseudopodium assembly, GO:0035019|somatic stem cell population maintenance, GO:0035234|ectopic germ cell programmed cell death, GO:0035556|intracellular signal transduction, GO:0035701|hematopoietic stem cell migration, GO:0043069|negative regulation of programmed cell death, GO:0043586|tongue development, GO:0045747|positive regulation of Notch signaling pathway, GO:0046686|response to cadmium ion, GO:0048066|developmental pigmentation, GO:0048070|regulation of developmental pigmentation, GO:0048103|somatic stem cell division, GO:0048170|positive regulation of long-term neuronal synaptic plasticity, GO:0050673|epithelial cell proliferation, GO:0097067|cellular response to thyroid hormone stimulus, GO:0120072|positive regulation of pyloric antrum smooth muscle contraction, GO:1904251|regulation of bile acid metabolic process, GO:1904343|positive regulation of colon smooth muscle contraction, GO:1904349|positive regulation of small intestine smooth muscle contraction","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0019955|cytokine binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0002020|protease binding, GO:0005020|stem cell factor receptor activity"
KDM6A,Missense,0.193384637595184,90,0.0678136403719108,N,"oncogene, TSG","",0.216759398215471,0.0401617658308184,ENSG00000147050,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0044666|MLL3/4 complex, GO:0035097|histone methyltransferase complex","GO:0055114|oxidation-reduction process, GO:0006325|chromatin organization, GO:0010468|regulation of gene expression, GO:0071557|histone H3-K27 demethylation, GO:0051568|histone H3-K4 methylation, GO:0006338|chromatin remodeling, GO:0001701|in utero embryonic development, GO:0001843|neural tube closure, GO:0003007|heart morphogenesis, GO:0003016|respiratory system process, GO:0007507|heart development, GO:0010628|positive regulation of gene expression, GO:0021915|neural tube development, GO:0032525|somite rostral/caudal axis specification, GO:0035264|multicellular organism growth, GO:0048333|mesodermal cell differentiation, GO:0048568|embryonic organ development, GO:0048570|notochord morphogenesis, GO:0060070|canonical Wnt signaling pathway, GO:0072358|cardiovascular system development","GO:0046872|metal ion binding, GO:0016491|oxidoreductase activity, GO:0051213|dioxygenase activity, GO:0071558|histone demethylase activity (H3-K27 specific), GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0043565|sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0031490|chromatin DNA binding, GO:0032452|histone demethylase activity, GO:0042802|identical protein binding"
TSC2,Missense,0.192696919020117,154,0.0166517887037077,N,TSG,TSG,0.177163240164234,0.0279460280290287,ENSG00000103197,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005794|Golgi apparatus, GO:0048471|perinuclear region of cytoplasm, GO:0005764|lysosome, GO:0033596|TSC1-TSC2 complex, GO:0014069|postsynaptic density","GO:0032007|negative regulation of TOR signaling, GO:0043547|positive regulation of GTPase activity, GO:0051056|regulation of small GTPase mediated signal transduction, GO:0051726|regulation of cell cycle, GO:0007507|heart development, GO:0008285|negative regulation of cell proliferation, GO:0030178|negative regulation of Wnt signaling pathway, GO:0016032|viral process, GO:0006606|protein import into nucleus, GO:0008104|protein localization, GO:0046627|negative regulation of insulin receptor signaling pathway, GO:0006469|negative regulation of protein kinase activity, GO:0014067|negative regulation of phosphatidylinositol 3-kinase signaling, GO:0051898|negative regulation of protein kinase B signaling, GO:0046626|regulation of insulin receptor signaling pathway, GO:0001843|neural tube closure, GO:0050918|positive chemotaxis, GO:0016192|vesicle-mediated transport, GO:0030100|regulation of endocytosis, GO:0006897|endocytosis, GO:0043491|protein kinase B signaling, GO:0048009|insulin-like growth factor receptor signaling pathway, GO:0043276|anoikis, GO:0016239|positive regulation of macroautophagy, GO:1901525|negative regulation of mitophagy","GO:0042803|protein homodimerization activity, GO:0005096|GTPase activator activity, GO:0005515|protein binding, GO:0019902|phosphatase binding, GO:0051879|Hsp90 protein binding, GO:0031267|small GTPase binding"
KMT2D,Missense,0.192081017407412,60,0.141484780984507,N,"oncogene, TSG","",0.297439150982741,0.0209995312525751,ENSG00000167548,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0035097|histone methyltransferase complex, GO:0044666|MLL3/4 complex","GO:0032259|methylation, GO:0006325|chromatin organization, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048477|oogenesis, GO:0008284|positive regulation of cell proliferation, GO:0006355|regulation of transcription, DNA-templated, GO:1904837|beta-catenin-TCF complex assembly, GO:0001555|oocyte growth, GO:0006342|chromatin silencing, GO:0033148|positive regulation of intracellular estrogen receptor signaling pathway, GO:0043627|response to estrogen, GO:0045652|regulation of megakaryocyte differentiation, GO:0051568|histone H3-K4 methylation","GO:0046872|metal ion binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0042393|histone binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003713|transcription coactivator activity, GO:0042800|histone methyltransferase activity (H3-K4 specific), GO:0044212|transcription regulatory region DNA binding"
ATRX,Missense,0.191882510891258,224,0.00394405927180453,Y,TSG,TSG,0.436330646376734,7.93454282022004e-12,ENSG00000085224,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0016604|nuclear body, GO:0000781|chromosome, telomeric region, GO:0000228|nuclear chromosome, GO:0000780|condensed nuclear chromosome, centromeric region, GO:0000784|nuclear chromosome, telomeric region, GO:0000792|heterochromatin, GO:0005721|pericentric heterochromatin, GO:0016605|PML body, GO:0031618|nuclear pericentric heterochromatin, GO:0031933|telomeric heterochromatin, GO:0005720|nuclear heterochromatin, GO:1990707|nuclear subtelomeric heterochromatin","GO:0006325|chromatin organization, GO:0006334|nucleosome assembly, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000212|meiotic spindle organization, GO:0007283|spermatogenesis, GO:0010571|positive regulation of nuclear cell cycle DNA replication, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0030900|forebrain development, GO:0031297|replication fork processing, GO:0032206|positive regulation of telomere maintenance, GO:0035128|post-embryonic forelimb morphogenesis, GO:0035264|multicellular organism growth, GO:0060009|Sertoli cell development, GO:0070192|chromosome organization involved in meiotic cell cycle, GO:0070198|protein localization to chromosome, telomeric region, GO:0072520|seminiferous tubule development, GO:0072711|cellular response to hydroxyurea, GO:1901581|negative regulation of telomeric RNA transcription from RNA pol II promoter, GO:0006336|DNA replication-independent nucleosome assembly, GO:0006355|regulation of transcription, DNA-templated, GO:0006338|chromatin remodeling, GO:1904908|negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric, GO:0006306|DNA methylation, GO:1900112|regulation of histone H3-K9 trimethylation, GO:1901582|positive regulation of telomeric RNA transcription from RNA pol II promoter","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004386|helicase activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0042393|histone binding, GO:0035064|methylated histone binding, GO:0070087|chromo shadow domain binding, GO:0015616|DNA translocase activity"
CSF3R,Missense,0.190981858704299,74,0.103110064479999,N,Oncogene,Oncogene,0.12978000207409,0.270430436273766,ENSG00000119535,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0009897|external side of plasma membrane, GO:0043235|receptor complex, GO:0005887|integral component of plasma membrane","GO:0007155|cell adhesion, GO:0007165|signal transduction, GO:0019221|cytokine-mediated signaling pathway, GO:0006952|defense response, GO:0036016|cellular response to interleukin-3, GO:0038156|interleukin-3-mediated signaling pathway, GO:0030593|neutrophil chemotaxis, GO:0045637|regulation of myeloid cell differentiation, GO:0097186|amelogenesis","GO:0005515|protein binding, GO:0004896|cytokine receptor activity, GO:0038023|signaling receptor activity, GO:0019955|cytokine binding, GO:0004912|interleukin-3 receptor activity, GO:0019978|interleukin-3 binding, GO:0051916|granulocyte colony-stimulating factor binding"
ERBB3,Missense,0.189500196212287,123,0.035793939298588,N,Oncogene,Oncogene,0.265886096950416,0.0029547408197535,ENSG00000065361,"GO:0005615|extracellular space, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0009925|basal plasma membrane, GO:0016323|basolateral plasma membrane, GO:0016324|apical plasma membrane, GO:0016328|lateral plasma membrane","GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0007162|negative regulation of cell adhesion, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0007165|signal transduction, GO:0046854|phosphatidylinositol phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0007399|nervous system development, GO:0051897|positive regulation of protein kinase B signaling, GO:0000165|MAPK cascade, GO:0038128|ERBB2 signaling pathway, GO:2000145|regulation of cell motility, GO:0007507|heart development, GO:0043524|negative regulation of neuron apoptotic process, GO:0007422|peripheral nervous system development, GO:0042127|regulation of cell proliferation, GO:0051048|negative regulation of secretion, GO:0042060|wound healing, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0097192|extrinsic apoptotic signaling pathway in absence of ligand, GO:0061098|positive regulation of protein tyrosine kinase activity, GO:0003197|endocardial cushion development, GO:0009968|negative regulation of signal transduction, GO:0010628|positive regulation of gene expression, GO:0014037|Schwann cell differentiation, GO:0021545|cranial nerve development, GO:0051402|neuron apoptotic process, GO:0055025|positive regulation of cardiac muscle tissue development, GO:0070886|positive regulation of calcineurin-NFAT signaling cascade","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0046982|protein heterodimerization activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0004713|protein tyrosine kinase activity, GO:0019838|growth factor binding, GO:0004888|transmembrane signaling receptor activity, GO:0038132|neuregulin binding, GO:0030296|protein tyrosine kinase activator activity, GO:0031625|ubiquitin protein ligase binding, GO:0038131|neuregulin receptor activity"
NKX2-1,Silent,0.189157463465303,15,0.499559199466146,N,"oncogene, TSG","",0.203745394538522,0.466406164397675,ENSG00000136352,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0048511|rhythmic process, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0010628|positive regulation of gene expression, GO:0045892|negative regulation of transcription, DNA-templated, GO:0042753|positive regulation of circadian rhythm, GO:0030878|thyroid gland development, GO:0007420|brain development, GO:0010719|negative regulation of epithelial to mesenchymal transition, GO:0030336|negative regulation of cell migration, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0009725|response to hormone, GO:0030324|lung development, GO:0030900|forebrain development, GO:0021759|globus pallidus development, GO:0060441|epithelial tube branching involved in lung morphogenesis, GO:0001764|neuron migration, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006644|phospholipid metabolic process, GO:0007389|pattern specification process, GO:0007411|axon guidance, GO:0007492|endoderm development, GO:0007626|locomotory behavior, GO:0009887|animal organ morphogenesis, GO:0021537|telencephalon development, GO:0021766|hippocampus development, GO:0021795|cerebral cortex cell migration, GO:0021798|forebrain dorsal/ventral pattern formation, GO:0021877|forebrain neuron fate commitment, GO:0021879|forebrain neuron differentiation, GO:0021892|cerebral cortex GABAergic interneuron differentiation, GO:0021895|cerebral cortex neuron differentiation, GO:0021983|pituitary gland development, GO:0022029|telencephalon cell migration, GO:0031128|developmental induction, GO:0033327|Leydig cell differentiation, GO:0048646|anatomical structure formation involved in morphogenesis, GO:0048663|neuron fate commitment, GO:0048709|oligodendrocyte differentiation, GO:0060430|lung saccule development, GO:0060486|Clara cell differentiation, GO:0060510|type II pneumocyte differentiation","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0044212|transcription regulatory region DNA binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0001161|intronic transcription regulatory region sequence-specific DNA binding, GO:0044213|intronic transcription regulatory region DNA binding"
NCOR1,Silent,0.189088861249811,59,0.151481381645894,N,TSG,TSG,0.207949854492554,0.114004193739418,ENSG00000141027,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin, GO:0000118|histone deacetylase complex, GO:0017053|transcriptional repressor complex, GO:0072686|mitotic spindle, GO:0016580|Sin3 complex","GO:0006325|chromatin organization, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0046329|negative regulation of JNK cascade, GO:0006366|transcription by RNA polymerase II, GO:0007623|circadian rhythm, GO:0019216|regulation of lipid metabolic process, GO:0051225|spindle assembly, GO:0060766|negative regulation of androgen receptor signaling pathway, GO:0072362|regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter, GO:0072368|regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter, GO:1903799|negative regulation of production of miRNAs involved in gene silencing by miRNA, GO:2000191|regulation of fatty acid transport","GO:0044212|transcription regulatory region DNA binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003714|transcription corepressor activity, GO:0003682|chromatin binding, GO:0042826|histone deacetylase binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0035257|nuclear hormone receptor binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0046966|thyroid hormone receptor binding"
TET2,Missense,0.187925623971882,120,0.039837939372815,N,TSG,TSG,0.138843930411593,0.130438615427579,ENSG00000168769,GO:0005634|nucleus,"GO:0055114|oxidation-reduction process, GO:0006325|chromatin organization, GO:0007049|cell cycle, GO:0006211|5-methylcytosine catabolic process, GO:0080111|DNA demethylation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006493|protein O-linked glycosylation, GO:0080182|histone H3-K4 trimethylation, GO:0070989|oxidative demethylation, GO:0030099|myeloid cell differentiation, GO:0014070|response to organic cyclic compound","GO:0046872|metal ion binding, GO:0016491|oxidoreductase activity, GO:0003677|DNA binding, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0051213|dioxygenase activity, GO:0070579|methylcytosine dioxygenase activity, GO:0005506|iron ion binding, GO:0008198|ferrous iron binding"
NCOR2,Missense,0.187924048894973,141,0.0256459560648761,N,TSG,TSG,0.202432088541521,0.0160696747833261,ENSG00000196498,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000785|chromatin, GO:0016020|membrane, GO:0000790|nuclear chromatin, GO:0016363|nuclear matrix, GO:0000118|histone deacetylase complex, GO:0017053|transcriptional repressor complex, GO:0016604|nuclear body","GO:0007595|lactation, GO:0010243|response to organonitrogen compound, GO:0032355|response to estradiol, GO:0044849|estrous cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0019216|regulation of lipid metabolic process, GO:0060766|negative regulation of androgen receptor signaling pathway, GO:1903799|negative regulation of production of miRNAs involved in gene silencing by miRNA, GO:0072365|regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter","GO:0003677|DNA binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0003682|chromatin binding, GO:0016922|nuclear receptor binding, GO:0035259|glucocorticoid receptor binding, GO:0042974|retinoic acid receptor binding, GO:0044877|protein-containing complex binding, GO:0046965|retinoid X receptor binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003714|transcription corepressor activity, GO:0042826|histone deacetylase binding, GO:0047485|protein N-terminus binding, GO:0005112|Notch binding, GO:0035257|nuclear hormone receptor binding"
FCRL4,Silent,0.187606624973076,22,0.403127070234966,N,"oncogene, fusion",Oncogene,0.094447007191856,0.675893094243568,ENSG00000163518,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0009986|cell surface","GO:0002376|immune system process, GO:0002250|adaptive immune response",GO:0005515|protein binding
NUMA1,Missense,0.187186394024618,140,0.0267892363308383,N,fusion,"",0.206393737981586,0.0144214148113148,ENSG00000137497,"GO:0005654|nucleoplasm, GO:0000139|Golgi membrane, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005694|chromosome, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0005874|microtubule, GO:0000922|spindle pole, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0070062|extracellular exosome, GO:0005938|cell cortex, GO:0032991|protein-containing complex, GO:0005876|spindle microtubule, GO:0016328|lateral plasma membrane, GO:0016363|nuclear matrix, GO:0097431|mitotic spindle pole, GO:1990023|mitotic spindle midzone, GO:0099738|cell cortex region, GO:0005819|spindle, GO:0072686|mitotic spindle, GO:0097427|microtubule bundle, GO:0036449|microtubule minus-end, GO:0031616|spindle pole centrosome, GO:0019897|extrinsic component of plasma membrane, GO:0035371|microtubule plus-end, GO:0097575|lateral cell cortex, GO:0055028|cortical microtubule, GO:0061673|mitotic spindle astral microtubule, GO:1905720|cytoplasmic microtubule bundle, GO:0030425|dendrite, GO:0043025|neuronal cell body","GO:0051301|cell division, GO:0007049|cell cycle, GO:0007059|chromosome segregation, GO:0001578|microtubule bundle formation, GO:0000132|establishment of mitotic spindle orientation, GO:0006997|nucleus organization, GO:1904778|positive regulation of protein localization to cell cortex, GO:0045618|positive regulation of keratinocyte differentiation, GO:0031116|positive regulation of microtubule polymerization, GO:0030513|positive regulation of BMP signaling pathway, GO:0030953|astral microtubule organization, GO:0060236|regulation of mitotic spindle organization, GO:1905832|positive regulation of spindle assembly, GO:0032388|positive regulation of intracellular transport, GO:0090235|regulation of metaphase plate congression, GO:0051798|positive regulation of hair follicle development, GO:0051984|positive regulation of chromosome segregation, GO:0055048|anastral spindle assembly, GO:1902365|positive regulation of protein localization to spindle pole body, GO:1902846|positive regulation of mitotic spindle elongation, GO:1905820|positive regulation of chromosome separation, GO:0051321|meiotic cell cycle","GO:0005515|protein binding, GO:0008289|lipid binding, GO:0008017|microtubule binding, GO:0035091|phosphatidylinositol binding, GO:0070840|dynein complex binding, GO:0019904|protein domain specific binding, GO:0015631|tubulin binding, GO:0005198|structural molecule activity, GO:0044877|protein-containing complex binding, GO:0051010|microtubule plus-end binding, GO:0097718|disordered domain specific binding, GO:0008022|protein C-terminus binding, GO:0051011|microtubule minus-end binding"
ERBB2,Silent,0.186971371899975,42,0.23576624610187,N,"oncogene, fusion",Oncogene,0.220256438019053,0.161026294716747,ENSG00000141736,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0048471|perinuclear region of cytoplasm, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0010008|endosome membrane, GO:0009925|basal plasma membrane, GO:0016323|basolateral plasma membrane, GO:0016324|apical plasma membrane, GO:0031410|cytoplasmic vesicle, GO:0043209|myelin sheath","GO:0001934|positive regulation of protein phosphorylation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0007165|signal transduction, GO:0045727|positive regulation of translation, GO:0046854|phosphatidylinositol phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0043410|positive regulation of MAPK cascade, GO:0030182|neuron differentiation, GO:0090314|positive regulation of protein targeting to membrane, GO:0043547|positive regulation of GTPase activity, GO:0051897|positive regulation of protein kinase B signaling, GO:0000165|MAPK cascade, GO:0008283|cell proliferation, GO:0030307|positive regulation of cell growth, GO:0035556|intracellular signal transduction, GO:0038128|ERBB2 signaling pathway, GO:2000145|regulation of cell motility, GO:0050679|positive regulation of epithelial cell proliferation, GO:0071363|cellular response to growth factor stimulus, GO:0032886|regulation of microtubule-based process, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0043406|positive regulation of MAP kinase activity, GO:0070372|regulation of ERK1 and ERK2 cascade, GO:0045765|regulation of angiogenesis, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007166|cell surface receptor signaling pathway, GO:1901185|negative regulation of ERBB signaling pathway, GO:0042060|wound healing, GO:0007167|enzyme linked receptor protein signaling pathway, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0045785|positive regulation of cell adhesion, GO:0045943|positive regulation of transcription by RNA polymerase I, GO:0046777|protein autophosphorylation, GO:0007399|nervous system development, GO:0007422|peripheral nervous system development, GO:0007507|heart development, GO:0007528|neuromuscular junction development, GO:0008045|motor neuron axon guidance, GO:0010628|positive regulation of gene expression, GO:0033088|negative regulation of immature T cell proliferation in thymus, GO:0042552|myelination, GO:0048709|oligodendrocyte differentiation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0042802|identical protein binding, GO:0008022|protein C-terminus binding, GO:0046982|protein heterodimerization activity, GO:0019903|protein phosphatase binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0019838|growth factor binding, GO:0046983|protein dimerization activity, GO:0001042|RNA polymerase I core binding, GO:0004888|transmembrane signaling receptor activity, GO:0043125|ErbB-3 class receptor binding"
TSC1,Nonsense,0.186747715855969,15,0.505139165729991,N,TSG,TSG,0.0618905467762231,0.826560636722746,ENSG00000165699,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005811|lipid droplet, GO:0005886|plasma membrane, GO:0030027|lamellipodium, GO:0005938|cell cortex, GO:0032991|protein-containing complex, GO:0005634|nucleus, GO:0048471|perinuclear region of cytoplasm, GO:0005884|actin filament, GO:0101031|chaperone complex, GO:0033596|TSC1-TSC2 complex, GO:0005856|cytoskeleton, GO:0030426|growth cone, GO:0042995|cell projection, GO:0043231|intracellular membrane-bounded organelle, GO:0016021|integral component of membrane","GO:0032007|negative regulation of TOR signaling, GO:0051726|regulation of cell cycle, GO:0050821|protein stabilization, GO:0008285|negative regulation of cell proliferation, GO:0006417|regulation of translation, GO:0090630|activation of GTPase activity, GO:0017148|negative regulation of translation, GO:0046627|negative regulation of insulin receptor signaling pathway, GO:0007160|cell-matrix adhesion, GO:1901214|regulation of neuron death, GO:0032868|response to insulin, GO:0008344|adult locomotory behavior, GO:0051492|regulation of stress fiber assembly, GO:0051894|positive regulation of focal adhesion assembly, GO:0001952|regulation of cell-matrix adhesion, GO:0032780|negative regulation of ATPase activity, GO:0016242|negative regulation of macroautophagy, GO:0001822|kidney development, GO:0001843|neural tube closure, GO:0002250|adaptive immune response, GO:0006407|rRNA export from nucleus, GO:0006813|potassium ion transport, GO:0007399|nervous system development, GO:0010977|negative regulation of neuron projection development, GO:0016239|positive regulation of macroautophagy, GO:0021766|hippocampus development, GO:0021987|cerebral cortex development, GO:0030030|cell projection organization, GO:0034260|negative regulation of GTPase activity, GO:0042552|myelination, GO:0043379|memory T cell differentiation, GO:0043666|regulation of phosphoprotein phosphatase activity, GO:0045792|negative regulation of cell size, GO:0045859|regulation of protein kinase activity, GO:0046323|glucose import, GO:0050808|synapse organization, GO:0051291|protein heterooligomerization, GO:0051496|positive regulation of stress fiber assembly, GO:0051893|regulation of focal adhesion assembly, GO:0055007|cardiac muscle cell differentiation, GO:0090650|cellular response to oxygen-glucose deprivation, GO:1903204|negative regulation of oxidative stress-induced neuron death","GO:0005515|protein binding, GO:0047485|protein N-terminus binding, GO:0051087|chaperone binding, GO:0051879|Hsp90 protein binding, GO:0030544|Hsp70 protein binding, GO:0042030|ATPase inhibitor activity, GO:0032794|GTPase activating protein binding"
PER1,Missense,0.1867260224589,89,0.079754451267484,N,"TSG, fusion",TSG,0.187336848687983,0.0787564077661648,ENSG00000179094,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm","GO:0007623|circadian rhythm, GO:0048511|rhythmic process, GO:0032922|circadian regulation of gene expression, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0043967|histone H4 acetylation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0046329|negative regulation of JNK cascade, GO:0042634|regulation of hair cycle, GO:2000323|negative regulation of glucocorticoid receptor signaling pathway, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0009416|response to light stimulus, GO:0042752|regulation of circadian rhythm, GO:0043153|entrainment of circadian clock by photoperiod, GO:0070932|histone H3 deacetylation, GO:0097167|circadian regulation of translation, GO:0002028|regulation of sodium ion transport, GO:0009649|entrainment of circadian clock, GO:0010608|posttranscriptional regulation of gene expression, GO:0043966|histone H3 acetylation, GO:0051591|response to cAMP, GO:1900015|regulation of cytokine production involved in inflammatory response, GO:1900744|regulation of p38MAPK cascade","GO:0031490|chromatin DNA binding, GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0031625|ubiquitin protein ligase binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0070888|E-box binding, GO:0001222|transcription corepressor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0019900|kinase binding"
B2M,Missense,0.186495367851493,27,0.351640887689378,N,TSG,TSG,0.100871608361627,0.616636802069505,ENSG00000166710,"GO:0016020|membrane, GO:0005794|Golgi apparatus, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0005615|extracellular space, GO:0009986|cell surface, GO:0005925|focal adhesion, GO:0042612|MHC class I protein complex, GO:0070062|extracellular exosome, GO:0030670|phagocytic vesicle membrane, GO:1990712|HFE-transferrin receptor complex, GO:0005788|endoplasmic reticulum lumen, GO:0035580|specific granule lumen, GO:1904724|tertiary granule lumen, GO:0000139|Golgi membrane, GO:0012507|ER to Golgi transport vesicle membrane, GO:0031901|early endosome membrane, GO:0055038|recycling endosome membrane, GO:0009897|external side of plasma membrane, GO:0031905|early endosome lumen","GO:0006955|immune response, GO:0002376|immune system process, GO:0050776|regulation of immune response, GO:0002474|antigen processing and presentation of peptide antigen via MHC class I, GO:0044267|cellular protein metabolic process, GO:0001895|retina homeostasis, GO:0045087|innate immune response, GO:0043312|neutrophil degranulation, GO:0002479|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, GO:0048260|positive regulation of receptor-mediated endocytosis, GO:0060333|interferon-gamma-mediated signaling pathway, GO:0032092|positive regulation of protein binding, GO:0050690|regulation of defense response to virus by virus, GO:0002480|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent, GO:0002726|positive regulation of T cell cytokine production, GO:0019885|antigen processing and presentation of endogenous peptide antigen via MHC class I, GO:0034756|regulation of iron ion transport, GO:0055072|iron ion homeostasis, GO:0071281|cellular response to iron ion, GO:0001916|positive regulation of T cell mediated cytotoxicity, GO:0002237|response to molecule of bacterial origin, GO:0002481|antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent, GO:0006826|iron ion transport, GO:0010977|negative regulation of neuron projection development, GO:0033077|T cell differentiation in thymus, GO:0042026|protein refolding, GO:0042493|response to drug, GO:0045646|regulation of erythrocyte differentiation, GO:0046686|response to cadmium ion, GO:0071283|cellular response to iron(III) ion, GO:1900121|negative regulation of receptor binding, GO:1900122|positive regulation of receptor binding, GO:1904434|positive regulation of ferrous iron binding, GO:1904437|positive regulation of transferrin receptor binding","GO:0005515|protein binding, GO:0042802|identical protein binding"
ATM,Missense,0.186312354129978,231,0.00449354665582152,Y,TSG,TSG,0.346860445153388,6.22601440570656e-08,ENSG00000149311,"GO:0005634|nucleus, GO:0031410|cytoplasmic vesicle, GO:0005730|nucleolus, GO:0005654|nucleoplasm, GO:0000784|nuclear chromosome, telomeric region, GO:0000781|chromosome, telomeric region, GO:1990391|DNA repair complex, GO:0005737|cytoplasm","GO:0000077|DNA damage checkpoint, GO:0006281|DNA repair, GO:0000723|telomere maintenance, GO:0010212|response to ionizing radiation, GO:0016572|histone phosphorylation, GO:0090399|replicative senescence, GO:0010628|positive regulation of gene expression, GO:0030335|positive regulation of cell migration, GO:0016310|phosphorylation, GO:0006974|cellular response to DNA damage stimulus, GO:0007049|cell cycle, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:1904262|negative regulation of TORC1 signaling, GO:0043065|positive regulation of apoptotic process, GO:0007165|signal transduction, GO:0042981|regulation of apoptotic process, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0006260|DNA replication, GO:0006468|protein phosphorylation, GO:0046777|protein autophosphorylation, GO:0032212|positive regulation of telomere maintenance via telomerase, GO:0006975|DNA damage induced protein phosphorylation, GO:0071044|histone mRNA catabolic process, GO:0018105|peptidyl-serine phosphorylation, GO:0007131|reciprocal meiotic recombination, GO:0007094|mitotic spindle assembly checkpoint, GO:0000729|DNA double-strand break processing, GO:0006303|double-strand break repair via nonhomologous end joining, GO:1904354|negative regulation of telomere capping, GO:1900034|regulation of cellular response to heat, GO:0030889|negative regulation of B cell proliferation, GO:0032210|regulation of telomere maintenance via telomerase, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0007050|cell cycle arrest, GO:0071480|cellular response to gamma radiation, GO:0010506|regulation of autophagy, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0002331|pre-B cell allelic exclusion, GO:0071300|cellular response to retinoic acid, GO:1904358|positive regulation of telomere maintenance via telomere lengthening, GO:0043517|positive regulation of DNA damage response, signal transduction by p53 class mediator, GO:0045785|positive regulation of cell adhesion, GO:0036289|peptidyl-serine autophosphorylation, GO:0071481|cellular response to X-ray, GO:0071500|cellular response to nitrosative stress, GO:0072434|signal transduction involved in mitotic G2 DNA damage checkpoint, GO:0097694|establishment of RNA localization to telomere, GO:0097695|establishment of protein-containing complex localization to telomere, GO:1904884|positive regulation of telomerase catalytic core complex assembly, GO:0001666|response to hypoxia, GO:0006915|apoptotic process, GO:0033129|positive regulation of histone phosphorylation, GO:0043525|positive regulation of neuron apoptotic process, GO:0051726|regulation of cell cycle, GO:1901216|positive regulation of neuron death, GO:1903626|positive regulation of DNA catabolic process, GO:1903978|regulation of microglial cell activation, GO:1905843|regulation of cellular response to gamma radiation, GO:2001022|positive regulation of response to DNA damage stimulus","GO:0004674|protein serine/threonine kinase activity, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0047485|protein N-terminus binding, GO:0044877|protein-containing complex binding, GO:0046983|protein dimerization activity, GO:0004677|DNA-dependent protein kinase activity"
RBM10,Missense,0.18575278126901,64,0.14168175234037,N,TSG,TSG,0.175354249812539,0.165761993429165,ENSG00000182872,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0032991|protein-containing complex","GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0042981|regulation of apoptotic process, GO:0000381|regulation of alternative mRNA splicing, via spliceosome, GO:0008150|biological_process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0008285|negative regulation of cell proliferation, GO:0034391|regulation of smooth muscle cell apoptotic process, GO:0034393|positive regulation of smooth muscle cell apoptotic process, GO:0048025|negative regulation of mRNA splicing, via spliceosome, GO:0070935|3'-UTR-mediated mRNA stabilization","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0035198|miRNA binding"
NOTCH2,Silent,0.185390643897866,65,0.139269705789295,N,"oncogene, TSG","",0.196688340020857,0.116329961343647,ENSG00000134250,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0009986|cell surface, GO:0005576|extracellular region, GO:0005887|integral component of plasma membrane, GO:0005789|endoplasmic reticulum membrane, GO:0000139|Golgi membrane, GO:0043235|receptor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006915|apoptotic process, GO:0007219|Notch signaling pathway, GO:0007399|nervous system development, GO:0050793|regulation of developmental process, GO:0007050|cell cycle arrest, GO:0043066|negative regulation of apoptotic process, GO:0010629|negative regulation of gene expression, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0001709|cell fate determination, GO:0002315|marginal zone B cell differentiation, GO:0030097|hemopoiesis, GO:0009887|animal organ morphogenesis, GO:0046579|positive regulation of Ras protein signal transduction, GO:0019827|stem cell population maintenance, GO:0003184|pulmonary valve morphogenesis, GO:0046849|bone remodeling, GO:0061314|Notch signaling involved in heart development, GO:0060413|atrial septum morphogenesis, GO:0045967|negative regulation of growth rate, GO:2001204|regulation of osteoclast development","GO:0005509|calcium ion binding, GO:0038023|signaling receptor activity, GO:0005515|protein binding"
DNMT3A,Missense,0.185340171637128,74,0.113890887927057,N,TSG,TSG,0.248028927283733,0.0331124606810303,ENSG00000119772,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0016363|nuclear matrix, GO:0000791|euchromatin, GO:0000775|chromosome, centromeric region, GO:0000792|heterochromatin, GO:0001741|XY body, GO:0005720|nuclear heterochromatin","GO:0032259|methylation, GO:0006325|chromatin organization, GO:0006349|regulation of gene expression by genetic imprinting, GO:0010468|regulation of gene expression, GO:0006306|DNA methylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045814|negative regulation of gene expression, epigenetic, GO:0090116|C-5 methylation of cytosine, GO:0000278|mitotic cell cycle, GO:0006346|methylation-dependent chromatin silencing, GO:0007283|spermatogenesis, GO:0007568|aging, GO:0009636|response to toxic substance, GO:0010212|response to ionizing radiation, GO:0010288|response to lead ion, GO:0010942|positive regulation of cell death, GO:0030182|neuron differentiation, GO:0031667|response to nutrient levels, GO:0032355|response to estradiol, GO:0032776|DNA methylation on cytosine, GO:0033189|response to vitamin A, GO:0042220|response to cocaine, GO:0042493|response to drug, GO:0043045|DNA methylation involved in embryo development, GO:0043046|DNA methylation involved in gamete generation, GO:0045471|response to ethanol, GO:0071230|cellular response to amino acid stimulus, GO:0071361|cellular response to ethanol, GO:0071456|cellular response to hypoxia, GO:0097284|hepatocyte apoptotic process","GO:0046872|metal ion binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0009008|DNA-methyltransferase activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0003886|DNA (cytosine-5-)-methyltransferase activity, GO:0003682|chromatin binding, GO:0003714|transcription corepressor activity"
KDM5C,Missense,0.184772852827028,99,0.0671129417569894,N,TSG,TSG,0.196202361310186,0.0516117677801651,ENSG00000126012,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0035097|histone methyltransferase complex","GO:0055114|oxidation-reduction process, GO:0006325|chromatin organization, GO:0048511|rhythmic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0034720|histone H3-K4 demethylation, GO:0034721|histone H3-K4 demethylation, trimethyl-H3-K4-specific","GO:0046872|metal ion binding, GO:0016491|oxidoreductase activity, GO:0003677|DNA binding, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0051213|dioxygenase activity, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0032452|histone demethylase activity, GO:0035064|methylated histone binding, GO:0032453|histone demethylase activity (H3-K4 specific), GO:0034647|histone demethylase activity (H3-trimethyl-K4 specific)"
CTCF,Nonsense,0.183430153736364,21,0.42609082995451,N,TSG,TSG,0.489995308880329,0.0241421876406376,ENSG00000102974,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0005730|nucleolus, GO:0000775|chromosome, centromeric region, GO:0000793|condensed chromosome","GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007059|chromosome segregation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0010628|positive regulation of gene expression, GO:0008285|negative regulation of cell proliferation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0016584|nucleosome positioning, GO:0040029|regulation of gene expression, epigenetic, GO:0040030|regulation of molecular function, epigenetic, GO:0070602|regulation of centromeric sister chromatid cohesion, GO:0071459|protein localization to chromosome, centromeric region, GO:0006306|DNA methylation, GO:0006349|regulation of gene expression by genetic imprinting, GO:0006355|regulation of transcription, DNA-templated, GO:0010216|maintenance of DNA methylation, GO:0010629|negative regulation of gene expression, GO:0031060|regulation of histone methylation, GO:0035065|regulation of histone acetylation","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0003714|transcription corepressor activity, GO:0043035|chromatin insulator sequence binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003682|chromatin binding"
DDR2,Silent,0.181254526213238,36,0.29008255276371,N,Oncogene,Oncogene,0.248595697612493,0.143741824545606,ENSG00000162733,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005887|integral component of plasma membrane, GO:0005886|plasma membrane, GO:0015629|actin cytoskeleton, GO:0016324|apical plasma membrane, GO:0005925|focal adhesion, GO:0043235|receptor complex","GO:0006468|protein phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0038063|collagen-activated tyrosine kinase receptor signaling pathway, GO:0016310|phosphorylation, GO:0003416|endochondral bone growth, GO:0008284|positive regulation of cell proliferation, GO:0010763|positive regulation of fibroblast migration, GO:0030199|collagen fibril organization, GO:0031214|biomineral tissue development, GO:0035988|chondrocyte proliferation, GO:0046777|protein autophosphorylation, GO:0048146|positive regulation of fibroblast proliferation, GO:0090091|positive regulation of extracellular matrix disassembly, GO:0030154|cell differentiation, GO:0030500|regulation of bone mineralization, GO:0007160|cell-matrix adhesion, GO:0001503|ossification, GO:0007165|signal transduction, GO:0007155|cell adhesion, GO:0030198|extracellular matrix organization, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0045860|positive regulation of protein kinase activity, GO:0045669|positive regulation of osteoblast differentiation, GO:0010715|regulation of extracellular matrix disassembly, GO:0001952|regulation of cell-matrix adhesion, GO:1903053|regulation of extracellular matrix organization","GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0004713|protein tyrosine kinase activity, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0038062|protein tyrosine kinase collagen receptor activity, GO:0000166|nucleotide binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0005518|collagen binding"
PAX7,Missense,0.18054681410626,47,0.224577152106872,N,fusion,"",0.133779576202256,0.369991634293064,ENSG00000009709,GO:0005634|nucleus,"GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0007517|muscle organ development, GO:0043066|negative regulation of apoptotic process, GO:0009653|anatomical structure morphogenesis, GO:0006338|chromatin remodeling, GO:0006366|transcription by RNA polymerase II, GO:0007519|skeletal muscle tissue development, GO:0010453|regulation of cell fate commitment, GO:0010468|regulation of gene expression, GO:0014813|skeletal muscle satellite cell commitment, GO:0021527|spinal cord association neuron differentiation, GO:0021904|dorsal/ventral neural tube patterning, GO:0031062|positive regulation of histone methylation, GO:0043393|regulation of protein binding, GO:0043403|skeletal muscle tissue regeneration, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048663|neuron fate commitment, GO:0048706|embryonic skeletal system development, GO:0051216|cartilage development, GO:0060415|muscle tissue morphogenesis, GO:2000288|positive regulation of myoblast proliferation","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003700|DNA-binding transcription factor activity, GO:0016251|RNA polymerase II general transcription initiation factor activity"
ASXL1,Silent,0.179722291274783,47,0.22673653681738,N,TSG,TSG,0.201284965551303,0.174871910401806,ENSG00000171456,"GO:0005634|nucleus, GO:0000790|nuclear chromatin, GO:0005654|nucleoplasm, GO:0035517|PR-DUB complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0006351|transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016579|protein deubiquitination, GO:0045599|negative regulation of fat cell differentiation, GO:0032526|response to retinoic acid, GO:0048386|positive regulation of retinoic acid receptor signaling pathway, GO:0009887|animal organ morphogenesis, GO:0035359|negative regulation of peroxisome proliferator activated receptor signaling pathway, GO:0035522|monoubiquitinated histone H2A deubiquitination, GO:0000902|cell morphogenesis, GO:0003007|heart morphogenesis, GO:0030097|hemopoiesis, GO:0048534|hematopoietic or lymphoid organ development, GO:0048538|thymus development, GO:0048539|bone marrow development, GO:0048872|homeostasis of number of cells, GO:0060348|bone development, GO:0060430|lung saccule development","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0042974|retinoic acid receptor binding, GO:0003682|chromatin binding, GO:0042975|peroxisome proliferator activated receptor binding"
RPN1,Missense,0.178981151635059,29,0.352900552632715,N,fusion,"",-0.0818371014244068,0.673003155223249,ENSG00000163902,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005829|cytosol, GO:0005789|endoplasmic reticulum membrane, GO:0042470|melanosome, GO:0005791|rough endoplasmic reticulum, GO:0008250|oligosaccharyltransferase complex","GO:0006486|protein glycosylation, GO:0018279|protein N-linked glycosylation via asparagine, GO:0006464|cellular protein modification process","GO:0003723|RNA binding, GO:0005515|protein binding, GO:0004579|dolichyl-diphosphooligosaccharide-protein glycotransferase activity, GO:0016740|transferase activity, GO:0016757|transferase activity, transferring glycosyl groups"
MSH6,Nonsense,0.176776695296637,10,0.625160427859996,N,TSG,TSG,-0.27912588617443,0.434801226204931,ENSG00000116062,"GO:0005634|nucleus, GO:0005794|Golgi apparatus, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0032301|MutSalpha complex, GO:0032300|mismatch repair complex, GO:0000790|nuclear chromatin","GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0006298|mismatch repair, GO:0016032|viral process, GO:0045910|negative regulation of DNA recombination, GO:0007095|mitotic G2 DNA damage checkpoint, GO:0008340|determination of adult lifespan, GO:0000710|meiotic mismatch repair, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0009411|response to UV, GO:0051096|positive regulation of helicase activity, GO:0043111|replication fork arrest, GO:0043570|maintenance of DNA repeat elements, GO:0016447|somatic recombination of immunoglobulin gene segments, GO:0045190|isotype switching, GO:0006290|pyrimidine dimer repair, GO:0016446|somatic hypermutation of immunoglobulin genes, GO:0032876|negative regulation of DNA endoreduplication, GO:0036297|interstrand cross-link repair, GO:0045830|positive regulation of isotype switching, GO:0097193|intrinsic apoptotic signaling pathway","GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0030983|mismatched DNA binding, GO:0035064|methylated histone binding, GO:0019899|enzyme binding, GO:0000400|four-way junction DNA binding, GO:0008094|DNA-dependent ATPase activity, GO:0032137|guanine/thymine mispair binding, GO:0032143|single thymine insertion binding, GO:0003684|damaged DNA binding, GO:0043531|ADP binding, GO:0032405|MutLalpha complex binding, GO:0016887|ATPase activity, GO:0032142|single guanine insertion binding, GO:0000287|magnesium ion binding, GO:0003690|double-stranded DNA binding, GO:0032357|oxidized purine DNA binding, GO:0003682|chromatin binding"
MAFB,Silent,0.176776695296637,10,0.625160427859996,N,"oncogene, fusion",Oncogene,0.209850175924132,0.560639320116823,ENSG00000204103,"GO:0005634|nucleus, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0045671|negative regulation of osteoclast differentiation, GO:0045647|negative regulation of erythrocyte differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007379|segment specification, GO:0007423|sensory organ development, GO:0007585|respiratory gaseous exchange, GO:0021571|rhombomere 5 development, GO:0021572|rhombomere 6 development, GO:0021599|abducens nerve formation, GO:0033077|T cell differentiation in thymus, GO:0035284|brain segmentation, GO:0042472|inner ear morphogenesis, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048538|thymus development","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0042803|protein homodimerization activity, GO:0046982|protein heterodimerization activity, GO:1990837|sequence-specific double-stranded DNA binding"
PTPRB,Nonsense,0.176232545409379,12,0.583767731352641,N,TSG,TSG,0.304478220876643,0.335925902024979,ENSG00000127329,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0035579|specific granule membrane, GO:0070821|tertiary granule membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex","GO:0006470|protein dephosphorylation, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0001525|angiogenesis, GO:0043312|neutrophil degranulation, GO:0006796|phosphate-containing compound metabolic process","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0005001|transmembrane receptor protein tyrosine phosphatase activity"
FLI1,Missense,0.17622684421256,10,0.626254280659782,N,"oncogene, fusion",Oncogene,0.308107168557096,0.386435046651236,ENSG00000151702,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0016604|nuclear body","GO:0006355|regulation of transcription, DNA-templated, GO:0008015|blood circulation, GO:0009887|animal organ morphogenesis, GO:0035855|megakaryocyte development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007599|hemostasis","GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
RPL10,Missense,0.174164239131395,25,0.405053547533485,N,TSG,TSG,0.197555657724132,0.343851783627165,ENSG00000147403,"GO:0016020|membrane, GO:0005783|endoplasmic reticulum, GO:0005829|cytosol, GO:0005840|ribosome, GO:0022625|cytosolic large ribosomal subunit, GO:0032991|protein-containing complex, GO:0005634|nucleus, GO:0005790|smooth endoplasmic reticulum","GO:0006412|translation, GO:0007275|multicellular organism development, GO:0000027|ribosomal large subunit assembly, GO:0006417|regulation of translation, GO:0006413|translational initiation, GO:0000184|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, GO:0006614|SRP-dependent cotranslational protein targeting to membrane, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0043066|negative regulation of apoptotic process, GO:1990403|embryonic brain development","GO:0003723|RNA binding, GO:0003735|structural constituent of ribosome, GO:0005515|protein binding, GO:0045182|translation regulator activity"
GNAS,Silent,0.174077655955698,10,0.630536075556976,N,Oncogene,Oncogene,0.0452315357597477,0.90125819584746,ENSG00000087460,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005576|extracellular region, GO:0048471|perinuclear region of cytoplasm, GO:0031410|cytoplasmic vesicle, GO:0030133|transport vesicle, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005834|heterotrimeric G-protein complex, GO:0070062|extracellular exosome, GO:0016324|apical plasma membrane, GO:0030425|dendrite, GO:0042995|cell projection, GO:0001726|ruffle, GO:0032588|trans-Golgi network membrane, GO:0031224|intrinsic component of membrane","GO:0071107|response to parathyroid hormone, GO:0007565|female pregnancy, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0009306|protein secretion, GO:0040015|negative regulation of multicellular organism growth, GO:0007186|G protein-coupled receptor signaling pathway, GO:0007165|signal transduction, GO:0043085|positive regulation of catalytic activity, GO:0060348|bone development, GO:0007188|adenylate cyclase-modulating G protein-coupled receptor signaling pathway, GO:0070527|platelet aggregation, GO:0007189|adenylate cyclase-activating G protein-coupled receptor signaling pathway, GO:0048589|developmental growth, GO:0007191|adenylate cyclase-activating dopamine receptor signaling pathway, GO:0001501|skeletal system development, GO:0001894|tissue homeostasis, GO:0001958|endochondral ossification, GO:0006112|energy reserve metabolic process, GO:0006306|DNA methylation, GO:0009791|post-embryonic development, GO:0035116|embryonic hindlimb morphogenesis, GO:0035264|multicellular organism growth, GO:0040032|post-embryonic body morphogenesis, GO:0042493|response to drug, GO:0043588|skin development, GO:0045669|positive regulation of osteoblast differentiation, GO:0045672|positive regulation of osteoclast differentiation, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0051216|cartilage development, GO:0071514|genetic imprinting, GO:2000828|regulation of parathyroid hormone secretion, GO:0050890|cognition, GO:0060789|hair follicle placode formation, GO:0009966|regulation of signal transduction, GO:0007608|sensory perception of smell, GO:0043547|positive regulation of GTPase activity, GO:0050796|regulation of insulin secretion, GO:0043950|positive regulation of cAMP-mediated signaling, GO:0003091|renal water homeostasis, GO:0071377|cellular response to glucagon stimulus, GO:0071380|cellular response to prostaglandin E stimulus, GO:0071870|cellular response to catecholamine stimulus, GO:0071880|adenylate cyclase-activating adrenergic receptor signaling pathway, GO:0046907|intracellular transport, GO:0007190|activation of adenylate cyclase activity","GO:0003674|molecular_function, GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0019001|guanyl nucleotide binding, GO:0031683|G-protein beta/gamma-subunit complex binding, GO:0035255|ionotropic glutamate receptor binding, GO:0001664|G protein-coupled receptor binding, GO:0031852|mu-type opioid receptor binding, GO:0051430|corticotropin-releasing hormone receptor 1 binding, GO:0010856|adenylate cyclase activator activity, GO:0031698|beta-2 adrenergic receptor binding, GO:0005159|insulin-like growth factor receptor binding, GO:0031748|D1 dopamine receptor binding"
DICER1,Nonsense,0.17392713482426,14,0.552068500291236,N,TSG,TSG,0.171867772164551,0.556858356914781,ENSG00000100697,"GO:0070062|extracellular exosome, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0070578|RISC-loading complex, GO:0035068|micro-ribonucleoprotein complex, GO:0016442|RISC complex, GO:0033167|ARC complex, GO:0005793|endoplasmic reticulum-Golgi intermediate compartment, GO:0030424|axon, GO:0030425|dendrite, GO:0030426|growth cone","GO:0032720|negative regulation of tumor necrosis factor production, GO:0038061|NIK/NF-kappaB signaling, GO:0006396|RNA processing, GO:0031047|gene silencing by RNA, GO:0006309|apoptotic DNA fragmentation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030422|production of siRNA involved in RNA interference, GO:0021675|nerve development, GO:0010586|miRNA metabolic process, GO:0031054|pre-miRNA processing, GO:0035196|production of miRNAs involved in gene silencing by miRNA, GO:0048812|neuron projection morphogenesis, GO:0030423|targeting of mRNA for destruction involved in RNA interference, GO:0035280|miRNA loading onto RISC involved in gene silencing by miRNA, GO:0035087|siRNA loading onto RISC involved in RNA interference, GO:0010626|negative regulation of Schwann cell proliferation, GO:0014040|positive regulation of Schwann cell differentiation, GO:0031643|positive regulation of myelination, GO:0032290|peripheral nervous system myelin formation, GO:0033168|conversion of ds siRNA to ss siRNA involved in RNA interference, GO:0036404|conversion of ds siRNA to ss siRNA, GO:0090502|RNA phosphodiester bond hydrolysis, endonucleolytic, GO:0090501|RNA phosphodiester bond hydrolysis","GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004519|endonuclease activity, GO:0004518|nuclease activity, GO:0004525|ribonuclease III activity, GO:0004386|helicase activity, GO:0019904|protein domain specific binding, GO:0016891|endoribonuclease activity, producing 5'-phosphomonoesters, GO:0003725|double-stranded RNA binding, GO:0070883|pre-miRNA binding, GO:0004530|deoxyribonuclease I activity, GO:0035197|siRNA binding, GO:0004521|endoribonuclease activity"
GOPC,Missense,0.173491358377191,33,0.334268354989218,N,fusion,"",0.230657065417474,0.196554738112254,ENSG00000047932,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0000139|Golgi membrane, GO:0030054|cell junction, GO:0045202|synapse, GO:0045211|postsynaptic membrane, GO:0030425|dendrite, GO:0014069|postsynaptic density, GO:0032991|protein-containing complex, GO:0030140|trans-Golgi network transport vesicle, GO:0005765|lysosomal membrane, GO:0030660|Golgi-associated vesicle membrane","GO:0015031|protein transport, GO:0006893|Golgi to plasma membrane transport, GO:0043004|cytoplasmic sequestering of CFTR protein, GO:0006888|ER to Golgi vesicle-mediated transport, GO:0010360|negative regulation of anion channel activity, GO:0051260|protein homooligomerization, GO:2000009|negative regulation of protein localization to cell surface, GO:0045176|apical protein localization","GO:0005515|protein binding, GO:0044325|ion channel binding"
PTCH1,Silent,0.173385542916319,51,0.223693736285385,N,TSG,TSG,0.159520651974279,0.263506600786254,ENSG00000185920,"GO:0048471|perinuclear region of cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0030666|endocytic vesicle membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005901|caveola, GO:0005794|Golgi apparatus, GO:0060170|ciliary membrane, GO:0005634|nucleus, GO:0005929|cilium, GO:0014069|postsynaptic density, GO:0030496|midbody, GO:0044294|dendritic growth cone, GO:0044295|axonal growth cone","GO:0071397|cellular response to cholesterol, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045668|negative regulation of osteoblast differentiation, GO:0007224|smoothened signaling pathway, GO:0060037|pharyngeal system development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0009887|animal organ morphogenesis, GO:0016485|protein processing, GO:0009953|dorsal/ventral pattern formation, GO:0040015|negative regulation of multicellular organism growth, GO:0010875|positive regulation of cholesterol efflux, GO:0072001|renal system development, GO:0007420|brain development, GO:0072659|protein localization to plasma membrane, GO:0008589|regulation of smoothened signaling pathway, GO:0045879|negative regulation of smoothened signaling pathway, GO:0061053|somite development, GO:0030326|embryonic limb morphogenesis, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0001701|in utero embryonic development, GO:0001709|cell fate determination, GO:0001841|neural tube formation, GO:0001843|neural tube closure, GO:0003007|heart morphogenesis, GO:0007165|signal transduction, GO:0007346|regulation of mitotic cell cycle, GO:0007389|pattern specification process, GO:0008285|negative regulation of cell proliferation, GO:0008544|epidermis development, GO:0009612|response to mechanical stimulus, GO:0009957|epidermal cell fate specification, GO:0010157|response to chlorate, GO:0014070|response to organic cyclic compound, GO:0021522|spinal cord motor neuron differentiation, GO:0021532|neural tube patterning, GO:0021904|dorsal/ventral neural tube patterning, GO:0021997|neural plate axis specification, GO:0030850|prostate gland development, GO:0030879|mammary gland development, GO:0032355|response to estradiol, GO:0032526|response to retinoic acid, GO:0032880|regulation of protein localization, GO:0035108|limb morphogenesis, GO:0035137|hindlimb morphogenesis, GO:0040008|regulation of growth, GO:0042127|regulation of cell proliferation, GO:0042493|response to drug, GO:0042593|glucose homeostasis, GO:0043616|keratinocyte proliferation, GO:0045606|positive regulation of epidermal cell differentiation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0048568|embryonic organ development, GO:0050680|negative regulation of epithelial cell proliferation, GO:0051782|negative regulation of cell division, GO:0060603|mammary gland duct morphogenesis, GO:0060644|mammary gland epithelial cell differentiation, GO:0060831|smoothened signaling pathway involved in dorsal/ventral neural tube patterning, GO:0061005|cell differentiation involved in kidney development, GO:0071679|commissural neuron axon guidance, GO:0072203|cell proliferation involved in metanephros development, GO:0097421|liver regeneration","GO:0005515|protein binding, GO:0015485|cholesterol binding, GO:0030332|cyclin binding, GO:0005113|patched binding, GO:0005119|smoothened binding, GO:0008158|hedgehog receptor activity, GO:0008201|heparin binding, GO:0044877|protein-containing complex binding, GO:0097108|hedgehog family protein binding"
ITK,Missense,0.173147832547628,93,0.0969636081372594,N,fusion,"",0.160992338817651,0.123163336287606,ENSG00000113263,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005911|cell-cell junction","GO:0035556|intracellular signal transduction, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0002376|immune system process, GO:0002250|adaptive immune response, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0050853|B cell receptor signaling pathway, GO:0050852|T cell receptor signaling pathway, GO:0001816|cytokine production, GO:0007165|signal transduction, GO:0042110|T cell activation, GO:0006968|cellular defense response, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0007202|activation of phospholipase C activity, GO:0001865|NK T cell differentiation, GO:0032609|interferon-gamma production, GO:0032633|interleukin-4 production","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity"
STAT5B,Missense,0.173080631772995,60,0.186008215539881,N,"oncogene, TSG, fusion","",0.244689398456601,0.0595327266143072,ENSG00000173757,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005829|cytosol","GO:0006355|regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0060397|JAK-STAT cascade involved in growth hormone signaling pathway, GO:0019221|cytokine-mediated signaling pathway, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007259|JAK-STAT cascade, GO:0032355|response to estradiol, GO:0032870|cellular response to hormone stimulus, GO:0038111|interleukin-7-mediated signaling pathway, GO:0071363|cellular response to growth factor stimulus, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0040014|regulation of multicellular organism growth, GO:0038110|interleukin-2-mediated signaling pathway, GO:0045648|positive regulation of erythrocyte differentiation, GO:0019530|taurine metabolic process, GO:0035723|interleukin-15-mediated signaling pathway, GO:0038113|interleukin-9-mediated signaling pathway, GO:0001553|luteinization, GO:0001779|natural killer cell differentiation, GO:0007548|sex differentiation, GO:0007565|female pregnancy, GO:0007595|lactation, GO:0008284|positive regulation of cell proliferation, GO:0019218|regulation of steroid metabolic process, GO:0019915|lipid storage, GO:0030155|regulation of cell adhesion, GO:0030856|regulation of epithelial cell differentiation, GO:0032819|positive regulation of natural killer cell proliferation, GO:0032825|positive regulation of natural killer cell differentiation, GO:0033077|T cell differentiation in thymus, GO:0040018|positive regulation of multicellular organism growth, GO:0042104|positive regulation of activated T cell proliferation, GO:0042448|progesterone metabolic process, GO:0043029|T cell homeostasis, GO:0043066|negative regulation of apoptotic process, GO:0045086|positive regulation of interleukin-2 biosynthetic process, GO:0045579|positive regulation of B cell differentiation, GO:0045588|positive regulation of gamma-delta T cell differentiation, GO:0045621|positive regulation of lymphocyte differentiation, GO:0045647|negative regulation of erythrocyte differentiation, GO:0045931|positive regulation of mitotic cell cycle, GO:0045954|positive regulation of natural killer cell mediated cytotoxicity, GO:0046543|development of secondary female sexual characteristics, GO:0046544|development of secondary male sexual characteristics, GO:0048541|Peyer's patch development, GO:0050729|positive regulation of inflammatory response, GO:0070669|response to interleukin-2, GO:0070670|response to interleukin-4, GO:0070672|response to interleukin-15, GO:0097531|mast cell migration","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0004713|protein tyrosine kinase activity, GO:0046983|protein dimerization activity, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0035259|glucocorticoid receptor binding"
MYH9,Silent,0.172861268036926,75,0.13805634044286,N,"TSG, fusion",TSG,0.190116068380245,0.102313965049661,ENSG00000100345,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016459|myosin complex, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0001725|stress fiber, GO:0001772|immunological synapse, GO:0001931|uropod, GO:0005819|spindle, GO:0005903|brush border, GO:0005913|cell-cell adherens junction, GO:0005925|focal adhesion, GO:0005938|cell cortex, GO:0016460|myosin II complex, GO:0030863|cortical cytoskeleton, GO:0031594|neuromuscular junction, GO:0031252|cell leading edge, GO:0070062|extracellular exosome, GO:0008180|COP9 signalosome, GO:0032154|cleavage furrow, GO:0032991|protein-containing complex, GO:0001726|ruffle, GO:0015629|actin cytoskeleton, GO:0005826|actomyosin contractile ring, GO:0042641|actomyosin, GO:0097513|myosin II filament","GO:0015031|protein transport, GO:0007155|cell adhesion, GO:0000212|meiotic spindle organization, GO:0000904|cell morphogenesis involved in differentiation, GO:0001701|in utero embryonic development, GO:0001768|establishment of T cell polarity, GO:0006911|phagocytosis, engulfment, GO:0007520|myoblast fusion, GO:0008360|regulation of cell shape, GO:0032796|uropod organization, GO:0051295|establishment of meiotic spindle localization, GO:0098609|cell-cell adhesion, GO:1903919|negative regulation of actin filament severing, GO:1903923|positive regulation of protein processing in phagocytic vesicle, GO:0007229|integrin-mediated signaling pathway, GO:0032506|cytokinetic process, GO:0001525|angiogenesis, GO:0070527|platelet aggregation, GO:0006509|membrane protein ectodomain proteolysis, GO:0031532|actin cytoskeleton reorganization, GO:0030048|actin filament-based movement, GO:0030220|platelet formation, GO:0030224|monocyte differentiation, GO:0031032|actomyosin structure organization, GO:0043534|blood vessel endothelial cell migration, GO:0050900|leukocyte migration","GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0003774|motor activity, GO:0003779|actin binding, GO:0051015|actin filament binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0019904|protein domain specific binding, GO:0005516|calmodulin binding, GO:0045296|cadherin binding, GO:0016887|ATPase activity, GO:0005178|integrin binding, GO:0000146|microfilament motor activity, GO:0043495|protein membrane anchor, GO:0030898|actin-dependent ATPase activity, GO:0043531|ADP binding"
NAB2,Silent,0.172384513355746,14,0.555654821376625,N,"TSG, fusion",TSG,0.0761459925069673,0.795848587890229,ENSG00000166886,GO:0005634|nucleus,"GO:0006355|regulation of transcription, DNA-templated, GO:0045892|negative regulation of transcription, DNA-templated, GO:0007399|nervous system development, GO:0008283|cell proliferation, GO:1902949|positive regulation of tau-protein kinase activity, GO:0001958|endochondral ossification, GO:0014037|Schwann cell differentiation, GO:0016480|negative regulation of transcription by RNA polymerase III, GO:0042552|myelination, GO:0045682|regulation of epidermis development","GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0003714|transcription corepressor activity, GO:0008134|transcription factor binding"
CTCF,Missense,0.171845686692421,88,0.109390234573076,N,TSG,TSG,0.205023589010105,0.0553395441449959,ENSG00000102974,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0005730|nucleolus, GO:0000775|chromosome, centromeric region, GO:0000793|condensed chromosome","GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007059|chromosome segregation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0010628|positive regulation of gene expression, GO:0008285|negative regulation of cell proliferation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0016584|nucleosome positioning, GO:0040029|regulation of gene expression, epigenetic, GO:0040030|regulation of molecular function, epigenetic, GO:0070602|regulation of centromeric sister chromatid cohesion, GO:0071459|protein localization to chromosome, centromeric region, GO:0006306|DNA methylation, GO:0006349|regulation of gene expression by genetic imprinting, GO:0006355|regulation of transcription, DNA-templated, GO:0010216|maintenance of DNA methylation, GO:0010629|negative regulation of gene expression, GO:0031060|regulation of histone methylation, GO:0035065|regulation of histone acetylation","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0003714|transcription corepressor activity, GO:0043035|chromatin insulator sequence binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003682|chromatin binding"
DDX3X,Missense,0.17164450550796,93,0.0999437619004832,N,TSG,TSG,0.141867229838345,0.174944443356223,ENSG00000215301,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0016020|membrane, GO:0005852|eukaryotic translation initiation factor 3 complex, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0022627|cytosolic small ribosomal subunit, GO:0005741|mitochondrial outer membrane, GO:0005576|extracellular region, GO:0070062|extracellular exosome, GO:0010494|cytoplasmic stress granule, GO:0034774|secretory granule lumen, GO:1904813|ficolin-1-rich granule lumen, GO:0016021|integral component of membrane","GO:0006413|translational initiation, GO:0032508|DNA duplex unwinding, GO:0006915|apoptotic process, GO:0016055|Wnt signaling pathway, GO:0045727|positive regulation of translation, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0042254|ribosome biogenesis, GO:0007059|chromosome segregation, GO:0045948|positive regulation of translational initiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0071902|positive regulation of protein serine/threonine kinase activity, GO:0006417|regulation of translation, GO:0009615|response to virus, GO:0043065|positive regulation of apoptotic process, GO:0016032|viral process, GO:0010628|positive regulation of gene expression, GO:0043312|neutrophil degranulation, GO:0017148|negative regulation of translation, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0043066|negative regulation of apoptotic process, GO:0030308|negative regulation of cell growth, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0030307|positive regulation of cell growth, GO:0035556|intracellular signal transduction, GO:0010501|RNA secondary structure unwinding, GO:0031333|negative regulation of protein complex assembly, GO:0032728|positive regulation of interferon-beta production, GO:0034063|stress granule assembly, GO:0042256|mature ribosome assembly, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0043280|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0045070|positive regulation of viral genome replication, GO:0071243|cellular response to arsenic-containing substance, GO:0071470|cellular response to osmotic stress, GO:0071651|positive regulation of chemokine (C-C motif) ligand 5 production, GO:0097193|intrinsic apoptotic signaling pathway, GO:1900087|positive regulation of G1/S transition of mitotic cell cycle, GO:1903608|protein localization to cytoplasmic stress granule, GO:2001243|negative regulation of intrinsic apoptotic signaling pathway","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004386|helicase activity, GO:0045296|cadherin binding, GO:0043539|protein serine/threonine kinase activator activity, GO:0016887|ATPase activity, GO:0004003|ATP-dependent DNA helicase activity, GO:0004004|ATP-dependent RNA helicase activity, GO:0008134|transcription factor binding, GO:0003924|GTPase activity, GO:0008143|poly(A) binding, GO:0008190|eukaryotic initiation factor 4E binding, GO:0017111|nucleoside-triphosphatase activity, GO:0031369|translation initiation factor binding, GO:0033592|RNA strand annealing activity, GO:0035613|RNA stem-loop binding, GO:0043024|ribosomal small subunit binding, GO:0043273|CTPase activity, GO:0048027|mRNA 5'-UTR binding"
TERT,Silent,0.171452827939851,49,0.238822963081999,N,"oncogene, TSG","",0.199302747937892,0.169776422726677,ENSG00000164362,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0005829|cytosol, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0000781|chromosome, telomeric region, GO:0000784|nuclear chromosome, telomeric region, GO:0016605|PML body, GO:0042645|mitochondrial nucleoid, GO:0000333|telomerase catalytic core complex, GO:0000783|nuclear telomere cap complex, GO:0005697|telomerase holoenzyme complex, GO:0005739|mitochondrion, GO:0005886|plasma membrane, GO:0031379|RNA-directed RNA polymerase complex, GO:1990572|TERT-RMRP complex","GO:0010629|negative regulation of gene expression, GO:2000773|negative regulation of cellular senescence, GO:0071456|cellular response to hypoxia, GO:0000723|telomere maintenance, GO:1904837|beta-catenin-TCF complex assembly, GO:0001172|transcription, RNA-templated, GO:0006278|RNA-dependent DNA biosynthetic process, GO:0007004|telomere maintenance via telomerase, GO:0007005|mitochondrion organization, GO:0022616|DNA strand elongation, GO:0030177|positive regulation of Wnt signaling pathway, GO:0030422|production of siRNA involved in RNA interference, GO:0031647|regulation of protein stability, GO:0032092|positive regulation of protein binding, GO:0032774|RNA biosynthetic process, GO:0042635|positive regulation of hair cycle, GO:0043066|negative regulation of apoptotic process, GO:0043524|negative regulation of neuron apoptotic process, GO:0045766|positive regulation of angiogenesis, GO:0046326|positive regulation of glucose import, GO:0046686|response to cadmium ion, GO:0051000|positive regulation of nitric-oxide synthase activity, GO:0060253|negative regulation of glial cell proliferation, GO:0070200|establishment of protein localization to telomere, GO:0071897|DNA biosynthetic process, GO:0090399|replicative senescence, GO:1900087|positive regulation of G1/S transition of mitotic cell cycle, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:1903620|positive regulation of transdifferentiation, GO:1903704|negative regulation of production of siRNA involved in RNA interference, GO:1904707|positive regulation of vascular smooth muscle cell proliferation, GO:1904751|positive regulation of protein localization to nucleolus, GO:1904754|positive regulation of vascular associated smooth muscle cell migration, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:2000648|positive regulation of stem cell proliferation, GO:2001240|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0016779|nucleotidyltransferase activity, GO:0042802|identical protein binding, GO:0042803|protein homodimerization activity, GO:0000049|tRNA binding, GO:0001223|transcription coactivator binding, GO:0003720|telomerase activity, GO:0003721|telomerase RNA reverse transcriptase activity, GO:0003723|RNA binding, GO:0003964|RNA-directed DNA polymerase activity, GO:0003968|RNA-directed 5'-3' RNA polymerase activity, GO:0008022|protein C-terminus binding, GO:0042162|telomeric DNA binding, GO:0047485|protein N-terminus binding, GO:0051087|chaperone binding, GO:0070034|telomerase RNA binding, GO:0098680|template-free RNA nucleotidyltransferase"
CLTCL1,Silent,0.171312483047695,37,0.310674907626159,N,"TSG, fusion",TSG,0.189503672867651,0.261285409460894,ENSG00000070371,"GO:0016020|membrane, GO:0031410|cytoplasmic vesicle, GO:0030659|cytoplasmic vesicle membrane, GO:0005905|clathrin-coated pit, GO:0030130|clathrin coat of trans-Golgi network vesicle, GO:0005819|spindle, GO:0071439|clathrin complex, GO:0030136|clathrin-coated vesicle, GO:0005829|cytosol, GO:0070062|extracellular exosome, GO:0005802|trans-Golgi network, GO:0005770|late endosome, GO:0045334|clathrin-coated endocytic vesicle, GO:0030135|coated vesicle, GO:0097443|sorting endosome, GO:0005623|cell, GO:0030132|clathrin coat of coated pit","GO:0006886|intracellular protein transport, GO:0016192|vesicle-mediated transport, GO:0048268|clathrin coat assembly, GO:0042147|retrograde transport, endosome to Golgi, GO:0061024|membrane organization, GO:0009653|anatomical structure morphogenesis, GO:0000278|mitotic cell cycle, GO:0006898|receptor-mediated endocytosis, GO:0046326|positive regulation of glucose import","GO:0005198|structural molecule activity, GO:0032051|clathrin light chain binding, GO:0005515|protein binding"
NTRK3,Missense,0.170260798181597,127,0.0556497807513772,N,"oncogene, fusion",Oncogene,0.0905660145053473,0.31124239121308,ENSG00000140538,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005887|integral component of plasma membrane, GO:0005886|plasma membrane, GO:0043235|receptor complex, GO:0030424|axon, GO:0005737|cytoplasm","GO:0010628|positive regulation of gene expression, GO:0008284|positive regulation of cell proliferation, GO:0030335|positive regulation of cell migration, GO:0001934|positive regulation of protein phosphorylation, GO:0032148|activation of protein kinase B activity, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0038179|neurotrophin signaling pathway, GO:0007275|multicellular organism development, GO:0048013|ephrin receptor signaling pathway, GO:0030154|cell differentiation, GO:0007399|nervous system development, GO:0043410|positive regulation of MAPK cascade, GO:0007507|heart development, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:2000251|positive regulation of actin cytoskeleton reorganization, GO:0000187|activation of MAPK activity, GO:0043408|regulation of MAPK cascade, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0090630|activation of GTPase activity, GO:0001933|negative regulation of protein phosphorylation, GO:0010976|positive regulation of neuron projection development, GO:1990090|cellular response to nerve growth factor stimulus, GO:0050927|positive regulation of positive chemotaxis, GO:0010863|positive regulation of phospholipase C activity, GO:0001764|neuron migration, GO:0007623|circadian rhythm, GO:0019056|modulation by virus of host transcription, GO:0019227|neuronal action potential propagation, GO:0022011|myelination in peripheral nervous system, GO:0042490|mechanoreceptor differentiation, GO:0043065|positive regulation of apoptotic process, GO:0045471|response to ethanol, GO:0048665|neuron fate specification, GO:0048678|response to axon injury, GO:0048691|positive regulation of axon extension involved in regeneration, GO:0048712|negative regulation of astrocyte differentiation, GO:0051412|response to corticosterone, GO:0051965|positive regulation of synapse assembly, GO:0060548|negative regulation of cell death, GO:0070306|lens fiber cell differentiation, GO:0071300|cellular response to retinoic acid, GO:0090102|cochlea development","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005030|neurotrophin receptor activity, GO:0002039|p53 binding, GO:0043121|neurotrophin binding, GO:0005004|GPI-linked ephrin receptor activity"
PDGFRB,Missense,0.17017616281308,106,0.0811517925665875,N,"oncogene, fusion",Oncogene,0.185223675591489,0.0573195383064229,ENSG00000113721,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0043231|intracellular membrane-bounded organelle, GO:0005886|plasma membrane, GO:0031410|cytoplasmic vesicle, GO:0005925|focal adhesion, GO:0005764|lysosome, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0016324|apical plasma membrane, GO:0031226|intrinsic component of plasma membrane, GO:0043202|lysosomal lumen, GO:0009986|cell surface","GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0030335|positive regulation of cell migration, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0007165|signal transduction, GO:0007275|multicellular organism development, GO:0048015|phosphatidylinositol-mediated signaling, GO:0006935|chemotaxis, GO:0046488|phosphatidylinositol metabolic process, GO:0046854|phosphatidylinositol phosphorylation, GO:0002244|hematopoietic progenitor cell differentiation, GO:0008284|positive regulation of cell proliferation, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0007186|G protein-coupled receptor signaling pathway, GO:0016477|cell migration, GO:2000379|positive regulation of reactive oxygen species metabolic process, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0060326|cell chemotaxis, GO:0014911|positive regulation of smooth muscle cell migration, GO:0045840|positive regulation of mitotic nuclear division, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0090280|positive regulation of calcium ion import, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0072277|metanephric glomerular capillary formation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0043406|positive regulation of MAP kinase activity, GO:0035791|platelet-derived growth factor receptor-beta signaling pathway, GO:2000573|positive regulation of DNA biosynthetic process, GO:0010863|positive regulation of phospholipase C activity, GO:0035793|positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0050921|positive regulation of chemotaxis, GO:0032956|regulation of actin cytoskeleton organization, GO:0032516|positive regulation of phosphoprotein phosphatase activity, GO:0006024|glycosaminoglycan biosynthetic process, GO:0007568|aging, GO:0008584|male gonad development, GO:0009636|response to toxic substance, GO:0014070|response to organic cyclic compound, GO:0032355|response to estradiol, GO:0032526|response to retinoic acid, GO:0032967|positive regulation of collagen biosynthetic process, GO:0033993|response to lipid, GO:0034405|response to fluid shear stress, GO:0035025|positive regulation of Rho protein signal transduction, GO:0035441|cell migration involved in vasculogenesis, GO:0035556|intracellular signal transduction, GO:0035789|metanephric mesenchymal cell migration, GO:0035909|aorta morphogenesis, GO:0036120|cellular response to platelet-derived growth factor stimulus, GO:0038091|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway, GO:0042060|wound healing, GO:0042542|response to hydrogen peroxide, GO:0043065|positive regulation of apoptotic process, GO:0043066|negative regulation of apoptotic process, GO:0043627|response to estrogen, GO:0048146|positive regulation of fibroblast proliferation, GO:0048839|inner ear development, GO:0055003|cardiac myofibril assembly, GO:0055093|response to hyperoxia, GO:0060437|lung growth, GO:0060981|cell migration involved in coronary angiogenesis, GO:0061298|retina vasculature development in camera-type eye, GO:0071670|smooth muscle cell chemotaxis, GO:0072075|metanephric mesenchyme development, GO:0072262|metanephric glomerular mesangial cell proliferation involved in metanephros development, GO:0072275|metanephric glomerulus morphogenesis, GO:0072278|metanephric comma-shaped body morphogenesis, GO:0072284|metanephric S-shaped body morphogenesis, GO:2000491|positive regulation of hepatic stellate cell activation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0048407|platelet-derived growth factor binding, GO:0019901|protein kinase binding, GO:0005102|signaling receptor binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0019899|enzyme binding, GO:0038085|vascular endothelial growth factor binding, GO:0005161|platelet-derived growth factor receptor binding, GO:0004992|platelet activating factor receptor activity, GO:0005017|platelet-derived growth factor-activated receptor activity, GO:0005019|platelet-derived growth factor beta-receptor activity, GO:0043548|phosphatidylinositol 3-kinase binding"
PIM1,Missense,0.170122747294487,49,0.242540836886396,N,"oncogene, fusion",Oncogene,-0.0339036310040549,0.817108765202521,ENSG00000137193,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005654|nucleoplasm","GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0006468|protein phosphorylation, GO:0043066|negative regulation of apoptotic process, GO:0016310|phosphorylation, GO:0007049|cell cycle, GO:0006915|apoptotic process, GO:0030212|hyaluronan metabolic process, GO:0008283|cell proliferation, GO:0007275|multicellular organism development, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0019221|cytokine-mediated signaling pathway, GO:0046777|protein autophosphorylation, GO:0070561|vitamin D receptor signaling pathway, GO:1905062|positive regulation of cardioblast proliferation","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0030145|manganese ion binding, GO:0008134|transcription factor binding, GO:0043024|ribosomal small subunit binding"
NSD1,Silent,0.169166972233401,55,0.216949132272313,N,fusion,"",0.179779689310774,0.189052122178265,ENSG00000165671,"GO:0005634|nucleus, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0000785|chromatin","GO:0032259|methylation, GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0034968|histone lysine methylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0016571|histone methylation, GO:0000414|regulation of histone H3-K36 methylation, GO:0010452|histone H3-K36 methylation, GO:0033135|regulation of peptidyl-serine phosphorylation, GO:0034770|histone H4-K20 methylation, GO:1903025|regulation of RNA polymerase II regulatory region sequence-specific DNA binding","GO:0046872|metal ion binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0046975|histone methyltransferase activity (H3-K36 specific), GO:0042799|histone methyltransferase activity (H4-K20 specific), GO:0003714|transcription corepressor activity, GO:0030331|estrogen receptor binding, GO:0042974|retinoic acid receptor binding, GO:0003682|chromatin binding, GO:0003712|transcription coregulator activity, GO:0050681|androgen receptor binding, GO:0046966|thyroid hormone receptor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0046965|retinoid X receptor binding"
RUNX1,Missense,0.16818029924739,32,0.357521787001572,N,"oncogene, TSG, fusion","",0.310828237964435,0.0833558300832055,ENSG00000159216,"GO:0005634|nucleus, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0016513|core-binding factor complex","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030182|neuron differentiation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:2000810|regulation of bicellular tight junction assembly, GO:0030097|hemopoiesis, GO:0045766|positive regulation of angiogenesis, GO:0045652|regulation of megakaryocyte differentiation, GO:0030111|regulation of Wnt signaling pathway, GO:0033146|regulation of intracellular estrogen receptor signaling pathway, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0032743|positive regulation of interleukin-2 production, GO:0045616|regulation of keratinocyte differentiation, GO:0071425|hematopoietic stem cell proliferation, GO:0045589|regulation of regulatory T cell differentiation, GO:0045637|regulation of myeloid cell differentiation, GO:0001959|regulation of cytokine-mediated signaling pathway, GO:0043371|negative regulation of CD4-positive, alpha-beta T cell differentiation, GO:0050855|regulation of B cell receptor signaling pathway, GO:0030854|positive regulation of granulocyte differentiation, GO:0048935|peripheral nervous system neuron development, GO:0043378|positive regulation of CD8-positive, alpha-beta T cell differentiation, GO:0010629|negative regulation of gene expression","GO:0005524|ATP binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding"
JAK2,Missense,0.167442271633705,80,0.137654725538634,N,"oncogene, fusion",Oncogene,0.163639439138993,0.146947873255499,ENSG00000096968,"GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0005925|focal adhesion, GO:0005856|cytoskeleton, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0012505|endomembrane system, GO:0031904|endosome lumen, GO:0005901|caveola, GO:0016363|nuclear matrix, GO:0045121|membrane raft","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0008285|negative regulation of cell proliferation, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0006325|chromatin organization, GO:0007165|signal transduction, GO:0030218|erythrocyte differentiation, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0002250|adaptive immune response, GO:0030154|cell differentiation, GO:0019221|cytokine-mediated signaling pathway, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0035722|interleukin-12-mediated signaling pathway, GO:0032496|response to lipopolysaccharide, GO:0032760|positive regulation of tumor necrosis factor production, GO:0051770|positive regulation of nitric-oxide synthase biosynthetic process, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0060333|interferon-gamma-mediated signaling pathway, GO:0007596|blood coagulation, GO:0007259|JAK-STAT cascade, GO:0060396|growth hormone receptor signaling pathway, GO:0060334|regulation of interferon-gamma-mediated signaling pathway, GO:0070102|interleukin-6-mediated signaling pathway, GO:0034612|response to tumor necrosis factor, GO:0033209|tumor necrosis factor-mediated signaling pathway, GO:0007498|mesoderm development, GO:0097191|extrinsic apoptotic signaling pathway, GO:0043392|negative regulation of DNA binding, GO:0000186|activation of MAPKK activity, GO:0006915|apoptotic process, GO:0006979|response to oxidative stress, GO:0007167|enzyme linked receptor protein signaling pathway, GO:0007186|G protein-coupled receptor signaling pathway, GO:0007204|positive regulation of cytosolic calcium ion concentration, GO:0007260|tyrosine phosphorylation of STAT protein, GO:0008284|positive regulation of cell proliferation, GO:0008631|intrinsic apoptotic signaling pathway in response to oxidative stress, GO:0009755|hormone-mediated signaling pathway, GO:0010667|negative regulation of cardiac muscle cell apoptotic process, GO:0010811|positive regulation of cell-substrate adhesion, GO:0022408|negative regulation of cell-cell adhesion, GO:0030041|actin filament polymerization, GO:0030335|positive regulation of cell migration, GO:0031103|axon regeneration, GO:0031959|mineralocorticoid receptor signaling pathway, GO:0032024|positive regulation of insulin secretion, GO:0032516|positive regulation of phosphoprotein phosphatase activity, GO:0032731|positive regulation of interleukin-1 beta production, GO:0033160|positive regulation of protein import into nucleus, translocation, GO:0033194|response to hydroperoxide, GO:0035409|histone H3-Y41 phosphorylation, GO:0038155|interleukin-23-mediated signaling pathway, GO:0042976|activation of Janus kinase activity, GO:0043065|positive regulation of apoptotic process, GO:0043388|positive regulation of DNA binding, GO:0043524|negative regulation of neuron apoptotic process, GO:0045428|regulation of nitric oxide biosynthetic process, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0045597|positive regulation of cell differentiation, GO:0045822|negative regulation of heart contraction, GO:0046425|regulation of JAK-STAT cascade, GO:0046579|positive regulation of Ras protein signal transduction, GO:0046677|response to antibiotic, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0050727|regulation of inflammatory response, GO:0050729|positive regulation of inflammatory response, GO:0050867|positive regulation of cell activation, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0060397|JAK-STAT cascade involved in growth hormone signaling pathway, GO:0060399|positive regulation of growth hormone receptor signaling pathway, GO:0060548|negative regulation of cell death, GO:0061180|mammary gland epithelium development, GO:0070106|interleukin-27-mediated signaling pathway, GO:0070671|response to interleukin-12, GO:0070757|interleukin-35-mediated signaling pathway, GO:0097296|activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway, GO:1902728|positive regulation of growth factor dependent skeletal muscle satellite cell proliferation, GO:1904037|positive regulation of epithelial cell apoptotic process, GO:1904707|positive regulation of vascular smooth muscle cell proliferation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0042393|histone binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0020037|heme binding, GO:0042169|SH2 domain binding, GO:0005102|signaling receptor binding, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0019901|protein kinase binding, GO:0005131|growth hormone receptor binding, GO:0005143|interleukin-12 receptor binding, GO:0008022|protein C-terminus binding, GO:0031702|type 1 angiotensin receptor binding, GO:0033130|acetylcholine receptor binding, GO:0035401|histone kinase activity (H3-Y41 specific), GO:0043548|phosphatidylinositol 3-kinase binding, GO:0043560|insulin receptor substrate binding, GO:0051428|peptide hormone receptor binding"
SYK,Missense,0.165796656824479,58,0.213568595101799,N,"oncogene, fusion",Oncogene,0.110893917185725,0.407263626899988,ENSG00000165025,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0019815|B cell receptor complex, GO:0032009|early phagosome, GO:0032991|protein-containing complex, GO:0005634|nucleus, GO:0042101|T cell receptor complex","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0000187|activation of MAPK activity, GO:0001820|serotonin secretion, GO:0001945|lymph vessel development, GO:0002092|positive regulation of receptor internalization, GO:0002281|macrophage activation involved in immune response, GO:0002283|neutrophil activation involved in immune response, GO:0002366|leukocyte activation involved in immune response, GO:0002554|serotonin secretion by platelet, GO:0007166|cell surface receptor signaling pathway, GO:0007167|enzyme linked receptor protein signaling pathway, GO:0007229|integrin-mediated signaling pathway, GO:0007257|activation of JUN kinase activity, GO:0010543|regulation of platelet activation, GO:0018105|peptidyl-serine phosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0019370|leukotriene biosynthetic process, GO:0031623|receptor internalization, GO:0032481|positive regulation of type I interferon production, GO:0032753|positive regulation of interleukin-4 production, GO:0032928|regulation of superoxide anion generation, GO:0033630|positive regulation of cell adhesion mediated by integrin, GO:0038063|collagen-activated tyrosine kinase receptor signaling pathway, GO:0038156|interleukin-3-mediated signaling pathway, GO:0042742|defense response to bacterium, GO:0043306|positive regulation of mast cell degranulation, GO:0043313|regulation of neutrophil degranulation, GO:0043366|beta selection, GO:0045087|innate immune response, GO:0045401|positive regulation of interleukin-3 biosynthetic process, GO:0045425|positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process, GO:0045579|positive regulation of B cell differentiation, GO:0045588|positive regulation of gamma-delta T cell differentiation, GO:0045780|positive regulation of bone resorption, GO:0046638|positive regulation of alpha-beta T cell differentiation, GO:0046641|positive regulation of alpha-beta T cell proliferation, GO:0046777|protein autophosphorylation, GO:0048514|blood vessel morphogenesis, GO:0050715|positive regulation of cytokine secretion, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0050764|regulation of phagocytosis, GO:0050850|positive regulation of calcium-mediated signaling, GO:0050853|B cell receptor signaling pathway, GO:0070372|regulation of ERK1 and ERK2 cascade, GO:0071226|cellular response to molecule of fungal origin, GO:0071404|cellular response to low-density lipoprotein particle stimulus, GO:0090237|regulation of arachidonic acid secretion, GO:0090330|regulation of platelet aggregation, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0002376|immune system process, GO:0002250|adaptive immune response, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0030593|neutrophil chemotaxis, GO:0016032|viral process, GO:0001525|angiogenesis, GO:0030168|platelet activation, GO:0008283|cell proliferation, GO:0009887|animal organ morphogenesis, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0006606|protein import into nucleus, GO:0038110|interleukin-2-mediated signaling pathway, GO:0007159|leukocyte cell-cell adhesion, GO:0010803|regulation of tumor necrosis factor-mediated signaling pathway, GO:0051090|regulation of DNA-binding transcription factor activity","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0019901|protein kinase binding, GO:0019902|phosphatase binding, GO:0035325|Toll-like receptor binding, GO:0042169|SH2 domain binding, GO:0005178|integrin binding, GO:0001784|phosphotyrosine residue binding, GO:0004674|protein serine/threonine kinase activity"
MAP2K1,Missense,0.165482999615523,45,0.277316702402286,N,Oncogene,Oncogene,0.0171197924779943,0.911125150975669,ENSG00000169032,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005739|mitochondrion, GO:0005856|cytoskeleton, GO:0005925|focal adhesion, GO:0005815|microtubule organizing center, GO:0005769|early endosome, GO:0005770|late endosome, GO:0005783|endoplasmic reticulum","GO:0008285|negative regulation of cell proliferation, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0030182|neuron differentiation, GO:0071902|positive regulation of protein serine/threonine kinase activity, GO:0010628|positive regulation of gene expression, GO:0000187|activation of MAPK activity, GO:0001932|regulation of protein phosphorylation, GO:0007507|heart development, GO:0021697|cerebellar cortex formation, GO:0030216|keratinocyte differentiation, GO:0030878|thyroid gland development, GO:0045597|positive regulation of cell differentiation, GO:0048538|thymus development, GO:0048679|regulation of axon regeneration, GO:0048870|cell motility, GO:0050772|positive regulation of axonogenesis, GO:0060020|Bergmann glial cell differentiation, GO:0060324|face development, GO:0060425|lung morphogenesis, GO:0060440|trachea formation, GO:0060502|epithelial cell proliferation involved in lung morphogenesis, GO:0060674|placenta blood vessel development, GO:0060711|labyrinthine layer development, GO:0070371|ERK1 and ERK2 cascade, GO:0006935|chemotaxis, GO:0007165|signal transduction, GO:0010629|negative regulation of gene expression, GO:0000165|MAPK cascade, GO:0023014|signal transduction by protein phosphorylation, GO:0031098|stress-activated protein kinase signaling cascade, GO:0032147|activation of protein kinase activity, GO:0018107|peptidyl-threonine phosphorylation, GO:2000641|regulation of early endosome to late endosome transport, GO:1903800|positive regulation of production of miRNAs involved in gene silencing by miRNA, GO:0007050|cell cycle arrest, GO:0090398|cellular senescence, GO:0032872|regulation of stress-activated MAPK cascade, GO:0090170|regulation of Golgi inheritance","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0043539|protein serine/threonine kinase activator activity, GO:0004708|MAP kinase kinase activity, GO:0004712|protein serine/threonine/tyrosine kinase activity, GO:0097110|scaffold protein binding, GO:0008022|protein C-terminus binding, GO:0047485|protein N-terminus binding"
CASP8,Missense,0.164064473350785,68,0.181253090985162,N,TSG,TSG,0.413841523003293,0.000451430870707517,ENSG00000064012,"GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005856|cytoskeleton, GO:0005741|mitochondrial outer membrane, GO:0005739|mitochondrion, GO:0031264|death-inducing signaling complex, GO:0097342|ripoptosome, GO:0031265|CD95 death-inducing signaling complex, GO:0005634|nucleus, GO:0032991|protein-containing complex, GO:0043005|neuron projection, GO:0044297|cell body, GO:0045121|membrane raft","GO:0042981|regulation of apoptotic process, GO:0006915|apoptotic process, GO:0006508|proteolysis, GO:0016032|viral process, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0071260|cellular response to mechanical stimulus, GO:0042113|B cell activation, GO:0035666|TRIF-dependent toll-like receptor signaling pathway, GO:0097190|apoptotic signaling pathway, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0007166|cell surface receptor signaling pathway, GO:0036462|TRAIL-activated apoptotic signaling pathway, GO:0097191|extrinsic apoptotic signaling pathway, GO:1902041|regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:1902042|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:0030101|natural killer cell activation, GO:0042110|T cell activation, GO:0097194|execution phase of apoptosis, GO:0034612|response to tumor necrosis factor, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0010803|regulation of tumor necrosis factor-mediated signaling pathway, GO:1900740|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, GO:0034138|toll-like receptor 3 signaling pathway, GO:0070423|nucleotide-binding oligomerization domain containing signaling pathway, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0071550|death-inducing signaling complex assembly, GO:0045651|positive regulation of macrophage differentiation, GO:0030225|macrophage differentiation, GO:0051603|proteolysis involved in cellular protein catabolic process, GO:0045862|positive regulation of proteolysis, GO:0097202|activation of cysteine-type endopeptidase activity, GO:0060544|regulation of necroptotic process, GO:0039650|suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process, GO:0060715|syncytiotrophoblast cell differentiation involved in labyrinthine layer development, GO:0097296|activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway, GO:0009409|response to cold, GO:0032025|response to cobalt ion, GO:0032355|response to estradiol, GO:0032496|response to lipopolysaccharide, GO:0045471|response to ethanol, GO:0046677|response to antibiotic, GO:0071407|cellular response to organic cyclic compound, GO:1901216|positive regulation of neuron death","GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0004197|cysteine-type endopeptidase activity, GO:0042802|identical protein binding, GO:0031625|ubiquitin protein ligase binding, GO:0097153|cysteine-type endopeptidase activity involved in apoptotic process, GO:0097199|cysteine-type endopeptidase activity involved in apoptotic signaling pathway, GO:0035877|death effector domain binding, GO:0097110|scaffold protein binding, GO:0005123|death receptor binding, GO:0005164|tumor necrosis factor receptor binding, GO:0044877|protein-containing complex binding"
ROS1,Nonsense,0.163726988632073,23,0.455378526462303,N,"oncogene, fusion",Oncogene,0.0833780579203,0.70526149470869,ENSG00000047936,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0009986|cell surface, GO:0048471|perinuclear region of cytoplasm","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0030154|cell differentiation, GO:0007283|spermatogenesis, GO:0008283|cell proliferation, GO:0001558|regulation of cell growth, GO:0032006|regulation of TOR signaling, GO:0070372|regulation of ERK1 and ERK2 cascade, GO:0002066|columnar/cuboidal epithelial cell development, GO:0010629|negative regulation of gene expression, GO:0010966|regulation of phosphate transport, GO:0023014|signal transduction by protein phosphorylation, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0019903|protein phosphatase binding"
NUMA1,Silent,0.163232339065828,47,0.272945798123121,N,fusion,"",0.126576127365169,0.39654216232164,ENSG00000137497,"GO:0005654|nucleoplasm, GO:0000139|Golgi membrane, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005694|chromosome, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0005874|microtubule, GO:0000922|spindle pole, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0070062|extracellular exosome, GO:0005938|cell cortex, GO:0032991|protein-containing complex, GO:0005876|spindle microtubule, GO:0016328|lateral plasma membrane, GO:0016363|nuclear matrix, GO:0097431|mitotic spindle pole, GO:1990023|mitotic spindle midzone, GO:0099738|cell cortex region, GO:0005819|spindle, GO:0072686|mitotic spindle, GO:0097427|microtubule bundle, GO:0036449|microtubule minus-end, GO:0031616|spindle pole centrosome, GO:0019897|extrinsic component of plasma membrane, GO:0035371|microtubule plus-end, GO:0097575|lateral cell cortex, GO:0055028|cortical microtubule, GO:0061673|mitotic spindle astral microtubule, GO:1905720|cytoplasmic microtubule bundle, GO:0030425|dendrite, GO:0043025|neuronal cell body","GO:0051301|cell division, GO:0007049|cell cycle, GO:0007059|chromosome segregation, GO:0001578|microtubule bundle formation, GO:0000132|establishment of mitotic spindle orientation, GO:0006997|nucleus organization, GO:1904778|positive regulation of protein localization to cell cortex, GO:0045618|positive regulation of keratinocyte differentiation, GO:0031116|positive regulation of microtubule polymerization, GO:0030513|positive regulation of BMP signaling pathway, GO:0030953|astral microtubule organization, GO:0060236|regulation of mitotic spindle organization, GO:1905832|positive regulation of spindle assembly, GO:0032388|positive regulation of intracellular transport, GO:0090235|regulation of metaphase plate congression, GO:0051798|positive regulation of hair follicle development, GO:0051984|positive regulation of chromosome segregation, GO:0055048|anastral spindle assembly, GO:1902365|positive regulation of protein localization to spindle pole body, GO:1902846|positive regulation of mitotic spindle elongation, GO:1905820|positive regulation of chromosome separation, GO:0051321|meiotic cell cycle","GO:0005515|protein binding, GO:0008289|lipid binding, GO:0008017|microtubule binding, GO:0035091|phosphatidylinositol binding, GO:0070840|dynein complex binding, GO:0019904|protein domain specific binding, GO:0015631|tubulin binding, GO:0005198|structural molecule activity, GO:0044877|protein-containing complex binding, GO:0051010|microtubule plus-end binding, GO:0097718|disordered domain specific binding, GO:0008022|protein C-terminus binding, GO:0051011|microtubule minus-end binding"
ALK,Silent,0.162697926141312,77,0.157433497220592,N,"oncogene, fusion",Oncogene,0.1120851256532,0.33178817569572,ENSG00000171094,"GO:0016021|integral component of membrane, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0070062|extracellular exosome, GO:0032991|protein-containing complex","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007165|signal transduction, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0000187|activation of MAPK activity, GO:0048666|neuron development, GO:0008283|cell proliferation, GO:0042981|regulation of apoptotic process, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0046777|protein autophosphorylation, GO:0042127|regulation of cell proliferation, GO:0045664|regulation of neuron differentiation, GO:0038061|NIK/NF-kappaB signaling, GO:0007399|nervous system development, GO:0007420|brain development, GO:0021766|hippocampus development, GO:0030534|adult behavior, GO:0036269|swimming behavior, GO:0060159|regulation of dopamine receptor signaling pathway, GO:0090648|response to environmental enrichment","GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0000166|nucleotide binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0004704|NF-kappaB-inducing kinase activity"
FBXO11,Missense,0.160666845860513,77,0.162752853617305,N,TSG,TSG,0.0274894856200138,0.812409622580163,ENSG00000138081,"GO:0000151|ubiquitin ligase complex, GO:0005634|nucleus, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005694|chromosome, GO:0005737|cytoplasm","GO:0016567|protein ubiquitination, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0043687|post-translational protein modification, GO:0000209|protein polyubiquitination, GO:0006464|cellular protein modification process, GO:0035246|peptidyl-arginine N-methylation, GO:0007605|sensory perception of sound","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0016274|protein-arginine N-methyltransferase activity"
PPM1D,Missense,0.158953988317685,39,0.333777022348054,N,Oncogene,Oncogene,0.0437088490536416,0.791620458311837,ENSG00000170836,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm","GO:0006468|protein phosphorylation, GO:0006470|protein dephosphorylation, GO:0007049|cell cycle, GO:0000086|G2/M transition of mitotic cell cycle, GO:0006306|DNA methylation, GO:0006342|chromatin silencing, GO:0009267|cellular response to starvation, GO:0009617|response to bacterium, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0008285|negative regulation of cell proliferation, GO:0009314|response to radiation, GO:0035970|peptidyl-threonine dephosphorylation, GO:0045814|negative regulation of gene expression, epigenetic","GO:0046872|metal ion binding, GO:0016787|hydrolase activity, GO:0003824|catalytic activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004722|protein serine/threonine phosphatase activity, GO:0043169|cation binding, GO:0004724|magnesium-dependent protein serine/threonine phosphatase activity, GO:0004674|protein serine/threonine kinase activity, GO:0051019|mitogen-activated protein kinase binding"
NCOA1,Missense,0.157384093549432,104,0.11058451487892,N,fusion,"",0.0518272059627113,0.601322783159281,ENSG00000084676,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0000790|nuclear chromatin, GO:0032991|protein-containing complex, GO:0005737|cytoplasm, GO:0043005|neuron projection","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006351|transcription, DNA-templated, GO:0030521|androgen receptor signaling pathway, GO:0019216|regulation of lipid metabolic process, GO:0015721|bile acid and bile salt transport, GO:0032870|cellular response to hormone stimulus, GO:0000435|positive regulation of transcription from RNA polymerase II promoter by galactose, GO:0002155|regulation of thyroid hormone mediated signaling pathway, GO:0007595|lactation, GO:0008584|male gonad development, GO:0009725|response to hormone, GO:0021549|cerebellum development, GO:0021766|hippocampus development, GO:0021854|hypothalamus development, GO:0021987|cerebral cortex development, GO:0032355|response to estradiol, GO:0032526|response to retinoic acid, GO:0032570|response to progesterone, GO:0043065|positive regulation of apoptotic process, GO:0043967|histone H4 acetylation, GO:0044849|estrous cycle, GO:0045666|positive regulation of neuron differentiation, GO:0045925|positive regulation of female receptivity, GO:0060179|male mating behavior, GO:0060713|labyrinthine layer morphogenesis, GO:1904017|cellular response to Thyroglobulin triiodothyronine, GO:2001038|regulation of cellular response to drug, GO:2001141|regulation of RNA biosynthetic process, GO:1903508|positive regulation of nucleic acid-templated transcription","GO:0016740|transferase activity, GO:0003713|transcription coactivator activity, GO:0046983|protein dimerization activity, GO:0016746|transferase activity, transferring acyl groups, GO:0005515|protein binding, GO:0004402|histone acetyltransferase activity, GO:0030374|nuclear receptor transcription coactivator activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0035257|nuclear hormone receptor binding, GO:0047485|protein N-terminus binding, GO:0019899|enzyme binding, GO:0017162|aryl hydrocarbon receptor binding, GO:0016922|nuclear receptor binding, GO:0050681|androgen receptor binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0003677|DNA binding, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0030331|estrogen receptor binding, GO:0033142|progesterone receptor binding, GO:0042974|retinoic acid receptor binding, GO:0044877|protein-containing complex binding, GO:0046965|retinoid X receptor binding"
BCOR,Missense,0.157212333462762,99,0.120170723160803,N,"TSG, fusion",TSG,-0.0270773692759583,0.790205668055795,ENSG00000183337,"GO:0005634|nucleus, GO:0140261|BCOR complex","GO:0006325|chromatin organization, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007507|heart development, GO:0045892|negative regulation of transcription, DNA-templated, GO:0060021|roof of mouth development, GO:0051572|negative regulation of histone H3-K4 methylation, GO:0035518|histone H2A monoubiquitination, GO:0030502|negative regulation of bone mineralization, GO:0042476|odontogenesis, GO:0000415|negative regulation of histone H3-K36 methylation, GO:0065001|specification of axis polarity, GO:0070171|negative regulation of tooth mineralization, GO:0001835|blastocyst hatching","GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0003714|transcription corepressor activity, GO:0008134|transcription factor binding, GO:0044212|transcription regulatory region DNA binding, GO:0042826|histone deacetylase binding, GO:0031072|heat shock protein binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding"
EPS15,Missense,0.157190760642317,63,0.218568231853584,N,"TSG, fusion",TSG,0.0765975532320055,0.550722899386481,ENSG00000085832,"GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005905|clathrin-coated pit, GO:0098794|postsynapse, GO:0005768|endosome, GO:0031901|early endosome membrane, GO:0016235|aggresome, GO:0005769|early endosome, GO:0009925|basal plasma membrane, GO:0016324|apical plasma membrane, GO:0030122|AP-2 adaptor complex, GO:0030132|clathrin coat of coated pit, GO:0030136|clathrin-coated vesicle, GO:0060170|ciliary membrane","GO:0015031|protein transport, GO:0006897|endocytosis, GO:0016032|viral process, GO:0006895|Golgi to endosome transport, GO:0061024|membrane organization, GO:0008283|cell proliferation, GO:0042059|negative regulation of epidermal growth factor receptor signaling pathway, GO:0046718|viral entry into host cell, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0001921|positive regulation of receptor recycling, GO:0016050|vesicle organization, GO:0019065|receptor-mediated endocytosis of virus by host cell, GO:0032456|endocytic recycling, GO:0042127|regulation of cell proliferation, GO:0048268|clathrin coat assembly","GO:0005509|calcium ion binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0045296|cadherin binding, GO:0017124|SH3 domain binding, GO:0031593|polyubiquitin modification-dependent protein binding, GO:0042802|identical protein binding"
CAMTA1,Silent,0.157096958951,82,0.158686503636657,N,"TSG, fusion",TSG,0.210465921304208,0.0577080823521778,ENSG00000171735,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005730|nucleolus, GO:0005829|cytosol","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0035307|positive regulation of protein dephosphorylation, GO:0070886|positive regulation of calcineurin-NFAT signaling cascade, GO:0050885|neuromuscular process controlling balance, GO:0006357|regulation of transcription by RNA polymerase II","GO:0003677|DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0043565|sequence-specific DNA binding"
KIF5B,Missense,0.15631992985171,66,0.210057766594738,N,fusion,"",0.132857710412052,0.287581795361397,ENSG00000170759,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:1904115|axon cytoplasm, GO:0005856|cytoskeleton, GO:0005815|microtubule organizing center, GO:0005874|microtubule, GO:0005871|kinesin complex, GO:0031982|vesicle, GO:0048471|perinuclear region of cytoplasm, GO:0015630|microtubule cytoskeleton, GO:0030139|endocytic vesicle, GO:0035253|ciliary rootlet, GO:0043005|neuron projection, GO:0043227|membrane-bounded organelle, GO:0044295|axonal growth cone, GO:0045335|phagocytic vesicle","GO:1903078|positive regulation of protein localization to plasma membrane, GO:0007018|microtubule-based movement, GO:0099641|anterograde axonal protein transport, GO:0042391|regulation of membrane potential, GO:0047496|vesicle transport along microtubule, GO:1990048|anterograde neuronal dense core vesicle transport, GO:1990049|retrograde neuronal dense core vesicle transport, GO:0043268|positive regulation of potassium ion transport, GO:0007028|cytoplasm organization, GO:0007420|brain development, GO:0021766|hippocampus development, GO:0031340|positive regulation of vesicle fusion, GO:0032230|positive regulation of synaptic transmission, GABAergic, GO:0035617|stress granule disassembly, GO:0035774|positive regulation of insulin secretion involved in cellular response to glucose stimulus, GO:0051642|centrosome localization, GO:0071346|cellular response to interferon-gamma, GO:0072383|plus-end-directed vesicle transport along microtubule, GO:0090316|positive regulation of intracellular protein transport, GO:1905152|positive regulation of voltage-gated sodium channel activity","GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0003774|motor activity, GO:0003777|microtubule motor activity, GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0042802|identical protein binding, GO:0016887|ATPase activity, GO:0045296|cadherin binding, GO:0008432|JUN kinase binding, GO:0099609|microtubule lateral binding"
MED12,Nonsense,0.155808784147601,13,0.611246906286513,N,TSG,TSG,-0.0177414780492554,0.954126243118493,ENSG00000184634,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016592|mediator complex, GO:0005654|nucleoplasm, GO:0000151|ubiquitin ligase complex","GO:0006357|regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0030178|negative regulation of Wnt signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0030518|intracellular steroid hormone receptor signaling pathway, GO:0030521|androgen receptor signaling pathway, GO:0001756|somitogenesis, GO:0001843|neural tube closure, GO:0007492|endoderm development, GO:0007507|heart development, GO:0014003|oligodendrocyte development, GO:0014044|Schwann cell development, GO:0016567|protein ubiquitination, GO:0019827|stem cell population maintenance, GO:0021510|spinal cord development, GO:0021915|neural tube development, GO:0036342|post-anal tail morphogenesis, GO:0048568|embryonic organ development, GO:0048702|embryonic neurocranium morphogenesis, GO:0060070|canonical Wnt signaling pathway, GO:0060071|Wnt signaling pathway, planar cell polarity pathway, GO:0090245|axis elongation involved in somitogenesis, GO:1990403|embryonic brain development","GO:0008013|beta-catenin binding, GO:0003712|transcription coregulator activity, GO:0005515|protein binding, GO:0030374|nuclear receptor transcription coactivator activity, GO:0038023|signaling receptor activity, GO:0003713|transcription coactivator activity, GO:0008022|protein C-terminus binding, GO:0019904|protein domain specific binding, GO:0042809|vitamin D receptor binding, GO:0046966|thyroid hormone receptor binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0061630|ubiquitin protein ligase activity"
HLA-A,Silent,0.154924291504949,15,0.581419807369343,N,fusion,"",0.138961978067478,0.621366577622374,ENSG00000206503,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0009986|cell surface, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0042612|MHC class I protein complex, GO:0005789|endoplasmic reticulum membrane, GO:0070062|extracellular exosome, GO:0030670|phagocytic vesicle membrane, GO:0000139|Golgi membrane, GO:0012507|ER to Golgi transport vesicle membrane, GO:0071556|integral component of lumenal side of endoplasmic reticulum membrane, GO:0031901|early endosome membrane, GO:0055038|recycling endosome membrane","GO:0006955|immune response, GO:0002376|immune system process, GO:0050776|regulation of immune response, GO:0019882|antigen processing and presentation, GO:0002474|antigen processing and presentation of peptide antigen via MHC class I, GO:0016567|protein ubiquitination, GO:0002479|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, GO:0060333|interferon-gamma-mediated signaling pathway, GO:0060337|type I interferon signaling pathway, GO:0002480|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent, GO:0042270|protection from natural killer cell mediated cytotoxicity","GO:0042605|peptide antigen binding, GO:0030881|beta-2-microglobulin binding, GO:0046977|TAP binding"
CALR,Missense,0.154913074860603,22,0.491221850845108,N,Oncogene,Oncogene,-0.0116420294068537,0.958990850891959,ENSG00000179218,"GO:0048471|perinuclear region of cytoplasm, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005783|endoplasmic reticulum, GO:0005829|cytosol, GO:0005576|extracellular region, GO:0005615|extracellular space, GO:0009986|cell surface, GO:0005925|focal adhesion, GO:0005788|endoplasmic reticulum lumen, GO:0070062|extracellular exosome, GO:0005622|intracellular, GO:0016529|sarcoplasmic reticulum, GO:0030670|phagocytic vesicle membrane, GO:0005635|nuclear envelope, GO:0033116|endoplasmic reticulum-Golgi intermediate compartment membrane, GO:0033018|sarcoplasmic reticulum lumen, GO:0071556|integral component of lumenal side of endoplasmic reticulum membrane, GO:0071682|endocytic vesicle lumen, GO:0001669|acrosomal vesicle, GO:0005790|smooth endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0005844|polysome, GO:0009897|external side of plasma membrane, GO:0032991|protein-containing complex, GO:0042824|MHC class I peptide loading complex, GO:0043231|intracellular membrane-bounded organelle, GO:0044322|endoplasmic reticulum quality control compartment, GO:0062023|collagen-containing extracellular matrix","GO:0008284|positive regulation of cell proliferation, GO:0050821|protein stabilization, GO:0045787|positive regulation of cell cycle, GO:0006457|protein folding, GO:0006898|receptor-mediated endocytosis, GO:0017148|negative regulation of translation, GO:0042981|regulation of apoptotic process, GO:0002479|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, GO:2000510|positive regulation of dendritic cell chemotaxis, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0034504|protein localization to nucleus, GO:0051208|sequestering of calcium ion, GO:0006355|regulation of transcription, DNA-templated, GO:0002474|antigen processing and presentation of peptide antigen via MHC class I, GO:1990668|vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane, GO:0048387|negative regulation of retinoic acid receptor signaling pathway, GO:0036500|ATF6-mediated unfolded protein response, GO:0006874|cellular calcium ion homeostasis, GO:0022417|protein maturation by protein folding, GO:0090398|cellular senescence, GO:0006611|protein export from nucleus, GO:1900026|positive regulation of substrate adhesion-dependent cell spreading, GO:0034975|protein folding in endoplasmic reticulum, GO:0071157|negative regulation of cell cycle arrest, GO:0002502|peptide antigen assembly with MHC class I protein complex, GO:0007283|spermatogenesis, GO:0010033|response to organic substance, GO:0010595|positive regulation of endothelial cell migration, GO:0010628|positive regulation of gene expression, GO:0030866|cortical actin cytoskeleton organization, GO:0032355|response to estradiol, GO:0033144|negative regulation of intracellular steroid hormone receptor signaling pathway, GO:0033574|response to testosterone, GO:0040020|regulation of meiotic nuclear division, GO:0042493|response to drug, GO:0042921|glucocorticoid receptor signaling pathway, GO:0045665|negative regulation of neuron differentiation, GO:0050766|positive regulation of phagocytosis, GO:0055007|cardiac muscle cell differentiation, GO:0071285|cellular response to lithium ion, GO:0071310|cellular response to organic substance, GO:1901164|negative regulation of trophoblast cell migration, GO:1901224|positive regulation of NIK/NF-kappaB signaling","GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0030246|carbohydrate binding, GO:0005509|calcium ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0051082|unfolded protein binding, GO:0031625|ubiquitin protein ligase binding, GO:0051087|chaperone binding, GO:0050681|androgen receptor binding, GO:0008270|zinc ion binding, GO:0001849|complement component C1q binding, GO:0005178|integrin binding, GO:0044183|protein binding involved in protein folding, GO:0003729|mRNA binding, GO:0005506|iron ion binding, GO:0042277|peptide binding, GO:0042562|hormone binding"
TET2,Silent,0.154223928141631,26,0.451910896223928,N,TSG,TSG,0.0103067510421961,0.960145649677165,ENSG00000168769,GO:0005634|nucleus,"GO:0055114|oxidation-reduction process, GO:0006325|chromatin organization, GO:0007049|cell cycle, GO:0006211|5-methylcytosine catabolic process, GO:0080111|DNA demethylation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006493|protein O-linked glycosylation, GO:0080182|histone H3-K4 trimethylation, GO:0070989|oxidative demethylation, GO:0030099|myeloid cell differentiation, GO:0014070|response to organic cyclic compound","GO:0046872|metal ion binding, GO:0016491|oxidoreductase activity, GO:0003677|DNA binding, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0051213|dioxygenase activity, GO:0070579|methylcytosine dioxygenase activity, GO:0005506|iron ion binding, GO:0008198|ferrous iron binding"
KEAP1,Silent,0.152184312025686,23,0.488181781922319,N,TSG,TSG,0.21896914302127,0.315461948900143,ENSG00000079999,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005815|microtubule organizing center, GO:0005783|endoplasmic reticulum, GO:0005884|actin filament, GO:0031463|Cul3-RING ubiquitin ligase complex, GO:0032991|protein-containing complex, GO:0030496|midbody","GO:0016567|protein ubiquitination, GO:0001701|in utero embryonic development, GO:0006355|regulation of transcription, DNA-templated, GO:0045604|regulation of epidermal cell differentiation, GO:0071353|cellular response to interleukin-4, GO:0016579|protein deubiquitination, GO:0043687|post-translational protein modification, GO:0016032|viral process, GO:0010499|proteasomal ubiquitin-independent protein catabolic process, GO:0032436|positive regulation of proteasomal ubiquitin-dependent protein catabolic process, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0042994|cytoplasmic sequestering of transcription factor","GO:0008134|transcription factor binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0042803|protein homodimerization activity, GO:0097718|disordered domain specific binding"
TFE3,Missense,0.151337914774589,51,0.289100907606125,N,"oncogene, fusion",Oncogene,0.124233516510683,0.385075958066774,ENSG00000068323,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0006959|humoral immune response, GO:0045670|regulation of osteoclast differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0002376|immune system process, GO:0002250|adaptive immune response, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0120163|negative regulation of cold-induced thermogenesis, GO:0045785|positive regulation of cell adhesion","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
HOXA11,Missense,0.151120060496793,27,0.451796466812332,N,"oncogene, TSG, fusion","",0.00885986881350439,0.965016367747611,ENSG00000005073,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0032993|protein-DNA complex, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0001501|skeletal system development, GO:0032332|positive regulation of chondrocyte differentiation, GO:0009653|anatomical structure morphogenesis, GO:0009953|dorsal/ventral pattern formation, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0048589|developmental growth, GO:0001656|metanephros development, GO:0001759|organ induction, GO:0007283|spermatogenesis, GO:0007338|single fertilization, GO:0007501|mesodermal cell fate specification, GO:0008584|male gonad development, GO:0009952|anterior/posterior pattern specification, GO:0009954|proximal/distal pattern formation, GO:0010468|regulation of gene expression, GO:0010720|positive regulation of cell development, GO:0030326|embryonic limb morphogenesis, GO:0032330|regulation of chondrocyte differentiation, GO:0035115|embryonic forelimb morphogenesis, GO:0042733|embryonic digit morphogenesis, GO:0060065|uterus development, GO:0060272|embryonic skeletal joint morphogenesis, GO:0060348|bone development, GO:0060351|cartilage development involved in endochondral bone morphogenesis","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
PTPN13,Missense,0.15065394523367,171,0.0492008769055159,N,TSG,TSG,0.252956967214381,0.000843726229478018,ENSG00000163629,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0005654|nucleoplasm, GO:0030027|lamellipodium, GO:0070062|extracellular exosome, GO:0043005|neuron projection, GO:0044297|cell body","GO:0006470|protein dephosphorylation, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0006661|phosphatidylinositol biosynthetic process, GO:0014066|regulation of phosphatidylinositol 3-kinase signaling, GO:0071345|cellular response to cytokine stimulus, GO:0070830|bicellular tight junction assembly","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0036312|phosphatidylinositol 3-kinase regulatory subunit binding"
USP6,Nonsense,0.150445155641407,11,0.65882560995107,N,"oncogene, fusion",Oncogene,0.333396887942123,0.316379433893775,ENSG00000129204,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005768|endosome, GO:0055037|recycling endosome, GO:0005764|lysosome","GO:0016579|protein deubiquitination, GO:0006508|proteolysis, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0006886|intracellular protein transport, GO:0090630|activation of GTPase activity, GO:0006464|cellular protein modification process, GO:0060627|regulation of vesicle-mediated transport","GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0005096|GTPase activator activity, GO:0017137|Rab GTPase binding, GO:0005516|calmodulin binding, GO:0004843|thiol-dependent ubiquitin-specific protease activity, GO:0003676|nucleic acid binding, GO:0004197|cysteine-type endopeptidase activity"
TPR,Missense,0.15018750343518,169,0.0512934697442282,N,fusion,"",0.253810252115034,0.00086926722384528,ENSG00000047410,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0031965|nuclear membrane, GO:0005694|chromosome, GO:0005856|cytoskeleton, GO:0005643|nuclear pore, GO:0005819|spindle, GO:0000775|chromosome, centromeric region, GO:0000776|kinetochore, GO:0005868|cytoplasmic dynein complex, GO:0005654|nucleoplasm, GO:0019898|extrinsic component of membrane, GO:0005635|nuclear envelope, GO:0072686|mitotic spindle, GO:0042405|nuclear inclusion body, GO:0034399|nuclear periphery, GO:0044615|nuclear pore nuclear basket","GO:0051028|mRNA transport, GO:0015031|protein transport, GO:0051301|cell division, GO:0007049|cell cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006406|mRNA export from nucleus, GO:0016032|viral process, GO:0042307|positive regulation of protein import into nucleus, GO:0006606|protein import into nucleus, GO:0007094|mitotic spindle assembly checkpoint, GO:0090267|positive regulation of mitotic cell cycle spindle assembly checkpoint, GO:0090316|positive regulation of intracellular protein transport, GO:0034605|cellular response to heat, GO:0032880|regulation of protein localization, GO:1901673|regulation of mitotic spindle assembly, GO:0045947|negative regulation of translational initiation, GO:0046827|positive regulation of protein export from nucleus, GO:0006404|RNA import into nucleus, GO:0006405|RNA export from nucleus, GO:0006999|nuclear pore organization, GO:0010965|regulation of mitotic sister chromatid separation, GO:0031453|positive regulation of heterochromatin assembly, GO:0031990|mRNA export from nucleus in response to heat stress, GO:0035457|cellular response to interferon-alpha, GO:0046832|negative regulation of RNA export from nucleus, GO:0070849|response to epidermal growth factor","GO:0003723|RNA binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0003729|mRNA binding, GO:0003682|chromatin binding, GO:0070840|dynein complex binding, GO:0017056|structural constituent of nuclear pore, GO:0015631|tubulin binding, GO:0051019|mitogen-activated protein kinase binding, GO:0031072|heat shock protein binding"
RUNX1,Silent,0.149417473527526,21,0.517998254966895,N,"oncogene, TSG, fusion","",0.172009865588168,0.455929955132194,ENSG00000159216,"GO:0005634|nucleus, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0016513|core-binding factor complex","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030182|neuron differentiation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:2000810|regulation of bicellular tight junction assembly, GO:0030097|hemopoiesis, GO:0045766|positive regulation of angiogenesis, GO:0045652|regulation of megakaryocyte differentiation, GO:0030111|regulation of Wnt signaling pathway, GO:0033146|regulation of intracellular estrogen receptor signaling pathway, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0032743|positive regulation of interleukin-2 production, GO:0045616|regulation of keratinocyte differentiation, GO:0071425|hematopoietic stem cell proliferation, GO:0045589|regulation of regulatory T cell differentiation, GO:0045637|regulation of myeloid cell differentiation, GO:0001959|regulation of cytokine-mediated signaling pathway, GO:0043371|negative regulation of CD4-positive, alpha-beta T cell differentiation, GO:0050855|regulation of B cell receptor signaling pathway, GO:0030854|positive regulation of granulocyte differentiation, GO:0048935|peripheral nervous system neuron development, GO:0043378|positive regulation of CD8-positive, alpha-beta T cell differentiation, GO:0010629|negative regulation of gene expression","GO:0005524|ATP binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding"
SPEN,Missense,0.148690338003914,270,0.014464929091712,N,TSG,TSG,0.189791604091413,0.00173237808388653,ENSG00000065526,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0017053|transcriptional repressor complex","GO:0007219|Notch signaling pathway, GO:0016032|viral process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0050769|positive regulation of neurogenesis","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0003714|transcription corepressor activity"
IDH1,Missense,0.148130189629696,36,0.388585573335659,N,Oncogene,Oncogene,0.44156567942821,0.00701732017556781,ENSG00000138413,"GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005576|extracellular region, GO:0005777|peroxisome, GO:0070062|extracellular exosome, GO:0005782|peroxisomal matrix, GO:0034774|secretory granule lumen, GO:1904813|ficolin-1-rich granule lumen, GO:1904724|tertiary granule lumen, GO:0005739|mitochondrion","GO:0055114|oxidation-reduction process, GO:0006099|tricarboxylic acid cycle, GO:0006625|protein targeting to peroxisome, GO:0043312|neutrophil degranulation, GO:0006102|isocitrate metabolic process, GO:0006097|glyoxylate cycle, GO:0006103|2-oxoglutarate metabolic process, GO:0006739|NADP metabolic process, GO:0006740|NADPH regeneration, GO:0048545|response to steroid hormone, GO:0060696|regulation of phospholipid catabolic process, GO:0071071|regulation of phospholipid biosynthetic process, GO:0006749|glutathione metabolic process, GO:0006979|response to oxidative stress, GO:0008585|female gonad development, GO:0014070|response to organic cyclic compound","GO:0046872|metal ion binding, GO:0000287|magnesium ion binding, GO:0016491|oxidoreductase activity, GO:0042803|protein homodimerization activity, GO:0016616|oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor, GO:0051287|NAD binding, GO:0042802|identical protein binding, GO:0045296|cadherin binding, GO:0005102|signaling receptor binding, GO:0004450|isocitrate dehydrogenase (NADP+) activity, GO:0051990|(R)-2-hydroxyglutarate dehydrogenase activity, GO:0004448|isocitrate dehydrogenase activity, GO:0050661|NADP binding"
PTK6,Silent,0.14790199457749,21,0.522300135875774,N,"oncogene, TSG","",0.210747050731883,0.359150059310543,ENSG00000101213,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0016604|nuclear body, GO:0031234|extrinsic component of cytoplasmic side of plasma membrane, GO:0001726|ruffle","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0030154|cell differentiation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0016477|cell migration, GO:0046777|protein autophosphorylation, GO:0038128|ERBB2 signaling pathway, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0061099|negative regulation of protein tyrosine kinase activity, GO:0010976|positive regulation of neuron projection development, GO:0071300|cellular response to retinoic acid, GO:0045787|positive regulation of cell cycle, GO:0007260|tyrosine phosphorylation of STAT protein, GO:0009968|negative regulation of signal transduction, GO:0045742|positive regulation of epidermal growth factor receptor signaling pathway, GO:0045926|negative regulation of growth, GO:0060575|intestinal epithelial cell differentiation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0042802|identical protein binding, GO:0005102|signaling receptor binding"
NOTCH2,Missense,0.147080530828871,181,0.0481756466296103,N,"oncogene, TSG","",0.0190938684094127,0.798626339117798,ENSG00000134250,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0009986|cell surface, GO:0005576|extracellular region, GO:0005887|integral component of plasma membrane, GO:0005789|endoplasmic reticulum membrane, GO:0000139|Golgi membrane, GO:0043235|receptor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006915|apoptotic process, GO:0007219|Notch signaling pathway, GO:0007399|nervous system development, GO:0050793|regulation of developmental process, GO:0007050|cell cycle arrest, GO:0043066|negative regulation of apoptotic process, GO:0010629|negative regulation of gene expression, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0001709|cell fate determination, GO:0002315|marginal zone B cell differentiation, GO:0030097|hemopoiesis, GO:0009887|animal organ morphogenesis, GO:0046579|positive regulation of Ras protein signal transduction, GO:0019827|stem cell population maintenance, GO:0003184|pulmonary valve morphogenesis, GO:0046849|bone remodeling, GO:0061314|Notch signaling involved in heart development, GO:0060413|atrial septum morphogenesis, GO:0045967|negative regulation of growth rate, GO:2001204|regulation of osteoclast development","GO:0005509|calcium ion binding, GO:0038023|signaling receptor activity, GO:0005515|protein binding"
SND1,Silent,0.14485976464552,26,0.480154999086474,N,"oncogene, fusion",Oncogene,0.132533552515903,0.518660360847061,ENSG00000197157,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0042470|melanosome, GO:0016442|RISC complex, GO:0097433|dense body, GO:0070062|extracellular exosome","GO:0090305|nucleic acid phosphodiester bond hydrolysis, GO:0090502|RNA phosphodiester bond hydrolysis, endonucleolytic, GO:1903506|regulation of nucleic acid-templated transcription, GO:0031047|gene silencing by RNA, GO:0016032|viral process, GO:0006401|RNA catabolic process, GO:0001649|osteoblast differentiation, GO:0010587|miRNA catabolic process, GO:0010564|regulation of cell cycle process","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0004518|nuclease activity, GO:0004519|endonuclease activity, GO:0004521|endoribonuclease activity, GO:0045296|cadherin binding, GO:0003712|transcription coregulator activity, GO:1905172|RISC complex binding"
IDH2,Missense,0.144810481706358,38,0.38570250393328,N,Oncogene,Oncogene,0.159175267994047,0.339805819420932,ENSG00000182054,"GO:0005739|mitochondrion, GO:0070062|extracellular exosome, GO:0005759|mitochondrial matrix, GO:0005777|peroxisome, GO:0005829|cytosol","GO:0055114|oxidation-reduction process, GO:0006099|tricarboxylic acid cycle, GO:0006102|isocitrate metabolic process, GO:0005975|carbohydrate metabolic process, GO:0006097|glyoxylate cycle, GO:0006103|2-oxoglutarate metabolic process, GO:0006739|NADP metabolic process, GO:0006741|NADP biosynthetic process, GO:0060253|negative regulation of glial cell proliferation, GO:1903976|negative regulation of glial cell migration, GO:1904465|negative regulation of matrix metallopeptidase secretion","GO:0046872|metal ion binding, GO:0000287|magnesium ion binding, GO:0016491|oxidoreductase activity, GO:0016616|oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor, GO:0051287|NAD binding, GO:0004450|isocitrate dehydrogenase (NADP+) activity, GO:0042803|protein homodimerization activity, GO:0004448|isocitrate dehydrogenase activity"
CDK12,Missense,0.144727968245969,122,0.111721689949445,N,TSG,TSG,0.208895609593028,0.0209374010175916,ENSG00000167258,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0001650|fibrillar center, GO:0000790|nuclear chromatin, GO:0005654|nucleoplasm, GO:0008024|cyclin/CDK positive transcription elongation factor complex, GO:0002944|cyclin K-CDK12 complex, GO:0005694|chromosome, GO:0000307|cyclin-dependent protein kinase holoenzyme complex, GO:0019908|nuclear cyclin-dependent protein kinase holoenzyme complex","GO:0006468|protein phosphorylation, GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0016310|phosphorylation, GO:0051726|regulation of cell cycle, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0043405|regulation of MAP kinase activity, GO:0046777|protein autophosphorylation, GO:0032968|positive regulation of transcription elongation from RNA polymerase II promoter, GO:0070816|phosphorylation of RNA polymerase II C-terminal domain, GO:0043484|regulation of RNA splicing, GO:2000737|negative regulation of stem cell differentiation","GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0000166|nucleotide binding, GO:0004674|protein serine/threonine kinase activity, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0044212|transcription regulatory region DNA binding, GO:0004693|cyclin-dependent protein serine/threonine kinase activity, GO:0030332|cyclin binding, GO:0008353|RNA polymerase II CTD heptapeptide repeat kinase activity, GO:0019901|protein kinase binding"
CREB3L1,Silent,0.143439287054317,13,0.640144443479888,N,"TSG, fusion",TSG,0.0346971182957599,0.910403929071462,ENSG00000157613,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0000790|nuclear chromatin","GO:0010629|negative regulation of gene expression, GO:1903671|negative regulation of sprouting angiogenesis, GO:0040037|negative regulation of fibroblast growth factor receptor signaling pathway, GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030968|endoplasmic reticulum unfolded protein response, GO:0006986|response to unfolded protein, GO:0045892|negative regulation of transcription, DNA-templated, GO:1990440|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress, GO:0001649|osteoblast differentiation, GO:1902236|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway, GO:0032967|positive regulation of collagen biosynthetic process, GO:0070278|extracellular matrix constituent secretion","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0035497|cAMP response element binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0046332|SMAD binding, GO:0044212|transcription regulatory region DNA binding, GO:0003682|chromatin binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
SH3GL1,Silent,0.14213381090374,16,0.599516678614782,N,"oncogene, fusion",Oncogene,0.209152413727249,0.436920727463416,ENSG00000141985,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0042995|cell projection, GO:0030054|cell junction, GO:0005768|endosome, GO:0002102|podosome, GO:0031901|early endosome membrane, GO:0098793|presynapse, GO:0098978|glutamatergic synapse, GO:0098686|hippocampal mossy fiber to CA3 synapse","GO:0006897|endocytosis, GO:0007165|signal transduction, GO:0007417|central nervous system development, GO:0016191|synaptic vesicle uncoating, GO:0098815|modulation of excitatory postsynaptic potential, GO:1900242|regulation of synaptic vesicle endocytosis, GO:1900244|positive regulation of synaptic vesicle endocytosis","GO:0005515|protein binding, GO:0008289|lipid binding, GO:0042802|identical protein binding, GO:0045296|cadherin binding, GO:0008022|protein C-terminus binding, GO:0017124|SH3 domain binding, GO:0019902|phosphatase binding, GO:0031697|beta-1 adrenergic receptor binding, GO:0044325|ion channel binding, GO:0051020|GTPase binding"
GATA1,Missense,0.141291299099066,41,0.378231468862326,N,"oncogene, TSG","",0.197782991121881,0.215140801613618,ENSG00000102145,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex, GO:0017053|transcriptional repressor complex, GO:0032993|protein-DNA complex","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0043066|negative regulation of apoptotic process, GO:0030218|erythrocyte differentiation, GO:0030219|megakaryocyte differentiation, GO:0030221|basophil differentiation, GO:0030222|eosinophil differentiation, GO:0048821|erythrocyte development, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0048468|cell development, GO:0007596|blood coagulation, GO:0045652|regulation of megakaryocyte differentiation, GO:2001240|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0006366|transcription by RNA polymerase II, GO:0030220|platelet formation, GO:0070527|platelet aggregation, GO:0097067|cellular response to thyroid hormone stimulus, GO:0045648|positive regulation of erythrocyte differentiation, GO:0001701|in utero embryonic development, GO:0007267|cell-cell signaling, GO:0008285|negative regulation of cell proliferation, GO:0008584|male gonad development, GO:0010559|regulation of glycoprotein biosynthetic process, GO:0010724|regulation of definitive erythrocyte differentiation, GO:0010725|regulation of primitive erythrocyte differentiation, GO:0030099|myeloid cell differentiation, GO:0030502|negative regulation of bone mineralization, GO:0033690|positive regulation of osteoblast proliferation, GO:0035162|embryonic hemopoiesis, GO:0035854|eosinophil fate commitment, GO:0048565|digestive tract development, GO:0048873|homeostasis of number of cells within a tissue, GO:0071733|transcriptional activation by promoter-enhancer looping, GO:0097028|dendritic cell differentiation, GO:2000678|negative regulation of transcription regulatory region DNA binding","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0031490|chromatin DNA binding, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0001085|RNA polymerase II transcription factor binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0001158|enhancer sequence-specific DNA binding, GO:0002039|p53 binding, GO:0003682|chromatin binding, GO:0070742|C2H2 zinc finger domain binding"
CUX1,Silent,0.140915404861458,62,0.27463522567872,N,"oncogene, TSG","",0.161055382205741,0.211107616080876,ENSG00000257923,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0005654|nucleoplasm, GO:0000139|Golgi membrane, GO:0030173|integral component of Golgi membrane, GO:0005829|cytosol","GO:0006355|regulation of transcription, DNA-templated, GO:0006891|intra-Golgi vesicle-mediated transport, GO:0006357|regulation of transcription by RNA polymerase II, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0007275|multicellular organism development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0048193|Golgi vesicle transport, GO:0050775|positive regulation of dendrite morphogenesis, GO:0000301|retrograde transport, vesicle recycling within Golgi","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0004713|protein tyrosine kinase activity, GO:0030674|protein binding, bridging"
PAX8,Missense,0.140396707430912,35,0.421149243222388,N,fusion,"",0.0702271708057659,0.688511129564996,ENSG00000125618,"GO:0005634|nucleus, GO:0005654|nucleoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0001822|kidney development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006351|transcription, DNA-templated, GO:0038194|thyroid-stimulating hormone signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0042981|regulation of apoptotic process, GO:0030878|thyroid gland development, GO:0009653|anatomical structure morphogenesis, GO:0001823|mesonephros development, GO:0042472|inner ear morphogenesis, GO:0007417|central nervous system development, GO:0090190|positive regulation of branching involved in ureteric bud morphogenesis, GO:0001658|branching involved in ureteric bud morphogenesis, GO:2000611|positive regulation of thyroid hormone generation, GO:0003337|mesenchymal to epithelial transition involved in metanephros morphogenesis, GO:0071371|cellular response to gonadotropin stimulus, GO:0072207|metanephric epithelium development, GO:0072284|metanephric S-shaped body morphogenesis, GO:0001655|urogenital system development, GO:0048793|pronephros development, GO:0072289|metanephric nephron tubule formation, GO:0039003|pronephric field specification, GO:0072108|positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis, GO:0072221|metanephric distal convoluted tubule development, GO:0072305|negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis, GO:0072307|regulation of metanephric nephron tubule epithelial cell differentiation, GO:1900212|negative regulation of mesenchymal cell apoptotic process involved in metanephros development, GO:1900215|negative regulation of apoptotic process involved in metanephric collecting duct development, GO:1900218|negative regulation of apoptotic process involved in metanephric nephron tubule development, GO:2000594|positive regulation of metanephric DCT cell differentiation, GO:0071599|otic vesicle development, GO:0072278|metanephric comma-shaped body morphogenesis, GO:2000612|regulation of thyroid-stimulating hormone secretion, GO:0001656|metanephros development, GO:0003281|ventricular septum development, GO:0006790|sulfur compound metabolic process, GO:0010667|negative regulation of cardiac muscle cell apoptotic process, GO:0072050|S-shaped body morphogenesis, GO:0072073|kidney epithelium development, GO:0072164|mesonephric tubule development","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0004996|thyroid-stimulating hormone receptor activity, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0043565|sequence-specific DNA binding"
AXIN1,Silent,0.140187385821325,31,0.45194209195736,N,TSG,TSG,0.196257240720561,0.289989992346891,ENSG00000103126,"GO:0048471|perinuclear region of cytoplasm, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0030877|beta-catenin destruction complex, GO:0005829|cytosol, GO:0031410|cytoplasmic vesicle, GO:0016328|lateral plasma membrane, GO:0071944|cell periphery","GO:0001934|positive regulation of protein phosphorylation, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:1904886|beta-catenin destruction complex disassembly, GO:0031398|positive regulation of protein ubiquitination, GO:0010800|positive regulation of peptidyl-threonine phosphorylation, GO:0030111|regulation of Wnt signaling pathway, GO:0032147|activation of protein kinase activity, GO:0033146|regulation of intracellular estrogen receptor signaling pathway, GO:0034622|cellular protein-containing complex assembly, GO:0045732|positive regulation of protein catabolic process, GO:0046330|positive regulation of JNK cascade, GO:0051443|positive regulation of ubiquitin-protein transferase activity, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:1904885|beta-catenin destruction complex assembly, GO:2000060|positive regulation of ubiquitin-dependent protein catabolic process","GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0030159|receptor signaling complex scaffold activity, GO:0032947|protein-containing complex scaffold activity, GO:0070016|armadillo repeat domain binding, GO:0031625|ubiquitin protein ligase binding, GO:0019899|enzyme binding, GO:0019901|protein kinase binding, GO:0008013|beta-catenin binding, GO:0070411|I-SMAD binding, GO:0035591|signaling adaptor activity, GO:0046332|SMAD binding"
MYOD1,Missense,0.139878987809655,32,0.44513008628988,N,Oncogene,Oncogene,0.112511585231156,0.539816071513989,ENSG00000129152,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0016604|nuclear body, GO:0005667|transcription factor complex, GO:0000790|nuclear chromatin, GO:0005737|cytoplasm, GO:0030016|myofibril","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0007517|muscle organ development, GO:0006468|protein phosphorylation, GO:0043967|histone H4 acetylation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043966|histone H3 acetylation, GO:0051149|positive regulation of muscle cell differentiation, GO:0071392|cellular response to estradiol stimulus, GO:0014904|myotube cell development, GO:0007519|skeletal muscle tissue development, GO:0035914|skeletal muscle cell differentiation, GO:0042693|muscle cell fate commitment, GO:0045663|positive regulation of myoblast differentiation, GO:0048743|positive regulation of skeletal muscle fiber development, GO:1901741|positive regulation of myoblast fusion, GO:0000381|regulation of alternative mRNA splicing, via spliceosome, GO:0007518|myoblast fate determination, GO:0007520|myoblast fusion, GO:0009267|cellular response to starvation, GO:0010468|regulation of gene expression, GO:0014902|myotube differentiation, GO:0014908|myotube differentiation involved in skeletal muscle regeneration, GO:0043415|positive regulation of skeletal muscle tissue regeneration, GO:0043484|regulation of RNA splicing, GO:0043503|skeletal muscle fiber adaptation, GO:0045445|myoblast differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0048741|skeletal muscle fiber development, GO:0051146|striated muscle cell differentiation, GO:0071356|cellular response to tumor necrosis factor, GO:0071385|cellular response to glucocorticoid stimulus, GO:0071453|cellular response to oxygen levels, GO:1905382|positive regulation of snRNA transcription by RNA polymerase II, GO:2000818|negative regulation of myoblast proliferation","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0031490|chromatin DNA binding, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0046982|protein heterodimerization activity, GO:0003713|transcription coactivator activity, GO:0070888|E-box binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0035257|nuclear hormone receptor binding, GO:1990841|promoter-specific chromatin binding, GO:0003700|DNA-binding transcription factor activity, GO:0008134|transcription factor binding, GO:0019899|enzyme binding, GO:0031625|ubiquitin protein ligase binding, GO:0043565|sequence-specific DNA binding"
RANBP2,Silent,0.139444373175665,60,0.287957953675141,N,"TSG, fusion",TSG,-0.00680075605007472,0.958870640466968,ENSG00000153201,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005643|nuclear pore, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005635|nuclear envelope, GO:0031965|nuclear membrane, GO:0005642|annulate lamellae, GO:0042405|nuclear inclusion body, GO:0044615|nuclear pore nuclear basket, GO:0005739|mitochondrion, GO:0044614|nuclear pore cytoplasmic filaments, GO:1990723|cytoplasmic periphery of the nuclear pore complex","GO:0051028|mRNA transport, GO:0015031|protein transport, GO:0000413|protein peptidyl-prolyl isomerization, GO:0006457|protein folding, GO:0043547|positive regulation of GTPase activity, GO:0046907|intracellular transport, GO:0006607|NLS-bearing protein import into nucleus, GO:0006406|mRNA export from nucleus, GO:0016032|viral process, GO:0016925|protein sumoylation, GO:0051642|centrosome localization, GO:0001975|response to amphetamine, GO:0006111|regulation of gluconeogenesis, GO:0033133|positive regulation of glucokinase activity","GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0005096|GTPase activator activity, GO:0008536|Ran GTPase binding, GO:0019789|SUMO transferase activity, GO:0044877|protein-containing complex binding"
AFF3,Missense,0.13917269808291,155,0.0841540254966397,N,"oncogene, fusion",Oncogene,0.119614357570236,0.13821790258824,ENSG00000144218,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0016604|nuclear body, GO:0008023|transcription elongation factor complex, GO:0032783|ELL-EAF complex","GO:0006355|regulation of transcription, DNA-templated, GO:0035116|embryonic hindlimb morphogenesis, GO:0034612|response to tumor necrosis factor","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0003690|double-stranded DNA binding"
SLC34A2,Missense,0.138482407996418,84,0.209022659026586,N,"TSG, fusion",TSG,0.0168547399140671,0.87905098010215,ENSG00000157765,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0016324|apical plasma membrane, GO:0031982|vesicle, GO:0031526|brush border membrane, GO:0005903|brush border","GO:0006811|ion transport, GO:0006814|sodium ion transport, GO:0035725|sodium ion transmembrane transport, GO:0055085|transmembrane transport, GO:0044341|sodium-dependent phosphate transport, GO:0044267|cellular protein metabolic process, GO:0006817|phosphate ion transport, GO:0043627|response to estrogen, GO:0030643|cellular phosphate ion homeostasis, GO:0001701|in utero embryonic development","GO:0015293|symporter activity, GO:0015321|sodium-dependent phosphate transmembrane transporter activity, GO:0042301|phosphate ion binding, GO:0005436|sodium:phosphate symporter activity, GO:0031402|sodium ion binding"
EWSR1,Silent,0.137907610684597,14,0.638246690389385,N,"oncogene, fusion",Oncogene,0.0128468384237837,0.965232771038231,ENSG00000182944,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005730|nucleolus, GO:0005886|plasma membrane","GO:0006355|regulation of transcription, DNA-templated","GO:0003723|RNA binding, GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0005516|calmodulin binding"
RAF1,Missense,0.135962524466389,57,0.313240665748611,N,"oncogene, fusion",Oncogene,0.357945895129021,0.00626114139269762,ENSG00000132155,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0016020|membrane, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005886|plasma membrane, GO:0031143|pseudopodium, GO:0005794|Golgi apparatus, GO:0005741|mitochondrial outer membrane","GO:0008285|negative regulation of cell proliferation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0007165|signal transduction, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:0034220|ion transmembrane transport, GO:0000165|MAPK cascade, GO:0001666|response to hypoxia, GO:0001678|cellular glucose homeostasis, GO:0001934|positive regulation of protein phosphorylation, GO:0007507|heart development, GO:0030154|cell differentiation, GO:0030878|thyroid gland development, GO:0035019|somatic stem cell population maintenance, GO:0035773|insulin secretion involved in cellular response to glucose stimulus, GO:0035994|response to muscle stretch, GO:0045104|intermediate filament cytoskeleton organization, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048011|neurotrophin TRK receptor signaling pathway, GO:0048538|thymus development, GO:0060324|face development, GO:0071550|death-inducing signaling complex assembly, GO:1902042|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:0042981|regulation of apoptotic process, GO:0043066|negative regulation of apoptotic process, GO:0030168|platelet activation, GO:0008283|cell proliferation, GO:0031333|negative regulation of protein complex assembly, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0006915|apoptotic process, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0042060|wound healing, GO:2000145|regulation of cell motility, GO:0045595|regulation of cell differentiation, GO:0000186|activation of MAPKK activity, GO:0007190|activation of adenylate cyclase activity, GO:0035023|regulation of Rho protein signal transduction","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0004709|MAP kinase kinase kinase activity, GO:0008179|adenylate cyclase binding, GO:0010856|adenylate cyclase activator activity, GO:0017016|Ras GTPase binding, GO:0031434|mitogen-activated protein kinase kinase binding, GO:0046982|protein heterodimerization activity, GO:0019899|enzyme binding"
CBLB,Missense,0.135769542501079,94,0.191970213466988,N,TSG,TSG,0.0689414425497368,0.509090207887278,ENSG00000114423,"GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0045121|membrane raft","GO:0016567|protein ubiquitination, GO:0023051|regulation of signaling, GO:0007166|cell surface receptor signaling pathway, GO:0007165|signal transduction, GO:0006607|NLS-bearing protein import into nucleus, GO:0007175|negative regulation of epidermal growth factor-activated receptor activity, GO:2000583|regulation of platelet-derived growth factor receptor-alpha signaling pathway","GO:0005509|calcium ion binding, GO:0004842|ubiquitin-protein transferase activity, GO:0001784|phosphotyrosine residue binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0061630|ubiquitin protein ligase activity, GO:0017124|SH3 domain binding, GO:0008270|zinc ion binding, GO:0030971|receptor tyrosine kinase binding"
UBR5,Missense,0.135304872880323,188,0.0641182447231944,N,TSG,TSG,0.216037984957596,0.00290465286565409,ENSG00000104517,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0048471|perinuclear region of cytoplasm","GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0016567|protein ubiquitination, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0016032|viral process, GO:0000209|protein polyubiquitination, GO:0008283|cell proliferation, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0010628|positive regulation of gene expression, GO:0033160|positive regulation of protein import into nucleus, translocation, GO:0050847|progesterone receptor signaling pathway, GO:0070936|protein K48-linked ubiquitination, GO:1901315|negative regulation of histone H2A K63-linked ubiquitination, GO:2000780|negative regulation of double-strand break repair","GO:0003723|RNA binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0004842|ubiquitin-protein transferase activity, GO:0005515|protein binding, GO:0043130|ubiquitin binding, GO:0034450|ubiquitin-ubiquitin ligase activity, GO:0061630|ubiquitin protein ligase activity"
PTEN,Missense,0.134899289433219,174,0.0759409433023343,N,TSG,TSG,0.313097797916366,2.59320008523426e-05,ENSG00000171862,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0005576|extracellular region, GO:0016324|apical plasma membrane, GO:0005739|mitochondrion, GO:0035749|myelin sheath adaxonal region, GO:0043005|neuron projection, GO:0043197|dendritic spine, GO:0043220|Schmidt-Lanterman incisure, GO:0045211|postsynaptic membrane, GO:0009898|cytoplasmic side of plasma membrane, GO:0016605|PML body","GO:0008284|positive regulation of cell proliferation, GO:1904706|negative regulation of vascular smooth muscle cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0051898|negative regulation of protein kinase B signaling, GO:0070373|negative regulation of ERK1 and ERK2 cascade, GO:0050821|protein stabilization, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle, GO:0030336|negative regulation of cell migration, GO:0010719|negative regulation of epithelial to mesenchymal transition, GO:0014067|negative regulation of phosphatidylinositol 3-kinase signaling, GO:0006629|lipid metabolic process, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0006915|apoptotic process, GO:0006470|protein dephosphorylation, GO:0046855|inositol phosphate dephosphorylation, GO:0046856|phosphatidylinositol dephosphorylation, GO:0007399|nervous system development, GO:0007507|heart development, GO:0016477|cell migration, GO:0016579|protein deubiquitination, GO:0008283|cell proliferation, GO:0001525|angiogenesis, GO:0001933|negative regulation of protein phosphorylation, GO:0002902|regulation of B cell apoptotic process, GO:0007270|neuron-neuron synaptic transmission, GO:0007416|synapse assembly, GO:0007417|central nervous system development, GO:0007568|aging, GO:0007584|response to nutrient, GO:0007611|learning or memory, GO:0007613|memory, GO:0007626|locomotory behavior, GO:0009749|response to glucose, GO:0010033|response to organic substance, GO:0010035|response to inorganic substance, GO:0010043|response to zinc ion, GO:0010628|positive regulation of gene expression, GO:0010666|positive regulation of cardiac muscle cell apoptotic process, GO:0010975|regulation of neuron projection development, GO:0014070|response to organic cyclic compound, GO:0014823|response to activity, GO:0021542|dentate gyrus development, GO:0021955|central nervous system neuron axonogenesis, GO:0030534|adult behavior, GO:0031175|neuron projection development, GO:0031642|negative regulation of myelination, GO:0032228|regulation of synaptic transmission, GABAergic, GO:0032286|central nervous system myelin maintenance, GO:0032355|response to estradiol, GO:0032535|regulation of cellular component size, GO:0032869|cellular response to insulin stimulus, GO:0033032|regulation of myeloid cell apoptotic process, GO:0033198|response to ATP, GO:0033555|multicellular organismal response to stress, GO:0035176|social behavior, GO:0036294|cellular response to decreased oxygen levels, GO:0042493|response to drug, GO:0042711|maternal behavior, GO:0043065|positive regulation of apoptotic process, GO:0043066|negative regulation of apoptotic process, GO:0043491|protein kinase B signaling, GO:0043542|endothelial cell migration, GO:0044320|cellular response to leptin stimulus, GO:0045471|response to ethanol, GO:0045475|locomotor rhythm, GO:0045666|positive regulation of neuron differentiation, GO:0045792|negative regulation of cell size, GO:0046621|negative regulation of organ growth, GO:0046685|response to arsenic-containing substance, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0048679|regulation of axon regeneration, GO:0048681|negative regulation of axon regeneration, GO:0048738|cardiac muscle tissue development, GO:0048853|forebrain morphogenesis, GO:0048854|brain morphogenesis, GO:0050680|negative regulation of epithelial cell proliferation, GO:0050765|negative regulation of phagocytosis, GO:0050771|negative regulation of axonogenesis, GO:0051726|regulation of cell cycle, GO:0060024|rhythmic synaptic transmission, GO:0060044|negative regulation of cardiac muscle cell proliferation, GO:0060074|synapse maturation, GO:0060134|prepulse inhibition, GO:0060179|male mating behavior, GO:0060291|long-term synaptic potentiation, GO:0060292|long-term synaptic depression, GO:0060341|regulation of cellular localization, GO:0060736|prostate gland growth, GO:0060997|dendritic spine morphogenesis, GO:0061002|negative regulation of dendritic spine morphogenesis, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0071361|cellular response to ethanol, GO:0071456|cellular response to hypoxia, GO:0090071|negative regulation of ribosome biogenesis, GO:0090344|negative regulation of cell aging, GO:0090394|negative regulation of excitatory postsynaptic potential, GO:0097105|presynaptic membrane assembly, GO:0097107|postsynaptic density assembly, GO:1901017|negative regulation of potassium ion transmembrane transporter activity, GO:1904668|positive regulation of ubiquitin protein ligase activity, GO:1990090|cellular response to nerve growth factor stimulus, GO:1990314|cellular response to insulin-like growth factor stimulus, GO:2000272|negative regulation of signaling receptor activity, GO:2000463|positive regulation of excitatory postsynaptic potential, GO:2000808|negative regulation of synaptic vesicle clustering, GO:2001235|positive regulation of apoptotic signaling pathway, GO:0031647|regulation of protein stability, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0006661|phosphatidylinositol biosynthetic process, GO:0060070|canonical Wnt signaling pathway, GO:0051895|negative regulation of focal adhesion assembly, GO:0043647|inositol phosphate metabolic process, GO:2000060|positive regulation of ubiquitin-dependent protein catabolic process, GO:0000079|regulation of cyclin-dependent protein serine/threonine kinase activity, GO:1903984|positive regulation of TRAIL-activated apoptotic signaling pathway, GO:0051548|negative regulation of keratinocyte migration, GO:0071257|cellular response to electrical stimulus, GO:1903690|negative regulation of wound healing, spreading of epidermal cells","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0008138|protein tyrosine/serine/threonine phosphatase activity, GO:0008289|lipid binding, GO:0042802|identical protein binding, GO:0005161|platelet-derived growth factor receptor binding, GO:0016314|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity, GO:0019901|protein kinase binding, GO:0030165|PDZ domain binding, GO:0035255|ionotropic glutamate receptor binding, GO:0051717|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity, GO:0051800|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity, GO:1990782|protein tyrosine kinase binding, GO:0019899|enzyme binding, GO:0004722|protein serine/threonine phosphatase activity, GO:0004438|phosphatidylinositol-3-phosphatase activity, GO:0010997|anaphase-promoting complex binding, GO:1990381|ubiquitin-specific protease binding"
ARID1B,Missense,0.13424274950727,162,0.0885459789864759,N,TSG,TSG,0.187008013452935,0.0171790652581327,ENSG00000049618,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0016514|SWI/SNF complex, GO:0071565|nBAF complex, GO:0070603|SWI/SNF superfamily-type complex, GO:0005737|cytoplasm","GO:0006325|chromatin organization, GO:0006338|chromatin remodeling, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007399|nervous system development, GO:0048096|chromatin-mediated maintenance of transcription, GO:0060996|dendritic spine development, GO:0002931|response to ischemia, GO:0007270|neuron-neuron synaptic transmission, GO:0097026|dendritic cell dendrite assembly, GO:1904385|cellular response to angiotensin","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
DNM2,Missense,0.133950038064648,67,0.27984228982274,N,TSG,TSG,0.164768502759115,0.182717358329738,ENSG00000079805,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005794|Golgi apparatus, GO:0005829|cytosol, GO:0098793|presynapse, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0030054|cell junction, GO:0031410|cytoplasmic vesicle, GO:0045202|synapse, GO:0045211|postsynaptic membrane, GO:0005874|microtubule, GO:0005905|clathrin-coated pit, GO:0005925|focal adhesion, GO:0030496|midbody, GO:0030426|growth cone, GO:0070062|extracellular exosome, GO:0001891|phagocytic cup, GO:0030670|phagocytic vesicle membrane, GO:0014069|postsynaptic density, GO:0030424|axon, GO:0000139|Golgi membrane, GO:0030666|endocytic vesicle membrane, GO:0043197|dendritic spine, GO:0044327|dendritic spine head, GO:0098844|postsynaptic endocytic zone membrane, GO:0001917|photoreceptor inner segment, GO:0005634|nucleus, GO:0005768|endosome, GO:0005802|trans-Golgi network, GO:0005813|centrosome, GO:0030027|lamellipodium, GO:0032587|ruffle membrane, GO:0032991|protein-containing complex, GO:0045334|clathrin-coated endocytic vesicle, GO:0048471|perinuclear region of cytoplasm","GO:0006897|endocytosis, GO:0007165|signal transduction, GO:0045893|positive regulation of transcription, DNA-templated, GO:0048812|neuron projection morphogenesis, GO:0043065|positive regulation of apoptotic process, GO:0019886|antigen processing and presentation of exogenous peptide antigen via MHC class II, GO:0006355|regulation of transcription, DNA-templated, GO:0061024|membrane organization, GO:0006909|phagocytosis, GO:0050999|regulation of nitric-oxide synthase activity, GO:1903526|negative regulation of membrane tubulation, GO:0048489|synaptic vesicle transport, GO:0098884|postsynaptic neurotransmitter receptor internalization, GO:0000086|G2/M transition of mitotic cell cycle, GO:0006898|receptor-mediated endocytosis, GO:0031623|receptor internalization, GO:0030516|regulation of axon extension, GO:0033572|transferrin transport, GO:0016185|synaptic vesicle budding from presynaptic endocytic zone membrane, GO:0050803|regulation of synapse structure or activity, GO:0002031|G protein-coupled receptor internalization, GO:0003281|ventricular septum development, GO:0006893|Golgi to plasma membrane transport, GO:0007283|spermatogenesis, GO:0009416|response to light stimulus, GO:0010592|positive regulation of lamellipodium assembly, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0035020|regulation of Rac protein signal transduction, GO:0035904|aorta development, GO:0042220|response to cocaine, GO:0044351|macropinocytosis, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0045807|positive regulation of endocytosis, GO:0050766|positive regulation of phagocytosis, GO:0060976|coronary vasculature development, GO:0071245|cellular response to carbon monoxide, GO:0071481|cellular response to X-ray, GO:0071732|cellular response to nitric oxide, GO:1900026|positive regulation of substrate adhesion-dependent cell spreading, GO:1902856|negative regulation of non-motile cilium assembly, GO:1903351|cellular response to dopamine, GO:1903358|regulation of Golgi organization, GO:1903408|positive regulation of sodium:potassium-exchanging ATPase activity, GO:2000370|positive regulation of clathrin-dependent endocytosis","GO:0000166|nucleotide binding, GO:0016787|hydrolase activity, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0017124|SH3 domain binding, GO:0019899|enzyme binding, GO:0019901|protein kinase binding, GO:0031749|D2 dopamine receptor binding, GO:0036312|phosphatidylinositol 3-kinase regulatory subunit binding, GO:0044877|protein-containing complex binding, GO:0050699|WW domain binding, GO:0050998|nitric-oxide synthase binding"
PRKAR1A,Missense,0.132720837821895,31,0.476619812448156,N,"oncogene, TSG, fusion","",-0.0146729540173472,0.937555697598847,ENSG00000108946,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005952|cAMP-dependent protein kinase complex, GO:0005829|cytosol, GO:0005930|axoneme, GO:0032991|protein-containing complex, GO:0001772|immunological synapse, GO:0044853|plasma membrane raft, GO:0097546|ciliary base, GO:0031588|nucleotide-activated protein kinase complex, GO:0031594|neuromuscular junction","GO:2000480|negative regulation of cAMP-dependent protein kinase activity, GO:0016310|phosphorylation, GO:0001932|regulation of protein phosphorylation, GO:0046007|negative regulation of activated T cell proliferation, GO:0019934|cGMP-mediated signaling, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007596|blood coagulation, GO:0035556|intracellular signal transduction, GO:0003091|renal water homeostasis, GO:0071377|cellular response to glucagon stimulus, GO:0034199|activation of protein kinase A activity, GO:0045859|regulation of protein kinase activity, GO:0001707|mesoderm formation, GO:0006469|negative regulation of protein kinase activity, GO:0007143|female meiotic nuclear division, GO:0007507|heart development, GO:0045214|sarcomere organization, GO:0045835|negative regulation of meiotic nuclear division, GO:0060038|cardiac muscle cell proliferation","GO:0000166|nucleotide binding, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0008603|cAMP-dependent protein kinase regulator activity, GO:0030552|cAMP binding, GO:0031625|ubiquitin protein ligase binding, GO:0019904|protein domain specific binding, GO:0047555|3',5'-cyclic-GMP phosphodiesterase activity, GO:0034236|protein kinase A catalytic subunit binding, GO:0004862|cAMP-dependent protein kinase inhibitor activity"
AFF3,Silent,0.132642203520074,76,0.253354673345137,N,"oncogene, fusion",Oncogene,0.133142333243822,0.251553349979213,ENSG00000144218,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0016604|nuclear body, GO:0008023|transcription elongation factor complex, GO:0032783|ELL-EAF complex","GO:0006355|regulation of transcription, DNA-templated, GO:0035116|embryonic hindlimb morphogenesis, GO:0034612|response to tumor necrosis factor","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0003690|double-stranded DNA binding"
DROSHA,Missense,0.132517277177272,99,0.191022742601006,N,TSG,TSG,0.141011824588696,0.163862449877278,ENSG00000113360,"GO:0005634|nucleus, GO:0005730|nucleolus, GO:0005654|nucleoplasm, GO:0070877|microprocessor complex, GO:0014069|postsynaptic density","GO:0006396|RNA processing, GO:0090305|nucleic acid phosphodiester bond hydrolysis, GO:0090501|RNA phosphodiester bond hydrolysis, GO:0090502|RNA phosphodiester bond hydrolysis, endonucleolytic, GO:0042254|ribosome biogenesis, GO:0031047|gene silencing by RNA, GO:0050829|defense response to Gram-negative bacterium, GO:0050830|defense response to Gram-positive bacterium, GO:0016075|rRNA catabolic process, GO:0031053|primary miRNA processing, GO:0030422|production of siRNA involved in RNA interference, GO:0031054|pre-miRNA processing, GO:0010468|regulation of gene expression, GO:0010586|miRNA metabolic process, GO:0010628|positive regulation of gene expression, GO:0045589|regulation of regulatory T cell differentiation, GO:0050727|regulation of inflammatory response, GO:2000628|regulation of miRNA metabolic process","GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0004519|endonuclease activity, GO:0004518|nuclease activity, GO:0004525|ribonuclease III activity, GO:0042803|protein homodimerization activity, GO:0001530|lipopolysaccharide binding, GO:0070412|R-SMAD binding, GO:0046332|SMAD binding, GO:0003725|double-stranded RNA binding, GO:0070878|primary miRNA binding, GO:0017151|DEAD/H-box RNA helicase binding, GO:0004521|endoribonuclease activity"
BCL11B,Missense,0.132387098490276,99,0.191462920269935,N,"oncogene, TSG, fusion","",0.162843479045963,0.107296659067831,ENSG00000127152,"GO:0005634|nucleus, GO:0043005|neuron projection","GO:0006355|regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0003334|keratinocyte development, GO:0003382|epithelial cell morphogenesis, GO:0007409|axonogenesis, GO:0008285|negative regulation of cell proliferation, GO:0009791|post-embryonic development, GO:0010468|regulation of gene expression, GO:0010837|regulation of keratinocyte proliferation, GO:0019216|regulation of lipid metabolic process, GO:0021773|striatal medium spiny neuron differentiation, GO:0021902|commitment of neuronal cell to specific neuron type in forebrain, GO:0021953|central nervous system neuron differentiation, GO:0031077|post-embryonic camera-type eye development, GO:0033077|T cell differentiation in thymus, GO:0033153|T cell receptor V(D)J recombination, GO:0042475|odontogenesis of dentin-containing tooth, GO:0043066|negative regulation of apoptotic process, GO:0043368|positive T cell selection, GO:0043588|skin development, GO:0045664|regulation of neuron differentiation, GO:0046632|alpha-beta T cell differentiation, GO:0048538|thymus development, GO:0071678|olfactory bulb axon guidance, GO:0035701|hematopoietic stem cell migration, GO:0097535|lymphoid lineage cell migration into thymus","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding"
LMNA,Missense,0.132090021447972,52,0.350583096400675,N,fusion,"",0.0547098278281581,0.700076970952724,ENSG00000160789,"GO:0005882|intermediate filament, GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005635|nuclear envelope, GO:0031965|nuclear membrane, GO:0005652|nuclear lamina, GO:0005638|lamin filament","GO:0030334|regulation of cell migration, GO:0036498|IRE1-mediated unfolded protein response, GO:0034504|protein localization to nucleus, GO:0071456|cellular response to hypoxia, GO:0007084|mitotic nuclear envelope reassembly, GO:0008285|negative regulation of cell proliferation, GO:0030951|establishment or maintenance of microtubule cytoskeleton polarity, GO:0090343|positive regulation of cell aging, GO:1903243|negative regulation of cardiac muscle hypertrophy in response to stress, GO:0006606|protein import into nucleus, GO:0006997|nucleus organization, GO:0006998|nuclear envelope organization, GO:0010628|positive regulation of gene expression, GO:0031647|regulation of protein stability, GO:0055015|ventricular cardiac muscle cell development, GO:0072201|negative regulation of mesenchymal cell proliferation, GO:0090201|negative regulation of release of cytochrome c from mitochondria, GO:1900114|positive regulation of histone H3-K9 trimethylation, GO:1900180|regulation of protein localization to nucleus, GO:2001237|negative regulation of extrinsic apoptotic signaling pathway","GO:0005198|structural molecule activity, GO:0005515|protein binding"
EP300,Missense,0.131664329033207,164,0.0928496839868971,N,"TSG, fusion",TSG,0.309626628800969,5.47365231341549e-05,ENSG00000100393,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0000123|histone acetyltransferase complex, GO:0032993|protein-DNA complex, GO:0005667|transcription factor complex, GO:0032991|protein-containing complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007049|cell cycle, GO:0007623|circadian rhythm, GO:0048511|rhythmic process, GO:0006915|apoptotic process, GO:0016573|histone acetylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045444|fat cell differentiation, GO:0031648|protein destabilization, GO:0050821|protein stabilization, GO:0045721|negative regulation of gluconeogenesis, GO:0001666|response to hypoxia, GO:0016032|viral process, GO:0007399|nervous system development, GO:0045815|positive regulation of gene expression, epigenetic, GO:0043967|histone H4 acetylation, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:1904837|beta-catenin-TCF complex assembly, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0043627|response to estrogen, GO:0045652|regulation of megakaryocyte differentiation, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0034644|cellular response to UV, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0006283|transcription-coupled nucleotide-excision repair, GO:0006473|protein acetylation, GO:1900034|regulation of cellular response to heat, GO:0051726|regulation of cell cycle, GO:0018393|internal peptidyl-lysine acetylation, GO:0007219|Notch signaling pathway, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0010976|positive regulation of neuron projection development, GO:0010506|regulation of autophagy, GO:0032481|positive regulation of type I interferon production, GO:0006990|positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response, GO:0060765|regulation of androgen receptor signaling pathway, GO:0006475|internal protein amino acid acetylation, GO:0010742|macrophage derived foam cell differentiation, GO:0007221|positive regulation of transcription of Notch receptor target, GO:0045747|positive regulation of Notch signaling pathway, GO:0043923|positive regulation by host of viral transcription, GO:0045893|positive regulation of transcription, DNA-templated, GO:0001756|somitogenesis, GO:0007507|heart development, GO:0007519|skeletal muscle tissue development, GO:0009887|animal organ morphogenesis, GO:0010628|positive regulation of gene expression, GO:0018076|N-terminal peptidyl-lysine acetylation, GO:0018394|peptidyl-lysine acetylation, GO:0030183|B cell differentiation, GO:0030220|platelet formation, GO:0030324|lung development, GO:0032092|positive regulation of protein binding, GO:0032460|negative regulation of protein oligomerization, GO:0035855|megakaryocyte development, GO:0043969|histone H2B acetylation, GO:0061921|peptidyl-lysine propionylation, GO:0090043|regulation of tubulin deacetylation, GO:0140066|peptidyl-lysine crotonylation, GO:0140067|peptidyl-lysine butyrylation","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003713|transcription coactivator activity, GO:0003712|transcription coregulator activity, GO:0003677|DNA binding, GO:0016746|transferase activity, transferring acyl groups, GO:0005515|protein binding, GO:0004402|histone acetyltransferase activity, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0048156|tau protein binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0008013|beta-catenin binding, GO:0003684|damaged DNA binding, GO:0035257|nuclear hormone receptor binding, GO:0050681|androgen receptor binding, GO:0008022|protein C-terminus binding, GO:0033613|activating transcription factor binding, GO:0016407|acetyltransferase activity, GO:0001085|RNA polymerase II transcription factor binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0002039|p53 binding, GO:0004468|lysine N-acetyltransferase activity, acting on acetyl phosphate as donor, GO:0031490|chromatin DNA binding, GO:0034212|peptide N-acetyltransferase activity, GO:0061733|peptide-lysine-N-acetyltransferase activity, GO:0061920|protein propionyltransferase activity, GO:0097157|pre-mRNA intronic binding, GO:0097677|STAT family protein binding, GO:0140065|peptide butyryltransferase activity, GO:0140068|histone crotonyltransferase activity, GO:0140069|histone butyryltransferase activity"
KMT2D,Nonsense,0.130267789455786,14,0.657133996987528,N,"oncogene, TSG","",-0.0138344439723516,0.962561671224672,ENSG00000167548,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0035097|histone methyltransferase complex, GO:0044666|MLL3/4 complex","GO:0032259|methylation, GO:0006325|chromatin organization, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0048477|oogenesis, GO:0008284|positive regulation of cell proliferation, GO:0006355|regulation of transcription, DNA-templated, GO:1904837|beta-catenin-TCF complex assembly, GO:0001555|oocyte growth, GO:0006342|chromatin silencing, GO:0033148|positive regulation of intracellular estrogen receptor signaling pathway, GO:0043627|response to estrogen, GO:0045652|regulation of megakaryocyte differentiation, GO:0051568|histone H3-K4 methylation","GO:0046872|metal ion binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0042393|histone binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003713|transcription coactivator activity, GO:0042800|histone methyltransferase activity (H3-K4 specific), GO:0044212|transcription regulatory region DNA binding"
PRDM16,Silent,0.129375592480184,75,0.268612315249821,N,"oncogene, fusion",Oncogene,0.135006335121567,0.248152765101527,ENSG00000142611,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0016235|aggresome, GO:0017053|transcriptional repressor complex","GO:0030154|cell differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0034968|histone lysine methylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0050873|brown fat cell differentiation, GO:0043457|regulation of cellular respiration, GO:0019827|stem cell population maintenance, GO:0022008|neurogenesis, GO:0035019|somatic stem cell population maintenance, GO:0043586|tongue development, GO:0050872|white fat cell differentiation, GO:0060021|roof of mouth development, GO:0090336|positive regulation of brown fat cell differentiation","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003713|transcription coactivator activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0018024|histone-lysine N-methyltransferase activity, GO:0033613|activating transcription factor binding, GO:0046332|SMAD binding"
NUP214,Silent,0.129215791465447,49,0.376222370199933,N,fusion,"",0.274168158300842,0.0566061414767582,ENSG00000126883,"GO:0005634|nucleus, GO:0043231|intracellular membrane-bounded organelle, GO:0005925|focal adhesion, GO:0005643|nuclear pore, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005635|nuclear envelope, GO:1990876|cytoplasmic side of nuclear pore","GO:0051028|mRNA transport, GO:0015031|protein transport, GO:0006406|mRNA export from nucleus, GO:0006606|protein import into nucleus, GO:0016032|viral process, GO:0043488|regulation of mRNA stability, GO:0006611|protein export from nucleus, GO:0046822|regulation of nucleocytoplasmic transport, GO:0000278|mitotic cell cycle, GO:0051726|regulation of cell cycle","GO:0005515|protein binding, GO:0008139|nuclear localization sequence binding, GO:0017056|structural constituent of nuclear pore, GO:0005049|nuclear export signal receptor activity"
CREBBP,Nonsense,0.129081872940011,43,0.409392221933056,N,"oncogene, TSG, fusion","",0.152194603754813,0.329912764708077,ENSG00000005339,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0000123|histone acetyltransferase complex, GO:0016604|nuclear body, GO:0000790|nuclear chromatin","GO:0006355|regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0048511|rhythmic process, GO:0016573|histone acetylation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0031648|protein destabilization, GO:0001666|response to hypoxia, GO:0016032|viral process, GO:0042981|regulation of apoptotic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1904837|beta-catenin-TCF complex assembly, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0065003|protein-containing complex assembly, GO:0042592|homeostatic process, GO:0042733|embryonic digit morphogenesis, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0034644|cellular response to UV, GO:0019216|regulation of lipid metabolic process, GO:0006473|protein acetylation, GO:1900034|regulation of cellular response to heat, GO:0007219|Notch signaling pathway, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0045637|regulation of myeloid cell differentiation, GO:0032481|positive regulation of type I interferon production, GO:0007221|positive regulation of transcription of Notch receptor target, GO:0045747|positive regulation of Notch signaling pathway, GO:0018076|N-terminal peptidyl-lysine acetylation, GO:0008589|regulation of smoothened signaling pathway","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003713|transcription coactivator activity, GO:0003712|transcription coregulator activity, GO:0016746|transferase activity, transferring acyl groups, GO:0005515|protein binding, GO:0004402|histone acetyltransferase activity, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0003714|transcription corepressor activity, GO:0002039|p53 binding, GO:0003684|damaged DNA binding, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0016407|acetyltransferase activity, GO:0034212|peptide N-acetyltransferase activity, GO:0043426|MRF binding"
TRIM27,Missense,0.128692098302952,23,0.558406866221161,N,"oncogene, fusion",Oncogene,0.0272595084208151,0.901739650294904,ENSG00000204713,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005730|nucleolus, GO:0001650|fibrillar center, GO:0005768|endosome, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005769|early endosome, GO:0016605|PML body, GO:0030904|retromer complex, GO:0031965|nuclear membrane","GO:0016925|protein sumoylation, GO:0045087|innate immune response, GO:0034314|Arp2/3 complex-mediated actin nucleation, GO:0042147|retrograde transport, endosome to Golgi, GO:0032720|negative regulation of tumor necrosis factor production, GO:0070534|protein K63-linked ubiquitination, GO:0072643|interferon-gamma secretion, GO:0008283|cell proliferation, GO:0007283|spermatogenesis, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0006469|negative regulation of protein kinase activity, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0032897|negative regulation of viral transcription, GO:0090281|negative regulation of calcium ion import, GO:0002820|negative regulation of adaptive immune response, GO:0045814|negative regulation of gene expression, epigenetic, GO:0070206|protein trimerization, GO:1900041|negative regulation of interleukin-2 secretion, GO:0051127|positive regulation of actin nucleation, GO:1902187|negative regulation of viral release from host cell","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0042802|identical protein binding, GO:0061630|ubiquitin protein ligase activity, GO:0019789|SUMO transferase activity, GO:0003676|nucleic acid binding"
IL7R,Missense,0.127816177153304,81,0.255480884141149,N,Oncogene,Oncogene,0.0964729939135806,0.391576092144437,ENSG00000168685,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0030665|clathrin-coated vesicle membrane, GO:0009897|external side of plasma membrane","GO:0008284|positive regulation of cell proliferation, GO:0006955|immune response, GO:0007165|signal transduction, GO:0007166|cell surface receptor signaling pathway, GO:0061024|membrane organization, GO:0038111|interleukin-7-mediated signaling pathway, GO:0000018|regulation of DNA recombination, GO:0000902|cell morphogenesis, GO:0001915|negative regulation of T cell mediated cytotoxicity, GO:0002377|immunoglobulin production, GO:0008361|regulation of cell size, GO:0010628|positive regulation of gene expression, GO:0030217|T cell differentiation, GO:0033089|positive regulation of T cell differentiation in thymus, GO:0042100|B cell proliferation, GO:0048535|lymph node development, GO:0048872|homeostasis of number of cells, GO:0070233|negative regulation of T cell apoptotic process, GO:1904894|positive regulation of STAT cascade, GO:0019221|cytokine-mediated signaling pathway","GO:0005515|protein binding, GO:0004896|cytokine receptor activity, GO:0003823|antigen binding, GO:0004917|interleukin-7 receptor activity"
SOCS1,Missense,0.127183817781248,53,0.364128439070936,N,TSG,TSG,-0.0397514197498244,0.7774791009874,ENSG00000185338,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0031410|cytoplasmic vesicle, GO:0036464|cytoplasmic ribonucleoprotein granule, GO:0005829|cytosol, GO:0005942|phosphatidylinositol 3-kinase complex","GO:0016567|protein ubiquitination, GO:0035556|intracellular signal transduction, GO:0046426|negative regulation of JAK-STAT cascade, GO:0043551|regulation of phosphatidylinositol 3-kinase activity, GO:0040008|regulation of growth, GO:0006469|negative regulation of protein kinase activity, GO:0046854|phosphatidylinositol phosphorylation, GO:0019221|cytokine-mediated signaling pathway, GO:0009968|negative regulation of signal transduction, GO:0038111|interleukin-7-mediated signaling pathway, GO:0046627|negative regulation of insulin receptor signaling pathway, GO:0042532|negative regulation of tyrosine phosphorylation of STAT protein, GO:0060334|regulation of interferon-gamma-mediated signaling pathway, GO:0001932|regulation of protein phosphorylation, GO:0043372|positive regulation of CD4-positive, alpha-beta T cell differentiation, GO:0043377|negative regulation of CD8-positive, alpha-beta T cell differentiation, GO:0033673|negative regulation of kinase activity, GO:0045591|positive regulation of regulatory T cell differentiation, GO:0007259|JAK-STAT cascade, GO:0010533|regulation of activation of Janus kinase activity, GO:0042509|regulation of tyrosine phosphorylation of STAT protein, GO:0045444|fat cell differentiation, GO:0046425|regulation of JAK-STAT cascade, GO:0050707|regulation of cytokine secretion, GO:0071230|cellular response to amino acid stimulus","GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0046935|1-phosphatidylinositol-3-kinase regulator activity, GO:0005159|insulin-like growth factor receptor binding, GO:0004860|protein kinase inhibitor activity, GO:0019210|kinase inhibitor activity"
KMT2C,Silent,0.126261173993109,108,0.19288424535052,N,TSG,TSG,0.0862627956943351,0.374705379289999,ENSG00000055609,"GO:0005634|nucleus, GO:0044666|MLL3/4 complex, GO:0005654|nucleoplasm, GO:0035097|histone methyltransferase complex","GO:0051568|histone H3-K4 methylation, GO:0006355|regulation of transcription, DNA-templated, GO:0032259|methylation, GO:0006325|chromatin organization, GO:0034968|histone lysine methylation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045652|regulation of megakaryocyte differentiation","GO:0046872|metal ion binding, GO:0042800|histone methyltransferase activity (H3-K4 specific), GO:0003723|RNA binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0016746|transferase activity, transferring acyl groups, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0042393|histone binding, GO:0003713|transcription coactivator activity"
FGFR1,Missense,0.12570743944222,84,0.254540131258863,N,"oncogene, fusion",Oncogene,0.0430029326770556,0.697718135929351,ENSG00000077782,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0031410|cytoplasmic vesicle, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex","GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:1905564|positive regulation of vascular endothelial cell proliferation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0048015|phosphatidylinositol-mediated signaling, GO:0046854|phosphatidylinositol phosphorylation, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0007399|nervous system development, GO:0016477|cell migration, GO:0043410|positive regulation of MAPK cascade, GO:0001501|skeletal system development, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0045595|regulation of cell differentiation, GO:0001764|neuron migration, GO:0043406|positive regulation of MAP kinase activity, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0010863|positive regulation of phospholipase C activity, GO:0045597|positive regulation of cell differentiation, GO:0010518|positive regulation of phospholipase activity, GO:0043009|chordate embryonic development, GO:0045666|positive regulation of neuron differentiation, GO:0048705|skeletal system morphogenesis, GO:2000546|positive regulation of endothelial cell chemotaxis to fibroblast growth factor, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001525|angiogenesis, GO:0001657|ureteric bud development, GO:0001701|in utero embryonic development, GO:0001759|organ induction, GO:0002053|positive regulation of mesenchymal cell proliferation, GO:0002062|chondrocyte differentiation, GO:0007420|brain development, GO:0007435|salivary gland morphogenesis, GO:0007605|sensory perception of sound, GO:0010468|regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0010966|regulation of phosphate transport, GO:0010976|positive regulation of neuron projection development, GO:0021769|orbitofrontal cortex development, GO:0021847|ventricular zone neuroblast division, GO:0030324|lung development, GO:0030326|embryonic limb morphogenesis, GO:0030901|midbrain development, GO:0035607|fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development, GO:0042127|regulation of cell proliferation, GO:0042472|inner ear morphogenesis, GO:0042473|outer ear morphogenesis, GO:0042474|middle ear morphogenesis, GO:0043583|ear development, GO:0045787|positive regulation of cell cycle, GO:0048339|paraxial mesoderm development, GO:0048378|regulation of lateral mesodermal cell fate specification, GO:0048469|cell maturation, GO:0048514|blood vessel morphogenesis, GO:0048699|generation of neurons, GO:0048762|mesenchymal cell differentiation, GO:0051174|regulation of phosphorus metabolic process, GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0060117|auditory receptor cell development, GO:0060445|branching involved in salivary gland morphogenesis, GO:0060484|lung-associated mesenchyme development, GO:0060665|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling, GO:0070640|vitamin D3 metabolic process, GO:0090080|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway, GO:0090272|negative regulation of fibroblast growth factor production, GO:1903465|positive regulation of mitotic cell cycle DNA replication, GO:2000830|positive regulation of parathyroid hormone secretion, GO:2001239|regulation of extrinsic apoptotic signaling pathway in absence of ligand","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0042802|identical protein binding, GO:0005007|fibroblast growth factor-activated receptor activity, GO:0008201|heparin binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0017134|fibroblast growth factor binding, GO:0090722|receptor-receptor interaction, GO:0042169|SH2 domain binding"
PPP2R1A,Missense,0.125140889077785,53,0.371946998227233,N,TSG,TSG,0.0714800747088424,0.611014713514162,ENSG00000105568,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005694|chromosome, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0000159|protein phosphatase type 2A complex, GO:0030425|dendrite, GO:0000775|chromosome, centromeric region, GO:0015630|microtubule cytoskeleton, GO:0070062|extracellular exosome, GO:0016328|lateral plasma membrane","GO:0008380|RNA splicing, GO:0006915|apoptotic process, GO:0043666|regulation of phosphoprotein phosphatase activity, GO:0007059|chromosome segregation, GO:0065003|protein-containing complex assembly, GO:0040008|regulation of growth, GO:0030155|regulation of cell adhesion, GO:0007143|female meiotic nuclear division, GO:0051232|meiotic spindle elongation, GO:0051306|mitotic sister chromatid separation, GO:0051754|meiotic sister chromatid cohesion, centromeric, GO:0070262|peptidyl-serine dephosphorylation, GO:1903538|regulation of meiotic cell cycle process involved in oocyte maturation, GO:2001241|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand, GO:0000086|G2/M transition of mitotic cell cycle, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0097711|ciliary basal body-plasma membrane docking, GO:0006355|regulation of transcription, DNA-templated, GO:0030308|negative regulation of cell growth, GO:0006470|protein dephosphorylation, GO:0000184|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, GO:0042532|negative regulation of tyrosine phosphorylation of STAT protein, GO:0010033|response to organic substance, GO:0045595|regulation of cell differentiation, GO:0030111|regulation of Wnt signaling pathway, GO:0006275|regulation of DNA replication, GO:0006672|ceramide metabolic process, GO:0000188|inactivation of MAPK activity, GO:0019932|second-messenger-mediated signaling","GO:0005515|protein binding, GO:0019888|protein phosphatase regulator activity, GO:0004722|protein serine/threonine phosphatase activity, GO:0046982|protein heterodimerization activity, GO:1990405|protein antigen binding"
RPL5,Missense,0.124675211367294,30,0.511549686742796,N,TSG,TSG,0.259007523334501,0.166947067971389,ENSG00000122406,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005783|endoplasmic reticulum, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005840|ribosome, GO:0005654|nucleoplasm, GO:0005925|focal adhesion, GO:0022625|cytosolic large ribosomal subunit, GO:0070062|extracellular exosome, GO:0032991|protein-containing complex, GO:1990904|ribonucleoprotein complex","GO:0006412|translation, GO:0006364|rRNA processing, GO:0000027|ribosomal large subunit assembly, GO:0042273|ribosomal large subunit biogenesis, GO:0006413|translational initiation, GO:0000184|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, GO:0006614|SRP-dependent cotranslational protein targeting to membrane, GO:0010628|positive regulation of gene expression, GO:0050821|protein stabilization, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0045727|positive regulation of translation, GO:1904667|negative regulation of ubiquitin protein ligase activity, GO:2000059|negative regulation of ubiquitin-dependent protein catabolic process, GO:2000435|negative regulation of protein neddylation","GO:0003723|RNA binding, GO:0003735|structural constituent of ribosome, GO:0005515|protein binding, GO:0019843|rRNA binding, GO:0008097|5S rRNA binding, GO:0003730|mRNA 3'-UTR binding, GO:0048027|mRNA 5'-UTR binding, GO:0031625|ubiquitin protein ligase binding, GO:1990948|ubiquitin ligase inhibitor activity"
PTPRB,Silent,0.123990943696812,97,0.226273549465387,N,TSG,TSG,0.135626051586458,0.185312240410801,ENSG00000127329,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0035579|specific granule membrane, GO:0070821|tertiary granule membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex","GO:0006470|protein dephosphorylation, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0001525|angiogenesis, GO:0043312|neutrophil degranulation, GO:0006796|phosphate-containing compound metabolic process","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0005001|transmembrane receptor protein tyrosine phosphatase activity"
PDGFRA,Missense,0.121601286849209,137,0.156914894783487,N,"oncogene, fusion",Oncogene,0.0965327342611864,0.261795737756303,ENSG00000134853,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0030054|cell junction, GO:0042995|cell projection, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005929|cilium, GO:0032991|protein-containing complex, GO:0031226|intrinsic component of plasma membrane, GO:0005902|microvillus, GO:0009897|external side of plasma membrane, GO:0009986|cell surface","GO:0008284|positive regulation of cell proliferation, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0030335|positive regulation of cell migration, GO:0048146|positive regulation of fibroblast proliferation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0007275|multicellular organism development, GO:0048015|phosphatidylinositol-mediated signaling, GO:0006935|chemotaxis, GO:0046854|phosphatidylinositol phosphorylation, GO:0002244|hematopoietic progenitor cell differentiation, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0016032|viral process, GO:0070527|platelet aggregation, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0007204|positive regulation of cytosolic calcium ion concentration, GO:0060326|cell chemotaxis, GO:0042060|wound healing, GO:2000249|regulation of actin cytoskeleton reorganization, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0048557|embryonic digestive tract morphogenesis, GO:0072277|metanephric glomerular capillary formation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0010863|positive regulation of phospholipase C activity, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0001775|cell activation, GO:0038091|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway, GO:0055003|cardiac myofibril assembly, GO:0061298|retina vasculature development in camera-type eye, GO:0001553|luteinization, GO:0001701|in utero embryonic development, GO:0008210|estrogen metabolic process, GO:0008585|female gonad development, GO:0009653|anatomical structure morphogenesis, GO:0009887|animal organ morphogenesis, GO:0010544|negative regulation of platelet activation, GO:0016477|cell migration, GO:0023019|signal transduction involved in regulation of gene expression, GO:0030198|extracellular matrix organization, GO:0030324|lung development, GO:0030325|adrenal gland development, GO:0030539|male genitalia development, GO:0033327|Leydig cell differentiation, GO:0034614|cellular response to reactive oxygen species, GO:0035790|platelet-derived growth factor receptor-alpha signaling pathway, GO:0042475|odontogenesis of dentin-containing tooth, GO:0048704|embryonic skeletal system morphogenesis, GO:0048705|skeletal system morphogenesis, GO:0050920|regulation of chemotaxis, GO:0060021|roof of mouth development, GO:0060325|face morphogenesis, GO:0071230|cellular response to amino acid stimulus, GO:2000739|regulation of mesenchymal stem cell differentiation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005018|platelet-derived growth factor alpha-receptor activity, GO:0048407|platelet-derived growth factor binding, GO:0042803|protein homodimerization activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005021|vascular endothelial growth factor-activated receptor activity, GO:0038085|vascular endothelial growth factor binding, GO:0005161|platelet-derived growth factor receptor binding, GO:0044877|protein-containing complex binding"
FGFR4,Silent,0.121122434095726,27,0.547299209920701,N,Oncogene,Oncogene,0.286110699377666,0.147960396800732,ENSG00000160867,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005768|endosome, GO:0005911|cell-cell junction, GO:0030133|transport vesicle","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0046854|phosphatidylinositol phosphorylation, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0007399|nervous system development, GO:0010628|positive regulation of gene expression, GO:0016477|cell migration, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0019216|regulation of lipid metabolic process, GO:0042632|cholesterol homeostasis, GO:0045862|positive regulation of proteolysis, GO:0042593|glucose homeostasis, GO:0043085|positive regulation of catalytic activity, GO:0018108|peptidyl-tyrosine phosphorylation, GO:2000573|positive regulation of DNA biosynthetic process, GO:0010715|regulation of extracellular matrix disassembly, GO:0055062|phosphate ion homeostasis, GO:0070857|regulation of bile acid biosynthetic process","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005007|fibroblast growth factor-activated receptor activity, GO:0008201|heparin binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0017134|fibroblast growth factor binding"
EGFR,Missense,0.121052837130192,153,0.136080063146251,N,Oncogene,Oncogene,-0.00675736420307711,0.933931478255299,ENSG00000146648,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0000139|Golgi membrane, GO:0005615|extracellular space, GO:0045121|membrane raft, GO:0009986|cell surface, GO:0005925|focal adhesion, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005768|endosome, GO:0031901|early endosome membrane, GO:0010008|endosome membrane, GO:0032991|protein-containing complex, GO:0031965|nuclear membrane, GO:0030665|clathrin-coated vesicle membrane, GO:0009925|basal plasma membrane, GO:0016323|basolateral plasma membrane, GO:0070435|Shc-EGFR complex, GO:0097489|multivesicular body, internal vesicle lumen, GO:0016324|apical plasma membrane, GO:0030139|endocytic vesicle, GO:0045202|synapse, GO:0048471|perinuclear region of cytoplasm","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0006898|receptor-mediated endocytosis, GO:0008284|positive regulation of cell proliferation, GO:0051897|positive regulation of protein kinase B signaling, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0007165|signal transduction, GO:0007275|multicellular organism development, GO:0046718|viral entry into host cell, GO:0046854|phosphatidylinositol phosphorylation, GO:0030154|cell differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0043066|negative regulation of apoptotic process, GO:0001934|positive regulation of protein phosphorylation, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:0008283|cell proliferation, GO:0030335|positive regulation of cell migration, GO:0045739|positive regulation of DNA repair, GO:0001503|ossification, GO:0061024|membrane organization, GO:0045746|negative regulation of Notch signaling pathway, GO:0046777|protein autophosphorylation, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0000165|MAPK cascade, GO:0030307|positive regulation of cell growth, GO:0038128|ERBB2 signaling pathway, GO:2000145|regulation of cell motility, GO:0042177|negative regulation of protein catabolic process, GO:0042327|positive regulation of phosphorylation, GO:0045740|positive regulation of DNA replication, GO:0042059|negative regulation of epidermal growth factor receptor signaling pathway, GO:0034614|cellular response to reactive oxygen species, GO:0045893|positive regulation of transcription, DNA-templated, GO:0071276|cellular response to cadmium ion, GO:0098609|cell-cell adhesion, GO:0050679|positive regulation of epithelial cell proliferation, GO:0051205|protein insertion into membrane, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0071392|cellular response to estradiol stimulus, GO:1901224|positive regulation of NIK/NF-kappaB signaling, GO:0043406|positive regulation of MAP kinase activity, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007166|cell surface receptor signaling pathway, GO:0007202|activation of phospholipase C activity, GO:0007611|learning or memory, GO:0010750|positive regulation of nitric oxide mediated signal transduction, GO:0014066|regulation of phosphatidylinositol 3-kinase signaling, GO:0043006|activation of phospholipase A2 activity by calcium-mediated signaling, GO:0046328|regulation of JNK cascade, GO:0050730|regulation of peptidyl-tyrosine phosphorylation, GO:0050999|regulation of nitric-oxide synthase activity, GO:0070141|response to UV-A, GO:0070372|regulation of ERK1 and ERK2 cascade, GO:1900020|positive regulation of protein kinase C activity, GO:1901185|negative regulation of ERBB signaling pathway, GO:1903078|positive regulation of protein localization to plasma membrane, GO:1903800|positive regulation of production of miRNAs involved in gene silencing by miRNA, GO:1905208|negative regulation of cardiocyte differentiation, GO:0000186|activation of MAPKK activity, GO:0000902|cell morphogenesis, GO:0001889|liver development, GO:0001892|embryonic placenta development, GO:0001942|hair follicle development, GO:0006412|translation, GO:0006970|response to osmotic stress, GO:0006979|response to oxidative stress, GO:0007435|salivary gland morphogenesis, GO:0007494|midgut development, GO:0007623|circadian rhythm, GO:0008544|epidermis development, GO:0010960|magnesium ion homeostasis, GO:0014070|response to organic cyclic compound, GO:0016101|diterpenoid metabolic process, GO:0021795|cerebral cortex cell migration, GO:0030324|lung development, GO:0032355|response to estradiol, GO:0032930|positive regulation of superoxide anion generation, GO:0033590|response to cobalamin, GO:0033594|response to hydroxyisoflavone, GO:0033993|response to lipid, GO:0035556|intracellular signal transduction, GO:0035690|cellular response to drug, GO:0042060|wound healing, GO:0042127|regulation of cell proliferation, GO:0042698|ovulation cycle, GO:0042743|hydrogen peroxide metabolic process, GO:0043586|tongue development, GO:0045780|positive regulation of bone resorption, GO:0045907|positive regulation of vasoconstriction, GO:0045930|negative regulation of mitotic cell cycle, GO:0048143|astrocyte activation, GO:0048146|positive regulation of fibroblast proliferation, GO:0048546|digestive tract morphogenesis, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0048812|neuron projection morphogenesis, GO:0050729|positive regulation of inflammatory response, GO:0051592|response to calcium ion, GO:0051968|positive regulation of synaptic transmission, glutamatergic, GO:0060571|morphogenesis of an epithelial fold, GO:0061029|eyelid development in camera-type eye, GO:0071230|cellular response to amino acid stimulus, GO:0071260|cellular response to mechanical stimulus, GO:0071363|cellular response to growth factor stimulus, GO:0071549|cellular response to dexamethasone stimulus, GO:0097421|liver regeneration, GO:0097755|positive regulation of blood vessel diameter, GO:1902722|positive regulation of prolactin secretion","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004709|MAP kinase kinase kinase activity, GO:0042802|identical protein binding, GO:0045296|cadherin binding, GO:0051015|actin filament binding, GO:0003682|chromatin binding, GO:0031625|ubiquitin protein ligase binding, GO:0003690|double-stranded DNA binding, GO:0019899|enzyme binding, GO:0019903|protein phosphatase binding, GO:0046982|protein heterodimerization activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0001618|virus receptor activity, GO:0030235|nitric-oxide synthase regulator activity, GO:0004888|transmembrane signaling receptor activity, GO:0005006|epidermal growth factor-activated receptor activity, GO:0048408|epidermal growth factor binding, GO:0005102|signaling receptor binding, GO:0005178|integrin binding, GO:0005516|calmodulin binding, GO:0019901|protein kinase binding"
GATA3,Missense,0.1204543423613,59,0.363484279828268,N,"oncogene, TSG","",0.171625714238909,0.193688637700389,ENSG00000107485,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin","GO:0006355|regulation of transcription, DNA-templated, GO:0045582|positive regulation of T cell differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0007165|signal transduction, GO:0001822|kidney development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0008285|negative regulation of cell proliferation, GO:0016579|protein deubiquitination, GO:0008584|male gonad development, GO:0009615|response to virus, GO:0045786|negative regulation of cell cycle, GO:0050728|negative regulation of inflammatory response, GO:0071356|cellular response to tumor necrosis factor, GO:0045892|negative regulation of transcription, DNA-templated, GO:0032753|positive regulation of interleukin-4 production, GO:2000667|positive regulation of interleukin-13 secretion, GO:0006366|transcription by RNA polymerase II, GO:0045599|negative regulation of fat cell differentiation, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0019221|cytokine-mediated signaling pathway, GO:0050852|T cell receptor signaling pathway, GO:0009653|anatomical structure morphogenesis, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:0001709|cell fate determination, GO:0007596|blood coagulation, GO:0006952|defense response, GO:0043627|response to estrogen, GO:0010595|positive regulation of endothelial cell migration, GO:0051897|positive regulation of protein kinase B signaling, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0001823|mesonephros development, GO:0060037|pharyngeal system development, GO:0048485|sympathetic nervous system development, GO:2000611|positive regulation of thyroid hormone generation, GO:2000679|positive regulation of transcription regulatory region DNA binding, GO:0042421|norepinephrine biosynthetic process, GO:2000146|negative regulation of cell motility, GO:0035457|cellular response to interferon-alpha, GO:0048565|digestive tract development, GO:0071353|cellular response to interleukin-4, GO:0060231|mesenchymal to epithelial transition, GO:0031929|TOR signaling, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0000902|cell morphogenesis, GO:0001701|in utero embryonic development, GO:0001764|neuron migration, GO:0001775|cell activation, GO:0001806|type IV hypersensitivity, GO:0001819|positive regulation of cytokine production, GO:0002088|lens development in camera-type eye, GO:0002572|pro-T cell differentiation, GO:0003180|aortic valve morphogenesis, GO:0003215|cardiac right ventricle morphogenesis, GO:0003281|ventricular septum development, GO:0006338|chromatin remodeling, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006959|humoral immune response, GO:0007399|nervous system development, GO:0007411|axon guidance, GO:0009791|post-embryonic development, GO:0009967|positive regulation of signal transduction, GO:0010332|response to gamma radiation, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0010975|regulation of neuron projection development, GO:0030182|neuron differentiation, GO:0030217|T cell differentiation, GO:0030218|erythrocyte differentiation, GO:0032689|negative regulation of interferon-gamma production, GO:0032703|negative regulation of interleukin-2 production, GO:0032736|positive regulation of interleukin-13 production, GO:0032754|positive regulation of interleukin-5 production, GO:0033077|T cell differentiation in thymus, GO:0033600|negative regulation of mammary gland epithelial cell proliferation, GO:0035162|embryonic hemopoiesis, GO:0035799|ureter maturation, GO:0035898|parathyroid hormone secretion, GO:0042035|regulation of cytokine biosynthetic process, GO:0042472|inner ear morphogenesis, GO:0042493|response to drug, GO:0043370|regulation of CD4-positive, alpha-beta T cell differentiation, GO:0043523|regulation of neuron apoptotic process, GO:0043583|ear development, GO:0045061|thymic T cell selection, GO:0045064|T-helper 2 cell differentiation, GO:0045471|response to ethanol, GO:0045597|positive regulation of cell differentiation, GO:0048469|cell maturation, GO:0048538|thymus development, GO:0048568|embryonic organ development, GO:0048589|developmental growth, GO:0048646|anatomical structure formation involved in morphogenesis, GO:0048872|homeostasis of number of cells, GO:0051569|regulation of histone H3-K4 methylation, GO:0060017|parathyroid gland development, GO:0060065|uterus development, GO:0060374|mast cell differentiation, GO:0060676|ureteric bud formation, GO:0061085|regulation of histone H3-K27 methylation, GO:0061290|canonical Wnt signaling pathway involved in metanephric kidney development, GO:0071345|cellular response to cytokine stimulus, GO:0071442|positive regulation of histone H3-K14 acetylation, GO:0071599|otic vesicle development, GO:0071773|cellular response to BMP stimulus, GO:0072001|renal system development, GO:0072107|positive regulation of ureteric bud formation, GO:0072178|nephric duct morphogenesis, GO:0072179|nephric duct formation, GO:0072182|regulation of nephron tubule epithelial cell differentiation, GO:0072602|interleukin-4 secretion, GO:0072643|interferon-gamma secretion, GO:0072676|lymphocyte migration, GO:0090102|cochlea development, GO:1901536|negative regulation of DNA demethylation, GO:2000114|regulation of establishment of cell polarity, GO:2000553|positive regulation of T-helper 2 cell cytokine production, GO:2000607|negative regulation of cell proliferation involved in mesonephros development, GO:2000617|positive regulation of histone H3-K9 acetylation, GO:2000664|positive regulation of interleukin-5 secretion, GO:2000683|regulation of cellular response to X-ray, GO:2000703|negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation, GO:2000734|negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation","GO:0008270|zinc ion binding, GO:0003700|DNA-binding transcription factor activity, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0070888|E-box binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0071837|HMG box domain binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001158|enhancer sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003712|transcription coregulator activity, GO:0005134|interleukin-2 receptor binding, GO:0046983|protein dimerization activity"
ARNT,Missense,0.117955753844989,57,0.382187420415141,N,"oncogene, TSG, fusion","",0.0691649746930723,0.609191244836375,ENSG00000143437,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016604|nuclear body, GO:0005667|transcription factor complex, GO:0005654|nucleoplasm, GO:0090575|RNA polymerase II transcription factor complex","GO:0030949|positive regulation of vascular endothelial growth factor receptor signaling pathway, GO:0045648|positive regulation of erythrocyte differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0006805|xenobiotic metabolic process, GO:0001938|positive regulation of endothelial cell proliferation, GO:0006351|transcription, DNA-templated, GO:0010575|positive regulation of vascular endothelial growth factor production, GO:0045821|positive regulation of glycolytic process, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0001666|response to hypoxia, GO:0043619|regulation of transcription from RNA polymerase II promoter in response to oxidative stress, GO:0042789|mRNA transcription by RNA polymerase II, GO:0001892|embryonic placenta development, GO:0030154|cell differentiation, GO:0033235|positive regulation of protein sumoylation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046886|positive regulation of hormone biosynthetic process","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0046982|protein heterodimerization activity, GO:0003713|transcription coactivator activity, GO:0017162|aryl hydrocarbon receptor binding, GO:0043565|sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0004874|aryl hydrocarbon receptor activity, GO:0035326|enhancer binding, GO:1990837|sequence-specific double-stranded DNA binding"
ETV6,Missense,0.117737292341477,62,0.362098899405532,N,"TSG, fusion",TSG,0.0341953305049435,0.79189407560852,ENSG00000139083,"GO:0005634|nucleus, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0016020|membrane, GO:0016021|integral component of membrane","GO:0006355|regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0007296|vitellogenesis, GO:0022008|neurogenesis, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0097152|mesenchymal cell apoptotic process, GO:0006357|regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0071425|hematopoietic stem cell proliferation","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0019904|protein domain specific binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding"
ARID1B,Nonsense,0.117710717211838,32,0.521122151477633,N,TSG,TSG,-0.0507260309431191,0.78277032485559,ENSG00000049618,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0016514|SWI/SNF complex, GO:0071565|nBAF complex, GO:0070603|SWI/SNF superfamily-type complex, GO:0005737|cytoplasm","GO:0006325|chromatin organization, GO:0006338|chromatin remodeling, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007399|nervous system development, GO:0048096|chromatin-mediated maintenance of transcription, GO:0060996|dendritic spine development, GO:0002931|response to ischemia, GO:0007270|neuron-neuron synaptic transmission, GO:0097026|dendritic cell dendrite assembly, GO:1904385|cellular response to angiotensin","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
ERBB4,Missense,0.117517270356309,235,0.0721555787388761,N,"oncogene, TSG","",0.211882357657556,0.0010832606150996,ENSG00000178568,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005739|mitochondrion, GO:0005886|plasma membrane, GO:0045211|postsynaptic membrane, GO:0005576|extracellular region, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005759|mitochondrial matrix, GO:0009925|basal plasma membrane, GO:0016323|basolateral plasma membrane","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0007165|signal transduction, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0046854|phosphatidylinositol phosphorylation, GO:0007399|nervous system development, GO:0008284|positive regulation of cell proliferation, GO:0001934|positive regulation of protein phosphorylation, GO:0007507|heart development, GO:0008285|negative regulation of cell proliferation, GO:0016477|cell migration, GO:0030334|regulation of cell migration, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0043653|mitochondrial fragmentation involved in apoptotic process, GO:0000165|MAPK cascade, GO:0008283|cell proliferation, GO:0038128|ERBB2 signaling pathway, GO:2000145|regulation of cell motility, GO:0060644|mammary gland epithelial cell differentiation, GO:0007595|lactation, GO:0001755|neural crest cell migration, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0046427|positive regulation of JAK-STAT cascade, GO:0009880|embryonic pattern specification, GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0060749|mammary gland alveolus development, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0021551|central nervous system morphogenesis, GO:0021889|olfactory bulb interneuron differentiation, GO:0045165|cell fate commitment, GO:0061026|cardiac muscle tissue regeneration, GO:0071364|cellular response to epidermal growth factor stimulus, GO:2000010|positive regulation of protein localization to cell surface, GO:2001223|negative regulation of neuron migration","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0044212|transcription regulatory region DNA binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005154|epidermal growth factor receptor binding"
UBR5,Silent,0.116582882186489,60,0.375035396500114,N,TSG,TSG,0.057692677485443,0.661495111107078,ENSG00000104517,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0048471|perinuclear region of cytoplasm","GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0016567|protein ubiquitination, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0016032|viral process, GO:0000209|protein polyubiquitination, GO:0008283|cell proliferation, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0010628|positive regulation of gene expression, GO:0033160|positive regulation of protein import into nucleus, translocation, GO:0050847|progesterone receptor signaling pathway, GO:0070936|protein K48-linked ubiquitination, GO:1901315|negative regulation of histone H2A K63-linked ubiquitination, GO:2000780|negative regulation of double-strand break repair","GO:0003723|RNA binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0004842|ubiquitin-protein transferase activity, GO:0005515|protein binding, GO:0043130|ubiquitin binding, GO:0034450|ubiquitin-ubiquitin ligase activity, GO:0061630|ubiquitin protein ligase activity"
CDKN2A,Missense,0.115690137580741,63,0.366573295723608,N,TSG,TSG,-0.00857693548723343,0.946808378230025,ENSG00000147889,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0035985|senescence-associated heterochromatin focus, GO:0005730|nucleolus, GO:0005739|mitochondrion, GO:0005654|nucleoplasm","GO:0008285|negative regulation of cell proliferation, GO:0001953|negative regulation of cell-matrix adhesion, GO:0032088|negative regulation of NF-kappaB transcription factor activity, GO:0016310|phosphorylation, GO:0007049|cell cycle, GO:0045892|negative regulation of transcription, DNA-templated, GO:0090399|replicative senescence, GO:0030308|negative regulation of cell growth, GO:0007050|cell cycle arrest, GO:0007265|Ras protein signal transduction, GO:0090398|cellular senescence, GO:0034393|positive regulation of smooth muscle cell apoptotic process, GO:0000082|G1/S transition of mitotic cell cycle, GO:0035986|senescence-associated heterochromatin focus assembly, GO:2000774|positive regulation of cellular senescence, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0042326|negative regulation of phosphorylation, GO:2000111|positive regulation of macrophage apoptotic process, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0006469|negative regulation of protein kinase activity, GO:0006915|apoptotic process, GO:0045893|positive regulation of transcription, DNA-templated, GO:0016925|protein sumoylation, GO:0006364|rRNA processing, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0043065|positive regulation of apoptotic process, GO:0070534|protein K63-linked ubiquitination, GO:0031647|regulation of protein stability, GO:0008637|apoptotic mitochondrial changes, GO:0051444|negative regulation of ubiquitin-protein transferase activity, GO:0000209|protein polyubiquitination, GO:1902510|regulation of apoptotic DNA fragmentation, GO:0010628|positive regulation of gene expression, GO:0050821|protein stabilization, GO:1990000|amyloid fibril formation, GO:0033088|negative regulation of immature T cell proliferation in thymus, GO:1904667|negative regulation of ubiquitin protein ligase activity, GO:2000059|negative regulation of ubiquitin-dependent protein catabolic process, GO:2000435|negative regulation of protein neddylation, GO:0031648|protein destabilization, GO:0030889|negative regulation of B cell proliferation, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0033235|positive regulation of protein sumoylation, GO:0048103|somatic stem cell division","GO:0003723|RNA binding, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0004861|cyclin-dependent protein serine/threonine kinase inhibitor activity, GO:0051059|NF-kappaB binding, GO:0003677|DNA binding, GO:0019789|SUMO transferase activity, GO:0008134|transcription factor binding, GO:0097718|disordered domain specific binding, GO:1990948|ubiquitin ligase inhibitor activity, GO:0055105|ubiquitin-protein transferase inhibitor activity"
SMO,Missense,0.114338825588671,65,0.364448193204379,N,Oncogene,Oncogene,0.0458066945646879,0.717105483014542,ENSG00000128602,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0005929|cilium, GO:0097542|ciliary tip, GO:0070062|extracellular exosome, GO:0030425|dendrite, GO:0030666|endocytic vesicle membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005901|caveola, GO:0005794|Golgi apparatus, GO:0060170|ciliary membrane, GO:0005737|cytoplasm","GO:0071397|cellular response to cholesterol, GO:0010628|positive regulation of gene expression, GO:0030335|positive regulation of cell migration, GO:0007165|signal transduction, GO:0007166|cell surface receptor signaling pathway, GO:0007186|G protein-coupled receptor signaling pathway, GO:0007275|multicellular organism development, GO:0007224|smoothened signaling pathway, GO:0010629|negative regulation of gene expression, GO:0001947|heart looping, GO:0007417|central nervous system development, GO:0072001|renal system development, GO:0090190|positive regulation of branching involved in ureteric bud morphogenesis, GO:0043392|negative regulation of DNA binding, GO:0061053|somite development, GO:0045880|positive regulation of smoothened signaling pathway, GO:0048853|forebrain morphogenesis, GO:0003140|determination of left/right asymmetry in lateral mesoderm, GO:0007228|positive regulation of hh target transcription factor activity, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001503|ossification, GO:0001570|vasculogenesis, GO:0001649|osteoblast differentiation, GO:0001701|in utero embryonic development, GO:0001708|cell fate specification, GO:0001755|neural crest cell migration, GO:0002052|positive regulation of neuroblast proliferation, GO:0002053|positive regulation of mesenchymal cell proliferation, GO:0003007|heart morphogenesis, GO:0003323|type B pancreatic cell development, GO:0007368|determination of left/right symmetry, GO:0007371|ventral midline determination, GO:0007389|pattern specification process, GO:0007494|midgut development, GO:0008284|positive regulation of cell proliferation, GO:0009952|anterior/posterior pattern specification, GO:0009953|dorsal/ventral pattern formation, GO:0010468|regulation of gene expression, GO:0021542|dentate gyrus development, GO:0021696|cerebellar cortex morphogenesis, GO:0021794|thalamus development, GO:0021904|dorsal/ventral neural tube patterning, GO:0021910|smoothened signaling pathway involved in ventral spinal cord patterning, GO:0021938|smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation, GO:0021953|central nervous system neuron differentiation, GO:0021987|cerebral cortex development, GO:0030857|negative regulation of epithelial cell differentiation, GO:0031069|hair follicle morphogenesis, GO:0034504|protein localization to nucleus, GO:0035264|multicellular organism growth, GO:0040018|positive regulation of multicellular organism growth, GO:0042307|positive regulation of protein import into nucleus, GO:0042475|odontogenesis of dentin-containing tooth, GO:0043066|negative regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046622|positive regulation of organ growth, GO:0048143|astrocyte activation, GO:0048468|cell development, GO:0048565|digestive tract development, GO:0048568|embryonic organ development, GO:0048589|developmental growth, GO:0048741|skeletal muscle fiber development, GO:0048873|homeostasis of number of cells within a tissue, GO:0050679|positive regulation of epithelial cell proliferation, GO:0050821|protein stabilization, GO:0051451|myoblast migration, GO:0051799|negative regulation of hair follicle development, GO:0060248|detection of cell density by contact stimulus involved in contact inhibition, GO:0060413|atrial septum morphogenesis, GO:0060644|mammary gland epithelial cell differentiation, GO:0060684|epithelial-mesenchymal cell signaling, GO:0061113|pancreas morphogenesis, GO:0070986|left/right axis specification, GO:0071679|commissural neuron axon guidance, GO:0072285|mesenchymal to epithelial transition involved in metanephric renal vesicle formation, GO:2000036|regulation of stem cell population maintenance, GO:2000826|regulation of heart morphogenesis","GO:0004888|transmembrane signaling receptor activity, GO:0004930|G protein-coupled receptor activity, GO:0005515|protein binding, GO:0008144|drug binding, GO:0005113|patched binding"
STAT5B,Silent,0.113683349937167,15,0.686647702080546,N,"oncogene, TSG, fusion","",0.159061436407612,0.571241940745681,ENSG00000173757,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005829|cytosol","GO:0006355|regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0060397|JAK-STAT cascade involved in growth hormone signaling pathway, GO:0019221|cytokine-mediated signaling pathway, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007259|JAK-STAT cascade, GO:0032355|response to estradiol, GO:0032870|cellular response to hormone stimulus, GO:0038111|interleukin-7-mediated signaling pathway, GO:0071363|cellular response to growth factor stimulus, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0040014|regulation of multicellular organism growth, GO:0038110|interleukin-2-mediated signaling pathway, GO:0045648|positive regulation of erythrocyte differentiation, GO:0019530|taurine metabolic process, GO:0035723|interleukin-15-mediated signaling pathway, GO:0038113|interleukin-9-mediated signaling pathway, GO:0001553|luteinization, GO:0001779|natural killer cell differentiation, GO:0007548|sex differentiation, GO:0007565|female pregnancy, GO:0007595|lactation, GO:0008284|positive regulation of cell proliferation, GO:0019218|regulation of steroid metabolic process, GO:0019915|lipid storage, GO:0030155|regulation of cell adhesion, GO:0030856|regulation of epithelial cell differentiation, GO:0032819|positive regulation of natural killer cell proliferation, GO:0032825|positive regulation of natural killer cell differentiation, GO:0033077|T cell differentiation in thymus, GO:0040018|positive regulation of multicellular organism growth, GO:0042104|positive regulation of activated T cell proliferation, GO:0042448|progesterone metabolic process, GO:0043029|T cell homeostasis, GO:0043066|negative regulation of apoptotic process, GO:0045086|positive regulation of interleukin-2 biosynthetic process, GO:0045579|positive regulation of B cell differentiation, GO:0045588|positive regulation of gamma-delta T cell differentiation, GO:0045621|positive regulation of lymphocyte differentiation, GO:0045647|negative regulation of erythrocyte differentiation, GO:0045931|positive regulation of mitotic cell cycle, GO:0045954|positive regulation of natural killer cell mediated cytotoxicity, GO:0046543|development of secondary female sexual characteristics, GO:0046544|development of secondary male sexual characteristics, GO:0048541|Peyer's patch development, GO:0050729|positive regulation of inflammatory response, GO:0070669|response to interleukin-2, GO:0070670|response to interleukin-4, GO:0070672|response to interleukin-15, GO:0097531|mast cell migration","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0004713|protein tyrosine kinase activity, GO:0046983|protein dimerization activity, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0035259|glucocorticoid receptor binding"
MAP3K13,Silent,0.113446079130188,25,0.589239357336814,N,"oncogene, TSG","",0.041513030570923,0.843809447886059,ENSG00000073803,"GO:0005737|cytoplasm, GO:0016020|membrane","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0000186|activation of MAPKK activity, GO:0007254|JNK cascade, GO:0046777|protein autophosphorylation, GO:0150012|positive regulation of neuron projection arborization, GO:0007257|activation of JUN kinase activity, GO:0000165|MAPK cascade, GO:0007256|activation of JNKK activity, GO:0014042|positive regulation of neuron maturation, GO:0018105|peptidyl-serine phosphorylation, GO:0045773|positive regulation of axon extension, GO:1905492|positive regulation of branching morphogenesis of a nerve","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0042803|protein homodimerization activity, GO:0004709|MAP kinase kinase kinase activity, GO:0042802|identical protein binding, GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0004706|JUN kinase kinase kinase activity, GO:0106137|IkappaB kinase complex binding"
STAT3,Silent,0.113419384520111,37,0.503887321366351,N,Oncogene,Oncogene,0.212980388433718,0.205647635875496,ENSG00000168610,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0000790|nuclear chromatin, GO:0090575|RNA polymerase II transcription factor complex, GO:0005739|mitochondrion, GO:0005743|mitochondrial inner membrane","GO:0035278|miRNA mediated inhibition of translation, GO:0010628|positive regulation of gene expression, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1904685|positive regulation of metalloendopeptidase activity, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030335|positive regulation of cell migration, GO:0016310|phosphorylation, GO:0006355|regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0006954|inflammatory response, GO:0006357|regulation of transcription by RNA polymerase II, GO:0016032|viral process, GO:0006606|protein import into nucleus, GO:0007399|nervous system development, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0060259|regulation of feeding behavior, GO:0051726|regulation of cell cycle, GO:0019221|cytokine-mediated signaling pathway, GO:0045747|positive regulation of Notch signaling pathway, GO:0097009|energy homeostasis, GO:0007259|JAK-STAT cascade, GO:0032355|response to estradiol, GO:0032870|cellular response to hormone stimulus, GO:0038111|interleukin-7-mediated signaling pathway, GO:0060396|growth hormone receptor signaling pathway, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0070102|interleukin-6-mediated signaling pathway, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0060019|radial glial cell differentiation, GO:0042593|glucose homeostasis, GO:0035019|somatic stem cell population maintenance, GO:0038155|interleukin-23-mediated signaling pathway, GO:0060397|JAK-STAT cascade involved in growth hormone signaling pathway, GO:0070106|interleukin-27-mediated signaling pathway, GO:0070757|interleukin-35-mediated signaling pathway, GO:0001659|temperature homeostasis, GO:0043066|negative regulation of apoptotic process, GO:0071345|cellular response to cytokine stimulus, GO:0045410|positive regulation of interleukin-6 biosynthetic process, GO:0072540|T-helper 17 cell lineage commitment, GO:0042755|eating behavior, GO:0019953|sexual reproduction, GO:0045648|positive regulation of erythrocyte differentiation, GO:0030522|intracellular receptor signaling pathway, GO:0010507|negative regulation of autophagy, GO:0035723|interleukin-15-mediated signaling pathway, GO:0038113|interleukin-9-mediated signaling pathway, GO:0044321|response to leptin, GO:0038114|interleukin-21-mediated signaling pathway, GO:0033210|leptin-mediated signaling pathway, GO:0001754|eye photoreceptor cell differentiation, GO:0006366|transcription by RNA polymerase II, GO:0006953|acute-phase response, GO:0007568|aging, GO:0008283|cell proliferation, GO:0008284|positive regulation of cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0010033|response to organic substance, GO:0010730|negative regulation of hydrogen peroxide biosynthetic process, GO:0014070|response to organic cyclic compound, GO:0019827|stem cell population maintenance, GO:0034097|response to cytokine, GO:0040014|regulation of multicellular organism growth, GO:0042493|response to drug, GO:0042789|mRNA transcription by RNA polymerase II, GO:0043434|response to peptide hormone, GO:0044320|cellular response to leptin stimulus, GO:0045471|response to ethanol, GO:0045766|positive regulation of angiogenesis, GO:0045820|negative regulation of glycolytic process, GO:0046902|regulation of mitochondrial membrane permeability, GO:0048708|astrocyte differentiation, GO:0060548|negative regulation of cell death, GO:0071407|cellular response to organic cyclic compound, GO:1901215|negative regulation of neuron death, GO:1902728|positive regulation of growth factor dependent skeletal muscle satellite cell proliferation, GO:1905564|positive regulation of vascular endothelial cell proliferation, GO:2000637|positive regulation of gene silencing by miRNA, GO:2000737|negative regulation of stem cell differentiation, GO:2001171|positive regulation of ATP biosynthetic process, GO:2001223|negative regulation of neuron migration","GO:0044212|transcription regulatory region DNA binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0031490|chromatin DNA binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019901|protein kinase binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019903|protein phosphatase binding, GO:0008134|transcription factor binding, GO:0001103|RNA polymerase II repressing transcription factor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0046983|protein dimerization activity, GO:0004879|nuclear receptor activity, GO:0031730|CCR5 chemokine receptor binding, GO:0035259|glucocorticoid receptor binding, GO:0043565|sequence-specific DNA binding"
COL1A1,Missense,0.112992097776106,150,0.168604608051717,N,fusion,"",0.0883681462393606,0.282224420214795,ENSG00000108821,"GO:0005615|extracellular space, GO:0005576|extracellular region, GO:0005581|collagen trimer, GO:0005737|cytoplasm, GO:0062023|collagen-containing extracellular matrix, GO:0031012|extracellular matrix, GO:0005788|endoplasmic reticulum lumen, GO:0005584|collagen type I trimer, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0030141|secretory granule","GO:0048706|embryonic skeletal system development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0050776|regulation of immune response, GO:0050900|leukocyte migration, GO:0001501|skeletal system development, GO:0001568|blood vessel development, GO:0030335|positive regulation of cell migration, GO:0007601|visual perception, GO:0030198|extracellular matrix organization, GO:0007605|sensory perception of sound, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0030168|platelet activation, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0007596|blood coagulation, GO:0034504|protein localization to nucleus, GO:0030199|collagen fibril organization, GO:0001503|ossification, GO:0001649|osteoblast differentiation, GO:0001957|intramembranous ossification, GO:0001958|endochondral ossification, GO:0007584|response to nutrient, GO:0009612|response to mechanical stimulus, GO:0010812|negative regulation of cell-substrate adhesion, GO:0015031|protein transport, GO:0031667|response to nutrient levels, GO:0031960|response to corticosteroid, GO:0032355|response to estradiol, GO:0032964|collagen biosynthetic process, GO:0034505|tooth mineralization, GO:0038063|collagen-activated tyrosine kinase receptor signaling pathway, GO:0042060|wound healing, GO:0042493|response to drug, GO:0042542|response to hydrogen peroxide, GO:0043434|response to peptide hormone, GO:0043588|skin development, GO:0043589|skin morphogenesis, GO:0044344|cellular response to fibroblast growth factor stimulus, GO:0044691|tooth eruption, GO:0048545|response to steroid hormone, GO:0048705|skeletal system morphogenesis, GO:0051591|response to cAMP, GO:0055093|response to hyperoxia, GO:0060325|face morphogenesis, GO:0060346|bone trabecula formation, GO:0060351|cartilage development involved in endochondral bone morphogenesis, GO:0070208|protein heterotrimerization, GO:0071230|cellular response to amino acid stimulus, GO:0071260|cellular response to mechanical stimulus, GO:0071300|cellular response to retinoic acid, GO:0071306|cellular response to vitamin E, GO:0071356|cellular response to tumor necrosis factor, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0071560|cellular response to transforming growth factor beta stimulus, GO:1902617|response to fluoride, GO:1902618|cellular response to fluoride","GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0005201|extracellular matrix structural constituent, GO:0042802|identical protein binding, GO:0030020|extracellular matrix structural constituent conferring tensile strength, GO:0002020|protease binding, GO:0048407|platelet-derived growth factor binding"
LIFR,Nonsense,0.112573580647983,11,0.741743519558837,N,fusion,"",0.109908285560533,0.747684244637975,ENSG00000113594,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0009897|external side of plasma membrane, GO:0043235|receptor complex, GO:0070062|extracellular exosome, GO:0005887|integral component of plasma membrane","GO:0008284|positive regulation of cell proliferation, GO:0007166|cell surface receptor signaling pathway, GO:0019221|cytokine-mediated signaling pathway, GO:0001959|regulation of cytokine-mediated signaling pathway, GO:0034097|response to cytokine, GO:0070120|ciliary neurotrophic factor-mediated signaling pathway, GO:0038165|oncostatin-M-mediated signaling pathway, GO:0048861|leukemia inhibitory factor signaling pathway","GO:0005515|protein binding, GO:0004896|cytokine receptor activity, GO:0019838|growth factor binding, GO:0005127|ciliary neurotrophic factor receptor binding, GO:0019955|cytokine binding, GO:0004897|ciliary neurotrophic factor receptor activity, GO:0004923|leukemia inhibitory factor receptor activity, GO:0004924|oncostatin-M receptor activity"
NCOA2,Missense,0.112392033928341,122,0.217747332088873,N,"oncogene, fusion",Oncogene,0.126199303351362,0.166018328245287,ENSG00000140396,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016604|nuclear body, GO:0032991|protein-containing complex, GO:0005737|cytoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0048511|rhythmic process, GO:0032922|circadian regulation of gene expression, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0019216|regulation of lipid metabolic process, GO:0015721|bile acid and bile salt transport, GO:0032870|cellular response to hormone stimulus, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007623|circadian rhythm, GO:0010468|regulation of gene expression, GO:0010906|regulation of glucose metabolic process, GO:0032570|response to progesterone, GO:0045475|locomotor rhythm, GO:0045892|negative regulation of transcription, DNA-templated, GO:1904017|cellular response to Thyroglobulin triiodothyronine, GO:1903508|positive regulation of nucleic acid-templated transcription","GO:0003713|transcription coactivator activity, GO:0046983|protein dimerization activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0030374|nuclear receptor transcription coactivator activity, GO:0035257|nuclear hormone receptor binding, GO:0017162|aryl hydrocarbon receptor binding, GO:0019904|protein domain specific binding, GO:0016922|nuclear receptor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001162|RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0005102|signaling receptor binding, GO:0008134|transcription factor binding, GO:0030375|thyroid hormone receptor coactivator activity"
BCL11A,Silent,0.112264488466767,46,0.457594758843488,N,"oncogene, fusion",Oncogene,0.0691170710299613,0.648087734827639,ENSG00000119866,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0014069|postsynaptic density","GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0016925|protein sumoylation, GO:0010628|positive regulation of gene expression, GO:1903860|negative regulation of dendrite extension, GO:1904800|negative regulation of neuron remodeling, GO:1905232|cellular response to L-glutamate, GO:2000171|negative regulation of dendrite development, GO:2000173|negative regulation of branching morphogenesis of a nerve","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0019901|protein kinase binding"
ARHGEF12,Silent,0.111983188929583,43,0.474647326093766,N,"TSG, fusion",TSG,0.0424155311946114,0.787111902635524,ENSG00000196914,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0070062|extracellular exosome","GO:0007186|G protein-coupled receptor signaling pathway, GO:0035556|intracellular signal transduction, GO:0035023|regulation of Rho protein signal transduction, GO:0043547|positive regulation of GTPase activity, GO:0007266|Rho protein signal transduction, GO:0051056|regulation of small GTPase mediated signal transduction, GO:0043065|positive regulation of apoptotic process","GO:0001664|G protein-coupled receptor binding, GO:0005085|guanyl-nucleotide exchange factor activity, GO:0005089|Rho guanyl-nucleotide exchange factor activity, GO:0005096|GTPase activator activity, GO:0005515|protein binding"
ERBB4,Nonsense,0.111346418457856,21,0.63086633092335,N,"oncogene, TSG","",0.0727539853401511,0.753976025824986,ENSG00000178568,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005739|mitochondrion, GO:0005886|plasma membrane, GO:0045211|postsynaptic membrane, GO:0005576|extracellular region, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005759|mitochondrial matrix, GO:0009925|basal plasma membrane, GO:0016323|basolateral plasma membrane","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0007165|signal transduction, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0046854|phosphatidylinositol phosphorylation, GO:0007399|nervous system development, GO:0008284|positive regulation of cell proliferation, GO:0001934|positive regulation of protein phosphorylation, GO:0007507|heart development, GO:0008285|negative regulation of cell proliferation, GO:0016477|cell migration, GO:0030334|regulation of cell migration, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0043653|mitochondrial fragmentation involved in apoptotic process, GO:0000165|MAPK cascade, GO:0008283|cell proliferation, GO:0038128|ERBB2 signaling pathway, GO:2000145|regulation of cell motility, GO:0060644|mammary gland epithelial cell differentiation, GO:0007595|lactation, GO:0001755|neural crest cell migration, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0046427|positive regulation of JAK-STAT cascade, GO:0009880|embryonic pattern specification, GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0060749|mammary gland alveolus development, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0021551|central nervous system morphogenesis, GO:0021889|olfactory bulb interneuron differentiation, GO:0045165|cell fate commitment, GO:0061026|cardiac muscle tissue regeneration, GO:0071364|cellular response to epidermal growth factor stimulus, GO:2000010|positive regulation of protein localization to cell surface, GO:2001223|negative regulation of neuron migration","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0044212|transcription regulatory region DNA binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005154|epidermal growth factor receptor binding"
AR,Missense,0.11042040362181,97,0.281608427049095,N,Oncogene,Oncogene,0.19827328679299,0.0515557383600672,ENSG00000169083,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0032991|protein-containing complex, GO:0000790|nuclear chromatin, GO:0005886|plasma membrane, GO:0016607|nuclear speck","GO:0008284|positive regulation of cell proliferation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0006351|transcription, DNA-templated, GO:0030521|androgen receptor signaling pathway, GO:0010628|positive regulation of gene expression, GO:0008285|negative regulation of cell proliferation, GO:0016579|protein deubiquitination, GO:0008283|cell proliferation, GO:0007548|sex differentiation, GO:0007165|signal transduction, GO:0007267|cell-cell signaling, GO:0045597|positive regulation of cell differentiation, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0042327|positive regulation of phosphorylation, GO:0030850|prostate gland development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:2001237|negative regulation of extrinsic apoptotic signaling pathway, GO:0051259|protein complex oligomerization, GO:0001701|in utero embryonic development, GO:0003073|regulation of systemic arterial blood pressure, GO:0003382|epithelial cell morphogenesis, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007283|spermatogenesis, GO:0007338|single fertilization, GO:0008584|male gonad development, GO:0009566|fertilization, GO:0009987|cellular process, GO:0010468|regulation of gene expression, GO:0019102|male somatic sex determination, GO:0030522|intracellular receptor signaling pathway, GO:0033148|positive regulation of intracellular estrogen receptor signaling pathway, GO:0033327|Leydig cell differentiation, GO:0035264|multicellular organism growth, GO:0043410|positive regulation of MAPK cascade, GO:0043568|positive regulation of insulin-like growth factor receptor signaling pathway, GO:0045720|negative regulation of integrin biosynthetic process, GO:0045726|positive regulation of integrin biosynthetic process, GO:0045945|positive regulation of transcription by RNA polymerase III, GO:0048608|reproductive structure development, GO:0048638|regulation of developmental growth, GO:0048645|animal organ formation, GO:0048808|male genitalia morphogenesis, GO:0050680|negative regulation of epithelial cell proliferation, GO:0050790|regulation of catalytic activity, GO:0060520|activation of prostate induction by androgen receptor signaling pathway, GO:0060571|morphogenesis of an epithelial fold, GO:0060599|lateral sprouting involved in mammary gland duct morphogenesis, GO:0060685|regulation of prostatic bud formation, GO:0060736|prostate gland growth, GO:0060740|prostate gland epithelium morphogenesis, GO:0060742|epithelial cell differentiation involved in prostate gland development, GO:0060748|tertiary branching involved in mammary gland duct morphogenesis, GO:0060749|mammary gland alveolus development, GO:0060769|positive regulation of epithelial cell proliferation involved in prostate gland development, GO:0061458|reproductive system development, GO:0071383|cellular response to steroid hormone stimulus, GO:0071394|cellular response to testosterone stimulus, GO:0072520|seminiferous tubule development, GO:1903076|regulation of protein localization to plasma membrane, GO:0043401|steroid hormone mediated signaling pathway","GO:0044212|transcription regulatory region DNA binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0008289|lipid binding, GO:0005496|steroid binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0005102|signaling receptor binding, GO:0019899|enzyme binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0004879|nuclear receptor activity, GO:0008013|beta-catenin binding, GO:0046983|protein dimerization activity, GO:0008134|transcription factor binding, GO:0051117|ATPase binding, GO:0001091|RNA polymerase II basal transcription factor binding, GO:0003707|steroid hormone receptor activity, GO:0005497|androgen binding, GO:0070974|POU domain binding"
PDE4DIP,Silent,0.110399552446799,87,0.308696809794266,N,fusion,"",0.242004419086475,0.0239270039866,ENSG00000178104,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005794|Golgi apparatus, GO:0005856|cytoskeleton, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0030016|myofibril","GO:0034622|cellular protein-containing complex assembly, GO:1903358|regulation of Golgi organization","GO:0005515|protein binding, GO:0019899|enzyme binding, GO:0032947|protein-containing complex scaffold activity"
TRIM33,Missense,0.10766145323783,71,0.371498190318834,N,"TSG, fusion",TSG,0.0908724911338665,0.451044220379422,ENSG00000197323,"GO:0005634|nucleus, GO:0005654|nucleoplasm","GO:0016567|protein ubiquitination, GO:0045892|negative regulation of transcription, DNA-templated, GO:0030514|negative regulation of BMP signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0017015|regulation of transforming growth factor beta receptor signaling pathway","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0070412|R-SMAD binding, GO:0070410|co-SMAD binding, GO:0004842|ubiquitin-protein transferase activity"
SF3B1,Silent,0.106739676029538,26,0.603770002335959,N,Oncogene,Oncogene,-0.0160449914136096,0.937991282899669,ENSG00000115524,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005681|spliceosomal complex, GO:0071013|catalytic step 2 spliceosome, GO:0005654|nucleoplasm, GO:0005686|U2 snRNP, GO:0071005|U2-type precatalytic spliceosome, GO:0071004|U2-type prespliceosome, GO:0005689|U12-type spliceosomal complex, GO:0034693|U11/U12 snRNP","GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0000398|mRNA splicing, via spliceosome, GO:0000245|spliceosomal complex assembly, GO:0045815|positive regulation of gene expression, epigenetic, GO:0000375|RNA splicing, via transesterification reactions","GO:0003723|RNA binding, GO:0003729|mRNA binding, GO:0005515|protein binding"
BCL9L,Missense,0.105777068014889,119,0.252239318614185,N,"oncogene, TSG","",0.0965188482085475,0.296382257892322,ENSG00000186174,"GO:0005634|nucleus, GO:0005730|nucleolus, GO:0005654|nucleoplasm, GO:1990907|beta-catenin-TCF complex","GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0060070|canonical Wnt signaling pathway, GO:1904837|beta-catenin-TCF complex assembly, GO:0022604|regulation of cell morphogenesis, GO:0035019|somatic stem cell population maintenance, GO:0035914|skeletal muscle cell differentiation, GO:1903508|positive regulation of nucleic acid-templated transcription","GO:0003713|transcription coactivator activity, GO:0008013|beta-catenin binding"
CD79B,Missense,0.105566965552264,24,0.623470608733356,N,Oncogene,Oncogene,-0.0438456899301405,0.838799142587257,ENSG00000007312,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0009897|external side of plasma membrane, GO:0070062|extracellular exosome, GO:0019815|B cell receptor complex, GO:0005887|integral component of plasma membrane","GO:0007166|cell surface receptor signaling pathway, GO:0002376|immune system process, GO:0002250|adaptive immune response, GO:0050853|B cell receptor signaling pathway, GO:0006955|immune response, GO:0007165|signal transduction, GO:0051260|protein homooligomerization, GO:0030183|B cell differentiation, GO:0009617|response to bacterium","GO:0005515|protein binding, GO:0004888|transmembrane signaling receptor activity, GO:0042803|protein homodimerization activity, GO:0042802|identical protein binding"
CACNA1D,Silent,0.104948919220624,84,0.342067937937425,N,Oncogene,Oncogene,0.124054617181475,0.260889019790885,ENSG00000157388,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005891|voltage-gated calcium channel complex, GO:0005886|plasma membrane, GO:0030018|Z disc, GO:1990454|L-type voltage-gated calcium channel complex","GO:0055085|transmembrane transport, GO:0006811|ion transport, GO:0034765|regulation of ion transmembrane transport, GO:0006816|calcium ion transport, GO:0070588|calcium ion transmembrane transport, GO:0099533|positive regulation of presynaptic cytosolic calcium concentration, GO:0099703|induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration, GO:1901016|regulation of potassium ion transmembrane transporter activity, GO:0050796|regulation of insulin secretion, GO:0070509|calcium ion import, GO:0086002|cardiac muscle cell action potential involved in contraction, GO:0086046|membrane depolarization during SA node cell action potential, GO:0086091|regulation of heart rate by cardiac conduction, GO:0007605|sensory perception of sound, GO:0086012|membrane depolarization during cardiac muscle cell action potential, GO:0051928|positive regulation of calcium ion transport, GO:0060372|regulation of atrial cardiac muscle cell membrane repolarization, GO:1901379|regulation of potassium ion transmembrane transport, GO:0045762|positive regulation of adenylate cyclase activity, GO:0007188|adenylate cyclase-modulating G protein-coupled receptor signaling pathway","GO:0005216|ion channel activity, GO:0005244|voltage-gated ion channel activity, GO:0005245|voltage-gated calcium channel activity, GO:0005262|calcium channel activity, GO:0046872|metal ion binding, GO:0008331|high voltage-gated calcium channel activity, GO:0086059|voltage-gated calcium channel activity involved SA node cell action potential, GO:0030506|ankyrin binding, GO:0051393|alpha-actinin binding, GO:0086007|voltage-gated calcium channel activity involved in cardiac muscle cell action potential"
RNF213,Missense,0.104098194362365,209,0.133618896183241,N,fusion,"",0.102294765339075,0.140519813597428,ENSG00000173821,"GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005737|cytoplasm, GO:0016020|membrane","GO:0016567|protein ubiquitination, GO:0001525|angiogenesis, GO:0051865|protein autoubiquitination, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0002040|sprouting angiogenesis, GO:0051260|protein homooligomerization, GO:0000209|protein polyubiquitination, GO:2000051|negative regulation of non-canonical Wnt signaling pathway","GO:0046872|metal ion binding, GO:0004842|ubiquitin-protein transferase activity, GO:0016887|ATPase activity, GO:0016740|transferase activity, GO:0016787|hydrolase activity"
NTRK3,Silent,0.103684218300601,60,0.430481509556553,N,"oncogene, fusion",Oncogene,0.108789738517121,0.40800196783925,ENSG00000140538,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005887|integral component of plasma membrane, GO:0005886|plasma membrane, GO:0043235|receptor complex, GO:0030424|axon, GO:0005737|cytoplasm","GO:0010628|positive regulation of gene expression, GO:0008284|positive regulation of cell proliferation, GO:0030335|positive regulation of cell migration, GO:0001934|positive regulation of protein phosphorylation, GO:0032148|activation of protein kinase B activity, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0038179|neurotrophin signaling pathway, GO:0007275|multicellular organism development, GO:0048013|ephrin receptor signaling pathway, GO:0030154|cell differentiation, GO:0007399|nervous system development, GO:0043410|positive regulation of MAPK cascade, GO:0007507|heart development, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:2000251|positive regulation of actin cytoskeleton reorganization, GO:0000187|activation of MAPK activity, GO:0043408|regulation of MAPK cascade, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0090630|activation of GTPase activity, GO:0001933|negative regulation of protein phosphorylation, GO:0010976|positive regulation of neuron projection development, GO:1990090|cellular response to nerve growth factor stimulus, GO:0050927|positive regulation of positive chemotaxis, GO:0010863|positive regulation of phospholipase C activity, GO:0001764|neuron migration, GO:0007623|circadian rhythm, GO:0019056|modulation by virus of host transcription, GO:0019227|neuronal action potential propagation, GO:0022011|myelination in peripheral nervous system, GO:0042490|mechanoreceptor differentiation, GO:0043065|positive regulation of apoptotic process, GO:0045471|response to ethanol, GO:0048665|neuron fate specification, GO:0048678|response to axon injury, GO:0048691|positive regulation of axon extension involved in regeneration, GO:0048712|negative regulation of astrocyte differentiation, GO:0051412|response to corticosterone, GO:0051965|positive regulation of synapse assembly, GO:0060548|negative regulation of cell death, GO:0070306|lens fiber cell differentiation, GO:0071300|cellular response to retinoic acid, GO:0090102|cochlea development","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005030|neurotrophin receptor activity, GO:0002039|p53 binding, GO:0043121|neurotrophin binding, GO:0005004|GPI-linked ephrin receptor activity"
SF3B1,Missense,0.103007785536262,120,0.262899599498992,N,Oncogene,Oncogene,-0.043179607918022,0.63958689896921,ENSG00000115524,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005681|spliceosomal complex, GO:0071013|catalytic step 2 spliceosome, GO:0005654|nucleoplasm, GO:0005686|U2 snRNP, GO:0071005|U2-type precatalytic spliceosome, GO:0071004|U2-type prespliceosome, GO:0005689|U12-type spliceosomal complex, GO:0034693|U11/U12 snRNP","GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0000398|mRNA splicing, via spliceosome, GO:0000245|spliceosomal complex assembly, GO:0045815|positive regulation of gene expression, epigenetic, GO:0000375|RNA splicing, via transesterification reactions","GO:0003723|RNA binding, GO:0003729|mRNA binding, GO:0005515|protein binding"
STAT6,Missense,0.101758285935871,67,0.412568137831918,N,"oncogene, fusion",Oncogene,0.00616445512694525,0.960513569352611,ENSG00000166888,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0031965|nuclear membrane, GO:0000790|nuclear chromatin, GO:0045121|membrane raft","GO:0006355|regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0019221|cytokine-mediated signaling pathway, GO:0006357|regulation of transcription by RNA polymerase II, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0032481|positive regulation of type I interferon production, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0002296|T-helper 1 cell lineage commitment, GO:0002829|negative regulation of type 2 immune response, GO:0033598|mammary gland epithelial cell proliferation, GO:0034097|response to cytokine, GO:0035771|interleukin-4-mediated signaling pathway, GO:0042127|regulation of cell proliferation, GO:0048295|positive regulation of isotype switching to IgE isotypes, GO:0060443|mammary gland morphogenesis, GO:0070301|cellular response to hydrogen peroxide, GO:1902170|cellular response to reactive nitrogen species","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019903|protein phosphatase binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0043565|sequence-specific DNA binding"
MAP3K13,Nonsense,0.101156107771775,11,0.767277441271752,N,"oncogene, TSG","",0.115005586224372,0.736333785527573,ENSG00000073803,"GO:0005737|cytoplasm, GO:0016020|membrane","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0000186|activation of MAPKK activity, GO:0007254|JNK cascade, GO:0046777|protein autophosphorylation, GO:0150012|positive regulation of neuron projection arborization, GO:0007257|activation of JUN kinase activity, GO:0000165|MAPK cascade, GO:0007256|activation of JNKK activity, GO:0014042|positive regulation of neuron maturation, GO:0018105|peptidyl-serine phosphorylation, GO:0045773|positive regulation of axon extension, GO:1905492|positive regulation of branching morphogenesis of a nerve","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0042803|protein homodimerization activity, GO:0004709|MAP kinase kinase kinase activity, GO:0042802|identical protein binding, GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0004706|JUN kinase kinase kinase activity, GO:0106137|IkappaB kinase complex binding"
WT1,Silent,0.100908526211107,25,0.631269970803305,N,"oncogene, TSG, fusion","",-0.0134398597442005,0.949160051797086,ENSG00000184937,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005730|nucleolus","GO:0010628|positive regulation of gene expression, GO:0008380|RNA splicing, GO:0006355|regulation of transcription, DNA-templated, GO:0001822|kidney development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043066|negative regulation of apoptotic process, GO:0007507|heart development, GO:0008285|negative regulation of cell proliferation, GO:0008584|male gonad development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030308|negative regulation of cell growth, GO:0045892|negative regulation of transcription, DNA-templated, GO:0030855|epithelial cell differentiation, GO:0071320|cellular response to cAMP, GO:0030539|male genitalia development, GO:0072112|glomerular visceral epithelial cell differentiation, GO:0007530|sex determination, GO:0032835|glomerulus development, GO:0060539|diaphragm development, GO:0032836|glomerular basement membrane development, GO:0001570|vasculogenesis, GO:0001657|ureteric bud development, GO:0030325|adrenal gland development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0043010|camera-type eye development, GO:1905643|positive regulation of DNA methylation, GO:0003156|regulation of animal organ formation, GO:0007281|germ cell development, GO:0007356|thorax and anterior abdomen determination, GO:0008406|gonad development, GO:0009888|tissue development, GO:0035802|adrenal cortex formation, GO:0060231|mesenchymal to epithelial transition, GO:0060421|positive regulation of heart growth, GO:0060923|cardiac muscle cell fate commitment, GO:0061032|visceral serous pericardium development, GO:0071371|cellular response to gonadotropin stimulus, GO:0072075|metanephric mesenchyme development, GO:0072166|posterior mesonephric tubule development, GO:0072207|metanephric epithelium development, GO:0072284|metanephric S-shaped body morphogenesis, GO:0072302|negative regulation of metanephric glomerular mesangial cell proliferation, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:2000020|positive regulation of male gonad development, GO:2000195|negative regulation of female gonad development, GO:2001076|positive regulation of metanephric ureteric bud development","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0010385|double-stranded methylated DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0044729|hemi-methylated DNA-binding, GO:0070742|C2H2 zinc finger domain binding"
BTG1,Silent,0.100457668294989,11,0.768846449249451,N,"TSG, fusion",TSG,0.156105275456767,0.646699895804702,ENSG00000133639,"GO:0005634|nucleus, GO:0005737|cytoplasm","GO:0008285|negative regulation of cell proliferation, GO:0016477|cell migration, GO:0006355|regulation of transcription, DNA-templated, GO:0030308|negative regulation of cell growth, GO:0045766|positive regulation of angiogenesis, GO:2000271|positive regulation of fibroblast apoptotic process, GO:0045930|negative regulation of mitotic cell cycle, GO:0045663|positive regulation of myoblast differentiation, GO:0006479|protein methylation, GO:0045603|positive regulation of endothelial cell differentiation","GO:0005515|protein binding, GO:0019899|enzyme binding, GO:0003712|transcription coregulator activity, GO:0019900|kinase binding"
HIST1H3B,Missense,0.100438534628631,42,0.526814705277058,N,Oncogene,Oncogene,-0.00187592940111988,0.990592747308982,ENSG00000274267,"GO:0005634|nucleus, GO:0016020|membrane, GO:0000786|nucleosome, GO:0005694|chromosome, GO:0005576|extracellular region, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0032991|protein-containing complex, GO:0000228|nuclear chromosome, GO:0000788|nuclear nucleosome","GO:0006334|nucleosome assembly, GO:0044267|cellular protein metabolic process, GO:0007596|blood coagulation, GO:0038111|interleukin-7-mediated signaling pathway, GO:0045652|regulation of megakaryocyte differentiation, GO:0006335|DNA replication-dependent nucleosome assembly, GO:0060964|regulation of gene silencing by miRNA, GO:0000183|chromatin silencing at rDNA, GO:0045814|negative regulation of gene expression, epigenetic, GO:0051290|protein heterotetramerization, GO:0006325|chromatin organization, GO:0032200|telomere organization, GO:0060968|regulation of gene silencing","GO:0003677|DNA binding, GO:0046982|protein heterodimerization activity, GO:0005515|protein binding, GO:0045296|cadherin binding, GO:0031492|nucleosomal DNA binding"
PPFIBP1,Silent,0.100030623182466,27,0.619592805371707,N,fusion,"",0.105892246930922,0.599112020439962,ENSG00000110841,"GO:0005925|focal adhesion, GO:0005829|cytosol, GO:0005886|plasma membrane",GO:0007155|cell adhesion,GO:0045296|cadherin binding
ASXL1,Missense,0.0977655972128305,103,0.325873638016086,N,TSG,TSG,0.138123846290822,0.164111774726102,ENSG00000171456,"GO:0005634|nucleus, GO:0000790|nuclear chromatin, GO:0005654|nucleoplasm, GO:0035517|PR-DUB complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0006351|transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016579|protein deubiquitination, GO:0045599|negative regulation of fat cell differentiation, GO:0032526|response to retinoic acid, GO:0048386|positive regulation of retinoic acid receptor signaling pathway, GO:0009887|animal organ morphogenesis, GO:0035359|negative regulation of peroxisome proliferator activated receptor signaling pathway, GO:0035522|monoubiquitinated histone H2A deubiquitination, GO:0000902|cell morphogenesis, GO:0003007|heart morphogenesis, GO:0030097|hemopoiesis, GO:0048534|hematopoietic or lymphoid organ development, GO:0048538|thymus development, GO:0048539|bone marrow development, GO:0048872|homeostasis of number of cells, GO:0060348|bone development, GO:0060430|lung saccule development","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0042974|retinoic acid receptor binding, GO:0003682|chromatin binding, GO:0042975|peroxisome proliferator activated receptor binding"
DICER1,Missense,0.0962088339220162,120,0.295879349002092,N,TSG,TSG,0.0429860087168594,0.641090272324914,ENSG00000100697,"GO:0070062|extracellular exosome, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0070578|RISC-loading complex, GO:0035068|micro-ribonucleoprotein complex, GO:0016442|RISC complex, GO:0033167|ARC complex, GO:0005793|endoplasmic reticulum-Golgi intermediate compartment, GO:0030424|axon, GO:0030425|dendrite, GO:0030426|growth cone","GO:0032720|negative regulation of tumor necrosis factor production, GO:0038061|NIK/NF-kappaB signaling, GO:0006396|RNA processing, GO:0031047|gene silencing by RNA, GO:0006309|apoptotic DNA fragmentation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030422|production of siRNA involved in RNA interference, GO:0021675|nerve development, GO:0010586|miRNA metabolic process, GO:0031054|pre-miRNA processing, GO:0035196|production of miRNAs involved in gene silencing by miRNA, GO:0048812|neuron projection morphogenesis, GO:0030423|targeting of mRNA for destruction involved in RNA interference, GO:0035280|miRNA loading onto RISC involved in gene silencing by miRNA, GO:0035087|siRNA loading onto RISC involved in RNA interference, GO:0010626|negative regulation of Schwann cell proliferation, GO:0014040|positive regulation of Schwann cell differentiation, GO:0031643|positive regulation of myelination, GO:0032290|peripheral nervous system myelin formation, GO:0033168|conversion of ds siRNA to ss siRNA involved in RNA interference, GO:0036404|conversion of ds siRNA to ss siRNA, GO:0090502|RNA phosphodiester bond hydrolysis, endonucleolytic, GO:0090501|RNA phosphodiester bond hydrolysis","GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004519|endonuclease activity, GO:0004518|nuclease activity, GO:0004525|ribonuclease III activity, GO:0004386|helicase activity, GO:0019904|protein domain specific binding, GO:0016891|endoribonuclease activity, producing 5'-phosphomonoesters, GO:0003725|double-stranded RNA binding, GO:0070883|pre-miRNA binding, GO:0004530|deoxyribonuclease I activity, GO:0035197|siRNA binding, GO:0004521|endoribonuclease activity"
NF1,Silent,0.0954935229588975,69,0.435082795272255,N,"TSG, fusion",TSG,0.099186048418933,0.417450841307937,ENSG00000196712,"GO:0005634|nucleus, GO:0016020|membrane, GO:0098793|presynapse, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005737|cytoplasm, GO:0030424|axon, GO:0030425|dendrite, GO:0016021|integral component of membrane","GO:0007165|signal transduction, GO:0043087|regulation of GTPase activity, GO:0043547|positive regulation of GTPase activity, GO:0050890|cognition, GO:0000165|MAPK cascade, GO:0007265|Ras protein signal transduction, GO:0048147|negative regulation of fibroblast proliferation, GO:0001937|negative regulation of endothelial cell proliferation, GO:0001649|osteoblast differentiation, GO:0001656|metanephros development, GO:0001666|response to hypoxia, GO:0001889|liver development, GO:0001952|regulation of cell-matrix adhesion, GO:0006469|negative regulation of protein kinase activity, GO:0007154|cell communication, GO:0007406|negative regulation of neuroblast proliferation, GO:0007420|brain development, GO:0007422|peripheral nervous system development, GO:0007507|heart development, GO:0008542|visual learning, GO:0014044|Schwann cell development, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0021510|spinal cord development, GO:0021897|forebrain astrocyte development, GO:0021987|cerebral cortex development, GO:0022011|myelination in peripheral nervous system, GO:0030036|actin cytoskeleton organization, GO:0030198|extracellular matrix organization, GO:0030199|collagen fibril organization, GO:0030325|adrenal gland development, GO:0030336|negative regulation of cell migration, GO:0042060|wound healing, GO:0043065|positive regulation of apoptotic process, GO:0043407|negative regulation of MAP kinase activity, GO:0043409|negative regulation of MAPK cascade, GO:0043473|pigmentation, GO:0043525|positive regulation of neuron apoptotic process, GO:0043535|regulation of blood vessel endothelial cell migration, GO:0045124|regulation of bone resorption, GO:0045685|regulation of glial cell differentiation, GO:0045762|positive regulation of adenylate cyclase activity, GO:0045765|regulation of angiogenesis, GO:0048485|sympathetic nervous system development, GO:0048593|camera-type eye morphogenesis, GO:0048715|negative regulation of oligodendrocyte differentiation, GO:0048745|smooth muscle tissue development, GO:0048844|artery morphogenesis, GO:0048853|forebrain morphogenesis, GO:0001938|positive regulation of endothelial cell proliferation, GO:0001953|negative regulation of cell-matrix adhesion, GO:0007519|skeletal muscle tissue development, GO:0008285|negative regulation of cell proliferation, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0010468|regulation of gene expression, GO:0016525|negative regulation of angiogenesis, GO:0021764|amygdala development, GO:0021915|neural tube development, GO:0032228|regulation of synaptic transmission, GABAergic, GO:0034605|cellular response to heat, GO:0035021|negative regulation of Rac protein signal transduction, GO:0042127|regulation of cell proliferation, GO:0042308|negative regulation of protein import into nucleus, GO:0043408|regulation of MAPK cascade, GO:0045671|negative regulation of osteoclast differentiation, GO:0046580|negative regulation of Ras protein signal transduction, GO:0046929|negative regulation of neurotransmitter secretion, GO:0048169|regulation of long-term neuronal synaptic plasticity, GO:0048712|negative regulation of astrocyte differentiation, GO:0048820|hair follicle maturation, GO:0061534|gamma-aminobutyric acid secretion, neurotransmission, GO:0061535|glutamate secretion, neurotransmission, GO:0098597|observational learning, GO:1900271|regulation of long-term synaptic potentiation, GO:1902043|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors, GO:2001241|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand","GO:0005515|protein binding, GO:0005096|GTPase activator activity, GO:0008289|lipid binding, GO:0008429|phosphatidylethanolamine binding, GO:0031210|phosphatidylcholine binding"
TAL1,Missense,0.0947330933431342,28,0.631578148157311,N,"oncogene, fusion",Oncogene,-0.0463785845792902,0.81471375896615,ENSG00000162367,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex, GO:0000790|nuclear chromatin, GO:0000118|histone deacetylase complex, GO:0033193|Lsd1/2 complex, GO:0032991|protein-containing complex","GO:0045648|positive regulation of erythrocyte differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045931|positive regulation of mitotic cell cycle, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0031334|positive regulation of protein complex assembly, GO:0030218|erythrocyte differentiation, GO:0035162|embryonic hemopoiesis, GO:0030219|megakaryocyte differentiation, GO:0030221|basophil differentiation, GO:0030097|hemopoiesis, GO:0045165|cell fate commitment, GO:0045799|positive regulation of chromatin assembly or disassembly, GO:0051781|positive regulation of cell division, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001525|angiogenesis, GO:0006366|transcription by RNA polymerase II, GO:0007626|locomotory behavior, GO:0021527|spinal cord association neuron differentiation, GO:0030099|myeloid cell differentiation, GO:0030182|neuron differentiation, GO:0030220|platelet formation, GO:0035855|megakaryocyte development, GO:0042127|regulation of cell proliferation, GO:0043249|erythrocyte maturation, GO:0045637|regulation of myeloid cell differentiation, GO:0045647|negative regulation of erythrocyte differentiation, GO:0048699|generation of neurons, GO:0060018|astrocyte fate commitment, GO:0060216|definitive hemopoiesis, GO:0060217|hemangioblast cell differentiation, GO:0060218|hematopoietic stem cell differentiation, GO:0060375|regulation of mast cell differentiation, GO:0061098|positive regulation of protein tyrosine kinase activity, GO:2000036|regulation of stem cell population maintenance, GO:2000273|positive regulation of signaling receptor activity","GO:0044212|transcription regulatory region DNA binding, GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001085|RNA polymerase II transcription factor binding, GO:0003700|DNA-binding transcription factor activity, GO:0070888|E-box binding, GO:0019899|enzyme binding, GO:0042826|histone deacetylase binding, GO:0003682|chromatin binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0046982|protein heterodimerization activity"
CTCF,Silent,0.0932097435008543,23,0.672286064334978,N,TSG,TSG,0.00379030176540691,0.986305836286105,ENSG00000102974,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0005730|nucleolus, GO:0000775|chromosome, centromeric region, GO:0000793|condensed chromosome","GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007059|chromosome segregation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0010628|positive regulation of gene expression, GO:0008285|negative regulation of cell proliferation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0016584|nucleosome positioning, GO:0040029|regulation of gene expression, epigenetic, GO:0040030|regulation of molecular function, epigenetic, GO:0070602|regulation of centromeric sister chromatid cohesion, GO:0071459|protein localization to chromosome, centromeric region, GO:0006306|DNA methylation, GO:0006349|regulation of gene expression by genetic imprinting, GO:0006355|regulation of transcription, DNA-templated, GO:0010216|maintenance of DNA methylation, GO:0010629|negative regulation of gene expression, GO:0031060|regulation of histone methylation, GO:0035065|regulation of histone acetylation","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0003714|transcription corepressor activity, GO:0043035|chromatin insulator sequence binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003682|chromatin binding"
TSHR,Missense,0.093116121285216,68,0.450091543746809,N,Oncogene,Oncogene,0.233894376544232,0.054895321008385,ENSG00000165409,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0009986|cell surface, GO:0005887|integral component of plasma membrane, GO:0016323|basolateral plasma membrane, GO:0043235|receptor complex","GO:0007186|G protein-coupled receptor signaling pathway, GO:0007165|signal transduction, GO:0007189|adenylate cyclase-activating G protein-coupled receptor signaling pathway, GO:0008344|adult locomotory behavior, GO:0030183|B cell differentiation, GO:0038194|thyroid-stimulating hormone signaling pathway, GO:0040012|regulation of locomotion, GO:0040018|positive regulation of multicellular organism growth, GO:0060119|inner ear receptor cell development, GO:0060122|inner ear receptor cell stereocilium organization, GO:0071542|dopaminergic neuron differentiation, GO:0090103|cochlea morphogenesis, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0009755|hormone-mediated signaling pathway, GO:0007267|cell-cell signaling, GO:0008284|positive regulation of cell proliferation, GO:0007190|activation of adenylate cyclase activity, GO:0007166|cell surface receptor signaling pathway, GO:0007187|G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger, GO:0045762|positive regulation of adenylate cyclase activity, GO:1904588|cellular response to glycoprotein, GO:1905229|cellular response to thyrotropin-releasing hormone","GO:0004930|G protein-coupled receptor activity, GO:0004996|thyroid-stimulating hormone receptor activity, GO:0016500|protein-hormone receptor activity, GO:0005515|protein binding, GO:0038023|signaling receptor activity, GO:0044877|protein-containing complex binding, GO:0008528|G protein-coupled peptide receptor activity"
MED12,Missense,0.0922455309610107,180,0.218095041541944,N,TSG,TSG,0.113347402907797,0.129770566938866,ENSG00000184634,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016592|mediator complex, GO:0005654|nucleoplasm, GO:0000151|ubiquitin ligase complex","GO:0006357|regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0030178|negative regulation of Wnt signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0030518|intracellular steroid hormone receptor signaling pathway, GO:0030521|androgen receptor signaling pathway, GO:0001756|somitogenesis, GO:0001843|neural tube closure, GO:0007492|endoderm development, GO:0007507|heart development, GO:0014003|oligodendrocyte development, GO:0014044|Schwann cell development, GO:0016567|protein ubiquitination, GO:0019827|stem cell population maintenance, GO:0021510|spinal cord development, GO:0021915|neural tube development, GO:0036342|post-anal tail morphogenesis, GO:0048568|embryonic organ development, GO:0048702|embryonic neurocranium morphogenesis, GO:0060070|canonical Wnt signaling pathway, GO:0060071|Wnt signaling pathway, planar cell polarity pathway, GO:0090245|axis elongation involved in somitogenesis, GO:1990403|embryonic brain development","GO:0008013|beta-catenin binding, GO:0003712|transcription coregulator activity, GO:0005515|protein binding, GO:0030374|nuclear receptor transcription coactivator activity, GO:0038023|signaling receptor activity, GO:0003713|transcription coactivator activity, GO:0008022|protein C-terminus binding, GO:0019904|protein domain specific binding, GO:0042809|vitamin D receptor binding, GO:0046966|thyroid hormone receptor binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0061630|ubiquitin protein ligase activity"
NUP214,Missense,0.0906899551125716,118,0.328731360091677,N,fusion,"",0.209668779378208,0.0226830402601724,ENSG00000126883,"GO:0005634|nucleus, GO:0043231|intracellular membrane-bounded organelle, GO:0005925|focal adhesion, GO:0005643|nuclear pore, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005635|nuclear envelope, GO:1990876|cytoplasmic side of nuclear pore","GO:0051028|mRNA transport, GO:0015031|protein transport, GO:0006406|mRNA export from nucleus, GO:0006606|protein import into nucleus, GO:0016032|viral process, GO:0043488|regulation of mRNA stability, GO:0006611|protein export from nucleus, GO:0046822|regulation of nucleocytoplasmic transport, GO:0000278|mitotic cell cycle, GO:0051726|regulation of cell cycle","GO:0005515|protein binding, GO:0008139|nuclear localization sequence binding, GO:0017056|structural constituent of nuclear pore, GO:0005049|nuclear export signal receptor activity"
PAX3,Silent,0.0906045369847758,24,0.673724253342392,N,"oncogene, fusion",Oncogene,0.176138219474267,0.410338021322129,ENSG00000135903,"GO:0005634|nucleus, GO:0005654|nucleoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0007399|nervous system development, GO:0007517|muscle organ development, GO:0006366|transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0009887|animal organ morphogenesis, GO:0006915|apoptotic process, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007605|sensory perception of sound","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003700|DNA-binding transcription factor activity, GO:0071837|HMG box domain binding"
KNL1,Missense,0.0872579419367317,121,0.341253711243701,N,"TSG, fusion",TSG,0.115828715741998,0.205816283162802,ENSG00000137812,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0016604|nuclear body, GO:0000775|chromosome, centromeric region, GO:0000776|kinetochore, GO:0000777|condensed chromosome kinetochore, GO:0001669|acrosomal vesicle","GO:0051301|cell division, GO:0007049|cell cycle, GO:0007059|chromosome segregation, GO:0010923|negative regulation of phosphatase activity, GO:0034080|CENP-A containing nucleosome assembly, GO:0008608|attachment of spindle microtubules to kinetochore, GO:0034501|protein localization to kinetochore, GO:0001675|acrosome assembly",GO:0005515|protein binding
FLT4,Missense,0.0870927688558207,138,0.30975617935869,N,Oncogene,Oncogene,0.0826192664406092,0.335358499836402,ENSG00000037280,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005887|integral component of plasma membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0043235|receptor complex","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0008284|positive regulation of cell proliferation, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0002040|sprouting angiogenesis, GO:0001934|positive regulation of protein phosphorylation, GO:0001525|angiogenesis, GO:0043066|negative regulation of apoptotic process, GO:0046777|protein autophosphorylation, GO:0010595|positive regulation of endothelial cell migration, GO:0035924|cellular response to vascular endothelial growth factor stimulus, GO:0046330|positive regulation of JNK cascade, GO:0048514|blood vessel morphogenesis, GO:0001938|positive regulation of endothelial cell proliferation, GO:0090037|positive regulation of protein kinase C signaling, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0001944|vasculature development, GO:0060312|regulation of blood vessel remodeling, GO:0010575|positive regulation of vascular endothelial growth factor production, GO:0001946|lymphangiogenesis, GO:0001945|lymph vessel development, GO:0003016|respiratory system process, GO:0007585|respiratory gaseous exchange, GO:0038084|vascular endothelial growth factor signaling pathway, GO:0048286|lung alveolus development","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005021|vascular endothelial growth factor-activated receptor activity, GO:0019903|protein phosphatase binding, GO:0019838|growth factor binding, GO:0038085|vascular endothelial growth factor binding, GO:0036328|VEGF-C-activated receptor activity"
CDK12,Nonsense,0.0869868179176459,19,0.723265612868716,N,TSG,TSG,0.0276415173205208,0.910563608378284,ENSG00000167258,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0001650|fibrillar center, GO:0000790|nuclear chromatin, GO:0005654|nucleoplasm, GO:0008024|cyclin/CDK positive transcription elongation factor complex, GO:0002944|cyclin K-CDK12 complex, GO:0005694|chromosome, GO:0000307|cyclin-dependent protein kinase holoenzyme complex, GO:0019908|nuclear cyclin-dependent protein kinase holoenzyme complex","GO:0006468|protein phosphorylation, GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0016310|phosphorylation, GO:0051726|regulation of cell cycle, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0043405|regulation of MAP kinase activity, GO:0046777|protein autophosphorylation, GO:0032968|positive regulation of transcription elongation from RNA polymerase II promoter, GO:0070816|phosphorylation of RNA polymerase II C-terminal domain, GO:0043484|regulation of RNA splicing, GO:2000737|negative regulation of stem cell differentiation","GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0000166|nucleotide binding, GO:0004674|protein serine/threonine kinase activity, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0044212|transcription regulatory region DNA binding, GO:0004693|cyclin-dependent protein serine/threonine kinase activity, GO:0030332|cyclin binding, GO:0008353|RNA polymerase II CTD heptapeptide repeat kinase activity, GO:0019901|protein kinase binding"
PTPN11,Missense,0.0869635659285357,66,0.487485516893611,N,Oncogene,Oncogene,0.100686996263908,0.421164128466436,ENSG00000179295,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0032991|protein-containing complex, GO:0005739|mitochondrion","GO:0046326|positive regulation of glucose import, GO:0006470|protein dephosphorylation, GO:0016311|dephosphorylation, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0050900|leukocyte migration, GO:0046854|phosphatidylinositol phosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0030168|platelet activation, GO:0007411|axon guidance, GO:0019221|cytokine-mediated signaling pathway, GO:0051897|positive regulation of protein kinase B signaling, GO:0070102|interleukin-6-mediated signaling pathway, GO:0007507|heart development, GO:0033628|regulation of cell adhesion mediated by integrin, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0031295|T cell costimulation, GO:0048013|ephrin receptor signaling pathway, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0043254|regulation of protein complex assembly, GO:0071345|cellular response to cytokine stimulus, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0046628|positive regulation of insulin receptor signaling pathway, GO:0007420|brain development, GO:0032760|positive regulation of tumor necrosis factor production, GO:0060325|face morphogenesis, GO:0060338|regulation of type I interferon-mediated signaling pathway, GO:0032755|positive regulation of interleukin-6 production, GO:0038127|ERBB signaling pathway, GO:0048806|genitalia development, GO:0048839|inner ear development, GO:0032728|positive regulation of interferon-beta production, GO:0036302|atrioventricular canal development, GO:0000077|DNA damage checkpoint, GO:0000187|activation of MAPK activity, GO:0006629|lipid metabolic process, GO:0006641|triglyceride metabolic process, GO:0007229|integrin-mediated signaling pathway, GO:0007409|axonogenesis, GO:0009755|hormone-mediated signaling pathway, GO:0009967|positive regulation of signal transduction, GO:0021697|cerebellar cortex formation, GO:0030220|platelet formation, GO:0032528|microvillus organization, GO:0033277|abortive mitotic cell cycle, GO:0033629|negative regulation of cell adhesion mediated by integrin, GO:0035264|multicellular organism growth, GO:0035265|organ growth, GO:0035855|megakaryocyte development, GO:0040014|regulation of multicellular organism growth, GO:0042445|hormone metabolic process, GO:0042593|glucose homeostasis, GO:0045931|positive regulation of mitotic cell cycle, GO:0046676|negative regulation of insulin secretion, GO:0046825|regulation of protein export from nucleus, GO:0046887|positive regulation of hormone secretion, GO:0046888|negative regulation of hormone secretion, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0048011|neurotrophin TRK receptor signaling pathway, GO:0048609|multicellular organismal reproductive process, GO:0048873|homeostasis of number of cells within a tissue, GO:0051463|negative regulation of cortisol secretion, GO:0060020|Bergmann glial cell differentiation, GO:0060125|negative regulation of growth hormone secretion, GO:0061582|intestinal epithelial cell migration, GO:0071260|cellular response to mechanical stimulus","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0016791|phosphatase activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0005158|insulin receptor binding, GO:0019901|protein kinase binding, GO:0001784|phosphotyrosine residue binding, GO:0005070|SH3/SH2 adaptor activity, GO:0004726|non-membrane spanning protein tyrosine phosphatase activity, GO:0019904|protein domain specific binding, GO:0030971|receptor tyrosine kinase binding, GO:0031748|D1 dopamine receptor binding, GO:0043274|phospholipase binding, GO:0043560|insulin receptor substrate binding, GO:0050839|cell adhesion molecule binding, GO:0051428|peptide hormone receptor binding, GO:1990782|protein tyrosine kinase binding"
STAT3,Missense,0.0869331216070939,77,0.452181725587045,N,Oncogene,Oncogene,-0.0422035757548548,0.715529481615987,ENSG00000168610,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0000790|nuclear chromatin, GO:0090575|RNA polymerase II transcription factor complex, GO:0005739|mitochondrion, GO:0005743|mitochondrial inner membrane","GO:0035278|miRNA mediated inhibition of translation, GO:0010628|positive regulation of gene expression, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1904685|positive regulation of metalloendopeptidase activity, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030335|positive regulation of cell migration, GO:0016310|phosphorylation, GO:0006355|regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0006954|inflammatory response, GO:0006357|regulation of transcription by RNA polymerase II, GO:0016032|viral process, GO:0006606|protein import into nucleus, GO:0007399|nervous system development, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0060259|regulation of feeding behavior, GO:0051726|regulation of cell cycle, GO:0019221|cytokine-mediated signaling pathway, GO:0045747|positive regulation of Notch signaling pathway, GO:0097009|energy homeostasis, GO:0007259|JAK-STAT cascade, GO:0032355|response to estradiol, GO:0032870|cellular response to hormone stimulus, GO:0038111|interleukin-7-mediated signaling pathway, GO:0060396|growth hormone receptor signaling pathway, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0070102|interleukin-6-mediated signaling pathway, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0060019|radial glial cell differentiation, GO:0042593|glucose homeostasis, GO:0035019|somatic stem cell population maintenance, GO:0038155|interleukin-23-mediated signaling pathway, GO:0060397|JAK-STAT cascade involved in growth hormone signaling pathway, GO:0070106|interleukin-27-mediated signaling pathway, GO:0070757|interleukin-35-mediated signaling pathway, GO:0001659|temperature homeostasis, GO:0043066|negative regulation of apoptotic process, GO:0071345|cellular response to cytokine stimulus, GO:0045410|positive regulation of interleukin-6 biosynthetic process, GO:0072540|T-helper 17 cell lineage commitment, GO:0042755|eating behavior, GO:0019953|sexual reproduction, GO:0045648|positive regulation of erythrocyte differentiation, GO:0030522|intracellular receptor signaling pathway, GO:0010507|negative regulation of autophagy, GO:0035723|interleukin-15-mediated signaling pathway, GO:0038113|interleukin-9-mediated signaling pathway, GO:0044321|response to leptin, GO:0038114|interleukin-21-mediated signaling pathway, GO:0033210|leptin-mediated signaling pathway, GO:0001754|eye photoreceptor cell differentiation, GO:0006366|transcription by RNA polymerase II, GO:0006953|acute-phase response, GO:0007568|aging, GO:0008283|cell proliferation, GO:0008284|positive regulation of cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0010033|response to organic substance, GO:0010730|negative regulation of hydrogen peroxide biosynthetic process, GO:0014070|response to organic cyclic compound, GO:0019827|stem cell population maintenance, GO:0034097|response to cytokine, GO:0040014|regulation of multicellular organism growth, GO:0042493|response to drug, GO:0042789|mRNA transcription by RNA polymerase II, GO:0043434|response to peptide hormone, GO:0044320|cellular response to leptin stimulus, GO:0045471|response to ethanol, GO:0045766|positive regulation of angiogenesis, GO:0045820|negative regulation of glycolytic process, GO:0046902|regulation of mitochondrial membrane permeability, GO:0048708|astrocyte differentiation, GO:0060548|negative regulation of cell death, GO:0071407|cellular response to organic cyclic compound, GO:1901215|negative regulation of neuron death, GO:1902728|positive regulation of growth factor dependent skeletal muscle satellite cell proliferation, GO:1905564|positive regulation of vascular endothelial cell proliferation, GO:2000637|positive regulation of gene silencing by miRNA, GO:2000737|negative regulation of stem cell differentiation, GO:2001171|positive regulation of ATP biosynthetic process, GO:2001223|negative regulation of neuron migration","GO:0044212|transcription regulatory region DNA binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0031490|chromatin DNA binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019901|protein kinase binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019903|protein phosphatase binding, GO:0008134|transcription factor binding, GO:0001103|RNA polymerase II repressing transcription factor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0046983|protein dimerization activity, GO:0004879|nuclear receptor activity, GO:0031730|CCR5 chemokine receptor binding, GO:0035259|glucocorticoid receptor binding, GO:0043565|sequence-specific DNA binding"
FLT3,Missense,0.0862742960828629,106,0.379207497944379,N,Oncogene,Oncogene,-0.0323125774338685,0.742291981227791,ENSG00000122025,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005886|plasma membrane, GO:0005788|endoplasmic reticulum lumen, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0032991|protein-containing complex","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0030154|cell differentiation, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0038084|vascular endothelial growth factor signaling pathway, GO:0002244|hematopoietic progenitor cell differentiation, GO:0008284|positive regulation of cell proliferation, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0016032|viral process, GO:0030097|hemopoiesis, GO:0019221|cytokine-mediated signaling pathway, GO:0042981|regulation of apoptotic process, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0071345|cellular response to cytokine stimulus, GO:0043406|positive regulation of MAP kinase activity, GO:0097028|dendritic cell differentiation, GO:0030183|B cell differentiation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0035726|common myeloid progenitor cell proliferation, GO:0001776|leukocyte homeostasis, GO:0002318|myeloid progenitor cell differentiation, GO:0002328|pro-B cell differentiation, GO:0002521|leukocyte differentiation, GO:0010243|response to organonitrogen compound, GO:0030098|lymphocyte differentiation, GO:0031100|animal organ regeneration, GO:0046651|lymphocyte proliferation, GO:0071385|cellular response to glucocorticoid stimulus","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0005021|vascular endothelial growth factor-activated receptor activity, GO:0004896|cytokine receptor activity, GO:0035259|glucocorticoid receptor binding, GO:0043621|protein self-association, GO:0044877|protein-containing complex binding"
KLF6,Missense,0.0861115387704885,22,0.703179820761112,N,TSG,TSG,-0.00557931168753582,0.980340670512635,ENSG00000067082,"GO:0005634|nucleus, GO:0043231|intracellular membrane-bounded organelle, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0001650|fibrillar center","GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0019221|cytokine-mediated signaling pathway, GO:0030183|B cell differentiation","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0003690|double-stranded DNA binding"
SMARCA4,Silent,0.0855920985021826,65,0.497821331437686,N,TSG,TSG,0.0730082527004666,0.56328940802416,ENSG00000127616,"GO:0005634|nucleus, GO:0016020|membrane, GO:0000790|nuclear chromatin, GO:0016514|SWI/SNF complex, GO:0005615|extracellular space, GO:0005730|nucleolus, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0071564|npBAF complex, GO:0071565|nBAF complex","GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0043044|ATP-dependent chromatin remodeling, GO:0007399|nervous system development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:1904837|beta-catenin-TCF complex assembly, GO:0045892|negative regulation of transcription, DNA-templated, GO:0006337|nucleosome disassembly, GO:0006338|chromatin remodeling, GO:0006357|regulation of transcription by RNA polymerase II, GO:0038111|interleukin-7-mediated signaling pathway, GO:0030177|positive regulation of Wnt signaling pathway, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0030308|negative regulation of cell growth, GO:0060766|negative regulation of androgen receptor signaling pathway, GO:0003407|neural retina development, GO:0001188|RNA polymerase I preinitiation complex assembly, GO:1901838|positive regulation of transcription of nucleolar large rRNA by RNA polymerase I, GO:0043923|positive regulation by host of viral transcription, GO:1902661|positive regulation of glucose mediated signaling pathway","GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0016887|ATPase activity, GO:0042393|histone binding, GO:0004386|helicase activity, GO:0016817|hydrolase activity, acting on acid anhydrides, GO:0003714|transcription corepressor activity, GO:0047485|protein N-terminus binding, GO:0008134|transcription factor binding, GO:0003713|transcription coactivator activity, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0050681|androgen receptor binding, GO:0002039|p53 binding, GO:0031492|nucleosomal DNA binding, GO:0070182|DNA polymerase binding, GO:0001164|RNA polymerase I CORE element sequence-specific DNA binding, GO:0070577|lysine-acetylated histone binding, GO:0008094|DNA-dependent ATPase activity, GO:0030957|Tat protein binding"
FOXA1,Missense,0.0846234310925258,67,0.495960043085384,N,Oncogene,Oncogene,0.0653053657152237,0.599549229757527,ENSG00000129514,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0001650|fibrillar center, GO:0005902|microvillus","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0010719|negative regulation of epithelial to mesenchymal transition, GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043065|positive regulation of apoptotic process, GO:0009653|anatomical structure morphogenesis, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0033148|positive regulation of intracellular estrogen receptor signaling pathway, GO:0006338|chromatin remodeling, GO:0071542|dopaminergic neuron differentiation, GO:0045931|positive regulation of mitotic cell cycle, GO:2000049|positive regulation of cell-cell adhesion mediated by cadherin, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007219|Notch signaling pathway, GO:0010468|regulation of gene expression, GO:0021904|dorsal/ventral neural tube patterning, GO:0030324|lung development, GO:0032355|response to estradiol, GO:0035239|tube morphogenesis, GO:0042445|hormone metabolic process, GO:0042593|glucose homeostasis, GO:0045666|positive regulation of neuron differentiation, GO:0045880|positive regulation of smoothened signaling pathway, GO:0048646|anatomical structure formation involved in morphogenesis, GO:0048665|neuron fate specification, GO:0051726|regulation of cell cycle, GO:0060425|lung morphogenesis, GO:0060441|epithelial tube branching involved in lung morphogenesis, GO:0060487|lung epithelial cell differentiation, GO:0060528|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development, GO:0060738|epithelial-mesenchymal signaling involved in prostate gland development, GO:0060740|prostate gland epithelium morphogenesis, GO:0060741|prostate gland stromal morphogenesis, GO:0060743|epithelial cell maturation involved in prostate gland development, GO:0061144|alveolar secondary septum development, GO:0061448|connective tissue development, GO:1902691|respiratory basal cell differentiation","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0019904|protein domain specific binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding"
TNFRSF17,Missense,0.0845783792435718,16,0.75547482402583,N,"oncogene, fusion",Oncogene,-0.0491182920191078,0.856647391607146,ENSG00000048462,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0012505|endomembrane system","GO:0007165|signal transduction, GO:0002376|immune system process, GO:0002250|adaptive immune response, GO:0007275|multicellular organism development, GO:0033209|tumor necrosis factor-mediated signaling pathway, GO:0008283|cell proliferation, GO:0002260|lymphocyte homeostasis",GO:0038023|signaling receptor activity
PIK3CA,Missense,0.0836642153737023,164,0.286831495966875,N,Oncogene,Oncogene,0.0788087163659567,0.315819569616505,ENSG00000121879,"GO:0005737|cytoplasm, GO:0005886|plasma membrane, GO:0016020|membrane, GO:0005829|cytosol, GO:0005942|phosphatidylinositol 3-kinase complex, GO:0005943|phosphatidylinositol 3-kinase complex, class IA, GO:0030027|lamellipodium","GO:0016310|phosphorylation, GO:0046854|phosphatidylinositol phosphorylation, GO:0048015|phosphatidylinositol-mediated signaling, GO:0032147|activation of protein kinase activity, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0050900|leukocyte migration, GO:0050852|T cell receptor signaling pathway, GO:0006468|protein phosphorylation, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0007186|G protein-coupled receptor signaling pathway, GO:0001525|angiogenesis, GO:0016477|cell migration, GO:0030168|platelet activation, GO:0006909|phagocytosis, GO:0007411|axon guidance, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0019221|cytokine-mediated signaling pathway, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0051897|positive regulation of protein kinase B signaling, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0038128|ERBB2 signaling pathway, GO:0031295|T cell costimulation, GO:0043542|endothelial cell migration, GO:0007173|epidermal growth factor receptor signaling pathway, GO:2000811|negative regulation of anoikis, GO:0001944|vasculature development, GO:0038028|insulin receptor signaling pathway via phosphatidylinositol 3-kinase, GO:0060048|cardiac muscle contraction, GO:0016242|negative regulation of macroautophagy, GO:0043276|anoikis, GO:0001889|liver development, GO:0006006|glucose metabolic process, GO:0010468|regulation of gene expression, GO:0032008|positive regulation of TOR signaling, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:0040014|regulation of multicellular organism growth, GO:0043457|regulation of cellular respiration, GO:0043491|protein kinase B signaling, GO:0043524|negative regulation of neuron apoptotic process, GO:0044029|hypomethylation of CpG island, GO:0060612|adipose tissue development, GO:0071333|cellular response to glucose stimulus, GO:0097009|energy homeostasis, GO:2000270|negative regulation of fibroblast apoptotic process, GO:2000653|regulation of genetic imprinting","GO:0000166|nucleotide binding, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0035004|phosphatidylinositol 3-kinase activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0035005|1-phosphatidylinositol-4-phosphate 3-kinase activity, GO:0030295|protein kinase activator activity, GO:0043560|insulin receptor substrate binding"
H3F3A,Missense,0.0826908276738052,21,0.721582474684631,N,Oncogene,Oncogene,-0.0860411842105833,0.71076005597053,ENSG00000163041,"GO:0005634|nucleus, GO:0000786|nucleosome, GO:0005694|chromosome, GO:0005576|extracellular region, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0032991|protein-containing complex, GO:0000784|nuclear chromosome, telomeric region, GO:0000228|nuclear chromosome, GO:0000788|nuclear nucleosome","GO:0006334|nucleosome assembly, GO:0044267|cellular protein metabolic process, GO:0030307|positive regulation of cell growth, GO:0007596|blood coagulation, GO:0045652|regulation of megakaryocyte differentiation, GO:0006336|DNA replication-independent nucleosome assembly, GO:0060964|regulation of gene silencing by miRNA, GO:0000183|chromatin silencing at rDNA, GO:0045814|negative regulation of gene expression, epigenetic, GO:0032200|telomere organization","GO:0003677|DNA binding, GO:0046982|protein heterodimerization activity, GO:0005515|protein binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0000979|RNA polymerase II core promoter sequence-specific DNA binding, GO:0031492|nucleosomal DNA binding"
MECOM,Silent,0.0816047571719776,51,0.569167698522139,N,"oncogene, fusion",Oncogene,-0.0384672541240733,0.788699398053247,ENSG00000085276,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0000118|histone deacetylase complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0034968|histone lysine methylation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0046329|negative regulation of JNK cascade, GO:0051726|regulation of cell cycle, GO:0071425|hematopoietic stem cell proliferation, GO:0043069|negative regulation of programmed cell death","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0018024|histone-lysine N-methyltransferase activity"
ARID1A,Silent,0.0813528282741505,45,0.59524116359249,N,"TSG, fusion",TSG,-0.00536700977592891,0.972087646428875,ENSG00000117713,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016514|SWI/SNF complex, GO:0070603|SWI/SNF superfamily-type complex, GO:0000790|nuclear chromatin, GO:0071564|npBAF complex, GO:0071565|nBAF complex","GO:0006338|chromatin remodeling, GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007399|nervous system development, GO:0030521|androgen receptor signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001704|formation of primary germ layer, GO:0001843|neural tube closure, GO:0003205|cardiac chamber development, GO:0003408|optic cup formation involved in camera-type eye development, GO:0006337|nucleosome disassembly, GO:0006344|maintenance of chromatin silencing, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007369|gastrulation, GO:0007566|embryo implantation, GO:0019827|stem cell population maintenance, GO:0030520|intracellular estrogen receptor signaling pathway, GO:0030900|forebrain development, GO:0042766|nucleosome mobilization, GO:0042921|glucocorticoid receptor signaling pathway, GO:0043044|ATP-dependent chromatin remodeling, GO:0048096|chromatin-mediated maintenance of transcription, GO:0055007|cardiac muscle cell differentiation, GO:0060674|placenta blood vessel development, GO:1901998|toxin transport","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003713|transcription coactivator activity, GO:0016922|nuclear receptor binding, GO:0031491|nucleosome binding"
MPL,Missense,0.0789874854256085,44,0.610291270990309,N,Oncogene,Oncogene,0.194767108185995,0.20518396706249,ENSG00000117400,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0009986|cell surface, GO:0005887|integral component of plasma membrane, GO:0043005|neuron projection, GO:0043025|neuronal cell body","GO:0019221|cytokine-mediated signaling pathway, GO:0007166|cell surface receptor signaling pathway, GO:0008283|cell proliferation, GO:0001780|neutrophil homeostasis, GO:0035702|monocyte homeostasis, GO:0038163|thrombopoietin-mediated signaling pathway, GO:0050671|positive regulation of lymphocyte proliferation, GO:0070527|platelet aggregation, GO:0071456|cellular response to hypoxia, GO:1905221|positive regulation of platelet formation, GO:1990959|eosinophil homeostasis, GO:1990960|basophil homeostasis","GO:0005515|protein binding, GO:0004896|cytokine receptor activity, GO:0004888|transmembrane signaling receptor activity, GO:0038164|thrombopoietin receptor activity"
SPEN,Nonsense,0.078132256013606,32,0.670801015913751,N,TSG,TSG,0.105531281815765,0.565404293885036,ENSG00000065526,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0017053|transcriptional repressor complex","GO:0007219|Notch signaling pathway, GO:0016032|viral process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0050769|positive regulation of neurogenesis","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0003714|transcription corepressor activity"
ABL1,Silent,0.0773574436306183,32,0.673885745987184,N,"oncogene, fusion",Oncogene,0.0530879233950433,0.772913529755475,ENSG00000097007,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005739|mitochondrion, GO:0005856|cytoskeleton, GO:0016604|nuclear body, GO:0048471|perinuclear region of cytoplasm, GO:0005829|cytosol, GO:0031965|nuclear membrane, GO:0043025|neuronal cell body, GO:0032991|protein-containing complex, GO:0005730|nucleolus, GO:0015629|actin cytoskeleton, GO:0030425|dendrite, GO:0031252|cell leading edge, GO:0098794|postsynapse","GO:0010595|positive regulation of endothelial cell migration, GO:0071901|negative regulation of protein serine/threonine kinase activity, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007155|cell adhesion, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0006915|apoptotic process, GO:0006914|autophagy, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0030154|cell differentiation, GO:0006897|endocytosis, GO:0001934|positive regulation of protein phosphorylation, GO:0032956|regulation of actin cytoskeleton organization, GO:0030155|regulation of cell adhesion, GO:0043065|positive regulation of apoptotic process, GO:0030036|actin cytoskeleton organization, GO:2000251|positive regulation of actin cytoskeleton reorganization, GO:0010506|regulation of autophagy, GO:0006464|cellular protein modification process, GO:0006975|DNA damage induced protein phosphorylation, GO:0007229|integrin-mediated signaling pathway, GO:0032489|regulation of Cdc42 protein signal transduction, GO:0038189|neuropilin signaling pathway, GO:0043542|endothelial cell migration, GO:0051496|positive regulation of stress fiber assembly, GO:0051894|positive regulation of focal adhesion assembly, GO:1900026|positive regulation of substrate adhesion-dependent cell spreading, GO:0006355|regulation of transcription, DNA-templated, GO:2000249|regulation of actin cytoskeleton reorganization, GO:0006298|mismatch repair, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:2000145|regulation of cell motility, GO:0034599|cellular response to oxidative stress, GO:0045184|establishment of protein localization, GO:1903351|cellular response to dopamine, GO:0051149|positive regulation of muscle cell differentiation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0046777|protein autophosphorylation, GO:0000278|mitotic cell cycle, GO:0001843|neural tube closure, GO:0001922|B-1 B cell homeostasis, GO:0002322|B cell proliferation involved in immune response, GO:0002333|transitional one stage B cell differentiation, GO:0006909|phagocytosis, GO:0006979|response to oxidative stress, GO:0007050|cell cycle arrest, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0007204|positive regulation of cytosolic calcium ion concentration, GO:0009791|post-embryonic development, GO:0021587|cerebellum morphogenesis, GO:0022408|negative regulation of cell-cell adhesion, GO:0030035|microspike assembly, GO:0030100|regulation of endocytosis, GO:0030182|neuron differentiation, GO:0030514|negative regulation of BMP signaling pathway, GO:0030516|regulation of axon extension, GO:0031113|regulation of microtubule polymerization, GO:0033690|positive regulation of osteoblast proliferation, GO:0034446|substrate adhesion-dependent cell spreading, GO:0035791|platelet-derived growth factor receptor-beta signaling pathway, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0042100|B cell proliferation, GO:0042127|regulation of cell proliferation, GO:0042770|signal transduction in response to DNA damage, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0045580|regulation of T cell differentiation, GO:0045930|negative regulation of mitotic cell cycle, GO:0045931|positive regulation of mitotic cell cycle, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046632|alpha-beta T cell differentiation, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0048536|spleen development, GO:0048538|thymus development, GO:0048668|collateral sprouting, GO:0050798|activated T cell proliferation, GO:0050852|T cell receptor signaling pathway, GO:0050853|B cell receptor signaling pathway, GO:0050885|neuromuscular process controlling balance, GO:0051281|positive regulation of release of sequestered calcium ion into cytosol, GO:0051353|positive regulation of oxidoreductase activity, GO:0051444|negative regulation of ubiquitin-protein transferase activity, GO:0051726|regulation of cell cycle, GO:0051882|mitochondrial depolarization, GO:0060020|Bergmann glial cell differentiation, GO:0060563|neuroepithelial cell differentiation, GO:0070301|cellular response to hydrogen peroxide, GO:0070373|negative regulation of ERK1 and ERK2 cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0071103|DNA conformation change, GO:0071222|cellular response to lipopolysaccharide, GO:0072358|cardiovascular system development, GO:0090050|positive regulation of cell migration involved in sprouting angiogenesis, GO:0090135|actin filament branching, GO:1900042|positive regulation of interleukin-2 secretion, GO:1900272|negative regulation of long-term synaptic potentiation, GO:1900275|negative regulation of phospholipase C activity, GO:1901216|positive regulation of neuron death, GO:1902715|positive regulation of interferon-gamma secretion, GO:1903053|regulation of extracellular matrix organization, GO:1904528|positive regulation of microtubule binding, GO:1904531|positive regulation of actin filament binding, GO:1905244|regulation of modification of synaptic structure, GO:1905555|positive regulation blood vessel branching, GO:1990051|activation of protein kinase C activity, GO:2000096|positive regulation of Wnt signaling pathway, planar cell polarity pathway, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:2000772|regulation of cellular senescence, GO:2000773|negative regulation of cellular senescence, GO:2001020|regulation of response to DNA damage stimulus","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0003677|DNA binding, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0000287|magnesium ion binding, GO:0030145|manganese ion binding, GO:0004515|nicotinate-nucleotide adenylyltransferase activity, GO:0003785|actin monomer binding, GO:0008022|protein C-terminus binding, GO:0017124|SH3 domain binding, GO:0019905|syntaxin binding, GO:0070064|proline-rich region binding, GO:0001784|phosphotyrosine residue binding, GO:0000400|four-way junction DNA binding, GO:0000405|bubble DNA binding, GO:0003713|transcription coactivator activity, GO:0005080|protein kinase C binding, GO:0019904|protein domain specific binding, GO:0038191|neuropilin binding, GO:0042169|SH2 domain binding, GO:0046875|ephrin receptor binding, GO:0051015|actin filament binding, GO:0051019|mitogen-activated protein kinase binding, GO:1990837|sequence-specific double-stranded DNA binding"
MTOR,Missense,0.07634186144162,228,0.250936682404932,N,Oncogene,Oncogene,0.09077702300094,0.171941766802803,ENSG00000198793,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0031090|organelle membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005794|Golgi apparatus, GO:0005765|lysosomal membrane, GO:0005739|mitochondrion, GO:0000139|Golgi membrane, GO:0005741|mitochondrial outer membrane, GO:0005764|lysosome, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0012505|endomembrane system, GO:0016605|PML body, GO:0031931|TORC1 complex, GO:0031932|TORC2 complex, GO:0030425|dendrite, GO:0032991|protein-containing complex, GO:0043025|neuronal cell body","GO:0016310|phosphorylation, GO:0006468|protein phosphorylation, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:1903691|positive regulation of wound healing, spreading of epidermal cells, GO:0045727|positive regulation of translation, GO:0010507|negative regulation of autophagy, GO:0001934|positive regulation of protein phosphorylation, GO:0010628|positive regulation of gene expression, GO:0032956|regulation of actin cytoskeleton organization, GO:0009267|cellular response to starvation, GO:0001558|regulation of cell growth, GO:0030163|protein catabolic process, GO:0018105|peptidyl-serine phosphorylation, GO:0071456|cellular response to hypoxia, GO:0032148|activation of protein kinase B activity, GO:0007050|cell cycle arrest, GO:0016241|regulation of macroautophagy, GO:0046889|positive regulation of lipid biosynthetic process, GO:1900034|regulation of cellular response to heat, GO:0031669|cellular response to nutrient levels, GO:0045670|regulation of osteoclast differentiation, GO:0051549|positive regulation of keratinocyte migration, GO:1901838|positive regulation of transcription of nucleolar large rRNA by RNA polymerase I, GO:0031929|TOR signaling, GO:0034198|cellular response to amino acid starvation, GO:0043276|anoikis, GO:0007584|response to nutrient, GO:0001932|regulation of protein phosphorylation, GO:0001933|negative regulation of protein phosphorylation, GO:0001938|positive regulation of endothelial cell proliferation, GO:0002296|T-helper 1 cell lineage commitment, GO:0003007|heart morphogenesis, GO:0003179|heart valve morphogenesis, GO:0005979|regulation of glycogen biosynthetic process, GO:0006109|regulation of carbohydrate metabolic process, GO:0006112|energy reserve metabolic process, GO:0006207|'de novo' pyrimidine nucleobase biosynthetic process, GO:0007281|germ cell development, GO:0007420|brain development, GO:0007569|cell aging, GO:0007616|long-term memory, GO:0008361|regulation of cell size, GO:0008542|visual learning, GO:0009791|post-embryonic development, GO:0010592|positive regulation of lamellipodium assembly, GO:0010831|positive regulation of myotube differentiation, GO:0010942|positive regulation of cell death, GO:0010976|positive regulation of neuron projection development, GO:0014042|positive regulation of neuron maturation, GO:0014736|negative regulation of muscle atrophy, GO:0014823|response to activity, GO:0016242|negative regulation of macroautophagy, GO:0018107|peptidyl-threonine phosphorylation, GO:0021510|spinal cord development, GO:0030030|cell projection organization, GO:0030838|positive regulation of actin filament polymerization, GO:0031397|negative regulation of protein ubiquitination, GO:0031529|ruffle organization, GO:0031641|regulation of myelination, GO:0031998|regulation of fatty acid beta-oxidation, GO:0032095|regulation of response to food, GO:0032516|positive regulation of phosphoprotein phosphatase activity, GO:0032868|response to insulin, GO:0035176|social behavior, GO:0035264|multicellular organism growth, GO:0038202|TORC1 signaling, GO:0042060|wound healing, GO:0042220|response to cocaine, GO:0043087|regulation of GTPase activity, GO:0043200|response to amino acid, GO:0043278|response to morphine, GO:0043610|regulation of carbohydrate utilization, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0045792|negative regulation of cell size, GO:0045859|regulation of protein kinase activity, GO:0045945|positive regulation of transcription by RNA polymerase III, GO:0046777|protein autophosphorylation, GO:0048255|mRNA stabilization, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0048714|positive regulation of oligodendrocyte differentiation, GO:0048738|cardiac muscle tissue development, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0050769|positive regulation of neurogenesis, GO:0050882|voluntary musculoskeletal movement, GO:0051496|positive regulation of stress fiber assembly, GO:0051896|regulation of protein kinase B signaling, GO:0051897|positive regulation of protein kinase B signaling, GO:0055006|cardiac cell development, GO:0055013|cardiac muscle cell development, GO:0060048|cardiac muscle contraction, GO:0060135|maternal process involved in female pregnancy, GO:0060252|positive regulation of glial cell proliferation, GO:0060999|positive regulation of dendritic spine development, GO:0061051|positive regulation of cell growth involved in cardiac muscle cell development, GO:0070885|negative regulation of calcineurin-NFAT signaling cascade, GO:0071230|cellular response to amino acid stimulus, GO:0071233|cellular response to leucine, GO:0090335|regulation of brown fat cell differentiation, GO:0090559|regulation of membrane permeability, GO:1901216|positive regulation of neuron death, GO:1904000|positive regulation of eating behavior, GO:1904056|positive regulation of cholangiocyte proliferation, GO:1904058|positive regulation of sensory perception of pain, GO:1904193|negative regulation of cholangiocyte apoptotic process, GO:1904197|positive regulation of granulosa cell proliferation, GO:1904206|positive regulation of skeletal muscle hypertrophy, GO:1904213|negative regulation of iodide transmembrane transport, GO:1904690|positive regulation of cytoplasmic translational initiation, GO:1990253|cellular response to leucine starvation","GO:0000166|nucleotide binding, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0044877|protein-containing complex binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0051219|phosphoprotein binding, GO:0001030|RNA polymerase III type 1 promoter DNA binding, GO:0001031|RNA polymerase III type 2 promoter DNA binding, GO:0001032|RNA polymerase III type 3 promoter DNA binding, GO:0001156|TFIIIC-class transcription factor complex binding, GO:0004672|protein kinase activity, GO:0019901|protein kinase binding, GO:0019904|protein domain specific binding, GO:0043022|ribosome binding"
GATA3,Silent,0.0752758651500371,33,0.677157673070611,N,"oncogene, TSG","",-0.0182153864979215,0.919857768740093,ENSG00000107485,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin","GO:0006355|regulation of transcription, DNA-templated, GO:0045582|positive regulation of T cell differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0007165|signal transduction, GO:0001822|kidney development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0008285|negative regulation of cell proliferation, GO:0016579|protein deubiquitination, GO:0008584|male gonad development, GO:0009615|response to virus, GO:0045786|negative regulation of cell cycle, GO:0050728|negative regulation of inflammatory response, GO:0071356|cellular response to tumor necrosis factor, GO:0045892|negative regulation of transcription, DNA-templated, GO:0032753|positive regulation of interleukin-4 production, GO:2000667|positive regulation of interleukin-13 secretion, GO:0006366|transcription by RNA polymerase II, GO:0045599|negative regulation of fat cell differentiation, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0019221|cytokine-mediated signaling pathway, GO:0050852|T cell receptor signaling pathway, GO:0009653|anatomical structure morphogenesis, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:0001709|cell fate determination, GO:0007596|blood coagulation, GO:0006952|defense response, GO:0043627|response to estrogen, GO:0010595|positive regulation of endothelial cell migration, GO:0051897|positive regulation of protein kinase B signaling, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0001823|mesonephros development, GO:0060037|pharyngeal system development, GO:0048485|sympathetic nervous system development, GO:2000611|positive regulation of thyroid hormone generation, GO:2000679|positive regulation of transcription regulatory region DNA binding, GO:0042421|norepinephrine biosynthetic process, GO:2000146|negative regulation of cell motility, GO:0035457|cellular response to interferon-alpha, GO:0048565|digestive tract development, GO:0071353|cellular response to interleukin-4, GO:0060231|mesenchymal to epithelial transition, GO:0031929|TOR signaling, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0000902|cell morphogenesis, GO:0001701|in utero embryonic development, GO:0001764|neuron migration, GO:0001775|cell activation, GO:0001806|type IV hypersensitivity, GO:0001819|positive regulation of cytokine production, GO:0002088|lens development in camera-type eye, GO:0002572|pro-T cell differentiation, GO:0003180|aortic valve morphogenesis, GO:0003215|cardiac right ventricle morphogenesis, GO:0003281|ventricular septum development, GO:0006338|chromatin remodeling, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006959|humoral immune response, GO:0007399|nervous system development, GO:0007411|axon guidance, GO:0009791|post-embryonic development, GO:0009967|positive regulation of signal transduction, GO:0010332|response to gamma radiation, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0010975|regulation of neuron projection development, GO:0030182|neuron differentiation, GO:0030217|T cell differentiation, GO:0030218|erythrocyte differentiation, GO:0032689|negative regulation of interferon-gamma production, GO:0032703|negative regulation of interleukin-2 production, GO:0032736|positive regulation of interleukin-13 production, GO:0032754|positive regulation of interleukin-5 production, GO:0033077|T cell differentiation in thymus, GO:0033600|negative regulation of mammary gland epithelial cell proliferation, GO:0035162|embryonic hemopoiesis, GO:0035799|ureter maturation, GO:0035898|parathyroid hormone secretion, GO:0042035|regulation of cytokine biosynthetic process, GO:0042472|inner ear morphogenesis, GO:0042493|response to drug, GO:0043370|regulation of CD4-positive, alpha-beta T cell differentiation, GO:0043523|regulation of neuron apoptotic process, GO:0043583|ear development, GO:0045061|thymic T cell selection, GO:0045064|T-helper 2 cell differentiation, GO:0045471|response to ethanol, GO:0045597|positive regulation of cell differentiation, GO:0048469|cell maturation, GO:0048538|thymus development, GO:0048568|embryonic organ development, GO:0048589|developmental growth, GO:0048646|anatomical structure formation involved in morphogenesis, GO:0048872|homeostasis of number of cells, GO:0051569|regulation of histone H3-K4 methylation, GO:0060017|parathyroid gland development, GO:0060065|uterus development, GO:0060374|mast cell differentiation, GO:0060676|ureteric bud formation, GO:0061085|regulation of histone H3-K27 methylation, GO:0061290|canonical Wnt signaling pathway involved in metanephric kidney development, GO:0071345|cellular response to cytokine stimulus, GO:0071442|positive regulation of histone H3-K14 acetylation, GO:0071599|otic vesicle development, GO:0071773|cellular response to BMP stimulus, GO:0072001|renal system development, GO:0072107|positive regulation of ureteric bud formation, GO:0072178|nephric duct morphogenesis, GO:0072179|nephric duct formation, GO:0072182|regulation of nephron tubule epithelial cell differentiation, GO:0072602|interleukin-4 secretion, GO:0072643|interferon-gamma secretion, GO:0072676|lymphocyte migration, GO:0090102|cochlea development, GO:1901536|negative regulation of DNA demethylation, GO:2000114|regulation of establishment of cell polarity, GO:2000553|positive regulation of T-helper 2 cell cytokine production, GO:2000607|negative regulation of cell proliferation involved in mesonephros development, GO:2000617|positive regulation of histone H3-K9 acetylation, GO:2000664|positive regulation of interleukin-5 secretion, GO:2000683|regulation of cellular response to X-ray, GO:2000703|negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation, GO:2000734|negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation","GO:0008270|zinc ion binding, GO:0003700|DNA-binding transcription factor activity, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0070888|E-box binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0071837|HMG box domain binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001158|enhancer sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003712|transcription coregulator activity, GO:0005134|interleukin-2 receptor binding, GO:0046983|protein dimerization activity"
TRIP11,Missense,0.069846381038306,143,0.40714762447172,N,fusion,"",0.235841530632463,0.00457374922535008,ENSG00000100815,"GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0016020|membrane, GO:0005794|Golgi apparatus, GO:0005634|nucleus, GO:0005856|cytoskeleton, GO:0005929|cilium, GO:0000139|Golgi membrane, GO:0030133|transport vesicle, GO:0002079|inner acrosomal membrane, GO:0002080|acrosomal membrane, GO:0002081|outer acrosomal membrane, GO:0005801|cis-Golgi network","GO:1903508|positive regulation of nucleic acid-templated transcription, GO:0035735|intraciliary transport involved in cilium assembly, GO:0006366|transcription by RNA polymerase II, GO:0003281|ventricular septum development, GO:0003413|chondrocyte differentiation involved in endochondral bone morphogenesis, GO:0006486|protein glycosylation, GO:0007030|Golgi organization, GO:0060122|inner ear receptor cell stereocilium organization, GO:0060348|bone development","GO:0005515|protein binding, GO:0003713|transcription coactivator activity"
TOP1,Missense,0.0697332980423628,45,0.648982313989318,N,fusion,"",-0.0193842037294385,0.899426529589078,ENSG00000198900,"GO:0005634|nucleus, GO:0001650|fibrillar center, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0000932|P-body, GO:0000228|nuclear chromosome, GO:0032993|protein-DNA complex, GO:0031298|replication fork protection complex, GO:0005737|cytoplasm, GO:0009330|DNA topoisomerase complex (ATP-hydrolyzing), GO:0043204|perikaryon","GO:0016310|phosphorylation, GO:0006265|DNA topological change, GO:0007623|circadian rhythm, GO:0048511|rhythmic process, GO:0032922|circadian regulation of gene expression, GO:0006338|chromatin remodeling, GO:0016032|viral process, GO:0012501|programmed cell death, GO:0007059|chromosome segregation, GO:0006260|DNA replication, GO:0042493|response to drug, GO:0018105|peptidyl-serine phosphorylation, GO:0040016|embryonic cleavage","GO:0003723|RNA binding, GO:0016853|isomerase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0003916|DNA topoisomerase activity, GO:0003917|DNA topoisomerase type I activity, GO:0003682|chromatin binding, GO:0019904|protein domain specific binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0005524|ATP binding, GO:0003690|double-stranded DNA binding, GO:0003697|single-stranded DNA binding, GO:0004674|protein serine/threonine kinase activity, GO:0097100|supercoiled DNA binding"
ETV5,Missense,0.0675702132183138,68,0.584039220870088,N,"oncogene, fusion",Oncogene,0.11303331638653,0.358743717205863,ENSG00000244405,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005886|plasma membrane","GO:0006355|regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0034599|cellular response to oxidative stress, GO:0007274|neuromuscular synaptic transmission, GO:0007626|locomotory behavior, GO:0045666|positive regulation of neuron differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0048133|male germ-line stem cell asymmetric division, GO:0050807|regulation of synapse organization, GO:0060252|positive regulation of glial cell proliferation, GO:0060762|regulation of branching involved in mammary gland duct morphogenesis, GO:0071340|skeletal muscle acetylcholine-gated channel clustering","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding"
SPEN,Silent,0.0673692057171381,109,0.486405265609227,N,TSG,TSG,0.158459322819216,0.0998242456051336,ENSG00000065526,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0017053|transcriptional repressor complex","GO:0007219|Notch signaling pathway, GO:0016032|viral process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0050769|positive regulation of neurogenesis","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0003714|transcription corepressor activity"
EP300,Silent,0.0672697931630012,37,0.692407135080341,N,"TSG, fusion",TSG,0.0953205910138528,0.574666440435691,ENSG00000100393,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0000123|histone acetyltransferase complex, GO:0032993|protein-DNA complex, GO:0005667|transcription factor complex, GO:0032991|protein-containing complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007049|cell cycle, GO:0007623|circadian rhythm, GO:0048511|rhythmic process, GO:0006915|apoptotic process, GO:0016573|histone acetylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045444|fat cell differentiation, GO:0031648|protein destabilization, GO:0050821|protein stabilization, GO:0045721|negative regulation of gluconeogenesis, GO:0001666|response to hypoxia, GO:0016032|viral process, GO:0007399|nervous system development, GO:0045815|positive regulation of gene expression, epigenetic, GO:0043967|histone H4 acetylation, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:1904837|beta-catenin-TCF complex assembly, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0043627|response to estrogen, GO:0045652|regulation of megakaryocyte differentiation, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0034644|cellular response to UV, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0006283|transcription-coupled nucleotide-excision repair, GO:0006473|protein acetylation, GO:1900034|regulation of cellular response to heat, GO:0051726|regulation of cell cycle, GO:0018393|internal peptidyl-lysine acetylation, GO:0007219|Notch signaling pathway, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0010976|positive regulation of neuron projection development, GO:0010506|regulation of autophagy, GO:0032481|positive regulation of type I interferon production, GO:0006990|positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response, GO:0060765|regulation of androgen receptor signaling pathway, GO:0006475|internal protein amino acid acetylation, GO:0010742|macrophage derived foam cell differentiation, GO:0007221|positive regulation of transcription of Notch receptor target, GO:0045747|positive regulation of Notch signaling pathway, GO:0043923|positive regulation by host of viral transcription, GO:0045893|positive regulation of transcription, DNA-templated, GO:0001756|somitogenesis, GO:0007507|heart development, GO:0007519|skeletal muscle tissue development, GO:0009887|animal organ morphogenesis, GO:0010628|positive regulation of gene expression, GO:0018076|N-terminal peptidyl-lysine acetylation, GO:0018394|peptidyl-lysine acetylation, GO:0030183|B cell differentiation, GO:0030220|platelet formation, GO:0030324|lung development, GO:0032092|positive regulation of protein binding, GO:0032460|negative regulation of protein oligomerization, GO:0035855|megakaryocyte development, GO:0043969|histone H2B acetylation, GO:0061921|peptidyl-lysine propionylation, GO:0090043|regulation of tubulin deacetylation, GO:0140066|peptidyl-lysine crotonylation, GO:0140067|peptidyl-lysine butyrylation","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003713|transcription coactivator activity, GO:0003712|transcription coregulator activity, GO:0003677|DNA binding, GO:0016746|transferase activity, transferring acyl groups, GO:0005515|protein binding, GO:0004402|histone acetyltransferase activity, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0048156|tau protein binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0008013|beta-catenin binding, GO:0003684|damaged DNA binding, GO:0035257|nuclear hormone receptor binding, GO:0050681|androgen receptor binding, GO:0008022|protein C-terminus binding, GO:0033613|activating transcription factor binding, GO:0016407|acetyltransferase activity, GO:0001085|RNA polymerase II transcription factor binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0002039|p53 binding, GO:0004468|lysine N-acetyltransferase activity, acting on acetyl phosphate as donor, GO:0031490|chromatin DNA binding, GO:0034212|peptide N-acetyltransferase activity, GO:0061733|peptide-lysine-N-acetyltransferase activity, GO:0061920|protein propionyltransferase activity, GO:0097157|pre-mRNA intronic binding, GO:0097677|STAT family protein binding, GO:0140065|peptide butyryltransferase activity, GO:0140068|histone crotonyltransferase activity, GO:0140069|histone butyryltransferase activity"
RNF213,Silent,0.0658838151194287,101,0.512729023666764,N,fusion,"",0.0636134689792456,0.527393162032411,ENSG00000173821,"GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005737|cytoplasm, GO:0016020|membrane","GO:0016567|protein ubiquitination, GO:0001525|angiogenesis, GO:0051865|protein autoubiquitination, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0002040|sprouting angiogenesis, GO:0051260|protein homooligomerization, GO:0000209|protein polyubiquitination, GO:2000051|negative regulation of non-canonical Wnt signaling pathway","GO:0046872|metal ion binding, GO:0004842|ubiquitin-protein transferase activity, GO:0016887|ATPase activity, GO:0016740|transferase activity, GO:0016787|hydrolase activity"
SUFU,Missense,0.0649375110100143,39,0.694500171279675,N,TSG,TSG,-0.0524991578554317,0.750933183986304,ENSG00000107882,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0097542|ciliary tip, GO:0005829|cytosol, GO:0097546|ciliary base, GO:0005929|cilium","GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045668|negative regulation of osteoblast differentiation, GO:0007275|multicellular organism development, GO:0007165|signal transduction, GO:0006355|regulation of transcription, DNA-templated, GO:0001501|skeletal system development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045879|negative regulation of smoothened signaling pathway, GO:0006508|proteolysis, GO:0042994|cytoplasmic sequestering of transcription factor, GO:0001843|neural tube closure, GO:0001947|heart looping, GO:0003281|ventricular septum development, GO:0007368|determination of left/right symmetry, GO:0021513|spinal cord dorsal/ventral patterning, GO:0021775|smoothened signaling pathway involved in ventral spinal cord interneuron specification, GO:0021776|smoothened signaling pathway involved in spinal cord motor neuron cell fate specification, GO:0035904|aorta development, GO:0042308|negative regulation of protein import into nucleus, GO:0043588|skin development, GO:0060976|coronary vasculature development, GO:1901621|negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning, GO:2000059|negative regulation of ubiquitin-dependent protein catabolic process","GO:0008134|transcription factor binding, GO:0005515|protein binding, GO:0003714|transcription corepressor activity, GO:0019901|protein kinase binding, GO:0008013|beta-catenin binding"
ATP2B3,Silent,0.0632535501283378,65,0.616671545543353,N,TSG,TSG,0.122556745689958,0.330759721187875,ENSG00000067842,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0098793|presynapse, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:1903561|extracellular vesicle, GO:0098978|glutamatergic synapse, GO:0098982|GABA-ergic synapse","GO:0006811|ion transport, GO:0006816|calcium ion transport, GO:0070588|calcium ion transmembrane transport, GO:0099132|ATP hydrolysis coupled cation transmembrane transport, GO:0099509|regulation of presynaptic cytosolic calcium ion concentration, GO:0034220|ion transmembrane transport, GO:1903779|regulation of cardiac conduction, GO:0006874|cellular calcium ion homeostasis, GO:0051480|regulation of cytosolic calcium ion concentration, GO:1990034|calcium ion export across plasma membrane","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0005388|calcium-transporting ATPase activity, GO:0005516|calmodulin binding, GO:0030165|PDZ domain binding, GO:0005515|protein binding, GO:0015085|calcium ion transmembrane transporter activity, GO:1905056|calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration"
SLC34A2,Silent,0.0631702313021723,49,0.666317538692383,N,"TSG, fusion",TSG,0.109321507770987,0.454616524740479,ENSG00000157765,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0016324|apical plasma membrane, GO:0031982|vesicle, GO:0031526|brush border membrane, GO:0005903|brush border","GO:0006811|ion transport, GO:0006814|sodium ion transport, GO:0035725|sodium ion transmembrane transport, GO:0055085|transmembrane transport, GO:0044341|sodium-dependent phosphate transport, GO:0044267|cellular protein metabolic process, GO:0006817|phosphate ion transport, GO:0043627|response to estrogen, GO:0030643|cellular phosphate ion homeostasis, GO:0001701|in utero embryonic development","GO:0015293|symporter activity, GO:0015321|sodium-dependent phosphate transmembrane transporter activity, GO:0042301|phosphate ion binding, GO:0005436|sodium:phosphate symporter activity, GO:0031402|sodium ion binding"
MITF,Missense,0.0624760945394483,37,0.713363213125439,N,Oncogene,Oncogene,-0.0595708280037601,0.72616643955282,ENSG00000187098,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex","GO:0030336|negative regulation of cell migration, GO:0006355|regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007275|multicellular organism development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0010628|positive regulation of gene expression, GO:0065003|protein-containing complex assembly, GO:0006351|transcription, DNA-templated, GO:0010468|regulation of gene expression, GO:0016055|Wnt signaling pathway, GO:0030154|cell differentiation, GO:0030316|osteoclast differentiation, GO:0030318|melanocyte differentiation, GO:0042127|regulation of cell proliferation, GO:0043010|camera-type eye development, GO:0043066|negative regulation of apoptotic process, GO:0043473|pigmentation, GO:0044336|canonical Wnt signaling pathway involved in negative regulation of apoptotic process, GO:0045165|cell fate commitment, GO:0045670|regulation of osteoclast differentiation, GO:0046849|bone remodeling, GO:2000144|positive regulation of DNA-templated transcription, initiation, GO:2001141|regulation of RNA biosynthetic process, GO:0006959|humoral immune response","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0070888|E-box binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0003682|chromatin binding"
H3F3B,Missense,0.0619142627057706,15,0.82649510709521,N,Oncogene,Oncogene,-0.0264548995585094,0.925438068234757,ENSG00000132475,"GO:0005634|nucleus, GO:0000786|nucleosome, GO:0005694|chromosome, GO:0005576|extracellular region, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0032991|protein-containing complex, GO:0000784|nuclear chromosome, telomeric region, GO:0000228|nuclear chromosome, GO:0000788|nuclear nucleosome","GO:0006334|nucleosome assembly, GO:0044267|cellular protein metabolic process, GO:0030307|positive regulation of cell growth, GO:0007596|blood coagulation, GO:0045652|regulation of megakaryocyte differentiation, GO:0006336|DNA replication-independent nucleosome assembly, GO:0060964|regulation of gene silencing by miRNA, GO:0000183|chromatin silencing at rDNA, GO:0045814|negative regulation of gene expression, epigenetic, GO:0032200|telomere organization","GO:0003677|DNA binding, GO:0046982|protein heterodimerization activity, GO:0005515|protein binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0000979|RNA polymerase II core promoter sequence-specific DNA binding, GO:0031492|nucleosomal DNA binding"
CREB3L1,Missense,0.0612398676402914,44,0.692919672759041,N,"TSG, fusion",TSG,0.159283677498459,0.301714564672152,ENSG00000157613,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0000790|nuclear chromatin","GO:0010629|negative regulation of gene expression, GO:1903671|negative regulation of sprouting angiogenesis, GO:0040037|negative regulation of fibroblast growth factor receptor signaling pathway, GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030968|endoplasmic reticulum unfolded protein response, GO:0006986|response to unfolded protein, GO:0045892|negative regulation of transcription, DNA-templated, GO:1990440|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress, GO:0001649|osteoblast differentiation, GO:1902236|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway, GO:0032967|positive regulation of collagen biosynthetic process, GO:0070278|extracellular matrix constituent secretion","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0035497|cAMP response element binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0046332|SMAD binding, GO:0044212|transcription regulatory region DNA binding, GO:0003682|chromatin binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
BCR,Silent,0.0612271446386374,49,0.676006832208851,N,fusion,"",0.0791426156794026,0.588820694009107,ENSG00000186716,"GO:0016020|membrane, GO:0005886|plasma membrane, GO:0030054|cell junction, GO:0045202|synapse, GO:0045211|postsynaptic membrane, GO:0005829|cytosol, GO:0070062|extracellular exosome, GO:0014069|postsynaptic density, GO:0032991|protein-containing complex, GO:0005737|cytoplasm","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0007165|signal transduction, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0035023|regulation of Rho protein signal transduction, GO:0043547|positive regulation of GTPase activity, GO:0051056|regulation of small GTPase mediated signal transduction, GO:0002692|negative regulation of cellular extravasation, GO:0003014|renal system process, GO:0007420|brain development, GO:0030036|actin cytoskeleton organization, GO:0030336|negative regulation of cell migration, GO:0032496|response to lipopolysaccharide, GO:0042472|inner ear morphogenesis, GO:0043114|regulation of vascular permeability, GO:0043314|negative regulation of neutrophil degranulation, GO:0046777|protein autophosphorylation, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0048872|homeostasis of number of cells, GO:0050728|negative regulation of inflammatory response, GO:0050766|positive regulation of phagocytosis, GO:0050885|neuromuscular process controlling balance, GO:0051171|regulation of nitrogen compound metabolic process, GO:0051726|regulation of cell cycle, GO:0060216|definitive hemopoiesis, GO:0060268|negative regulation of respiratory burst, GO:0060313|negative regulation of blood vessel remodeling, GO:0065002|intracellular protein transmembrane transport, GO:0071222|cellular response to lipopolysaccharide, GO:2000378|negative regulation of reactive oxygen species metabolic process","GO:0000166|nucleotide binding, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005085|guanyl-nucleotide exchange factor activity, GO:0005089|Rho guanyl-nucleotide exchange factor activity, GO:0005096|GTPase activator activity, GO:0005515|protein binding, GO:0004713|protein tyrosine kinase activity, GO:0019899|enzyme binding"
TSC2,Silent,0.0606706687142543,65,0.631160350333336,N,TSG,TSG,0.108239734728663,0.390754591508965,ENSG00000103197,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005794|Golgi apparatus, GO:0048471|perinuclear region of cytoplasm, GO:0005764|lysosome, GO:0033596|TSC1-TSC2 complex, GO:0014069|postsynaptic density","GO:0032007|negative regulation of TOR signaling, GO:0043547|positive regulation of GTPase activity, GO:0051056|regulation of small GTPase mediated signal transduction, GO:0051726|regulation of cell cycle, GO:0007507|heart development, GO:0008285|negative regulation of cell proliferation, GO:0030178|negative regulation of Wnt signaling pathway, GO:0016032|viral process, GO:0006606|protein import into nucleus, GO:0008104|protein localization, GO:0046627|negative regulation of insulin receptor signaling pathway, GO:0006469|negative regulation of protein kinase activity, GO:0014067|negative regulation of phosphatidylinositol 3-kinase signaling, GO:0051898|negative regulation of protein kinase B signaling, GO:0046626|regulation of insulin receptor signaling pathway, GO:0001843|neural tube closure, GO:0050918|positive chemotaxis, GO:0016192|vesicle-mediated transport, GO:0030100|regulation of endocytosis, GO:0006897|endocytosis, GO:0043491|protein kinase B signaling, GO:0048009|insulin-like growth factor receptor signaling pathway, GO:0043276|anoikis, GO:0016239|positive regulation of macroautophagy, GO:1901525|negative regulation of mitophagy","GO:0042803|protein homodimerization activity, GO:0005096|GTPase activator activity, GO:0005515|protein binding, GO:0019902|phosphatase binding, GO:0051879|Hsp90 protein binding, GO:0031267|small GTPase binding"
KDR,Silent,0.0600168724225133,65,0.634850190366933,N,Oncogene,Oncogene,0.092723655128087,0.462557719257987,ENSG00000128052,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0030054|cell junction, GO:0031410|cytoplasmic vesicle, GO:0045121|membrane raft, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005768|endosome, GO:0005769|early endosome, GO:0097443|sorting endosome","GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:0010629|negative regulation of gene expression, GO:0045766|positive regulation of angiogenesis, GO:0008284|positive regulation of cell proliferation, GO:0010595|positive regulation of endothelial cell migration, GO:0090050|positive regulation of cell migration involved in sprouting angiogenesis, GO:0030335|positive regulation of cell migration, GO:0008360|regulation of cell shape, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0038084|vascular endothelial growth factor signaling pathway, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0001934|positive regulation of protein phosphorylation, GO:0016032|viral process, GO:0001525|angiogenesis, GO:0016477|cell migration, GO:0043066|negative regulation of apoptotic process, GO:0001938|positive regulation of endothelial cell proliferation, GO:0046777|protein autophosphorylation, GO:0030198|extracellular matrix organization, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:0035924|cellular response to vascular endothelial growth factor stimulus, GO:0002042|cell migration involved in sprouting angiogenesis, GO:0051894|positive regulation of focal adhesion assembly, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0002040|sprouting angiogenesis, GO:0016239|positive regulation of macroautophagy, GO:0001570|vasculogenesis, GO:0035584|calcium-mediated signaling using intracellular calcium source, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0038033|positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway, GO:0070371|ERK1 and ERK2 cascade, GO:0051901|positive regulation of mitochondrial depolarization, GO:0090141|positive regulation of mitochondrial fission, GO:0050927|positive regulation of positive chemotaxis, GO:0035162|embryonic hemopoiesis, GO:2001214|positive regulation of vasculogenesis, GO:0003158|endothelium development, GO:0043491|protein kinase B signaling, GO:0045446|endothelial cell differentiation, GO:0051770|positive regulation of nitric-oxide synthase biosynthetic process, GO:1904881|cellular response to hydrogen sulfide","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005021|vascular endothelial growth factor-activated receptor activity, GO:0019838|growth factor binding, GO:0042802|identical protein binding, GO:0051879|Hsp90 protein binding, GO:0005178|integrin binding, GO:0038085|vascular endothelial growth factor binding"
NONO,Missense,0.0599439842917061,47,0.688972780481612,N,fusion,"",-0.00531484601972248,0.971716279047641,ENSG00000147140,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0090575|RNA polymerase II transcription factor complex, GO:0016363|nuclear matrix, GO:0042382|paraspeckles","GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0006281|DNA repair, GO:0006310|DNA recombination, GO:0006974|cellular response to DNA damage stimulus, GO:0007623|circadian rhythm, GO:0048511|rhythmic process, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0006357|regulation of transcription by RNA polymerase II, GO:0042752|regulation of circadian rhythm, GO:0045892|negative regulation of transcription, DNA-templated, GO:0002218|activation of innate immune response, GO:1903377|negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0070888|E-box binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000976|transcription regulatory region sequence-specific DNA binding"
CDH1,Missense,0.0573059725939193,108,0.555797052870848,N,TSG,TSG,0.0366967218337327,0.706134253158784,ENSG00000039068,"GO:0048471|perinuclear region of cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005794|Golgi apparatus, GO:0030054|cell junction, GO:0005576|extracellular region, GO:0005737|cytoplasm, GO:0009986|cell surface, GO:0005768|endosome, GO:0030027|lamellipodium, GO:0070062|extracellular exosome, GO:0043296|apical junction complex, GO:0005913|cell-cell adherens junction, GO:0015629|actin cytoskeleton, GO:0009898|cytoplasmic side of plasma membrane, GO:0030864|cortical actin cytoskeleton, GO:0016328|lateral plasma membrane, GO:0016342|catenin complex, GO:0016600|flotillin complex, GO:0005802|trans-Golgi network","GO:0030336|negative regulation of cell migration, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007155|cell adhesion, GO:0007156|homophilic cell adhesion via plasma membrane adhesion molecules, GO:0098609|cell-cell adhesion, GO:0007416|synapse assembly, GO:0009636|response to toxic substance, GO:0010033|response to organic substance, GO:0021983|pituitary gland development, GO:0031175|neuron projection development, GO:0042493|response to drug, GO:0007043|cell-cell junction assembly, GO:0030198|extracellular matrix organization, GO:0022408|negative regulation of cell-cell adhesion, GO:0072659|protein localization to plasma membrane, GO:0034332|adherens junction organization, GO:0035635|entry of bacterium into host cell, GO:0000902|cell morphogenesis, GO:0010468|regulation of gene expression, GO:0042307|positive regulation of protein import into nucleus, GO:0016339|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules, GO:0044331|cell-cell adhesion mediated by cadherin, GO:0071285|cellular response to lithium ion, GO:0071681|cellular response to indole-3-methanol","GO:0046872|metal ion binding, GO:0005509|calcium ion binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0045296|cadherin binding, GO:0042803|protein homodimerization activity, GO:0008092|cytoskeletal protein binding, GO:0008013|beta-catenin binding, GO:0030506|ankyrin binding, GO:0050839|cell adhesion molecule binding, GO:0032794|GTPase activating protein binding, GO:0045295|gamma-catenin binding"
CLIP1,Silent,0.0554609912989568,42,0.727201962373413,N,fusion,"",0.0827044053901645,0.60257297928632,ENSG00000130779,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0031410|cytoplasmic vesicle, GO:0005874|microtubule, GO:0030659|cytoplasmic vesicle membrane, GO:0005813|centrosome, GO:0000776|kinetochore, GO:0005829|cytosol, GO:0015630|microtubule cytoskeleton, GO:0001726|ruffle, GO:0005768|endosome, GO:0005882|intermediate filament, GO:0035371|microtubule plus-end, GO:0044354|macropinosome, GO:0005635|nuclear envelope, GO:0005881|cytoplasmic microtubule","GO:0001578|microtubule bundle formation, GO:0000278|mitotic cell cycle, GO:0031116|positive regulation of microtubule polymerization, GO:0044861|protein transport into plasma membrane raft","GO:0046872|metal ion binding, GO:0008270|zinc ion binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0015631|tubulin binding, GO:0051010|microtubule plus-end binding"
PTCH1,Missense,0.0535269137127611,128,0.548454492222482,N,TSG,TSG,0.0493478091928304,0.580149024132962,ENSG00000185920,"GO:0048471|perinuclear region of cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0030666|endocytic vesicle membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005901|caveola, GO:0005794|Golgi apparatus, GO:0060170|ciliary membrane, GO:0005634|nucleus, GO:0005929|cilium, GO:0014069|postsynaptic density, GO:0030496|midbody, GO:0044294|dendritic growth cone, GO:0044295|axonal growth cone","GO:0071397|cellular response to cholesterol, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045668|negative regulation of osteoblast differentiation, GO:0007224|smoothened signaling pathway, GO:0060037|pharyngeal system development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0009887|animal organ morphogenesis, GO:0016485|protein processing, GO:0009953|dorsal/ventral pattern formation, GO:0040015|negative regulation of multicellular organism growth, GO:0010875|positive regulation of cholesterol efflux, GO:0072001|renal system development, GO:0007420|brain development, GO:0072659|protein localization to plasma membrane, GO:0008589|regulation of smoothened signaling pathway, GO:0045879|negative regulation of smoothened signaling pathway, GO:0061053|somite development, GO:0030326|embryonic limb morphogenesis, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0001701|in utero embryonic development, GO:0001709|cell fate determination, GO:0001841|neural tube formation, GO:0001843|neural tube closure, GO:0003007|heart morphogenesis, GO:0007165|signal transduction, GO:0007346|regulation of mitotic cell cycle, GO:0007389|pattern specification process, GO:0008285|negative regulation of cell proliferation, GO:0008544|epidermis development, GO:0009612|response to mechanical stimulus, GO:0009957|epidermal cell fate specification, GO:0010157|response to chlorate, GO:0014070|response to organic cyclic compound, GO:0021522|spinal cord motor neuron differentiation, GO:0021532|neural tube patterning, GO:0021904|dorsal/ventral neural tube patterning, GO:0021997|neural plate axis specification, GO:0030850|prostate gland development, GO:0030879|mammary gland development, GO:0032355|response to estradiol, GO:0032526|response to retinoic acid, GO:0032880|regulation of protein localization, GO:0035108|limb morphogenesis, GO:0035137|hindlimb morphogenesis, GO:0040008|regulation of growth, GO:0042127|regulation of cell proliferation, GO:0042493|response to drug, GO:0042593|glucose homeostasis, GO:0043616|keratinocyte proliferation, GO:0045606|positive regulation of epidermal cell differentiation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0048568|embryonic organ development, GO:0050680|negative regulation of epithelial cell proliferation, GO:0051782|negative regulation of cell division, GO:0060603|mammary gland duct morphogenesis, GO:0060644|mammary gland epithelial cell differentiation, GO:0060831|smoothened signaling pathway involved in dorsal/ventral neural tube patterning, GO:0061005|cell differentiation involved in kidney development, GO:0071679|commissural neuron axon guidance, GO:0072203|cell proliferation involved in metanephros development, GO:0097421|liver regeneration","GO:0005515|protein binding, GO:0015485|cholesterol binding, GO:0030332|cyclin binding, GO:0005113|patched binding, GO:0005119|smoothened binding, GO:0008158|hedgehog receptor activity, GO:0008201|heparin binding, GO:0044877|protein-containing complex binding, GO:0097108|hedgehog family protein binding"
TERT,Missense,0.051981388015045,83,0.640709756633045,N,"oncogene, TSG","",0.0673206576043019,0.545374632970242,ENSG00000164362,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0005829|cytosol, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0000781|chromosome, telomeric region, GO:0000784|nuclear chromosome, telomeric region, GO:0016605|PML body, GO:0042645|mitochondrial nucleoid, GO:0000333|telomerase catalytic core complex, GO:0000783|nuclear telomere cap complex, GO:0005697|telomerase holoenzyme complex, GO:0005739|mitochondrion, GO:0005886|plasma membrane, GO:0031379|RNA-directed RNA polymerase complex, GO:1990572|TERT-RMRP complex","GO:0010629|negative regulation of gene expression, GO:2000773|negative regulation of cellular senescence, GO:0071456|cellular response to hypoxia, GO:0000723|telomere maintenance, GO:1904837|beta-catenin-TCF complex assembly, GO:0001172|transcription, RNA-templated, GO:0006278|RNA-dependent DNA biosynthetic process, GO:0007004|telomere maintenance via telomerase, GO:0007005|mitochondrion organization, GO:0022616|DNA strand elongation, GO:0030177|positive regulation of Wnt signaling pathway, GO:0030422|production of siRNA involved in RNA interference, GO:0031647|regulation of protein stability, GO:0032092|positive regulation of protein binding, GO:0032774|RNA biosynthetic process, GO:0042635|positive regulation of hair cycle, GO:0043066|negative regulation of apoptotic process, GO:0043524|negative regulation of neuron apoptotic process, GO:0045766|positive regulation of angiogenesis, GO:0046326|positive regulation of glucose import, GO:0046686|response to cadmium ion, GO:0051000|positive regulation of nitric-oxide synthase activity, GO:0060253|negative regulation of glial cell proliferation, GO:0070200|establishment of protein localization to telomere, GO:0071897|DNA biosynthetic process, GO:0090399|replicative senescence, GO:1900087|positive regulation of G1/S transition of mitotic cell cycle, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:1903620|positive regulation of transdifferentiation, GO:1903704|negative regulation of production of siRNA involved in RNA interference, GO:1904707|positive regulation of vascular smooth muscle cell proliferation, GO:1904751|positive regulation of protein localization to nucleolus, GO:1904754|positive regulation of vascular associated smooth muscle cell migration, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:2000648|positive regulation of stem cell proliferation, GO:2001240|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0016779|nucleotidyltransferase activity, GO:0042802|identical protein binding, GO:0042803|protein homodimerization activity, GO:0000049|tRNA binding, GO:0001223|transcription coactivator binding, GO:0003720|telomerase activity, GO:0003721|telomerase RNA reverse transcriptase activity, GO:0003723|RNA binding, GO:0003964|RNA-directed DNA polymerase activity, GO:0003968|RNA-directed 5'-3' RNA polymerase activity, GO:0008022|protein C-terminus binding, GO:0042162|telomeric DNA binding, GO:0047485|protein N-terminus binding, GO:0051087|chaperone binding, GO:0070034|telomerase RNA binding, GO:0098680|template-free RNA nucleotidyltransferase"
SLC45A3,Missense,0.0511001725962345,49,0.727318297681135,N,fusion,"",-0.0465387381937791,0.750838897157446,ENSG00000158715,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane","GO:0055085|transmembrane transport, GO:0008645|hexose transmembrane transport, GO:0015770|sucrose transport, GO:0010907|positive regulation of glucose metabolic process, GO:0045723|positive regulation of fatty acid biosynthetic process, GO:0048713|regulation of oligodendrocyte differentiation","GO:0008506|sucrose:proton symporter activity, GO:0051119|sugar transmembrane transporter activity"
FBXO11,Silent,0.0510936895376045,17,0.845592916925176,N,TSG,TSG,-0.122565996570664,0.639331510441222,ENSG00000138081,"GO:0000151|ubiquitin ligase complex, GO:0005634|nucleus, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005694|chromosome, GO:0005737|cytoplasm","GO:0016567|protein ubiquitination, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0043687|post-translational protein modification, GO:0000209|protein polyubiquitination, GO:0006464|cellular protein modification process, GO:0035246|peptidyl-arginine N-methylation, GO:0007605|sensory perception of sound","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0016274|protein-arginine N-methyltransferase activity"
HSP90AA1,Missense,0.0506361981984645,56,0.710922027216261,N,fusion,"",-0.0118547525700924,0.930898065638024,ENSG00000080824,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0042470|melanosome, GO:0005576|extracellular region, GO:0009986|cell surface, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0032991|protein-containing complex, GO:0043025|neuronal cell body, GO:0034774|secretory granule lumen, GO:1904813|ficolin-1-rich granule lumen, GO:0048471|perinuclear region of cytoplasm, GO:0044295|axonal growth cone, GO:0071682|endocytic vesicle lumen, GO:0043209|myelin sheath, GO:0043202|lysosomal lumen, GO:0044294|dendritic growth cone","GO:0051897|positive regulation of protein kinase B signaling, GO:0001934|positive regulation of protein phosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0006457|protein folding, GO:0007165|signal transduction, GO:0009409|response to cold, GO:0009408|response to heat, GO:0006898|receptor-mediated endocytosis, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0034605|cellular response to heat, GO:0006986|response to unfolded protein, GO:0050821|protein stabilization, GO:0000086|G2/M transition of mitotic cell cycle, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0097711|ciliary basal body-plasma membrane docking, GO:0043312|neutrophil degranulation, GO:0046677|response to antibiotic, GO:0019221|cytokine-mediated signaling pathway, GO:0050999|regulation of nitric-oxide synthase activity, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0038128|ERBB2 signaling pathway, GO:0051973|positive regulation of telomerase activity, GO:0007004|telomere maintenance via telomerase, GO:0042026|protein refolding, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:1900034|regulation of cellular response to heat, GO:1902949|positive regulation of tau-protein kinase activity, GO:0006839|mitochondrial transport, GO:0021955|central nervous system neuron axonogenesis, GO:0030010|establishment of cell polarity, GO:0031396|regulation of protein ubiquitination, GO:0032273|positive regulation of protein polymerization, GO:0043254|regulation of protein complex assembly, GO:0043335|protein unfolding, GO:0045040|protein import into mitochondrial outer membrane, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0048675|axon extension, GO:0051131|chaperone-mediated protein complex assembly, GO:0051186|cofactor metabolic process, GO:0061684|chaperone-mediated autophagy, GO:1903364|positive regulation of cellular protein catabolic process, GO:1903827|regulation of cellular protein localization, GO:1905323|telomerase holoenzyme complex assembly","GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0051082|unfolded protein binding, GO:0042802|identical protein binding, GO:0016887|ATPase activity, GO:0030911|TPR domain binding, GO:0048156|tau protein binding, GO:0004713|protein tyrosine kinase activity, GO:0042826|histone deacetylase binding, GO:0097110|scaffold protein binding, GO:0051020|GTPase binding, GO:0097718|disordered domain specific binding, GO:0030235|nitric-oxide synthase regulator activity, GO:1990782|protein tyrosine kinase binding, GO:0023026|MHC class II protein complex binding, GO:0031625|ubiquitin protein ligase binding, GO:0042623|ATPase activity, coupled, GO:0070182|DNA polymerase binding"
PLAG1,Silent,0.05,22,0.825116529961507,N,"oncogene, fusion",Oncogene,0.0825776429384782,0.714857947766816,ENSG00000181690,"GO:0005634|nucleus, GO:0016607|nuclear speck","GO:0006351|transcription, DNA-templated, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0022612|gland morphogenesis, GO:0035264|multicellular organism growth, GO:0035265|organ growth, GO:0060252|positive regulation of glial cell proliferation, GO:0060736|prostate gland growth, GO:0006355|regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
IL6ST,Missense,0.0498583818483336,77,0.666746506430816,N,Oncogene,Oncogene,-0.016053979432017,0.88978376608358,ENSG00000134352,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0009897|external side of plasma membrane, GO:0043235|receptor complex, GO:0070062|extracellular exosome, GO:0005896|interleukin-6 receptor complex, GO:0070110|ciliary neurotrophic factor receptor complex, GO:0005900|oncostatin-M receptor complex, GO:0030425|dendrite, GO:0043025|neuronal cell body, GO:0044297|cell body","GO:0008284|positive regulation of cell proliferation, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0043066|negative regulation of apoptotic process, GO:0010613|positive regulation of cardiac muscle hypertrophy, GO:0002675|positive regulation of acute inflammatory response, GO:0045669|positive regulation of osteoblast differentiation, GO:0042102|positive regulation of T cell proliferation, GO:0016032|viral process, GO:0019221|cytokine-mediated signaling pathway, GO:0070102|interleukin-6-mediated signaling pathway, GO:0070106|interleukin-27-mediated signaling pathway, GO:0070757|interleukin-35-mediated signaling pathway, GO:0010575|positive regulation of vascular endothelial growth factor production, GO:0034097|response to cytokine, GO:0070120|ciliary neurotrophic factor-mediated signaling pathway, GO:0038165|oncostatin-M-mediated signaling pathway, GO:0048861|leukemia inhibitory factor signaling pathway, GO:0002821|positive regulation of adaptive immune response, GO:0005977|glycogen metabolic process, GO:0007165|signal transduction, GO:0008593|regulation of Notch signaling pathway, GO:0038154|interleukin-11-mediated signaling pathway, GO:0048711|positive regulation of astrocyte differentiation","GO:0005515|protein binding, GO:0004896|cytokine receptor activity, GO:0042802|identical protein binding, GO:0042803|protein homodimerization activity, GO:0019838|growth factor binding, GO:0005127|ciliary neurotrophic factor receptor binding, GO:0019955|cytokine binding, GO:0005138|interleukin-6 receptor binding, GO:0004897|ciliary neurotrophic factor receptor activity, GO:0004915|interleukin-6 receptor activity, GO:0019981|interleukin-6 binding, GO:0004923|leukemia inhibitory factor receptor activity, GO:0004924|oncostatin-M receptor activity, GO:0004921|interleukin-11 receptor activity, GO:0019970|interleukin-11 binding, GO:0045509|interleukin-27 receptor activity"
PICALM,Missense,0.0489526835778897,47,0.743848131839309,N,fusion,"",-0.0366185519740076,0.806947355380499,ENSG00000073921,"GO:0048471|perinuclear region of cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005794|Golgi apparatus, GO:0031410|cytoplasmic vesicle, GO:0030136|clathrin-coated vesicle, GO:0005905|clathrin-coated pit, GO:0005829|cytosol, GO:0009986|cell surface, GO:0042734|presynaptic membrane, GO:0030132|clathrin coat of coated pit, GO:0030122|AP-2 adaptor complex, GO:0045334|clathrin-coated endocytic vesicle, GO:0045211|postsynaptic membrane, GO:0005769|early endosome, GO:0097418|neurofibrillary tangle, GO:0031224|intrinsic component of membrane, GO:0031982|vesicle, GO:0043025|neuronal cell body, GO:0070381|endosome to plasma membrane transport vesicle","GO:0045893|positive regulation of transcription, DNA-templated, GO:0006897|endocytosis, GO:0048268|clathrin coat assembly, GO:0061024|membrane organization, GO:0065003|protein-containing complex assembly, GO:0016192|vesicle-mediated transport, GO:0006898|receptor-mediated endocytosis, GO:0007611|learning or memory, GO:0090647|modulation of age-related behavioral decline, GO:0016197|endosomal transport, GO:0043547|positive regulation of GTPase activity, GO:1903077|negative regulation of protein localization to plasma membrane, GO:0032880|regulation of protein localization, GO:0048261|negative regulation of receptor-mediated endocytosis, GO:1901216|positive regulation of neuron death, GO:1902004|positive regulation of amyloid-beta formation, GO:0150093|amyloid-beta clearance by transcytosis, GO:0031623|receptor internalization, GO:0030100|regulation of endocytosis, GO:0072583|clathrin-dependent endocytosis, GO:0006900|vesicle budding from membrane, GO:0008283|cell proliferation, GO:0010629|negative regulation of gene expression, GO:0016188|synaptic vesicle maturation, GO:0035459|cargo loading into vesicle, GO:0055072|iron ion homeostasis, GO:0097494|regulation of vesicle size, GO:0097753|membrane bending, GO:0098711|iron ion import across plasma membrane, GO:1902959|regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process, GO:1902961|positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process, GO:1902963|negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process, GO:2000009|negative regulation of protein localization to cell surface, GO:0007409|axonogenesis, GO:0030097|hemopoiesis, GO:0048813|dendrite morphogenesis","GO:0030276|clathrin binding, GO:0005515|protein binding, GO:0005543|phospholipid binding, GO:0005545|1-phosphatidylinositol binding, GO:0045296|cadherin binding, GO:0001540|amyloid-beta binding, GO:0048156|tau protein binding, GO:0050750|low-density lipoprotein particle receptor binding, GO:0032050|clathrin heavy chain binding, GO:0005546|phosphatidylinositol-4,5-bisphosphate binding, GO:0017137|Rab GTPase binding"
NSD1,Missense,0.0469213948419463,165,0.549530397369255,N,fusion,"",0.11922836571598,0.127179501034905,ENSG00000165671,"GO:0005634|nucleus, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0000785|chromatin","GO:0032259|methylation, GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0034968|histone lysine methylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0016571|histone methylation, GO:0000414|regulation of histone H3-K36 methylation, GO:0010452|histone H3-K36 methylation, GO:0033135|regulation of peptidyl-serine phosphorylation, GO:0034770|histone H4-K20 methylation, GO:1903025|regulation of RNA polymerase II regulatory region sequence-specific DNA binding","GO:0046872|metal ion binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0046975|histone methyltransferase activity (H3-K36 specific), GO:0042799|histone methyltransferase activity (H4-K20 specific), GO:0003714|transcription corepressor activity, GO:0030331|estrogen receptor binding, GO:0042974|retinoic acid receptor binding, GO:0003682|chromatin binding, GO:0003712|transcription coregulator activity, GO:0050681|androgen receptor binding, GO:0046966|thyroid hormone receptor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0046965|retinoid X receptor binding"
NOTCH1,Missense,0.0465499947600163,235,0.477593793994535,N,"oncogene, TSG, fusion","",0.0310108213922214,0.63623757622659,ENSG00000148400,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0005789|endoplasmic reticulum membrane, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005912|adherens junction, GO:0016324|apical plasma membrane, GO:0000139|Golgi membrane, GO:0043235|receptor complex, GO:0001669|acrosomal vesicle, GO:0002193|MAML1-RBP-Jkappa- ICN1 complex, GO:0005737|cytoplasm, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0009986|cell surface, GO:0031410|cytoplasmic vesicle, GO:0071944|cell periphery","GO:0010628|positive regulation of gene expression, GO:0008284|positive regulation of cell proliferation, GO:0010812|negative regulation of cell-substrate adhesion, GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0030514|negative regulation of BMP signaling pathway, GO:0030335|positive regulation of cell migration, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0010614|negative regulation of cardiac muscle hypertrophy, GO:0060412|ventricular septum morphogenesis, GO:0003151|outflow tract morphogenesis, GO:0045668|negative regulation of osteoblast differentiation, GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006955|immune response, GO:0007219|Notch signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0050793|regulation of developmental process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0060271|cilium assembly, GO:0008285|negative regulation of cell proliferation, GO:0007050|cell cycle arrest, GO:0001525|angiogenesis, GO:0010629|negative regulation of gene expression, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0120163|negative regulation of cold-induced thermogenesis, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0045892|negative regulation of transcription, DNA-templated, GO:0001947|heart looping, GO:0007368|determination of left/right symmetry, GO:0045662|negative regulation of myoblast differentiation, GO:0097150|neuronal stem cell population maintenance, GO:0035148|tube formation, GO:0035924|cellular response to vascular endothelial growth factor stimulus, GO:0090051|negative regulation of cell migration involved in sprouting angiogenesis, GO:0043086|negative regulation of catalytic activity, GO:0055008|cardiac muscle tissue morphogenesis, GO:0046579|positive regulation of Ras protein signal transduction, GO:0003180|aortic valve morphogenesis, GO:0003184|pulmonary valve morphogenesis, GO:0030279|negative regulation of ossification, GO:0001837|epithelial to mesenchymal transition, GO:0003198|epithelial to mesenchymal transition involved in endocardial cushion formation, GO:0003273|cell migration involved in endocardial cushion formation, GO:2000811|negative regulation of anoikis, GO:0003181|atrioventricular valve morphogenesis, GO:0070168|negative regulation of biomineral tissue development, GO:2000737|negative regulation of stem cell differentiation, GO:0061314|Notch signaling involved in heart development, GO:0060411|cardiac septum morphogenesis, GO:1901201|regulation of extracellular matrix assembly, GO:2001027|negative regulation of endothelial cell chemotaxis, GO:0010832|negative regulation of myotube differentiation, GO:0046427|positive regulation of JAK-STAT cascade, GO:0003203|endocardial cushion morphogenesis, GO:0048711|positive regulation of astrocyte differentiation, GO:0060317|cardiac epithelial to mesenchymal transition, GO:0030513|positive regulation of BMP signaling pathway, GO:0003169|coronary vein morphogenesis, GO:0060948|cardiac vascular smooth muscle cell development, GO:0060982|coronary artery morphogenesis, GO:0003214|cardiac left ventricle morphogenesis, GO:0003208|cardiac ventricle morphogenesis, GO:0003209|cardiac atrium morphogenesis, GO:0003222|ventricular trabecula myocardium morphogenesis, GO:0003344|pericardium morphogenesis, GO:0061384|heart trabecula morphogenesis, GO:0003332|negative regulation of extracellular matrix constituent secretion, GO:1902339|positive regulation of apoptotic process involved in morphogenesis, GO:0050768|negative regulation of neurogenesis, GO:0060956|endocardial cell differentiation, GO:0060253|negative regulation of glial cell proliferation, GO:0007221|positive regulation of transcription of Notch receptor target, GO:0045747|positive regulation of Notch signaling pathway, GO:0001701|in utero embryonic development, GO:0001708|cell fate specification, GO:0001889|liver development, GO:0002040|sprouting angiogenesis, GO:0002052|positive regulation of neuroblast proliferation, GO:0002437|inflammatory response to antigenic stimulus, GO:0003157|endocardium development, GO:0003160|endocardium morphogenesis, GO:0003162|atrioventricular node development, GO:0003182|coronary sinus valve morphogenesis, GO:0003192|mitral valve formation, GO:0003197|endocardial cushion development, GO:0003207|cardiac chamber formation, GO:0003213|cardiac right atrium morphogenesis, GO:0003219|cardiac right ventricle formation, GO:0003241|growth involved in heart morphogenesis, GO:0003252|negative regulation of cell proliferation involved in heart valve morphogenesis, GO:0003256|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation, GO:0003264|regulation of cardioblast proliferation, GO:0003270|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006959|humoral immune response, GO:0007283|spermatogenesis, GO:0007386|compartment pattern specification, GO:0007409|axonogenesis, GO:0007420|brain development, GO:0007440|foregut morphogenesis, GO:0007492|endoderm development, GO:0007507|heart development, GO:0008544|epidermis development, GO:0008593|regulation of Notch signaling pathway, GO:0009912|auditory receptor cell fate commitment, GO:0010001|glial cell differentiation, GO:0010468|regulation of gene expression, GO:0014031|mesenchymal cell development, GO:0014807|regulation of somitogenesis, GO:0021515|cell differentiation in spinal cord, GO:0021915|neural tube development, GO:0030182|neuron differentiation, GO:0030216|keratinocyte differentiation, GO:0030324|lung development, GO:0030326|embryonic limb morphogenesis, GO:0030334|regulation of cell migration, GO:0030900|forebrain development, GO:0031069|hair follicle morphogenesis, GO:0031100|animal organ regeneration, GO:0031960|response to corticosteroid, GO:0032495|response to muramyl dipeptide, GO:0032496|response to lipopolysaccharide, GO:0035116|embryonic hindlimb morphogenesis, GO:0035914|skeletal muscle cell differentiation, GO:0042127|regulation of cell proliferation, GO:0042246|tissue regeneration, GO:0043065|positive regulation of apoptotic process, GO:0045070|positive regulation of viral genome replication, GO:0045165|cell fate commitment, GO:0045596|negative regulation of cell differentiation, GO:0045603|positive regulation of endothelial cell differentiation, GO:0045607|regulation of inner ear auditory receptor cell differentiation, GO:0045608|negative regulation of inner ear auditory receptor cell differentiation, GO:0045618|positive regulation of keratinocyte differentiation, GO:0045665|negative regulation of neuron differentiation, GO:0045687|positive regulation of glial cell differentiation, GO:0045955|negative regulation of calcium ion-dependent exocytosis, GO:0045967|negative regulation of growth rate, GO:0046533|negative regulation of photoreceptor cell differentiation, GO:0048103|somatic stem cell division, GO:0048663|neuron fate commitment, GO:0048708|astrocyte differentiation, GO:0048709|oligodendrocyte differentiation, GO:0048715|negative regulation of oligodendrocyte differentiation, GO:0048754|branching morphogenesis of an epithelial tube, GO:0048845|venous blood vessel morphogenesis, GO:0048873|homeostasis of number of cells within a tissue, GO:0050678|regulation of epithelial cell proliferation, GO:0050679|positive regulation of epithelial cell proliferation, GO:0050767|regulation of neurogenesis, GO:0060038|cardiac muscle cell proliferation, GO:0060528|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development, GO:0060548|negative regulation of cell death, GO:0060740|prostate gland epithelium morphogenesis, GO:0060768|regulation of epithelial cell proliferation involved in prostate gland development, GO:0060842|arterial endothelial cell differentiation, GO:0060843|venous endothelial cell differentiation, GO:0060979|vasculogenesis involved in coronary vascular morphogenesis, GO:0061419|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0062043|positive regulation of cardiac epithelial to mesenchymal transition, GO:0070986|left/right axis specification, GO:0071372|cellular response to follicle-stimulating hormone stimulus, GO:0072017|distal tubule development, GO:0072044|collecting duct development, GO:0072144|glomerular mesangial cell development, GO:0072602|interleukin-4 secretion, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:1902263|apoptotic process involved in embryonic digit morphogenesis, GO:1903849|positive regulation of aorta morphogenesis, GO:2000974|negative regulation of pro-B cell differentiation","GO:0046872|metal ion binding, GO:0005509|calcium ion binding, GO:0005515|protein binding, GO:0038023|signaling receptor activity, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0004857|enzyme inhibitor activity, GO:0003682|chromatin binding, GO:0003700|DNA-binding transcription factor activity, GO:0004888|transmembrane signaling receptor activity, GO:0005112|Notch binding, GO:0031490|chromatin DNA binding, GO:0043565|sequence-specific DNA binding, GO:0046982|protein heterodimerization activity"
ERBB2,Missense,0.0452381204419283,109,0.640432612078293,N,"oncogene, fusion",Oncogene,0.0839209027971573,0.385618479626128,ENSG00000141736,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0048471|perinuclear region of cytoplasm, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0010008|endosome membrane, GO:0009925|basal plasma membrane, GO:0016323|basolateral plasma membrane, GO:0016324|apical plasma membrane, GO:0031410|cytoplasmic vesicle, GO:0043209|myelin sheath","GO:0001934|positive regulation of protein phosphorylation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0007165|signal transduction, GO:0045727|positive regulation of translation, GO:0046854|phosphatidylinositol phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0043410|positive regulation of MAPK cascade, GO:0030182|neuron differentiation, GO:0090314|positive regulation of protein targeting to membrane, GO:0043547|positive regulation of GTPase activity, GO:0051897|positive regulation of protein kinase B signaling, GO:0000165|MAPK cascade, GO:0008283|cell proliferation, GO:0030307|positive regulation of cell growth, GO:0035556|intracellular signal transduction, GO:0038128|ERBB2 signaling pathway, GO:2000145|regulation of cell motility, GO:0050679|positive regulation of epithelial cell proliferation, GO:0071363|cellular response to growth factor stimulus, GO:0032886|regulation of microtubule-based process, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0043406|positive regulation of MAP kinase activity, GO:0070372|regulation of ERK1 and ERK2 cascade, GO:0045765|regulation of angiogenesis, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007166|cell surface receptor signaling pathway, GO:1901185|negative regulation of ERBB signaling pathway, GO:0042060|wound healing, GO:0007167|enzyme linked receptor protein signaling pathway, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0045785|positive regulation of cell adhesion, GO:0045943|positive regulation of transcription by RNA polymerase I, GO:0046777|protein autophosphorylation, GO:0007399|nervous system development, GO:0007422|peripheral nervous system development, GO:0007507|heart development, GO:0007528|neuromuscular junction development, GO:0008045|motor neuron axon guidance, GO:0010628|positive regulation of gene expression, GO:0033088|negative regulation of immature T cell proliferation in thymus, GO:0042552|myelination, GO:0048709|oligodendrocyte differentiation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0042802|identical protein binding, GO:0008022|protein C-terminus binding, GO:0046982|protein heterodimerization activity, GO:0019903|protein phosphatase binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0019838|growth factor binding, GO:0046983|protein dimerization activity, GO:0001042|RNA polymerase I core binding, GO:0004888|transmembrane signaling receptor activity, GO:0043125|ErbB-3 class receptor binding"
CREBBP,Silent,0.045059175828258,79,0.693351058512822,N,"oncogene, TSG, fusion","",0.0799456036448215,0.483697327562086,ENSG00000005339,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0000123|histone acetyltransferase complex, GO:0016604|nuclear body, GO:0000790|nuclear chromatin","GO:0006355|regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0048511|rhythmic process, GO:0016573|histone acetylation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0031648|protein destabilization, GO:0001666|response to hypoxia, GO:0016032|viral process, GO:0042981|regulation of apoptotic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1904837|beta-catenin-TCF complex assembly, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0065003|protein-containing complex assembly, GO:0042592|homeostatic process, GO:0042733|embryonic digit morphogenesis, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0034644|cellular response to UV, GO:0019216|regulation of lipid metabolic process, GO:0006473|protein acetylation, GO:1900034|regulation of cellular response to heat, GO:0007219|Notch signaling pathway, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0045637|regulation of myeloid cell differentiation, GO:0032481|positive regulation of type I interferon production, GO:0007221|positive regulation of transcription of Notch receptor target, GO:0045747|positive regulation of Notch signaling pathway, GO:0018076|N-terminal peptidyl-lysine acetylation, GO:0008589|regulation of smoothened signaling pathway","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003713|transcription coactivator activity, GO:0003712|transcription coregulator activity, GO:0016746|transferase activity, transferring acyl groups, GO:0005515|protein binding, GO:0004402|histone acetyltransferase activity, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0003714|transcription corepressor activity, GO:0002039|p53 binding, GO:0003684|damaged DNA binding, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0016407|acetyltransferase activity, GO:0034212|peptide N-acetyltransferase activity, GO:0043426|MRF binding"
CANT1,Missense,0.0439307200202448,33,0.808199746790552,N,fusion,"",0.0112373138666474,0.950510092871003,ENSG00000171302,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0032580|Golgi cisterna membrane, GO:0070062|extracellular exosome, GO:1904813|ficolin-1-rich granule lumen, GO:0035580|specific granule lumen, GO:1904724|tertiary granule lumen","GO:0043312|neutrophil degranulation, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0030166|proteoglycan biosynthetic process","GO:0046872|metal ion binding, GO:0016787|hydrolase activity, GO:0005509|calcium ion binding, GO:0042803|protein homodimerization activity, GO:0017110|nucleoside-diphosphatase activity, GO:0045134|uridine-diphosphatase activity, GO:0004382|guanosine-diphosphatase activity, GO:0043262|adenosine-diphosphatase activity"
XPO1,Silent,0.04307094640853,19,0.861019335958569,N,Oncogene,Oncogene,-0.11325399366765,0.644340481678438,ENSG00000082898,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0031965|nuclear membrane, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0000776|kinetochore, GO:0032991|protein-containing complex, GO:0005635|nuclear envelope, GO:0043657|host cell, GO:0005642|annulate lamellae, GO:0015030|Cajal body, GO:1990904|ribonucleoprotein complex, GO:0005623|cell","GO:0051028|mRNA transport, GO:0006886|intracellular protein transport, GO:0015031|protein transport, GO:0000056|ribosomal small subunit export from nucleus, GO:0016032|viral process, GO:0000055|ribosomal large subunit export from nucleus, GO:0043488|regulation of mRNA stability, GO:0000054|ribosomal subunit export from nucleus, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006611|protein export from nucleus, GO:0006913|nucleocytoplasmic transport, GO:0010824|regulation of centrosome duplication, GO:0034504|protein localization to nucleus, GO:0042176|regulation of protein catabolic process, GO:0042254|ribosome biogenesis, GO:0042493|response to drug, GO:0046825|regulation of protein export from nucleus, GO:0075733|intracellular transport of virus","GO:0003723|RNA binding, GO:0005515|protein binding, GO:0008536|Ran GTPase binding, GO:0005049|nuclear export signal receptor activity, GO:0005215|transporter activity, GO:0008565|protein transporter activity, GO:0019904|protein domain specific binding"
USP6,Silent,0.0414119343661963,33,0.81900986376975,N,"oncogene, fusion",Oncogene,0.0319269877174462,0.85999582834197,ENSG00000129204,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005768|endosome, GO:0055037|recycling endosome, GO:0005764|lysosome","GO:0016579|protein deubiquitination, GO:0006508|proteolysis, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0006886|intracellular protein transport, GO:0090630|activation of GTPase activity, GO:0006464|cellular protein modification process, GO:0060627|regulation of vesicle-mediated transport","GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0005096|GTPase activator activity, GO:0017137|Rab GTPase binding, GO:0005516|calmodulin binding, GO:0004843|thiol-dependent ubiquitin-specific protease activity, GO:0003676|nucleic acid binding, GO:0004197|cysteine-type endopeptidase activity"
AKT2,Missense,0.0402190216210913,41,0.802847035631863,N,Oncogene,Oncogene,-0.0211509687920595,0.895570776159342,ENSG00000105221,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005768|endosome, GO:0005654|nucleoplasm, GO:0005769|early endosome, GO:0005938|cell cortex, GO:0032587|ruffle membrane, GO:0032991|protein-containing complex","GO:0046326|positive regulation of glucose import, GO:0030335|positive regulation of cell migration, GO:0032869|cellular response to insulin stimulus, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007165|signal transduction, GO:0006915|apoptotic process, GO:0005975|carbohydrate metabolic process, GO:0007275|multicellular organism development, GO:0008643|carbohydrate transport, GO:0043491|protein kinase B signaling, GO:0035556|intracellular signal transduction, GO:0018105|peptidyl-serine phosphorylation, GO:0045444|fat cell differentiation, GO:0001934|positive regulation of protein phosphorylation, GO:0006417|regulation of translation, GO:0090314|positive regulation of protein targeting to membrane, GO:0005977|glycogen metabolic process, GO:0006006|glucose metabolic process, GO:0008284|positive regulation of cell proliferation, GO:0005978|glycogen biosynthetic process, GO:0030334|regulation of cell migration, GO:0043066|negative regulation of apoptotic process, GO:0006464|cellular protein modification process, GO:0008286|insulin receptor signaling pathway, GO:2000147|positive regulation of cell motility, GO:0060644|mammary gland epithelial cell differentiation, GO:0045725|positive regulation of glycogen biosynthetic process, GO:0031340|positive regulation of vesicle fusion, GO:0010748|negative regulation of plasma membrane long-chain fatty acid transport, GO:0010907|positive regulation of glucose metabolic process, GO:0010918|positive regulation of mitochondrial membrane potential, GO:0032000|positive regulation of fatty acid beta-oxidation, GO:0032287|peripheral nervous system myelin maintenance, GO:0065002|intracellular protein transmembrane transport, GO:0071156|regulation of cell cycle arrest, GO:0071486|cellular response to high light intensity, GO:0072659|protein localization to plasma membrane, GO:0090630|activation of GTPase activity, GO:0097473|retinal rod cell apoptotic process","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding"
POT1,Missense,0.0400734525292572,76,0.731071558230031,N,TSG,TSG,0.210544773318149,0.0679121702889523,ENSG00000128513,"GO:0005634|nucleus, GO:0005694|chromosome, GO:0000784|nuclear chromosome, telomeric region, GO:0000781|chromosome, telomeric region, GO:0005654|nucleoplasm, GO:0000783|nuclear telomere cap complex, GO:0070187|shelterin complex","GO:0000723|telomere maintenance, GO:0032212|positive regulation of telomere maintenance via telomerase, GO:0051973|positive regulation of telomerase activity, GO:0007004|telomere maintenance via telomerase, GO:0070200|establishment of protein localization to telomere, GO:0016233|telomere capping, GO:0032508|DNA duplex unwinding, GO:0061820|telomeric D-loop disassembly, GO:0032210|regulation of telomere maintenance via telomerase, GO:0051974|negative regulation of telomerase activity, GO:0032211|negative regulation of telomere maintenance via telomerase, GO:0051096|positive regulation of helicase activity, GO:0032202|telomere assembly, GO:0060383|positive regulation of DNA strand elongation, GO:1905774|regulation of DNA helicase activity, GO:1905776|positive regulation of DNA helicase activity","GO:0043047|single-stranded telomeric DNA binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042162|telomeric DNA binding, GO:0061821|telomeric D-loop binding, GO:0098505|G-rich strand telomeric DNA binding, GO:1905773|8-hydroxy-2'-deoxyguanosine DNA binding, GO:0017151|DEAD/H-box RNA helicase binding, GO:0010521|telomerase inhibitor activity, GO:1990955|G-rich single-stranded DNA binding"
SALL4,Silent,0.0378703156606809,57,0.779722556879639,N,Oncogene,Oncogene,0.0236725965038049,0.86124538879427,ENSG00000101115,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0000792|heterochromatin, GO:0032991|protein-containing complex","GO:0006355|regulation of transcription, DNA-templated, GO:0035019|somatic stem cell population maintenance, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001701|in utero embryonic development, GO:0001833|inner cell mass cell proliferation, GO:0001843|neural tube closure, GO:0003281|ventricular septum development, GO:0007507|heart development, GO:0009888|tissue development, GO:0019827|stem cell population maintenance, GO:0021915|neural tube development, GO:0030326|embryonic limb morphogenesis, GO:0045944|positive regulation of transcription by RNA polymerase II","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding"
OLIG2,Missense,0.0376857693259789,17,0.885818732160885,N,"oncogene, fusion",Oncogene,-0.00446566079079649,0.986428753165305,ENSG00000205927,"GO:0005634|nucleus, GO:0005737|cytoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0030182|neuron differentiation, GO:0007275|multicellular organism development, GO:0042552|myelination, GO:0021778|oligodendrocyte cell fate specification, GO:0048709|oligodendrocyte differentiation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007399|nervous system development, GO:0021522|spinal cord motor neuron differentiation, GO:0021529|spinal cord oligodendrocyte cell differentiation, GO:0021530|spinal cord oligodendrocyte cell fate specification, GO:0021794|thalamus development, GO:0045665|negative regulation of neuron differentiation, GO:0048663|neuron fate commitment, GO:0048714|positive regulation of oligodendrocyte differentiation","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0042803|protein homodimerization activity, GO:0071837|HMG box domain binding"
ELL,Silent,0.0364567804004258,24,0.865700367851381,N,"TSG, fusion",TSG,0.0537164059199402,0.803138758600333,ENSG00000105656,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0008023|transcription elongation factor complex, GO:0005654|nucleoplasm, GO:0015030|Cajal body, GO:0035327|transcriptionally active chromatin, GO:0035363|histone locus body","GO:0006366|transcription by RNA polymerase II, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0010923|negative regulation of phosphatase activity, GO:0032968|positive regulation of transcription elongation from RNA polymerase II promoter, GO:0042795|snRNA transcription by RNA polymerase II, GO:0032786|positive regulation of DNA-templated transcription, elongation, GO:0045945|positive regulation of transcription by RNA polymerase III, GO:0001701|in utero embryonic development, GO:0042796|snRNA transcription by RNA polymerase III","GO:0005515|protein binding, GO:0019902|phosphatase binding"
RUNX1T1,Silent,0.0360857105667268,44,0.816110664222687,N,"oncogene, TSG, fusion","",-0.046260053673722,0.765565551818775,ENSG00000079102,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016363|nuclear matrix","GO:0006355|regulation of transcription, DNA-templated, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045599|negative regulation of fat cell differentiation, GO:0006091|generation of precursor metabolites and energy","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0003714|transcription corepressor activity, GO:0005515|protein binding"
SDHA,Missense,0.0353284890150947,62,0.785160165829916,N,TSG,TSG,0.0611874979114165,0.63662061683407,ENSG00000073578,"GO:0016020|membrane, GO:0005730|nucleolus, GO:0005739|mitochondrion, GO:0005743|mitochondrial inner membrane, GO:0043209|myelin sheath, GO:0005749|mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone), GO:0045282|plasma membrane succinate dehydrogenase complex","GO:0055114|oxidation-reduction process, GO:0006099|tricarboxylic acid cycle, GO:0006105|succinate metabolic process, GO:0022900|electron transport chain, GO:0022904|respiratory electron transport chain, GO:0007399|nervous system development, GO:0006121|mitochondrial electron transport, succinate to ubiquinone","GO:0016491|oxidoreductase activity, GO:0050660|flavin adenine dinucleotide binding, GO:0008177|succinate dehydrogenase (ubiquinone) activity, GO:0016627|oxidoreductase activity, acting on the CH-CH group of donors, GO:0005515|protein binding, GO:0000104|succinate dehydrogenase activity, GO:0009055|electron transfer activity"
GATA1,Silent,0.0341261816394968,18,0.893063240454479,N,"oncogene, TSG","",0.0525398206105863,0.835973210267591,ENSG00000102145,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex, GO:0017053|transcriptional repressor complex, GO:0032993|protein-DNA complex","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0043066|negative regulation of apoptotic process, GO:0030218|erythrocyte differentiation, GO:0030219|megakaryocyte differentiation, GO:0030221|basophil differentiation, GO:0030222|eosinophil differentiation, GO:0048821|erythrocyte development, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0048468|cell development, GO:0007596|blood coagulation, GO:0045652|regulation of megakaryocyte differentiation, GO:2001240|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0006366|transcription by RNA polymerase II, GO:0030220|platelet formation, GO:0070527|platelet aggregation, GO:0097067|cellular response to thyroid hormone stimulus, GO:0045648|positive regulation of erythrocyte differentiation, GO:0001701|in utero embryonic development, GO:0007267|cell-cell signaling, GO:0008285|negative regulation of cell proliferation, GO:0008584|male gonad development, GO:0010559|regulation of glycoprotein biosynthetic process, GO:0010724|regulation of definitive erythrocyte differentiation, GO:0010725|regulation of primitive erythrocyte differentiation, GO:0030099|myeloid cell differentiation, GO:0030502|negative regulation of bone mineralization, GO:0033690|positive regulation of osteoblast proliferation, GO:0035162|embryonic hemopoiesis, GO:0035854|eosinophil fate commitment, GO:0048565|digestive tract development, GO:0048873|homeostasis of number of cells within a tissue, GO:0071733|transcriptional activation by promoter-enhancer looping, GO:0097028|dendritic cell differentiation, GO:2000678|negative regulation of transcription regulatory region DNA binding","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0031490|chromatin DNA binding, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0001085|RNA polymerase II transcription factor binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0001158|enhancer sequence-specific DNA binding, GO:0002039|p53 binding, GO:0003682|chromatin binding, GO:0070742|C2H2 zinc finger domain binding"
ABI1,Missense,0.033388870250085,33,0.853652595545227,N,"TSG, fusion",TSG,-0.0573533021613299,0.751223189914465,ENSG00000136754,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0030054|cell junction, GO:0045202|synapse, GO:0045211|postsynaptic membrane, GO:0005829|cytosol, GO:0030027|lamellipodium, GO:0030175|filopodium, GO:0030426|growth cone, GO:0070062|extracellular exosome, GO:0014069|postsynaptic density, GO:0005783|endoplasmic reticulum, GO:0032433|filopodium tip, GO:0031209|SCAR complex, GO:0031252|cell leading edge, GO:0043005|neuron projection","GO:0008154|actin polymerization or depolymerization, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0061098|positive regulation of protein tyrosine kinase activity, GO:0016032|viral process, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0008285|negative regulation of cell proliferation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0001756|somitogenesis, GO:0035855|megakaryocyte development, GO:0048813|dendrite morphogenesis, GO:0072673|lamellipodium morphogenesis","GO:0005515|protein binding, GO:0030296|protein tyrosine kinase activator activity, GO:0045296|cadherin binding, GO:0017124|SH3 domain binding, GO:0008092|cytoskeletal protein binding"
TPM3,Silent,0.0324442842261525,12,0.920268599027619,N,"TSG, fusion",TSG,-0.0850194929473064,0.79277575279496,ENSG00000143549,"GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0015629|actin cytoskeleton, GO:0005856|cytoskeleton, GO:0070062|extracellular exosome, GO:0005884|actin filament, GO:0001725|stress fiber, GO:0005862|muscle thin filament tropomyosin","GO:0007015|actin filament organization, GO:0006936|muscle contraction, GO:0030049|muscle filament sliding","GO:0003779|actin binding, GO:0005515|protein binding, GO:0051015|actin filament binding, GO:0003674|molecular_function"
CNOT3,Silent,0.0323820991675035,23,0.883387302566231,N,TSG,TSG,0.100989078375382,0.646598521167584,ENSG00000088038,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0030015|CCR4-NOT core complex, GO:0000932|P-body, GO:0005829|cytosol, GO:0030014|CCR4-NOT complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0031047|gene silencing by RNA, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0000289|nuclear-transcribed mRNA poly(A) tail shortening, GO:0006417|regulation of translation, GO:0017148|negative regulation of translation, GO:2000036|regulation of stem cell population maintenance, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0001829|trophectodermal cell differentiation",GO:0005515|protein binding
TSC1,Missense,0.0318032992156391,81,0.778056863579741,N,TSG,TSG,-0.0224971701705866,0.841986848557283,ENSG00000165699,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005811|lipid droplet, GO:0005886|plasma membrane, GO:0030027|lamellipodium, GO:0005938|cell cortex, GO:0032991|protein-containing complex, GO:0005634|nucleus, GO:0048471|perinuclear region of cytoplasm, GO:0005884|actin filament, GO:0101031|chaperone complex, GO:0033596|TSC1-TSC2 complex, GO:0005856|cytoskeleton, GO:0030426|growth cone, GO:0042995|cell projection, GO:0043231|intracellular membrane-bounded organelle, GO:0016021|integral component of membrane","GO:0032007|negative regulation of TOR signaling, GO:0051726|regulation of cell cycle, GO:0050821|protein stabilization, GO:0008285|negative regulation of cell proliferation, GO:0006417|regulation of translation, GO:0090630|activation of GTPase activity, GO:0017148|negative regulation of translation, GO:0046627|negative regulation of insulin receptor signaling pathway, GO:0007160|cell-matrix adhesion, GO:1901214|regulation of neuron death, GO:0032868|response to insulin, GO:0008344|adult locomotory behavior, GO:0051492|regulation of stress fiber assembly, GO:0051894|positive regulation of focal adhesion assembly, GO:0001952|regulation of cell-matrix adhesion, GO:0032780|negative regulation of ATPase activity, GO:0016242|negative regulation of macroautophagy, GO:0001822|kidney development, GO:0001843|neural tube closure, GO:0002250|adaptive immune response, GO:0006407|rRNA export from nucleus, GO:0006813|potassium ion transport, GO:0007399|nervous system development, GO:0010977|negative regulation of neuron projection development, GO:0016239|positive regulation of macroautophagy, GO:0021766|hippocampus development, GO:0021987|cerebral cortex development, GO:0030030|cell projection organization, GO:0034260|negative regulation of GTPase activity, GO:0042552|myelination, GO:0043379|memory T cell differentiation, GO:0043666|regulation of phosphoprotein phosphatase activity, GO:0045792|negative regulation of cell size, GO:0045859|regulation of protein kinase activity, GO:0046323|glucose import, GO:0050808|synapse organization, GO:0051291|protein heterooligomerization, GO:0051496|positive regulation of stress fiber assembly, GO:0051893|regulation of focal adhesion assembly, GO:0055007|cardiac muscle cell differentiation, GO:0090650|cellular response to oxygen-glucose deprivation, GO:1903204|negative regulation of oxidative stress-induced neuron death","GO:0005515|protein binding, GO:0047485|protein N-terminus binding, GO:0051087|chaperone binding, GO:0051879|Hsp90 protein binding, GO:0030544|Hsp70 protein binding, GO:0042030|ATPase inhibitor activity, GO:0032794|GTPase activating protein binding"
VHL,Missense,0.0317776659587381,87,0.770142078793609,N,TSG,TSG,0.0222993884657264,0.837562793606279,ENSG00000134086,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005783|endoplasmic reticulum, GO:0005739|mitochondrion, GO:0005829|cytosol, GO:0030891|VCB complex","GO:0016567|protein ubiquitination, GO:0045893|positive regulation of transcription, DNA-templated, GO:0050821|protein stabilization, GO:0043687|post-translational protein modification, GO:0043066|negative regulation of apoptotic process, GO:0045597|positive regulation of cell differentiation, GO:0008285|negative regulation of cell proliferation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006508|proteolysis, GO:0006355|regulation of transcription, DNA-templated, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0000902|cell morphogenesis, GO:0010629|negative regulation of gene expression, GO:0046426|negative regulation of JAK-STAT cascade, GO:0061428|negative regulation of transcription from RNA polymerase II promoter in response to hypoxia","GO:0005515|protein binding, GO:0061630|ubiquitin protein ligase activity, GO:0008134|transcription factor binding, GO:0019899|enzyme binding, GO:0004842|ubiquitin-protein transferase activity"
EZR,Missense,0.0316563560109855,48,0.830863783384387,N,fusion,"",-0.0428470109466008,0.772458448857472,ENSG00000092820,"GO:0045177|apical part of cell, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0001650|fibrillar center, GO:0005886|plasma membrane, GO:0005829|cytosol, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0048471|perinuclear region of cytoplasm, GO:0005615|extracellular space, GO:0005925|focal adhesion, GO:0005768|endosome, GO:0030175|filopodium, GO:0070062|extracellular exosome, GO:0071944|cell periphery, GO:0005938|cell cortex, GO:0032587|ruffle membrane, GO:0016323|basolateral plasma membrane, GO:0032991|protein-containing complex, GO:0071437|invadopodium, GO:0019898|extrinsic component of membrane, GO:0005902|microvillus, GO:0005903|brush border, GO:0016324|apical plasma membrane, GO:0001726|ruffle, GO:0031982|vesicle, GO:0031528|microvillus membrane, GO:0098592|cytoplasmic side of apical plasma membrane, GO:0015629|actin cytoskeleton, GO:0001772|immunological synapse, GO:0044853|plasma membrane raft, GO:0005884|actin filament, GO:0030863|cortical cytoskeleton, GO:0001931|uropod, GO:0030315|T-tubule, GO:0036064|ciliary basal body, GO:0043209|myelin sheath, GO:0044297|cell body, GO:0044393|microspike, GO:0045121|membrane raft, GO:0051286|cell tip, GO:0097449|astrocyte projection, GO:0097454|Schwann cell microvillus","GO:0048015|phosphatidylinositol-mediated signaling, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0010628|positive regulation of gene expression, GO:0046847|filopodium assembly, GO:0008360|regulation of cell shape, GO:0051017|actin filament bundle assembly, GO:0007411|axon guidance, GO:0061028|establishment of endothelial barrier, GO:0071320|cellular response to cAMP, GO:0050714|positive regulation of protein secretion, GO:0070373|negative regulation of ERK1 and ERK2 cascade, GO:0030033|microvillus assembly, GO:0072659|protein localization to plasma membrane, GO:0031532|actin cytoskeleton reorganization, GO:0003376|sphingosine-1-phosphate receptor signaling pathway, GO:0050860|negative regulation of T cell receptor signaling pathway, GO:0007159|leukocyte cell-cell adhesion, GO:0022614|membrane to membrane docking, GO:0010737|protein kinase A signaling, GO:1900041|negative regulation of interleukin-2 secretion, GO:0007016|cytoskeletal anchoring at plasma membrane, GO:0030953|astral microtubule organization, GO:0034629|cellular protein-containing complex localization, GO:0043622|cortical microtubule organization, GO:0051660|establishment of centrosome localization, GO:0072697|protein localization to cell cortex, GO:1902115|regulation of organelle assembly, GO:1902966|positive regulation of protein localization to early endosome, GO:1903364|positive regulation of cellular protein catabolic process, GO:1903753|negative regulation of p38MAPK cascade, GO:2000643|positive regulation of early endosome to late endosome transport, GO:0001951|intestinal D-glucose absorption, GO:0030855|epithelial cell differentiation, GO:0031623|receptor internalization, GO:0032532|regulation of microvillus length, GO:0035088|establishment or maintenance of apical/basal cell polarity, GO:0040018|positive regulation of multicellular organism growth, GO:1902896|terminal web assembly, GO:1903078|positive regulation of protein localization to plasma membrane","GO:0003723|RNA binding, GO:0003779|actin binding, GO:0005515|protein binding, GO:0008092|cytoskeletal protein binding, GO:0008017|microtubule binding, GO:0042802|identical protein binding, GO:0045296|cadherin binding, GO:0051015|actin filament binding, GO:0019904|protein domain specific binding, GO:0044548|S100 protein binding, GO:0034236|protein kinase A catalytic subunit binding, GO:0034237|protein kinase A regulatory subunit binding, GO:0051018|protein kinase A binding, GO:0051117|ATPase binding, GO:0050839|cell adhesion molecule binding, GO:0008022|protein C-terminus binding, GO:0044877|protein-containing complex binding, GO:0097718|disordered domain specific binding"
POLE,Missense,0.0312422283430822,182,0.675450772311605,N,TSG,TSG,-0.0252305939107267,0.73529690100461,ENSG00000177084,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0008622|epsilon DNA polymerase complex","GO:0006281|DNA repair, GO:0090305|nucleic acid phosphodiester bond hydrolysis, GO:0006974|cellular response to DNA damage stimulus, GO:0006260|DNA replication, GO:0000278|mitotic cell cycle, GO:0000082|G1/S transition of mitotic cell cycle, GO:0000731|DNA synthesis involved in DNA repair, GO:0006272|leading strand elongation, GO:0006287|base-excision repair, gap-filling, GO:0006297|nucleotide-excision repair, DNA gap filling, GO:0045004|DNA replication proofreading, GO:0048568|embryonic organ development, GO:0071897|DNA biosynthetic process","GO:0003676|nucleic acid binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000166|nucleotide binding, GO:0016779|nucleotidyltransferase activity, GO:0003887|DNA-directed DNA polymerase activity, GO:0051536|iron-sulfur cluster binding, GO:0051539|4 iron, 4 sulfur cluster binding, GO:0003682|chromatin binding, GO:0008310|single-stranded DNA 3'-5' exodeoxyribonuclease activity"
AKT1,Silent,0.0310405364380808,15,0.912555906211693,N,Oncogene,Oncogene,-0.0245881086516732,0.93068743308468,ENSG00000142208,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0015630|microtubule cytoskeleton, GO:0098794|postsynapse, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0005739|mitochondrion, GO:0005819|spindle, GO:0005911|cell-cell junction, GO:0036064|ciliary basal body, GO:0031982|vesicle","GO:0010628|positive regulation of gene expression, GO:0046326|positive regulation of glucose import, GO:1903078|positive regulation of protein localization to plasma membrane, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0001934|positive regulation of protein phosphorylation, GO:0045600|positive regulation of fat cell differentiation, GO:0010507|negative regulation of autophagy, GO:0032869|cellular response to insulin stimulus, GO:0006469|negative regulation of protein kinase activity, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007165|signal transduction, GO:0006915|apoptotic process, GO:0005975|carbohydrate metabolic process, GO:0007275|multicellular organism development, GO:0060416|response to growth hormone, GO:0030154|cell differentiation, GO:0008643|carbohydrate transport, GO:0043491|protein kinase B signaling, GO:0007399|nervous system development, GO:0035556|intracellular signal transduction, GO:0018105|peptidyl-serine phosphorylation, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:0006417|regulation of translation, GO:0008283|cell proliferation, GO:0005977|glycogen metabolic process, GO:0071356|cellular response to tumor necrosis factor, GO:0006006|glucose metabolic process, GO:0001649|osteoblast differentiation, GO:0001893|maternal placenta development, GO:0005978|glycogen biosynthetic process, GO:0006412|translation, GO:0006954|inflammatory response, GO:0006974|cellular response to DNA damage stimulus, GO:0007281|germ cell development, GO:0007568|aging, GO:0008286|insulin receptor signaling pathway, GO:0008637|apoptotic mitochondrial changes, GO:0009725|response to hormone, GO:0010033|response to organic substance, GO:0010629|negative regulation of gene expression, GO:0010763|positive regulation of fibroblast migration, GO:0010765|positive regulation of sodium ion transport, GO:0010975|regulation of neuron projection development, GO:0016567|protein ubiquitination, GO:0021510|spinal cord development, GO:0030030|cell projection organization, GO:0030163|protein catabolic process, GO:0030212|hyaluronan metabolic process, GO:0030307|positive regulation of cell growth, GO:0030334|regulation of cell migration, GO:0031641|regulation of myelination, GO:0031663|lipopolysaccharide-mediated signaling pathway, GO:0032094|response to food, GO:0032270|positive regulation of cellular protein metabolic process, GO:0032287|peripheral nervous system myelin maintenance, GO:0032436|positive regulation of proteasomal ubiquitin-dependent protein catabolic process, GO:0032880|regulation of protein localization, GO:0035924|cellular response to vascular endothelial growth factor stimulus, GO:0036294|cellular response to decreased oxygen levels, GO:0042593|glucose homeostasis, GO:0042981|regulation of apoptotic process, GO:0043065|positive regulation of apoptotic process, GO:0043066|negative regulation of apoptotic process, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0045792|negative regulation of cell size, GO:0045907|positive regulation of vasoconstriction, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046329|negative regulation of JNK cascade, GO:0046622|positive regulation of organ growth, GO:0051146|striated muscle cell differentiation, GO:0060709|glycogen cell differentiation involved in embryonic placenta development, GO:0060716|labyrinthine layer blood vessel development, GO:0071260|cellular response to mechanical stimulus, GO:0071363|cellular response to growth factor stimulus, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0071380|cellular response to prostaglandin E stimulus, GO:0071407|cellular response to organic cyclic compound, GO:0071456|cellular response to hypoxia, GO:0090201|negative regulation of release of cytochrome c from mitochondria, GO:0097011|cellular response to granulocyte macrophage colony-stimulating factor stimulus, GO:0097194|execution phase of apoptosis, GO:1901653|cellular response to peptide, GO:1990090|cellular response to nerve growth factor stimulus, GO:1990418|response to insulin-like growth factor stimulus, GO:2000010|positive regulation of protein localization to cell surface, GO:0008284|positive regulation of cell proliferation, GO:0007186|G protein-coupled receptor signaling pathway, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0006464|cellular protein modification process, GO:0045746|negative regulation of Notch signaling pathway, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0019221|cytokine-mediated signaling pathway, GO:0050999|regulation of nitric-oxide synthase activity, GO:0046777|protein autophosphorylation, GO:0043488|regulation of mRNA stability, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0051000|positive regulation of nitric-oxide synthase activity, GO:2001240|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand, GO:0018107|peptidyl-threonine phosphorylation, GO:0002042|cell migration involved in sprouting angiogenesis, GO:0060644|mammary gland epithelial cell differentiation, GO:0007249|I-kappaB kinase/NF-kappaB signaling, GO:0034614|cellular response to reactive oxygen species, GO:0038061|NIK/NF-kappaB signaling, GO:0045893|positive regulation of transcription, DNA-templated, GO:0071276|cellular response to cadmium ion, GO:0031295|T cell costimulation, GO:0032148|activation of protein kinase B activity, GO:0031018|endocrine pancreas development, GO:1901215|negative regulation of neuron death, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0001938|positive regulation of endothelial cell proliferation, GO:0006979|response to oxidative stress, GO:0000060|protein import into nucleus, translocation, GO:1902176|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway, GO:0031397|negative regulation of protein ubiquitination, GO:0032091|negative regulation of protein binding, GO:0006809|nitric oxide biosynthetic process, GO:0070141|response to UV-A, GO:0045861|negative regulation of proteolysis, GO:1903038|negative regulation of leukocyte cell-cell adhesion, GO:0035655|interleukin-18-mediated signaling pathway, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0045725|positive regulation of glycogen biosynthetic process, GO:0046889|positive regulation of lipid biosynthetic process, GO:0010951|negative regulation of endopeptidase activity, GO:0048009|insulin-like growth factor receptor signaling pathway, GO:1900182|positive regulation of protein localization to nucleus, GO:0051186|cofactor metabolic process, GO:0010748|negative regulation of plasma membrane long-chain fatty acid transport, GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:0060079|excitatory postsynaptic potential, GO:0072655|establishment of protein localization to mitochondrion, GO:0072656|maintenance of protein location in mitochondrion, GO:0045742|positive regulation of epidermal growth factor receptor signaling pathway, GO:0032079|positive regulation of endodeoxyribonuclease activity, GO:0034405|response to fluid shear stress, GO:0005979|regulation of glycogen biosynthetic process, GO:0006924|activation-induced cell death of T cells, GO:0009408|response to heat, GO:0010907|positive regulation of glucose metabolic process, GO:0010918|positive regulation of mitochondrial membrane potential, GO:0016242|negative regulation of macroautophagy, GO:0031929|TOR signaling, GO:0031999|negative regulation of fatty acid beta-oxidation, GO:0043276|anoikis, GO:0051898|negative regulation of protein kinase B signaling, GO:0071901|negative regulation of protein serine/threonine kinase activity, GO:0100002|negative regulation of protein kinase activity by protein phosphorylation, GO:0140052|cellular response to oxidised low-density lipoprotein particle stimulus, GO:1903721|positive regulation of I-kappaB phosphorylation, GO:2000402|negative regulation of lymphocyte migration","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0005547|phosphatidylinositol-3,4,5-trisphosphate binding, GO:0043325|phosphatidylinositol-3,4-bisphosphate binding, GO:0005080|protein kinase C binding, GO:0019899|enzyme binding, GO:0019901|protein kinase binding, GO:0032794|GTPase activating protein binding, GO:0051721|protein phosphatase 2A binding, GO:0004712|protein serine/threonine/tyrosine kinase activity, GO:0071889|14-3-3 protein binding, GO:0030235|nitric-oxide synthase regulator activity"
CCND2,Missense,0.0300513809705523,28,0.879343892447234,N,"oncogene, fusion",Oncogene,-0.117563929861685,0.551309152147603,ENSG00000118971,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005730|nucleolus, GO:0031965|nuclear membrane, GO:0000785|chromatin, GO:0000307|cyclin-dependent protein kinase holoenzyme complex","GO:0008284|positive regulation of cell proliferation, GO:1900087|positive regulation of G1/S transition of mitotic cell cycle, GO:0043066|negative regulation of apoptotic process, GO:0001934|positive regulation of protein phosphorylation, GO:0006468|protein phosphorylation, GO:0051301|cell division, GO:0007049|cell cycle, GO:0000278|mitotic cell cycle, GO:0000079|regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0007088|regulation of mitotic nuclear division, GO:0045787|positive regulation of cell cycle, GO:0045737|positive regulation of cyclin-dependent protein serine/threonine kinase activity","GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0004672|protein kinase activity, GO:0016538|cyclin-dependent protein serine/threonine kinase regulator activity"
CHD4,Silent,0.0297248530243849,44,0.848103859442918,N,Oncogene,Oncogene,0.011029181537507,0.943353763789758,ENSG00000111642,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0000790|nuclear chromatin, GO:0005856|cytoskeleton, GO:0005654|nucleoplasm, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0032991|protein-containing complex, GO:0016581|NuRD complex","GO:0006325|chromatin organization, GO:0016575|histone deacetylation, GO:0032508|DNA duplex unwinding, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043044|ATP-dependent chromatin remodeling","GO:0046872|metal ion binding, GO:0005524|ATP binding, GO:0000166|nucleotide binding, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004386|helicase activity, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0004407|histone deacetylase activity, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0004003|ATP-dependent DNA helicase activity, GO:0001103|RNA polymerase II repressing transcription factor binding, GO:0008270|zinc ion binding, GO:0042826|histone deacetylase binding, GO:0031492|nucleosomal DNA binding"
USP8,Missense,0.0285558658112912,69,0.815825948757333,N,Oncogene,Oncogene,-0.0430491297420393,0.725421051853969,ENSG00000138592,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005768|endosome, GO:0005769|early endosome, GO:0010008|endosome membrane, GO:0014069|postsynaptic density, GO:0030496|midbody, GO:0043197|dendritic spine, GO:0019897|extrinsic component of plasma membrane, GO:0031313|extrinsic component of endosome membrane","GO:0016579|protein deubiquitination, GO:0006508|proteolysis, GO:0007049|cell cycle, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0007032|endosome organization, GO:0070536|protein K63-linked deubiquitination, GO:0071108|protein K48-linked deubiquitination, GO:0031647|regulation of protein stability, GO:0008283|cell proliferation, GO:0032880|regulation of protein localization, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0000281|mitotic cytokinesis, GO:0007265|Ras protein signal transduction, GO:0071549|cellular response to dexamethasone stimulus, GO:1990090|cellular response to nerve growth factor stimulus","GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0004843|thiol-dependent ubiquitin-specific protease activity, GO:0045296|cadherin binding, GO:0017124|SH3 domain binding, GO:0004197|cysteine-type endopeptidase activity"
MYC,Missense,0.0281269624355163,84,0.799514525907875,N,"oncogene, fusion",Oncogene,-0.0535345214237989,0.628636275727187,ENSG00000136997,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005635|nuclear envelope, GO:0005791|rough endoplasmic reticulum, GO:0044195|nucleoplasmic reticulum, GO:0005739|mitochondrion, GO:0005730|nucleolus, GO:0032991|protein-containing complex, GO:0000790|nuclear chromatin","GO:0006355|regulation of transcription, DNA-templated, GO:0045727|positive regulation of translation, GO:0008150|biological_process, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006974|cellular response to DNA damage stimulus, GO:0006879|cellular iron ion homeostasis, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0015671|oxygen transport, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016579|protein deubiquitination, GO:0007050|cell cycle arrest, GO:0043066|negative regulation of apoptotic process, GO:0000165|MAPK cascade, GO:0010332|response to gamma radiation, GO:1904837|beta-catenin-TCF complex assembly, GO:0000082|G1/S transition of mitotic cell cycle, GO:0019221|cytokine-mediated signaling pathway, GO:0035690|cellular response to drug, GO:0043280|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0051973|positive regulation of telomerase activity, GO:0048146|positive regulation of fibroblast proliferation, GO:0006338|chromatin remodeling, GO:0034644|cellular response to UV, GO:0010468|regulation of gene expression, GO:0050679|positive regulation of epithelial cell proliferation, GO:0002053|positive regulation of mesenchymal cell proliferation, GO:0051782|negative regulation of cell division, GO:0042493|response to drug, GO:0008284|positive regulation of cell proliferation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0071456|cellular response to hypoxia, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0006112|energy reserve metabolic process, GO:0007219|Notch signaling pathway, GO:0010628|positive regulation of gene expression, GO:0032204|regulation of telomere maintenance, GO:0032873|negative regulation of stress-activated MAPK cascade, GO:0032986|protein-DNA complex disassembly, GO:0044346|fibroblast apoptotic process, GO:0045656|negative regulation of monocyte differentiation, GO:0048147|negative regulation of fibroblast proliferation, GO:0051276|chromosome organization, GO:0070371|ERK1 and ERK2 cascade, GO:0070848|response to growth factor, GO:0090096|positive regulation of metanephric cap mesenchymal cell proliferation, GO:1905643|positive regulation of DNA methylation, GO:2000573|positive regulation of DNA biosynthetic process, GO:2001022|positive regulation of response to DNA damage stimulus","GO:0003700|DNA-binding transcription factor activity, GO:0003729|mRNA binding, GO:0005515|protein binding, GO:0071074|eukaryotic initiation factor eIF2 binding, GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0070491|repressing transcription factor binding, GO:0070888|E-box binding, GO:0044877|protein-containing complex binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0033613|activating transcription factor binding"
PCM1,Missense,0.0258389012071712,101,0.797573829265208,N,fusion,"",-0.0494380903294328,0.623452858322582,ENSG00000078674,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005813|centrosome, GO:0005829|cytosol, GO:0031965|nuclear membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0005815|microtubule organizing center, GO:0035869|ciliary transition zone, GO:0036064|ciliary basal body, GO:0034451|centriolar satellite, GO:0005814|centriole, GO:0032991|protein-containing complex, GO:0000242|pericentriolar material, GO:0045177|apical part of cell","GO:0060271|cilium assembly, GO:0071539|protein localization to centrosome, GO:0034454|microtubule anchoring at centrosome, GO:0035735|intraciliary transport involved in cilium assembly, GO:0030030|cell projection organization, GO:0000086|G2/M transition of mitotic cell cycle, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0097711|ciliary basal body-plasma membrane docking, GO:0007098|centrosome cycle, GO:0050768|negative regulation of neurogenesis, GO:0090316|positive regulation of intracellular protein transport, GO:1905515|non-motile cilium assembly, GO:0001764|neuron migration, GO:0022027|interkinetic nuclear migration, GO:0031122|cytoplasmic microtubule organization, GO:0033365|protein localization to organelle, GO:0034453|microtubule anchoring, GO:0035176|social behavior, GO:0097150|neuronal stem cell population maintenance","GO:0005515|protein binding, GO:0042802|identical protein binding"
CTNNB1,Missense,0.024284846545989,113,0.79847686862961,N,"oncogene, fusion",Oncogene,-0.0813078191386703,0.391929950816326,ENSG00000168036,"GO:0048471|perinuclear region of cytoplasm, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005829|cytosol, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0030054|cell junction, GO:0045202|synapse, GO:0005925|focal adhesion, GO:0000922|spindle pole, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0005622|intracellular, GO:0016323|basolateral plasma membrane, GO:0005912|adherens junction, GO:0032991|protein-containing complex, GO:0005913|cell-cell adherens junction, GO:0005667|transcription factor complex, GO:1990907|beta-catenin-TCF complex, GO:0005911|cell-cell junction, GO:0016342|catenin complex, GO:0016328|lateral plasma membrane, GO:0030877|beta-catenin destruction complex, GO:0071944|cell periphery, GO:0005938|cell cortex, GO:1990909|Wnt signalosome, GO:0005719|nuclear euchromatin, GO:0032993|protein-DNA complex, GO:0070369|beta-catenin-TCF7L2 complex, GO:0005916|fascia adherens, GO:0005923|bicellular tight junction, GO:0014704|intercalated disc, GO:0016600|flotillin complex, GO:0030018|Z disc, GO:0030027|lamellipodium, GO:0031253|cell projection membrane, GO:0031528|microvillus membrane, GO:0034750|Scrib-APC-beta-catenin complex, GO:0043296|apical junction complex, GO:0044798|nuclear transcription factor complex, GO:0045177|apical part of cell","GO:0016525|negative regulation of angiogenesis, GO:0043066|negative regulation of apoptotic process, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0061154|endothelial tube morphogenesis, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007155|cell adhesion, GO:0016055|Wnt signaling pathway, GO:0007399|nervous system development, GO:0008285|negative regulation of cell proliferation, GO:0043065|positive regulation of apoptotic process, GO:0016032|viral process, GO:0045892|negative regulation of transcription, DNA-templated, GO:1904837|beta-catenin-TCF complex assembly, GO:0060070|canonical Wnt signaling pathway, GO:0030521|androgen receptor signaling pathway, GO:0032355|response to estradiol, GO:1904886|beta-catenin destruction complex disassembly, GO:0001569|branching involved in blood vessel morphogenesis, GO:1904948|midbrain dopaminergic neuron differentiation, GO:0034333|adherens junction assembly, GO:0007223|Wnt signaling pathway, calcium modulating pathway, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0071363|cellular response to growth factor stimulus, GO:0045765|regulation of angiogenesis, GO:0051149|positive regulation of muscle cell differentiation, GO:0035635|entry of bacterium into host cell, GO:0019827|stem cell population maintenance, GO:0035315|hair cell differentiation, GO:0042493|response to drug, GO:0098609|cell-cell adhesion, GO:0090279|regulation of calcium ion import, GO:2000008|regulation of protein localization to cell surface, GO:1904954|canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation, GO:0071681|cellular response to indole-3-methanol, GO:0032481|positive regulation of type I interferon production, GO:0001837|epithelial to mesenchymal transition, GO:0034394|protein localization to cell surface, GO:0033234|negative regulation of protein sumoylation, GO:0072182|regulation of nephron tubule epithelial cell differentiation, GO:0002052|positive regulation of neuroblast proliferation, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0010909|positive regulation of heparan sulfate proteoglycan biosynthetic process, GO:0030997|regulation of centriole-centriole cohesion, GO:0036023|embryonic skeletal limb joint morphogenesis, GO:0043525|positive regulation of neuron apoptotic process, GO:0044334|canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition, GO:0044336|canonical Wnt signaling pathway involved in negative regulation of apoptotic process, GO:0045976|negative regulation of mitotic cell cycle, embryonic, GO:0048145|regulation of fibroblast proliferation, GO:0048660|regulation of smooth muscle cell proliferation, GO:0050767|regulation of neurogenesis, GO:0051571|positive regulation of histone H3-K4 methylation, GO:0060828|regulation of canonical Wnt signaling pathway, GO:0061324|canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation, GO:0061549|sympathetic ganglion development, GO:0070602|regulation of centromeric sister chromatid cohesion, GO:1904798|positive regulation of core promoter binding, GO:1990138|neuron projection extension, GO:2000144|positive regulation of DNA-templated transcription, initiation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0000578|embryonic axis specification, GO:0000904|cell morphogenesis involved in differentiation, GO:0001501|skeletal system development, GO:0001570|vasculogenesis, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0001701|in utero embryonic development, GO:0001702|gastrulation with mouth forming second, GO:0001706|endoderm formation, GO:0001708|cell fate specification, GO:0001709|cell fate determination, GO:0001711|endodermal cell fate commitment, GO:0001764|neuron migration, GO:0001822|kidney development, GO:0001840|neural plate development, GO:0001944|vasculature development, GO:0002053|positive regulation of mesenchymal cell proliferation, GO:0002089|lens morphogenesis in camera-type eye, GO:0003266|regulation of secondary heart field cardioblast proliferation, GO:0003338|metanephros morphogenesis, GO:0003340|negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis, GO:0006355|regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007160|cell-matrix adhesion, GO:0007268|chemical synaptic transmission, GO:0007398|ectoderm development, GO:0007403|glial cell fate determination, GO:0007507|heart development, GO:0008283|cell proliferation, GO:0008284|positive regulation of cell proliferation, GO:0009948|anterior/posterior axis specification, GO:0009950|dorsal/ventral axis specification, GO:0009953|dorsal/ventral pattern formation, GO:0009954|proximal/distal pattern formation, GO:0009987|cellular process, GO:0010468|regulation of gene expression, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0016331|morphogenesis of embryonic epithelium, GO:0021819|layer formation in cerebral cortex, GO:0022009|central nervous system vasculogenesis, GO:0022405|hair cycle process, GO:0030097|hemopoiesis, GO:0030154|cell differentiation, GO:0030182|neuron differentiation, GO:0030217|T cell differentiation, GO:0030316|osteoclast differentiation, GO:0030324|lung development, GO:0030539|male genitalia development, GO:0030856|regulation of epithelial cell differentiation, GO:0030857|negative regulation of epithelial cell differentiation, GO:0030858|positive regulation of epithelial cell differentiation, GO:0030900|forebrain development, GO:0030901|midbrain development, GO:0030902|hindbrain development, GO:0031016|pancreas development, GO:0031069|hair follicle morphogenesis, GO:0031641|regulation of myelination, GO:0032212|positive regulation of telomere maintenance via telomerase, GO:0032331|negative regulation of chondrocyte differentiation, GO:0033077|T cell differentiation in thymus, GO:0034332|adherens junction organization, GO:0034613|cellular protein localization, GO:0035050|embryonic heart tube development, GO:0035112|genitalia morphogenesis, GO:0035115|embryonic forelimb morphogenesis, GO:0035116|embryonic hindlimb morphogenesis, GO:0042127|regulation of cell proliferation, GO:0042129|regulation of T cell proliferation, GO:0042475|odontogenesis of dentin-containing tooth, GO:0042733|embryonic digit morphogenesis, GO:0042981|regulation of apoptotic process, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0043410|positive regulation of MAPK cascade, GO:0043588|skin development, GO:0044093|positive regulation of molecular function, GO:0045453|bone resorption, GO:0045595|regulation of cell differentiation, GO:0045596|negative regulation of cell differentiation, GO:0045603|positive regulation of endothelial cell differentiation, GO:0045667|regulation of osteoblast differentiation, GO:0045669|positive regulation of osteoblast differentiation, GO:0045670|regulation of osteoclast differentiation, GO:0045671|negative regulation of osteoclast differentiation, GO:0045743|positive regulation of fibroblast growth factor receptor signaling pathway, GO:0048096|chromatin-mediated maintenance of transcription, GO:0048469|cell maturation, GO:0048489|synaptic vesicle transport, GO:0048513|animal organ development, GO:0048538|thymus development, GO:0048599|oocyte development, GO:0048617|embryonic foregut morphogenesis, GO:0048643|positive regulation of skeletal muscle tissue development, GO:0048715|negative regulation of oligodendrocyte differentiation, GO:0050679|positive regulation of epithelial cell proliferation, GO:0050768|negative regulation of neurogenesis, GO:0050808|synapse organization, GO:0051145|smooth muscle cell differentiation, GO:0051884|regulation of timing of anagen, GO:0051973|positive regulation of telomerase activity, GO:0060066|oviduct development, GO:0060173|limb development, GO:0060439|trachea morphogenesis, GO:0060440|trachea formation, GO:0060441|epithelial tube branching involved in lung morphogenesis, GO:0060479|lung cell differentiation, GO:0060484|lung-associated mesenchyme development, GO:0060492|lung induction, GO:0060742|epithelial cell differentiation involved in prostate gland development, GO:0060769|positive regulation of epithelial cell proliferation involved in prostate gland development, GO:0060789|hair follicle placode formation, GO:0060916|mesenchymal cell proliferation involved in lung development, GO:0061047|positive regulation of branching involved in lung morphogenesis, GO:0061198|fungiform papilla formation, GO:0061550|cranial ganglion development, GO:0072001|renal system development, GO:0072033|renal vesicle formation, GO:0072053|renal inner medulla development, GO:0072054|renal outer medulla development, GO:0072079|nephron tubule formation, GO:1901215|negative regulation of neuron death, GO:1903204|negative regulation of oxidative stress-induced neuron death, GO:1904501|positive regulation of chromatin-mediated maintenance of transcription, GO:1904793|regulation of euchromatin binding, GO:1904796|regulation of core promoter binding, GO:1904888|cranial skeletal system development, GO:1990403|embryonic brain development, GO:1990791|dorsal root ganglion development, GO:2000017|positive regulation of determination of dorsal identity, GO:2000179|positive regulation of neural precursor cell proliferation, GO:2001234|negative regulation of apoptotic signaling pathway","GO:0005515|protein binding, GO:0045296|cadherin binding, GO:0008134|transcription factor binding, GO:0003713|transcription coactivator activity, GO:0008022|protein C-terminus binding, GO:0044325|ion channel binding, GO:0019899|enzyme binding, GO:0019903|protein phosphatase binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0070411|I-SMAD binding, GO:0046332|SMAD binding, GO:0050681|androgen receptor binding, GO:0019900|kinase binding, GO:0035257|nuclear hormone receptor binding, GO:0045294|alpha-catenin binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0003682|chromatin binding, GO:0030331|estrogen receptor binding, GO:0003700|DNA-binding transcription factor activity, GO:0019901|protein kinase binding, GO:0046982|protein heterodimerization activity, GO:0070491|repressing transcription factor binding, GO:0097718|disordered domain specific binding"
MLLT3,Missense,0.0224678010944207,47,0.880841450738857,N,fusion,"",-0.0282241856768813,0.850623984796316,ENSG00000171843,"GO:0005634|nucleus, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0008023|transcription elongation factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007379|segment specification, GO:0009952|anterior/posterior pattern specification, GO:0006366|transcription by RNA polymerase II, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:2000096|positive regulation of Wnt signaling pathway, planar cell polarity pathway","GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0042393|histone binding, GO:0070577|lysine-acetylated histone binding, GO:0140030|modification-dependent protein binding"
SND1,Missense,0.018309019424952,72,0.87867353247234,N,"oncogene, fusion",Oncogene,-0.0791970765736182,0.508427510482985,ENSG00000197157,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0042470|melanosome, GO:0016442|RISC complex, GO:0097433|dense body, GO:0070062|extracellular exosome","GO:0090305|nucleic acid phosphodiester bond hydrolysis, GO:0090502|RNA phosphodiester bond hydrolysis, endonucleolytic, GO:1903506|regulation of nucleic acid-templated transcription, GO:0031047|gene silencing by RNA, GO:0016032|viral process, GO:0006401|RNA catabolic process, GO:0001649|osteoblast differentiation, GO:0010587|miRNA catabolic process, GO:0010564|regulation of cell cycle process","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0004518|nuclease activity, GO:0004519|endonuclease activity, GO:0004521|endoribonuclease activity, GO:0045296|cadherin binding, GO:0003712|transcription coregulator activity, GO:1905172|RISC complex binding"
PPARG,Missense,0.0182125048166179,42,0.908858952432827,N,"TSG, fusion",TSG,-0.00509280405519276,0.974464660823559,ENSG00000132170,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0090575|RNA polymerase II transcription factor complex, GO:0005829|cytosol, GO:0032991|protein-containing complex, GO:0048471|perinuclear region of cytoplasm","GO:0043537|negative regulation of blood vessel endothelial cell migration, GO:1905563|negative regulation of vascular endothelial cell proliferation, GO:1904706|negative regulation of vascular smooth muscle cell proliferation, GO:0071404|cellular response to low-density lipoprotein particle stimulus, GO:0016525|negative regulation of angiogenesis, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1905461|positive regulation of vascular associated smooth muscle cell apoptotic process, GO:0055088|lipid homeostasis, GO:0042953|lipoprotein transport, GO:0045893|positive regulation of transcription, DNA-templated, GO:0032869|cellular response to insulin stimulus, GO:0042593|glucose homeostasis, GO:0048662|negative regulation of smooth muscle cell proliferation, GO:0006355|regulation of transcription, DNA-templated, GO:0030522|intracellular receptor signaling pathway, GO:0043401|steroid hormone mediated signaling pathway, GO:0048511|rhythmic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030154|cell differentiation, GO:0007186|G protein-coupled receptor signaling pathway, GO:0006357|regulation of transcription by RNA polymerase II, GO:0009755|hormone-mediated signaling pathway, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045087|innate immune response, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0006629|lipid metabolic process, GO:0048469|cell maturation, GO:0042752|regulation of circadian rhythm, GO:0050872|white fat cell differentiation, GO:0060850|regulation of transcription involved in cell fate commitment, GO:0006631|fatty acid metabolic process, GO:0007584|response to nutrient, GO:0032526|response to retinoic acid, GO:0061614|pri-miRNA transcription by RNA polymerase II, GO:0007275|multicellular organism development, GO:0007165|signal transduction, GO:0008217|regulation of blood pressure, GO:0010745|negative regulation of macrophage derived foam cell differentiation, GO:0010887|negative regulation of cholesterol storage, GO:0060965|negative regulation of gene silencing by miRNA, GO:0019216|regulation of lipid metabolic process, GO:0033993|response to lipid, GO:0030855|epithelial cell differentiation, GO:0045165|cell fate commitment, GO:0010871|negative regulation of receptor biosynthetic process, GO:0001890|placenta development, GO:0010742|macrophage derived foam cell differentiation, GO:0010891|negative regulation of sequestering of triglyceride, GO:0015909|long-chain fatty acid transport, GO:0030224|monocyte differentiation, GO:0035357|peroxisome proliferator activated receptor signaling pathway, GO:0043388|positive regulation of DNA binding, GO:0045600|positive regulation of fat cell differentiation, GO:0045713|low-density lipoprotein particle receptor biosynthetic process, GO:0060336|negative regulation of interferon-gamma-mediated signaling pathway, GO:0060694|regulation of cholesterol transporter activity, GO:0002674|negative regulation of acute inflammatory response, GO:0007507|heart development, GO:0008285|negative regulation of cell proliferation, GO:0009409|response to cold, GO:0009612|response to mechanical stimulus, GO:0010033|response to organic substance, GO:0014070|response to organic cyclic compound, GO:0019395|fatty acid oxidation, GO:0030308|negative regulation of cell growth, GO:0031000|response to caffeine, GO:0031100|animal organ regeneration, GO:0032966|negative regulation of collagen biosynthetic process, GO:0033189|response to vitamin A, GO:0035902|response to immobilization stress, GO:0042493|response to drug, GO:0042594|response to starvation, GO:0043065|positive regulation of apoptotic process, GO:0043627|response to estrogen, GO:0045598|regulation of fat cell differentiation, GO:0046321|positive regulation of fatty acid oxidation, GO:0048714|positive regulation of oligodendrocyte differentiation, GO:0051974|negative regulation of telomerase activity, GO:0060100|positive regulation of phagocytosis, engulfment, GO:0071300|cellular response to retinoic acid, GO:0071306|cellular response to vitamin E, GO:0071379|cellular response to prostaglandin stimulus, GO:0071380|cellular response to prostaglandin E stimulus, GO:0071455|cellular response to hyperoxia, GO:1901558|response to metformin, GO:2000230|negative regulation of pancreatic stellate cell proliferation","GO:0044212|transcription regulatory region DNA binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0003707|steroid hormone receptor activity, GO:0004879|nuclear receptor activity, GO:0030374|nuclear receptor transcription coactivator activity, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0003682|chromatin binding, GO:0038023|signaling receptor activity, GO:0008289|lipid binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0019899|enzyme binding, GO:0070888|E-box binding, GO:0046982|protein heterodimerization activity, GO:0005504|fatty acid binding, GO:0001103|RNA polymerase II repressing transcription factor binding, GO:0008144|drug binding, GO:0008022|protein C-terminus binding, GO:0051393|alpha-actinin binding, GO:0003690|double-stranded DNA binding, GO:0046965|retinoid X receptor binding, GO:0042277|peptide binding, GO:0050692|DBD domain binding, GO:0050693|LBD domain binding, GO:0033613|activating transcription factor binding, GO:0043621|protein self-association, GO:0004955|prostaglandin receptor activity, GO:0050544|arachidonic acid binding, GO:0019903|protein phosphatase binding, GO:0030331|estrogen receptor binding"
SH2B3,Missense,0.0178576017857832,38,0.915254900648831,N,TSG,TSG,-0.0599328027840944,0.720769439163197,ENSG00000111252,"GO:0005886|plasma membrane, GO:0005829|cytosol","GO:0007165|signal transduction, GO:0009967|positive regulation of signal transduction, GO:0035556|intracellular signal transduction, GO:0030097|hemopoiesis, GO:0007596|blood coagulation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0030154|cell differentiation, GO:0035162|embryonic hemopoiesis","GO:0035591|signaling adaptor activity, GO:0005515|protein binding, GO:0005068|transmembrane receptor protein tyrosine kinase adaptor activity"
POLD1,Missense,0.0160712494340283,106,0.87011509205749,N,TSG,TSG,0.0539166977048619,0.58305757584458,ENSG00000062822,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0016235|aggresome, GO:0043625|delta DNA polymerase complex, GO:0000784|nuclear chromosome, telomeric region, GO:0000109|nucleotide-excision repair complex","GO:0006260|DNA replication, GO:0071897|DNA biosynthetic process, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0006261|DNA-dependent DNA replication, GO:0019985|translesion synthesis, GO:0034644|cellular response to UV, GO:0006283|transcription-coupled nucleotide-excision repair, GO:0042769|DNA damage response, detection of DNA damage, GO:0006296|nucleotide-excision repair, DNA incision, 5'-to lesion, GO:0033683|nucleotide-excision repair, DNA incision, GO:0000731|DNA synthesis involved in DNA repair, GO:0032201|telomere maintenance via semi-conservative replication, GO:0006297|nucleotide-excision repair, DNA gap filling, GO:0000723|telomere maintenance, GO:0055089|fatty acid homeostasis, GO:0006287|base-excision repair, gap-filling, GO:0009411|response to UV, GO:0045004|DNA replication proofreading, GO:0090305|nucleic acid phosphodiester bond hydrolysis","GO:0003676|nucleic acid binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0000166|nucleotide binding, GO:0016779|nucleotidyltransferase activity, GO:0003887|DNA-directed DNA polymerase activity, GO:0046872|metal ion binding, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0004527|exonuclease activity, GO:0004518|nuclease activity, GO:0051536|iron-sulfur cluster binding, GO:0051539|4 iron, 4 sulfur cluster binding, GO:0003682|chromatin binding, GO:0003684|damaged DNA binding, GO:0008296|3'-5'-exodeoxyribonuclease activity, GO:0008408|3'-5' exonuclease activity, GO:0019899|enzyme binding"
SRSF2,Missense,0.0151505007465285,24,0.94398392063596,N,Oncogene,Oncogene,-0.0658030923720684,0.759992996142965,ENSG00000161547,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005737|cytoplasm","GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:1903507|negative regulation of nucleic acid-templated transcription, GO:0043484|regulation of RNA splicing, GO:0000381|regulation of alternative mRNA splicing, via spliceosome, GO:0006406|mRNA export from nucleus, GO:0006405|RNA export from nucleus, GO:0031124|mRNA 3'-end processing, GO:0000398|mRNA splicing, via spliceosome, GO:0045292|mRNA cis splicing, via spliceosome","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0005515|protein binding, GO:0003714|transcription corepressor activity"
AXIN1,Nonsense,0.0147178194664579,40,0.928178533138735,N,TSG,TSG,0.228703125183487,0.1557615447592,ENSG00000103126,"GO:0048471|perinuclear region of cytoplasm, GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0030877|beta-catenin destruction complex, GO:0005829|cytosol, GO:0031410|cytoplasmic vesicle, GO:0016328|lateral plasma membrane, GO:0071944|cell periphery","GO:0001934|positive regulation of protein phosphorylation, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0007165|signal transduction, GO:0006915|apoptotic process, GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:1904886|beta-catenin destruction complex disassembly, GO:0031398|positive regulation of protein ubiquitination, GO:0010800|positive regulation of peptidyl-threonine phosphorylation, GO:0030111|regulation of Wnt signaling pathway, GO:0032147|activation of protein kinase activity, GO:0033146|regulation of intracellular estrogen receptor signaling pathway, GO:0034622|cellular protein-containing complex assembly, GO:0045732|positive regulation of protein catabolic process, GO:0046330|positive regulation of JNK cascade, GO:0051443|positive regulation of ubiquitin-protein transferase activity, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:1904885|beta-catenin destruction complex assembly, GO:2000060|positive regulation of ubiquitin-dependent protein catabolic process","GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0030159|receptor signaling complex scaffold activity, GO:0032947|protein-containing complex scaffold activity, GO:0070016|armadillo repeat domain binding, GO:0031625|ubiquitin protein ligase binding, GO:0019899|enzyme binding, GO:0019901|protein kinase binding, GO:0008013|beta-catenin binding, GO:0070411|I-SMAD binding, GO:0035591|signaling adaptor activity, GO:0046332|SMAD binding"
FGFR2,Missense,0.0118600984911857,120,0.897701458369097,N,"oncogene, fusion",Oncogene,-0.0608886772214483,0.508847102357201,ENSG00000066468,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0031410|cytoplasmic vesicle, GO:0009986|cell surface, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0062023|collagen-containing extracellular matrix, GO:0005938|cell cortex, GO:0060076|excitatory synapse","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0006915|apoptotic process, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0030177|positive regulation of Wnt signaling pathway, GO:0060348|bone development, GO:0046854|phosphatidylinositol phosphorylation, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007409|axonogenesis, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0051781|positive regulation of cell division, GO:0043410|positive regulation of MAPK cascade, GO:0030282|bone mineralization, GO:0060349|bone morphogenesis, GO:0001525|angiogenesis, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0030855|epithelial cell differentiation, GO:0051897|positive regulation of protein kinase B signaling, GO:0031069|hair follicle morphogenesis, GO:0048562|embryonic organ morphogenesis, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0035265|organ growth, GO:0001701|in utero embryonic development, GO:0007267|cell-cell signaling, GO:0022612|gland morphogenesis, GO:0009887|animal organ morphogenesis, GO:0045787|positive regulation of cell cycle, GO:0045165|cell fate commitment, GO:0032808|lacrimal gland development, GO:0050679|positive regulation of epithelial cell proliferation, GO:0002053|positive regulation of mesenchymal cell proliferation, GO:0003148|outflow tract septum morphogenesis, GO:0042472|inner ear morphogenesis, GO:0048286|lung alveolus development, GO:0048557|embryonic digestive tract morphogenesis, GO:0048608|reproductive structure development, GO:0030901|midbrain development, GO:0001657|ureteric bud development, GO:0070372|regulation of ERK1 and ERK2 cascade, GO:0060484|lung-associated mesenchyme development, GO:0040014|regulation of multicellular organism growth, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0042476|odontogenesis, GO:0008589|regulation of smoothened signaling pathway, GO:0030324|lung development, GO:0048565|digestive tract development, GO:0010518|positive regulation of phospholipase activity, GO:0048705|skeletal system morphogenesis, GO:0048762|mesenchymal cell differentiation, GO:0010453|regulation of cell fate commitment, GO:0033688|regulation of osteoblast proliferation, GO:0045667|regulation of osteoblast differentiation, GO:0003149|membranous septum morphogenesis, GO:0009791|post-embryonic development, GO:0009880|embryonic pattern specification, GO:0016331|morphogenesis of embryonic epithelium, GO:0021769|orbitofrontal cortex development, GO:0021847|ventricular zone neuroblast division, GO:0021860|pyramidal neuron development, GO:0030916|otic vesicle formation, GO:0035264|multicellular organism growth, GO:0035602|fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow, GO:0035603|fibroblast growth factor receptor signaling pathway involved in hemopoiesis, GO:0035604|fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow, GO:0035607|fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development, GO:0040036|regulation of fibroblast growth factor receptor signaling pathway, GO:0048568|embryonic organ development, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0048730|epidermis morphogenesis, GO:0048755|branching morphogenesis of a nerve, GO:0051150|regulation of smooth muscle cell differentiation, GO:0055010|ventricular cardiac muscle tissue morphogenesis, GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0060174|limb bud formation, GO:0060442|branching involved in prostate gland morphogenesis, GO:0060445|branching involved in salivary gland morphogenesis, GO:0060449|bud elongation involved in lung branching, GO:0060463|lung lobe morphogenesis, GO:0060501|positive regulation of epithelial cell proliferation involved in lung morphogenesis, GO:0060512|prostate gland morphogenesis, GO:0060523|prostate epithelial cord elongation, GO:0060527|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis, GO:0060529|squamous basal epithelial stem cell differentiation involved in prostate gland acinus development, GO:0060595|fibroblast growth factor receptor signaling pathway involved in mammary gland specification, GO:0060601|lateral sprouting from an epithelium, GO:0060615|mammary gland bud formation, GO:0060664|epithelial cell proliferation involved in salivary gland morphogenesis, GO:0060667|branch elongation involved in salivary gland morphogenesis, GO:0060670|branching involved in labyrinthine layer morphogenesis, GO:0060687|regulation of branching involved in prostate gland morphogenesis, GO:0060688|regulation of morphogenesis of a branching structure, GO:0060915|mesenchymal cell differentiation involved in lung development, GO:0060916|mesenchymal cell proliferation involved in lung development, GO:0001837|epithelial to mesenchymal transition, GO:0003416|endochondral bone growth, GO:0032496|response to lipopolysaccharide, GO:0042060|wound healing, GO:0044344|cellular response to fibroblast growth factor stimulus, GO:0045471|response to ethanol, GO:0048333|mesodermal cell differentiation, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0050680|negative regulation of epithelial cell proliferation, GO:0071300|cellular response to retinoic acid, GO:0071560|cellular response to transforming growth factor beta stimulus","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005007|fibroblast growth factor-activated receptor activity, GO:0008201|heparin binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0017134|fibroblast growth factor binding"
JUN,Missense,0.00963734259012099,26,0.962732307732719,N,Oncogene,Oncogene,0.199634864009362,0.328189126332385,ENSG00000177606,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin, GO:0005667|transcription factor complex, GO:0000228|nuclear chromosome, GO:0035976|transcription factor AP-1 complex, GO:0005719|nuclear euchromatin, GO:0005829|cytosol, GO:0017053|transcriptional repressor complex","GO:1904707|positive regulation of vascular smooth muscle cell proliferation, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0043547|positive regulation of GTPase activity, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0051726|regulation of cell cycle, GO:0007265|Ras protein signal transduction, GO:0032496|response to lipopolysaccharide, GO:0045892|negative regulation of transcription, DNA-templated, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0034614|cellular response to reactive oxygen species, GO:0071276|cellular response to cadmium ion, GO:0060395|SMAD protein signal transduction, GO:0034097|response to cytokine, GO:0043065|positive regulation of apoptotic process, GO:0042493|response to drug, GO:0032870|cellular response to hormone stimulus, GO:2000144|positive regulation of DNA-templated transcription, initiation, GO:0009314|response to radiation, GO:0010033|response to organic substance, GO:0051090|regulation of DNA-binding transcription factor activity, GO:0009612|response to mechanical stimulus, GO:0001525|angiogenesis, GO:0001774|microglial cell activation, GO:0001836|release of cytochrome c from mitochondria, GO:0001889|liver development, GO:0001938|positive regulation of endothelial cell proliferation, GO:0003151|outflow tract morphogenesis, GO:0006351|transcription, DNA-templated, GO:0006366|transcription by RNA polymerase II, GO:0007568|aging, GO:0007612|learning, GO:0007623|circadian rhythm, GO:0008284|positive regulation of cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0009987|cellular process, GO:0010634|positive regulation of epithelial cell migration, GO:0014070|response to organic cyclic compound, GO:0030224|monocyte differentiation, GO:0031103|axon regeneration, GO:0031953|negative regulation of protein autophosphorylation, GO:0035026|leading edge cell differentiation, GO:0035994|response to muscle stretch, GO:0042542|response to hydrogen peroxide, GO:0043066|negative regulation of apoptotic process, GO:0043392|negative regulation of DNA binding, GO:0043524|negative regulation of neuron apoptotic process, GO:0043525|positive regulation of neuron apoptotic process, GO:0043922|negative regulation by host of viral transcription, GO:0043923|positive regulation by host of viral transcription, GO:0045597|positive regulation of cell differentiation, GO:0045657|positive regulation of monocyte differentiation, GO:0045740|positive regulation of DNA replication, GO:0048146|positive regulation of fibroblast proliferation, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0051365|cellular response to potassium ion starvation, GO:0051591|response to cAMP, GO:0051899|membrane depolarization, GO:0061029|eyelid development in camera-type eye, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0071277|cellular response to calcium ion, GO:1990441|negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress","GO:0044212|transcription regulatory region DNA binding, GO:0003723|RNA binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0005096|GTPase activator activity, GO:0003713|transcription coactivator activity, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0031625|ubiquitin protein ligase binding, GO:0019899|enzyme binding, GO:0070412|R-SMAD binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0044389|ubiquitin-like protein ligase binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0046982|protein heterodimerization activity, GO:0042803|protein homodimerization activity, GO:0003682|chromatin binding, GO:0003690|double-stranded DNA binding, GO:0033613|activating transcription factor binding, GO:0035497|cAMP response element binding, GO:0043565|sequence-specific DNA binding, GO:0071837|HMG box domain binding"
BRAF,Missense,0.00911206155520891,94,0.93054078651733,N,"oncogene, fusion",Oncogene,-0.0711582727778589,0.495530595384685,ENSG00000157764,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005739|mitochondrion, GO:0043005|neuron projection, GO:0044297|cell body","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0007165|signal transduction, GO:0010628|positive regulation of gene expression, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0000186|activation of MAPKK activity, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:0043066|negative regulation of apoptotic process, GO:0000165|MAPK cascade, GO:0009887|animal organ morphogenesis, GO:0002318|myeloid progenitor cell differentiation, GO:0008542|visual learning, GO:0010764|negative regulation of fibroblast migration, GO:0010828|positive regulation of glucose transmembrane transport, GO:0030154|cell differentiation, GO:0030878|thyroid gland development, GO:0035019|somatic stem cell population maintenance, GO:0035690|cellular response to drug, GO:0042127|regulation of cell proliferation, GO:0043367|CD4-positive, alpha-beta T cell differentiation, GO:0043368|positive T cell selection, GO:0043369|CD4-positive or CD8-positive, alpha-beta T cell lineage commitment, GO:0043434|response to peptide hormone, GO:0043524|negative regulation of neuron apoptotic process, GO:0045580|regulation of T cell differentiation, GO:0046632|alpha-beta T cell differentiation, GO:0048538|thymus development, GO:0048679|regulation of axon regeneration, GO:0048680|positive regulation of axon regeneration, GO:0050772|positive regulation of axonogenesis, GO:0050852|T cell receptor signaling pathway, GO:0051291|protein heterooligomerization, GO:0051496|positive regulation of stress fiber assembly, GO:0051591|response to cAMP, GO:0060291|long-term synaptic potentiation, GO:0060323|head morphogenesis, GO:0060324|face development, GO:0070413|trehalose metabolism in response to stress, GO:0071277|cellular response to calcium ion, GO:0090150|establishment of protein localization to membrane, GO:1900026|positive regulation of substrate adhesion-dependent cell spreading, GO:1990090|cellular response to nerve growth factor stimulus, GO:2000301|negative regulation of synaptic vesicle exocytosis, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:0018108|peptidyl-tyrosine phosphorylation","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0005509|calcium ion binding, GO:0004709|MAP kinase kinase kinase activity, GO:0031434|mitogen-activated protein kinase kinase binding, GO:0046982|protein heterodimerization activity, GO:0004713|protein tyrosine kinase activity"
RSPO3,Missense,0.00908812772046281,27,0.964115639544863,N,"oncogene, fusion",Oncogene,-0.0896920982353286,0.656392500336933,ENSG00000146374,"GO:0005576|extracellular region, GO:0005615|extracellular space","GO:0016055|Wnt signaling pathway, GO:0030177|positive regulation of Wnt signaling pathway, GO:0050896|response to stimulus, GO:0002040|sprouting angiogenesis, GO:0030111|regulation of Wnt signaling pathway, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0001974|blood vessel remodeling, GO:2000052|positive regulation of non-canonical Wnt signaling pathway, GO:0001525|angiogenesis, GO:0060670|branching involved in labyrinthine layer morphogenesis, GO:2000096|positive regulation of Wnt signaling pathway, planar cell polarity pathway","GO:0008201|heparin binding, GO:0005102|signaling receptor binding, GO:0005109|frizzled binding"
DNMT3A,Silent,0.00890821968789733,38,0.957667743546138,N,TSG,TSG,0.0658968380550109,0.694265230970284,ENSG00000119772,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0016363|nuclear matrix, GO:0000791|euchromatin, GO:0000775|chromosome, centromeric region, GO:0000792|heterochromatin, GO:0001741|XY body, GO:0005720|nuclear heterochromatin","GO:0032259|methylation, GO:0006325|chromatin organization, GO:0006349|regulation of gene expression by genetic imprinting, GO:0010468|regulation of gene expression, GO:0006306|DNA methylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045814|negative regulation of gene expression, epigenetic, GO:0090116|C-5 methylation of cytosine, GO:0000278|mitotic cell cycle, GO:0006346|methylation-dependent chromatin silencing, GO:0007283|spermatogenesis, GO:0007568|aging, GO:0009636|response to toxic substance, GO:0010212|response to ionizing radiation, GO:0010288|response to lead ion, GO:0010942|positive regulation of cell death, GO:0030182|neuron differentiation, GO:0031667|response to nutrient levels, GO:0032355|response to estradiol, GO:0032776|DNA methylation on cytosine, GO:0033189|response to vitamin A, GO:0042220|response to cocaine, GO:0042493|response to drug, GO:0043045|DNA methylation involved in embryo development, GO:0043046|DNA methylation involved in gamete generation, GO:0045471|response to ethanol, GO:0071230|cellular response to amino acid stimulus, GO:0071361|cellular response to ethanol, GO:0071456|cellular response to hypoxia, GO:0097284|hepatocyte apoptotic process","GO:0046872|metal ion binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0009008|DNA-methyltransferase activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0003886|DNA (cytosine-5-)-methyltransferase activity, GO:0003682|chromatin binding, GO:0003714|transcription corepressor activity"
SMAD4,Nonsense,0.00881024023948687,31,0.962482667117714,N,TSG,TSG,0.695694128121204,1.39387959255299e-05,ENSG00000141646,"GO:0005634|nucleus, GO:0005667|transcription factor complex, GO:0005737|cytoplasm, GO:0005813|centrosome, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin, GO:0032444|activin responsive factor complex, GO:0071141|SMAD protein complex, GO:0090575|RNA polymerase II transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0070373|negative regulation of ERK1 and ERK2 cascade, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0010614|negative regulation of cardiac muscle hypertrophy, GO:0060412|ventricular septum morphogenesis, GO:0030513|positive regulation of BMP signaling pathway, GO:0030509|BMP signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:0016579|protein deubiquitination, GO:0071773|cellular response to BMP stimulus, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0062009|secondary palate development, GO:0003148|outflow tract septum morphogenesis, GO:0017015|regulation of transforming growth factor beta receptor signaling pathway, GO:0060395|SMAD protein signal transduction, GO:1901522|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus, GO:0030308|negative regulation of cell growth, GO:0070207|protein homotrimerization, GO:0035019|somatic stem cell population maintenance, GO:0010862|positive regulation of pathway-restricted SMAD protein phosphorylation, GO:0007183|SMAD protein complex assembly, GO:0060391|positive regulation of SMAD protein signal transduction, GO:0070102|interleukin-6-mediated signaling pathway, GO:0001666|response to hypoxia, GO:0006879|cellular iron ion homeostasis, GO:0051571|positive regulation of histone H3-K4 methylation, GO:2000617|positive regulation of histone H3-K9 acetylation, GO:0032909|regulation of transforming growth factor beta2 production, GO:0003220|left ventricular cardiac muscle tissue morphogenesis, GO:0035556|intracellular signal transduction, GO:0071559|response to transforming growth factor beta, GO:1905305|negative regulation of cardiac myofibril assembly, GO:0001541|ovarian follicle development, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0001701|in utero embryonic development, GO:0001702|gastrulation with mouth forming second, GO:0001822|kidney development, GO:0003190|atrioventricular valve formation, GO:0003198|epithelial to mesenchymal transition involved in endocardial cushion formation, GO:0003251|positive regulation of cell proliferation involved in heart valve morphogenesis, GO:0003279|cardiac septum development, GO:0003360|brainstem development, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007283|spermatogenesis, GO:0007338|single fertilization, GO:0007369|gastrulation, GO:0007411|axon guidance, GO:0007492|endoderm development, GO:0007498|mesoderm development, GO:0008283|cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0008584|male gonad development, GO:0008585|female gonad development, GO:0009952|anterior/posterior pattern specification, GO:0014033|neural crest cell differentiation, GO:0032525|somite rostral/caudal axis specification, GO:0033686|positive regulation of luteinizing hormone secretion, GO:0036302|atrioventricular canal development, GO:0042118|endothelial cell activation, GO:0042127|regulation of cell proliferation, GO:0042733|embryonic digit morphogenesis, GO:0046881|positive regulation of follicle-stimulating hormone secretion, GO:0048589|developmental growth, GO:0048663|neuron fate commitment, GO:0048729|tissue morphogenesis, GO:0048733|sebaceous gland development, GO:0048859|formation of anatomical boundary, GO:0051098|regulation of binding, GO:0051797|regulation of hair follicle development, GO:0060065|uterus development, GO:0060548|negative regulation of cell death, GO:0060956|endocardial cell differentiation, GO:0061040|female gonad morphogenesis, GO:0061614|pri-miRNA transcription by RNA polymerase II, GO:0072133|metanephric mesenchyme morphogenesis, GO:0072134|nephrogenic mesenchyme morphogenesis, GO:0072520|seminiferous tubule development","GO:0003700|DNA-binding transcription factor activity, GO:0044212|transcription regulatory region DNA binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0042803|protein homodimerization activity, GO:0070412|R-SMAD binding, GO:0003712|transcription coregulator activity, GO:0070411|I-SMAD binding, GO:0043565|sequence-specific DNA binding, GO:0043199|sulfate binding, GO:0030616|transforming growth factor beta receptor, common-partner cytoplasmic mediator activity, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0003682|chromatin binding, GO:0005518|collagen binding, GO:0046982|protein heterodimerization activity"
AXIN2,Missense,0.00840040801657552,73,0.94376740443862,N,TSG,TSG,-0.0519001421611374,0.662781944582424,ENSG00000168646,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005813|centrosome, GO:0030877|beta-catenin destruction complex","GO:0008285|negative regulation of cell proliferation, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0001934|positive regulation of protein phosphorylation, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0010942|positive regulation of cell death, GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:1904837|beta-catenin-TCF complex assembly, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:0034613|cellular protein localization, GO:0042476|odontogenesis, GO:0070602|regulation of centromeric sister chromatid cohesion, GO:0048255|mRNA stabilization, GO:0043570|maintenance of DNA repeat elements, GO:0001756|somitogenesis, GO:0001957|intramembranous ossification, GO:0003139|secondary heart field specification, GO:0003413|chondrocyte differentiation involved in endochondral bone morphogenesis, GO:0008283|cell proliferation, GO:0030111|regulation of Wnt signaling pathway, GO:0030282|bone mineralization, GO:0032423|regulation of mismatch repair, GO:0045668|negative regulation of osteoblast differentiation, GO:0061181|regulation of chondrocyte development","GO:0005515|protein binding, GO:0031625|ubiquitin protein ligase binding, GO:0019899|enzyme binding, GO:0008013|beta-catenin binding, GO:0070411|I-SMAD binding"
KMT2C,Missense,0.00325868121896654,378,0.949649972721413,N,TSG,TSG,0.0402108108418271,0.435677220677686,ENSG00000055609,"GO:0005634|nucleus, GO:0044666|MLL3/4 complex, GO:0005654|nucleoplasm, GO:0035097|histone methyltransferase complex","GO:0051568|histone H3-K4 methylation, GO:0006355|regulation of transcription, DNA-templated, GO:0032259|methylation, GO:0006325|chromatin organization, GO:0034968|histone lysine methylation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045652|regulation of megakaryocyte differentiation","GO:0046872|metal ion binding, GO:0042800|histone methyltransferase activity (H3-K4 specific), GO:0003723|RNA binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0016746|transferase activity, transferring acyl groups, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0042393|histone binding, GO:0003713|transcription coactivator activity"
CCND3,Missense,0,24,1,N,"oncogene, fusion",Oncogene,-0.0853049223412984,0.691867943399655,ENSG00000112576,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0000307|cyclin-dependent protein kinase holoenzyme complex","GO:0001934|positive regulation of protein phosphorylation, GO:0006468|protein phosphorylation, GO:0051301|cell division, GO:0007049|cell cycle, GO:0008284|positive regulation of cell proliferation, GO:0000278|mitotic cell cycle, GO:1900087|positive regulation of G1/S transition of mitotic cell cycle, GO:0000079|regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0007088|regulation of mitotic nuclear division, GO:0045787|positive regulation of cell cycle, GO:0045737|positive regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007165|signal transduction, GO:0042098|T cell proliferation, GO:0042127|regulation of cell proliferation, GO:0046626|regulation of insulin receptor signaling pathway, GO:0051726|regulation of cell cycle","GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0004672|protein kinase activity, GO:0016538|cyclin-dependent protein serine/threonine kinase regulator activity, GO:0004693|cyclin-dependent protein serine/threonine kinase activity"
MKL1,Missense,0,75,1,N,"oncogene, TSG, fusion","",0.0432437299966708,0.712586937905297,ENSG00000196588,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0010735|positive regulation of transcription via serum response element binding, GO:0030036|actin cytoskeleton organization, GO:0051145|smooth muscle cell differentiation, GO:0001764|neuron migration, GO:0006357|regulation of transcription by RNA polymerase II, GO:0030900|forebrain development, GO:0031175|neuron projection development, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0045893|positive regulation of transcription, DNA-templated, GO:2001234|negative regulation of apoptotic signaling pathway, GO:0032515|negative regulation of phosphoprotein phosphatase activity","GO:0003713|transcription coactivator activity, GO:0003779|actin binding, GO:0005515|protein binding, GO:0003785|actin monomer binding, GO:0043522|leucine zipper domain binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0004864|protein phosphatase inhibitor activity"
POT1,Silent,0,12,1,N,TSG,TSG,0.301664510302953,0.340635735484745,ENSG00000128513,"GO:0005634|nucleus, GO:0005694|chromosome, GO:0000784|nuclear chromosome, telomeric region, GO:0000781|chromosome, telomeric region, GO:0005654|nucleoplasm, GO:0000783|nuclear telomere cap complex, GO:0070187|shelterin complex","GO:0000723|telomere maintenance, GO:0032212|positive regulation of telomere maintenance via telomerase, GO:0051973|positive regulation of telomerase activity, GO:0007004|telomere maintenance via telomerase, GO:0070200|establishment of protein localization to telomere, GO:0016233|telomere capping, GO:0032508|DNA duplex unwinding, GO:0061820|telomeric D-loop disassembly, GO:0032210|regulation of telomere maintenance via telomerase, GO:0051974|negative regulation of telomerase activity, GO:0032211|negative regulation of telomere maintenance via telomerase, GO:0051096|positive regulation of helicase activity, GO:0032202|telomere assembly, GO:0060383|positive regulation of DNA strand elongation, GO:1905774|regulation of DNA helicase activity, GO:1905776|positive regulation of DNA helicase activity","GO:0043047|single-stranded telomeric DNA binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042162|telomeric DNA binding, GO:0061821|telomeric D-loop binding, GO:0098505|G-rich strand telomeric DNA binding, GO:1905773|8-hydroxy-2'-deoxyguanosine DNA binding, GO:0017151|DEAD/H-box RNA helicase binding, GO:0010521|telomerase inhibitor activity, GO:1990955|G-rich single-stranded DNA binding"
RPN1,Silent,0,15,1,N,fusion,"",0.0915092729657902,0.745674378884066,ENSG00000163902,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005829|cytosol, GO:0005789|endoplasmic reticulum membrane, GO:0042470|melanosome, GO:0005791|rough endoplasmic reticulum, GO:0008250|oligosaccharyltransferase complex","GO:0006486|protein glycosylation, GO:0018279|protein N-linked glycosylation via asparagine, GO:0006464|cellular protein modification process","GO:0003723|RNA binding, GO:0005515|protein binding, GO:0004579|dolichyl-diphosphooligosaccharide-protein glycotransferase activity, GO:0016740|transferase activity, GO:0016757|transferase activity, transferring glycosyl groups"
JUN,Silent,0,13,1,N,Oncogene,Oncogene,-0.0629796412464147,0.838043306131041,ENSG00000177606,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin, GO:0005667|transcription factor complex, GO:0000228|nuclear chromosome, GO:0035976|transcription factor AP-1 complex, GO:0005719|nuclear euchromatin, GO:0005829|cytosol, GO:0017053|transcriptional repressor complex","GO:1904707|positive regulation of vascular smooth muscle cell proliferation, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0043547|positive regulation of GTPase activity, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0051726|regulation of cell cycle, GO:0007265|Ras protein signal transduction, GO:0032496|response to lipopolysaccharide, GO:0045892|negative regulation of transcription, DNA-templated, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0034614|cellular response to reactive oxygen species, GO:0071276|cellular response to cadmium ion, GO:0060395|SMAD protein signal transduction, GO:0034097|response to cytokine, GO:0043065|positive regulation of apoptotic process, GO:0042493|response to drug, GO:0032870|cellular response to hormone stimulus, GO:2000144|positive regulation of DNA-templated transcription, initiation, GO:0009314|response to radiation, GO:0010033|response to organic substance, GO:0051090|regulation of DNA-binding transcription factor activity, GO:0009612|response to mechanical stimulus, GO:0001525|angiogenesis, GO:0001774|microglial cell activation, GO:0001836|release of cytochrome c from mitochondria, GO:0001889|liver development, GO:0001938|positive regulation of endothelial cell proliferation, GO:0003151|outflow tract morphogenesis, GO:0006351|transcription, DNA-templated, GO:0006366|transcription by RNA polymerase II, GO:0007568|aging, GO:0007612|learning, GO:0007623|circadian rhythm, GO:0008284|positive regulation of cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0009987|cellular process, GO:0010634|positive regulation of epithelial cell migration, GO:0014070|response to organic cyclic compound, GO:0030224|monocyte differentiation, GO:0031103|axon regeneration, GO:0031953|negative regulation of protein autophosphorylation, GO:0035026|leading edge cell differentiation, GO:0035994|response to muscle stretch, GO:0042542|response to hydrogen peroxide, GO:0043066|negative regulation of apoptotic process, GO:0043392|negative regulation of DNA binding, GO:0043524|negative regulation of neuron apoptotic process, GO:0043525|positive regulation of neuron apoptotic process, GO:0043922|negative regulation by host of viral transcription, GO:0043923|positive regulation by host of viral transcription, GO:0045597|positive regulation of cell differentiation, GO:0045657|positive regulation of monocyte differentiation, GO:0045740|positive regulation of DNA replication, GO:0048146|positive regulation of fibroblast proliferation, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0051365|cellular response to potassium ion starvation, GO:0051591|response to cAMP, GO:0051899|membrane depolarization, GO:0061029|eyelid development in camera-type eye, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0071277|cellular response to calcium ion, GO:1990441|negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress","GO:0044212|transcription regulatory region DNA binding, GO:0003723|RNA binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0005096|GTPase activator activity, GO:0003713|transcription coactivator activity, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0031625|ubiquitin protein ligase binding, GO:0019899|enzyme binding, GO:0070412|R-SMAD binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0044389|ubiquitin-like protein ligase binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0046982|protein heterodimerization activity, GO:0042803|protein homodimerization activity, GO:0003682|chromatin binding, GO:0003690|double-stranded DNA binding, GO:0033613|activating transcription factor binding, GO:0035497|cAMP response element binding, GO:0043565|sequence-specific DNA binding, GO:0071837|HMG box domain binding"
FGFR3,Missense,-0.000146364869480738,75,0.999005623234929,N,"oncogene, fusion",Oncogene,-0.0300351788804641,0.798104389541738,ENSG00000068078,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0031410|cytoplasmic vesicle, GO:0005925|focal adhesion, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0030133|transport vesicle, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0009986|cell surface","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0006915|apoptotic process, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0046854|phosphatidylinositol phosphorylation, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0043410|positive regulation of MAPK cascade, GO:0060349|bone morphogenesis, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0001501|skeletal system development, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0002062|chondrocyte differentiation, GO:0001958|endochondral ossification, GO:0030282|bone mineralization, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0070977|bone maturation, GO:0010518|positive regulation of phospholipase activity, GO:0003416|endochondral bone growth, GO:0035988|chondrocyte proliferation, GO:0048640|negative regulation of developmental growth, GO:1902178|fibroblast growth factor receptor apoptotic signaling pathway, GO:0007267|cell-cell signaling","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0042802|identical protein binding, GO:0005007|fibroblast growth factor-activated receptor activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0017134|fibroblast growth factor binding"
NRG1,Silent,-0.00248349394977534,28,0.989992992007081,N,"TSG, fusion",TSG,-0.0478340358802797,0.809003295071576,ENSG00000157168,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005634|nucleus, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0005615|extracellular space, GO:0005737|cytoplasm, GO:0005887|integral component of plasma membrane, GO:0030424|axon, GO:0031594|neuromuscular junction, GO:0045202|synapse","GO:0007399|nervous system development, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0010469|regulation of signaling receptor activity, GO:0046854|phosphatidylinositol phosphorylation, GO:0061098|positive regulation of protein tyrosine kinase activity, GO:0035556|intracellular signal transduction, GO:0008284|positive regulation of cell proliferation, GO:0051897|positive regulation of protein kinase B signaling, GO:0000165|MAPK cascade, GO:0038128|ERBB2 signaling pathway, GO:2000145|regulation of cell motility, GO:0032148|activation of protein kinase B activity, GO:0055007|cardiac muscle cell differentiation, GO:0000187|activation of MAPK activity, GO:0014032|neural crest cell development, GO:0045892|negative regulation of transcription, DNA-templated, GO:0051048|negative regulation of secretion, GO:0042060|wound healing, GO:0030879|mammary gland development, GO:0003222|ventricular trabecula myocardium morphogenesis, GO:0038127|ERBB signaling pathway, GO:0060956|endocardial cell differentiation, GO:0007154|cell communication, GO:0007171|activation of transmembrane receptor protein tyrosine kinase activity, GO:0038129|ERBB3 signaling pathway, GO:0043496|regulation of protein homodimerization activity, GO:0043497|regulation of protein heterodimerization activity, GO:0051155|positive regulation of striated muscle cell differentiation, GO:0060379|cardiac muscle cell myoblast differentiation, GO:0000902|cell morphogenesis, GO:0003161|cardiac conduction system development, GO:0007416|synapse assembly, GO:0007420|brain development, GO:0007422|peripheral nervous system development, GO:0007507|heart development, GO:0007517|muscle organ development, GO:0007626|locomotory behavior, GO:0010001|glial cell differentiation, GO:0010628|positive regulation of gene expression, GO:0016477|cell migration, GO:0021781|glial cell fate commitment, GO:0021842|chemorepulsion involved in interneuron migration from the subpallium to the cortex, GO:0022011|myelination in peripheral nervous system, GO:0042177|negative regulation of protein catabolic process, GO:0045213|neurotransmitter receptor metabolic process, GO:0045595|regulation of cell differentiation, GO:0045860|positive regulation of protein kinase activity, GO:0046579|positive regulation of Ras protein signal transduction, GO:0048663|neuron fate commitment, GO:0048709|oligodendrocyte differentiation, GO:0048738|cardiac muscle tissue development, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0070886|positive regulation of calcineurin-NFAT signaling cascade, GO:2000727|positive regulation of cardiac muscle cell differentiation, GO:2001223|negative regulation of neuron migration","GO:0005102|signaling receptor binding, GO:0008083|growth factor activity, GO:0005178|integrin binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0030971|receptor tyrosine kinase binding, GO:0005125|cytokine activity, GO:0004713|protein tyrosine kinase activity, GO:0030297|transmembrane receptor protein tyrosine kinase activator activity, GO:0043125|ErbB-3 class receptor binding, GO:0003712|transcription coregulator activity, GO:0030296|protein tyrosine kinase activator activity, GO:0005176|ErbB-2 class receptor binding, GO:0045499|chemorepellent activity"
APC,Missense,-0.00500368947126905,212,0.942264061867287,N,TSG,TSG,0.190586215023284,0.00536705016681434,ENSG00000134982,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0030054|cell junction, GO:0005874|microtubule, GO:0005813|centrosome, GO:0000776|kinetochore, GO:0005923|bicellular tight junction, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0030027|lamellipodium, GO:0032587|ruffle membrane, GO:0005912|adherens junction, GO:0005881|cytoplasmic microtubule, GO:0030877|beta-catenin destruction complex, GO:0016328|lateral plasma membrane, GO:1990909|Wnt signalosome, GO:0005913|cell-cell adherens junction, GO:0048471|perinuclear region of cytoplasm, GO:0016342|catenin complex","GO:0006974|cellular response to DNA damage stimulus, GO:0007050|cell cycle arrest, GO:0016477|cell migration, GO:0008285|negative regulation of cell proliferation, GO:0043065|positive regulation of apoptotic process, GO:0000281|mitotic cytokinesis, GO:0007026|negative regulation of microtubule depolymerization, GO:0030178|negative regulation of Wnt signaling pathway, GO:0016055|Wnt signaling pathway, GO:0007155|cell adhesion, GO:0045732|positive regulation of protein catabolic process, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0016579|protein deubiquitination, GO:0001708|cell fate specification, GO:0007389|pattern specification process, GO:0045595|regulation of cell differentiation, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0120162|positive regulation of cold-induced thermogenesis, GO:1904886|beta-catenin destruction complex disassembly, GO:0065003|protein-containing complex assembly, GO:1904885|beta-catenin destruction complex assembly, GO:0070830|bicellular tight junction assembly, GO:0051260|protein homooligomerization, GO:0032886|regulation of microtubule-based process, GO:0030335|positive regulation of cell migration, GO:0007094|mitotic spindle assembly checkpoint, GO:0008286|insulin receptor signaling pathway, GO:0010942|positive regulation of cell death, GO:0031274|positive regulation of pseudopodium assembly, GO:0051988|regulation of attachment of spindle microtubules to kinetochore, GO:1904781|positive regulation of protein localization to centrosome","GO:0008013|beta-catenin binding, GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0019901|protein kinase binding, GO:0045295|gamma-catenin binding, GO:0042802|identical protein binding, GO:0051010|microtubule plus-end binding, GO:0019887|protein kinase regulator activity, GO:0031625|ubiquitin protein ligase binding, GO:0070840|dynein complex binding"
BRD4,Missense,-0.00579938637598982,57,0.965849231400987,N,"oncogene, fusion",Oncogene,-0.0351904880778963,0.794958855023258,ENSG00000141867,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0000794|condensed nuclear chromosome","GO:0006325|chromatin organization, GO:0006468|protein phosphorylation, GO:0006974|cellular response to DNA damage stimulus, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016032|viral process, GO:0032968|positive regulation of transcription elongation from RNA polymerase II promoter, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0000083|regulation of transcription involved in G1/S transition of mitotic cell cycle, GO:0010971|positive regulation of G2/M transition of mitotic cell cycle, GO:0050727|regulation of inflammatory response, GO:1901407|regulation of phosphorylation of RNA polymerase II C-terminal domain, GO:2001255|positive regulation of histone H3-K36 trimethylation","GO:0005515|protein binding, GO:0003682|chromatin binding, GO:0019899|enzyme binding, GO:0002039|p53 binding, GO:0070577|lysine-acetylated histone binding, GO:0008353|RNA polymerase II CTD heptapeptide repeat kinase activity, GO:0099122|RNA polymerase II C-terminal domain binding, GO:0106140|P-TEFb complex binding"
PRCC,Missense,-0.00700011375277273,32,0.969668909098618,N,fusion,"",0.0812312339157319,0.65851616856483,ENSG00000143294,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005654|nucleoplasm","GO:0007049|cell cycle, GO:0000398|mRNA splicing, via spliceosome, GO:0007093|mitotic cell cycle checkpoint",GO:0005515|protein binding
KIT,Missense,-0.00744141121560453,112,0.937931396422922,N,Oncogene,Oncogene,-0.0730156767511305,0.444224791801485,ENSG00000157404,"GO:0005615|extracellular space, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0042629|mast cell granule, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0001669|acrosomal vesicle, GO:0005911|cell-cell junction, GO:0009897|external side of plasma membrane, GO:0009898|cytoplasmic side of plasma membrane, GO:0009986|cell surface","GO:1905065|positive regulation of vascular smooth muscle cell differentiation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0030218|erythrocyte differentiation, GO:0006954|inflammatory response, GO:0007283|spermatogenesis, GO:0038093|Fc receptor signaling pathway, GO:0038109|Kit signaling pathway, GO:0046854|phosphatidylinositol phosphorylation, GO:0002244|hematopoietic progenitor cell differentiation, GO:0008284|positive regulation of cell proliferation, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0008584|male gonad development, GO:0048863|stem cell differentiation, GO:0008360|regulation of cell shape, GO:0042127|regulation of cell proliferation, GO:0007165|signal transduction, GO:0030032|lamellipodium assembly, GO:0002551|mast cell chemotaxis, GO:0030217|T cell differentiation, GO:0043303|mast cell degranulation, GO:0051897|positive regulation of protein kinase B signaling, GO:0060374|mast cell differentiation, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0030097|hemopoiesis, GO:0060326|cell chemotaxis, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0019221|cytokine-mediated signaling pathway, GO:0030335|positive regulation of cell migration, GO:0000187|activation of MAPK activity, GO:0031532|actin cytoskeleton reorganization, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0019827|stem cell population maintenance, GO:0042531|positive regulation of tyrosine phosphorylation of STAT protein, GO:0030318|melanocyte differentiation, GO:0035855|megakaryocyte development, GO:0001541|ovarian follicle development, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0010863|positive regulation of phospholipase C activity, GO:0043406|positive regulation of MAP kinase activity, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0046427|positive regulation of JAK-STAT cascade, GO:0030183|B cell differentiation, GO:0038162|erythropoietin-mediated signaling pathway, GO:0050910|detection of mechanical stimulus involved in sensory perception of sound, GO:0032762|mast cell cytokine production, GO:0002327|immature B cell differentiation, GO:0002371|dendritic cell cytokine production, GO:0035162|embryonic hemopoiesis, GO:0043473|pigmentation, GO:0048565|digestive tract development, GO:0070662|mast cell proliferation, GO:0097324|melanocyte migration, GO:0097326|melanocyte adhesion, GO:0002318|myeloid progenitor cell differentiation, GO:0002320|lymphoid progenitor cell differentiation, GO:0002573|myeloid leukocyte differentiation, GO:0006687|glycosphingolipid metabolic process, GO:0007286|spermatid development, GO:0008354|germ cell migration, GO:0008542|visual learning, GO:0009314|response to radiation, GO:0010628|positive regulation of gene expression, GO:0031274|positive regulation of pseudopodium assembly, GO:0035019|somatic stem cell population maintenance, GO:0035234|ectopic germ cell programmed cell death, GO:0035556|intracellular signal transduction, GO:0035701|hematopoietic stem cell migration, GO:0043069|negative regulation of programmed cell death, GO:0043586|tongue development, GO:0045747|positive regulation of Notch signaling pathway, GO:0046686|response to cadmium ion, GO:0048066|developmental pigmentation, GO:0048070|regulation of developmental pigmentation, GO:0048103|somatic stem cell division, GO:0048170|positive regulation of long-term neuronal synaptic plasticity, GO:0050673|epithelial cell proliferation, GO:0097067|cellular response to thyroid hormone stimulus, GO:0120072|positive regulation of pyloric antrum smooth muscle contraction, GO:1904251|regulation of bile acid metabolic process, GO:1904343|positive regulation of colon smooth muscle contraction, GO:1904349|positive regulation of small intestine smooth muscle contraction","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0019955|cytokine binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0002020|protease binding, GO:0005020|stem cell factor receptor activity"
NOTCH1,Silent,-0.0100498638201036,99,0.921354708738736,N,"oncogene, TSG, fusion","",-0.0577045537142331,0.570487111093332,ENSG00000148400,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0005789|endoplasmic reticulum membrane, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005912|adherens junction, GO:0016324|apical plasma membrane, GO:0000139|Golgi membrane, GO:0043235|receptor complex, GO:0001669|acrosomal vesicle, GO:0002193|MAML1-RBP-Jkappa- ICN1 complex, GO:0005737|cytoplasm, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0009986|cell surface, GO:0031410|cytoplasmic vesicle, GO:0071944|cell periphery","GO:0010628|positive regulation of gene expression, GO:0008284|positive regulation of cell proliferation, GO:0010812|negative regulation of cell-substrate adhesion, GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0030514|negative regulation of BMP signaling pathway, GO:0030335|positive regulation of cell migration, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0010614|negative regulation of cardiac muscle hypertrophy, GO:0060412|ventricular septum morphogenesis, GO:0003151|outflow tract morphogenesis, GO:0045668|negative regulation of osteoblast differentiation, GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006955|immune response, GO:0007219|Notch signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0050793|regulation of developmental process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0060271|cilium assembly, GO:0008285|negative regulation of cell proliferation, GO:0007050|cell cycle arrest, GO:0001525|angiogenesis, GO:0010629|negative regulation of gene expression, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0120163|negative regulation of cold-induced thermogenesis, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0045892|negative regulation of transcription, DNA-templated, GO:0001947|heart looping, GO:0007368|determination of left/right symmetry, GO:0045662|negative regulation of myoblast differentiation, GO:0097150|neuronal stem cell population maintenance, GO:0035148|tube formation, GO:0035924|cellular response to vascular endothelial growth factor stimulus, GO:0090051|negative regulation of cell migration involved in sprouting angiogenesis, GO:0043086|negative regulation of catalytic activity, GO:0055008|cardiac muscle tissue morphogenesis, GO:0046579|positive regulation of Ras protein signal transduction, GO:0003180|aortic valve morphogenesis, GO:0003184|pulmonary valve morphogenesis, GO:0030279|negative regulation of ossification, GO:0001837|epithelial to mesenchymal transition, GO:0003198|epithelial to mesenchymal transition involved in endocardial cushion formation, GO:0003273|cell migration involved in endocardial cushion formation, GO:2000811|negative regulation of anoikis, GO:0003181|atrioventricular valve morphogenesis, GO:0070168|negative regulation of biomineral tissue development, GO:2000737|negative regulation of stem cell differentiation, GO:0061314|Notch signaling involved in heart development, GO:0060411|cardiac septum morphogenesis, GO:1901201|regulation of extracellular matrix assembly, GO:2001027|negative regulation of endothelial cell chemotaxis, GO:0010832|negative regulation of myotube differentiation, GO:0046427|positive regulation of JAK-STAT cascade, GO:0003203|endocardial cushion morphogenesis, GO:0048711|positive regulation of astrocyte differentiation, GO:0060317|cardiac epithelial to mesenchymal transition, GO:0030513|positive regulation of BMP signaling pathway, GO:0003169|coronary vein morphogenesis, GO:0060948|cardiac vascular smooth muscle cell development, GO:0060982|coronary artery morphogenesis, GO:0003214|cardiac left ventricle morphogenesis, GO:0003208|cardiac ventricle morphogenesis, GO:0003209|cardiac atrium morphogenesis, GO:0003222|ventricular trabecula myocardium morphogenesis, GO:0003344|pericardium morphogenesis, GO:0061384|heart trabecula morphogenesis, GO:0003332|negative regulation of extracellular matrix constituent secretion, GO:1902339|positive regulation of apoptotic process involved in morphogenesis, GO:0050768|negative regulation of neurogenesis, GO:0060956|endocardial cell differentiation, GO:0060253|negative regulation of glial cell proliferation, GO:0007221|positive regulation of transcription of Notch receptor target, GO:0045747|positive regulation of Notch signaling pathway, GO:0001701|in utero embryonic development, GO:0001708|cell fate specification, GO:0001889|liver development, GO:0002040|sprouting angiogenesis, GO:0002052|positive regulation of neuroblast proliferation, GO:0002437|inflammatory response to antigenic stimulus, GO:0003157|endocardium development, GO:0003160|endocardium morphogenesis, GO:0003162|atrioventricular node development, GO:0003182|coronary sinus valve morphogenesis, GO:0003192|mitral valve formation, GO:0003197|endocardial cushion development, GO:0003207|cardiac chamber formation, GO:0003213|cardiac right atrium morphogenesis, GO:0003219|cardiac right ventricle formation, GO:0003241|growth involved in heart morphogenesis, GO:0003252|negative regulation of cell proliferation involved in heart valve morphogenesis, GO:0003256|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation, GO:0003264|regulation of cardioblast proliferation, GO:0003270|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006959|humoral immune response, GO:0007283|spermatogenesis, GO:0007386|compartment pattern specification, GO:0007409|axonogenesis, GO:0007420|brain development, GO:0007440|foregut morphogenesis, GO:0007492|endoderm development, GO:0007507|heart development, GO:0008544|epidermis development, GO:0008593|regulation of Notch signaling pathway, GO:0009912|auditory receptor cell fate commitment, GO:0010001|glial cell differentiation, GO:0010468|regulation of gene expression, GO:0014031|mesenchymal cell development, GO:0014807|regulation of somitogenesis, GO:0021515|cell differentiation in spinal cord, GO:0021915|neural tube development, GO:0030182|neuron differentiation, GO:0030216|keratinocyte differentiation, GO:0030324|lung development, GO:0030326|embryonic limb morphogenesis, GO:0030334|regulation of cell migration, GO:0030900|forebrain development, GO:0031069|hair follicle morphogenesis, GO:0031100|animal organ regeneration, GO:0031960|response to corticosteroid, GO:0032495|response to muramyl dipeptide, GO:0032496|response to lipopolysaccharide, GO:0035116|embryonic hindlimb morphogenesis, GO:0035914|skeletal muscle cell differentiation, GO:0042127|regulation of cell proliferation, GO:0042246|tissue regeneration, GO:0043065|positive regulation of apoptotic process, GO:0045070|positive regulation of viral genome replication, GO:0045165|cell fate commitment, GO:0045596|negative regulation of cell differentiation, GO:0045603|positive regulation of endothelial cell differentiation, GO:0045607|regulation of inner ear auditory receptor cell differentiation, GO:0045608|negative regulation of inner ear auditory receptor cell differentiation, GO:0045618|positive regulation of keratinocyte differentiation, GO:0045665|negative regulation of neuron differentiation, GO:0045687|positive regulation of glial cell differentiation, GO:0045955|negative regulation of calcium ion-dependent exocytosis, GO:0045967|negative regulation of growth rate, GO:0046533|negative regulation of photoreceptor cell differentiation, GO:0048103|somatic stem cell division, GO:0048663|neuron fate commitment, GO:0048708|astrocyte differentiation, GO:0048709|oligodendrocyte differentiation, GO:0048715|negative regulation of oligodendrocyte differentiation, GO:0048754|branching morphogenesis of an epithelial tube, GO:0048845|venous blood vessel morphogenesis, GO:0048873|homeostasis of number of cells within a tissue, GO:0050678|regulation of epithelial cell proliferation, GO:0050679|positive regulation of epithelial cell proliferation, GO:0050767|regulation of neurogenesis, GO:0060038|cardiac muscle cell proliferation, GO:0060528|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development, GO:0060548|negative regulation of cell death, GO:0060740|prostate gland epithelium morphogenesis, GO:0060768|regulation of epithelial cell proliferation involved in prostate gland development, GO:0060842|arterial endothelial cell differentiation, GO:0060843|venous endothelial cell differentiation, GO:0060979|vasculogenesis involved in coronary vascular morphogenesis, GO:0061419|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0062043|positive regulation of cardiac epithelial to mesenchymal transition, GO:0070986|left/right axis specification, GO:0071372|cellular response to follicle-stimulating hormone stimulus, GO:0072017|distal tubule development, GO:0072044|collecting duct development, GO:0072144|glomerular mesangial cell development, GO:0072602|interleukin-4 secretion, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:1902263|apoptotic process involved in embryonic digit morphogenesis, GO:1903849|positive regulation of aorta morphogenesis, GO:2000974|negative regulation of pro-B cell differentiation","GO:0046872|metal ion binding, GO:0005509|calcium ion binding, GO:0005515|protein binding, GO:0038023|signaling receptor activity, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0004857|enzyme inhibitor activity, GO:0003682|chromatin binding, GO:0003700|DNA-binding transcription factor activity, GO:0004888|transmembrane signaling receptor activity, GO:0005112|Notch binding, GO:0031490|chromatin DNA binding, GO:0043565|sequence-specific DNA binding, GO:0046982|protein heterodimerization activity"
DCTN1,Silent,-0.0102154795458846,31,0.956503858956094,N,fusion,"",-0.0689365480449375,0.712509068909132,ENSG00000204843,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005813|centrosome, GO:0005829|cytosol, GO:0045111|intermediate filament cytoskeleton, GO:0005856|cytoskeleton, GO:0005874|microtubule, GO:0000922|spindle pole, GO:0005815|microtubule organizing center, GO:0005819|spindle, GO:0000776|kinetochore, GO:0005869|dynactin complex, GO:0030286|dynein complex, GO:0005814|centriole, GO:0005938|cell cortex, GO:0120103|centriolar subdistal appendage, GO:0043005|neuron projection, GO:0043025|neuronal cell body, GO:0005635|nuclear envelope, GO:0099738|cell cortex region, GO:0030904|retromer complex, GO:0035371|microtubule plus-end, GO:0005875|microtubule associated complex, GO:0030424|axon","GO:0051301|cell division, GO:0007049|cell cycle, GO:0007399|nervous system development, GO:0042147|retrograde transport, endosome to Golgi, GO:0000086|G2/M transition of mitotic cell cycle, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0097711|ciliary basal body-plasma membrane docking, GO:0010970|transport along microtubule, GO:0019886|antigen processing and presentation of exogenous peptide antigen via MHC class II, GO:0006888|ER to Golgi vesicle-mediated transport, GO:0036498|IRE1-mediated unfolded protein response, GO:0000132|establishment of mitotic spindle orientation, GO:0000278|mitotic cell cycle, GO:1990535|neuron projection maintenance, GO:0070050|neuron cellular homeostasis, GO:0031116|positive regulation of microtubule polymerization, GO:0090063|positive regulation of microtubule nucleation, GO:0060236|regulation of mitotic spindle organization, GO:0051081|nuclear envelope disassembly, GO:0061744|motor behavior, GO:0007528|neuromuscular junction development, GO:0010457|centriole-centriole cohesion, GO:0021517|ventral spinal cord development, GO:0034454|microtubule anchoring at centrosome, GO:0050905|neuromuscular process, GO:0099558|maintenance of synapse structure, GO:1904398|positive regulation of neuromuscular junction development, GO:1905515|non-motile cilium assembly","GO:0003774|motor activity, GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0070840|dynein complex binding, GO:0015631|tubulin binding, GO:0048156|tau protein binding, GO:0019901|protein kinase binding"
NCOR2,Silent,-0.0136884596968486,60,0.917324323396745,N,TSG,TSG,-0.14596463407727,0.265783239634395,ENSG00000196498,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000785|chromatin, GO:0016020|membrane, GO:0000790|nuclear chromatin, GO:0016363|nuclear matrix, GO:0000118|histone deacetylase complex, GO:0017053|transcriptional repressor complex, GO:0016604|nuclear body","GO:0007595|lactation, GO:0010243|response to organonitrogen compound, GO:0032355|response to estradiol, GO:0044849|estrous cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0019216|regulation of lipid metabolic process, GO:0060766|negative regulation of androgen receptor signaling pathway, GO:1903799|negative regulation of production of miRNAs involved in gene silencing by miRNA, GO:0072365|regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter","GO:0003677|DNA binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0003682|chromatin binding, GO:0016922|nuclear receptor binding, GO:0035259|glucocorticoid receptor binding, GO:0042974|retinoic acid receptor binding, GO:0044877|protein-containing complex binding, GO:0046965|retinoid X receptor binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003714|transcription corepressor activity, GO:0042826|histone deacetylase binding, GO:0047485|protein N-terminus binding, GO:0005112|Notch binding, GO:0035257|nuclear hormone receptor binding"
MLLT1,Missense,-0.0143837054888514,41,0.928877719045511,N,fusion,"",0.0640290001984295,0.6908400990573,ENSG00000130382,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0001650|fibrillar center, GO:0008023|transcription elongation factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006366|transcription by RNA polymerase II, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0006469|negative regulation of protein kinase activity","GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003677|DNA binding"
PDGFRB,Silent,-0.0146204790343715,49,0.920577265424068,N,"oncogene, fusion",Oncogene,0.0224912250922634,0.878087910938227,ENSG00000113721,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005794|Golgi apparatus, GO:0043231|intracellular membrane-bounded organelle, GO:0005886|plasma membrane, GO:0031410|cytoplasmic vesicle, GO:0005925|focal adhesion, GO:0005764|lysosome, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0016324|apical plasma membrane, GO:0031226|intrinsic component of plasma membrane, GO:0043202|lysosomal lumen, GO:0009986|cell surface","GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0030335|positive regulation of cell migration, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0007165|signal transduction, GO:0007275|multicellular organism development, GO:0048015|phosphatidylinositol-mediated signaling, GO:0006935|chemotaxis, GO:0046488|phosphatidylinositol metabolic process, GO:0046854|phosphatidylinositol phosphorylation, GO:0002244|hematopoietic progenitor cell differentiation, GO:0008284|positive regulation of cell proliferation, GO:0043410|positive regulation of MAPK cascade, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0007186|G protein-coupled receptor signaling pathway, GO:0016477|cell migration, GO:2000379|positive regulation of reactive oxygen species metabolic process, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0060326|cell chemotaxis, GO:0014911|positive regulation of smooth muscle cell migration, GO:0045840|positive regulation of mitotic nuclear division, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0090280|positive regulation of calcium ion import, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0072277|metanephric glomerular capillary formation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0043406|positive regulation of MAP kinase activity, GO:0035791|platelet-derived growth factor receptor-beta signaling pathway, GO:2000573|positive regulation of DNA biosynthetic process, GO:0010863|positive regulation of phospholipase C activity, GO:0035793|positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0050921|positive regulation of chemotaxis, GO:0032956|regulation of actin cytoskeleton organization, GO:0032516|positive regulation of phosphoprotein phosphatase activity, GO:0006024|glycosaminoglycan biosynthetic process, GO:0007568|aging, GO:0008584|male gonad development, GO:0009636|response to toxic substance, GO:0014070|response to organic cyclic compound, GO:0032355|response to estradiol, GO:0032526|response to retinoic acid, GO:0032967|positive regulation of collagen biosynthetic process, GO:0033993|response to lipid, GO:0034405|response to fluid shear stress, GO:0035025|positive regulation of Rho protein signal transduction, GO:0035441|cell migration involved in vasculogenesis, GO:0035556|intracellular signal transduction, GO:0035789|metanephric mesenchymal cell migration, GO:0035909|aorta morphogenesis, GO:0036120|cellular response to platelet-derived growth factor stimulus, GO:0038091|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway, GO:0042060|wound healing, GO:0042542|response to hydrogen peroxide, GO:0043065|positive regulation of apoptotic process, GO:0043066|negative regulation of apoptotic process, GO:0043627|response to estrogen, GO:0048146|positive regulation of fibroblast proliferation, GO:0048839|inner ear development, GO:0055003|cardiac myofibril assembly, GO:0055093|response to hyperoxia, GO:0060437|lung growth, GO:0060981|cell migration involved in coronary angiogenesis, GO:0061298|retina vasculature development in camera-type eye, GO:0071670|smooth muscle cell chemotaxis, GO:0072075|metanephric mesenchyme development, GO:0072262|metanephric glomerular mesangial cell proliferation involved in metanephros development, GO:0072275|metanephric glomerulus morphogenesis, GO:0072278|metanephric comma-shaped body morphogenesis, GO:0072284|metanephric S-shaped body morphogenesis, GO:2000491|positive regulation of hepatic stellate cell activation","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0048407|platelet-derived growth factor binding, GO:0019901|protein kinase binding, GO:0005102|signaling receptor binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0019899|enzyme binding, GO:0038085|vascular endothelial growth factor binding, GO:0005161|platelet-derived growth factor receptor binding, GO:0004992|platelet activating factor receptor activity, GO:0005017|platelet-derived growth factor-activated receptor activity, GO:0005019|platelet-derived growth factor beta-receptor activity, GO:0043548|phosphatidylinositol 3-kinase binding"
BCL9L,Silent,-0.0150488145589976,38,0.928546917523714,N,"oncogene, TSG","",-0.0748617298331983,0.655098408232744,ENSG00000186174,"GO:0005634|nucleus, GO:0005730|nucleolus, GO:0005654|nucleoplasm, GO:1990907|beta-catenin-TCF complex","GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0060070|canonical Wnt signaling pathway, GO:1904837|beta-catenin-TCF complex assembly, GO:0022604|regulation of cell morphogenesis, GO:0035019|somatic stem cell population maintenance, GO:0035914|skeletal muscle cell differentiation, GO:1903508|positive regulation of nucleic acid-templated transcription","GO:0003713|transcription coactivator activity, GO:0008013|beta-catenin binding"
JAK1,Missense,-0.0217630562855189,105,0.825589564885449,N,"oncogene, TSG","",-0.0450202586476254,0.648368773294425,ENSG00000162434,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005856|cytoskeleton, GO:0005925|focal adhesion, GO:0005829|cytosol, GO:0012505|endomembrane system, GO:0005768|endosome","GO:1903672|positive regulation of sprouting angiogenesis, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0035556|intracellular signal transduction, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0019221|cytokine-mediated signaling pathway, GO:0035722|interleukin-12-mediated signaling pathway, GO:0000165|MAPK cascade, GO:0060333|interferon-gamma-mediated signaling pathway, GO:0038111|interleukin-7-mediated signaling pathway, GO:0060334|regulation of interferon-gamma-mediated signaling pathway, GO:0070102|interleukin-6-mediated signaling pathway, GO:0060337|type I interferon signaling pathway, GO:0046677|response to antibiotic, GO:0070106|interleukin-27-mediated signaling pathway, GO:0070757|interleukin-35-mediated signaling pathway, GO:0038110|interleukin-2-mediated signaling pathway, GO:0035723|interleukin-15-mediated signaling pathway, GO:0038113|interleukin-9-mediated signaling pathway, GO:0038114|interleukin-21-mediated signaling pathway","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0031625|ubiquitin protein ligase binding, GO:0019903|protein phosphatase binding, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005131|growth hormone receptor binding, GO:0031730|CCR5 chemokine receptor binding"
GATA2,Missense,-0.0230696839769033,47,0.877673316229512,N,Oncogene,Oncogene,0.0290429771431379,0.846341972372316,ENSG00000179348,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex","GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0045766|positive regulation of angiogenesis, GO:2000352|negative regulation of endothelial cell apoptotic process, GO:1903589|positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis, GO:0090050|positive regulation of cell migration involved in sprouting angiogenesis, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0006351|transcription, DNA-templated, GO:0030097|hemopoiesis, GO:0006909|phagocytosis, GO:0050766|positive regulation of phagocytosis, GO:0045599|negative regulation of fat cell differentiation, GO:0070345|negative regulation of fat cell proliferation, GO:0007596|blood coagulation, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0035854|eosinophil fate commitment, GO:0048565|digestive tract development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001655|urogenital system development, GO:0001709|cell fate determination, GO:0001764|neuron migration, GO:0001892|embryonic placenta development, GO:0007204|positive regulation of cytosolic calcium ion concentration, GO:0010725|regulation of primitive erythrocyte differentiation, GO:0021514|ventral spinal cord interneuron differentiation, GO:0021533|cell differentiation in hindbrain, GO:0021902|commitment of neuronal cell to specific neuron type in forebrain, GO:0021954|central nervous system neuron development, GO:0021983|pituitary gland development, GO:0030154|cell differentiation, GO:0030182|neuron differentiation, GO:0033993|response to lipid, GO:0035019|somatic stem cell population maintenance, GO:0035065|regulation of histone acetylation, GO:0042472|inner ear morphogenesis, GO:0043306|positive regulation of mast cell degranulation, GO:0045638|negative regulation of myeloid cell differentiation, GO:0045648|positive regulation of erythrocyte differentiation, GO:0045650|negative regulation of macrophage differentiation, GO:0045654|positive regulation of megakaryocyte differentiation, GO:0045666|positive regulation of neuron differentiation, GO:0045746|negative regulation of Notch signaling pathway, GO:0048469|cell maturation, GO:0048663|neuron fate commitment, GO:0048873|homeostasis of number of cells within a tissue, GO:0060100|positive regulation of phagocytosis, engulfment, GO:0060216|definitive hemopoiesis, GO:0060872|semicircular canal development, GO:0090102|cochlea development, GO:0097154|GABAergic neuron differentiation, GO:2000178|negative regulation of neural precursor cell proliferation, GO:2000977|regulation of forebrain neuron differentiation","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0070742|C2H2 zinc finger domain binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0001158|enhancer sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
TBX3,Silent,-0.024026113414799,28,0.90340973958561,N,"oncogene, TSG","",-0.0289157642341135,0.88387235552949,ENSG00000135111,GO:0005634|nucleus,"GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001501|skeletal system development, GO:0006357|regulation of transcription by RNA polymerase II, GO:0008284|positive regulation of cell proliferation, GO:0043066|negative regulation of apoptotic process, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045662|negative regulation of myoblast differentiation, GO:0007569|cell aging, GO:0008595|anterior/posterior axis specification, embryo, GO:0009887|animal organ morphogenesis, GO:0030539|male genitalia development, GO:0030540|female genitalia development, GO:0030879|mammary gland development, GO:0032275|luteinizing hormone secretion, GO:0035115|embryonic forelimb morphogenesis, GO:0035136|forelimb morphogenesis, GO:0042733|embryonic digit morphogenesis, GO:0045787|positive regulation of cell cycle, GO:0046884|follicle-stimulating hormone secretion, GO:0048332|mesoderm morphogenesis, GO:0090398|cellular senescence, GO:0001568|blood vessel development, GO:0001701|in utero embryonic development, GO:0001947|heart looping, GO:0003007|heart morphogenesis, GO:0003151|outflow tract morphogenesis, GO:0003167|atrioventricular bundle cell differentiation, GO:0010159|specification of animal organ position, GO:0019827|stem cell population maintenance, GO:0021761|limbic system development, GO:0030857|negative regulation of epithelial cell differentiation, GO:0035050|embryonic heart tube development, GO:0035108|limb morphogenesis, GO:0035116|embryonic hindlimb morphogenesis, GO:0042127|regulation of cell proliferation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0055007|cardiac muscle cell differentiation, GO:0060021|roof of mouth development, GO:0060412|ventricular septum morphogenesis, GO:0060444|branching involved in mammary gland duct morphogenesis, GO:0060596|mammary placode formation, GO:0060923|cardiac muscle cell fate commitment, GO:0060931|sinoatrial node cell development, GO:2000648|positive regulation of stem cell proliferation","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0001085|RNA polymerase II transcription factor binding, GO:0001102|RNA polymerase II activating transcription factor binding"
COL2A1,Missense,-0.0263475387460309,143,0.754767157824069,N,fusion,"",-0.0106313396332673,0.899716016407012,ENSG00000139219,"GO:0005576|extracellular region, GO:0005581|collagen trimer, GO:0005615|extracellular space, GO:0062023|collagen-containing extracellular matrix, GO:0031012|extracellular matrix, GO:0005788|endoplasmic reticulum lumen, GO:0005585|collagen type II trimer, GO:0005604|basement membrane, GO:0005737|cytoplasm","GO:0050776|regulation of immune response, GO:0001501|skeletal system development, GO:0007601|visual perception, GO:0030198|extracellular matrix organization, GO:0030199|collagen fibril organization, GO:0007605|sensory perception of sound, GO:0001502|cartilage condensation, GO:0001503|ossification, GO:0001894|tissue homeostasis, GO:0001958|endochondral ossification, GO:0002062|chondrocyte differentiation, GO:0003007|heart morphogenesis, GO:0006029|proteoglycan metabolic process, GO:0007417|central nervous system development, GO:0010468|regulation of gene expression, GO:0030903|notochord development, GO:0035108|limb morphogenesis, GO:0042472|inner ear morphogenesis, GO:0048705|skeletal system morphogenesis, GO:0048839|inner ear development, GO:0051216|cartilage development, GO:0060021|roof of mouth development, GO:0060174|limb bud formation, GO:0060272|embryonic skeletal joint morphogenesis, GO:0060348|bone development, GO:0060351|cartilage development involved in endochondral bone morphogenesis, GO:0071599|otic vesicle development, GO:0071773|cellular response to BMP stimulus, GO:0097065|anterior head development, GO:2001240|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand","GO:0046872|metal ion binding, GO:0005201|extracellular matrix structural constituent, GO:0030020|extracellular matrix structural constituent conferring tensile strength, GO:0042802|identical protein binding, GO:0042289|MHC class II protein binding, GO:0048407|platelet-derived growth factor binding, GO:0043394|proteoglycan binding"
RANBP2,Missense,-0.0266661587913909,212,0.699468332113831,N,"TSG, fusion",TSG,0.091269919690159,0.18556352230222,ENSG00000153201,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005643|nuclear pore, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005635|nuclear envelope, GO:0031965|nuclear membrane, GO:0005642|annulate lamellae, GO:0042405|nuclear inclusion body, GO:0044615|nuclear pore nuclear basket, GO:0005739|mitochondrion, GO:0044614|nuclear pore cytoplasmic filaments, GO:1990723|cytoplasmic periphery of the nuclear pore complex","GO:0051028|mRNA transport, GO:0015031|protein transport, GO:0000413|protein peptidyl-prolyl isomerization, GO:0006457|protein folding, GO:0043547|positive regulation of GTPase activity, GO:0046907|intracellular transport, GO:0006607|NLS-bearing protein import into nucleus, GO:0006406|mRNA export from nucleus, GO:0016032|viral process, GO:0016925|protein sumoylation, GO:0051642|centrosome localization, GO:0001975|response to amphetamine, GO:0006111|regulation of gluconeogenesis, GO:0033133|positive regulation of glucokinase activity","GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0005096|GTPase activator activity, GO:0008536|Ran GTPase binding, GO:0019789|SUMO transferase activity, GO:0044877|protein-containing complex binding"
NOTCH1,Nonsense,-0.0268276570611562,26,0.896495150157048,N,"oncogene, TSG, fusion","",-0.0879251310069154,0.669298224094056,ENSG00000148400,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0005789|endoplasmic reticulum membrane, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005912|adherens junction, GO:0016324|apical plasma membrane, GO:0000139|Golgi membrane, GO:0043235|receptor complex, GO:0001669|acrosomal vesicle, GO:0002193|MAML1-RBP-Jkappa- ICN1 complex, GO:0005737|cytoplasm, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0009986|cell surface, GO:0031410|cytoplasmic vesicle, GO:0071944|cell periphery","GO:0010628|positive regulation of gene expression, GO:0008284|positive regulation of cell proliferation, GO:0010812|negative regulation of cell-substrate adhesion, GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0030514|negative regulation of BMP signaling pathway, GO:0030335|positive regulation of cell migration, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0010614|negative regulation of cardiac muscle hypertrophy, GO:0060412|ventricular septum morphogenesis, GO:0003151|outflow tract morphogenesis, GO:0045668|negative regulation of osteoblast differentiation, GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006955|immune response, GO:0007219|Notch signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0050793|regulation of developmental process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0060271|cilium assembly, GO:0008285|negative regulation of cell proliferation, GO:0007050|cell cycle arrest, GO:0001525|angiogenesis, GO:0010629|negative regulation of gene expression, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0120163|negative regulation of cold-induced thermogenesis, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0045892|negative regulation of transcription, DNA-templated, GO:0001947|heart looping, GO:0007368|determination of left/right symmetry, GO:0045662|negative regulation of myoblast differentiation, GO:0097150|neuronal stem cell population maintenance, GO:0035148|tube formation, GO:0035924|cellular response to vascular endothelial growth factor stimulus, GO:0090051|negative regulation of cell migration involved in sprouting angiogenesis, GO:0043086|negative regulation of catalytic activity, GO:0055008|cardiac muscle tissue morphogenesis, GO:0046579|positive regulation of Ras protein signal transduction, GO:0003180|aortic valve morphogenesis, GO:0003184|pulmonary valve morphogenesis, GO:0030279|negative regulation of ossification, GO:0001837|epithelial to mesenchymal transition, GO:0003198|epithelial to mesenchymal transition involved in endocardial cushion formation, GO:0003273|cell migration involved in endocardial cushion formation, GO:2000811|negative regulation of anoikis, GO:0003181|atrioventricular valve morphogenesis, GO:0070168|negative regulation of biomineral tissue development, GO:2000737|negative regulation of stem cell differentiation, GO:0061314|Notch signaling involved in heart development, GO:0060411|cardiac septum morphogenesis, GO:1901201|regulation of extracellular matrix assembly, GO:2001027|negative regulation of endothelial cell chemotaxis, GO:0010832|negative regulation of myotube differentiation, GO:0046427|positive regulation of JAK-STAT cascade, GO:0003203|endocardial cushion morphogenesis, GO:0048711|positive regulation of astrocyte differentiation, GO:0060317|cardiac epithelial to mesenchymal transition, GO:0030513|positive regulation of BMP signaling pathway, GO:0003169|coronary vein morphogenesis, GO:0060948|cardiac vascular smooth muscle cell development, GO:0060982|coronary artery morphogenesis, GO:0003214|cardiac left ventricle morphogenesis, GO:0003208|cardiac ventricle morphogenesis, GO:0003209|cardiac atrium morphogenesis, GO:0003222|ventricular trabecula myocardium morphogenesis, GO:0003344|pericardium morphogenesis, GO:0061384|heart trabecula morphogenesis, GO:0003332|negative regulation of extracellular matrix constituent secretion, GO:1902339|positive regulation of apoptotic process involved in morphogenesis, GO:0050768|negative regulation of neurogenesis, GO:0060956|endocardial cell differentiation, GO:0060253|negative regulation of glial cell proliferation, GO:0007221|positive regulation of transcription of Notch receptor target, GO:0045747|positive regulation of Notch signaling pathway, GO:0001701|in utero embryonic development, GO:0001708|cell fate specification, GO:0001889|liver development, GO:0002040|sprouting angiogenesis, GO:0002052|positive regulation of neuroblast proliferation, GO:0002437|inflammatory response to antigenic stimulus, GO:0003157|endocardium development, GO:0003160|endocardium morphogenesis, GO:0003162|atrioventricular node development, GO:0003182|coronary sinus valve morphogenesis, GO:0003192|mitral valve formation, GO:0003197|endocardial cushion development, GO:0003207|cardiac chamber formation, GO:0003213|cardiac right atrium morphogenesis, GO:0003219|cardiac right ventricle formation, GO:0003241|growth involved in heart morphogenesis, GO:0003252|negative regulation of cell proliferation involved in heart valve morphogenesis, GO:0003256|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation, GO:0003264|regulation of cardioblast proliferation, GO:0003270|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006959|humoral immune response, GO:0007283|spermatogenesis, GO:0007386|compartment pattern specification, GO:0007409|axonogenesis, GO:0007420|brain development, GO:0007440|foregut morphogenesis, GO:0007492|endoderm development, GO:0007507|heart development, GO:0008544|epidermis development, GO:0008593|regulation of Notch signaling pathway, GO:0009912|auditory receptor cell fate commitment, GO:0010001|glial cell differentiation, GO:0010468|regulation of gene expression, GO:0014031|mesenchymal cell development, GO:0014807|regulation of somitogenesis, GO:0021515|cell differentiation in spinal cord, GO:0021915|neural tube development, GO:0030182|neuron differentiation, GO:0030216|keratinocyte differentiation, GO:0030324|lung development, GO:0030326|embryonic limb morphogenesis, GO:0030334|regulation of cell migration, GO:0030900|forebrain development, GO:0031069|hair follicle morphogenesis, GO:0031100|animal organ regeneration, GO:0031960|response to corticosteroid, GO:0032495|response to muramyl dipeptide, GO:0032496|response to lipopolysaccharide, GO:0035116|embryonic hindlimb morphogenesis, GO:0035914|skeletal muscle cell differentiation, GO:0042127|regulation of cell proliferation, GO:0042246|tissue regeneration, GO:0043065|positive regulation of apoptotic process, GO:0045070|positive regulation of viral genome replication, GO:0045165|cell fate commitment, GO:0045596|negative regulation of cell differentiation, GO:0045603|positive regulation of endothelial cell differentiation, GO:0045607|regulation of inner ear auditory receptor cell differentiation, GO:0045608|negative regulation of inner ear auditory receptor cell differentiation, GO:0045618|positive regulation of keratinocyte differentiation, GO:0045665|negative regulation of neuron differentiation, GO:0045687|positive regulation of glial cell differentiation, GO:0045955|negative regulation of calcium ion-dependent exocytosis, GO:0045967|negative regulation of growth rate, GO:0046533|negative regulation of photoreceptor cell differentiation, GO:0048103|somatic stem cell division, GO:0048663|neuron fate commitment, GO:0048708|astrocyte differentiation, GO:0048709|oligodendrocyte differentiation, GO:0048715|negative regulation of oligodendrocyte differentiation, GO:0048754|branching morphogenesis of an epithelial tube, GO:0048845|venous blood vessel morphogenesis, GO:0048873|homeostasis of number of cells within a tissue, GO:0050678|regulation of epithelial cell proliferation, GO:0050679|positive regulation of epithelial cell proliferation, GO:0050767|regulation of neurogenesis, GO:0060038|cardiac muscle cell proliferation, GO:0060528|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development, GO:0060548|negative regulation of cell death, GO:0060740|prostate gland epithelium morphogenesis, GO:0060768|regulation of epithelial cell proliferation involved in prostate gland development, GO:0060842|arterial endothelial cell differentiation, GO:0060843|venous endothelial cell differentiation, GO:0060979|vasculogenesis involved in coronary vascular morphogenesis, GO:0061419|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0062043|positive regulation of cardiac epithelial to mesenchymal transition, GO:0070986|left/right axis specification, GO:0071372|cellular response to follicle-stimulating hormone stimulus, GO:0072017|distal tubule development, GO:0072044|collecting duct development, GO:0072144|glomerular mesangial cell development, GO:0072602|interleukin-4 secretion, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:1902263|apoptotic process involved in embryonic digit morphogenesis, GO:1903849|positive regulation of aorta morphogenesis, GO:2000974|negative regulation of pro-B cell differentiation","GO:0046872|metal ion binding, GO:0005509|calcium ion binding, GO:0005515|protein binding, GO:0038023|signaling receptor activity, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0019899|enzyme binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0004857|enzyme inhibitor activity, GO:0003682|chromatin binding, GO:0003700|DNA-binding transcription factor activity, GO:0004888|transmembrane signaling receptor activity, GO:0005112|Notch binding, GO:0031490|chromatin DNA binding, GO:0043565|sequence-specific DNA binding, GO:0046982|protein heterodimerization activity"
BCOR,Silent,-0.0277029613806267,51,0.84698166249615,N,"TSG, fusion",TSG,0.0464841292414335,0.746007320599469,ENSG00000183337,"GO:0005634|nucleus, GO:0140261|BCOR complex","GO:0006325|chromatin organization, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007507|heart development, GO:0045892|negative regulation of transcription, DNA-templated, GO:0060021|roof of mouth development, GO:0051572|negative regulation of histone H3-K4 methylation, GO:0035518|histone H2A monoubiquitination, GO:0030502|negative regulation of bone mineralization, GO:0042476|odontogenesis, GO:0000415|negative regulation of histone H3-K36 methylation, GO:0065001|specification of axis polarity, GO:0070171|negative regulation of tooth mineralization, GO:0001835|blastocyst hatching","GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0003714|transcription corepressor activity, GO:0008134|transcription factor binding, GO:0044212|transcription regulatory region DNA binding, GO:0042826|histone deacetylase binding, GO:0031072|heat shock protein binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding"
TSHR,Silent,-0.0280374162707859,37,0.869161514229029,N,Oncogene,Oncogene,-0.0606915431553287,0.721218663897664,ENSG00000165409,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0009986|cell surface, GO:0005887|integral component of plasma membrane, GO:0016323|basolateral plasma membrane, GO:0043235|receptor complex","GO:0007186|G protein-coupled receptor signaling pathway, GO:0007165|signal transduction, GO:0007189|adenylate cyclase-activating G protein-coupled receptor signaling pathway, GO:0008344|adult locomotory behavior, GO:0030183|B cell differentiation, GO:0038194|thyroid-stimulating hormone signaling pathway, GO:0040012|regulation of locomotion, GO:0040018|positive regulation of multicellular organism growth, GO:0060119|inner ear receptor cell development, GO:0060122|inner ear receptor cell stereocilium organization, GO:0071542|dopaminergic neuron differentiation, GO:0090103|cochlea morphogenesis, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0009755|hormone-mediated signaling pathway, GO:0007267|cell-cell signaling, GO:0008284|positive regulation of cell proliferation, GO:0007190|activation of adenylate cyclase activity, GO:0007166|cell surface receptor signaling pathway, GO:0007187|G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger, GO:0045762|positive regulation of adenylate cyclase activity, GO:1904588|cellular response to glycoprotein, GO:1905229|cellular response to thyrotropin-releasing hormone","GO:0004930|G protein-coupled receptor activity, GO:0004996|thyroid-stimulating hormone receptor activity, GO:0016500|protein-hormone receptor activity, GO:0005515|protein binding, GO:0038023|signaling receptor activity, GO:0044877|protein-containing complex binding, GO:0008528|G protein-coupled peptide receptor activity"
MSH2,Missense,-0.0287082326509736,63,0.823265021296539,N,TSG,TSG,-0.0941761044525002,0.462848170014241,ENSG00000095002,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005694|chromosome, GO:0032300|mismatch repair complex, GO:0032301|MutSalpha complex, GO:0005654|nucleoplasm, GO:0000784|nuclear chromosome, telomeric region, GO:0032302|MutSbeta complex","GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0006298|mismatch repair, GO:0006302|double-strand break repair, GO:0031573|intra-S DNA damage checkpoint, GO:0045910|negative regulation of DNA recombination, GO:0006301|postreplication repair, GO:0071168|protein localization to chromatin, GO:0043524|negative regulation of neuron apoptotic process, GO:0010165|response to X-ray, GO:0030183|B cell differentiation, GO:0008584|male gonad development, GO:0043570|maintenance of DNA repeat elements, GO:0051096|positive regulation of helicase activity, GO:0001701|in utero embryonic development, GO:0002204|somatic recombination of immunoglobulin genes involved in immune response, GO:0006119|oxidative phosphorylation, GO:0007050|cell cycle arrest, GO:0007281|germ cell development, GO:0008340|determination of adult lifespan, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0010224|response to UV-B, GO:0016446|somatic hypermutation of immunoglobulin genes, GO:0016447|somatic recombination of immunoglobulin gene segments, GO:0019724|B cell mediated immunity, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0045190|isotype switching, GO:0048298|positive regulation of isotype switching to IgA isotypes, GO:0048304|positive regulation of isotype switching to IgG isotypes","GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0030983|mismatched DNA binding, GO:0019901|protein kinase binding, GO:0003682|chromatin binding, GO:0008022|protein C-terminus binding, GO:0019899|enzyme binding, GO:0000400|four-way junction DNA binding, GO:0008094|DNA-dependent ATPase activity, GO:0032137|guanine/thymine mispair binding, GO:0032143|single thymine insertion binding, GO:0003684|damaged DNA binding, GO:0042803|protein homodimerization activity, GO:0003697|single-stranded DNA binding, GO:0032405|MutLalpha complex binding, GO:0016887|ATPase activity, GO:0032139|dinucleotide insertion or deletion binding, GO:0032142|single guanine insertion binding, GO:0032181|dinucleotide repeat insertion binding, GO:0000287|magnesium ion binding, GO:0003690|double-stranded DNA binding, GO:0032357|oxidized purine DNA binding, GO:0043531|ADP binding, GO:0019237|centromeric DNA binding"
SPOP,Missense,-0.0288023229939392,66,0.818427484092146,N,TSG,TSG,-0.00648128305291149,0.958808637433126,ENSG00000121067,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005737|cytoplasm, GO:0005654|nucleoplasm, GO:0031463|Cul3-RING ubiquitin ligase complex","GO:0016567|protein ubiquitination, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0043161|proteasome-mediated ubiquitin-dependent protein catabolic process, GO:0030162|regulation of proteolysis","GO:0005515|protein binding, GO:0031625|ubiquitin protein ligase binding"
TCF3,Missense,-0.0301628119544021,48,0.838735010861064,N,"oncogene, TSG, fusion","",0.039778649512351,0.78836358442207,ENSG00000071564,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex, GO:0000790|nuclear chromatin, GO:0090575|RNA polymerase II transcription factor complex","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0006351|transcription, DNA-templated, GO:0007399|nervous system development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:1902036|regulation of hematopoietic stem cell differentiation, GO:0051149|positive regulation of muscle cell differentiation, GO:0045666|positive regulation of neuron differentiation, GO:0030183|B cell differentiation, GO:0002326|B cell lineage commitment, GO:0033152|immunoglobulin V(D)J recombination","GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0046982|protein heterodimerization activity, GO:0043425|bHLH transcription factor binding, GO:0070491|repressing transcription factor binding, GO:0070888|E-box binding, GO:0008134|transcription factor binding, GO:0035326|enhancer binding, GO:0070644|vitamin D response element binding, GO:0031435|mitogen-activated protein kinase kinase kinase binding"
MEN1,Nonsense,-0.0346301341047119,14,0.906442247305416,N,TSG,TSG,-0.14435014265653,0.622475774406237,ENSG00000133895,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005737|cytoplasm, GO:0032154|cleavage furrow, GO:0032991|protein-containing complex, GO:0000784|nuclear chromosome, telomeric region, GO:0035097|histone methyltransferase complex, GO:0000785|chromatin, GO:0000790|nuclear chromatin, GO:0005788|endoplasmic reticulum lumen, GO:0016363|nuclear matrix","GO:0006325|chromatin organization, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0034968|histone lysine methylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0044267|cellular protein metabolic process, GO:0008285|negative regulation of cell proliferation, GO:0043687|post-translational protein modification, GO:0045786|negative regulation of cell cycle, GO:0000165|MAPK cascade, GO:0001933|negative regulation of protein phosphorylation, GO:0002076|osteoblast development, GO:0009411|response to UV, GO:0010332|response to gamma radiation, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:0032092|positive regulation of protein binding, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045668|negative regulation of osteoblast differentiation, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046329|negative regulation of JNK cascade, GO:0051974|negative regulation of telomerase activity, GO:1904837|beta-catenin-TCF complex assembly, GO:0000278|mitotic cell cycle, GO:0003309|type B pancreatic cell differentiation, GO:0007420|brain development, GO:0010812|negative regulation of cell-substrate adhesion, GO:0032925|regulation of activin receptor signaling pathway, GO:0046697|decidualization, GO:0050680|negative regulation of epithelial cell proliferation, GO:0061469|regulation of type B pancreatic cell proliferation, GO:0071333|cellular response to glucose stimulus, GO:0071375|cellular response to peptide hormone stimulus, GO:0071559|response to transforming growth factor beta, GO:1902807|negative regulation of cell cycle G1/S phase transition","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0030674|protein binding, bridging, GO:0003690|double-stranded DNA binding, GO:0003682|chromatin binding, GO:0047485|protein N-terminus binding, GO:0000400|four-way junction DNA binding, GO:0000403|Y-form DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0070412|R-SMAD binding"
AMER1,Silent,-0.0349796771348117,23,0.874102667706386,N,TSG,TSG,-0.000349780685138865,0.998736203521287,ENSG00000184675,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005886|plasma membrane, GO:0016604|nuclear body, GO:0005829|cytosol","GO:0016055|Wnt signaling pathway, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0090263|positive regulation of canonical Wnt signaling pathway, GO:1904886|beta-catenin destruction complex disassembly, GO:1904885|beta-catenin destruction complex assembly, GO:0031398|positive regulation of protein ubiquitination, GO:0060828|regulation of canonical Wnt signaling pathway, GO:1903364|positive regulation of cellular protein catabolic process, GO:0001822|kidney development, GO:0060348|bone development, GO:0060612|adipose tissue development, GO:0072161|mesenchymal cell differentiation involved in kidney development","GO:0005515|protein binding, GO:0008289|lipid binding, GO:0005546|phosphatidylinositol-4,5-bisphosphate binding, GO:0008013|beta-catenin binding, GO:1904713|beta-catenin destruction complex binding"
MSN,Silent,-0.0368565616518889,20,0.877399907252846,N,fusion,"",-0.157640297622968,0.506840901418984,ENSG00000147065,"GO:0005856|cytoskeleton, GO:0045177|apical part of cell, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0048471|perinuclear region of cytoplasm, GO:0005615|extracellular space, GO:0005925|focal adhesion, GO:0030175|filopodium, GO:0070062|extracellular exosome, GO:0071944|cell periphery, GO:0072562|blood microparticle, GO:0071437|invadopodium, GO:0005902|microvillus, GO:0016324|apical plasma membrane, GO:0031982|vesicle, GO:0031528|microvillus membrane, GO:0031143|pseudopodium, GO:0009986|cell surface, GO:0001931|uropod, GO:0016323|basolateral plasma membrane, GO:0043209|myelin sheath","GO:0007010|cytoskeleton organization, GO:0010628|positive regulation of gene expression, GO:0072678|T cell migration, GO:0045198|establishment of epithelial cell apical/basal polarity, GO:0008360|regulation of cell shape, GO:0035722|interleukin-12-mediated signaling pathway, GO:0061028|establishment of endothelial barrier, GO:0008361|regulation of cell size, GO:0022612|gland morphogenesis, GO:0042098|T cell proliferation, GO:0071394|cellular response to testosterone stimulus, GO:2000401|regulation of lymphocyte migration, GO:0007159|leukocyte cell-cell adhesion, GO:0022614|membrane to membrane docking, GO:0050900|leukocyte migration, GO:0001771|immunological synapse formation, GO:1902115|regulation of organelle assembly, GO:1902966|positive regulation of protein localization to early endosome, GO:1903364|positive regulation of cellular protein catabolic process, GO:2000643|positive regulation of early endosome to late endosome transport, GO:0070489|T cell aggregation, GO:0071803|positive regulation of podosome assembly","GO:0008092|cytoskeletal protein binding, GO:0003779|actin binding, GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0005102|signaling receptor binding, GO:0005200|structural constituent of cytoskeleton, GO:0003725|double-stranded RNA binding, GO:0019899|enzyme binding, GO:0050839|cell adhesion molecule binding"
RET,Missense,-0.0376352174583694,129,0.671971787595264,N,"oncogene, fusion",Oncogene,-0.0588355397219343,0.50777059524535,ENSG00000165731,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0043231|intracellular membrane-bounded organelle, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005768|endosome, GO:0010008|endosome membrane, GO:0030424|axon, GO:0098797|plasma membrane protein complex, GO:0005769|early endosome, GO:0030425|dendrite, GO:0043025|neuronal cell body, GO:0045121|membrane raft","GO:0007156|homophilic cell adhesion via plasma membrane adhesion molecules, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007155|cell adhesion, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0035860|glial cell-derived neurotrophic factor receptor signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0043410|positive regulation of MAPK cascade, GO:0007399|nervous system development, GO:0030335|positive regulation of cell migration, GO:0030155|regulation of cell adhesion, GO:0007165|signal transduction, GO:0007411|axon guidance, GO:0000165|MAPK cascade, GO:0051897|positive regulation of protein kinase B signaling, GO:0000187|activation of MAPK activity, GO:0022008|neurogenesis, GO:2001241|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand, GO:0033619|membrane protein proteolysis, GO:0048265|response to pain, GO:0010976|positive regulation of neuron projection development, GO:0071300|cellular response to retinoic acid, GO:0007158|neuron cell-cell adhesion, GO:0007497|posterior midgut development, GO:0033630|positive regulation of cell adhesion mediated by integrin, GO:0061146|Peyer's patch morphogenesis, GO:0072300|positive regulation of metanephric glomerulus development, GO:0097021|lymphocyte migration into lymphoid organs, GO:0001657|ureteric bud development, GO:0001755|neural crest cell migration, GO:0001838|embryonic epithelial tube formation, GO:0010628|positive regulation of gene expression, GO:0014042|positive regulation of neuron maturation, GO:0030182|neuron differentiation, GO:0033141|positive regulation of peptidyl-serine phosphorylation of STAT protein, GO:0035799|ureter maturation, GO:0042493|response to drug, GO:0042551|neuron maturation, GO:0045793|positive regulation of cell size, GO:0048484|enteric nervous system development, GO:0050770|regulation of axonogenesis, GO:0060041|retina development in camera-type eye, GO:0060384|innervation","GO:0005509|calcium ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0038023|signaling receptor activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity"
KLK2,Silent,-0.0386289357090363,13,0.900294150208775,N,fusion,"",-0.0855490471799711,0.781104130122879,ENSG00000167751,"GO:0005576|extracellular region, GO:0070062|extracellular exosome, GO:0030141|secretory granule","GO:0006508|proteolysis, GO:0022617|extracellular matrix disassembly, GO:0031638|zymogen activation, GO:0003073|regulation of systemic arterial blood pressure","GO:0016787|hydrolase activity, GO:0008233|peptidase activity, GO:0004252|serine-type endopeptidase activity, GO:0008236|serine-type peptidase activity"
DAXX,Missense,-0.0406677883457172,57,0.763904780442803,N,"oncogene, TSG","",-0.0796528665248054,0.55587470104133,ENSG00000204209,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005694|chromosome, GO:0005829|cytosol, GO:0016604|nuclear body, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0000775|chromosome, centromeric region, GO:0016605|PML body","GO:0006325|chromatin organization, GO:1903508|positive regulation of nucleic acid-templated transcription, GO:0006334|nucleosome assembly, GO:0006915|apoptotic process, GO:0016032|viral process, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0045892|negative regulation of transcription, DNA-templated, GO:0030521|androgen receptor signaling pathway, GO:0006338|chromatin remodeling, GO:1903936|cellular response to sodium arsenite, GO:0034605|cellular response to heat, GO:0007257|activation of JUN kinase activity, GO:0071276|cellular response to cadmium ion, GO:1901216|positive regulation of neuron death, GO:0071280|cellular response to copper ion, GO:0031396|regulation of protein ubiquitination, GO:0001934|positive regulation of protein phosphorylation, GO:0034620|cellular response to unfolded protein, GO:0072738|cellular response to diamide, GO:0006355|regulation of transcription, DNA-templated, GO:0045860|positive regulation of protein kinase activity","GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0003714|transcription corepressor activity, GO:0031625|ubiquitin protein ligase binding, GO:0047485|protein N-terminus binding, GO:0019899|enzyme binding, GO:0042393|histone binding, GO:0046982|protein heterodimerization activity, GO:0002039|p53 binding, GO:0050681|androgen receptor binding, GO:0019901|protein kinase binding, GO:0031072|heat shock protein binding, GO:0032183|SUMO binding, GO:0030295|protein kinase activator activity"
APC,Silent,-0.0418971966507009,52,0.768062534803272,N,TSG,TSG,-0.0993024229690222,0.483673247080446,ENSG00000134982,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0030054|cell junction, GO:0005874|microtubule, GO:0005813|centrosome, GO:0000776|kinetochore, GO:0005923|bicellular tight junction, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0030027|lamellipodium, GO:0032587|ruffle membrane, GO:0005912|adherens junction, GO:0005881|cytoplasmic microtubule, GO:0030877|beta-catenin destruction complex, GO:0016328|lateral plasma membrane, GO:1990909|Wnt signalosome, GO:0005913|cell-cell adherens junction, GO:0048471|perinuclear region of cytoplasm, GO:0016342|catenin complex","GO:0006974|cellular response to DNA damage stimulus, GO:0007050|cell cycle arrest, GO:0016477|cell migration, GO:0008285|negative regulation of cell proliferation, GO:0043065|positive regulation of apoptotic process, GO:0000281|mitotic cytokinesis, GO:0007026|negative regulation of microtubule depolymerization, GO:0030178|negative regulation of Wnt signaling pathway, GO:0016055|Wnt signaling pathway, GO:0007155|cell adhesion, GO:0045732|positive regulation of protein catabolic process, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0016579|protein deubiquitination, GO:0001708|cell fate specification, GO:0007389|pattern specification process, GO:0045595|regulation of cell differentiation, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0120162|positive regulation of cold-induced thermogenesis, GO:1904886|beta-catenin destruction complex disassembly, GO:0065003|protein-containing complex assembly, GO:1904885|beta-catenin destruction complex assembly, GO:0070830|bicellular tight junction assembly, GO:0051260|protein homooligomerization, GO:0032886|regulation of microtubule-based process, GO:0030335|positive regulation of cell migration, GO:0007094|mitotic spindle assembly checkpoint, GO:0008286|insulin receptor signaling pathway, GO:0010942|positive regulation of cell death, GO:0031274|positive regulation of pseudopodium assembly, GO:0051988|regulation of attachment of spindle microtubules to kinetochore, GO:1904781|positive regulation of protein localization to centrosome","GO:0008013|beta-catenin binding, GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0019901|protein kinase binding, GO:0045295|gamma-catenin binding, GO:0042802|identical protein binding, GO:0051010|microtubule plus-end binding, GO:0019887|protein kinase regulator activity, GO:0031625|ubiquitin protein ligase binding, GO:0070840|dynein complex binding"
LCK,Silent,-0.0431665847301716,18,0.864954448947542,N,"oncogene, fusion",Oncogene,-0.0806712772885574,0.750327896210812,ENSG00000182866,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0045121|membrane raft, GO:0005829|cytosol, GO:0031234|extrinsic component of cytoplasmic side of plasma membrane, GO:0070062|extracellular exosome, GO:0001772|immunological synapse, GO:0000242|pericentriolar material","GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0006470|protein dephosphorylation, GO:0050900|leukocyte migration, GO:0050853|B cell receptor signaling pathway, GO:0046854|phosphatidylinositol phosphorylation, GO:0030154|cell differentiation, GO:0050852|T cell receptor signaling pathway, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0050862|positive regulation of T cell receptor signaling pathway, GO:0050870|positive regulation of T cell activation, GO:0016032|viral process, GO:0030168|platelet activation, GO:0030217|T cell differentiation, GO:0051897|positive regulation of protein kinase B signaling, GO:2001244|positive regulation of intrinsic apoptotic signaling pathway, GO:0030097|hemopoiesis, GO:0006919|activation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0031295|T cell costimulation, GO:0050690|regulation of defense response to virus by virus, GO:0042493|response to drug, GO:0051209|release of sequestered calcium ion into cytosol, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0034116|positive regulation of heterotypic cell-cell adhesion, GO:0006882|cellular zinc ion homeostasis, GO:0051249|regulation of lymphocyte activation, GO:1903039|positive regulation of leukocyte cell-cell adhesion","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0004715|non-membrane spanning protein tyrosine kinase activity, GO:0042802|identical protein binding, GO:0019901|protein kinase binding, GO:0042169|SH2 domain binding, GO:0008022|protein C-terminus binding, GO:0019903|protein phosphatase binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0001784|phosphotyrosine residue binding, GO:0005102|signaling receptor binding, GO:0042609|CD4 receptor binding, GO:0004722|protein serine/threonine phosphatase activity, GO:0051117|ATPase binding, GO:0043548|phosphatidylinositol 3-kinase binding, GO:0042608|T cell receptor binding, GO:0042610|CD8 receptor binding"
ERC1,Missense,-0.0460087757793094,68,0.709474828401637,N,fusion,"",-0.0137764654047545,0.911217718121493,ENSG00000082805,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005794|Golgi apparatus, GO:0000139|Golgi membrane, GO:0048786|presynaptic active zone, GO:0042734|presynaptic membrane, GO:0008385|IkappaB kinase complex, GO:0045202|synapse","GO:0015031|protein transport, GO:0007275|multicellular organism development, GO:0043066|negative regulation of apoptotic process, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0006355|regulation of transcription, DNA-templated, GO:0007252|I-kappaB phosphorylation, GO:0042147|retrograde transport, endosome to Golgi","GO:0005515|protein binding, GO:0045296|cadherin binding, GO:0017137|Rab GTPase binding, GO:0043522|leucine zipper domain binding, GO:0030165|PDZ domain binding"
PIK3R1,Missense,-0.0472800971159084,86,0.665535373210503,N,TSG,TSG,-0.0499193171897457,0.648071204151031,ENSG00000145675,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005801|cis-Golgi network, GO:0005829|cytosol, GO:0005911|cell-cell junction, GO:0005942|phosphatidylinositol 3-kinase complex, GO:0032991|protein-containing complex, GO:1990578|perinuclear endoplasmic reticulum membrane, GO:0005943|phosphatidylinositol 3-kinase complex, class IA","GO:0046326|positive regulation of glucose import, GO:1903078|positive regulation of protein localization to plasma membrane, GO:0015031|protein transport, GO:0007165|signal transduction, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0038095|Fc-epsilon receptor signaling pathway, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0050900|leukocyte migration, GO:0043551|regulation of phosphatidylinositol 3-kinase activity, GO:0050852|T cell receptor signaling pathway, GO:0001678|cellular glucose homeostasis, GO:0001953|negative regulation of cell-matrix adhesion, GO:0006468|protein phosphorylation, GO:0006606|protein import into nucleus, GO:0007162|negative regulation of cell adhesion, GO:0008286|insulin receptor signaling pathway, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0030183|B cell differentiation, GO:0030335|positive regulation of cell migration, GO:0032760|positive regulation of tumor necrosis factor production, GO:0032869|cellular response to insulin stimulus, GO:0034644|cellular response to UV, GO:0034976|response to endoplasmic reticulum stress, GO:0042307|positive regulation of protein import into nucleus, GO:0043066|negative regulation of apoptotic process, GO:0045671|negative regulation of osteoclast differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046626|regulation of insulin receptor signaling pathway, GO:0051492|regulation of stress fiber assembly, GO:1903076|regulation of protein localization to plasma membrane, GO:0050821|protein stabilization, GO:0016032|viral process, GO:0007186|G protein-coupled receptor signaling pathway, GO:0046854|phosphatidylinositol phosphorylation, GO:0030168|platelet activation, GO:0007411|axon guidance, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0019221|cytokine-mediated signaling pathway, GO:0051897|positive regulation of protein kinase B signaling, GO:0048010|vascular endothelial growth factor receptor signaling pathway, GO:0048015|phosphatidylinositol-mediated signaling, GO:0060396|growth hormone receptor signaling pathway, GO:0038128|ERBB2 signaling pathway, GO:0031295|T cell costimulation, GO:0033120|positive regulation of RNA splicing, GO:1900103|positive regulation of endoplasmic reticulum unfolded protein response, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0048009|insulin-like growth factor receptor signaling pathway","GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0035014|phosphatidylinositol 3-kinase regulator activity, GO:0036312|phosphatidylinositol 3-kinase regulatory subunit binding, GO:0043560|insulin receptor substrate binding, GO:0046982|protein heterodimerization activity, GO:0046935|1-phosphatidylinositol-3-kinase regulator activity, GO:0019903|protein phosphatase binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0001784|phosphotyrosine residue binding, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0005159|insulin-like growth factor receptor binding, GO:0005158|insulin receptor binding, GO:0043559|insulin binding, GO:0005168|neurotrophin TRKA receptor binding, GO:0005068|transmembrane receptor protein tyrosine kinase adaptor activity, GO:0043125|ErbB-3 class receptor binding, GO:0043548|phosphatidylinositol 3-kinase binding"
PDGFB,Silent,-0.0474495187015044,17,0.856494434723378,N,"oncogene, fusion",Oncogene,-0.0464785606297031,0.859403275083636,ENSG00000100311,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005576|extracellular region, GO:0005615|extracellular space, GO:0016323|basolateral plasma membrane, GO:0062023|collagen-containing extracellular matrix, GO:0009986|cell surface, GO:0005788|endoplasmic reticulum lumen, GO:0031093|platelet alpha granule lumen, GO:0000139|Golgi membrane, GO:0005796|Golgi lumen","GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:1904707|positive regulation of vascular smooth muscle cell proliferation, GO:1904754|positive regulation of vascular associated smooth muscle cell migration, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0008284|positive regulation of cell proliferation, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:1905064|negative regulation of vascular smooth muscle cell differentiation, GO:1905176|positive regulation of vascular smooth muscle cell dedifferentiation, GO:0030335|positive regulation of cell migration, GO:0048146|positive regulation of fibroblast proliferation, GO:0010469|regulation of signaling receptor activity, GO:0007275|multicellular organism development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0046854|phosphatidylinositol phosphorylation, GO:0050918|positive chemotaxis, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0007507|heart development, GO:0051781|positive regulation of cell division, GO:0043410|positive regulation of MAPK cascade, GO:0061098|positive regulation of protein tyrosine kinase activity, GO:2000379|positive regulation of reactive oxygen species metabolic process, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0001938|positive regulation of endothelial cell proliferation, GO:0002576|platelet degranulation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0006468|protein phosphorylation, GO:0051897|positive regulation of protein kinase B signaling, GO:0000165|MAPK cascade, GO:0030198|extracellular matrix organization, GO:0050921|positive regulation of chemotaxis, GO:0060326|cell chemotaxis, GO:1902894|negative regulation of pri-miRNA transcription by RNA polymerase II, GO:0032091|negative regulation of protein binding, GO:0032148|activation of protein kinase B activity, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0014911|positive regulation of smooth muscle cell migration, GO:0002548|monocyte chemotaxis, GO:0043406|positive regulation of MAP kinase activity, GO:0018105|peptidyl-serine phosphorylation, GO:0045840|positive regulation of mitotic nuclear division, GO:0090280|positive regulation of calcium ion import, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0072593|reactive oxygen species metabolic process, GO:0071363|cellular response to growth factor stimulus, GO:0009611|response to wounding, GO:0031954|positive regulation of protein autophosphorylation, GO:0032147|activation of protein kinase activity, GO:0045737|positive regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0070528|protein kinase C signaling, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0010544|negative regulation of platelet activation, GO:2000573|positive regulation of DNA biosynthetic process, GO:0001892|embryonic placenta development, GO:0003104|positive regulation of glomerular filtration, GO:0010512|negative regulation of phosphatidylinositol biosynthetic process, GO:0035655|interleukin-18-mediated signaling pathway, GO:0035793|positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway, GO:0038001|paracrine signaling, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0071506|cellular response to mycophenolic acid, GO:0072126|positive regulation of glomerular mesangial cell proliferation, GO:0072255|metanephric glomerular mesangial cell development, GO:1900127|positive regulation of hyaluronan biosynthetic process, GO:2000591|positive regulation of metanephric mesenchymal cell migration","GO:0008083|growth factor activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0042803|protein homodimerization activity, GO:0046982|protein heterodimerization activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005161|platelet-derived growth factor receptor binding, GO:0005518|collagen binding, GO:0016176|superoxide-generating NADPH oxidase activator activity, GO:0042056|chemoattractant activity, GO:0048407|platelet-derived growth factor binding"
NFE2L2,Missense,-0.048002619078926,74,0.684640965083499,N,"oncogene, TSG","",0.0494519182083659,0.675643493687885,ENSG00000116044,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005794|Golgi apparatus, GO:0005813|centrosome, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0032993|protein-DNA complex, GO:0000785|chromatin","GO:2000352|negative regulation of endothelial cell apoptotic process, GO:0071499|cellular response to laminar fluid shear stress, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0071356|cellular response to tumor necrosis factor, GO:0006355|regulation of transcription, DNA-templated, GO:0016567|protein ubiquitination, GO:0045893|positive regulation of transcription, DNA-templated, GO:0016032|viral process, GO:0034599|cellular response to oxidative stress, GO:0006366|transcription by RNA polymerase II, GO:0043161|proteasome-mediated ubiquitin-dependent protein catabolic process, GO:0045454|cell redox homeostasis, GO:0010499|proteasomal ubiquitin-independent protein catabolic process, GO:1903206|negative regulation of hydrogen peroxide-induced cell death, GO:0071498|cellular response to fluid shear stress, GO:1903071|positive regulation of ER-associated ubiquitin-dependent protein catabolic process, GO:0010628|positive regulation of gene expression, GO:1902176|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway, GO:0036499|PERK-mediated unfolded protein response, GO:0070301|cellular response to hydrogen peroxide, GO:0061419|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0036003|positive regulation of transcription from RNA polymerase II promoter in response to stress, GO:0030968|endoplasmic reticulum unfolded protein response, GO:0006954|inflammatory response, GO:0007568|aging, GO:0010667|negative regulation of cardiac muscle cell apoptotic process, GO:0010976|positive regulation of neuron projection development, GO:0030194|positive regulation of blood coagulation, GO:0034976|response to endoplasmic reticulum stress, GO:0035690|cellular response to drug, GO:0036091|positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress, GO:0042149|cellular response to glucose starvation, GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:0045766|positive regulation of angiogenesis, GO:0045995|regulation of embryonic development, GO:0046223|aflatoxin catabolic process, GO:0046326|positive regulation of glucose import, GO:0060548|negative regulation of cell death, GO:0071456|cellular response to hypoxia, GO:1902037|negative regulation of hematopoietic stem cell differentiation, GO:1903788|positive regulation of glutathione biosynthetic process, GO:1904385|cellular response to angiotensin, GO:1904753|negative regulation of vascular associated smooth muscle cell migration, GO:2000121|regulation of removal of superoxide radicals, GO:2000379|positive regulation of reactive oxygen species metabolic process","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0019904|protein domain specific binding, GO:0001102|RNA polymerase II activating transcription factor binding, GO:0044212|transcription regulatory region DNA binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0001221|transcription cofactor binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0043565|sequence-specific DNA binding"
CXCR4,Silent,-0.0511251028141888,17,0.845499056516559,N,Oncogene,Oncogene,-0.0522467721436663,0.842148892928007,ENSG00000121966,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0030054|cell junction, GO:0031410|cytoplasmic vesicle, GO:0009986|cell surface, GO:0005764|lysosome, GO:0009897|external side of plasma membrane, GO:0005768|endosome, GO:0005769|early endosome, GO:0031252|cell leading edge, GO:0070062|extracellular exosome, GO:0005770|late endosome, GO:0005737|cytoplasm, GO:0032991|protein-containing complex","GO:0007186|G protein-coupled receptor signaling pathway, GO:0007165|signal transduction, GO:0006935|chemotaxis, GO:0006955|immune response, GO:0060326|cell chemotaxis, GO:0001666|response to hypoxia, GO:0016032|viral process, GO:0006954|inflammatory response, GO:0007411|axon guidance, GO:0007204|positive regulation of cytosolic calcium ion concentration, GO:0019722|calcium-mediated signaling, GO:0002407|dendritic cell chemotaxis, GO:0009615|response to virus, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0007420|brain development, GO:0006915|apoptotic process, GO:0022008|neurogenesis, GO:0071345|cellular response to cytokine stimulus, GO:0000187|activation of MAPK activity, GO:0019064|fusion of virus membrane with host plasma membrane, GO:0030260|entry into host cell, GO:0050920|regulation of chemotaxis, GO:0038160|CXCL12-activated CXCR4 signaling pathway, GO:0043217|myelin maintenance, GO:0048714|positive regulation of oligodendrocyte differentiation","GO:0004930|G protein-coupled receptor activity, GO:0003779|actin binding, GO:0005515|protein binding, GO:0004950|chemokine receptor activity, GO:0019955|cytokine binding, GO:0031625|ubiquitin protein ligase binding, GO:0043130|ubiquitin binding, GO:0016493|C-C chemokine receptor activity, GO:0019956|chemokine binding, GO:0019957|C-C chemokine binding, GO:0015026|coreceptor activity, GO:0001618|virus receptor activity, GO:0016494|C-X-C chemokine receptor activity, GO:0032027|myosin light chain binding, GO:0038147|C-X-C motif chemokine 12 receptor activity"
BAP1,Missense,-0.0519132358129834,84,0.639084008370696,N,TSG,TSG,-0.0208485735741663,0.850690361450252,ENSG00000163930,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0035517|PR-DUB complex","GO:0006325|chromatin organization, GO:0006508|proteolysis, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0010035|response to inorganic substance, GO:0050727|regulation of inflammatory response, GO:0061519|macrophage homeostasis, GO:1900015|regulation of cytokine production involved in inflammatory response, GO:0016579|protein deubiquitination, GO:0071108|protein K48-linked deubiquitination, GO:0001558|regulation of cell growth, GO:0051726|regulation of cell cycle, GO:0006464|cellular protein modification process, GO:0008285|negative regulation of cell proliferation, GO:1903955|positive regulation of protein targeting to mitochondrion, GO:0035520|monoubiquitinated protein deubiquitination, GO:0035522|monoubiquitinated histone H2A deubiquitination","GO:0004843|thiol-dependent ubiquitin-specific protease activity, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0003682|chromatin binding"
LMNA,Silent,-0.0524448129917054,22,0.816702507464368,N,fusion,"",-0.0712452764647513,0.752712785899056,ENSG00000160789,"GO:0005882|intermediate filament, GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005635|nuclear envelope, GO:0031965|nuclear membrane, GO:0005652|nuclear lamina, GO:0005638|lamin filament","GO:0030334|regulation of cell migration, GO:0036498|IRE1-mediated unfolded protein response, GO:0034504|protein localization to nucleus, GO:0071456|cellular response to hypoxia, GO:0007084|mitotic nuclear envelope reassembly, GO:0008285|negative regulation of cell proliferation, GO:0030951|establishment or maintenance of microtubule cytoskeleton polarity, GO:0090343|positive regulation of cell aging, GO:1903243|negative regulation of cardiac muscle hypertrophy in response to stress, GO:0006606|protein import into nucleus, GO:0006997|nucleus organization, GO:0006998|nuclear envelope organization, GO:0010628|positive regulation of gene expression, GO:0031647|regulation of protein stability, GO:0055015|ventricular cardiac muscle cell development, GO:0072201|negative regulation of mesenchymal cell proliferation, GO:0090201|negative regulation of release of cytochrome c from mitochondria, GO:1900114|positive regulation of histone H3-K9 trimethylation, GO:1900180|regulation of protein localization to nucleus, GO:2001237|negative regulation of extrinsic apoptotic signaling pathway","GO:0005198|structural molecule activity, GO:0005515|protein binding"
MAML2,Missense,-0.0623068333383278,87,0.566433997193343,N,"oncogene, fusion",Oncogene,-0.0638188115335378,0.557034695126378,ENSG00000184384,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005654|nucleoplasm","GO:0007219|Notch signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0007221|positive regulation of transcription of Notch receptor target, GO:0045747|positive regulation of Notch signaling pathway",GO:0003713|transcription coactivator activity
EIF3E,Missense,-0.0629489926383912,32,0.732151098892465,N,"TSG, fusion",TSG,-0.0632918447516206,0.730745969620258,ENSG00000104408,"GO:0005737|cytoplasm, GO:0005852|eukaryotic translation initiation factor 3 complex, GO:0005829|cytosol, GO:0016604|nuclear body, GO:0005634|nucleus, GO:0016020|membrane, GO:0016282|eukaryotic 43S preinitiation complex, GO:0033290|eukaryotic 48S preinitiation complex, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0071540|eukaryotic translation initiation factor 3 complex, eIF3e, GO:0000785|chromatin, GO:0016605|PML body","GO:0006413|translational initiation, GO:0001732|formation of cytoplasmic translation initiation complex, GO:0002183|cytoplasmic translational initiation, GO:0006412|translation, GO:0000184|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, GO:0045727|positive regulation of translation, GO:1902416|positive regulation of mRNA binding, GO:0006446|regulation of translational initiation, GO:0045947|negative regulation of translational initiation","GO:0003743|translation initiation factor activity, GO:0003723|RNA binding, GO:0005515|protein binding, GO:0045296|cadherin binding, GO:0047485|protein N-terminus binding"
EPAS1,Missense,-0.0689414337179983,62,0.594426741021805,N,"oncogene, TSG","",-0.0580022235295635,0.654302755014877,ENSG00000116016,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005667|transcription factor complex, GO:0016607|nuclear speck, GO:0005654|nucleoplasm, GO:0005829|cytosol","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0043687|post-translational protein modification, GO:0001525|angiogenesis, GO:0007165|signal transduction, GO:0006366|transcription by RNA polymerase II, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0071456|cellular response to hypoxia, GO:0061418|regulation of transcription from RNA polymerase II promoter in response to hypoxia, GO:0001666|response to hypoxia, GO:0001892|embryonic placenta development, GO:0001974|blood vessel remodeling, GO:0002027|regulation of heart rate, GO:0006979|response to oxidative stress, GO:0007005|mitochondrion organization, GO:0007601|visual perception, GO:0030097|hemopoiesis, GO:0030218|erythrocyte differentiation, GO:0030324|lung development, GO:0042415|norepinephrine metabolic process, GO:0043129|surfactant homeostasis, GO:0043619|regulation of transcription from RNA polymerase II promoter in response to oxidative stress, GO:0048469|cell maturation, GO:0048625|myoblast fate commitment, GO:0055072|iron ion homeostasis","GO:0046983|protein dimerization activity, GO:0003700|DNA-binding transcription factor activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0046982|protein heterodimerization activity, GO:0043565|sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0035035|histone acetyltransferase binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
HLA-A,Missense,-0.0696217628791854,40,0.669464836190916,N,fusion,"",-0.119020008800894,0.464482854945691,ENSG00000206503,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0009986|cell surface, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0042612|MHC class I protein complex, GO:0005789|endoplasmic reticulum membrane, GO:0070062|extracellular exosome, GO:0030670|phagocytic vesicle membrane, GO:0000139|Golgi membrane, GO:0012507|ER to Golgi transport vesicle membrane, GO:0071556|integral component of lumenal side of endoplasmic reticulum membrane, GO:0031901|early endosome membrane, GO:0055038|recycling endosome membrane","GO:0006955|immune response, GO:0002376|immune system process, GO:0050776|regulation of immune response, GO:0019882|antigen processing and presentation, GO:0002474|antigen processing and presentation of peptide antigen via MHC class I, GO:0016567|protein ubiquitination, GO:0002479|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, GO:0060333|interferon-gamma-mediated signaling pathway, GO:0060337|type I interferon signaling pathway, GO:0002480|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent, GO:0042270|protection from natural killer cell mediated cytotoxicity","GO:0042605|peptide antigen binding, GO:0030881|beta-2-microglobulin binding, GO:0046977|TAP binding"
ATP1A1,Missense,-0.0700089023239338,71,0.561815336036482,N,"oncogene, TSG","",-0.0684313888871512,0.57068454173164,ENSG00000163399,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0042470|melanosome, GO:0070062|extracellular exosome, GO:0042383|sarcolemma, GO:0032991|protein-containing complex, GO:0005783|endoplasmic reticulum, GO:0005890|sodium:potassium-exchanging ATPase complex, GO:1903561|extracellular vesicle, GO:0005794|Golgi apparatus, GO:0005768|endosome, GO:0005901|caveola, GO:0014069|postsynaptic density, GO:0014704|intercalated disc, GO:0016323|basolateral plasma membrane, GO:0016324|apical plasma membrane, GO:0030315|T-tubule, GO:0043209|myelin sheath, GO:0045121|membrane raft","GO:0016311|dephosphorylation, GO:0006811|ion transport, GO:0006813|potassium ion transport, GO:0006814|sodium ion transport, GO:0010248|establishment or maintenance of transmembrane electrochemical gradient, GO:1990573|potassium ion import across plasma membrane, GO:0002028|regulation of sodium ion transport, GO:0086002|cardiac muscle cell action potential involved in contraction, GO:0006883|cellular sodium ion homeostasis, GO:0015991|ATP hydrolysis coupled proton transport, GO:0030007|cellular potassium ion homeostasis, GO:0036376|sodium ion export across plasma membrane, GO:0055119|relaxation of cardiac muscle, GO:0071383|cellular response to steroid hormone stimulus, GO:0086009|membrane repolarization, GO:0086013|membrane repolarization during cardiac muscle cell action potential, GO:0086064|cell communication by electrical coupling involved in cardiac conduction, GO:1903416|response to glycoside, GO:0002026|regulation of the force of heart contraction, GO:0008217|regulation of blood pressure, GO:0031947|negative regulation of glucocorticoid biosynthetic process, GO:0042493|response to drug, GO:0045822|negative regulation of heart contraction, GO:0045823|positive regulation of heart contraction, GO:0045989|positive regulation of striated muscle contraction, GO:0060081|membrane hyperpolarization, GO:0071260|cellular response to mechanical stimulus, GO:0086004|regulation of cardiac muscle cell contraction, GO:0090662|ATP hydrolysis coupled transmembrane transport","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0005391|sodium:potassium-exchanging ATPase activity, GO:0051087|chaperone binding, GO:0030955|potassium ion binding, GO:0031402|sodium ion binding, GO:1990239|steroid hormone binding, GO:0016791|phosphatase activity, GO:0019901|protein kinase binding, GO:0019904|protein domain specific binding, GO:0030506|ankyrin binding, GO:0043531|ADP binding, GO:0043548|phosphatidylinositol 3-kinase binding"
TP53,Silent,-0.0724059532727548,26,0.725210569648111,N,"oncogene, TSG, fusion","",0.402087889436635,0.0417223213880789,ENSG00000141510,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005783|endoplasmic reticulum, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005759|mitochondrial matrix, GO:0005730|nucleolus, GO:0000790|nuclear chromatin, GO:0016363|nuclear matrix, GO:0032991|protein-containing complex, GO:0016605|PML body, GO:0005622|intracellular, GO:0005669|transcription factor TFIID complex, GO:0016604|nuclear body, GO:0005667|transcription factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006915|apoptotic process, GO:0007049|cell cycle, GO:0051262|protein tetramerization, GO:0010628|positive regulation of gene expression, GO:0008285|negative regulation of cell proliferation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045899|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly, GO:0006974|cellular response to DNA damage stimulus, GO:0048511|rhythmic process, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0016579|protein deubiquitination, GO:0008283|cell proliferation, GO:0007050|cell cycle arrest, GO:0043065|positive regulation of apoptotic process, GO:0016032|viral process, GO:0006284|base-excision repair, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0008104|protein localization, GO:0030308|negative regulation of cell growth, GO:0042981|regulation of apoptotic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0019221|cytokine-mediated signaling pathway, GO:0035690|cellular response to drug, GO:0012501|programmed cell death, GO:0090200|positive regulation of release of cytochrome c from mitochondria, GO:2001244|positive regulation of intrinsic apoptotic signaling pathway, GO:0090399|replicative senescence, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0065003|protein-containing complex assembly, GO:0032461|positive regulation of protein oligomerization, GO:0009299|mRNA transcription, GO:0007569|cell aging, GO:0071456|cellular response to hypoxia, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:1900740|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, GO:0043153|entrainment of circadian clock by photoperiod, GO:0042149|cellular response to glucose starvation, GO:0071158|positive regulation of cell cycle arrest, GO:0072332|intrinsic apoptotic signaling pathway by p53 class mediator, GO:1990440|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0046677|response to antibiotic, GO:0097252|oligodendrocyte apoptotic process, GO:0048512|circadian behavior, GO:0000733|DNA strand renaturation, GO:0043066|negative regulation of apoptotic process, GO:1903800|positive regulation of production of miRNAs involved in gene silencing by miRNA, GO:2000379|positive regulation of reactive oxygen species metabolic process, GO:0048147|negative regulation of fibroblast proliferation, GO:0007265|Ras protein signal transduction, GO:0071480|cellular response to gamma radiation, GO:0006289|nucleotide-excision repair, GO:0006914|autophagy, GO:0006978|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator, GO:0006983|ER overload response, GO:0008340|determination of adult lifespan, GO:0010332|response to gamma radiation, GO:0031497|chromatin assembly, GO:0031571|mitotic G1 DNA damage checkpoint, GO:0034644|cellular response to UV, GO:0046827|positive regulation of protein export from nucleus, GO:0046902|regulation of mitochondrial membrane permeability, GO:0051097|negative regulation of helicase activity, GO:0051123|RNA polymerase II preinitiation complex assembly, GO:0051289|protein homotetramerization, GO:0051974|negative regulation of telomerase activity, GO:0070245|positive regulation of thymocyte apoptotic process, GO:0071479|cellular response to ionizing radiation, GO:0072331|signal transduction by p53 class mediator, GO:0072717|cellular response to actinomycin D, GO:0090403|oxidative stress-induced premature senescence, GO:0097193|intrinsic apoptotic signaling pathway, GO:1900119|positive regulation of execution phase of apoptosis, GO:1902749|regulation of cell cycle G2/M phase transition","GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0044212|transcription regulatory region DNA binding, GO:0005524|ATP binding, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019901|protein kinase binding, GO:0003682|chromatin binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0031625|ubiquitin protein ligase binding, GO:0047485|protein N-terminus binding, GO:0019899|enzyme binding, GO:0019903|protein phosphatase binding, GO:0008134|transcription factor binding, GO:0002020|protease binding, GO:0005507|copper ion binding, GO:0046982|protein heterodimerization activity, GO:0001085|RNA polymerase II transcription factor binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0051087|chaperone binding, GO:0002039|p53 binding, GO:1990841|promoter-specific chromatin binding, GO:0051721|protein phosphatase 2A binding, GO:0003730|mRNA 3'-UTR binding, GO:0097718|disordered domain specific binding, GO:0035035|histone acetyltransferase binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001046|core promoter sequence-specific DNA binding, GO:0001094|TFIID-class transcription factor complex binding, GO:0030971|receptor tyrosine kinase binding, GO:0042826|histone deacetylase binding, GO:0043621|protein self-association"
NSD1,Nonsense,-0.077795510969476,13,0.800566254269681,N,fusion,"",-0.147219856613072,0.631260292397521,ENSG00000165671,"GO:0005634|nucleus, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0000785|chromatin","GO:0032259|methylation, GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0034968|histone lysine methylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0016571|histone methylation, GO:0000414|regulation of histone H3-K36 methylation, GO:0010452|histone H3-K36 methylation, GO:0033135|regulation of peptidyl-serine phosphorylation, GO:0034770|histone H4-K20 methylation, GO:1903025|regulation of RNA polymerase II regulatory region sequence-specific DNA binding","GO:0046872|metal ion binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0046975|histone methyltransferase activity (H3-K36 specific), GO:0042799|histone methyltransferase activity (H4-K20 specific), GO:0003714|transcription corepressor activity, GO:0030331|estrogen receptor binding, GO:0042974|retinoic acid receptor binding, GO:0003682|chromatin binding, GO:0003712|transcription coregulator activity, GO:0050681|androgen receptor binding, GO:0046966|thyroid hormone receptor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0046965|retinoid X receptor binding"
ATRX,Silent,-0.080143914252411,43,0.609438061711586,N,TSG,TSG,-0.124177467323579,0.427562693722953,ENSG00000085224,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0016604|nuclear body, GO:0000781|chromosome, telomeric region, GO:0000228|nuclear chromosome, GO:0000780|condensed nuclear chromosome, centromeric region, GO:0000784|nuclear chromosome, telomeric region, GO:0000792|heterochromatin, GO:0005721|pericentric heterochromatin, GO:0016605|PML body, GO:0031618|nuclear pericentric heterochromatin, GO:0031933|telomeric heterochromatin, GO:0005720|nuclear heterochromatin, GO:1990707|nuclear subtelomeric heterochromatin","GO:0006325|chromatin organization, GO:0006334|nucleosome assembly, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0000212|meiotic spindle organization, GO:0007283|spermatogenesis, GO:0010571|positive regulation of nuclear cell cycle DNA replication, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0030900|forebrain development, GO:0031297|replication fork processing, GO:0032206|positive regulation of telomere maintenance, GO:0035128|post-embryonic forelimb morphogenesis, GO:0035264|multicellular organism growth, GO:0060009|Sertoli cell development, GO:0070192|chromosome organization involved in meiotic cell cycle, GO:0070198|protein localization to chromosome, telomeric region, GO:0072520|seminiferous tubule development, GO:0072711|cellular response to hydroxyurea, GO:1901581|negative regulation of telomeric RNA transcription from RNA pol II promoter, GO:0006336|DNA replication-independent nucleosome assembly, GO:0006355|regulation of transcription, DNA-templated, GO:0006338|chromatin remodeling, GO:1904908|negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric, GO:0006306|DNA methylation, GO:1900112|regulation of histone H3-K9 trimethylation, GO:1901582|positive regulation of telomeric RNA transcription from RNA pol II promoter","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004386|helicase activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0042393|histone binding, GO:0035064|methylated histone binding, GO:0070087|chromo shadow domain binding, GO:0015616|DNA translocase activity"
KRAS,Missense,-0.0835210888022851,48,0.572491723050932,N,Oncogene,Oncogene,-0.058169171806089,0.694528144017456,ENSG00000133703,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005925|focal adhesion, GO:0031234|extrinsic component of cytoplasmic side of plasma membrane, GO:0005739|mitochondrion, GO:0045121|membrane raft","GO:0010628|positive regulation of gene expression, GO:0001934|positive regulation of protein phosphorylation, GO:0007165|signal transduction, GO:0008284|positive regulation of cell proliferation, GO:0031647|regulation of protein stability, GO:0000165|MAPK cascade, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0007265|Ras protein signal transduction, GO:0001889|liver development, GO:0007565|female pregnancy, GO:0008542|visual learning, GO:0019221|cytokine-mediated signaling pathway, GO:0021897|forebrain astrocyte development, GO:0030036|actin cytoskeleton organization, GO:0032228|regulation of synaptic transmission, GABAergic, GO:0035022|positive regulation of Rac protein signal transduction, GO:0035900|response to isolation stress, GO:0038002|endocrine signaling, GO:0043406|positive regulation of MAP kinase activity, GO:0043524|negative regulation of neuron apoptotic process, GO:0045596|negative regulation of cell differentiation, GO:0048169|regulation of long-term neuronal synaptic plasticity, GO:0048873|homeostasis of number of cells within a tissue, GO:0051000|positive regulation of nitric-oxide synthase activity, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0051146|striated muscle cell differentiation, GO:0051384|response to glucocorticoid, GO:0051385|response to mineralocorticoid, GO:0060441|epithelial tube branching involved in lung morphogenesis, GO:2000774|positive regulation of cellular senescence","GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0044877|protein-containing complex binding, GO:0019002|GMP binding, GO:0019003|GDP binding, GO:0030275|LRR domain binding"
DDX5,Missense,-0.0876745388634721,56,0.520524287508756,N,"oncogene, fusion",Oncogene,-0.0712226571395739,0.60193234671821,ENSG00000108654,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005681|spliceosomal complex, GO:0071013|catalytic step 2 spliceosome, GO:0005730|nucleolus, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:1990904|ribonucleoprotein complex","GO:0030509|BMP signaling pathway, GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0048511|rhythmic process, GO:0000398|mRNA splicing, via spliceosome, GO:0000956|nuclear-transcribed mRNA catabolic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0006357|regulation of transcription by RNA polymerase II, GO:0000381|regulation of alternative mRNA splicing, via spliceosome, GO:0030521|androgen receptor signaling pathway, GO:0030520|intracellular estrogen receptor signaling pathway, GO:0072332|intrinsic apoptotic signaling pathway by p53 class mediator, GO:0043517|positive regulation of DNA damage response, signal transduction by p53 class mediator, GO:0000380|alternative mRNA splicing, via spliceosome, GO:0001837|epithelial to mesenchymal transition, GO:1903800|positive regulation of production of miRNAs involved in gene silencing by miRNA, GO:0045445|myoblast differentiation, GO:0045667|regulation of osteoblast differentiation, GO:0009299|mRNA transcription, GO:0045069|regulation of viral genome replication, GO:0060765|regulation of androgen receptor signaling pathway, GO:0061614|pri-miRNA transcription by RNA polymerase II, GO:2001014|regulation of skeletal muscle cell differentiation","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016787|hydrolase activity, GO:0005515|protein binding, GO:0004386|helicase activity, GO:0003724|RNA helicase activity, GO:0043021|ribonucleoprotein complex binding, GO:0070412|R-SMAD binding, GO:0003730|mRNA 3'-UTR binding, GO:0046332|SMAD binding, GO:0050681|androgen receptor binding, GO:1990841|promoter-specific chromatin binding, GO:0036002|pre-mRNA binding, GO:0070878|primary miRNA binding, GO:0004004|ATP-dependent RNA helicase activity, GO:0005516|calmodulin binding, GO:0019899|enzyme binding, GO:0035500|MH2 domain binding, GO:0048306|calcium-dependent protein binding"
MN1,Silent,-0.0914468145069198,41,0.569606742464937,N,"oncogene, fusion",Oncogene,-0.00542745595830139,0.973133805602228,ENSG00000169184,GO:0005575|cellular_component,"GO:0006355|regulation of transcription, DNA-templated, GO:0001957|intramembranous ossification, GO:0007275|multicellular organism development, GO:0008150|biological_process",GO:0003674|molecular_function
PDGFB,Missense,-0.0955870817326218,28,0.62849285917722,N,"oncogene, fusion",Oncogene,-0.185286985794838,0.345192958537972,ENSG00000100311,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005576|extracellular region, GO:0005615|extracellular space, GO:0016323|basolateral plasma membrane, GO:0062023|collagen-containing extracellular matrix, GO:0009986|cell surface, GO:0005788|endoplasmic reticulum lumen, GO:0031093|platelet alpha granule lumen, GO:0000139|Golgi membrane, GO:0005796|Golgi lumen","GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:1904707|positive regulation of vascular smooth muscle cell proliferation, GO:1904754|positive regulation of vascular associated smooth muscle cell migration, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0008284|positive regulation of cell proliferation, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:1905064|negative regulation of vascular smooth muscle cell differentiation, GO:1905176|positive regulation of vascular smooth muscle cell dedifferentiation, GO:0030335|positive regulation of cell migration, GO:0048146|positive regulation of fibroblast proliferation, GO:0010469|regulation of signaling receptor activity, GO:0007275|multicellular organism development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0046854|phosphatidylinositol phosphorylation, GO:0050918|positive chemotaxis, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0007507|heart development, GO:0051781|positive regulation of cell division, GO:0043410|positive regulation of MAPK cascade, GO:0061098|positive regulation of protein tyrosine kinase activity, GO:2000379|positive regulation of reactive oxygen species metabolic process, GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation, GO:0001938|positive regulation of endothelial cell proliferation, GO:0002576|platelet degranulation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0006468|protein phosphorylation, GO:0051897|positive regulation of protein kinase B signaling, GO:0000165|MAPK cascade, GO:0030198|extracellular matrix organization, GO:0050921|positive regulation of chemotaxis, GO:0060326|cell chemotaxis, GO:1902894|negative regulation of pri-miRNA transcription by RNA polymerase II, GO:0032091|negative regulation of protein binding, GO:0032148|activation of protein kinase B activity, GO:1902895|positive regulation of pri-miRNA transcription by RNA polymerase II, GO:0014911|positive regulation of smooth muscle cell migration, GO:0002548|monocyte chemotaxis, GO:0043406|positive regulation of MAP kinase activity, GO:0018105|peptidyl-serine phosphorylation, GO:0045840|positive regulation of mitotic nuclear division, GO:0090280|positive regulation of calcium ion import, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0072593|reactive oxygen species metabolic process, GO:0071363|cellular response to growth factor stimulus, GO:0009611|response to wounding, GO:0031954|positive regulation of protein autophosphorylation, GO:0032147|activation of protein kinase activity, GO:0045737|positive regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0070528|protein kinase C signaling, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0010544|negative regulation of platelet activation, GO:2000573|positive regulation of DNA biosynthetic process, GO:0001892|embryonic placenta development, GO:0003104|positive regulation of glomerular filtration, GO:0010512|negative regulation of phosphatidylinositol biosynthetic process, GO:0035655|interleukin-18-mediated signaling pathway, GO:0035793|positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway, GO:0038001|paracrine signaling, GO:0043552|positive regulation of phosphatidylinositol 3-kinase activity, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0071506|cellular response to mycophenolic acid, GO:0072126|positive regulation of glomerular mesangial cell proliferation, GO:0072255|metanephric glomerular mesangial cell development, GO:1900127|positive regulation of hyaluronan biosynthetic process, GO:2000591|positive regulation of metanephric mesenchymal cell migration","GO:0008083|growth factor activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0042803|protein homodimerization activity, GO:0046982|protein heterodimerization activity, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0005161|platelet-derived growth factor receptor binding, GO:0005518|collagen binding, GO:0016176|superoxide-generating NADPH oxidase activator activity, GO:0042056|chemoattractant activity, GO:0048407|platelet-derived growth factor binding"
PIM1,Silent,-0.10145502076044,24,0.637131421899143,N,"oncogene, fusion",Oncogene,-0.10972329703001,0.609783695245274,ENSG00000137193,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005654|nucleoplasm","GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0006468|protein phosphorylation, GO:0043066|negative regulation of apoptotic process, GO:0016310|phosphorylation, GO:0007049|cell cycle, GO:0006915|apoptotic process, GO:0030212|hyaluronan metabolic process, GO:0008283|cell proliferation, GO:0007275|multicellular organism development, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0019221|cytokine-mediated signaling pathway, GO:0046777|protein autophosphorylation, GO:0070561|vitamin D receptor signaling pathway, GO:1905062|positive regulation of cardioblast proliferation","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0030145|manganese ion binding, GO:0008134|transcription factor binding, GO:0043024|ribosomal small subunit binding"
RHOH,Silent,-0.102520780871541,14,0.727273766941679,N,"TSG, fusion",TSG,-0.157553893369026,0.59062561656378,ENSG00000168421,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005886|plasma membrane, GO:0005829|cytosol, GO:0005938|cell cortex, GO:0042995|cell projection, GO:0001772|immunological synapse","GO:0007264|small GTPase mediated signal transduction, GO:0051056|regulation of small GTPase mediated signal transduction, GO:0007266|Rho protein signal transduction, GO:0008360|regulation of cell shape, GO:0030036|actin cytoskeleton organization, GO:0007015|actin filament organization, GO:0032956|regulation of actin cytoskeleton organization, GO:0006355|regulation of transcription, DNA-templated, GO:0030217|T cell differentiation, GO:0034260|negative regulation of GTPase activity, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0007163|establishment or maintenance of cell polarity, GO:0033673|negative regulation of kinase activity, GO:0045576|mast cell activation","GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0019901|protein kinase binding, GO:0017048|Rho GTPase binding, GO:0019210|kinase inhibitor activity, GO:0005095|GTPase inhibitor activity"
PTEN,Silent,-0.103203137423067,14,0.725522280810238,N,TSG,TSG,-0.14854296943403,0.612291732593283,ENSG00000171862,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0005576|extracellular region, GO:0016324|apical plasma membrane, GO:0005739|mitochondrion, GO:0035749|myelin sheath adaxonal region, GO:0043005|neuron projection, GO:0043197|dendritic spine, GO:0043220|Schmidt-Lanterman incisure, GO:0045211|postsynaptic membrane, GO:0009898|cytoplasmic side of plasma membrane, GO:0016605|PML body","GO:0008284|positive regulation of cell proliferation, GO:1904706|negative regulation of vascular smooth muscle cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0051898|negative regulation of protein kinase B signaling, GO:0070373|negative regulation of ERK1 and ERK2 cascade, GO:0050821|protein stabilization, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle, GO:0030336|negative regulation of cell migration, GO:0010719|negative regulation of epithelial to mesenchymal transition, GO:0014067|negative regulation of phosphatidylinositol 3-kinase signaling, GO:0006629|lipid metabolic process, GO:0016311|dephosphorylation, GO:0035335|peptidyl-tyrosine dephosphorylation, GO:0006915|apoptotic process, GO:0006470|protein dephosphorylation, GO:0046855|inositol phosphate dephosphorylation, GO:0046856|phosphatidylinositol dephosphorylation, GO:0007399|nervous system development, GO:0007507|heart development, GO:0016477|cell migration, GO:0016579|protein deubiquitination, GO:0008283|cell proliferation, GO:0001525|angiogenesis, GO:0001933|negative regulation of protein phosphorylation, GO:0002902|regulation of B cell apoptotic process, GO:0007270|neuron-neuron synaptic transmission, GO:0007416|synapse assembly, GO:0007417|central nervous system development, GO:0007568|aging, GO:0007584|response to nutrient, GO:0007611|learning or memory, GO:0007613|memory, GO:0007626|locomotory behavior, GO:0009749|response to glucose, GO:0010033|response to organic substance, GO:0010035|response to inorganic substance, GO:0010043|response to zinc ion, GO:0010628|positive regulation of gene expression, GO:0010666|positive regulation of cardiac muscle cell apoptotic process, GO:0010975|regulation of neuron projection development, GO:0014070|response to organic cyclic compound, GO:0014823|response to activity, GO:0021542|dentate gyrus development, GO:0021955|central nervous system neuron axonogenesis, GO:0030534|adult behavior, GO:0031175|neuron projection development, GO:0031642|negative regulation of myelination, GO:0032228|regulation of synaptic transmission, GABAergic, GO:0032286|central nervous system myelin maintenance, GO:0032355|response to estradiol, GO:0032535|regulation of cellular component size, GO:0032869|cellular response to insulin stimulus, GO:0033032|regulation of myeloid cell apoptotic process, GO:0033198|response to ATP, GO:0033555|multicellular organismal response to stress, GO:0035176|social behavior, GO:0036294|cellular response to decreased oxygen levels, GO:0042493|response to drug, GO:0042711|maternal behavior, GO:0043065|positive regulation of apoptotic process, GO:0043066|negative regulation of apoptotic process, GO:0043491|protein kinase B signaling, GO:0043542|endothelial cell migration, GO:0044320|cellular response to leptin stimulus, GO:0045471|response to ethanol, GO:0045475|locomotor rhythm, GO:0045666|positive regulation of neuron differentiation, GO:0045792|negative regulation of cell size, GO:0046621|negative regulation of organ growth, GO:0046685|response to arsenic-containing substance, GO:0048008|platelet-derived growth factor receptor signaling pathway, GO:0048679|regulation of axon regeneration, GO:0048681|negative regulation of axon regeneration, GO:0048738|cardiac muscle tissue development, GO:0048853|forebrain morphogenesis, GO:0048854|brain morphogenesis, GO:0050680|negative regulation of epithelial cell proliferation, GO:0050765|negative regulation of phagocytosis, GO:0050771|negative regulation of axonogenesis, GO:0051726|regulation of cell cycle, GO:0060024|rhythmic synaptic transmission, GO:0060044|negative regulation of cardiac muscle cell proliferation, GO:0060074|synapse maturation, GO:0060134|prepulse inhibition, GO:0060179|male mating behavior, GO:0060291|long-term synaptic potentiation, GO:0060292|long-term synaptic depression, GO:0060341|regulation of cellular localization, GO:0060736|prostate gland growth, GO:0060997|dendritic spine morphogenesis, GO:0061002|negative regulation of dendritic spine morphogenesis, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0071361|cellular response to ethanol, GO:0071456|cellular response to hypoxia, GO:0090071|negative regulation of ribosome biogenesis, GO:0090344|negative regulation of cell aging, GO:0090394|negative regulation of excitatory postsynaptic potential, GO:0097105|presynaptic membrane assembly, GO:0097107|postsynaptic density assembly, GO:1901017|negative regulation of potassium ion transmembrane transporter activity, GO:1904668|positive regulation of ubiquitin protein ligase activity, GO:1990090|cellular response to nerve growth factor stimulus, GO:1990314|cellular response to insulin-like growth factor stimulus, GO:2000272|negative regulation of signaling receptor activity, GO:2000463|positive regulation of excitatory postsynaptic potential, GO:2000808|negative regulation of synaptic vesicle clustering, GO:2001235|positive regulation of apoptotic signaling pathway, GO:0031647|regulation of protein stability, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0006661|phosphatidylinositol biosynthetic process, GO:0060070|canonical Wnt signaling pathway, GO:0051895|negative regulation of focal adhesion assembly, GO:0043647|inositol phosphate metabolic process, GO:2000060|positive regulation of ubiquitin-dependent protein catabolic process, GO:0000079|regulation of cyclin-dependent protein serine/threonine kinase activity, GO:1903984|positive regulation of TRAIL-activated apoptotic signaling pathway, GO:0051548|negative regulation of keratinocyte migration, GO:0071257|cellular response to electrical stimulus, GO:1903690|negative regulation of wound healing, spreading of epidermal cells","GO:0016787|hydrolase activity, GO:0004721|phosphoprotein phosphatase activity, GO:0005515|protein binding, GO:0004725|protein tyrosine phosphatase activity, GO:0008138|protein tyrosine/serine/threonine phosphatase activity, GO:0008289|lipid binding, GO:0042802|identical protein binding, GO:0005161|platelet-derived growth factor receptor binding, GO:0016314|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity, GO:0019901|protein kinase binding, GO:0030165|PDZ domain binding, GO:0035255|ionotropic glutamate receptor binding, GO:0051717|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity, GO:0051800|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity, GO:1990782|protein tyrosine kinase binding, GO:0019899|enzyme binding, GO:0004722|protein serine/threonine phosphatase activity, GO:0004438|phosphatidylinositol-3-phosphatase activity, GO:0010997|anaphase-promoting complex binding, GO:1990381|ubiquitin-specific protease binding"
ETNK1,Missense,-0.104175710089583,40,0.522356789690475,N,TSG,TSG,-0.103070217259671,0.526804500299887,ENSG00000139163,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0016021|integral component of membrane","GO:0016310|phosphorylation, GO:0006629|lipid metabolic process, GO:0006646|phosphatidylethanolamine biosynthetic process, GO:0008654|phospholipid biosynthetic process","GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0004305|ethanolamine kinase activity"
TRIP11,Silent,-0.106409332220066,37,0.530770219660684,N,fusion,"",-0.129849969493359,0.443683087851834,ENSG00000100815,"GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0016020|membrane, GO:0005794|Golgi apparatus, GO:0005634|nucleus, GO:0005856|cytoskeleton, GO:0005929|cilium, GO:0000139|Golgi membrane, GO:0030133|transport vesicle, GO:0002079|inner acrosomal membrane, GO:0002080|acrosomal membrane, GO:0002081|outer acrosomal membrane, GO:0005801|cis-Golgi network","GO:1903508|positive regulation of nucleic acid-templated transcription, GO:0035735|intraciliary transport involved in cilium assembly, GO:0006366|transcription by RNA polymerase II, GO:0003281|ventricular septum development, GO:0003413|chondrocyte differentiation involved in endochondral bone morphogenesis, GO:0006486|protein glycosylation, GO:0007030|Golgi organization, GO:0060122|inner ear receptor cell stereocilium organization, GO:0060348|bone development","GO:0005515|protein binding, GO:0003713|transcription coactivator activity"
CBFA2T3,Silent,-0.107509569497509,21,0.64275423797079,N,"TSG, fusion",TSG,-0.058344398328503,0.801652176897201,ENSG00000129993,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005794|Golgi apparatus, GO:0000139|Golgi membrane, GO:0005730|nucleolus","GO:0006355|regulation of transcription, DNA-templated, GO:0045892|negative regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0008285|negative regulation of cell proliferation, GO:0001666|response to hypoxia, GO:0008283|cell proliferation, GO:0030851|granulocyte differentiation, GO:0032436|positive regulation of proteasomal ubiquitin-dependent protein catabolic process, GO:0045820|negative regulation of glycolytic process, GO:1903715|regulation of aerobic respiration","GO:0046872|metal ion binding, GO:0003700|DNA-binding transcription factor activity, GO:0003714|transcription corepressor activity, GO:0005515|protein binding"
NSD3,Missense,-0.108125173280167,44,0.484785785468055,N,"oncogene, fusion",Oncogene,-0.0844676419992309,0.585656675814564,ENSG00000147548,"GO:0005634|nucleus, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0000785|chromatin","GO:0032259|methylation, GO:0006325|chromatin organization, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006355|regulation of transcription, DNA-templated, GO:0034968|histone lysine methylation, GO:2001255|positive regulation of histone H3-K36 trimethylation, GO:0016571|histone methylation, GO:0010452|histone H3-K36 methylation","GO:0046872|metal ion binding, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0003713|transcription coactivator activity, GO:0046975|histone methyltransferase activity (H3-K36 specific)"
FGFR1,Silent,-0.10833784750436,30,0.568773783143826,N,"oncogene, fusion",Oncogene,-0.0369080831412868,0.846465785543136,ENSG00000077782,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005730|nucleolus, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0031410|cytoplasmic vesicle, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex","GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:1905564|positive regulation of vascular endothelial cell proliferation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0036092|phosphatidylinositol-3-phosphate biosynthetic process, GO:0048015|phosphatidylinositol-mediated signaling, GO:0046854|phosphatidylinositol phosphorylation, GO:0008543|fibroblast growth factor receptor signaling pathway, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0007399|nervous system development, GO:0016477|cell migration, GO:0043410|positive regulation of MAPK cascade, GO:0001501|skeletal system development, GO:0051897|positive regulation of protein kinase B signaling, GO:0046777|protein autophosphorylation, GO:0000165|MAPK cascade, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0045595|regulation of cell differentiation, GO:0001764|neuron migration, GO:0043406|positive regulation of MAP kinase activity, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0010863|positive regulation of phospholipase C activity, GO:0045597|positive regulation of cell differentiation, GO:0010518|positive regulation of phospholipase activity, GO:0043009|chordate embryonic development, GO:0045666|positive regulation of neuron differentiation, GO:0048705|skeletal system morphogenesis, GO:2000546|positive regulation of endothelial cell chemotaxis to fibroblast growth factor, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001525|angiogenesis, GO:0001657|ureteric bud development, GO:0001701|in utero embryonic development, GO:0001759|organ induction, GO:0002053|positive regulation of mesenchymal cell proliferation, GO:0002062|chondrocyte differentiation, GO:0007420|brain development, GO:0007435|salivary gland morphogenesis, GO:0007605|sensory perception of sound, GO:0010468|regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0010966|regulation of phosphate transport, GO:0010976|positive regulation of neuron projection development, GO:0021769|orbitofrontal cortex development, GO:0021847|ventricular zone neuroblast division, GO:0030324|lung development, GO:0030326|embryonic limb morphogenesis, GO:0030901|midbrain development, GO:0035607|fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development, GO:0042127|regulation of cell proliferation, GO:0042472|inner ear morphogenesis, GO:0042473|outer ear morphogenesis, GO:0042474|middle ear morphogenesis, GO:0043583|ear development, GO:0045787|positive regulation of cell cycle, GO:0048339|paraxial mesoderm development, GO:0048378|regulation of lateral mesodermal cell fate specification, GO:0048469|cell maturation, GO:0048514|blood vessel morphogenesis, GO:0048699|generation of neurons, GO:0048762|mesenchymal cell differentiation, GO:0051174|regulation of phosphorus metabolic process, GO:0060045|positive regulation of cardiac muscle cell proliferation, GO:0060117|auditory receptor cell development, GO:0060445|branching involved in salivary gland morphogenesis, GO:0060484|lung-associated mesenchyme development, GO:0060665|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling, GO:0070640|vitamin D3 metabolic process, GO:0090080|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway, GO:0090272|negative regulation of fibroblast growth factor production, GO:1903465|positive regulation of mitotic cell cycle DNA replication, GO:2000830|positive regulation of parathyroid hormone secretion, GO:2001239|regulation of extrinsic apoptotic signaling pathway in absence of ligand","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0042802|identical protein binding, GO:0005007|fibroblast growth factor-activated receptor activity, GO:0008201|heparin binding, GO:0046934|phosphatidylinositol-4,5-bisphosphate 3-kinase activity, GO:0005088|Ras guanyl-nucleotide exchange factor activity, GO:0016303|1-phosphatidylinositol-3-kinase activity, GO:0017134|fibroblast growth factor binding, GO:0090722|receptor-receptor interaction, GO:0042169|SH2 domain binding"
POU5F1,Missense,-0.113402302906629,25,0.589383993445119,N,"oncogene, fusion",Oncogene,-0.108223967568979,0.606599691497839,ENSG00000204531,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005739|mitochondrion, GO:0000790|nuclear chromatin","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0009653|anatomical structure morphogenesis, GO:0006366|transcription by RNA polymerase II, GO:0035019|somatic stem cell population maintenance, GO:0009611|response to wounding, GO:0001824|blastocyst development, GO:0010468|regulation of gene expression, GO:0042789|mRNA transcription by RNA polymerase II, GO:0001714|endodermal cell fate specification, GO:0009786|regulation of asymmetric cell division, GO:0060965|negative regulation of gene silencing by miRNA","GO:0003723|RNA binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001158|enhancer sequence-specific DNA binding, GO:0019955|cytokine binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0031625|ubiquitin protein ligase binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0035198|miRNA binding"
CREB3L2,Missense,-0.116339562770274,47,0.43612305186563,N,"oncogene, fusion",Oncogene,-0.116073557639381,0.437180048633436,ENSG00000182158,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005654|nucleoplasm, GO:0005789|endoplasmic reticulum membrane, GO:0000785|chromatin, GO:0097038|perinuclear endoplasmic reticulum","GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0051216|cartilage development, GO:0045893|positive regulation of transcription, DNA-templated, GO:0030968|endoplasmic reticulum unfolded protein response, GO:0006986|response to unfolded protein, GO:0034976|response to endoplasmic reticulum stress, GO:0002062|chondrocyte differentiation, GO:0006888|ER to Golgi vesicle-mediated transport, GO:0009611|response to wounding, GO:0010628|positive regulation of gene expression, GO:0010976|positive regulation of neuron projection development","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0035497|cAMP response element binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
RNF43,Silent,-0.120692916834604,22,0.592637400341926,N,TSG,TSG,-0.128782435282865,0.567883683080905,ENSG00000108375,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0005635|nuclear envelope","GO:0016567|protein ubiquitination, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0007275|multicellular organism development, GO:0016055|Wnt signaling pathway, GO:0030178|negative regulation of Wnt signaling pathway, GO:0072089|stem cell proliferation, GO:0038018|Wnt receptor catabolic process","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity, GO:0061630|ubiquitin protein ligase activity, GO:0005109|frizzled binding"
HIST1H3B,Silent,-0.124386063239458,15,0.658725169237014,N,Oncogene,Oncogene,-0.171554279430407,0.540971132298018,ENSG00000274267,"GO:0005634|nucleus, GO:0016020|membrane, GO:0000786|nucleosome, GO:0005694|chromosome, GO:0005576|extracellular region, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0032991|protein-containing complex, GO:0000228|nuclear chromosome, GO:0000788|nuclear nucleosome","GO:0006334|nucleosome assembly, GO:0044267|cellular protein metabolic process, GO:0007596|blood coagulation, GO:0038111|interleukin-7-mediated signaling pathway, GO:0045652|regulation of megakaryocyte differentiation, GO:0006335|DNA replication-dependent nucleosome assembly, GO:0060964|regulation of gene silencing by miRNA, GO:0000183|chromatin silencing at rDNA, GO:0045814|negative regulation of gene expression, epigenetic, GO:0051290|protein heterotetramerization, GO:0006325|chromatin organization, GO:0032200|telomere organization, GO:0060968|regulation of gene silencing","GO:0003677|DNA binding, GO:0046982|protein heterodimerization activity, GO:0005515|protein binding, GO:0045296|cadherin binding, GO:0031492|nucleosomal DNA binding"
MYC,Silent,-0.127509314735898,29,0.509797368713822,N,"oncogene, fusion",Oncogene,-0.196651256498731,0.306570582255187,ENSG00000136997,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005635|nuclear envelope, GO:0005791|rough endoplasmic reticulum, GO:0044195|nucleoplasmic reticulum, GO:0005739|mitochondrion, GO:0005730|nucleolus, GO:0032991|protein-containing complex, GO:0000790|nuclear chromatin","GO:0006355|regulation of transcription, DNA-templated, GO:0045727|positive regulation of translation, GO:0008150|biological_process, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006974|cellular response to DNA damage stimulus, GO:0006879|cellular iron ion homeostasis, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0015671|oxygen transport, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016579|protein deubiquitination, GO:0007050|cell cycle arrest, GO:0043066|negative regulation of apoptotic process, GO:0000165|MAPK cascade, GO:0010332|response to gamma radiation, GO:1904837|beta-catenin-TCF complex assembly, GO:0000082|G1/S transition of mitotic cell cycle, GO:0019221|cytokine-mediated signaling pathway, GO:0035690|cellular response to drug, GO:0043280|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0051973|positive regulation of telomerase activity, GO:0048146|positive regulation of fibroblast proliferation, GO:0006338|chromatin remodeling, GO:0034644|cellular response to UV, GO:0010468|regulation of gene expression, GO:0050679|positive regulation of epithelial cell proliferation, GO:0002053|positive regulation of mesenchymal cell proliferation, GO:0051782|negative regulation of cell division, GO:0042493|response to drug, GO:0008284|positive regulation of cell proliferation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0071456|cellular response to hypoxia, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0006112|energy reserve metabolic process, GO:0007219|Notch signaling pathway, GO:0010628|positive regulation of gene expression, GO:0032204|regulation of telomere maintenance, GO:0032873|negative regulation of stress-activated MAPK cascade, GO:0032986|protein-DNA complex disassembly, GO:0044346|fibroblast apoptotic process, GO:0045656|negative regulation of monocyte differentiation, GO:0048147|negative regulation of fibroblast proliferation, GO:0051276|chromosome organization, GO:0070371|ERK1 and ERK2 cascade, GO:0070848|response to growth factor, GO:0090096|positive regulation of metanephric cap mesenchymal cell proliferation, GO:1905643|positive regulation of DNA methylation, GO:2000573|positive regulation of DNA biosynthetic process, GO:2001022|positive regulation of response to DNA damage stimulus","GO:0003700|DNA-binding transcription factor activity, GO:0003729|mRNA binding, GO:0005515|protein binding, GO:0071074|eukaryotic initiation factor eIF2 binding, GO:0046983|protein dimerization activity, GO:0003677|DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0070491|repressing transcription factor binding, GO:0070888|E-box binding, GO:0044877|protein-containing complex binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0033613|activating transcription factor binding"
ARHGAP26,Silent,-0.138155320161601,16,0.609874850075229,N,"TSG, fusion",TSG,-0.236499057986736,0.377849539495271,ENSG00000145819,"GO:0005737|cytoplasm, GO:0005856|cytoskeleton, GO:0030054|cell junction, GO:0005925|focal adhesion, GO:0005829|cytosol, GO:0005575|cellular_component","GO:0007165|signal transduction, GO:0043547|positive regulation of GTPase activity, GO:0030036|actin cytoskeleton organization, GO:0051056|regulation of small GTPase mediated signal transduction, GO:0007399|nervous system development","GO:0005096|GTPase activator activity, GO:0005515|protein binding, GO:0005543|phospholipid binding"
ELL,Missense,-0.140095824788769,52,0.321889007755561,N,"TSG, fusion",TSG,-0.140386013461103,0.320877671359948,ENSG00000105656,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0008023|transcription elongation factor complex, GO:0005654|nucleoplasm, GO:0015030|Cajal body, GO:0035327|transcriptionally active chromatin, GO:0035363|histone locus body","GO:0006366|transcription by RNA polymerase II, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0010923|negative regulation of phosphatase activity, GO:0032968|positive regulation of transcription elongation from RNA polymerase II promoter, GO:0042795|snRNA transcription by RNA polymerase II, GO:0032786|positive regulation of DNA-templated transcription, elongation, GO:0045945|positive regulation of transcription by RNA polymerase III, GO:0001701|in utero embryonic development, GO:0042796|snRNA transcription by RNA polymerase III","GO:0005515|protein binding, GO:0019902|phosphatase binding"
TCF7L2,Silent,-0.1402815984299,30,0.459680322692703,N,"oncogene, fusion",Oncogene,-0.160554512433613,0.396691564805378,ENSG00000148737,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005667|transcription factor complex, GO:0000790|nuclear chromatin, GO:0016605|PML body, GO:0032993|protein-DNA complex, GO:0070369|beta-catenin-TCF7L2 complex","GO:0009749|response to glucose, GO:0051897|positive regulation of protein kinase B signaling, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0042593|glucose homeostasis, GO:0060070|canonical Wnt signaling pathway, GO:0006357|regulation of transcription by RNA polymerase II, GO:0016055|Wnt signaling pathway, GO:0006355|regulation of transcription, DNA-templated, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0032024|positive regulation of insulin secretion, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:1904837|beta-catenin-TCF complex assembly, GO:0032092|positive regulation of protein binding, GO:0007223|Wnt signaling pathway, calcium modulating pathway, GO:0045444|fat cell differentiation, GO:2000675|negative regulation of type B pancreatic cell apoptotic process, GO:0007050|cell cycle arrest, GO:0046827|positive regulation of protein export from nucleus, GO:2001237|negative regulation of extrinsic apoptotic signaling pathway, GO:0008283|cell proliferation, GO:0010909|positive regulation of heparan sulfate proteoglycan biosynthetic process, GO:0044334|canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition, GO:0048660|regulation of smooth muscle cell proliferation, GO:0001568|blood vessel development, GO:0031016|pancreas development, GO:0048625|myoblast fate commitment, GO:0032350|regulation of hormone metabolic process, GO:0043570|maintenance of DNA repeat elements","GO:0008013|beta-catenin binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0043565|sequence-specific DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0019901|protein kinase binding, GO:0070016|armadillo repeat domain binding, GO:0003682|chromatin binding, GO:0044212|transcription regulatory region DNA binding, GO:0001103|RNA polymerase II repressing transcription factor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0045295|gamma-catenin binding, GO:0035257|nuclear hormone receptor binding"
KAT6B,Silent,-0.141375397031727,55,0.303212697585556,N,"TSG, fusion",TSG,-0.169735142604232,0.215386474296935,ENSG00000156650,"GO:0005634|nucleus, GO:0000786|nucleosome, GO:0000790|nuclear chromatin, GO:0005654|nucleoplasm, GO:0000123|histone acetyltransferase complex, GO:0070776|MOZ/MORF histone acetyltransferase complex","GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0006334|nucleosome assembly, GO:0016573|histone acetylation, GO:0043967|histone H4 acetylation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0043966|histone H3 acetylation, GO:1990830|cellular response to leukemia inhibitory factor","GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0016746|transferase activity, transferring acyl groups, GO:0004402|histone acetyltransferase activity, GO:0042393|histone binding, GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0010485|H4 histone acetyltransferase activity, GO:0016407|acetyltransferase activity"
CRTC1,Missense,-0.146289612599399,56,0.281998412489641,N,"oncogene, fusion",Oncogene,-0.108918572237067,0.424249874144311,ENSG00000105662,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0016604|nuclear body, GO:0030425|dendrite, GO:0043025|neuronal cell body, GO:0045202|synapse","GO:0051289|protein homotetramerization, GO:0048511|rhythmic process, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0016032|viral process, GO:0032793|positive regulation of CREB transcription factor activity, GO:0043153|entrainment of circadian clock by photoperiod, GO:0007613|memory, GO:0097009|energy homeostasis, GO:1900006|positive regulation of dendrite development, GO:1900273|positive regulation of long-term synaptic potentiation, GO:1902631|negative regulation of membrane hyperpolarization","GO:0005515|protein binding, GO:0008140|cAMP response element binding protein binding"
RPL22,Missense,-0.150445155641407,11,0.65882560995107,N,"TSG, fusion",TSG,-0.168708636200231,0.61997844913658,ENSG00000116251,"GO:0005634|nucleus, GO:0005840|ribosome, GO:0005925|focal adhesion, GO:0022625|cytosolic large ribosomal subunit, GO:0005829|cytosol, GO:0070062|extracellular exosome, GO:0005737|cytoplasm, GO:1990904|ribonucleoprotein complex","GO:0006412|translation, GO:0006413|translational initiation, GO:0000184|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, GO:0006614|SRP-dependent cotranslational protein targeting to membrane","GO:0003723|RNA binding, GO:0003735|structural constituent of ribosome, GO:0005515|protein binding, GO:0008201|heparin binding"
FOXO3,Silent,-0.151308095071704,14,0.60561074863947,N,"oncogene, TSG, fusion","",-0.127938231245099,0.662931857282295,ENSG00000118689,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005741|mitochondrial outer membrane, GO:0005759|mitochondrial matrix, GO:0032991|protein-containing complex","GO:0043065|positive regulation of apoptotic process, GO:0030336|negative regulation of cell migration, GO:0006355|regulation of transcription, DNA-templated, GO:0006915|apoptotic process, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006417|regulation of translation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0008286|insulin receptor signaling pathway, GO:0042593|glucose homeostasis, GO:0034599|cellular response to oxidative stress, GO:0019221|cytokine-mediated signaling pathway, GO:0006390|mitochondrial transcription, GO:0033209|tumor necrosis factor-mediated signaling pathway, GO:0043525|positive regulation of neuron apoptotic process, GO:0045648|positive regulation of erythrocyte differentiation, GO:0001542|ovulation from ovarian follicle, GO:0001544|initiation of primordial ovarian follicle growth, GO:0001547|antral ovarian follicle growth, GO:0001556|oocyte maturation, GO:0007568|aging, GO:0030330|DNA damage response, signal transduction by p53 class mediator, GO:0031667|response to nutrient levels, GO:0042493|response to drug, GO:0045665|negative regulation of neuron differentiation, GO:0048854|brain morphogenesis, GO:0071333|cellular response to glucose stimulus, GO:0071386|cellular response to corticosterone stimulus, GO:0071456|cellular response to hypoxia, GO:0071548|response to dexamethasone, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0097150|neuronal stem cell population maintenance, GO:0097192|extrinsic apoptotic signaling pathway in absence of ligand, GO:1901300|positive regulation of hydrogen peroxide-mediated programmed cell death, GO:1903428|positive regulation of reactive oxygen species biosynthetic process, GO:1904646|cellular response to amyloid-beta, GO:1990090|cellular response to nerve growth factor stimulus, GO:1990785|response to water-immersion restraint stress, GO:2000177|regulation of neural precursor cell proliferation, GO:2000353|positive regulation of endothelial cell apoptotic process, GO:2000377|regulation of reactive oxygen species metabolic process","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0031490|chromatin DNA binding, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0019901|protein kinase binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0008013|beta-catenin binding, GO:0034246|mitochondrial sequence-specific DNA-binding transcription factor activity, GO:0001221|transcription cofactor binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific"
MED12,Silent,-0.1519397948,56,0.263620866723278,N,TSG,TSG,-0.120371581252338,0.376868410239142,ENSG00000184634,"GO:0005634|nucleus, GO:0016020|membrane, GO:0016592|mediator complex, GO:0005654|nucleoplasm, GO:0000151|ubiquitin ligase complex","GO:0006357|regulation of transcription by RNA polymerase II, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0030178|negative regulation of Wnt signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0030518|intracellular steroid hormone receptor signaling pathway, GO:0030521|androgen receptor signaling pathway, GO:0001756|somitogenesis, GO:0001843|neural tube closure, GO:0007492|endoderm development, GO:0007507|heart development, GO:0014003|oligodendrocyte development, GO:0014044|Schwann cell development, GO:0016567|protein ubiquitination, GO:0019827|stem cell population maintenance, GO:0021510|spinal cord development, GO:0021915|neural tube development, GO:0036342|post-anal tail morphogenesis, GO:0048568|embryonic organ development, GO:0048702|embryonic neurocranium morphogenesis, GO:0060070|canonical Wnt signaling pathway, GO:0060071|Wnt signaling pathway, planar cell polarity pathway, GO:0090245|axis elongation involved in somitogenesis, GO:1990403|embryonic brain development","GO:0008013|beta-catenin binding, GO:0003712|transcription coregulator activity, GO:0005515|protein binding, GO:0030374|nuclear receptor transcription coactivator activity, GO:0038023|signaling receptor activity, GO:0003713|transcription coactivator activity, GO:0008022|protein C-terminus binding, GO:0019904|protein domain specific binding, GO:0042809|vitamin D receptor binding, GO:0046966|thyroid hormone receptor binding, GO:0000980|RNA polymerase II distal enhancer sequence-specific DNA binding, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0061630|ubiquitin protein ligase activity"
ACVR2A,Nonsense,-0.152078115795682,14,0.603755319331723,N,TSG,TSG,-0.195686886786138,0.50256637388605,ENSG00000121989,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005737|cytoplasm, GO:0034673|inhibin-betaglycan-ActRII complex, GO:0009986|cell surface, GO:0048179|activin receptor complex","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0030509|BMP signaling pathway, GO:0045669|positive regulation of osteoblast differentiation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007178|transmembrane receptor protein serine/threonine kinase signaling pathway, GO:0007389|pattern specification process, GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0030501|positive regulation of bone mineralization, GO:0071773|cellular response to BMP stimulus, GO:0010862|positive regulation of pathway-restricted SMAD protein phosphorylation, GO:0032924|activin receptor signaling pathway, GO:0045648|positive regulation of erythrocyte differentiation, GO:0001934|positive regulation of protein phosphorylation, GO:0001702|gastrulation with mouth forming second, GO:0007283|spermatogenesis, GO:0007368|determination of left/right symmetry, GO:0007498|mesoderm development, GO:0008584|male gonad development, GO:0009952|anterior/posterior pattern specification, GO:0009966|regulation of signal transduction, GO:0030510|regulation of BMP signaling pathway, GO:0032927|positive regulation of activin receptor signaling pathway, GO:0042713|sperm ejaculation, GO:0043084|penile erection, GO:0048706|embryonic skeletal system development, GO:0050999|regulation of nitric-oxide synthase activity, GO:0060011|Sertoli cell proliferation","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004675|transmembrane receptor protein serine/threonine kinase activity, GO:0005515|protein binding, GO:0005024|transforming growth factor beta-activated receptor activity, GO:0019838|growth factor binding, GO:0046332|SMAD binding, GO:0015026|coreceptor activity, GO:0017002|activin-activated receptor activity, GO:0048185|activin binding, GO:0005026|transforming growth factor beta receptor activity, type II, GO:0030165|PDZ domain binding, GO:0034711|inhibin binding, GO:0034713|type I transforming growth factor beta receptor binding, GO:0043621|protein self-association, GO:0098821|BMP receptor activity"
RANBP2,Nonsense,-0.153608286293343,14,0.60007485206681,N,"TSG, fusion",TSG,-0.187973361041367,0.519877428402987,ENSG00000153201,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005643|nuclear pore, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005635|nuclear envelope, GO:0031965|nuclear membrane, GO:0005642|annulate lamellae, GO:0042405|nuclear inclusion body, GO:0044615|nuclear pore nuclear basket, GO:0005739|mitochondrion, GO:0044614|nuclear pore cytoplasmic filaments, GO:1990723|cytoplasmic periphery of the nuclear pore complex","GO:0051028|mRNA transport, GO:0015031|protein transport, GO:0000413|protein peptidyl-prolyl isomerization, GO:0006457|protein folding, GO:0043547|positive regulation of GTPase activity, GO:0046907|intracellular transport, GO:0006607|NLS-bearing protein import into nucleus, GO:0006406|mRNA export from nucleus, GO:0016032|viral process, GO:0016925|protein sumoylation, GO:0051642|centrosome localization, GO:0001975|response to amphetamine, GO:0006111|regulation of gluconeogenesis, GO:0033133|positive regulation of glucokinase activity","GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0005096|GTPase activator activity, GO:0008536|Ran GTPase binding, GO:0019789|SUMO transferase activity, GO:0044877|protein-containing complex binding"
NTRK1,Silent,-0.154771024522785,43,0.321693838263002,N,"oncogene, TSG, fusion","",-0.156474609393104,0.316330646012291,ENSG00000198400,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005887|integral component of plasma membrane, GO:0005886|plasma membrane, GO:0031902|late endosome membrane, GO:0043235|receptor complex, GO:0005768|endosome, GO:0005769|early endosome, GO:0031901|early endosome membrane, GO:0010008|endosome membrane, GO:0032991|protein-containing complex, GO:0005770|late endosome, GO:0030424|axon, GO:0000139|Golgi membrane, GO:0005737|cytoplasm, GO:0009986|cell surface, GO:0030425|dendrite, GO:0031410|cytoplasmic vesicle, GO:0043025|neuronal cell body, GO:0055037|recycling endosome","GO:0043066|negative regulation of apoptotic process, GO:0001934|positive regulation of protein phosphorylation, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007169|transmembrane receptor protein tyrosine kinase signaling pathway, GO:0007275|multicellular organism development, GO:0048013|ephrin receptor signaling pathway, GO:0030154|cell differentiation, GO:0007399|nervous system development, GO:0043410|positive regulation of MAPK cascade, GO:0043547|positive regulation of GTPase activity, GO:0008285|negative regulation of cell proliferation, GO:0043524|negative regulation of neuron apoptotic process, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0043408|regulation of MAPK cascade, GO:0046777|protein autophosphorylation, GO:0048015|phosphatidylinositol-mediated signaling, GO:0046579|positive regulation of Ras protein signal transduction, GO:0010976|positive regulation of neuron projection development, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0038083|peptidyl-tyrosine autophosphorylation, GO:0014068|positive regulation of phosphatidylinositol 3-kinase signaling, GO:0000186|activation of MAPKK activity, GO:0038180|nerve growth factor signaling pathway, GO:0048011|neurotrophin TRK receptor signaling pathway, GO:0043068|positive regulation of programmed cell death, GO:0010623|programmed cell death involved in cell development, GO:0048485|sympathetic nervous system development, GO:0060385|axonogenesis involved in innervation, GO:1990090|cellular response to nerve growth factor stimulus, GO:0038179|neurotrophin signaling pathway, GO:0007411|axon guidance, GO:0007568|aging, GO:0007611|learning or memory, GO:0007623|circadian rhythm, GO:0009314|response to radiation, GO:0019233|sensory perception of pain, GO:0021553|olfactory nerve development, GO:0030183|B cell differentiation, GO:0031667|response to nutrient levels, GO:0035094|response to nicotine, GO:0042490|mechanoreceptor differentiation, GO:0042493|response to drug, GO:0048678|response to axon injury, GO:0050965|detection of temperature stimulus involved in sensory perception of pain, GO:0050966|detection of mechanical stimulus involved in sensory perception of pain, GO:0051599|response to hydrostatic pressure, GO:0051602|response to electrical stimulus, GO:0051965|positive regulation of synapse assembly, GO:0051968|positive regulation of synaptic transmission, glutamatergic, GO:0060009|Sertoli cell development, GO:0060384|innervation, GO:0061368|behavioral response to formalin induced pain, GO:0071316|cellular response to nicotine, GO:0071363|cellular response to growth factor stimulus, GO:1901215|negative regulation of neuron death","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004714|transmembrane receptor protein tyrosine kinase activity, GO:0005030|neurotrophin receptor activity, GO:0010465|nerve growth factor receptor activity, GO:0043121|neurotrophin binding, GO:0048406|nerve growth factor binding, GO:0005004|GPI-linked ephrin receptor activity, GO:0005166|neurotrophin p75 receptor binding, GO:0019900|kinase binding"
POLE,Silent,-0.16235018817034,71,0.176151911766556,N,TSG,TSG,-0.156263751782588,0.193141723530356,ENSG00000177084,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0008622|epsilon DNA polymerase complex","GO:0006281|DNA repair, GO:0090305|nucleic acid phosphodiester bond hydrolysis, GO:0006974|cellular response to DNA damage stimulus, GO:0006260|DNA replication, GO:0000278|mitotic cell cycle, GO:0000082|G1/S transition of mitotic cell cycle, GO:0000731|DNA synthesis involved in DNA repair, GO:0006272|leading strand elongation, GO:0006287|base-excision repair, gap-filling, GO:0006297|nucleotide-excision repair, DNA gap filling, GO:0045004|DNA replication proofreading, GO:0048568|embryonic organ development, GO:0071897|DNA biosynthetic process","GO:0003676|nucleic acid binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000166|nucleotide binding, GO:0016779|nucleotidyltransferase activity, GO:0003887|DNA-directed DNA polymerase activity, GO:0051536|iron-sulfur cluster binding, GO:0051539|4 iron, 4 sulfur cluster binding, GO:0003682|chromatin binding, GO:0008310|single-stranded DNA 3'-5' exodeoxyribonuclease activity"
CDKN1B,Nonsense,-0.16544564900209,12,0.607346819106877,N,TSG,TSG,-0.127299046894471,0.693395888858583,ENSG00000111276,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0043231|intracellular membrane-bounded organelle, GO:0005768|endosome, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0031464|Cul4A-RING E3 ubiquitin ligase complex, GO:0032991|protein-containing complex","GO:1904706|negative regulation of vascular smooth muscle cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0016310|phosphorylation, GO:0007049|cell cycle, GO:0007050|cell cycle arrest, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0042127|regulation of cell proliferation, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0045786|negative regulation of cell cycle, GO:0045892|negative regulation of transcription, DNA-templated, GO:0000082|G1/S transition of mitotic cell cycle, GO:0007507|heart development, GO:0045930|negative regulation of mitotic cell cycle, GO:0030308|negative regulation of cell growth, GO:0010942|positive regulation of cell death, GO:0045732|positive regulation of protein catabolic process, GO:0000079|regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0045787|positive regulation of cell cycle, GO:0071850|mitotic cell cycle arrest, GO:0033673|negative regulation of kinase activity, GO:0042326|negative regulation of phosphorylation, GO:1904030|negative regulation of cyclin-dependent protein kinase activity, GO:1905179|negative regulation of cardiac muscle tissue regeneration, GO:0001666|response to hypoxia, GO:0001890|placenta development, GO:0006813|potassium ion transport, GO:0007096|regulation of exit from mitosis, GO:0007219|Notch signaling pathway, GO:0007605|sensory perception of sound, GO:0008219|cell death, GO:0008284|positive regulation of cell proliferation, GO:0009749|response to glucose, GO:0014070|response to organic cyclic compound, GO:0031116|positive regulation of microtubule polymerization, GO:0032355|response to estradiol, GO:0042493|response to drug, GO:0043066|negative regulation of apoptotic process, GO:0043200|response to amino acid, GO:0043434|response to peptide hormone, GO:0045737|positive regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0046686|response to cadmium ion, GO:0048102|autophagic cell death, GO:0048839|inner ear development, GO:0050680|negative regulation of epithelial cell proliferation, GO:0051271|negative regulation of cellular component movement, GO:0060770|negative regulation of epithelial cell proliferation involved in prostate gland development, GO:0071236|cellular response to antibiotic, GO:0071285|cellular response to lithium ion, GO:0071407|cellular response to organic cyclic compound, GO:1902746|regulation of lens fiber cell differentiation","GO:0016301|kinase activity, GO:0005515|protein binding, GO:0004860|protein kinase inhibitor activity, GO:0004861|cyclin-dependent protein serine/threonine kinase inhibitor activity, GO:0019903|protein phosphatase binding, GO:0051087|chaperone binding, GO:0004693|cyclin-dependent protein serine/threonine kinase activity, GO:0030332|cyclin binding, GO:0019901|protein kinase binding, GO:0044877|protein-containing complex binding, GO:0005072|transforming growth factor beta receptor, cytoplasmic mediator activity, GO:0030544|Hsp70 protein binding"
ATR,Silent,-0.174098423006684,46,0.247206974009415,N,TSG,TSG,-0.132844905104174,0.378798690054127,ENSG00000175054,"GO:0005634|nucleus, GO:0005794|Golgi apparatus, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0000784|nuclear chromosome, telomeric region, GO:0016605|PML body","GO:0016310|phosphorylation, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0036297|interstrand cross-link repair, GO:0007275|multicellular organism development, GO:0006260|DNA replication, GO:0032212|positive regulation of telomere maintenance via telomerase, GO:0090399|replicative senescence, GO:0000077|DNA damage checkpoint, GO:0018105|peptidyl-serine phosphorylation, GO:0034644|cellular response to UV, GO:0000723|telomere maintenance, GO:1900034|regulation of cellular response to heat, GO:0008156|negative regulation of DNA replication, GO:0070198|protein localization to chromosome, telomeric region, GO:0046777|protein autophosphorylation, GO:0043517|positive regulation of DNA damage response, signal transduction by p53 class mediator, GO:0071480|cellular response to gamma radiation, GO:0097694|establishment of RNA localization to telomere, GO:0097695|establishment of protein-containing complex localization to telomere, GO:1904884|positive regulation of telomerase catalytic core complex assembly, GO:0042493|response to drug","GO:0016301|kinase activity, GO:0000166|nucleotide binding, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0004672|protein kinase activity, GO:0032405|MutLalpha complex binding, GO:0032407|MutSalpha complex binding"
MSH2,Nonsense,-0.174607573942395,10,0.629479402175556,N,TSG,TSG,-0.228559297481372,0.525336367410798,ENSG00000095002,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005694|chromosome, GO:0032300|mismatch repair complex, GO:0032301|MutSalpha complex, GO:0005654|nucleoplasm, GO:0000784|nuclear chromosome, telomeric region, GO:0032302|MutSbeta complex","GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0006298|mismatch repair, GO:0006302|double-strand break repair, GO:0031573|intra-S DNA damage checkpoint, GO:0045910|negative regulation of DNA recombination, GO:0006301|postreplication repair, GO:0071168|protein localization to chromatin, GO:0043524|negative regulation of neuron apoptotic process, GO:0010165|response to X-ray, GO:0030183|B cell differentiation, GO:0008584|male gonad development, GO:0043570|maintenance of DNA repeat elements, GO:0051096|positive regulation of helicase activity, GO:0001701|in utero embryonic development, GO:0002204|somatic recombination of immunoglobulin genes involved in immune response, GO:0006119|oxidative phosphorylation, GO:0007050|cell cycle arrest, GO:0007281|germ cell development, GO:0008340|determination of adult lifespan, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0010224|response to UV-B, GO:0016446|somatic hypermutation of immunoglobulin genes, GO:0016447|somatic recombination of immunoglobulin gene segments, GO:0019724|B cell mediated immunity, GO:0042771|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0045190|isotype switching, GO:0048298|positive regulation of isotype switching to IgA isotypes, GO:0048304|positive regulation of isotype switching to IgG isotypes","GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0030983|mismatched DNA binding, GO:0019901|protein kinase binding, GO:0003682|chromatin binding, GO:0008022|protein C-terminus binding, GO:0019899|enzyme binding, GO:0000400|four-way junction DNA binding, GO:0008094|DNA-dependent ATPase activity, GO:0032137|guanine/thymine mispair binding, GO:0032143|single thymine insertion binding, GO:0003684|damaged DNA binding, GO:0042803|protein homodimerization activity, GO:0003697|single-stranded DNA binding, GO:0032405|MutLalpha complex binding, GO:0016887|ATPase activity, GO:0032139|dinucleotide insertion or deletion binding, GO:0032142|single guanine insertion binding, GO:0032181|dinucleotide repeat insertion binding, GO:0000287|magnesium ion binding, GO:0003690|double-stranded DNA binding, GO:0032357|oxidized purine DNA binding, GO:0043531|ADP binding, GO:0019237|centromeric DNA binding"
GNA11,Silent,-0.176569448800233,17,0.497823079961854,N,Oncogene,Oncogene,-0.125025339671112,0.632571091977565,ENSG00000088256,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005765|lysosomal membrane, GO:0005886|plasma membrane, GO:0005834|heterotrimeric G-protein complex, GO:0001750|photoreceptor outer segment, GO:0070062|extracellular exosome","GO:0007186|G protein-coupled receptor signaling pathway, GO:0007165|signal transduction, GO:0007213|G protein-coupled acetylcholine receptor signaling pathway, GO:0007603|phototransduction, visible light, GO:0009649|entrainment of circadian clock, GO:0007188|adenylate cyclase-modulating G protein-coupled receptor signaling pathway, GO:0030168|platelet activation, GO:0060158|phospholipase C-activating dopamine receptor signaling pathway, GO:0001501|skeletal system development, GO:0001508|action potential, GO:0007507|heart development, GO:0045634|regulation of melanocyte differentiation, GO:0048066|developmental pigmentation, GO:0071467|cellular response to pH","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0001664|G protein-coupled receptor binding, GO:0019001|guanyl nucleotide binding, GO:0031683|G-protein beta/gamma-subunit complex binding, GO:0031826|type 2A serotonin receptor binding"
ETNK1,Silent,-0.18641092980036,15,0.505921312215124,N,TSG,TSG,-0.263621707702734,0.342433379551788,ENSG00000139163,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0016021|integral component of membrane","GO:0016310|phosphorylation, GO:0006629|lipid metabolic process, GO:0006646|phosphatidylethanolamine biosynthetic process, GO:0008654|phospholipid biosynthetic process","GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0004305|ethanolamine kinase activity"
STAG2,Silent,-0.187024686184205,33,0.297328137576169,N,TSG,TSG,-0.114364889249908,0.526257710455855,ENSG00000101972,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005694|chromosome, GO:0000775|chromosome, centromeric region, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0000785|chromatin, GO:0016363|nuclear matrix, GO:0097431|mitotic spindle pole, GO:0008278|cohesin complex","GO:0051301|cell division, GO:0007049|cell cycle, GO:0051321|meiotic cell cycle, GO:0007059|chromosome segregation, GO:1901673|regulation of mitotic spindle assembly, GO:0007062|sister chromatid cohesion, GO:0032876|negative regulation of DNA endoreduplication","GO:0005515|protein binding, GO:0003682|chromatin binding"
MAML2,Silent,-0.192775735732224,49,0.184481785237869,N,"oncogene, fusion",Oncogene,-0.234457537492604,0.104904859652042,ENSG00000184384,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0005654|nucleoplasm","GO:0007219|Notch signaling pathway, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0007221|positive regulation of transcription of Notch receptor target, GO:0045747|positive regulation of Notch signaling pathway",GO:0003713|transcription coactivator activity
DNM2,Silent,-0.196020406052656,34,0.266544902565764,N,TSG,TSG,-0.161416838175148,0.361763940994791,ENSG00000079805,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005794|Golgi apparatus, GO:0005829|cytosol, GO:0098793|presynapse, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0030054|cell junction, GO:0031410|cytoplasmic vesicle, GO:0045202|synapse, GO:0045211|postsynaptic membrane, GO:0005874|microtubule, GO:0005905|clathrin-coated pit, GO:0005925|focal adhesion, GO:0030496|midbody, GO:0030426|growth cone, GO:0070062|extracellular exosome, GO:0001891|phagocytic cup, GO:0030670|phagocytic vesicle membrane, GO:0014069|postsynaptic density, GO:0030424|axon, GO:0000139|Golgi membrane, GO:0030666|endocytic vesicle membrane, GO:0043197|dendritic spine, GO:0044327|dendritic spine head, GO:0098844|postsynaptic endocytic zone membrane, GO:0001917|photoreceptor inner segment, GO:0005634|nucleus, GO:0005768|endosome, GO:0005802|trans-Golgi network, GO:0005813|centrosome, GO:0030027|lamellipodium, GO:0032587|ruffle membrane, GO:0032991|protein-containing complex, GO:0045334|clathrin-coated endocytic vesicle, GO:0048471|perinuclear region of cytoplasm","GO:0006897|endocytosis, GO:0007165|signal transduction, GO:0045893|positive regulation of transcription, DNA-templated, GO:0048812|neuron projection morphogenesis, GO:0043065|positive regulation of apoptotic process, GO:0019886|antigen processing and presentation of exogenous peptide antigen via MHC class II, GO:0006355|regulation of transcription, DNA-templated, GO:0061024|membrane organization, GO:0006909|phagocytosis, GO:0050999|regulation of nitric-oxide synthase activity, GO:1903526|negative regulation of membrane tubulation, GO:0048489|synaptic vesicle transport, GO:0098884|postsynaptic neurotransmitter receptor internalization, GO:0000086|G2/M transition of mitotic cell cycle, GO:0006898|receptor-mediated endocytosis, GO:0031623|receptor internalization, GO:0030516|regulation of axon extension, GO:0033572|transferrin transport, GO:0016185|synaptic vesicle budding from presynaptic endocytic zone membrane, GO:0050803|regulation of synapse structure or activity, GO:0002031|G protein-coupled receptor internalization, GO:0003281|ventricular septum development, GO:0006893|Golgi to plasma membrane transport, GO:0007283|spermatogenesis, GO:0009416|response to light stimulus, GO:0010592|positive regulation of lamellipodium assembly, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0035020|regulation of Rac protein signal transduction, GO:0035904|aorta development, GO:0042220|response to cocaine, GO:0044351|macropinocytosis, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0045807|positive regulation of endocytosis, GO:0050766|positive regulation of phagocytosis, GO:0060976|coronary vasculature development, GO:0071245|cellular response to carbon monoxide, GO:0071481|cellular response to X-ray, GO:0071732|cellular response to nitric oxide, GO:1900026|positive regulation of substrate adhesion-dependent cell spreading, GO:1902856|negative regulation of non-motile cilium assembly, GO:1903351|cellular response to dopamine, GO:1903358|regulation of Golgi organization, GO:1903408|positive regulation of sodium:potassium-exchanging ATPase activity, GO:2000370|positive regulation of clathrin-dependent endocytosis","GO:0000166|nucleotide binding, GO:0016787|hydrolase activity, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0017124|SH3 domain binding, GO:0019899|enzyme binding, GO:0019901|protein kinase binding, GO:0031749|D2 dopamine receptor binding, GO:0036312|phosphatidylinositol 3-kinase regulatory subunit binding, GO:0044877|protein-containing complex binding, GO:0050699|WW domain binding, GO:0050998|nitric-oxide synthase binding"
YWHAE,Missense,-0.196178246346436,24,0.358231872555368,N,"TSG, fusion",TSG,-0.183416521140779,0.390948898104377,ENSG00000108953,"GO:0005739|mitochondrion, GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0042470|melanosome, GO:0005925|focal adhesion, GO:0005829|cytosol, GO:0070062|extracellular exosome, GO:0005886|plasma membrane, GO:0005871|kinesin complex, GO:0030424|axon, GO:0090724|central region of growth cone","GO:0016032|viral process, GO:0000086|G2/M transition of mitotic cell cycle, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0097711|ciliary basal body-plasma membrane docking, GO:0021762|substantia nigra development, GO:0000165|MAPK cascade, GO:0061024|membrane organization, GO:1901016|regulation of potassium ion transmembrane transporter activity, GO:0035329|hippo signaling, GO:0034504|protein localization to nucleus, GO:0035556|intracellular signal transduction, GO:0060306|regulation of membrane repolarization, GO:1900740|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, GO:0034605|cellular response to heat, GO:0086091|regulation of heart rate by cardiac conduction, GO:1900034|regulation of cellular response to heat, GO:0046827|positive regulation of protein export from nucleus, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0086013|membrane repolarization during cardiac muscle cell action potential, GO:0051480|regulation of cytosolic calcium ion concentration, GO:0001764|neuron migration, GO:0003064|regulation of heart rate by hormone, GO:0006605|protein targeting, GO:0021766|hippocampus development, GO:0021987|cerebral cortex development, GO:0035308|negative regulation of protein dephosphorylation, GO:1901020|negative regulation of calcium ion transmembrane transporter activity, GO:1902309|negative regulation of peptidyl-serine dephosphorylation, GO:1905913|negative regulation of calcium ion export across plasma membrane","GO:0003723|RNA binding, GO:0019904|protein domain specific binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0045296|cadherin binding, GO:0017112|Rab guanyl-nucleotide exchange factor activity, GO:0046982|protein heterodimerization activity, GO:0044325|ion channel binding, GO:0019899|enzyme binding, GO:0031625|ubiquitin protein ligase binding, GO:0042826|histone deacetylase binding, GO:0015459|potassium channel regulator activity, GO:0097110|scaffold protein binding, GO:0023026|MHC class II protein complex binding, GO:0050815|phosphoserine residue binding, GO:0051219|phosphoprotein binding, GO:0005246|calcium channel regulator activity, GO:0044877|protein-containing complex binding"
TRAF7,Silent,-0.196870345431314,19,0.419187308054438,N,TSG,TSG,-0.213922408314229,0.379181192654555,ENSG00000131653,"GO:0043231|intracellular membrane-bounded organelle, GO:0005886|plasma membrane, GO:0031410|cytoplasmic vesicle, GO:0005730|nucleolus, GO:0000151|ubiquitin ligase complex","GO:0016567|protein ubiquitination, GO:0006915|apoptotic process, GO:0000027|ribosomal large subunit assembly, GO:0007219|Notch signaling pathway, GO:0000185|activation of MAPKKK activity, GO:2001235|positive regulation of apoptotic signaling pathway, GO:0043410|positive regulation of MAPK cascade","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0005515|protein binding, GO:0004842|ubiquitin-protein transferase activity"
CYLD,Silent,-0.198760997060611,25,0.340855907670006,N,TSG,TSG,-0.19091106506799,0.360646893144277,ENSG00000083799,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0048471|perinuclear region of cytoplasm, GO:0005874|microtubule, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0005819|spindle, GO:0030496|midbody, GO:0036064|ciliary basal body, GO:0031234|extrinsic component of cytoplasmic side of plasma membrane, GO:0005881|cytoplasmic microtubule, GO:0097542|ciliary tip","GO:0016579|protein deubiquitination, GO:0006508|proteolysis, GO:0007049|cell cycle, GO:0006511|ubiquitin-dependent protein catabolic process, GO:0016055|Wnt signaling pathway, GO:0002376|immune system process, GO:0045087|innate immune response, GO:0070507|regulation of microtubule cytoskeleton organization, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:1902017|regulation of cilium assembly, GO:0032088|negative regulation of NF-kappaB transcription factor activity, GO:0070536|protein K63-linked deubiquitination, GO:0007346|regulation of mitotic cell cycle, GO:0071108|protein K48-linked deubiquitination, GO:0046329|negative regulation of JNK cascade, GO:0010803|regulation of tumor necrosis factor-mediated signaling pathway, GO:0032480|negative regulation of type I interferon production, GO:0060544|regulation of necroptotic process, GO:0070423|nucleotide-binding oligomerization domain containing signaling pathway, GO:2001238|positive regulation of extrinsic apoptotic signaling pathway, GO:1901223|negative regulation of NIK/NF-kappaB signaling, GO:0050727|regulation of inflammatory response, GO:1903753|negative regulation of p38MAPK cascade, GO:2001242|regulation of intrinsic apoptotic signaling pathway, GO:1990108|protein linear deubiquitination, GO:0070266|necroptotic process, GO:0043369|CD4-positive or CD8-positive, alpha-beta T cell lineage commitment, GO:0043393|regulation of protein binding, GO:0045577|regulation of B cell differentiation, GO:0045582|positive regulation of T cell differentiation, GO:0048872|homeostasis of number of cells, GO:0050862|positive regulation of T cell receptor signaling pathway, GO:1901026|ripoptosome assembly involved in necroptotic process, GO:1903829|positive regulation of cellular protein localization","GO:0046872|metal ion binding, GO:0016787|hydrolase activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0008233|peptidase activity, GO:0008234|cysteine-type peptidase activity, GO:0036459|thiol-dependent ubiquitinyl hydrolase activity, GO:0004843|thiol-dependent ubiquitin-specific protease activity, GO:0019901|protein kinase binding, GO:0061578|Lys63-specific deubiquitinase activity, GO:0070064|proline-rich region binding, GO:1990380|Lys48-specific deubiquitinase activity"
CCND1,Missense,-0.199571628143157,15,0.475780224151883,N,"oncogene, fusion",Oncogene,-0.221269315431051,0.428054651517155,ENSG00000110092,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0005622|intracellular, GO:0017053|transcriptional repressor complex, GO:0000307|cyclin-dependent protein kinase holoenzyme complex, GO:0005923|bicellular tight junction","GO:0001934|positive regulation of protein phosphorylation, GO:0051301|cell division, GO:0006974|cellular response to DNA damage stimulus, GO:0007049|cell cycle, GO:0008284|positive regulation of cell proliferation, GO:0000278|mitotic cell cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0071157|negative regulation of cell cycle arrest, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0010971|positive regulation of G2/M transition of mitotic cell cycle, GO:0019221|cytokine-mediated signaling pathway, GO:1900087|positive regulation of G1/S transition of mitotic cell cycle, GO:0042493|response to drug, GO:0000079|regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0007088|regulation of mitotic nuclear division, GO:0045787|positive regulation of cell cycle, GO:0070141|response to UV-A, GO:0000082|G1/S transition of mitotic cell cycle, GO:0031571|mitotic G1 DNA damage checkpoint, GO:0044321|response to leptin, GO:0000320|re-entry into mitotic cell cycle, GO:0001889|liver development, GO:0006468|protein phosphorylation, GO:0007595|lactation, GO:0010033|response to organic substance, GO:0010039|response to iron ion, GO:0010165|response to X-ray, GO:0010243|response to organonitrogen compound, GO:0014070|response to organic cyclic compound, GO:0016055|Wnt signaling pathway, GO:0030857|negative regulation of epithelial cell differentiation, GO:0030968|endoplasmic reticulum unfolded protein response, GO:0031100|animal organ regeneration, GO:0032026|response to magnesium ion, GO:0032355|response to estradiol, GO:0033197|response to vitamin E, GO:0033327|Leydig cell differentiation, GO:0033598|mammary gland epithelial cell proliferation, GO:0033601|positive regulation of mammary gland epithelial cell proliferation, GO:0043627|response to estrogen, GO:0045444|fat cell differentiation, GO:0045471|response to ethanol, GO:0045737|positive regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0048545|response to steroid hormone, GO:0050679|positive regulation of epithelial cell proliferation, GO:0051384|response to glucocorticoid, GO:0051412|response to corticosterone, GO:0051592|response to calcium ion, GO:0051726|regulation of cell cycle, GO:0060749|mammary gland alveolus development, GO:0071310|cellular response to organic substance, GO:0097421|liver regeneration, GO:2000045|regulation of G1/S transition of mitotic cell cycle","GO:0005515|protein binding, GO:0003714|transcription corepressor activity, GO:0019901|protein kinase binding, GO:0019899|enzyme binding, GO:0008134|transcription factor binding, GO:0070064|proline-rich region binding, GO:0042826|histone deacetylase binding, GO:0004672|protein kinase activity, GO:0016538|cyclin-dependent protein serine/threonine kinase regulator activity, GO:0004693|cyclin-dependent protein serine/threonine kinase activity, GO:0016301|kinase activity, GO:0044877|protein-containing complex binding"
PHOX2B,Silent,-0.201652920670487,18,0.422313049095601,N,TSG,TSG,-0.116962523842783,0.643940041786605,ENSG00000109132,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0071157|negative regulation of cell cycle arrest, GO:0071773|cellular response to BMP stimulus, GO:0010971|positive regulation of G2/M transition of mitotic cell cycle, GO:0120162|positive regulation of cold-induced thermogenesis, GO:0001764|neuron migration, GO:1901166|neural crest cell migration involved in autonomic nervous system development, GO:0003357|noradrenergic neuron differentiation, GO:0071542|dopaminergic neuron differentiation, GO:0010468|regulation of gene expression, GO:0048484|enteric nervous system development, GO:0061549|sympathetic ganglion development, GO:0003358|noradrenergic neuron development, GO:0048839|inner ear development, GO:0021533|cell differentiation in hindbrain, GO:0003360|brainstem development, GO:0048485|sympathetic nervous system development, GO:0002087|regulation of respiratory gaseous exchange by neurological system process, GO:0008285|negative regulation of cell proliferation, GO:0010001|glial cell differentiation, GO:0021723|medullary reticular formation development, GO:0021934|hindbrain tangential cell migration, GO:0030182|neuron differentiation, GO:0035914|skeletal muscle cell differentiation, GO:0045665|negative regulation of neuron differentiation, GO:0045666|positive regulation of neuron differentiation, GO:0048468|cell development, GO:0048483|autonomic nervous system development, GO:0048486|parasympathetic nervous system development, GO:0048894|efferent axon development in a lateral line nerve, GO:0060541|respiratory system development, GO:0061452|retrotrapezoid nucleus neuron differentiation","GO:0003677|DNA binding, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding"
BCL2,Silent,-0.201823363982102,51,0.155538486912805,N,"oncogene, fusion",Oncogene,-0.210209751956242,0.138718317822917,ENSG00000171791,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005654|nucleoplasm, GO:0005783|endoplasmic reticulum, GO:0005789|endoplasmic reticulum membrane, GO:0031965|nuclear membrane, GO:0005739|mitochondrion, GO:0005829|cytosol, GO:0031966|mitochondrial membrane, GO:0043209|myelin sheath, GO:0005741|mitochondrial outer membrane, GO:0032991|protein-containing complex, GO:0046930|pore complex","GO:0043066|negative regulation of apoptotic process, GO:0042981|regulation of apoptotic process, GO:0006974|cellular response to DNA damage stimulus, GO:0000902|cell morphogenesis, GO:0001503|ossification, GO:0001541|ovarian follicle development, GO:0001656|metanephros development, GO:0001657|ureteric bud development, GO:0001658|branching involved in ureteric bud morphogenesis, GO:0001662|behavioral fear response, GO:0001776|leukocyte homeostasis, GO:0001782|B cell homeostasis, GO:0001822|kidney development, GO:0001836|release of cytochrome c from mitochondria, GO:0001952|regulation of cell-matrix adhesion, GO:0002260|lymphocyte homeostasis, GO:0002320|lymphoid progenitor cell differentiation, GO:0002326|B cell lineage commitment, GO:0002360|T cell lineage commitment, GO:0002520|immune system development, GO:0002931|response to ischemia, GO:0003014|renal system process, GO:0006470|protein dephosphorylation, GO:0006582|melanin metabolic process, GO:0006808|regulation of nitrogen utilization, GO:0006874|cellular calcium ion homeostasis, GO:0006915|apoptotic process, GO:0006979|response to oxidative stress, GO:0007015|actin filament organization, GO:0007409|axonogenesis, GO:0007569|cell aging, GO:0008283|cell proliferation, GO:0008284|positive regulation of cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0008584|male gonad development, GO:0008630|intrinsic apoptotic signaling pathway in response to DNA damage, GO:0008631|intrinsic apoptotic signaling pathway in response to oxidative stress, GO:0008637|apoptotic mitochondrial changes, GO:0009636|response to toxic substance, GO:0009791|post-embryonic development, GO:0009887|animal organ morphogenesis, GO:0010224|response to UV-B, GO:0010332|response to gamma radiation, GO:0010468|regulation of gene expression, GO:0010506|regulation of autophagy, GO:0010507|negative regulation of autophagy, GO:0010523|negative regulation of calcium ion transport into cytosol, GO:0010559|regulation of glycoprotein biosynthetic process, GO:0014031|mesenchymal cell development, GO:0014042|positive regulation of neuron maturation, GO:0014911|positive regulation of smooth muscle cell migration, GO:0018105|peptidyl-serine phosphorylation, GO:0018107|peptidyl-threonine phosphorylation, GO:0021747|cochlear nucleus development, GO:0022612|gland morphogenesis, GO:0030097|hemopoiesis, GO:0030183|B cell differentiation, GO:0030217|T cell differentiation, GO:0030279|negative regulation of ossification, GO:0030308|negative regulation of cell growth, GO:0030318|melanocyte differentiation, GO:0030336|negative regulation of cell migration, GO:0031069|hair follicle morphogenesis, GO:0031103|axon regeneration, GO:0031647|regulation of protein stability, GO:0032469|endoplasmic reticulum calcium ion homeostasis, GO:0032835|glomerulus development, GO:0032880|regulation of protein localization, GO:0033033|negative regulation of myeloid cell apoptotic process, GO:0033077|T cell differentiation in thymus, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:0033689|negative regulation of osteoblast proliferation, GO:0034097|response to cytokine, GO:0035265|organ growth, GO:0040008|regulation of growth, GO:0040018|positive regulation of multicellular organism growth, GO:0042149|cellular response to glucose starvation, GO:0042493|response to drug, GO:0042542|response to hydrogen peroxide, GO:0043029|T cell homeostasis, GO:0043067|regulation of programmed cell death, GO:0043085|positive regulation of catalytic activity, GO:0043375|CD8-positive, alpha-beta T cell lineage commitment, GO:0043473|pigmentation, GO:0043524|negative regulation of neuron apoptotic process, GO:0043583|ear development, GO:0045069|regulation of viral genome replication, GO:0045636|positive regulation of melanocyte differentiation, GO:0045930|negative regulation of mitotic cell cycle, GO:0046671|negative regulation of retinal cell programmed cell death, GO:0046902|regulation of mitochondrial membrane permeability, GO:0048041|focal adhesion assembly, GO:0048066|developmental pigmentation, GO:0048070|regulation of developmental pigmentation, GO:0048087|positive regulation of developmental pigmentation, GO:0048536|spleen development, GO:0048538|thymus development, GO:0048545|response to steroid hormone, GO:0048546|digestive tract morphogenesis, GO:0048589|developmental growth, GO:0048599|oocyte development, GO:0048743|positive regulation of skeletal muscle fiber development, GO:0048753|pigment granule organization, GO:0048873|homeostasis of number of cells within a tissue, GO:0050790|regulation of catalytic activity, GO:0051384|response to glucocorticoid, GO:0051402|neuron apoptotic process, GO:0051726|regulation of cell cycle, GO:0051881|regulation of mitochondrial membrane potential, GO:0071310|cellular response to organic substance, GO:0071456|cellular response to hypoxia, GO:0072593|reactive oxygen species metabolic process, GO:0097192|extrinsic apoptotic signaling pathway in absence of ligand, GO:0098609|cell-cell adhesion, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle, GO:2000378|negative regulation of reactive oxygen species metabolic process, GO:2001234|negative regulation of apoptotic signaling pathway, GO:0055085|transmembrane transport, GO:0051607|defense response to virus, GO:0051902|negative regulation of mitochondrial depolarization, GO:0007565|female pregnancy, GO:0019221|cytokine-mediated signaling pathway, GO:0050853|B cell receptor signaling pathway, GO:2001243|negative regulation of intrinsic apoptotic signaling pathway, GO:1900740|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, GO:0009314|response to radiation, GO:2001244|positive regulation of intrinsic apoptotic signaling pathway, GO:1902166|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, GO:0006959|humoral immune response, GO:0000209|protein polyubiquitination, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0022898|regulation of transmembrane transporter activity, GO:0030890|positive regulation of B cell proliferation, GO:2000811|negative regulation of anoikis, GO:0010039|response to iron ion, GO:0030307|positive regulation of cell growth, GO:0032848|negative regulation of cellular pH reduction, GO:0035094|response to nicotine, GO:0042100|B cell proliferation, GO:0043496|regulation of protein homodimerization activity, GO:0043497|regulation of protein heterodimerization activity, GO:0051924|regulation of calcium ion transport, GO:0070059|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, GO:2001240|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand","GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0019903|protein phosphatase binding, GO:0046982|protein heterodimerization activity, GO:0051721|protein phosphatase 2A binding, GO:0042802|identical protein binding, GO:0051434|BH3 domain binding, GO:0031625|ubiquitin protein ligase binding, GO:0002020|protease binding, GO:0043565|sequence-specific DNA binding, GO:0015267|channel activity, GO:0016248|channel inhibitor activity"
SH3GL1,Missense,-0.203240363923633,37,0.227635458901588,N,"oncogene, fusion",Oncogene,-0.154074158078074,0.362567981193756,ENSG00000141985,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0042995|cell projection, GO:0030054|cell junction, GO:0005768|endosome, GO:0002102|podosome, GO:0031901|early endosome membrane, GO:0098793|presynapse, GO:0098978|glutamatergic synapse, GO:0098686|hippocampal mossy fiber to CA3 synapse","GO:0006897|endocytosis, GO:0007165|signal transduction, GO:0007417|central nervous system development, GO:0016191|synaptic vesicle uncoating, GO:0098815|modulation of excitatory postsynaptic potential, GO:1900242|regulation of synaptic vesicle endocytosis, GO:1900244|positive regulation of synaptic vesicle endocytosis","GO:0005515|protein binding, GO:0008289|lipid binding, GO:0042802|identical protein binding, GO:0045296|cadherin binding, GO:0008022|protein C-terminus binding, GO:0017124|SH3 domain binding, GO:0019902|phosphatase binding, GO:0031697|beta-1 adrenergic receptor binding, GO:0044325|ion channel binding, GO:0051020|GTPase binding"
PHF6,Missense,-0.207445476525747,28,0.289495705196226,N,TSG,TSG,-0.117975724229417,0.549905874285144,ENSG00000156531,"GO:0005634|nucleus, GO:0005730|nucleolus, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0000775|chromosome, centromeric region, GO:0000776|kinetochore, GO:0000777|condensed chromosome kinetochore","GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001835|blastocyst hatching","GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific, GO:0043565|sequence-specific DNA binding, GO:0043021|ribonucleoprotein complex binding, GO:0019899|enzyme binding, GO:0042393|histone binding, GO:0015631|tubulin binding, GO:0051219|phosphoprotein binding, GO:0042826|histone deacetylase binding, GO:0097110|scaffold protein binding"
AKT1,Missense,-0.210612209799753,34,0.231851844617543,N,Oncogene,Oncogene,0.0100627673179745,0.954957730652919,ENSG00000142208,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005886|plasma membrane, GO:0015630|microtubule cytoskeleton, GO:0098794|postsynapse, GO:0005654|nucleoplasm, GO:0032991|protein-containing complex, GO:0005739|mitochondrion, GO:0005819|spindle, GO:0005911|cell-cell junction, GO:0036064|ciliary basal body, GO:0031982|vesicle","GO:0010628|positive regulation of gene expression, GO:0046326|positive regulation of glucose import, GO:1903078|positive regulation of protein localization to plasma membrane, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0001934|positive regulation of protein phosphorylation, GO:0045600|positive regulation of fat cell differentiation, GO:0010507|negative regulation of autophagy, GO:0032869|cellular response to insulin stimulus, GO:0006469|negative regulation of protein kinase activity, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0007165|signal transduction, GO:0006915|apoptotic process, GO:0005975|carbohydrate metabolic process, GO:0007275|multicellular organism development, GO:0060416|response to growth hormone, GO:0030154|cell differentiation, GO:0008643|carbohydrate transport, GO:0043491|protein kinase B signaling, GO:0007399|nervous system development, GO:0035556|intracellular signal transduction, GO:0018105|peptidyl-serine phosphorylation, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:0006417|regulation of translation, GO:0008283|cell proliferation, GO:0005977|glycogen metabolic process, GO:0071356|cellular response to tumor necrosis factor, GO:0006006|glucose metabolic process, GO:0001649|osteoblast differentiation, GO:0001893|maternal placenta development, GO:0005978|glycogen biosynthetic process, GO:0006412|translation, GO:0006954|inflammatory response, GO:0006974|cellular response to DNA damage stimulus, GO:0007281|germ cell development, GO:0007568|aging, GO:0008286|insulin receptor signaling pathway, GO:0008637|apoptotic mitochondrial changes, GO:0009725|response to hormone, GO:0010033|response to organic substance, GO:0010629|negative regulation of gene expression, GO:0010763|positive regulation of fibroblast migration, GO:0010765|positive regulation of sodium ion transport, GO:0010975|regulation of neuron projection development, GO:0016567|protein ubiquitination, GO:0021510|spinal cord development, GO:0030030|cell projection organization, GO:0030163|protein catabolic process, GO:0030212|hyaluronan metabolic process, GO:0030307|positive regulation of cell growth, GO:0030334|regulation of cell migration, GO:0031641|regulation of myelination, GO:0031663|lipopolysaccharide-mediated signaling pathway, GO:0032094|response to food, GO:0032270|positive regulation of cellular protein metabolic process, GO:0032287|peripheral nervous system myelin maintenance, GO:0032436|positive regulation of proteasomal ubiquitin-dependent protein catabolic process, GO:0032880|regulation of protein localization, GO:0035924|cellular response to vascular endothelial growth factor stimulus, GO:0036294|cellular response to decreased oxygen levels, GO:0042593|glucose homeostasis, GO:0042981|regulation of apoptotic process, GO:0043065|positive regulation of apoptotic process, GO:0043066|negative regulation of apoptotic process, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0045792|negative regulation of cell size, GO:0045907|positive regulation of vasoconstriction, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046329|negative regulation of JNK cascade, GO:0046622|positive regulation of organ growth, GO:0051146|striated muscle cell differentiation, GO:0060709|glycogen cell differentiation involved in embryonic placenta development, GO:0060716|labyrinthine layer blood vessel development, GO:0071260|cellular response to mechanical stimulus, GO:0071363|cellular response to growth factor stimulus, GO:0071364|cellular response to epidermal growth factor stimulus, GO:0071380|cellular response to prostaglandin E stimulus, GO:0071407|cellular response to organic cyclic compound, GO:0071456|cellular response to hypoxia, GO:0090201|negative regulation of release of cytochrome c from mitochondria, GO:0097011|cellular response to granulocyte macrophage colony-stimulating factor stimulus, GO:0097194|execution phase of apoptosis, GO:1901653|cellular response to peptide, GO:1990090|cellular response to nerve growth factor stimulus, GO:1990418|response to insulin-like growth factor stimulus, GO:2000010|positive regulation of protein localization to cell surface, GO:0008284|positive regulation of cell proliferation, GO:0007186|G protein-coupled receptor signaling pathway, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0006464|cellular protein modification process, GO:0045746|negative regulation of Notch signaling pathway, GO:0014065|phosphatidylinositol 3-kinase signaling, GO:0019221|cytokine-mediated signaling pathway, GO:0050999|regulation of nitric-oxide synthase activity, GO:0046777|protein autophosphorylation, GO:0043488|regulation of mRNA stability, GO:0007173|epidermal growth factor receptor signaling pathway, GO:0051000|positive regulation of nitric-oxide synthase activity, GO:2001240|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand, GO:0018107|peptidyl-threonine phosphorylation, GO:0002042|cell migration involved in sprouting angiogenesis, GO:0060644|mammary gland epithelial cell differentiation, GO:0007249|I-kappaB kinase/NF-kappaB signaling, GO:0034614|cellular response to reactive oxygen species, GO:0038061|NIK/NF-kappaB signaling, GO:0045893|positive regulation of transcription, DNA-templated, GO:0071276|cellular response to cadmium ion, GO:0031295|T cell costimulation, GO:0032148|activation of protein kinase B activity, GO:0031018|endocrine pancreas development, GO:1901215|negative regulation of neuron death, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0001938|positive regulation of endothelial cell proliferation, GO:0006979|response to oxidative stress, GO:0000060|protein import into nucleus, translocation, GO:1902176|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway, GO:0031397|negative regulation of protein ubiquitination, GO:0032091|negative regulation of protein binding, GO:0006809|nitric oxide biosynthetic process, GO:0070141|response to UV-A, GO:0045861|negative regulation of proteolysis, GO:1903038|negative regulation of leukocyte cell-cell adhesion, GO:0035655|interleukin-18-mediated signaling pathway, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0045725|positive regulation of glycogen biosynthetic process, GO:0046889|positive regulation of lipid biosynthetic process, GO:0010951|negative regulation of endopeptidase activity, GO:0048009|insulin-like growth factor receptor signaling pathway, GO:1900182|positive regulation of protein localization to nucleus, GO:0051186|cofactor metabolic process, GO:0010748|negative regulation of plasma membrane long-chain fatty acid transport, GO:0043536|positive regulation of blood vessel endothelial cell migration, GO:0060079|excitatory postsynaptic potential, GO:0072655|establishment of protein localization to mitochondrion, GO:0072656|maintenance of protein location in mitochondrion, GO:0045742|positive regulation of epidermal growth factor receptor signaling pathway, GO:0032079|positive regulation of endodeoxyribonuclease activity, GO:0034405|response to fluid shear stress, GO:0005979|regulation of glycogen biosynthetic process, GO:0006924|activation-induced cell death of T cells, GO:0009408|response to heat, GO:0010907|positive regulation of glucose metabolic process, GO:0010918|positive regulation of mitochondrial membrane potential, GO:0016242|negative regulation of macroautophagy, GO:0031929|TOR signaling, GO:0031999|negative regulation of fatty acid beta-oxidation, GO:0043276|anoikis, GO:0051898|negative regulation of protein kinase B signaling, GO:0071901|negative regulation of protein serine/threonine kinase activity, GO:0100002|negative regulation of protein kinase activity by protein phosphorylation, GO:0140052|cellular response to oxidised low-density lipoprotein particle stimulus, GO:1903721|positive regulation of I-kappaB phosphorylation, GO:2000402|negative regulation of lymphocyte migration","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0005547|phosphatidylinositol-3,4,5-trisphosphate binding, GO:0043325|phosphatidylinositol-3,4-bisphosphate binding, GO:0005080|protein kinase C binding, GO:0019899|enzyme binding, GO:0019901|protein kinase binding, GO:0032794|GTPase activating protein binding, GO:0051721|protein phosphatase 2A binding, GO:0004712|protein serine/threonine/tyrosine kinase activity, GO:0071889|14-3-3 protein binding, GO:0030235|nitric-oxide synthase regulator activity"
MYO5A,Silent,-0.212380142196905,35,0.22062848650662,N,fusion,"",-0.177071797149425,0.30887018598474,ENSG00000197535,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005783|endoplasmic reticulum, GO:0016459|myosin complex, GO:0005829|cytosol, GO:0042470|melanosome, GO:0005764|lysosome, GO:0005777|peroxisome, GO:0005769|early endosome, GO:0030426|growth cone, GO:0070062|extracellular exosome, GO:0005770|late endosome, GO:0055037|recycling endosome, GO:0001726|ruffle, GO:0043005|neuron projection, GO:0031982|vesicle, GO:0005884|actin filament, GO:0032433|filopodium tip, GO:0032593|insulin-responsive compartment, GO:0001750|photoreceptor outer segment, GO:0005794|Golgi apparatus, GO:0005882|intermediate filament, GO:0016461|unconventional myosin complex, GO:0030141|secretory granule, GO:0035371|microtubule plus-end, GO:0042641|actomyosin, GO:0043025|neuronal cell body","GO:0015031|protein transport, GO:0016192|vesicle-mediated transport, GO:0032869|cellular response to insulin stimulus, GO:0072659|protein localization to plasma membrane, GO:0030050|vesicle transport along actin filament, GO:0006892|post-Golgi vesicle-mediated transport, GO:0030048|actin filament-based movement, GO:0032402|melanosome transport, GO:0006582|melanin metabolic process, GO:0006887|exocytosis, GO:0007268|chemical synaptic transmission, GO:0007601|visual perception, GO:0030073|insulin secretion, GO:0030318|melanocyte differentiation, GO:0031585|regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity, GO:0031987|locomotion involved in locomotory behavior, GO:0032252|secretory granule localization, GO:0032400|melanosome localization, GO:0042438|melanin biosynthetic process, GO:0042476|odontogenesis, GO:0042552|myelination, GO:0042759|long-chain fatty acid biosynthetic process, GO:0043473|pigmentation, GO:0048066|developmental pigmentation, GO:0048820|hair follicle maturation, GO:0050808|synapse organization, GO:0051643|endoplasmic reticulum localization, GO:0099089|establishment of endoplasmic reticulum localization to postsynapse","GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0003774|motor activity, GO:0003779|actin binding, GO:0051015|actin filament binding, GO:0005516|calmodulin binding, GO:0005515|protein binding, GO:0017137|Rab GTPase binding, GO:0000146|microfilament motor activity, GO:0005509|calcium ion binding, GO:0042802|identical protein binding, GO:0097718|disordered domain specific binding"
FUS,Missense,-0.219917157013034,36,0.197474290556744,N,"TSG, fusion",TSG,-0.104325941944645,0.544833121237442,ENSG00000089280,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005737|cytoplasm, GO:0005844|polysome, GO:0030425|dendrite, GO:0043025|neuronal cell body, GO:0043197|dendritic spine, GO:0043204|perikaryon, GO:0044327|dendritic spine head, GO:0048471|perinuclear region of cytoplasm","GO:0008380|RNA splicing, GO:0006355|regulation of transcription, DNA-templated, GO:1903508|positive regulation of nucleic acid-templated transcription, GO:0051260|protein homooligomerization, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043484|regulation of RNA splicing, GO:0000398|mRNA splicing, via spliceosome, GO:0071277|cellular response to calcium ion, GO:1905168|positive regulation of double-strand break repair via homologous recombination","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0003682|chromatin binding, GO:0003713|transcription coactivator activity, GO:0030331|estrogen receptor binding, GO:0031489|myosin V binding, GO:0035255|ionotropic glutamate receptor binding, GO:0046965|retinoid X receptor binding, GO:0046966|thyroid hormone receptor binding"
RARA,Silent,-0.225977046753474,16,0.400038989187916,N,"oncogene, fusion",Oncogene,-0.237947528930003,0.374848732736722,ENSG00000131759,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0015629|actin cytoskeleton, GO:0005654|nucleoplasm, GO:0090575|RNA polymerase II transcription factor complex, GO:0009986|cell surface, GO:0000790|nuclear chromatin, GO:0030425|dendrite, GO:0043005|neuron projection, GO:0048471|perinuclear region of cytoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0043401|steroid hormone mediated signaling pathway, GO:0045893|positive regulation of transcription, DNA-templated, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0030154|cell differentiation, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0060349|bone morphogenesis, GO:0009755|hormone-mediated signaling pathway, GO:0048384|retinoic acid receptor signaling pathway, GO:0008284|positive regulation of cell proliferation, GO:0032689|negative regulation of interferon-gamma production, GO:0032720|negative regulation of tumor necrosis factor production, GO:0045892|negative regulation of transcription, DNA-templated, GO:0006367|transcription initiation from RNA polymerase II promoter, GO:0006468|protein phosphorylation, GO:0071300|cellular response to retinoic acid, GO:0043277|apoptotic cell clearance, GO:0032526|response to retinoic acid, GO:0045787|positive regulation of cell cycle, GO:0071391|cellular response to estrogen stimulus, GO:0007275|multicellular organism development, GO:0007165|signal transduction, GO:0001889|liver development, GO:0001657|ureteric bud development, GO:0001843|neural tube closure, GO:0002068|glandular epithelial cell development, GO:0003148|outflow tract septum morphogenesis, GO:0003417|growth plate cartilage development, GO:0007281|germ cell development, GO:0007283|spermatogenesis, GO:0007565|female pregnancy, GO:0008285|negative regulation of cell proliferation, GO:0008584|male gonad development, GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0017148|negative regulation of translation, GO:0021766|hippocampus development, GO:0030850|prostate gland development, GO:0030852|regulation of granulocyte differentiation, GO:0030853|negative regulation of granulocyte differentiation, GO:0031076|embryonic camera-type eye development, GO:0031641|regulation of myelination, GO:0032355|response to estradiol, GO:0032736|positive regulation of interleukin-13 production, GO:0032753|positive regulation of interleukin-4 production, GO:0032754|positive regulation of interleukin-5 production, GO:0033189|response to vitamin A, GO:0033993|response to lipid, GO:0034097|response to cytokine, GO:0035264|multicellular organism growth, GO:0042981|regulation of apoptotic process, GO:0043066|negative regulation of apoptotic process, GO:0045471|response to ethanol, GO:0045596|negative regulation of cell differentiation, GO:0045630|positive regulation of T-helper 2 cell differentiation, GO:0045666|positive regulation of neuron differentiation, GO:0048167|regulation of synaptic plasticity, GO:0048732|gland development, GO:0051099|positive regulation of binding, GO:0055012|ventricular cardiac muscle cell differentiation, GO:0060010|Sertoli cell fate commitment, GO:0060173|limb development, GO:0060324|face development, GO:0060348|bone development, GO:0060429|epithelium development, GO:0060534|trachea cartilage development, GO:0060591|chondroblast differentiation, GO:0061037|negative regulation of cartilage development, GO:0071222|cellular response to lipopolysaccharide","GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0031490|chromatin DNA binding, GO:0043565|sequence-specific DNA binding, GO:0005515|protein binding, GO:0003707|steroid hormone receptor activity, GO:0003713|transcription coactivator activity, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003714|transcription corepressor activity, GO:0008134|transcription factor binding, GO:0038023|signaling receptor activity, GO:0005102|signaling receptor binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0019899|enzyme binding, GO:0019904|protein domain specific binding, GO:0046982|protein heterodimerization activity, GO:0004879|nuclear receptor activity, GO:0001972|retinoic acid binding, GO:0051018|protein kinase A binding, GO:0030374|nuclear receptor transcription coactivator activity, GO:0043422|protein kinase B binding, GO:0000900|translation repressor activity, mRNA regulatory element binding, GO:0001012|RNA polymerase II regulatory region DNA binding, GO:0008144|drug binding, GO:0042826|histone deacetylase binding, GO:0044212|transcription regulatory region DNA binding, GO:0044323|retinoic acid-responsive element binding, GO:0048027|mRNA 5'-UTR binding, GO:0051393|alpha-actinin binding"
GNAQ,Missense,-0.226016191132889,29,0.238427048576807,N,Oncogene,Oncogene,-0.109960964267198,0.570145628797433,ENSG00000156052,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005765|lysosomal membrane, GO:0005834|heterotrimeric G-protein complex, GO:0001750|photoreceptor outer segment, GO:0005886|plasma membrane, GO:0070062|extracellular exosome, GO:0031965|nuclear membrane, GO:0005737|cytoplasm","GO:0050821|protein stabilization, GO:0006469|negative regulation of protein kinase activity, GO:0007186|G protein-coupled receptor signaling pathway, GO:0007165|signal transduction, GO:0043547|positive regulation of GTPase activity, GO:0007213|G protein-coupled acetylcholine receptor signaling pathway, GO:0007603|phototransduction, visible light, GO:0009649|entrainment of circadian clock, GO:0007188|adenylate cyclase-modulating G protein-coupled receptor signaling pathway, GO:0007596|blood coagulation, GO:0030168|platelet activation, GO:0007189|adenylate cyclase-activating G protein-coupled receptor signaling pathway, GO:0060828|regulation of canonical Wnt signaling pathway, GO:0007202|activation of phospholipase C activity, GO:0001508|action potential, GO:0007215|glutamate receptor signaling pathway","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0001664|G protein-coupled receptor binding, GO:0005515|protein binding, GO:0019001|guanyl nucleotide binding, GO:0031683|G-protein beta/gamma-subunit complex binding, GO:0005096|GTPase activator activity, GO:0031826|type 2A serotonin receptor binding"
DAXX,Silent,-0.226116379053422,24,0.288035120455803,N,"oncogene, TSG","",-0.179311050036479,0.401821276278134,ENSG00000204209,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005694|chromosome, GO:0005829|cytosol, GO:0016604|nuclear body, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0000775|chromosome, centromeric region, GO:0016605|PML body","GO:0006325|chromatin organization, GO:1903508|positive regulation of nucleic acid-templated transcription, GO:0006334|nucleosome assembly, GO:0006915|apoptotic process, GO:0016032|viral process, GO:0008625|extrinsic apoptotic signaling pathway via death domain receptors, GO:0045892|negative regulation of transcription, DNA-templated, GO:0030521|androgen receptor signaling pathway, GO:0006338|chromatin remodeling, GO:1903936|cellular response to sodium arsenite, GO:0034605|cellular response to heat, GO:0007257|activation of JUN kinase activity, GO:0071276|cellular response to cadmium ion, GO:1901216|positive regulation of neuron death, GO:0071280|cellular response to copper ion, GO:0031396|regulation of protein ubiquitination, GO:0001934|positive regulation of protein phosphorylation, GO:0034620|cellular response to unfolded protein, GO:0072738|cellular response to diamide, GO:0006355|regulation of transcription, DNA-templated, GO:0045860|positive regulation of protein kinase activity","GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0003714|transcription corepressor activity, GO:0031625|ubiquitin protein ligase binding, GO:0047485|protein N-terminus binding, GO:0019899|enzyme binding, GO:0042393|histone binding, GO:0046982|protein heterodimerization activity, GO:0002039|p53 binding, GO:0050681|androgen receptor binding, GO:0019901|protein kinase binding, GO:0031072|heat shock protein binding, GO:0032183|SUMO binding, GO:0030295|protein kinase activator activity"
PRKACA,Missense,-0.227055127391534,26,0.264650934531068,N,Oncogene,Oncogene,-0.17193432719744,0.400986777549584,ENSG00000072062,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016607|nuclear speck, GO:0016020|membrane, GO:0005829|cytosol, GO:0031514|motile cilium, GO:0045171|intercellular bridge, GO:0005739|mitochondrion, GO:0005886|plasma membrane, GO:0042995|cell projection, GO:0048471|perinuclear region of cytoplasm, GO:0031410|cytoplasmic vesicle, GO:0001669|acrosomal vesicle, GO:0005952|cAMP-dependent protein kinase complex, GO:0031594|neuromuscular junction, GO:0036126|sperm flagellum, GO:0043197|dendritic spine, GO:0097546|ciliary base, GO:0005813|centrosome, GO:0005929|cilium, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0005930|axoneme, GO:0034704|calcium channel complex, GO:0044853|plasma membrane raft","GO:0010881|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion, GO:0002027|regulation of heart rate, GO:0006397|mRNA processing, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0001707|mesoderm formation, GO:0001843|neural tube closure, GO:0010737|protein kinase A signaling, GO:0018105|peptidyl-serine phosphorylation, GO:0018107|peptidyl-threonine phosphorylation, GO:0046777|protein autophosphorylation, GO:0046827|positive regulation of protein export from nucleus, GO:0048240|sperm capacitation, GO:0050804|modulation of chemical synaptic transmission, GO:0070613|regulation of protein processing, GO:0071158|positive regulation of cell cycle arrest, GO:0071333|cellular response to glucose stimulus, GO:0071374|cellular response to parathyroid hormone stimulus, GO:1901621|negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning, GO:0000086|G2/M transition of mitotic cell cycle, GO:0010389|regulation of G2/M transition of mitotic cell cycle, GO:0097711|ciliary basal body-plasma membrane docking, GO:2000810|regulation of bicellular tight junction assembly, GO:0019221|cytokine-mediated signaling pathway, GO:0061136|regulation of proteasomal protein catabolic process, GO:0007596|blood coagulation, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:1903779|regulation of cardiac conduction, GO:0055117|regulation of cardiac muscle contraction, GO:0016241|regulation of macroautophagy, GO:0003091|renal water homeostasis, GO:0071377|cellular response to glucagon stimulus, GO:0034605|cellular response to heat, GO:0034380|high-density lipoprotein particle assembly, GO:0051480|regulation of cytosolic calcium ion concentration, GO:0086064|cell communication by electrical coupling involved in cardiac conduction, GO:0034199|activation of protein kinase A activity, GO:0060314|regulation of ryanodine-sensitive calcium-release channel activity, GO:0035584|calcium-mediated signaling using intracellular calcium source, GO:0043393|regulation of protein binding, GO:0045667|regulation of osteoblast differentiation, GO:0071872|cellular response to epinephrine stimulus","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0000287|magnesium ion binding, GO:0004691|cAMP-dependent protein kinase activity, GO:0019904|protein domain specific binding, GO:0030145|manganese ion binding, GO:0034237|protein kinase A regulatory subunit binding, GO:0019901|protein kinase binding, GO:0031625|ubiquitin protein ligase binding, GO:0004712|protein serine/threonine/tyrosine kinase activity"
IL7R,Silent,-0.227343279695654,28,0.244645494996518,N,Oncogene,Oncogene,0.0831039926306164,0.674175282149566,ENSG00000168685,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0030665|clathrin-coated vesicle membrane, GO:0009897|external side of plasma membrane","GO:0008284|positive regulation of cell proliferation, GO:0006955|immune response, GO:0007165|signal transduction, GO:0007166|cell surface receptor signaling pathway, GO:0061024|membrane organization, GO:0038111|interleukin-7-mediated signaling pathway, GO:0000018|regulation of DNA recombination, GO:0000902|cell morphogenesis, GO:0001915|negative regulation of T cell mediated cytotoxicity, GO:0002377|immunoglobulin production, GO:0008361|regulation of cell size, GO:0010628|positive regulation of gene expression, GO:0030217|T cell differentiation, GO:0033089|positive regulation of T cell differentiation in thymus, GO:0042100|B cell proliferation, GO:0048535|lymph node development, GO:0048872|homeostasis of number of cells, GO:0070233|negative regulation of T cell apoptotic process, GO:1904894|positive regulation of STAT cascade, GO:0019221|cytokine-mediated signaling pathway","GO:0005515|protein binding, GO:0004896|cytokine receptor activity, GO:0003823|antigen binding, GO:0004917|interleukin-7 receptor activity"
STK11,Silent,-0.227480354817635,11,0.501134230979533,N,TSG,TSG,-0.344995308084321,0.29877496789859,ENSG00000118046,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005739|mitochondrion, GO:0070062|extracellular exosome","GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0001558|regulation of cell growth, GO:0006974|cellular response to DNA damage stimulus, GO:0007049|cell cycle, GO:0006915|apoptotic process, GO:0006914|autophagy, GO:0030010|establishment of cell polarity, GO:0030154|cell differentiation, GO:0007283|spermatogenesis, GO:0032147|activation of protein kinase activity, GO:0001894|tissue homeostasis, GO:0001944|vasculature development, GO:0007409|axonogenesis, GO:0008285|negative regulation of cell proliferation, GO:0010212|response to ionizing radiation, GO:0030111|regulation of Wnt signaling pathway, GO:0030308|negative regulation of cell growth, GO:0042593|glucose homeostasis, GO:0045059|positive thymic T cell selection, GO:0046777|protein autophosphorylation, GO:0048814|regulation of dendrite morphogenesis, GO:0050772|positive regulation of axonogenesis, GO:0050852|T cell receptor signaling pathway, GO:0051645|Golgi localization, GO:0051896|regulation of protein kinase B signaling, GO:0060070|canonical Wnt signaling pathway, GO:0060770|negative regulation of epithelial cell proliferation involved in prostate gland development, GO:0071493|cellular response to UV-B, GO:0097484|dendrite extension, GO:0120163|negative regulation of cold-induced thermogenesis, GO:1900182|positive regulation of protein localization to nucleus, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:0007050|cell cycle arrest, GO:1901796|regulation of signal transduction by p53 class mediator, GO:0006470|protein dephosphorylation, GO:0072332|intrinsic apoptotic signaling pathway by p53 class mediator, GO:0043276|anoikis, GO:0010508|positive regulation of autophagy, GO:1904262|negative regulation of TORC1 signaling","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0000287|magnesium ion binding, GO:0030275|LRR domain binding, GO:0030295|protein kinase activator activity, GO:0002039|p53 binding"
FOXA1,Silent,-0.241591589496027,22,0.278734724673444,N,Oncogene,Oncogene,-0.224685587493197,0.314761101503163,ENSG00000129514,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0001650|fibrillar center, GO:0005902|microvillus","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0010719|negative regulation of epithelial to mesenchymal transition, GO:0006355|regulation of transcription, DNA-templated, GO:0006325|chromatin organization, GO:0007275|multicellular organism development, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043065|positive regulation of apoptotic process, GO:0009653|anatomical structure morphogenesis, GO:0051091|positive regulation of DNA-binding transcription factor activity, GO:0033148|positive regulation of intracellular estrogen receptor signaling pathway, GO:0006338|chromatin remodeling, GO:0071542|dopaminergic neuron differentiation, GO:0045931|positive regulation of mitotic cell cycle, GO:2000049|positive regulation of cell-cell adhesion mediated by cadherin, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0007219|Notch signaling pathway, GO:0010468|regulation of gene expression, GO:0021904|dorsal/ventral neural tube patterning, GO:0030324|lung development, GO:0032355|response to estradiol, GO:0035239|tube morphogenesis, GO:0042445|hormone metabolic process, GO:0042593|glucose homeostasis, GO:0045666|positive regulation of neuron differentiation, GO:0045880|positive regulation of smoothened signaling pathway, GO:0048646|anatomical structure formation involved in morphogenesis, GO:0048665|neuron fate specification, GO:0051726|regulation of cell cycle, GO:0060425|lung morphogenesis, GO:0060441|epithelial tube branching involved in lung morphogenesis, GO:0060487|lung epithelial cell differentiation, GO:0060528|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development, GO:0060738|epithelial-mesenchymal signaling involved in prostate gland development, GO:0060740|prostate gland epithelium morphogenesis, GO:0060741|prostate gland stromal morphogenesis, GO:0060743|epithelial cell maturation involved in prostate gland development, GO:0061144|alveolar secondary septum development, GO:0061448|connective tissue development, GO:1902691|respiratory basal cell differentiation","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0008134|transcription factor binding, GO:0019904|protein domain specific binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding"
KNL1,Silent,-0.241656847529946,23,0.266619676600437,N,"TSG, fusion",TSG,-0.168756043963198,0.441455407600064,ENSG00000137812,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0016604|nuclear body, GO:0000775|chromosome, centromeric region, GO:0000776|kinetochore, GO:0000777|condensed chromosome kinetochore, GO:0001669|acrosomal vesicle","GO:0051301|cell division, GO:0007049|cell cycle, GO:0007059|chromosome segregation, GO:0010923|negative regulation of phosphatase activity, GO:0034080|CENP-A containing nucleosome assembly, GO:0008608|attachment of spindle microtubules to kinetochore, GO:0034501|protein localization to kinetochore, GO:0001675|acrosome assembly",GO:0005515|protein binding
CDK12,Silent,-0.243611147226607,28,0.211584188495335,N,TSG,TSG,-0.250336099746978,0.198850344606528,ENSG00000167258,"GO:0005634|nucleus, GO:0016607|nuclear speck, GO:0001650|fibrillar center, GO:0000790|nuclear chromatin, GO:0005654|nucleoplasm, GO:0008024|cyclin/CDK positive transcription elongation factor complex, GO:0002944|cyclin K-CDK12 complex, GO:0005694|chromosome, GO:0000307|cyclin-dependent protein kinase holoenzyme complex, GO:0019908|nuclear cyclin-dependent protein kinase holoenzyme complex","GO:0006468|protein phosphorylation, GO:0006397|mRNA processing, GO:0008380|RNA splicing, GO:0016310|phosphorylation, GO:0051726|regulation of cell cycle, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0043405|regulation of MAP kinase activity, GO:0046777|protein autophosphorylation, GO:0032968|positive regulation of transcription elongation from RNA polymerase II promoter, GO:0070816|phosphorylation of RNA polymerase II C-terminal domain, GO:0043484|regulation of RNA splicing, GO:2000737|negative regulation of stem cell differentiation","GO:0004672|protein kinase activity, GO:0005524|ATP binding, GO:0000166|nucleotide binding, GO:0004674|protein serine/threonine kinase activity, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0044212|transcription regulatory region DNA binding, GO:0004693|cyclin-dependent protein serine/threonine kinase activity, GO:0030332|cyclin binding, GO:0008353|RNA polymerase II CTD heptapeptide repeat kinase activity, GO:0019901|protein kinase binding"
MAP2K2,Missense,-0.245196272649509,31,0.18368481656945,N,Oncogene,Oncogene,-0.135755011658842,0.466508195467205,ENSG00000126934,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005783|endoplasmic reticulum, GO:0005794|Golgi apparatus, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005576|extracellular region, GO:0048471|perinuclear region of cytoplasm, GO:0005874|microtubule, GO:0005925|focal adhesion, GO:0005778|peroxisomal membrane, GO:0005769|early endosome, GO:0005770|late endosome, GO:0009898|cytoplasmic side of plasma membrane, GO:0005911|cell-cell junction","GO:0045893|positive regulation of transcription, DNA-templated, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0071902|positive regulation of protein serine/threonine kinase activity, GO:0010629|negative regulation of gene expression, GO:0000165|MAPK cascade, GO:0023014|signal transduction by protein phosphorylation, GO:0031098|stress-activated protein kinase signaling cascade, GO:0032147|activation of protein kinase activity, GO:0000187|activation of MAPK activity, GO:2000641|regulation of early endosome to late endosome transport, GO:1903800|positive regulation of production of miRNAs involved in gene silencing by miRNA, GO:0070371|ERK1 and ERK2 cascade, GO:0032872|regulation of stress-activated MAPK cascade, GO:0090170|regulation of Golgi inheritance, GO:0036289|peptidyl-serine autophosphorylation","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0043539|protein serine/threonine kinase activator activity, GO:0030165|PDZ domain binding, GO:0004708|MAP kinase kinase activity, GO:0004712|protein serine/threonine/tyrosine kinase activity, GO:0097110|scaffold protein binding"
MEN1,Missense,-0.24532475916959,49,0.0893165585739003,N,TSG,TSG,-0.124133330920072,0.395438910600033,ENSG00000133895,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005737|cytoplasm, GO:0032154|cleavage furrow, GO:0032991|protein-containing complex, GO:0000784|nuclear chromosome, telomeric region, GO:0035097|histone methyltransferase complex, GO:0000785|chromatin, GO:0000790|nuclear chromatin, GO:0005788|endoplasmic reticulum lumen, GO:0016363|nuclear matrix","GO:0006325|chromatin organization, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0034968|histone lysine methylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0044267|cellular protein metabolic process, GO:0008285|negative regulation of cell proliferation, GO:0043687|post-translational protein modification, GO:0045786|negative regulation of cell cycle, GO:0000165|MAPK cascade, GO:0001933|negative regulation of protein phosphorylation, GO:0002076|osteoblast development, GO:0009411|response to UV, GO:0010332|response to gamma radiation, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:0032092|positive regulation of protein binding, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045668|negative regulation of osteoblast differentiation, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046329|negative regulation of JNK cascade, GO:0051974|negative regulation of telomerase activity, GO:1904837|beta-catenin-TCF complex assembly, GO:0000278|mitotic cell cycle, GO:0003309|type B pancreatic cell differentiation, GO:0007420|brain development, GO:0010812|negative regulation of cell-substrate adhesion, GO:0032925|regulation of activin receptor signaling pathway, GO:0046697|decidualization, GO:0050680|negative regulation of epithelial cell proliferation, GO:0061469|regulation of type B pancreatic cell proliferation, GO:0071333|cellular response to glucose stimulus, GO:0071375|cellular response to peptide hormone stimulus, GO:0071559|response to transforming growth factor beta, GO:1902807|negative regulation of cell cycle G1/S phase transition","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0030674|protein binding, bridging, GO:0003690|double-stranded DNA binding, GO:0003682|chromatin binding, GO:0047485|protein N-terminus binding, GO:0000400|four-way junction DNA binding, GO:0000403|Y-form DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0070412|R-SMAD binding"
MYD88,Missense,-0.248701241225961,21,0.276992656290152,N,Oncogene,Oncogene,-0.237900473546283,0.299062695656938,ENSG00000172936,"GO:0005737|cytoplasm, GO:0005634|nucleus, GO:0005886|plasma membrane, GO:0005829|cytosol, GO:0010008|endosome membrane, GO:0014069|postsynaptic density, GO:0032991|protein-containing complex","GO:0007165|signal transduction, GO:0006954|inflammatory response, GO:0043123|positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0002376|immune system process, GO:0002755|MyD88-dependent toll-like receptor signaling pathway, GO:1900017|positive regulation of cytokine production involved in inflammatory response, GO:0010628|positive regulation of gene expression, GO:0042742|defense response to bacterium, GO:0032755|positive regulation of interleukin-6 production, GO:0045087|innate immune response, GO:0050830|defense response to Gram-positive bacterium, GO:0071260|cellular response to mechanical stimulus, GO:0002224|toll-like receptor signaling pathway, GO:0032757|positive regulation of interleukin-8 production, GO:0140052|cellular response to oxidised low-density lipoprotein particle stimulus, GO:0007166|cell surface receptor signaling pathway, GO:0043066|negative regulation of apoptotic process, GO:0070498|interleukin-1-mediated signaling pathway, GO:0034162|toll-like receptor 9 signaling pathway, GO:0070555|response to interleukin-1, GO:0050727|regulation of inflammatory response, GO:0032740|positive regulation of interleukin-17 production, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0060337|type I interferon signaling pathway, GO:0032747|positive regulation of interleukin-23 production, GO:0032481|positive regulation of type I interferon production, GO:0070935|3'-UTR-mediated mRNA stabilization, GO:0006915|apoptotic process, GO:0002238|response to molecule of fungal origin, GO:0007254|JNK cascade, GO:0008063|Toll signaling pathway, GO:0009615|response to virus, GO:0009682|induced systemic resistance, GO:0010468|regulation of gene expression, GO:0016064|immunoglobulin mediated immune response, GO:0019221|cytokine-mediated signaling pathway, GO:0031663|lipopolysaccharide-mediated signaling pathway, GO:0032494|response to peptidoglycan, GO:0032496|response to lipopolysaccharide, GO:0032675|regulation of interleukin-6 production, GO:0032680|regulation of tumor necrosis factor production, GO:0032760|positive regulation of tumor necrosis factor production, GO:0042127|regulation of cell proliferation, GO:0044130|negative regulation of growth of symbiont in host, GO:0045080|positive regulation of chemokine biosynthetic process, GO:0045351|type I interferon biosynthetic process, GO:0046330|positive regulation of JNK cascade, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0050671|positive regulation of lymphocyte proliferation, GO:0090557|establishment of endothelial intestinal barrier, GO:1902622|regulation of neutrophil migration, GO:2000338|regulation of chemokine (C-X-C motif) ligand 1 production, GO:2000341|regulation of chemokine (C-X-C motif) ligand 2 production","GO:0070976|TIR domain binding, GO:0005515|protein binding, GO:0042802|identical protein binding, GO:0043621|protein self-association, GO:0005123|death receptor binding, GO:0005102|signaling receptor binding, GO:0005121|Toll binding, GO:0005149|interleukin-1 receptor binding, GO:0035325|Toll-like receptor binding"
PER1,Silent,-0.250139367031158,40,0.119537377147112,N,"TSG, fusion",TSG,-0.19163382990719,0.23618211417081,ENSG00000179094,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005654|nucleoplasm","GO:0007623|circadian rhythm, GO:0048511|rhythmic process, GO:0032922|circadian regulation of gene expression, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0043967|histone H4 acetylation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0046329|negative regulation of JNK cascade, GO:0042634|regulation of hair cycle, GO:2000323|negative regulation of glucocorticoid receptor signaling pathway, GO:0043124|negative regulation of I-kappaB kinase/NF-kappaB signaling, GO:0009416|response to light stimulus, GO:0042752|regulation of circadian rhythm, GO:0043153|entrainment of circadian clock by photoperiod, GO:0070932|histone H3 deacetylation, GO:0097167|circadian regulation of translation, GO:0002028|regulation of sodium ion transport, GO:0009649|entrainment of circadian clock, GO:0010608|posttranscriptional regulation of gene expression, GO:0043966|histone H3 acetylation, GO:0051591|response to cAMP, GO:1900015|regulation of cytokine production involved in inflammatory response, GO:1900744|regulation of p38MAPK cascade","GO:0031490|chromatin DNA binding, GO:0005515|protein binding, GO:0008134|transcription factor binding, GO:0031625|ubiquitin protein ligase binding, GO:0000976|transcription regulatory region sequence-specific DNA binding, GO:0070888|E-box binding, GO:0001222|transcription corepressor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0019900|kinase binding"
PATZ1,Missense,-0.260375726458254,13,0.390248218118836,N,"TSG, fusion",TSG,-0.331557301591197,0.26843554615967,ENSG00000100105,"GO:0005634|nucleus, GO:0005654|nucleoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0007283|spermatogenesis, GO:0008584|male gonad development, GO:0010468|regulation of gene expression, GO:0030217|T cell differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
FOXL2,Missense,-0.26319076690782,28,0.175998440227798,N,"oncogene, TSG","",-0.182718855140317,0.352037822589995,ENSG00000183770,"GO:0005634|nucleus, GO:0045171|intercellular bridge, GO:0005654|nucleoplasm","GO:0006355|regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0043065|positive regulation of apoptotic process, GO:0009653|anatomical structure morphogenesis, GO:0045892|negative regulation of transcription, DNA-templated, GO:0043280|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0001541|ovarian follicle development, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001555|oocyte growth, GO:0002074|extraocular skeletal muscle development, GO:0006309|apoptotic DNA fragmentation, GO:0007338|single fertilization, GO:0008585|female gonad development, GO:0019101|female somatic sex determination, GO:0033686|positive regulation of luteinizing hormone secretion, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046881|positive regulation of follicle-stimulating hormone secretion, GO:0048048|embryonic eye morphogenesis, GO:0060014|granulosa cell differentiation, GO:0060065|uterus development","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0005515|protein binding, GO:0031624|ubiquitin conjugating enzyme binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0030331|estrogen receptor binding, GO:0043028|cysteine-type endopeptidase regulator activity involved in apoptotic process"
EZH2,Missense,-0.267682521486856,60,0.0386642894689657,N,"oncogene, TSG","",-0.163586146226073,0.21169780501518,ENSG00000106462,"GO:0005634|nucleus, GO:0000790|nuclear chromatin, GO:0005654|nucleoplasm, GO:0035098|ESC/E(Z) complex, GO:0005737|cytoplasm, GO:0045120|pronucleus","GO:0034968|histone lysine methylation, GO:0008284|positive regulation of cell proliferation, GO:0032259|methylation, GO:0006325|chromatin organization, GO:0048511|rhythmic process, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0043547|positive regulation of GTPase activity, GO:0071902|positive regulation of protein serine/threonine kinase activity, GO:0048387|negative regulation of retinoic acid receptor signaling pathway, GO:0045892|negative regulation of transcription, DNA-templated, GO:0070317|negative regulation of G0 to G1 transition, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0006355|regulation of transcription, DNA-templated, GO:0042752|regulation of circadian rhythm, GO:0045814|negative regulation of gene expression, epigenetic, GO:0043406|positive regulation of MAP kinase activity, GO:1902808|positive regulation of cell cycle G1/S phase transition, GO:0016571|histone methylation, GO:0070734|histone H3-K27 methylation, GO:0001932|regulation of protein phosphorylation, GO:0006306|DNA methylation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0010468|regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0014013|regulation of gliogenesis, GO:0014834|skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration, GO:0014898|cardiac muscle hypertrophy in response to stress, GO:0021695|cerebellar cortex development, GO:0021766|hippocampus development, GO:0032355|response to estradiol, GO:0034244|negative regulation of transcription elongation from RNA polymerase II promoter, GO:0035984|cellular response to trichostatin A, GO:0036333|hepatocyte homeostasis, GO:0042127|regulation of cell proliferation, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045605|negative regulation of epidermal cell differentiation, GO:0050767|regulation of neurogenesis, GO:0051154|negative regulation of striated muscle cell differentiation, GO:0070301|cellular response to hydrogen peroxide, GO:0070314|G1 to G0 transition, GO:0071168|protein localization to chromatin, GO:0097421|liver regeneration, GO:0098532|histone H3-K27 trimethylation, GO:1900006|positive regulation of dendrite development, GO:1904772|response to tetrachloromethane, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle","GO:0018024|histone-lysine N-methyltransferase activity, GO:0008168|methyltransferase activity, GO:0016740|transferase activity, GO:0031490|chromatin DNA binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0003677|DNA binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0042054|histone methyltransferase activity, GO:1990841|promoter-specific chromatin binding, GO:0046976|histone methyltransferase activity (H3-K27 specific), GO:0016279|protein-lysine N-methyltransferase activity, GO:0000979|RNA polymerase II core promoter sequence-specific DNA binding, GO:0003723|RNA binding, GO:0043021|ribonucleoprotein complex binding, GO:0043565|sequence-specific DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0070878|primary miRNA binding"
TSC1,Silent,-0.289266529867194,35,0.0919073734326252,N,TSG,TSG,-0.251767928177194,0.144563386510663,ENSG00000165699,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005811|lipid droplet, GO:0005886|plasma membrane, GO:0030027|lamellipodium, GO:0005938|cell cortex, GO:0032991|protein-containing complex, GO:0005634|nucleus, GO:0048471|perinuclear region of cytoplasm, GO:0005884|actin filament, GO:0101031|chaperone complex, GO:0033596|TSC1-TSC2 complex, GO:0005856|cytoskeleton, GO:0030426|growth cone, GO:0042995|cell projection, GO:0043231|intracellular membrane-bounded organelle, GO:0016021|integral component of membrane","GO:0032007|negative regulation of TOR signaling, GO:0051726|regulation of cell cycle, GO:0050821|protein stabilization, GO:0008285|negative regulation of cell proliferation, GO:0006417|regulation of translation, GO:0090630|activation of GTPase activity, GO:0017148|negative regulation of translation, GO:0046627|negative regulation of insulin receptor signaling pathway, GO:0007160|cell-matrix adhesion, GO:1901214|regulation of neuron death, GO:0032868|response to insulin, GO:0008344|adult locomotory behavior, GO:0051492|regulation of stress fiber assembly, GO:0051894|positive regulation of focal adhesion assembly, GO:0001952|regulation of cell-matrix adhesion, GO:0032780|negative regulation of ATPase activity, GO:0016242|negative regulation of macroautophagy, GO:0001822|kidney development, GO:0001843|neural tube closure, GO:0002250|adaptive immune response, GO:0006407|rRNA export from nucleus, GO:0006813|potassium ion transport, GO:0007399|nervous system development, GO:0010977|negative regulation of neuron projection development, GO:0016239|positive regulation of macroautophagy, GO:0021766|hippocampus development, GO:0021987|cerebral cortex development, GO:0030030|cell projection organization, GO:0034260|negative regulation of GTPase activity, GO:0042552|myelination, GO:0043379|memory T cell differentiation, GO:0043666|regulation of phosphoprotein phosphatase activity, GO:0045792|negative regulation of cell size, GO:0045859|regulation of protein kinase activity, GO:0046323|glucose import, GO:0050808|synapse organization, GO:0051291|protein heterooligomerization, GO:0051496|positive regulation of stress fiber assembly, GO:0051893|regulation of focal adhesion assembly, GO:0055007|cardiac muscle cell differentiation, GO:0090650|cellular response to oxygen-glucose deprivation, GO:1903204|negative regulation of oxidative stress-induced neuron death","GO:0005515|protein binding, GO:0047485|protein N-terminus binding, GO:0051087|chaperone binding, GO:0051879|Hsp90 protein binding, GO:0030544|Hsp70 protein binding, GO:0042030|ATPase inhibitor activity, GO:0032794|GTPase activating protein binding"
DEK,Missense,-0.289772478716895,23,0.179859120664074,N,"oncogene, fusion",Oncogene,-0.162492223076752,0.458831659775929,ENSG00000124795,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0043292|contractile fiber","GO:0006325|chromatin organization, GO:0045815|positive regulation of gene expression, epigenetic, GO:0007165|signal transduction, GO:0006366|transcription by RNA polymerase II, GO:0006357|regulation of transcription by RNA polymerase II, GO:0019079|viral genome replication, GO:2000779|regulation of double-strand break repair, GO:2001032|regulation of double-strand break repair via nonhomologous end joining","GO:0003723|RNA binding, GO:0003677|DNA binding, GO:0042393|histone binding"
MAP2K1,Silent,-0.300684151401615,11,0.368938990523154,N,Oncogene,Oncogene,-0.300958688873501,0.368480380065721,ENSG00000169032,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0005739|mitochondrion, GO:0005856|cytoskeleton, GO:0005925|focal adhesion, GO:0005815|microtubule organizing center, GO:0005769|early endosome, GO:0005770|late endosome, GO:0005783|endoplasmic reticulum","GO:0008285|negative regulation of cell proliferation, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0018108|peptidyl-tyrosine phosphorylation, GO:0030182|neuron differentiation, GO:0071902|positive regulation of protein serine/threonine kinase activity, GO:0010628|positive regulation of gene expression, GO:0000187|activation of MAPK activity, GO:0001932|regulation of protein phosphorylation, GO:0007507|heart development, GO:0021697|cerebellar cortex formation, GO:0030216|keratinocyte differentiation, GO:0030878|thyroid gland development, GO:0045597|positive regulation of cell differentiation, GO:0048538|thymus development, GO:0048679|regulation of axon regeneration, GO:0048870|cell motility, GO:0050772|positive regulation of axonogenesis, GO:0060020|Bergmann glial cell differentiation, GO:0060324|face development, GO:0060425|lung morphogenesis, GO:0060440|trachea formation, GO:0060502|epithelial cell proliferation involved in lung morphogenesis, GO:0060674|placenta blood vessel development, GO:0060711|labyrinthine layer development, GO:0070371|ERK1 and ERK2 cascade, GO:0006935|chemotaxis, GO:0007165|signal transduction, GO:0010629|negative regulation of gene expression, GO:0000165|MAPK cascade, GO:0023014|signal transduction by protein phosphorylation, GO:0031098|stress-activated protein kinase signaling cascade, GO:0032147|activation of protein kinase activity, GO:0018107|peptidyl-threonine phosphorylation, GO:2000641|regulation of early endosome to late endosome transport, GO:1903800|positive regulation of production of miRNAs involved in gene silencing by miRNA, GO:0007050|cell cycle arrest, GO:0090398|cellular senescence, GO:0032872|regulation of stress-activated MAPK cascade, GO:0090170|regulation of Golgi inheritance","GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0004713|protein tyrosine kinase activity, GO:0005515|protein binding, GO:0043539|protein serine/threonine kinase activator activity, GO:0004708|MAP kinase kinase activity, GO:0004712|protein serine/threonine/tyrosine kinase activity, GO:0097110|scaffold protein binding, GO:0008022|protein C-terminus binding, GO:0047485|protein N-terminus binding"
HRAS,Missense,-0.300969802724661,22,0.173488944319228,N,Oncogene,Oncogene,-0.227733679246666,0.308066131842139,ENSG00000174775,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0000139|Golgi membrane, GO:0048471|perinuclear region of cytoplasm, GO:0005829|cytosol, GO:0098978|glutamatergic synapse, GO:0043231|intracellular membrane-bounded organelle","GO:0010629|negative regulation of gene expression, GO:0008284|positive regulation of cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0034260|negative regulation of GTPase activity, GO:0070374|positive regulation of ERK1 and ERK2 cascade, GO:0030335|positive regulation of cell migration, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0001934|positive regulation of protein phosphorylation, GO:0007165|signal transduction, GO:0090314|positive regulation of protein targeting to membrane, GO:2000251|positive regulation of actin cytoskeleton reorganization, GO:0006935|chemotaxis, GO:0043547|positive regulation of GTPase activity, GO:0007166|cell surface receptor signaling pathway, GO:0048013|ephrin receptor signaling pathway, GO:0000165|MAPK cascade, GO:0046330|positive regulation of JNK cascade, GO:0009887|animal organ morphogenesis, GO:0043406|positive regulation of MAP kinase activity, GO:0007093|mitotic cell cycle checkpoint, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0007265|Ras protein signal transduction, GO:0007050|cell cycle arrest, GO:0010863|positive regulation of phospholipase C activity, GO:0043410|positive regulation of MAPK cascade, GO:0050679|positive regulation of epithelial cell proliferation, GO:0071480|cellular response to gamma radiation, GO:0090303|positive regulation of wound healing, GO:0090398|cellular senescence, GO:0098696|regulation of neurotransmitter receptor localization to postsynaptic specialization membrane, GO:1900029|positive regulation of ruffle assembly, GO:2000630|positive regulation of miRNA metabolic process, GO:0006897|endocytosis, GO:0006915|apoptotic process, GO:0007264|small GTPase mediated signal transduction, GO:0007569|cell aging, GO:0008283|cell proliferation, GO:0010628|positive regulation of gene expression, GO:0032729|positive regulation of interferon-gamma production, GO:0035900|response to isolation stress, GO:0042088|T-helper 1 type immune response, GO:0042832|defense response to protozoan, GO:0043524|negative regulation of neuron apoptotic process, GO:0045740|positive regulation of DNA replication, GO:0046579|positive regulation of Ras protein signal transduction, GO:0048169|regulation of long-term neuronal synaptic plasticity, GO:0050852|T cell receptor signaling pathway, GO:0051291|protein heterooligomerization, GO:0097193|intrinsic apoptotic signaling pathway","GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0008022|protein C-terminus binding, GO:0019003|GDP binding"
KLF4,Missense,-0.302606143363096,37,0.0686903516161285,N,"oncogene, TSG","",-0.174846460869148,0.300647450115999,ENSG00000136826,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0000790|nuclear chromatin, GO:0000785|chromatin, GO:0005667|transcription factor complex, GO:0005719|nuclear euchromatin, GO:0005737|cytoplasm, GO:0044798|nuclear transcription factor complex","GO:0010628|positive regulation of gene expression, GO:0010629|negative regulation of gene expression, GO:0090051|negative regulation of cell migration involved in sprouting angiogenesis, GO:0050728|negative regulation of inflammatory response, GO:0016525|negative regulation of angiogenesis, GO:0034115|negative regulation of heterotypic cell-cell adhesion, GO:2000134|negative regulation of G1/S transition of mitotic cell cycle, GO:0071499|cellular response to laminar fluid shear stress, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:1903672|positive regulation of sprouting angiogenesis, GO:0043154|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, GO:0032088|negative regulation of NF-kappaB transcription factor activity, GO:0045893|positive regulation of transcription, DNA-templated, GO:0043551|regulation of phosphatidylinositol 3-kinase activity, GO:0006357|regulation of transcription by RNA polymerase II, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0045892|negative regulation of transcription, DNA-templated, GO:0008285|negative regulation of cell proliferation, GO:0051973|positive regulation of telomerase activity, GO:0032270|positive regulation of cellular protein metabolic process, GO:0006351|transcription, DNA-templated, GO:0006366|transcription by RNA polymerase II, GO:0007500|mesodermal cell fate determination, GO:0009913|epidermal cell differentiation, GO:0010033|response to organic substance, GO:0014067|negative regulation of phosphatidylinositol 3-kinase signaling, GO:0014740|negative regulation of muscle hyperplasia, GO:0019827|stem cell population maintenance, GO:0030154|cell differentiation, GO:0030336|negative regulation of cell migration, GO:0031077|post-embryonic camera-type eye development, GO:0032526|response to retinoic acid, GO:0035019|somatic stem cell population maintenance, GO:0035166|post-embryonic hemopoiesis, GO:0042127|regulation of cell proliferation, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045415|negative regulation of interleukin-8 biosynthetic process, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0045444|fat cell differentiation, GO:0045595|regulation of cell differentiation, GO:0046985|positive regulation of hemoglobin biosynthetic process, GO:0048662|negative regulation of smooth muscle cell proliferation, GO:0048679|regulation of axon regeneration, GO:0048730|epidermis morphogenesis, GO:0051247|positive regulation of protein metabolic process, GO:0051898|negative regulation of protein kinase B signaling, GO:0060070|canonical Wnt signaling pathway, GO:0060761|negative regulation of response to cytokine stimulus, GO:0061614|pri-miRNA transcription by RNA polymerase II, GO:0070301|cellular response to hydrogen peroxide, GO:0070373|negative regulation of ERK1 and ERK2 cascade, GO:0071300|cellular response to retinoic acid, GO:0071363|cellular response to growth factor stimulus, GO:0071407|cellular response to organic cyclic compound, GO:0071409|cellular response to cycloheximide, GO:1901653|cellular response to peptide, GO:1904798|positive regulation of core promoter binding, GO:1904998|negative regulation of leukocyte adhesion to arterial endothelial cell, GO:1990830|cellular response to leukemia inhibitory factor, GO:2000342|negative regulation of chemokine (C-X-C motif) ligand 2 production","GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0008270|zinc ion binding, GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0001085|RNA polymerase II transcription factor binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0000987|proximal promoter sequence-specific DNA binding, GO:0001010|RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity, GO:0001221|transcription cofactor binding, GO:0003690|double-stranded DNA binding, GO:0008013|beta-catenin binding, GO:0008134|transcription factor binding, GO:0035014|phosphatidylinositol 3-kinase regulator activity, GO:0042826|histone deacetylase binding, GO:0043565|sequence-specific DNA binding, GO:1990841|promoter-specific chromatin binding"
POLE,Nonsense,-0.303468323315324,11,0.364301607658944,N,TSG,TSG,-0.209306788685036,0.536791189848625,ENSG00000177084,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005886|plasma membrane, GO:0008622|epsilon DNA polymerase complex","GO:0006281|DNA repair, GO:0090305|nucleic acid phosphodiester bond hydrolysis, GO:0006974|cellular response to DNA damage stimulus, GO:0006260|DNA replication, GO:0000278|mitotic cell cycle, GO:0000082|G1/S transition of mitotic cell cycle, GO:0000731|DNA synthesis involved in DNA repair, GO:0006272|leading strand elongation, GO:0006287|base-excision repair, gap-filling, GO:0006297|nucleotide-excision repair, DNA gap filling, GO:0045004|DNA replication proofreading, GO:0048568|embryonic organ development, GO:0071897|DNA biosynthetic process","GO:0003676|nucleic acid binding, GO:0008270|zinc ion binding, GO:0046872|metal ion binding, GO:0016740|transferase activity, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0000166|nucleotide binding, GO:0016779|nucleotidyltransferase activity, GO:0003887|DNA-directed DNA polymerase activity, GO:0051536|iron-sulfur cluster binding, GO:0051539|4 iron, 4 sulfur cluster binding, GO:0003682|chromatin binding, GO:0008310|single-stranded DNA 3'-5' exodeoxyribonuclease activity"
ETV5,Silent,-0.306186217847897,17,0.231988124423214,N,"oncogene, fusion",Oncogene,-0.262905160201508,0.307966526057405,ENSG00000244405,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005886|plasma membrane","GO:0006355|regulation of transcription, DNA-templated, GO:0030154|cell differentiation, GO:0006357|regulation of transcription by RNA polymerase II, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0034599|cellular response to oxidative stress, GO:0007274|neuromuscular synaptic transmission, GO:0007626|locomotory behavior, GO:0045666|positive regulation of neuron differentiation, GO:0045893|positive regulation of transcription, DNA-templated, GO:0048133|male germ-line stem cell asymmetric division, GO:0050807|regulation of synapse organization, GO:0060252|positive regulation of glial cell proliferation, GO:0060762|regulation of branching involved in mammary gland duct morphogenesis, GO:0071340|skeletal muscle acetylcholine-gated channel clustering","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0043565|sequence-specific DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0005515|protein binding, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0044212|transcription regulatory region DNA binding, GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding"
CCDC6,Missense,-0.306712284808479,31,0.0932983089473815,N,"TSG, fusion",TSG,-0.150973636916781,0.417535150742035,ENSG00000108091,"GO:0005737|cytoplasm, GO:0005829|cytosol, GO:0005856|cytoskeleton","GO:0007010|cytoskeleton organization, GO:0008150|biological_process","GO:0005515|protein binding, GO:0017124|SH3 domain binding, GO:0005200|structural constituent of cytoskeleton"
MEN1,Silent,-0.318539644692918,20,0.171062643925116,N,TSG,TSG,-0.303718676562084,0.192976840870437,ENSG00000133895,"GO:0005634|nucleus, GO:0005829|cytosol, GO:0005654|nucleoplasm, GO:0005737|cytoplasm, GO:0032154|cleavage furrow, GO:0032991|protein-containing complex, GO:0000784|nuclear chromosome, telomeric region, GO:0035097|histone methyltransferase complex, GO:0000785|chromatin, GO:0000790|nuclear chromatin, GO:0005788|endoplasmic reticulum lumen, GO:0016363|nuclear matrix","GO:0006325|chromatin organization, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0034968|histone lysine methylation, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0044267|cellular protein metabolic process, GO:0008285|negative regulation of cell proliferation, GO:0043687|post-translational protein modification, GO:0045786|negative regulation of cell cycle, GO:0000165|MAPK cascade, GO:0001933|negative regulation of protein phosphorylation, GO:0002076|osteoblast development, GO:0009411|response to UV, GO:0010332|response to gamma radiation, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:0032092|positive regulation of protein binding, GO:0043433|negative regulation of DNA-binding transcription factor activity, GO:0045668|negative regulation of osteoblast differentiation, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0045892|negative regulation of transcription, DNA-templated, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0046329|negative regulation of JNK cascade, GO:0051974|negative regulation of telomerase activity, GO:1904837|beta-catenin-TCF complex assembly, GO:0000278|mitotic cell cycle, GO:0003309|type B pancreatic cell differentiation, GO:0007420|brain development, GO:0010812|negative regulation of cell-substrate adhesion, GO:0032925|regulation of activin receptor signaling pathway, GO:0046697|decidualization, GO:0050680|negative regulation of epithelial cell proliferation, GO:0061469|regulation of type B pancreatic cell proliferation, GO:0071333|cellular response to glucose stimulus, GO:0071375|cellular response to peptide hormone stimulus, GO:0071559|response to transforming growth factor beta, GO:1902807|negative regulation of cell cycle G1/S phase transition","GO:0003677|DNA binding, GO:0005515|protein binding, GO:0018024|histone-lysine N-methyltransferase activity, GO:0030674|protein binding, bridging, GO:0003690|double-stranded DNA binding, GO:0003682|chromatin binding, GO:0047485|protein N-terminus binding, GO:0000400|four-way junction DNA binding, GO:0000403|Y-form DNA binding, GO:0044212|transcription regulatory region DNA binding, GO:0070412|R-SMAD binding"
NRAS,Missense,-0.340621868457063,27,0.0821060312792855,N,Oncogene,Oncogene,-0.184901104996692,0.355846824534417,ENSG00000213281,"GO:0016020|membrane, GO:0005794|Golgi apparatus, GO:0005886|plasma membrane, GO:0000139|Golgi membrane, GO:0070062|extracellular exosome, GO:0070821|tertiary granule membrane","GO:0007165|signal transduction, GO:0043312|neutrophil degranulation, GO:0001938|positive regulation of endothelial cell proliferation, GO:0000165|MAPK cascade, GO:0002223|stimulatory C-type lectin receptor signaling pathway, GO:0007265|Ras protein signal transduction","GO:0000166|nucleotide binding, GO:0003924|GTPase activity, GO:0005525|GTP binding, GO:0005515|protein binding, GO:0044877|protein-containing complex binding"
NPM1,Missense,-0.35126723712154,21,0.11843440820295,N,"oncogene, fusion",Oncogene,-0.149532270444806,0.517673076577582,ENSG00000181163,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005856|cytoskeleton, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0005925|focal adhesion, GO:0005813|centrosome, GO:0005815|microtubule organizing center, GO:0005829|cytosol, GO:1990904|ribonucleoprotein complex, GO:0032991|protein-containing complex, GO:0032993|protein-DNA complex, GO:0031616|spindle pole centrosome","GO:0006886|intracellular protein transport, GO:0006334|nucleosome assembly, GO:0007165|signal transduction, GO:0006281|DNA repair, GO:0045893|positive regulation of transcription, DNA-templated, GO:0045727|positive regulation of translation, GO:0000056|ribosomal small subunit export from nucleus, GO:0042274|ribosomal small subunit biogenesis, GO:0006338|chromatin remodeling, GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0008285|negative regulation of cell proliferation, GO:0016032|viral process, GO:0034080|CENP-A containing nucleosome assembly, GO:0007098|centrosome cycle, GO:0000055|ribosomal large subunit export from nucleus, GO:0008284|positive regulation of cell proliferation, GO:0042273|ribosomal large subunit biogenesis, GO:0043066|negative regulation of apoptotic process, GO:0051092|positive regulation of NF-kappaB transcription factor activity, GO:0008104|protein localization, GO:0006913|nucleocytoplasmic transport, GO:0007569|cell aging, GO:1902751|positive regulation of cell cycle G2/M phase transition, GO:0006357|regulation of transcription by RNA polymerase II, GO:0034644|cellular response to UV, GO:0006407|rRNA export from nucleus, GO:0010824|regulation of centrosome duplication, GO:0010826|negative regulation of centrosome duplication, GO:0032071|regulation of endodeoxyribonuclease activity, GO:0042255|ribosome assembly, GO:0044387|negative regulation of protein kinase activity by regulation of protein phosphorylation, GO:0046599|regulation of centriole replication, GO:0051259|protein complex oligomerization, GO:0060699|regulation of endoribonuclease activity, GO:0060735|regulation of eIF2 alpha phosphorylation by dsRNA, GO:1902629|regulation of mRNA stability involved in cellular response to UV","GO:0003676|nucleic acid binding, GO:0003723|RNA binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0004860|protein kinase inhibitor activity, GO:0003713|transcription coactivator activity, GO:0042393|histone binding, GO:0019901|protein kinase binding, GO:0003682|chromatin binding, GO:0008134|transcription factor binding, GO:0046982|protein heterodimerization activity, GO:0030957|Tat protein binding, GO:0051082|unfolded protein binding, GO:0051059|NF-kappaB binding, GO:0033613|activating transcription factor binding, GO:0001047|core promoter binding, GO:0043023|ribosomal large subunit binding, GO:0043024|ribosomal small subunit binding"
TGFBR2,Silent,-0.365418751841679,16,0.163982125393958,N,TSG,TSG,-0.300426114049126,0.258227424579154,ENSG00000163513,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005886|plasma membrane, GO:0045121|membrane raft, GO:0005887|integral component of plasma membrane, GO:0043235|receptor complex, GO:0005829|cytosol, GO:0009897|external side of plasma membrane, GO:0005901|caveola, GO:0005737|cytoplasm, GO:0009986|cell surface","GO:0007179|transforming growth factor beta receptor signaling pathway, GO:0010718|positive regulation of epithelial to mesenchymal transition, GO:0060412|ventricular septum morphogenesis, GO:0003151|outflow tract morphogenesis, GO:0006468|protein phosphorylation, GO:0016310|phosphorylation, GO:0006915|apoptotic process, GO:0030154|cell differentiation, GO:0007178|transmembrane receptor protein serine/threonine kinase signaling pathway, GO:0040008|regulation of growth, GO:0007507|heart development, GO:0007389|pattern specification process, GO:0001947|heart looping, GO:0062009|secondary palate development, GO:0001569|branching involved in blood vessel morphogenesis, GO:0003148|outflow tract septum morphogenesis, GO:0030512|negative regulation of transforming growth factor beta receptor signaling pathway, GO:0060389|pathway-restricted SMAD protein phosphorylation, GO:0032147|activation of protein kinase activity, GO:0018105|peptidyl-serine phosphorylation, GO:0018107|peptidyl-threonine phosphorylation, GO:0008284|positive regulation of cell proliferation, GO:0003181|atrioventricular valve morphogenesis, GO:0002053|positive regulation of mesenchymal cell proliferation, GO:0042127|regulation of cell proliferation, GO:2000379|positive regulation of reactive oxygen species metabolic process, GO:0001570|vasculogenesis, GO:0070723|response to cholesterol, GO:0007420|brain development, GO:0003149|membranous septum morphogenesis, GO:0042493|response to drug, GO:0003214|cardiac left ventricle morphogenesis, GO:0002666|positive regulation of T cell tolerance induction, GO:1905007|positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation, GO:0048701|embryonic cranial skeleton morphogenesis, GO:0003186|tricuspid valve morphogenesis, GO:0001568|blood vessel development, GO:0002651|positive regulation of tolerance induction to self antigen, GO:0002663|positive regulation of B cell tolerance induction, GO:0003274|endocardial cushion fusion, GO:0035162|embryonic hemopoiesis, GO:0043011|myeloid dendritic cell differentiation, GO:0051138|positive regulation of NK T cell differentiation, GO:1905317|inferior endocardial cushion morphogenesis, GO:1990428|miRNA transport, GO:2000563|positive regulation of CD4-positive, alpha-beta T cell proliferation, GO:0001666|response to hypoxia, GO:0001701|in utero embryonic development, GO:0002088|lens development in camera-type eye, GO:0003417|growth plate cartilage development, GO:0003430|growth plate cartilage chondrocyte growth, GO:0006898|receptor-mediated endocytosis, GO:0007182|common-partner SMAD protein phosphorylation, GO:0007219|Notch signaling pathway, GO:0007224|smoothened signaling pathway, GO:0007369|gastrulation, GO:0007566|embryo implantation, GO:0007568|aging, GO:0007584|response to nutrient, GO:0008285|negative regulation of cell proliferation, GO:0009612|response to mechanical stimulus, GO:0009749|response to glucose, GO:0009887|animal organ morphogenesis, GO:0010033|response to organic substance, GO:0010468|regulation of gene expression, GO:0010634|positive regulation of epithelial cell migration, GO:0014070|response to organic cyclic compound, GO:0030324|lung development, GO:0031100|animal organ regeneration, GO:0042060|wound healing, GO:0043415|positive regulation of skeletal muscle tissue regeneration, GO:0043627|response to estrogen, GO:0045766|positive regulation of angiogenesis, GO:0048545|response to steroid hormone, GO:0048565|digestive tract development, GO:0048661|positive regulation of smooth muscle cell proliferation, GO:0051216|cartilage development, GO:0060044|negative regulation of cardiac muscle cell proliferation, GO:0060425|lung morphogenesis, GO:0060433|bronchus development, GO:0060434|bronchus morphogenesis, GO:0060439|trachea morphogenesis, GO:0060440|trachea formation, GO:0060443|mammary gland morphogenesis, GO:0060463|lung lobe morphogenesis, GO:1990086|lens fiber cell apoptotic process","GO:0046872|metal ion binding, GO:0000166|nucleotide binding, GO:0004672|protein kinase activity, GO:0004674|protein serine/threonine kinase activity, GO:0005524|ATP binding, GO:0016740|transferase activity, GO:0016301|kinase activity, GO:0005515|protein binding, GO:0038023|signaling receptor activity, GO:0004675|transmembrane receptor protein serine/threonine kinase activity, GO:0005026|transforming growth factor beta receptor activity, type II, GO:0005024|transforming growth factor beta-activated receptor activity, GO:0019838|growth factor binding, GO:0046332|SMAD binding, GO:0034713|type I transforming growth factor beta receptor binding, GO:0050431|transforming growth factor beta binding, GO:0005539|glycosaminoglycan binding, GO:0031435|mitogen-activated protein kinase kinase kinase binding"
CACNA1D,Nonsense,-0.372942146341225,13,0.209455049108591,N,Oncogene,Oncogene,-0.456639478726555,0.116744386797591,ENSG00000157388,"GO:0016020|membrane, GO:0016021|integral component of membrane, GO:0005891|voltage-gated calcium channel complex, GO:0005886|plasma membrane, GO:0030018|Z disc, GO:1990454|L-type voltage-gated calcium channel complex","GO:0055085|transmembrane transport, GO:0006811|ion transport, GO:0034765|regulation of ion transmembrane transport, GO:0006816|calcium ion transport, GO:0070588|calcium ion transmembrane transport, GO:0099533|positive regulation of presynaptic cytosolic calcium concentration, GO:0099703|induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration, GO:1901016|regulation of potassium ion transmembrane transporter activity, GO:0050796|regulation of insulin secretion, GO:0070509|calcium ion import, GO:0086002|cardiac muscle cell action potential involved in contraction, GO:0086046|membrane depolarization during SA node cell action potential, GO:0086091|regulation of heart rate by cardiac conduction, GO:0007605|sensory perception of sound, GO:0086012|membrane depolarization during cardiac muscle cell action potential, GO:0051928|positive regulation of calcium ion transport, GO:0060372|regulation of atrial cardiac muscle cell membrane repolarization, GO:1901379|regulation of potassium ion transmembrane transport, GO:0045762|positive regulation of adenylate cyclase activity, GO:0007188|adenylate cyclase-modulating G protein-coupled receptor signaling pathway","GO:0005216|ion channel activity, GO:0005244|voltage-gated ion channel activity, GO:0005245|voltage-gated calcium channel activity, GO:0005262|calcium channel activity, GO:0046872|metal ion binding, GO:0008331|high voltage-gated calcium channel activity, GO:0086059|voltage-gated calcium channel activity involved SA node cell action potential, GO:0030506|ankyrin binding, GO:0051393|alpha-actinin binding, GO:0086007|voltage-gated calcium channel activity involved in cardiac muscle cell action potential"
PSIP1,Missense,-0.374565879519357,18,0.125659632080622,N,"oncogene, fusion",Oncogene,-0.163498227349005,0.516823221682805,ENSG00000164985,"GO:0005634|nucleus, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0035327|transcriptionally active chromatin","GO:0000395|mRNA 5'-splice site recognition, GO:0016032|viral process, GO:0006979|response to oxidative stress, GO:0009408|response to heat, GO:0051169|nuclear transport, GO:0075713|establishment of integrated proviral latency","GO:0003723|RNA binding, GO:0003677|DNA binding, GO:0005515|protein binding, GO:0097100|supercoiled DNA binding"
HSP90AB1,Silent,-0.378963059882963,20,0.0993977268376614,N,fusion,"",-0.234837215518306,0.318944464442317,ENSG00000096384,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005829|cytosol, GO:0005739|mitochondrion, GO:0005886|plasma membrane, GO:0005576|extracellular region, GO:0042470|melanosome, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0008180|COP9 signalosome, GO:0032991|protein-containing complex, GO:0034774|secretory granule lumen, GO:1904813|ficolin-1-rich granule lumen, GO:0043025|neuronal cell body, GO:0044295|axonal growth cone, GO:0048471|perinuclear region of cytoplasm, GO:0044294|dendritic growth cone, GO:0034751|aryl hydrocarbon receptor complex, GO:1990565|HSP90-CDC37 chaperone complex","GO:0051897|positive regulation of protein kinase B signaling, GO:0006457|protein folding, GO:0038096|Fc-gamma receptor signaling pathway involved in phagocytosis, GO:0006986|response to unfolded protein, GO:0071157|negative regulation of cell cycle arrest, GO:0006805|xenobiotic metabolic process, GO:0043312|neutrophil degranulation, GO:0032435|negative regulation of proteasomal ubiquitin-dependent protein catabolic process, GO:0045597|positive regulation of cell differentiation, GO:0030511|positive regulation of transforming growth factor beta receptor signaling pathway, GO:0051973|positive regulation of telomerase activity, GO:0007004|telomere maintenance via telomerase, GO:1901799|negative regulation of proteasomal protein catabolic process, GO:0033138|positive regulation of peptidyl-serine phosphorylation, GO:1900034|regulation of cellular response to heat, GO:1902949|positive regulation of tau-protein kinase activity, GO:0051248|negative regulation of protein metabolic process, GO:0021955|central nervous system neuron axonogenesis, GO:0030010|establishment of cell polarity, GO:0031396|regulation of protein ubiquitination, GO:0045429|positive regulation of nitric oxide biosynthetic process, GO:0048675|axon extension, GO:0050821|protein stabilization, GO:1903827|regulation of cellular protein localization, GO:1905323|telomerase holoenzyme complex assembly, GO:0019062|virion attachment to host cell, GO:0032516|positive regulation of phosphoprotein phosphatase activity, GO:0051131|chaperone-mediated protein complex assembly, GO:0060334|regulation of interferon-gamma-mediated signaling pathway, GO:0060338|regulation of type I interferon-mediated signaling pathway, GO:0097435|supramolecular fiber organization, GO:1901389|negative regulation of transforming growth factor beta activation, GO:1904031|positive regulation of cyclin-dependent protein kinase activity, GO:2000010|positive regulation of protein localization to cell surface, GO:0001890|placenta development, GO:0010033|response to organic substance, GO:0043066|negative regulation of apoptotic process, GO:0071353|cellular response to interleukin-4","GO:0003723|RNA binding, GO:0000166|nucleotide binding, GO:0005524|ATP binding, GO:0005515|protein binding, GO:0051082|unfolded protein binding, GO:0042802|identical protein binding, GO:0045296|cadherin binding, GO:0019901|protein kinase binding, GO:0030911|TPR domain binding, GO:0048156|tau protein binding, GO:1990226|histone methyltransferase binding, GO:0042277|peptide binding, GO:0042826|histone deacetylase binding, GO:0019900|kinase binding, GO:0003725|double-stranded RNA binding, GO:0042803|protein homodimerization activity, GO:0046983|protein dimerization activity, GO:0031072|heat shock protein binding, GO:0097718|disordered domain specific binding, GO:0030235|nitric-oxide synthase regulator activity, GO:0023026|MHC class II protein complex binding, GO:0031625|ubiquitin protein ligase binding, GO:0042623|ATPase activity, coupled, GO:0070182|DNA polymerase binding, GO:0043008|ATP-dependent protein binding, GO:0019887|protein kinase regulator activity"
RAD21,Silent,-0.379245929382641,14,0.18111633948212,N,"oncogene, TSG","",-0.253599581548843,0.381658221726167,ENSG00000164754,"GO:0005634|nucleus, GO:0016020|membrane, GO:0005654|nucleoplasm, GO:0005694|chromosome, GO:0000228|nuclear chromosome, GO:0000785|chromatin, GO:0000794|condensed nuclear chromosome, GO:0008278|cohesin complex, GO:0000775|chromosome, centromeric region, GO:0005829|cytosol, GO:0016363|nuclear matrix, GO:0030893|meiotic cohesin complex","GO:0051301|cell division, GO:0006281|DNA repair, GO:0006974|cellular response to DNA damage stimulus, GO:0007049|cell cycle, GO:0006915|apoptotic process, GO:0007062|sister chromatid cohesion, GO:0010972|negative regulation of G2/M transition of mitotic cell cycle, GO:0045841|negative regulation of mitotic metaphase/anaphase transition, GO:0007059|chromosome segregation, GO:0006302|double-strand break repair, GO:0006357|regulation of transcription by RNA polymerase II, GO:0006310|DNA recombination, GO:0007131|reciprocal meiotic recombination, GO:0045876|positive regulation of sister chromatid cohesion, GO:0051321|meiotic cell cycle, GO:0071168|protein localization to chromatin","GO:0005515|protein binding, GO:0003682|chromatin binding"
CDKN1B,Missense,-0.408749516300836,17,0.103305956249795,N,TSG,TSG,-0.293597256389507,0.252723731919735,ENSG00000111276,"GO:0005634|nucleus, GO:0005737|cytoplasm, GO:0043231|intracellular membrane-bounded organelle, GO:0005768|endosome, GO:0005654|nucleoplasm, GO:0005829|cytosol, GO:0031464|Cul4A-RING E3 ubiquitin ligase complex, GO:0032991|protein-containing complex","GO:1904706|negative regulation of vascular smooth muscle cell proliferation, GO:0008285|negative regulation of cell proliferation, GO:0016310|phosphorylation, GO:0007049|cell cycle, GO:0007050|cell cycle arrest, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0042127|regulation of cell proliferation, GO:0006977|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, GO:0045786|negative regulation of cell cycle, GO:0045892|negative regulation of transcription, DNA-templated, GO:0000082|G1/S transition of mitotic cell cycle, GO:0007507|heart development, GO:0045930|negative regulation of mitotic cell cycle, GO:0030308|negative regulation of cell growth, GO:0010942|positive regulation of cell death, GO:0045732|positive regulation of protein catabolic process, GO:0000079|regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0045787|positive regulation of cell cycle, GO:0071850|mitotic cell cycle arrest, GO:0033673|negative regulation of kinase activity, GO:0042326|negative regulation of phosphorylation, GO:1904030|negative regulation of cyclin-dependent protein kinase activity, GO:1905179|negative regulation of cardiac muscle tissue regeneration, GO:0001666|response to hypoxia, GO:0001890|placenta development, GO:0006813|potassium ion transport, GO:0007096|regulation of exit from mitosis, GO:0007219|Notch signaling pathway, GO:0007605|sensory perception of sound, GO:0008219|cell death, GO:0008284|positive regulation of cell proliferation, GO:0009749|response to glucose, GO:0014070|response to organic cyclic compound, GO:0031116|positive regulation of microtubule polymerization, GO:0032355|response to estradiol, GO:0042493|response to drug, GO:0043066|negative regulation of apoptotic process, GO:0043200|response to amino acid, GO:0043434|response to peptide hormone, GO:0045737|positive regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0046686|response to cadmium ion, GO:0048102|autophagic cell death, GO:0048839|inner ear development, GO:0050680|negative regulation of epithelial cell proliferation, GO:0051271|negative regulation of cellular component movement, GO:0060770|negative regulation of epithelial cell proliferation involved in prostate gland development, GO:0071236|cellular response to antibiotic, GO:0071285|cellular response to lithium ion, GO:0071407|cellular response to organic cyclic compound, GO:1902746|regulation of lens fiber cell differentiation","GO:0016301|kinase activity, GO:0005515|protein binding, GO:0004860|protein kinase inhibitor activity, GO:0004861|cyclin-dependent protein serine/threonine kinase inhibitor activity, GO:0019903|protein phosphatase binding, GO:0051087|chaperone binding, GO:0004693|cyclin-dependent protein serine/threonine kinase activity, GO:0030332|cyclin binding, GO:0019901|protein kinase binding, GO:0044877|protein-containing complex binding, GO:0005072|transforming growth factor beta receptor, cytoplasmic mediator activity, GO:0030544|Hsp70 protein binding"
CLIP1,Nonsense,-0.41565297251648,11,0.203588122174816,N,fusion,"",-0.311628927857342,0.350883079365995,ENSG00000130779,"GO:0005737|cytoplasm, GO:0016020|membrane, GO:0005856|cytoskeleton, GO:0042995|cell projection, GO:0031410|cytoplasmic vesicle, GO:0005874|microtubule, GO:0030659|cytoplasmic vesicle membrane, GO:0005813|centrosome, GO:0000776|kinetochore, GO:0005829|cytosol, GO:0015630|microtubule cytoskeleton, GO:0001726|ruffle, GO:0005768|endosome, GO:0005882|intermediate filament, GO:0035371|microtubule plus-end, GO:0044354|macropinosome, GO:0005635|nuclear envelope, GO:0005881|cytoplasmic microtubule","GO:0001578|microtubule bundle formation, GO:0000278|mitotic cell cycle, GO:0031116|positive regulation of microtubule polymerization, GO:0044861|protein transport into plasma membrane raft","GO:0046872|metal ion binding, GO:0008270|zinc ion binding, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0008017|microtubule binding, GO:0015631|tubulin binding, GO:0051010|microtubule plus-end binding"
MLLT3,Silent,-0.422383750369563,27,0.0281781034394648,N,fusion,"",-0.215787965049956,0.279692769529151,ENSG00000171843,"GO:0005634|nucleus, GO:0005694|chromosome, GO:0005654|nucleoplasm, GO:0070062|extracellular exosome, GO:0008023|transcription elongation factor complex","GO:0006355|regulation of transcription, DNA-templated, GO:0045893|positive regulation of transcription, DNA-templated, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007379|segment specification, GO:0009952|anterior/posterior pattern specification, GO:0006366|transcription by RNA polymerase II, GO:0006368|transcription elongation from RNA polymerase II promoter, GO:0090090|negative regulation of canonical Wnt signaling pathway, GO:2000096|positive regulation of Wnt signaling pathway, planar cell polarity pathway","GO:0005515|protein binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0003682|chromatin binding, GO:0042393|histone binding, GO:0070577|lysine-acetylated histone binding, GO:0140030|modification-dependent protein binding"
CEBPA,Missense,-0.423840439980512,16,0.101831031580135,N,TSG,TSG,-0.244224000899226,0.361997805877977,ENSG00000245848,"GO:0005634|nucleus, GO:0043231|intracellular membrane-bounded organelle, GO:0005654|nucleoplasm, GO:0005730|nucleolus, GO:0090575|RNA polymerase II transcription factor complex, GO:0005667|transcription factor complex","GO:0045944|positive regulation of transcription by RNA polymerase II, GO:0050729|positive regulation of inflammatory response, GO:0006355|regulation of transcription, DNA-templated, GO:0007275|multicellular organism development, GO:0006351|transcription, DNA-templated, GO:0045444|fat cell differentiation, GO:0008285|negative regulation of cell proliferation, GO:0016032|viral process, GO:0043032|positive regulation of macrophage activation, GO:0045892|negative regulation of transcription, DNA-templated, GO:0006366|transcription by RNA polymerase II, GO:0006091|generation of precursor metabolites and energy, GO:0019221|cytokine-mediated signaling pathway, GO:0001889|liver development, GO:0042593|glucose homeostasis, GO:0032436|positive regulation of proteasomal ubiquitin-dependent protein catabolic process, GO:0055088|lipid homeostasis, GO:0030851|granulocyte differentiation, GO:0030324|lung development, GO:0030099|myeloid cell differentiation, GO:0045945|positive regulation of transcription by RNA polymerase III, GO:0000050|urea cycle, GO:0000122|negative regulation of transcription by RNA polymerase II, GO:0001892|embryonic placenta development, GO:0006357|regulation of transcription by RNA polymerase II, GO:0007005|mitochondrion organization, GO:0007219|Notch signaling pathway, GO:0008203|cholesterol metabolic process, GO:0030225|macrophage differentiation, GO:0042127|regulation of cell proliferation, GO:0045600|positive regulation of fat cell differentiation, GO:0045669|positive regulation of osteoblast differentiation, GO:0045736|negative regulation of cyclin-dependent protein serine/threonine kinase activity, GO:0045786|negative regulation of cell cycle, GO:0045893|positive regulation of transcription, DNA-templated, GO:0048469|cell maturation, GO:0048839|inner ear development, GO:0050872|white fat cell differentiation, GO:0050873|brown fat cell differentiation, GO:0071285|cellular response to lithium ion, GO:0071356|cellular response to tumor necrosis factor, GO:0071407|cellular response to organic cyclic compound","GO:0003677|DNA binding, GO:0003700|DNA-binding transcription factor activity, GO:0042803|protein homodimerization activity, GO:0005515|protein binding, GO:0003713|transcription coactivator activity, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific, GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific, GO:0008134|transcription factor binding, GO:0044212|transcription regulatory region DNA binding, GO:0019900|kinase binding, GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding, GO:0043565|sequence-specific DNA binding"
BCL7A,Silent,-0.538815906080325,10,0.108044536126438,N,fusion,"",-0.562278741668252,0.090670569638787,ENSG00000110987,GO:0005575|cellular_component,"GO:0045892|negative regulation of transcription, DNA-templated","GO:0005515|protein binding, GO:0003674|molecular_function"
ZNF384,Silent,-0.549135347654181,15,0.0339930576000466,N,fusion,"",-0.419637956849303,0.119432044450353,ENSG00000126746,GO:0005634|nucleus,GO:0006357|regulation of transcription by RNA polymerase II,"GO:0003676|nucleic acid binding, GO:0046872|metal ion binding, GO:0003677|DNA binding, GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific"
